primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
114529865,11452986,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Chondrocalcinosis,,2023,Q1,5,F,20150821.0,20221104.0,20150903,20230307,EXP,,US-ABBVIE-15P-163-1454946-00,ABBVIE,,76.0,YR,,M,Y,,,20221117,,MD,US,US,2023,Q1,Elderly
114529865,11452986,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Hyperuricaemia,,2023,Q1,5,F,20150821.0,20221104.0,20150903,20230307,EXP,,US-ABBVIE-15P-163-1454946-00,ABBVIE,,76.0,YR,,M,Y,,,20221117,,MD,US,US,2023,Q1,Elderly
1325964310,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2023,Q1,Liver disorder,,2023,Q1,10,F,20161201.0,20230221.0,20170222,20230224,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20230224,,CN,US,US,2023,Q1,Elderly
1325964310,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,10,F,20161201.0,20230221.0,20170222,20230224,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20230224,,CN,US,US,2023,Q1,Elderly
1325964310,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2023,Q1,Blindness,,2023,Q1,10,F,20161201.0,20230221.0,20170222,20230224,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20230224,,CN,US,US,2023,Q1,Elderly
1325964310,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2023,Q1,Renal disorder,,2023,Q1,10,F,20161201.0,20230221.0,20170222,20230224,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20230224,,CN,US,US,2023,Q1,Elderly
1325964310,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2023,Q1,Visual impairment,,2023,Q1,10,F,20161201.0,20230221.0,20170222,20230224,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20230224,,CN,US,US,2023,Q1,Elderly
1492875522,14928755,43,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q1,Low birth weight baby,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,43,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q1,Foetal exposure during pregnancy,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,43,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q1,Foetal disorder,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,43,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q1,Premature baby,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,43,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q1,Neutropenia neonatal,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,44,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 microgram/sq. meter, Once a Day",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q1,Low birth weight baby,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,44,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 microgram/sq. meter, Once a Day",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q1,Foetal exposure during pregnancy,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,44,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 microgram/sq. meter, Once a Day",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q1,Foetal disorder,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,44,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 microgram/sq. meter, Once a Day",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q1,Premature baby,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
1492875522,14928755,44,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 microgram/sq. meter, Once a Day",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q1,Neutropenia neonatal,,2023,Q1,22,F,20170914.0,20230119.0,20180523,20230202,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20230202,,PH,FR,FR,2023,Q1,Child
156383795,15638379,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 milligram, qd",,,,,,,,40.0,MG,,QD,2023,Q1,Ischaemic stroke,,2023,Q1,5,F,20180101.0,20230322.0,20181120,20230330,PER,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20230330,,PH,PT,PT,2023,Q1,Adult
156383795,15638379,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 milligram, qd",,,,,,,,40.0,MG,,QD,2023,Q1,Chest pain,,2023,Q1,5,F,20180101.0,20230322.0,20181120,20230330,PER,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20230330,,PH,PT,PT,2023,Q1,Adult
156383795,15638379,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 milligram, qd",,,,,,,,40.0,MG,,QD,2023,Q1,Headache,,2023,Q1,5,F,20180101.0,20230322.0,20181120,20230330,PER,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20230330,,PH,PT,PT,2023,Q1,Adult
1564428132,15644281,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, 1x/day ((25/75: + 20U 20U daily)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Headache,,2023,Q1,32,F,,20230201.0,20181121,20230202,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20230202,,PH,PT,PT,2023,Q1,Adult
1564428132,15644281,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, 1x/day ((25/75: + 20U 20U daily)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Chest pain,,2023,Q1,32,F,,20230201.0,20181121,20230202,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20230202,,PH,PT,PT,2023,Q1,Adult
1564428132,15644281,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, 1x/day ((25/75: + 20U 20U daily)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Ischaemic stroke,,2023,Q1,32,F,,20230201.0,20181121,20230202,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20230202,,PH,PT,PT,2023,Q1,Adult
156579649,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / d)) QD,,,U,,,,209196.0,40.0,IU,Solution for injection,QD,2023,Q1,Chest pain,,2023,Q1,9,F,,20230119.0,20181126,20230201,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230201,,PH,PT,PT,2023,Q1,Adult
156579649,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / d)) QD,,,U,,,,209196.0,40.0,IU,Solution for injection,QD,2023,Q1,Ischaemic stroke,,2023,Q1,9,F,,20230119.0,20181126,20230201,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230201,,PH,PT,PT,2023,Q1,Adult
156579649,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / d)) QD,,,U,,,,209196.0,40.0,IU,Solution for injection,QD,2023,Q1,Headache,,2023,Q1,9,F,,20230119.0,20181126,20230201,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230201,,PH,PT,PT,2023,Q1,Adult
1567028914,15670289,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, qd,(25/75: + 20U 20U / d)",,,U,U,,,,40.0,IU,Solution for injection,QD,2023,Q1,Headache,,2023,Q1,14,F,,20230206.0,20181129,20230214,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20230214,,PH,PT,PT,2023,Q1,Adult
1567028914,15670289,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, qd,(25/75: + 20U 20U / d)",,,U,U,,,,40.0,IU,Solution for injection,QD,2023,Q1,Ischaemic stroke,,2023,Q1,14,F,,20230206.0,20181129,20230214,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20230214,,PH,PT,PT,2023,Q1,Adult
1567028914,15670289,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, qd,(25/75: + 20U 20U / d)",,,U,U,,,,40.0,IU,Solution for injection,QD,2023,Q1,Chest pain,,2023,Q1,14,F,,20230206.0,20181129,20230214,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20230214,,PH,PT,PT,2023,Q1,Adult
1567028914,15670289,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 iU, QD",,,U,U,,,,,,Solution for injection,QD,2023,Q1,Headache,,2023,Q1,14,F,,20230206.0,20181129,20230214,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20230214,,PH,PT,PT,2023,Q1,Adult
1567028914,15670289,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 iU, QD",,,U,U,,,,,,Solution for injection,QD,2023,Q1,Ischaemic stroke,,2023,Q1,14,F,,20230206.0,20181129,20230214,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20230214,,PH,PT,PT,2023,Q1,Adult
1567028914,15670289,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 iU, QD",,,U,U,,,,,,Solution for injection,QD,2023,Q1,Chest pain,,2023,Q1,14,F,,20230206.0,20181129,20230214,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20230214,,PH,PT,PT,2023,Q1,Adult
1578275811,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; plus 20U 20U/d)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Ischaemic stroke,,2023,Q1,11,F,,20230201.0,20190102,20230209,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20230209,,PH,PT,PT,2023,Q1,Adult
1578275811,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; plus 20U 20U/d)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Chest pain,,2023,Q1,11,F,,20230201.0,20190102,20230209,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20230209,,PH,PT,PT,2023,Q1,Adult
1578275811,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; plus 20U 20U/d)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Headache,,2023,Q1,11,F,,20230201.0,20190102,20230209,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20230209,,PH,PT,PT,2023,Q1,Adult
160015708,16001570,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,End stage renal disease,,2023,Q1,8,F,20130101.0,20230124.0,20190225,20230127,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20230127,,LW,US,,2023,Q1,Elderly
160015708,16001570,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Chronic left ventricular failure,,2023,Q1,8,F,20130101.0,20230124.0,20190225,20230127,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20230127,,LW,US,,2023,Q1,Elderly
160015708,16001570,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Nephrogenic anaemia,,2023,Q1,8,F,20130101.0,20230124.0,20190225,20230127,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20230127,,LW,US,,2023,Q1,Elderly
160015708,16001570,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Renal failure,,2023,Q1,8,F,20130101.0,20230124.0,20190225,20230127,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20230127,,LW,US,,2023,Q1,Elderly
160015708,16001570,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,8,F,20130101.0,20230124.0,20190225,20230127,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20230127,,LW,US,,2023,Q1,Elderly
160015708,16001570,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Renal injury,,2023,Q1,8,F,20130101.0,20230124.0,20190225,20230127,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20230127,,LW,US,,2023,Q1,Elderly
160015708,16001570,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Chronic kidney disease,,2023,Q1,8,F,20130101.0,20230124.0,20190225,20230127,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20230127,,LW,US,,2023,Q1,Elderly
160015708,16001570,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Chronic kidney disease-mineral and bone disorder,,2023,Q1,8,F,20130101.0,20230124.0,20190225,20230127,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20230127,,LW,US,,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Oedema peripheral,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Discomfort,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Obstructive airways disorder,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Diaphragmatic disorder,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Wheezing,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Oropharyngeal pain,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Pyrexia,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Left ventricular hypertrophy,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Asthma,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Dyspnoea,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Full blood count abnormal,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Hypoxia,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Chest discomfort,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Cough,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
169116753,16911675,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2023,Q1,Weight increased,,2023,Q1,3,F,,20221222.0,20191013,20230105,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20230105,,HP,CA,CA,2023,Q1,Elderly
174538062,17453806,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ml, nach Schema (after scheme)",,,,,,,,,,,,2023,Q1,Polydipsia,,2023,Q1,2,F,,20230109.0,20200224,20230109,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2020-12-009172",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20230109,,MD,DE,DE,2023,Q1,Elderly
174538062,17453806,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ml, nach Schema (after scheme)",,,,,,,,,,,,2023,Q1,Polyuria,,2023,Q1,2,F,,20230109.0,20200224,20230109,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2020-12-009172",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20230109,,MD,DE,DE,2023,Q1,Elderly
174538062,17453806,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ml, nach Schema (after scheme)",,,,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,2,F,,20230109.0,20200224,20230109,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2020-12-009172",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20230109,,MD,DE,DE,2023,Q1,Elderly
174538062,17453806,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ml, nach Schema (after scheme)",,,,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,,20230109.0,20200224,20230109,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2020-12-009172",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20230109,,MD,DE,DE,2023,Q1,Elderly
174675742,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 iU, Q8H (100 IE, 4-4-3-0)",,,D,,,,209196.0,100.0,IU,,Q8H,2023,Q1,Product administration error,,2023,Q1,2,F,20190724.0,20230111.0,20200227,20230113,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
174675742,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 iU, Q8H (100 IE, 4-4-3-0)",,,D,,,,209196.0,100.0,IU,,Q8H,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,20190724.0,20230111.0,20200227,20230113,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
174675742,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 iU, Q8H (100 IE, 4-4-3-0)",,,D,,,,209196.0,100.0,IU,,Q8H,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,20190724.0,20230111.0,20200227,20230113,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
174675742,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 iU, Q8H (100 IE, 4-4-3-0)",,,D,,,,209196.0,100.0,IU,,Q8H,2023,Q1,Dizziness,,2023,Q1,2,F,20190724.0,20230111.0,20200227,20230113,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
174675742,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 iU, Q8H (100 IE, 4-4-3-0)",,,D,,,,209196.0,100.0,IU,,Q8H,2023,Q1,Blood glucose fluctuation,,2023,Q1,2,F,20190724.0,20230111.0,20200227,20230113,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
174675742,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 iU, Q8H (100 IE, 4-4-3-0)",,,D,,,,209196.0,100.0,IU,,Q8H,2023,Q1,Nausea,,2023,Q1,2,F,20190724.0,20230111.0,20200227,20230113,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
174675742,17467574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 iU, Q8H (100 IE, 4-4-3-0)",,,D,,,,209196.0,100.0,IU,,Q8H,2023,Q1,Decreased appetite,,2023,Q1,2,F,20190724.0,20230111.0,20200227,20230113,EXP,,DE-SA-2020SA045570,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
174688652,17468865,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, tid",15525.0,IU,,,,,,25.0,IU,,TID,2023,Q1,Pancreatitis acute,,2023,Q1,2,F,20160320.0,20221213.0,20200227,20230207,PER,,"US-AEGERION PHARMACEUTICAL, INC-AEGR004335",AEGERION,,16.0,YR,,F,Y,,,20230207,,HP,US,US,2023,Q1,Youth
1820593325,18205933,84,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 international unit, unknown",,,U,,,,,1.0,IU,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,25,F,20200809.0,20230327.0,20200827,20230331,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008010103,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230331,,CN,FR,FR,2023,Q1,Elderly
1822548717,18225487,55,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,U,,,,,1.0,IU,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,17,F,20200809.0,20230222.0,20200903,20230304,EXP,,FR-AUROBINDO-AUR-APL-2020-045739,AUROBINDO,,74.0,YR,,M,Y,,,20230304,,MD,FR,FR,2023,Q1,Elderly
1823583923,18235839,74,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,D,,,,,1.0,IU,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,23,F,20200809.0,20230317.0,20200905,20230331,EXP,,FR-SA-2020SA239827,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20230331,,MD,FR,FR,2023,Q1,Elderly
182416597,18241659,41,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,D,,,,,1.0,IU,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,7,F,20200809.0,20230302.0,20200908,20230314,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-Accord-199762,ACCORD,,75.0,YR,E,M,Y,,,20230314,,MD,FR,FR,2023,Q1,Elderly
182556837,18255683,89,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 [iU] (international unit), 1 iu, CO",,,,,,,,,,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,7,F,20200809.0,20230227.0,20200910,20230307,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-BAXTER-2020BAX018061,BAXTER,,74.0,YR,,M,Y,,,20230307,,CN,FR,FR,2023,Q1,Elderly
182836043,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Myalgia,,2023,Q1,3,F,20170331.0,20230202.0,20200918,20230210,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20230209,,CN,JP,JP,2023,Q1,Elderly
182836043,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Pulmonary arterial hypertension,,2023,Q1,3,F,20170331.0,20230202.0,20200918,20230210,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20230209,,CN,JP,JP,2023,Q1,Elderly
182836043,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,3,F,20170331.0,20230202.0,20200918,20230210,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20230209,,CN,JP,JP,2023,Q1,Elderly
182836043,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Epistaxis,,2023,Q1,3,F,20170331.0,20230202.0,20200918,20230210,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20230209,,CN,JP,JP,2023,Q1,Elderly
182836043,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,3,F,20170331.0,20230202.0,20200918,20230210,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20230209,,CN,JP,JP,2023,Q1,Elderly
183905685,18390568,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8UI plus 81ui plus 8UI,,,U,,,,,24.0,IU,,,2023,Q1,Rash,,2023,Q1,5,F,20190930.0,20230216.0,20201015,20230217,EXP,,NVSC2020PT273340,NOVARTIS,"Lima F, Vidal H. 319 pustulose generalizada exantematica aguda-um caso de iatrogenia a quinolonas [Acute exanthematic generalized pustulosis- a case of iatrogenic to quinolones]. PORTUGUESE JOURNAL OF INTERNAL MEDICINE. 2020;27:335",72.0,YR,,M,Y,100.0,KG,20230217,,HP,PT,PT,2023,Q1,Elderly
183905685,18390568,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8UI plus 81ui plus 8UI,,,U,,,,,24.0,IU,,,2023,Q1,Rash pruritic,,2023,Q1,5,F,20190930.0,20230216.0,20201015,20230217,EXP,,NVSC2020PT273340,NOVARTIS,"Lima F, Vidal H. 319 pustulose generalizada exantematica aguda-um caso de iatrogenia a quinolonas [Acute exanthematic generalized pustulosis- a case of iatrogenic to quinolones]. PORTUGUESE JOURNAL OF INTERNAL MEDICINE. 2020;27:335",72.0,YR,,M,Y,100.0,KG,20230217,,HP,PT,PT,2023,Q1,Elderly
183905685,18390568,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8UI plus 81ui plus 8UI,,,U,,,,,24.0,IU,,,2023,Q1,Pyrexia,,2023,Q1,5,F,20190930.0,20230216.0,20201015,20230217,EXP,,NVSC2020PT273340,NOVARTIS,"Lima F, Vidal H. 319 pustulose generalizada exantematica aguda-um caso de iatrogenia a quinolonas [Acute exanthematic generalized pustulosis- a case of iatrogenic to quinolones]. PORTUGUESE JOURNAL OF INTERNAL MEDICINE. 2020;27:335",72.0,YR,,M,Y,100.0,KG,20230217,,HP,PT,PT,2023,Q1,Elderly
183905685,18390568,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8UI plus 81ui plus 8UI,,,U,,,,,24.0,IU,,,2023,Q1,Pustule,,2023,Q1,5,F,20190930.0,20230216.0,20201015,20230217,EXP,,NVSC2020PT273340,NOVARTIS,"Lima F, Vidal H. 319 pustulose generalizada exantematica aguda-um caso de iatrogenia a quinolonas [Acute exanthematic generalized pustulosis- a case of iatrogenic to quinolones]. PORTUGUESE JOURNAL OF INTERNAL MEDICINE. 2020;27:335",72.0,YR,,M,Y,100.0,KG,20230217,,HP,PT,PT,2023,Q1,Elderly
183905685,18390568,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8UI plus 81ui plus 8UI,,,U,,,,,24.0,IU,,,2023,Q1,Acute generalised exanthematous pustulosis,,2023,Q1,5,F,20190930.0,20230216.0,20201015,20230217,EXP,,NVSC2020PT273340,NOVARTIS,"Lima F, Vidal H. 319 pustulose generalizada exantematica aguda-um caso de iatrogenia a quinolonas [Acute exanthematic generalized pustulosis- a case of iatrogenic to quinolones]. PORTUGUESE JOURNAL OF INTERNAL MEDICINE. 2020;27:335",72.0,YR,,M,Y,100.0,KG,20230217,,HP,PT,PT,2023,Q1,Elderly
1848217513,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q1,Cataract,,2023,Q1,13,F,20201019.0,20230323.0,20201110,20230329,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230329,,MD,JP,JP,2023,Q1,Adult
1848217513,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q1,Angina pectoris,,2023,Q1,13,F,20201019.0,20230323.0,20201110,20230329,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230329,,MD,JP,JP,2023,Q1,Adult
1848217513,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q1,Rash pruritic,,2023,Q1,13,F,20201019.0,20230323.0,20201110,20230329,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230329,,MD,JP,JP,2023,Q1,Adult
1848217513,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q1,Eczema asteatotic,,2023,Q1,13,F,20201019.0,20230323.0,20201110,20230329,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230329,,MD,JP,JP,2023,Q1,Adult
1848217513,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q1,Arthralgia,,2023,Q1,13,F,20201019.0,20230323.0,20201110,20230329,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230329,,MD,JP,JP,2023,Q1,Adult
184968384,18496838,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Urticaria,,2023,Q1,4,F,,20230225.0,20201112,20230301,EXP,,GB-MYLANLABS-2020M1091456,MYLAN,,73.0,YR,,M,Y,,,20230301,,CN,GB,GB,2023,Q1,Elderly
184968384,18496838,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Hypersensitivity,,2023,Q1,4,F,,20230225.0,20201112,20230301,EXP,,GB-MYLANLABS-2020M1091456,MYLAN,,73.0,YR,,M,Y,,,20230301,,CN,GB,GB,2023,Q1,Elderly
184968384,18496838,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Incorrect dose administered,,2023,Q1,4,F,,20230225.0,20201112,20230301,EXP,,GB-MYLANLABS-2020M1091456,MYLAN,,73.0,YR,,M,Y,,,20230301,,CN,GB,GB,2023,Q1,Elderly
184968384,18496838,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,4,F,,20230225.0,20201112,20230301,EXP,,GB-MYLANLABS-2020M1091456,MYLAN,,73.0,YR,,M,Y,,,20230301,,CN,GB,GB,2023,Q1,Elderly
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diverticulitis,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Influenza,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Ascites,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Gastrointestinal disorder,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pancytopenia,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Osteoarthritis,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Gamma-glutamyltransferase increased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Alanine aminotransferase increased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Intensive care unit acquired weakness,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Heart rate increased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Nerve compression,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood potassium increased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Myelopathy,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hypersensitivity,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Peripheral sensorimotor neuropathy,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Abscess,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Fibrosis,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Infusion related reaction,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Injection site extravasation,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Myopathy,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Peritonitis,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Joint effusion,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Neutropenia,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Congestive hepatopathy,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pneumonia,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pseudomonal bacteraemia,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Micturition disorder,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Joint swelling,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Septic shock,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Neuropathy peripheral,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Herpes zoster,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Nasopharyngitis,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Asthenia,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood alkaline phosphatase increased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Enterococcus test positive,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Therapeutic response decreased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Rheumatoid arthritis,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Blood bilirubin increased,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Adrenal insufficiency,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Endometrial disorder,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Intervertebral disc protrusion,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Increased appetite,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Depression,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
190986662,19098666,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Nausea,,2023,Q1,2,F,,20230213.0,20210406,20230220,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230220,,HP,CA,CA,2023,Q1,Adult
191945959,19194595,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U,,,,,,,,,,Injection,QID,2023,Q1,Dizziness,,2023,Q1,9,F,20210416.0,20230223.0,20210429,20230302,EXP,,US-ROCHE-2818631,ROCHE,,70.0,YR,,M,Y,96.2,KG,20230302,,MD,US,,2023,Q1,Elderly
192772203,19277220,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,3,F,20210101.0,20230327.0,20210520,20230327,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-104614",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20230327,,CN,US,US,2023,Q1,Elderly
192772203,19277220,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,3,F,20210101.0,20230327.0,20210520,20230327,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-104614",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20230327,,CN,US,US,2023,Q1,Elderly
193219952,19321995,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 international unit, each evening",,,,,,,,12.0,IU,,QD,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230121.0,20210528,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202105000408,ELI LILLY AND CO,"Helen Berlie, Hannah Moore, Viva Zaya, Carly Burns..Accidental once-daily use of dulaglutide: A case report..JACCP Journal of the American College of Clinical Pharmacy. Conference:2022 2022;5(12):pp1346.",65.0,YR,,F,Y,,,20230126,,PH,US,US,2023,Q1,Elderly
193219952,19321995,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 international unit, each evening",,,,,,,,12.0,IU,,QD,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,2,F,,20230121.0,20210528,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202105000408,ELI LILLY AND CO,"Helen Berlie, Hannah Moore, Viva Zaya, Carly Burns..Accidental once-daily use of dulaglutide: A case report..JACCP Journal of the American College of Clinical Pharmacy. Conference:2022 2022;5(12):pp1346.",65.0,YR,,F,Y,,,20230126,,PH,US,US,2023,Q1,Elderly
193219952,19321995,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 international unit, each evening",,,,,,,,12.0,IU,,QD,2023,Q1,Overdose,,2023,Q1,2,F,,20230121.0,20210528,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202105000408,ELI LILLY AND CO,"Helen Berlie, Hannah Moore, Viva Zaya, Carly Burns..Accidental once-daily use of dulaglutide: A case report..JACCP Journal of the American College of Clinical Pharmacy. Conference:2022 2022;5(12):pp1346.",65.0,YR,,F,Y,,,20230126,,PH,US,US,2023,Q1,Elderly
193219952,19321995,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 international unit, each evening",,,,,,,,12.0,IU,,QD,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,2,F,,20230121.0,20210528,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202105000408,ELI LILLY AND CO,"Helen Berlie, Hannah Moore, Viva Zaya, Carly Burns..Accidental once-daily use of dulaglutide: A case report..JACCP Journal of the American College of Clinical Pharmacy. Conference:2022 2022;5(12):pp1346.",65.0,YR,,F,Y,,,20230126,,PH,US,US,2023,Q1,Elderly
193219952,19321995,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 international unit, other",,,,,,,,4.0,IU,,,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230121.0,20210528,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202105000408,ELI LILLY AND CO,"Helen Berlie, Hannah Moore, Viva Zaya, Carly Burns..Accidental once-daily use of dulaglutide: A case report..JACCP Journal of the American College of Clinical Pharmacy. Conference:2022 2022;5(12):pp1346.",65.0,YR,,F,Y,,,20230126,,PH,US,US,2023,Q1,Elderly
193219952,19321995,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 international unit, other",,,,,,,,4.0,IU,,,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,2,F,,20230121.0,20210528,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202105000408,ELI LILLY AND CO,"Helen Berlie, Hannah Moore, Viva Zaya, Carly Burns..Accidental once-daily use of dulaglutide: A case report..JACCP Journal of the American College of Clinical Pharmacy. Conference:2022 2022;5(12):pp1346.",65.0,YR,,F,Y,,,20230126,,PH,US,US,2023,Q1,Elderly
193219952,19321995,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 international unit, other",,,,,,,,4.0,IU,,,2023,Q1,Overdose,,2023,Q1,2,F,,20230121.0,20210528,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202105000408,ELI LILLY AND CO,"Helen Berlie, Hannah Moore, Viva Zaya, Carly Burns..Accidental once-daily use of dulaglutide: A case report..JACCP Journal of the American College of Clinical Pharmacy. Conference:2022 2022;5(12):pp1346.",65.0,YR,,F,Y,,,20230126,,PH,US,US,2023,Q1,Elderly
193219952,19321995,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 international unit, other",,,,,,,,4.0,IU,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,2,F,,20230121.0,20210528,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202105000408,ELI LILLY AND CO,"Helen Berlie, Hannah Moore, Viva Zaya, Carly Burns..Accidental once-daily use of dulaglutide: A case report..JACCP Journal of the American College of Clinical Pharmacy. Conference:2022 2022;5(12):pp1346.",65.0,YR,,F,Y,,,20230126,,PH,US,US,2023,Q1,Elderly
194123396,19412339,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, BID",,,,,,,,,,,,2023,Q1,Influenza like illness,,2023,Q1,6,F,20210606.0,20230123.0,20210614,20230216,EXP,,NVSC2021US131276,NOVARTIS,,49.0,YR,,M,Y,69.0,KG,20230216,,MD,US,US,2023,Q1,Adult
194123396,19412339,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, BID",,,,,,,,,,,,2023,Q1,Gastrointestinal disorder,,2023,Q1,6,F,20210606.0,20230123.0,20210614,20230216,EXP,,NVSC2021US131276,NOVARTIS,,49.0,YR,,M,Y,69.0,KG,20230216,,MD,US,US,2023,Q1,Adult
194615614,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Seizure,,2023,Q1,4,F,20210614.0,20230127.0,20210625,20230203,EXP,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230203,,MD,US,US,2023,Q1,Elderly
194615614,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Escherichia bacteraemia,,2023,Q1,4,F,20210614.0,20230127.0,20210625,20230203,EXP,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230203,,MD,US,US,2023,Q1,Elderly
194615614,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Nephrolithiasis,,2023,Q1,4,F,20210614.0,20230127.0,20210625,20230203,EXP,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230203,,MD,US,US,2023,Q1,Elderly
194615614,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,4,F,20210614.0,20230127.0,20210625,20230203,EXP,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230203,,MD,US,US,2023,Q1,Elderly
194615614,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pruritus,,2023,Q1,4,F,20210614.0,20230127.0,20210625,20230203,EXP,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230203,,MD,US,US,2023,Q1,Elderly
194615614,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Hypoxia,,2023,Q1,4,F,20210614.0,20230127.0,20210625,20230203,EXP,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230203,,MD,US,US,2023,Q1,Elderly
194615614,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Anxiety,,2023,Q1,4,F,20210614.0,20230127.0,20210625,20230203,EXP,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230203,,MD,US,US,2023,Q1,Elderly
194615614,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Aortic stenosis,,2023,Q1,4,F,20210614.0,20230127.0,20210625,20230203,EXP,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230203,,MD,US,US,2023,Q1,Elderly
194693442,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,2,F,,20230106.0,20210629,20230111,PER,DE-ADRED-06496-01,DE-Shilpa Medicare Limited-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20230111,,MD,DE,DE,2023,Q1,Elderly
194693442,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,2,F,,20230106.0,20210629,20230111,PER,DE-ADRED-06496-01,DE-Shilpa Medicare Limited-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20230111,,MD,DE,DE,2023,Q1,Elderly
194693442,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2023,Q1,Fatigue,,2023,Q1,2,F,,20230106.0,20210629,20230111,PER,DE-ADRED-06496-01,DE-Shilpa Medicare Limited-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20230111,,MD,DE,DE,2023,Q1,Elderly
194693442,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2023,Q1,Medication error,,2023,Q1,2,F,,20230106.0,20210629,20230111,PER,DE-ADRED-06496-01,DE-Shilpa Medicare Limited-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20230111,,MD,DE,DE,2023,Q1,Elderly
194693442,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2023,Q1,Night sweats,,2023,Q1,2,F,,20230106.0,20210629,20230111,PER,DE-ADRED-06496-01,DE-Shilpa Medicare Limited-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20230111,,MD,DE,DE,2023,Q1,Elderly
194840549,19484054,69,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,U,,,,,1.0,IU,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,9,F,20200809.0,20230327.0,20210701,20230329,EXP,,NVSC2021FR146473,NOVARTIS,,74.0,YR,,M,Y,,,20230329,,MD,FR,FR,2023,Q1,Elderly
194846979,19484697,86,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,U,,ASKED BUT UNKNOWN,,,1.0,IU,Unknown,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,9,F,20200809.0,20230317.0,20210702,20230328,EXP,,FR-ROCHE-2860051,ROCHE,,74.0,YR,,M,Y,,,20230328,,HP,FR,FR,2023,Q1,Elderly
194908982,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Diarrhoea,,2023,Q1,2,F,,20230113.0,20210705,20230123,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20230123,,MD,DE,DE,2023,Q1,Elderly
194908982,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Fatigue,,2023,Q1,2,F,,20230113.0,20210705,20230123,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20230123,,MD,DE,DE,2023,Q1,Elderly
194908982,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,General physical health deterioration,,2023,Q1,2,F,,20230113.0,20210705,20230123,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20230123,,MD,DE,DE,2023,Q1,Elderly
194908982,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Night sweats,,2023,Q1,2,F,,20230113.0,20210705,20230123,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20230123,,MD,DE,DE,2023,Q1,Elderly
194908982,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Medication error,,2023,Q1,2,F,,20230113.0,20210705,20230123,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20230123,,MD,DE,DE,2023,Q1,Elderly
195875146,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2023,Q1,Acute kidney injury,,2023,Q1,6,F,20210509.0,20230320.0,20210721,20230324,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20230324,,MD,FR,FR,2023,Q1,Adult
195875146,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2023,Q1,Cholestasis,,2023,Q1,6,F,20210509.0,20230320.0,20210721,20230324,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20230324,,MD,FR,FR,2023,Q1,Adult
195875146,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2023,Q1,Bronchopulmonary aspergillosis,,2023,Q1,6,F,20210509.0,20230320.0,20210721,20230324,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20230324,,MD,FR,FR,2023,Q1,Adult
195875146,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2023,Q1,Stomatitis,,2023,Q1,6,F,20210509.0,20230320.0,20210721,20230324,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20230324,,MD,FR,FR,2023,Q1,Adult
195875146,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2023,Q1,Diabetes insipidus,,2023,Q1,6,F,20210509.0,20230320.0,20210721,20230324,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20230324,,MD,FR,FR,2023,Q1,Adult
195875146,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2023,Q1,Systemic candida,,2023,Q1,6,F,20210509.0,20230320.0,20210721,20230324,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20230324,,MD,FR,FR,2023,Q1,Adult
1964310815,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,U,,,,,,,,BID,2023,Q1,Liver abscess,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,U,,,,,,,,BID,2023,Q1,Enterocolitis,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,U,,,,,,,,BID,2023,Q1,Gastrointestinal disorder,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,U,,,,,,,,BID,2023,Q1,Diarrhoea,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,U,,,,,,,,BID,2023,Q1,Peripheral ischaemia,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,U,,,,,,,,BID,2023,Q1,Pancreatic carcinoma,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,U,,,,,,,,BID,2023,Q1,Malignant neoplasm progression,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Liver abscess,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Enterocolitis,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Gastrointestinal disorder,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Peripheral ischaemia,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pancreatic carcinoma,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1964310815,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Malignant neoplasm progression,,2023,Q1,15,F,20210305.0,20230327.0,20210730,20230331,EXP,,NVSC2021US163698,NOVARTIS,,48.0,YR,,M,Y,75.8,KG,20230331,,MD,US,US,2023,Q1,Adult
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Menstrual disorder,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Blood bilirubin increased,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Jaundice,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Steatohepatitis,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Hyperglycaemia,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Hepatic cirrhosis,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,COVID-19,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Therapy interrupted,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Drug ineffective,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Weight decreased,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Laboratory test abnormal,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Autoimmune hepatitis,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Abdominal pain,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Influenza,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Viral infection,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q1,Treatment noncompliance,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Menstrual disorder,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Blood bilirubin increased,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Jaundice,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Steatohepatitis,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Hyperglycaemia,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Hepatic cirrhosis,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,COVID-19,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Therapy interrupted,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Drug ineffective,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Weight decreased,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Laboratory test abnormal,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Autoimmune hepatitis,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Abdominal pain,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Influenza,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Viral infection,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
1966698216,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q1,Treatment noncompliance,,2023,Q1,16,F,20201201.0,20230221.0,20210806,20230228,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230228,,CN,US,US,2023,Q1,Youth
198012292,19801229,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,General physical health deterioration,,2023,Q1,2,F,20210620.0,20230112.0,20210908,20230118,EXP,,DE-SA-2021SA294075,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20230118,,MD,DE,DE,2023,Q1,Elderly
198012292,19801229,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Anaemia,,2023,Q1,2,F,20210620.0,20230112.0,20210908,20230118,EXP,,DE-SA-2021SA294075,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20230118,,MD,DE,DE,2023,Q1,Elderly
198012292,19801229,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Diarrhoea,,2023,Q1,2,F,20210620.0,20230112.0,20210908,20230118,EXP,,DE-SA-2021SA294075,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20230118,,MD,DE,DE,2023,Q1,Elderly
198012292,19801229,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Dehydration,,2023,Q1,2,F,20210620.0,20230112.0,20210908,20230118,EXP,,DE-SA-2021SA294075,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20230118,,MD,DE,DE,2023,Q1,Elderly
198012292,19801229,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Product monitoring error,,2023,Q1,2,F,20210620.0,20230112.0,20210908,20230118,EXP,,DE-SA-2021SA294075,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20230118,,MD,DE,DE,2023,Q1,Elderly
198012292,19801229,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Product prescribing error,,2023,Q1,2,F,20210620.0,20230112.0,20210908,20230118,EXP,,DE-SA-2021SA294075,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20230118,,MD,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Pyrexia,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Oedema peripheral,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Electrocardiogram abnormal,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Anaemia,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Tachycardia,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Renal impairment,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Tachypnoea,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Disorientation,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198184672,19818467,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk (Schema),,,U,,,,,,,,,2023,Q1,Systemic infection,,2023,Q1,2,F,,20230109.0,20210911,20230113,EXP,,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20230113,,PH,DE,DE,2023,Q1,Elderly
198242352,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19-17-25-0",,,D,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,20210111.0,20230112.0,20210913,20230118,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20230118,,PH,DE,DE,2023,Q1,Elderly
198242352,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19-17-25-0",,,D,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,2,F,20210111.0,20230112.0,20210913,20230118,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20230118,,PH,DE,DE,2023,Q1,Elderly
198242352,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19-17-25-0",,,D,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Lack of application site rotation,,2023,Q1,2,F,20210111.0,20230112.0,20210913,20230118,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20230118,,PH,DE,DE,2023,Q1,Elderly
198242352,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19-17-25-0",,,D,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20210111.0,20230112.0,20210913,20230118,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20230118,,PH,DE,DE,2023,Q1,Elderly
198242352,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19-17-25-0",,,D,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Fatigue,,2023,Q1,2,F,20210111.0,20230112.0,20210913,20230118,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20230118,,PH,DE,DE,2023,Q1,Elderly
198242352,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19-17-25-0",,,D,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Abdominal pain upper,,2023,Q1,2,F,20210111.0,20230112.0,20210913,20230118,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20230118,,PH,DE,DE,2023,Q1,Elderly
198326172,19832617,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19-17-25-0, Fertigspritzen",,,U,,,,20563.0,,,Solution for injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20210111.0,20230109.0,20210914,20230120,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20230120,,CN,DE,DE,2023,Q1,Elderly
198326172,19832617,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19-17-25-0, Fertigspritzen",,,U,,,,20563.0,,,Solution for injection,,2023,Q1,Abdominal pain upper,,2023,Q1,2,F,20210111.0,20230109.0,20210914,20230120,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20230120,,CN,DE,DE,2023,Q1,Elderly
198326172,19832617,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19-17-25-0, Fertigspritzen",,,U,,,,20563.0,,,Solution for injection,,2023,Q1,Fatigue,,2023,Q1,2,F,20210111.0,20230109.0,20210914,20230120,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20230120,,CN,DE,DE,2023,Q1,Elderly
198326172,19832617,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19-17-25-0, Fertigspritzen",,,U,,,,20563.0,,,Solution for injection,,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,2,F,20210111.0,20230109.0,20210914,20230120,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20230120,,CN,DE,DE,2023,Q1,Elderly
198326172,19832617,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19-17-25-0, Fertigspritzen",,,U,,,,20563.0,,,Solution for injection,,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,20210111.0,20230109.0,20210914,20230120,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20230120,,CN,DE,DE,2023,Q1,Elderly
198326172,19832617,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19-17-25-0, Fertigspritzen",,,U,,,,20563.0,,,Solution for injection,,2023,Q1,Lack of application site rotation,,2023,Q1,2,F,20210111.0,20230109.0,20210914,20230120,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20230120,,CN,DE,DE,2023,Q1,Elderly
199617443,19961744,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: as necessary,,,,,,,,,,,,2023,Q1,Oesophageal varices haemorrhage,,2023,Q1,3,F,20210919.0,20230223.0,20211018,20230228,EXP,,DE-ABBVIE-21K-062-4121976-00,ABBVIE,,72.0,YR,,M,Y,75.0,KG,20230228,,MD,DE,DE,2023,Q1,Elderly
200376727,20037672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,Injection,TID,2023,Q1,Hyponatraemia,,2023,Q1,7,F,20211025.0,20230128.0,20211105,20230201,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20230201,,MD,US,,2023,Q1,Elderly
200376727,20037672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,Injection,TID,2023,Q1,Adrenal insufficiency,,2023,Q1,7,F,20211025.0,20230128.0,20211105,20230201,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20230201,,MD,US,,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Hyperlipidaemia,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Diarrhoea,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Respiratory disorder,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Nausea,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Vertigo,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Drug intolerance,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,COVID-19,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Malaise,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Chronic kidney disease,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Eating disorder,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Fatigue,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,10,C,insulin lispro/Humalog,,2,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2023,Q1,Diarrhoea,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Hyperlipidaemia,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Diarrhoea,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Respiratory disorder,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Nausea,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Vertigo,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Drug intolerance,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,COVID-19,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Hyperglycaemia,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Malaise,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Chronic kidney disease,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Eating disorder,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Fatigue,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200380603,20038060,11,C,insulin lispro/Humalog,,2,,strength: 100 unit/ml?300 unit every 3 day with insulin pump,,,U,,,,,300.0,IU,,,2023,Q1,Diarrhoea,,2023,Q1,3,F,20180208.0,20230126.0,20211105,20230203,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20230203,,CN,US,US,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Pyrexia,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Systemic infection,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Anaemia,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Disorientation,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Tachycardia,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Tachypnoea,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Renal impairment,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Oedema peripheral,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
200832492,20083249,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK Schema,,,,,,,,,,,,2023,Q1,Electrocardiogram abnormal,,2023,Q1,2,F,,20230201.0,20211117,20230207,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Pneumonitis,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Staphylococcal infection,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Hypercalcaemia,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Cholangitis acute,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Blood thyroid stimulating hormone increased,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Adrenocorticotropic hormone deficiency,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Thrombosis,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Hypertension,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Stomatitis,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Hypoalbuminaemia,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Aspergillus infection,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Pyrexia,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Proteinuria,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Sepsis,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Ascites,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Blood thyroid stimulating hormone decreased,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,COVID-19 pneumonia,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Blood corticotrophin increased,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Hypothyroidism,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204683387,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2023,Q1,Adrenal insufficiency,,2023,Q1,7,F,20210728.0,20230126.0,20220214,20230206,EXP,,JP-ROCHE-3018327,ROCHE,,72.0,YR,,M,Y,68.0,KG,20230206,,MD,JP,JP,2023,Q1,Elderly
204843668,20484366,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-11 units TID AC; 2-7 units nightly,,,,,,,,,,,,2023,Q1,Stevens-Johnson syndrome,,2023,Q1,8,F,20220202.0,20230111.0,20220217,20230113,EXP,,US-JNJFOC-20220214179,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230113,,MD,US,US,2023,Q1,Adult
204843668,20484366,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-11 units TID AC; 2-7 units nightly,,,,,,,,,,,,2023,Q1,Hypertransaminasaemia,,2023,Q1,8,F,20220202.0,20230111.0,20220217,20230113,EXP,,US-JNJFOC-20220214179,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230113,,MD,US,US,2023,Q1,Adult
205201744,20520174,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Uveitis,,2023,Q1,4,F,20210721.0,20230315.0,20220225,20230320,EXP,,PL-ROCHE-2895531,ROCHE,,63.0,YR,,M,Y,,,20230320,,MD,PL,,2023,Q1,Adult
206103933,20610393,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Recurrence of neuromuscular blockade,,2023,Q1,3,F,20220227.0,20230317.0,20220318,20230327,EXP,,ES-009507513-2203ESP005084,MERCK,,72.0,YR,,M,Y,,,20230327,,MD,ES,ES,2023,Q1,Elderly
206103933,20610393,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Respiratory failure,,2023,Q1,3,F,20220227.0,20230317.0,20220318,20230327,EXP,,ES-009507513-2203ESP005084,MERCK,,72.0,YR,,M,Y,,,20230327,,MD,ES,ES,2023,Q1,Elderly
206310522,20631052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, Once a Day",,,U,,,,,24.0,IU,,QD,2023,Q1,Rash pruritic,,2023,Q1,2,F,20190930.0,20230214.0,20220324,20230222,EXP,,PT-AUROBINDO-AUR-APL-2020-050071,AUROBINDO,"Lima F, Vidal H, Calado D, Costa P, Rocha M, Dias L. IM-181 319 Pustulose generalizada exantem?tica aguda - um caso de iatrogenia a quinolonas. .. Revista da Sociedade Portuguesa de Medicina Interna: Livro de Resumos ? Edi??o E. 2020;27:335",72.0,YR,,M,Y,,,20230222,,MD,PT,PT,2023,Q1,Elderly
206310522,20631052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, Once a Day",,,U,,,,,24.0,IU,,QD,2023,Q1,Pustule,,2023,Q1,2,F,20190930.0,20230214.0,20220324,20230222,EXP,,PT-AUROBINDO-AUR-APL-2020-050071,AUROBINDO,"Lima F, Vidal H, Calado D, Costa P, Rocha M, Dias L. IM-181 319 Pustulose generalizada exantem?tica aguda - um caso de iatrogenia a quinolonas. .. Revista da Sociedade Portuguesa de Medicina Interna: Livro de Resumos ? Edi??o E. 2020;27:335",72.0,YR,,M,Y,,,20230222,,MD,PT,PT,2023,Q1,Elderly
206310522,20631052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, Once a Day",,,U,,,,,24.0,IU,,QD,2023,Q1,Pyrexia,,2023,Q1,2,F,20190930.0,20230214.0,20220324,20230222,EXP,,PT-AUROBINDO-AUR-APL-2020-050071,AUROBINDO,"Lima F, Vidal H, Calado D, Costa P, Rocha M, Dias L. IM-181 319 Pustulose generalizada exantem?tica aguda - um caso de iatrogenia a quinolonas. .. Revista da Sociedade Portuguesa de Medicina Interna: Livro de Resumos ? Edi??o E. 2020;27:335",72.0,YR,,M,Y,,,20230222,,MD,PT,PT,2023,Q1,Elderly
206310522,20631052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, Once a Day",,,U,,,,,24.0,IU,,QD,2023,Q1,Acute generalised exanthematous pustulosis,,2023,Q1,2,F,20190930.0,20230214.0,20220324,20230222,EXP,,PT-AUROBINDO-AUR-APL-2020-050071,AUROBINDO,"Lima F, Vidal H, Calado D, Costa P, Rocha M, Dias L. IM-181 319 Pustulose generalizada exantem?tica aguda - um caso de iatrogenia a quinolonas. .. Revista da Sociedade Portuguesa de Medicina Interna: Livro de Resumos ? Edi??o E. 2020;27:335",72.0,YR,,M,Y,,,20230222,,MD,PT,PT,2023,Q1,Elderly
206310522,20631052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, Once a Day",,,U,,,,,24.0,IU,,QD,2023,Q1,Rash,,2023,Q1,2,F,20190930.0,20230214.0,20220324,20230222,EXP,,PT-AUROBINDO-AUR-APL-2020-050071,AUROBINDO,"Lima F, Vidal H, Calado D, Costa P, Rocha M, Dias L. IM-181 319 Pustulose generalizada exantem?tica aguda - um caso de iatrogenia a quinolonas. .. Revista da Sociedade Portuguesa de Medicina Interna: Livro de Resumos ? Edi??o E. 2020;27:335",72.0,YR,,M,Y,,,20230222,,MD,PT,PT,2023,Q1,Elderly
206852266,20685226,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNK,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,6,F,20220402.0,20230120.0,20220407,20230124,PER,,US-AMGEN-USACT2022059516,AMGEN,,78.0,YR,E,M,Y,93.73,KG,20230124,,MD,US,US,2023,Q1,Elderly
206852266,20685226,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNK,,,,,,,,,,,,2023,Q1,Angina pectoris,,2023,Q1,6,F,20220402.0,20230120.0,20220407,20230124,PER,,US-AMGEN-USACT2022059516,AMGEN,,78.0,YR,E,M,Y,93.73,KG,20230124,,MD,US,US,2023,Q1,Elderly
207285764,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2023,Q1,Hypocalcaemia,,2023,Q1,4,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20230329,,HP,US,US,2023,Q1,Elderly
207285764,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2023,Q1,Thrombocytopenia,,2023,Q1,4,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20230329,,HP,US,US,2023,Q1,Elderly
207285764,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2023,Q1,Hypomagnesaemia,,2023,Q1,4,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20230329,,HP,US,US,2023,Q1,Elderly
207285764,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2023,Q1,Anaemia,,2023,Q1,4,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20230329,,HP,US,US,2023,Q1,Elderly
2073129111,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q1,Hypertransaminasaemia,,2023,Q1,11,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230329,,MD,US,US,2023,Q1,Elderly
2073129111,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q1,Sepsis,,2023,Q1,11,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230329,,MD,US,US,2023,Q1,Elderly
2073129111,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q1,Hypoxia,,2023,Q1,11,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230329,,MD,US,US,2023,Q1,Elderly
2073129111,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q1,Alkalosis,,2023,Q1,11,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230329,,MD,US,US,2023,Q1,Elderly
2073129111,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q1,Tachycardia,,2023,Q1,11,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230329,,MD,US,US,2023,Q1,Elderly
2073129111,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q1,Pleural effusion,,2023,Q1,11,F,20220211.0,20230327.0,20220420,20230329,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230329,,MD,US,US,2023,Q1,Elderly
207435073,20743507,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,according to plan,,,,,,,,,,Solution for injection,,2023,Q1,Oedema peripheral,,2023,Q1,3,F,20220301.0,20230109.0,20220425,20230113,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20230113,,MD,DE,DE,2023,Q1,Elderly
207435073,20743507,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,according to plan,,,,,,,,,,Solution for injection,,2023,Q1,Off label use,,2023,Q1,3,F,20220301.0,20230109.0,20220425,20230113,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20230113,,MD,DE,DE,2023,Q1,Elderly
207435073,20743507,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,according to plan,,,,,,,,,,Solution for injection,,2023,Q1,Diarrhoea,,2023,Q1,3,F,20220301.0,20230109.0,20220425,20230113,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20230113,,MD,DE,DE,2023,Q1,Elderly
207435073,20743507,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,according to plan,,,,,,,,,,Solution for injection,,2023,Q1,Anal haemorrhage,,2023,Q1,3,F,20220301.0,20230109.0,20220425,20230113,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20230113,,MD,DE,DE,2023,Q1,Elderly
207435073,20743507,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,according to plan,,,,,,,,,,Solution for injection,,2023,Q1,Protein deficiency,,2023,Q1,3,F,20220301.0,20230109.0,20220425,20230113,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20230113,,MD,DE,DE,2023,Q1,Elderly
207435073,20743507,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,according to plan,,,,,,,,,,Solution for injection,,2023,Q1,Nausea,,2023,Q1,3,F,20220301.0,20230109.0,20220425,20230113,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20230113,,MD,DE,DE,2023,Q1,Elderly
207435073,20743507,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,according to plan,,,,,,,,,,Solution for injection,,2023,Q1,Hypochromic anaemia,,2023,Q1,3,F,20220301.0,20230109.0,20220425,20230113,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20230113,,MD,DE,DE,2023,Q1,Elderly
207435073,20743507,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,according to plan,,,,,,,,,,Solution for injection,,2023,Q1,Gastrointestinal haemorrhage,,2023,Q1,3,F,20220301.0,20230109.0,20220425,20230113,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20230113,,MD,DE,DE,2023,Q1,Elderly
207480653,20748065,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,9,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,9,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,9,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,9,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,10,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,10,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,10,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,10,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,11,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,11,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,11,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,11,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,12,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,12,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,12,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,12,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,13,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,13,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,13,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,13,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,14,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429199D,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,14,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429199D,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,14,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429199D,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,14,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429199D,,,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,15,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429199D,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,15,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429199D,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,15,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429199D,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
207480653,20748065,15,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429199D,,,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,3,F,20220404.0,20230106.0,20220426,20230112,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230112,,CN,US,US,2023,Q1,Adult
209166495,20916649,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2023,Q1,Off label use,,2023,Q1,5,F,20220422.0,20230228.0,20220605,20230302,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,83.19,KG,20230302,,HP,US,US,2023,Q1,Elderly
209166495,20916649,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2023,Q1,Liver function test decreased,,2023,Q1,5,F,20220422.0,20230228.0,20220605,20230302,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,83.19,KG,20230302,,HP,US,US,2023,Q1,Elderly
209166495,20916649,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,5,F,20220422.0,20230228.0,20220605,20230302,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,83.19,KG,20230302,,HP,US,US,2023,Q1,Elderly
209166495,20916649,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2023,Q1,Hypersomnia,,2023,Q1,5,F,20220422.0,20230228.0,20220605,20230302,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,83.19,KG,20230302,,HP,US,US,2023,Q1,Elderly
209166495,20916649,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2023,Q1,Headache,,2023,Q1,5,F,20220422.0,20230228.0,20220605,20230302,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,83.19,KG,20230302,,HP,US,US,2023,Q1,Elderly
209166495,20916649,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2023,Q1,Thrombocytopenia,,2023,Q1,5,F,20220422.0,20230228.0,20220605,20230302,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,83.19,KG,20230302,,HP,US,US,2023,Q1,Elderly
209166495,20916649,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2023,Q1,Tremor,,2023,Q1,5,F,20220422.0,20230228.0,20220605,20230302,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,83.19,KG,20230302,,HP,US,US,2023,Q1,Elderly
210410345,21041034,5,C,Insulin lispro bs,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q1,Erythema multiforme,,2023,Q1,5,F,20210602.0,20230111.0,20220704,20230117,PER,,JP-AMGEN-JPNSP2022113332,AMGEN,"Ishii K, Yoshibayashi H, Torii M, Nakakimura T, Matsutani Y. A case of male recurrent breast cancer successfully treated with hormone therapy in combination with palbociclib as 1st-line treatment. The 30th Annual Meeting of the Japanese Breast Cancer Society. 2022;312",8.0,DEC,E,M,Y,,,20230117,,MD,JP,JP,2023,Q1,Child
210604345,21060434,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (100/ml),,,U,,,,,,,Injection,,2023,Q1,Drug ineffective,,2023,Q1,5,F,20220630.0,20230106.0,20220708,20230111,PER,,US-SA-2022SA262496,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20230111,,MD,US,US,2023,Q1,Adult
210604345,21060434,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (100/ml),,,U,,,,,,,Injection,,2023,Q1,Asthma,,2023,Q1,5,F,20220630.0,20230106.0,20220708,20230111,PER,,US-SA-2022SA262496,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20230111,,MD,US,US,2023,Q1,Adult
210604345,21060434,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (100/ml),,,U,,,,,,,Injection,,2023,Q1,Sepsis,,2023,Q1,5,F,20220630.0,20230106.0,20220708,20230111,PER,,US-SA-2022SA262496,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20230111,,MD,US,US,2023,Q1,Adult
210604345,21060434,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (100/ml),,,U,,,,,,,Injection,,2023,Q1,Impaired quality of life,,2023,Q1,5,F,20220630.0,20230106.0,20220708,20230111,PER,,US-SA-2022SA262496,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20230111,,MD,US,US,2023,Q1,Adult
210639154,21063915,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Cataract,,2023,Q1,4,F,20211217.0,20230126.0,20220711,20230131,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,104.32,KG,20230131,,CN,US,US,2023,Q1,Elderly
210639154,21063915,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Thrombosis,,2023,Q1,4,F,20211217.0,20230126.0,20220711,20230131,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,104.32,KG,20230131,,CN,US,US,2023,Q1,Elderly
210639154,21063915,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Epistaxis,,2023,Q1,4,F,20211217.0,20230126.0,20220711,20230131,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,104.32,KG,20230131,,CN,US,US,2023,Q1,Elderly
210639154,21063915,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Asthenia,,2023,Q1,4,F,20211217.0,20230126.0,20220711,20230131,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,104.32,KG,20230131,,CN,US,US,2023,Q1,Elderly
210639154,21063915,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Anaemia,,2023,Q1,4,F,20211217.0,20230126.0,20220711,20230131,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,104.32,KG,20230131,,CN,US,US,2023,Q1,Elderly
210674434,21067443,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3-5x daily,,,,,,,,,,,QD,2023,Q1,Cholecystitis,,2023,Q1,4,F,20220308.0,20230220.0,20220712,20230228,EXP,,DE-ROCHE-3054456,ROCHE,,35.0,YR,,F,Y,,,20230228,,CN,DE,,2023,Q1,Adult
210674434,21067443,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3-5x daily,,,,,,,,,,,QD,2023,Q1,Diabetes mellitus,,2023,Q1,4,F,20220308.0,20230220.0,20220712,20230228,EXP,,DE-ROCHE-3054456,ROCHE,,35.0,YR,,F,Y,,,20230228,,CN,DE,,2023,Q1,Adult
210674434,21067443,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3-5x daily,,,,,,,,,,,QD,2023,Q1,Drug ineffective,,2023,Q1,4,F,20220308.0,20230220.0,20220712,20230228,EXP,,DE-ROCHE-3054456,ROCHE,,35.0,YR,,F,Y,,,20230228,,CN,DE,,2023,Q1,Adult
210674434,21067443,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3-5x daily,,,,,,,,,,,QD,2023,Q1,Fatigue,,2023,Q1,4,F,20220308.0,20230220.0,20220712,20230228,EXP,,DE-ROCHE-3054456,ROCHE,,35.0,YR,,F,Y,,,20230228,,CN,DE,,2023,Q1,Adult
210674434,21067443,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3-5x daily,,,,,,,,,,,QD,2023,Q1,Hypertension,,2023,Q1,4,F,20220308.0,20230220.0,20220712,20230228,EXP,,DE-ROCHE-3054456,ROCHE,,35.0,YR,,F,Y,,,20230228,,CN,DE,,2023,Q1,Adult
210813664,21081366,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNK,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,4,F,20220701.0,20230120.0,20220714,20230123,PER,,US-AMGEN-USACT2022118312,AMGEN,,79.0,YR,E,M,Y,93.73,KG,20230123,,MD,US,US,2023,Q1,Elderly
2114551114,21145511,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2023,Q1,Hyperglycaemia,,2023,Q1,14,F,20211201.0,20230324.0,20220729,20230329,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20230329,,MD,CA,,2023,Q1,Adult
2114551114,21145511,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2023,Q1,Hyperthyroidism,,2023,Q1,14,F,20211201.0,20230324.0,20220729,20230329,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20230329,,MD,CA,,2023,Q1,Adult
2114551114,21145511,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2023,Q1,Diabetic ketoacidosis,,2023,Q1,14,F,20211201.0,20230324.0,20220729,20230329,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20230329,,MD,CA,,2023,Q1,Adult
211953222,21195322,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,U,,,,,8.0,IU,Injection,TID,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,,20230221.0,20220810,20230227,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202207010740,ELI LILLY AND CO,"Nagasawa S,et al..Identification, measurement, and evaluation of blood concentrations of insulin glargine and insulin lispro by UPLC-MS-MS in a dead body suspected of insulin overdose.Journal of forensic sciences 2023;:.",35.0,YR,,F,Y,,,20230227,,CN,JP,JP,2023,Q1,Adult
211953222,21195322,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,U,,,,,8.0,IU,Injection,TID,2023,Q1,Incorrect dose administered,,2023,Q1,2,F,,20230221.0,20220810,20230227,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202207010740,ELI LILLY AND CO,"Nagasawa S,et al..Identification, measurement, and evaluation of blood concentrations of insulin glargine and insulin lispro by UPLC-MS-MS in a dead body suspected of insulin overdose.Journal of forensic sciences 2023;:.",35.0,YR,,F,Y,,,20230227,,CN,JP,JP,2023,Q1,Adult
211953222,21195322,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,U,,,,,8.0,IU,Injection,TID,2023,Q1,Completed suicide,,2023,Q1,2,F,,20230221.0,20220810,20230227,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202207010740,ELI LILLY AND CO,"Nagasawa S,et al..Identification, measurement, and evaluation of blood concentrations of insulin glargine and insulin lispro by UPLC-MS-MS in a dead body suspected of insulin overdose.Journal of forensic sciences 2023;:.",35.0,YR,,F,Y,,,20230227,,CN,JP,JP,2023,Q1,Adult
212079263,21207926,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q1,Cytomegalovirus chorioretinitis,,2023,Q1,3,F,20221128.0,20230227.0,20220812,20230309,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230309,,HP,US,US,2023,Q1,Adult
212079263,21207926,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q1,Drug resistance,,2023,Q1,3,F,20221128.0,20230227.0,20220812,20230309,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230309,,HP,US,US,2023,Q1,Adult
212079263,21207926,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q1,Respiratory syncytial virus infection,,2023,Q1,3,F,20221128.0,20230227.0,20220812,20230309,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230309,,HP,US,US,2023,Q1,Adult
212079263,21207926,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q1,Product use issue,,2023,Q1,3,F,20221128.0,20230227.0,20220812,20230309,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230309,,HP,US,US,2023,Q1,Adult
212079263,21207926,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,,TID,2023,Q1,Cytomegalovirus chorioretinitis,,2023,Q1,3,F,20221128.0,20230227.0,20220812,20230309,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230309,,HP,US,US,2023,Q1,Adult
212079263,21207926,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,,TID,2023,Q1,Drug resistance,,2023,Q1,3,F,20221128.0,20230227.0,20220812,20230309,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230309,,HP,US,US,2023,Q1,Adult
212079263,21207926,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,,TID,2023,Q1,Respiratory syncytial virus infection,,2023,Q1,3,F,20221128.0,20230227.0,20220812,20230309,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230309,,HP,US,US,2023,Q1,Adult
212079263,21207926,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,,TID,2023,Q1,Product use issue,,2023,Q1,3,F,20221128.0,20230227.0,20220812,20230309,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230309,,HP,US,US,2023,Q1,Adult
212794842,21279484,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Unknown,,2023,Q1,Muscle spasms,,2023,Q1,2,F,20220801.0,20230105.0,20220901,20230108,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-097744,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,144.7,KG,20230109,,PH,US,US,2023,Q1,Adult
212794842,21279484,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Unknown,,2023,Q1,Alopecia,,2023,Q1,2,F,20220801.0,20230105.0,20220901,20230108,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-097744,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,144.7,KG,20230109,,PH,US,US,2023,Q1,Adult
212794842,21279484,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Unknown,,2023,Q1,Off label use,,2023,Q1,2,F,20220801.0,20230105.0,20220901,20230108,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-097744,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,144.7,KG,20230109,,PH,US,US,2023,Q1,Adult
212794842,21279484,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Unknown,,2023,Q1,Pain in extremity,,2023,Q1,2,F,20220801.0,20230105.0,20220901,20230108,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-097744,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,144.7,KG,20230109,,PH,US,US,2023,Q1,Adult
212794842,21279484,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Unknown,,2023,Q1,Neuropathy peripheral,,2023,Q1,2,F,20220801.0,20230105.0,20220901,20230108,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-097744,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,144.7,KG,20230109,,PH,US,US,2023,Q1,Adult
213238453,21323845,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,D,,,,,1.0,IU,Unknown,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,3,F,20200809.0,20230224.0,20220912,20230228,EXP,FR-EMA-DD-20220830-7180173-082651,FR-JNJFOC-20200841529,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,,,20230228,,MD,FR,FR,2023,Q1,Elderly
213817943,21381794,12,C,INSULINE LISPRO,,1,Subcutaneous,100 unit per mL,,,,,,,,,,,,2023,Q1,Knee arthroplasty,,2023,Q1,3,F,20220101.0,20221109.0,20220927,20230224,PER,,US-AMGEN-USASP2022162206,AMGEN,,69.0,YR,E,M,Y,,,20230224,,HP,US,US,2023,Q1,Elderly
213817943,21381794,12,C,INSULINE LISPRO,,1,Subcutaneous,100 unit per mL,,,,,,,,,,,,2023,Q1,Device difficult to use,,2023,Q1,3,F,20220101.0,20221109.0,20220927,20230224,PER,,US-AMGEN-USASP2022162206,AMGEN,,69.0,YR,E,M,Y,,,20230224,,HP,US,US,2023,Q1,Elderly
213817943,21381794,12,C,INSULINE LISPRO,,1,Subcutaneous,100 unit per mL,,,,,,,,,,,,2023,Q1,Urinary tract infection,,2023,Q1,3,F,20220101.0,20221109.0,20220927,20230224,PER,,US-AMGEN-USASP2022162206,AMGEN,,69.0,YR,E,M,Y,,,20230224,,HP,US,US,2023,Q1,Elderly
213817943,21381794,12,C,INSULINE LISPRO,,1,Subcutaneous,100 unit per mL,,,,,,,,,,,,2023,Q1,Sepsis,,2023,Q1,3,F,20220101.0,20221109.0,20220927,20230224,PER,,US-AMGEN-USASP2022162206,AMGEN,,69.0,YR,E,M,Y,,,20230224,,HP,US,US,2023,Q1,Elderly
213817943,21381794,12,C,INSULINE LISPRO,,1,Subcutaneous,100 unit per mL,,,,,,,,,,,,2023,Q1,Superficial vein thrombosis,,2023,Q1,3,F,20220101.0,20221109.0,20220927,20230224,PER,,US-AMGEN-USASP2022162206,AMGEN,,69.0,YR,E,M,Y,,,20230224,,HP,US,US,2023,Q1,Elderly
213817943,21381794,12,C,INSULINE LISPRO,,1,Subcutaneous,100 unit per mL,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,3,F,20220101.0,20221109.0,20220927,20230224,PER,,US-AMGEN-USASP2022162206,AMGEN,,69.0,YR,E,M,Y,,,20230224,,HP,US,US,2023,Q1,Elderly
213817943,21381794,12,C,INSULINE LISPRO,,1,Subcutaneous,100 unit per mL,,,,,,,,,,,,2023,Q1,Heart rate irregular,,2023,Q1,3,F,20220101.0,20221109.0,20220927,20230224,PER,,US-AMGEN-USASP2022162206,AMGEN,,69.0,YR,E,M,Y,,,20230224,,HP,US,US,2023,Q1,Elderly
213817943,21381794,12,C,INSULINE LISPRO,,1,Subcutaneous,100 unit per mL,,,,,,,,,,,,2023,Q1,Fall,,2023,Q1,3,F,20220101.0,20221109.0,20220927,20230224,PER,,US-AMGEN-USASP2022162206,AMGEN,,69.0,YR,E,M,Y,,,20230224,,HP,US,US,2023,Q1,Elderly
213934373,21393437,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Angioedema,,2023,Q1,3,F,20220901.0,20230119.0,20220929,20230126,EXP,,US-GILEAD-2022-0599288,GILEAD,,43.0,YR,A,M,Y,90.9,KG,20230126,,HP,US,US,2023,Q1,Adult
213934373,21393437,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Cytokine release syndrome,,2023,Q1,3,F,20220901.0,20230119.0,20220929,20230126,EXP,,US-GILEAD-2022-0599288,GILEAD,,43.0,YR,A,M,Y,90.9,KG,20230126,,HP,US,US,2023,Q1,Adult
213934373,21393437,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Aspartate aminotransferase increased,,2023,Q1,3,F,20220901.0,20230119.0,20220929,20230126,EXP,,US-GILEAD-2022-0599288,GILEAD,,43.0,YR,A,M,Y,90.9,KG,20230126,,HP,US,US,2023,Q1,Adult
213934373,21393437,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Alanine aminotransferase increased,,2023,Q1,3,F,20220901.0,20230119.0,20220929,20230126,EXP,,US-GILEAD-2022-0599288,GILEAD,,43.0,YR,A,M,Y,90.9,KG,20230126,,HP,US,US,2023,Q1,Adult
213954742,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2023,Q1,Fatigue,,2023,Q1,2,F,,20230116.0,20220930,20230125,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20230125,,MD,DE,DE,2023,Q1,Elderly
213954742,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2023,Q1,Night sweats,,2023,Q1,2,F,,20230116.0,20220930,20230125,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20230125,,MD,DE,DE,2023,Q1,Elderly
213954742,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,2,F,,20230116.0,20220930,20230125,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20230125,,MD,DE,DE,2023,Q1,Elderly
213954742,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,2,F,,20230116.0,20220930,20230125,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20230125,,MD,DE,DE,2023,Q1,Elderly
213954742,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2023,Q1,Medication error,,2023,Q1,2,F,,20230116.0,20220930,20230125,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20230125,,MD,DE,DE,2023,Q1,Elderly
213955522,21395552,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 1-0-0-0, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2023,Q1,Renal impairment,,2023,Q1,2,F,,20221226.0,20220930,20230110,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-357094,RANBAXY,,48.0,YR,,M,Y,72.0,KG,20230110,,PH,DE,DE,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Multi-organ disorder,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Weight decreased,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Blood glucose increased,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Arthritis,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Cardiac failure congestive,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Pericardial effusion,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Myalgia,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Thyroid disorder,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Malnutrition,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Diarrhoea,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Headache,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Chest pain,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Eye haemorrhage,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Pulmonary oedema,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Neuropathy peripheral,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
213979553,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Abdominal pain upper,,2023,Q1,3,F,,20230131.0,20220930,20230206,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230206,,CN,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Myalgia,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Weight decreased,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Thyroid disorder,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Diarrhoea,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Headache,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Arthritis,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Pericardial effusion,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Multi-organ disorder,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Eye haemorrhage,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Malnutrition,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Abdominal pain upper,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Neuropathy peripheral,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Pulmonary oedema,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Chest pain,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214168692,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Cardiac failure congestive,,2023,Q1,2,F,,20230106.0,20221006,20230111,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230111,,HP,CA,CA,2023,Q1,Adult
214483725,21448372,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Musculoskeletal disorder,,2023,Q1,5,F,20220305.0,20230105.0,20221013,20230110,EXP,,US-ABBVIE-4151513,ABBVIE,,76.0,YR,,F,Y,48.08,KG,20230110,,CN,US,US,2023,Q1,Elderly
214483725,21448372,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,5,F,20220305.0,20230105.0,20221013,20230110,EXP,,US-ABBVIE-4151513,ABBVIE,,76.0,YR,,F,Y,48.08,KG,20230110,,CN,US,US,2023,Q1,Elderly
214483725,21448372,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Weight decreased,,2023,Q1,5,F,20220305.0,20230105.0,20221013,20230110,EXP,,US-ABBVIE-4151513,ABBVIE,,76.0,YR,,F,Y,48.08,KG,20230110,,CN,US,US,2023,Q1,Elderly
214483725,21448372,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Fall,,2023,Q1,5,F,20220305.0,20230105.0,20221013,20230110,EXP,,US-ABBVIE-4151513,ABBVIE,,76.0,YR,,F,Y,48.08,KG,20230110,,CN,US,US,2023,Q1,Elderly
214483725,21448372,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Cervical vertebral fracture,,2023,Q1,5,F,20220305.0,20230105.0,20221013,20230110,EXP,,US-ABBVIE-4151513,ABBVIE,,76.0,YR,,F,Y,48.08,KG,20230110,,CN,US,US,2023,Q1,Elderly
214483725,21448372,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Vertebral body replacement,,2023,Q1,5,F,20220305.0,20230105.0,20221013,20230110,EXP,,US-ABBVIE-4151513,ABBVIE,,76.0,YR,,F,Y,48.08,KG,20230110,,CN,US,US,2023,Q1,Elderly
214525648,21452564,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 U,,,,,,,,,,Injection,QD,2023,Q1,Haemophagocytic lymphohistiocytosis,,2023,Q1,8,F,20221001.0,20230225.0,20221013,20230301,EXP,,US-ROCHE-3195833,ROCHE,,67.0,YR,,M,Y,98.0,KG,20230301,,MD,US,,2023,Q1,Elderly
214525648,21452564,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 U,,,,,,,,,,Injection,QD,2023,Q1,Acute myeloid leukaemia,,2023,Q1,8,F,20221001.0,20230225.0,20221013,20230301,EXP,,US-ROCHE-3195833,ROCHE,,67.0,YR,,M,Y,98.0,KG,20230301,,MD,US,,2023,Q1,Elderly
214525648,21452564,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U,,,,,,,,,,Injection,TID,2023,Q1,Haemophagocytic lymphohistiocytosis,,2023,Q1,8,F,20221001.0,20230225.0,20221013,20230301,EXP,,US-ROCHE-3195833,ROCHE,,67.0,YR,,M,Y,98.0,KG,20230301,,MD,US,,2023,Q1,Elderly
214525648,21452564,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U,,,,,,,,,,Injection,TID,2023,Q1,Acute myeloid leukaemia,,2023,Q1,8,F,20221001.0,20230225.0,20221013,20230301,EXP,,US-ROCHE-3195833,ROCHE,,67.0,YR,,M,Y,98.0,KG,20230301,,MD,US,,2023,Q1,Elderly
215061473,21506147,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, 3 Times a Day",,,U,,,,,12.0,IU,,TID,2023,Q1,Hypoglycaemia,,2023,Q1,3,F,20220508.0,20230127.0,20221026,20230207,EXP,,IT-AUROBINDO-AUR-APL-2022-044077,AUROBINDO,,81.0,YR,,F,Y,,,20230207,,MD,IT,IT,2023,Q1,Elderly
215069093,21506909,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Cellulitis,,2023,Q1,3,F,20220910.0,20230223.0,20221026,20230228,EXP,,US-ROCHE-3205294,ROCHE,,57.0,YR,,M,Y,,,20230228,,MD,US,,2023,Q1,Adult
215127072,21512707,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,2,F,20221014.0,20230111.0,20221027,20230116,EXP,,US-SA-2022SA431445,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20230116,,CN,US,US,2023,Q1,Elderly
215127072,21512707,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,2,F,20221014.0,20230111.0,20221027,20230116,EXP,,US-SA-2022SA431445,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20230116,,CN,US,US,2023,Q1,Elderly
215127072,21512707,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Injection site pain,,2023,Q1,2,F,20221014.0,20230111.0,20221027,20230116,EXP,,US-SA-2022SA431445,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20230116,,CN,US,US,2023,Q1,Elderly
215127072,21512707,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Neoplasm malignant,,2023,Q1,2,F,20221014.0,20230111.0,20221027,20230116,EXP,,US-SA-2022SA431445,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20230116,,CN,US,US,2023,Q1,Elderly
215143882,21514388,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown (10/14/8VARIABILE)",,,U,,,,20563.0,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,2,F,20220516.0,20230131.0,20221027,20230203,EXP,IT-MINISAL02-888961,IT-ELI_LILLY_AND_COMPANY-IT202210006806,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20230203,,CN,IT,IT,2023,Q1,Elderly
215143882,21514388,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown (10/14/8VARIABILE)",,,U,,,,20563.0,,,,,2023,Q1,Confusional state,,2023,Q1,2,F,20220516.0,20230131.0,20221027,20230203,EXP,IT-MINISAL02-888961,IT-ELI_LILLY_AND_COMPANY-IT202210006806,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20230203,,CN,IT,IT,2023,Q1,Elderly
2154855910,21548559,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Malaise,,2023,Q1,10,F,20221028.0,20230317.0,20221103,20230323,EXP,,NVSC2022US247333,NOVARTIS,,56.0,YR,,M,Y,80.0,KG,20230323,,MD,US,US,2023,Q1,Adult
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Product storage error,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Feeling abnormal,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Kussmaul respiration,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Nausea,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Vomiting,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Diabetic ketoacidosis,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Altered state of consciousness,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 to 20 units, QID",,,,,,,,,,Solution for injection,Q6H,2023,Q1,Hyperventilation,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Product storage error,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Feeling abnormal,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Kussmaul respiration,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Nausea,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Vomiting,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Diabetic ketoacidosis,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Altered state of consciousness,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
215514725,21551472,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, 1X",,,,,,,,,,Solution for injection,1X,2023,Q1,Hyperventilation,,2023,Q1,5,F,20190606.0,20230206.0,20221103,20230207,EXP,,JP-SA-2022SA442426,SANOFI AVENTIS,,13.0,YR,T,F,Y,52.3,KG,20230208,,CN,JP,JP,2023,Q1,Child
216124844,21612484,14,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Malignant neoplasm progression,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,14,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Acute kidney injury,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,14,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Blood creatinine increased,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,14,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Tubulointerstitial nephritis,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,14,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Pneumonia aspiration,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,14,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Urinary tract disorder,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,15,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Malignant neoplasm progression,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,15,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Acute kidney injury,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,15,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Blood creatinine increased,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,15,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Tubulointerstitial nephritis,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,15,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Pneumonia aspiration,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216124844,21612484,15,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2023,Q1,Urinary tract disorder,,2023,Q1,4,F,20220622.0,20230309.0,20221118,20230309,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20230309,,MD,JP,JP,2023,Q1,Elderly
216356082,21635608,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, qid",,,,,,,,,,,QID,2023,Q1,Acute kidney injury,,2023,Q1,2,F,20221115.0,20230324.0,20221123,20230329,EXP,,US-SEATTLE GENETICS-2022SGN10891,SEATTLE GENETICS,,74.0,YR,,M,Y,93.424,KG,20230329,,MD,US,US,2023,Q1,Elderly
216357466,21635746,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,UNKNOWN,,,,,,,2023,Q1,Oropharyngeal discomfort,,2023,Q1,6,F,20221003.0,20230109.0,20221123,20230116,EXP,,CA-ROCHE-3223072,ROCHE,,40.0,YR,,F,Y,,,20230116,,CN,CA,CA,2023,Q1,Adult
216357466,21635746,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,UNKNOWN,,,,,,,2023,Q1,Hypertension,,2023,Q1,6,F,20221003.0,20230109.0,20221123,20230116,EXP,,CA-ROCHE-3223072,ROCHE,,40.0,YR,,F,Y,,,20230116,,CN,CA,CA,2023,Q1,Adult
216357466,21635746,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,UNKNOWN,,,,,,,2023,Q1,Flushing,,2023,Q1,6,F,20221003.0,20230109.0,20221123,20230116,EXP,,CA-ROCHE-3223072,ROCHE,,40.0,YR,,F,Y,,,20230116,,CN,CA,CA,2023,Q1,Adult
216357466,21635746,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,UNKNOWN,,,,,,,2023,Q1,Anaphylactic reaction,,2023,Q1,6,F,20221003.0,20230109.0,20221123,20230116,EXP,,CA-ROCHE-3223072,ROCHE,,40.0,YR,,F,Y,,,20230116,,CN,CA,CA,2023,Q1,Adult
216357466,21635746,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,UNKNOWN,,,,,,,2023,Q1,Chest discomfort,,2023,Q1,6,F,20221003.0,20230109.0,20221123,20230116,EXP,,CA-ROCHE-3223072,ROCHE,,40.0,YR,,F,Y,,,20230116,,CN,CA,CA,2023,Q1,Adult
216357466,21635746,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,UNKNOWN,,,,,,,2023,Q1,Pruritus,,2023,Q1,6,F,20221003.0,20230109.0,20221123,20230116,EXP,,CA-ROCHE-3223072,ROCHE,,40.0,YR,,F,Y,,,20230116,,CN,CA,CA,2023,Q1,Adult
216357466,21635746,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,UNKNOWN,,,,,,,2023,Q1,Injection site pruritus,,2023,Q1,6,F,20221003.0,20230109.0,20221123,20230116,EXP,,CA-ROCHE-3223072,ROCHE,,40.0,YR,,F,Y,,,20230116,,CN,CA,CA,2023,Q1,Adult
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Intentional product use issue,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Product use issue,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Aortic valve disease,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Cardiac pacemaker removal,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216577484,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Stent placement,,2023,Q1,4,F,20220516.0,20230120.0,20221129,20230125,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20230125,,HP,CA,CA,2023,Q1,Elderly
216636913,21663691,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Neutrophil count decreased,,2023,Q1,3,F,20221103.0,20221209.0,20221130,20230105,EXP,,US-Accord-287713,ACCORD,,57.0,YR,A,F,Y,75.3,KG,20230105,,HP,US,US,2023,Q1,Adult
216636913,21663691,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Wound infection bacterial,,2023,Q1,3,F,20221103.0,20221209.0,20221130,20230105,EXP,,US-Accord-287713,ACCORD,,57.0,YR,A,F,Y,75.3,KG,20230105,,HP,US,US,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Dehydration,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Vomiting,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Systemic infection,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Death,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,General physical health deterioration,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Tenderness,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Pain,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Tachycardia,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Nausea,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Depressed level of consciousness,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Condition aggravated,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Anaemia,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Haematochezia,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Hyperglycaemia,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Fatigue,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
216699204,21669920,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, scheme",,,U,,,,,1.0,IU,,,2023,Q1,Cachexia,,2023,Q1,4,F,20210702.0,20230103.0,20221201,20230105,EXP,,DE-MYLANLABS-2022M1133085,MYLAN,,48.0,YR,,M,Y,68.0,KG,20230105,,PH,DE,DE,2023,Q1,Adult
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Rash,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Blood glucose increased,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Weight increased,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Therapy non-responder,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Drug hypersensitivity,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Chronic obstructive pulmonary disease,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Drug ineffective,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217790504,21779050,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q1,Dyspnoea,,2023,Q1,4,F,20190101.0,20230118.0,20221226,20230120,EXP,,US-SA-2022SA511233,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230120,,HP,US,US,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Asthenia,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Cerebrovascular accident,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Drug intolerance,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Product dispensing error,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Overdose,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217792013,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Product dose omission issue,,2023,Q1,3,F,20221216.0,20230124.0,20221226,20230202,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20230202,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hepatotoxicity,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Movement disorder,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Psoriatic arthropathy,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Headache,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Drug intolerance,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Grip strength decreased,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Pain,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Hepatic cirrhosis,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diabetes mellitus,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Therapeutic product effect decreased,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Osteoarthritis,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217814432,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Arthropathy,,2023,Q1,2,F,,20230308.0,20221227,20230316,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20230316,,HP,CA,CA,2023,Q1,Elderly
217849455,21784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Gastrointestinal haemorrhage,,2023,Q1,5,F,20221217.0,20230322.0,20221227,20230329,PER,,US-Eisai Medical Research-EC-2022-130765,EISAI,,73.0,YR,E,F,Y,80.9,KG,20230329,,MD,US,,2023,Q1,Elderly
217849455,21784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Biliary obstruction,,2023,Q1,5,F,20221217.0,20230322.0,20221227,20230329,PER,,US-Eisai Medical Research-EC-2022-130765,EISAI,,73.0,YR,E,F,Y,80.9,KG,20230329,,MD,US,,2023,Q1,Elderly
217849455,21784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Hyponatraemia,,2023,Q1,5,F,20221217.0,20230322.0,20221227,20230329,PER,,US-Eisai Medical Research-EC-2022-130765,EISAI,,73.0,YR,E,F,Y,80.9,KG,20230329,,MD,US,,2023,Q1,Elderly
218034251,21803425,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Asthenia,,2023,Q1,1,I,20221201.0,20221229.0,20230101,20230101,PER,,US-ABBVIE-4254981,ABBVIE,,74.0,YR,,F,Y,,,20230101,,HP,US,US,2023,Q1,Elderly
218034251,21803425,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,1,I,20221201.0,20221229.0,20230101,20230101,PER,,US-ABBVIE-4254981,ABBVIE,,74.0,YR,,F,Y,,,20230101,,HP,US,US,2023,Q1,Elderly
218084831,21808483,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100u/ml,,,D,,,,,,,Unknown,,2023,Q1,Urosepsis,,2023,Q1,1,I,20220101.0,20221229.0,20230103,20230103,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-160902,BRISTOL MYERS SQUIBB,,73.0,YR,E,M,Y,,,20230103,,PH,US,US,2023,Q1,Elderly
218084841,21808484,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100u/ml,,,D,,,,,,,Unknown,,2023,Q1,Death,,2023,Q1,1,I,20221201.0,20221229.0,20230103,20230103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-000583,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,,,20230103,,PH,US,US,2023,Q1,Elderly
218116002,21811600,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Type III immune complex mediated reaction,,2023,Q1,2,F,,20230217.0,20230103,20230224,EXP,,US-MYLANLABS-2022M1142706,MYLAN,"Alkhatib E, Grundman J, Brooks J, Adamusiak A, Janssen E, McNerney K, et al. Insulin hypersensitivity case series in youth with type 1 diabetes. Pediatr-Diabetes 2022;23 (Suppl. 31):74-75 (plus poster) abstr. P067.",9.0,YR,,F,Y,,,20230224,,HP,US,US,2023,Q1,Child
218116002,21811600,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,2,F,,20230217.0,20230103,20230224,EXP,,US-MYLANLABS-2022M1142706,MYLAN,"Alkhatib E, Grundman J, Brooks J, Adamusiak A, Janssen E, McNerney K, et al. Insulin hypersensitivity case series in youth with type 1 diabetes. Pediatr-Diabetes 2022;23 (Suppl. 31):74-75 (plus poster) abstr. P067.",9.0,YR,,F,Y,,,20230224,,HP,US,US,2023,Q1,Child
218116002,21811600,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Drug ineffective for unapproved indication,,2023,Q1,2,F,,20230217.0,20230103,20230224,EXP,,US-MYLANLABS-2022M1142706,MYLAN,"Alkhatib E, Grundman J, Brooks J, Adamusiak A, Janssen E, McNerney K, et al. Insulin hypersensitivity case series in youth with type 1 diabetes. Pediatr-Diabetes 2022;23 (Suppl. 31):74-75 (plus poster) abstr. P067.",9.0,YR,,F,Y,,,20230224,,HP,US,US,2023,Q1,Child
218140161,21814016,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Tremor,,2023,Q1,1,I,20221201.0,20230103.0,20230104,20230104,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-210907",BOEHRINGER INGELHEIM,,41.0,YR,A,F,Y,,,20230104,,PH,US,US,2023,Q1,Adult
218146762,21814676,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2023,Q1,Fall,,2023,Q1,2,F,20221222.0,20221230.0,20230104,20230111,EXP,,US-ROCHE-3250835,ROCHE,,76.0,YR,,F,Y,76.66,KG,20230111,,MD,US,,2023,Q1,Elderly
218146762,21814676,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QID,2023,Q1,Craniocerebral injury,,2023,Q1,2,F,20221222.0,20221230.0,20230104,20230111,EXP,,US-ROCHE-3250835,ROCHE,,76.0,YR,,F,Y,76.66,KG,20230111,,MD,US,,2023,Q1,Elderly
218162482,21816248,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,Injection,,2023,Q1,Respiratory distress,,2023,Q1,2,F,,20230102.0,20230104,20230106,EXP,,US-MYLANLABS-2022M1142752,MYLAN,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant 2022;null:null.",13.0,YR,,F,Y,,,20230106,,HP,US,US,2023,Q1,Child
218162482,21816248,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,Injection,,2023,Q1,BK virus infection,,2023,Q1,2,F,,20230102.0,20230104,20230106,EXP,,US-MYLANLABS-2022M1142752,MYLAN,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant 2022;null:null.",13.0,YR,,F,Y,,,20230106,,HP,US,US,2023,Q1,Child
218162482,21816248,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,Injection,,2023,Q1,Urinary tract infection,,2023,Q1,2,F,,20230102.0,20230104,20230106,EXP,,US-MYLANLABS-2022M1142752,MYLAN,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant 2022;null:null.",13.0,YR,,F,Y,,,20230106,,HP,US,US,2023,Q1,Child
218162482,21816248,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,Injection,,2023,Q1,Rash,,2023,Q1,2,F,,20230102.0,20230104,20230106,EXP,,US-MYLANLABS-2022M1142752,MYLAN,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant 2022;null:null.",13.0,YR,,F,Y,,,20230106,,HP,US,US,2023,Q1,Child
218162482,21816248,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,Injection,,2023,Q1,Upper respiratory tract infection,,2023,Q1,2,F,,20230102.0,20230104,20230106,EXP,,US-MYLANLABS-2022M1142752,MYLAN,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant 2022;null:null.",13.0,YR,,F,Y,,,20230106,,HP,US,US,2023,Q1,Child
218162482,21816248,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,Injection,,2023,Q1,Cytomegalovirus infection,,2023,Q1,2,F,,20230102.0,20230104,20230106,EXP,,US-MYLANLABS-2022M1142752,MYLAN,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant 2022;null:null.",13.0,YR,,F,Y,,,20230106,,HP,US,US,2023,Q1,Child
218165501,21816550,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Treatment noncompliance,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-057335,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Possible association between diabetic ketoacidosis and use of a sodium-gCMAJ.. 2021;193:1746-49",17.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Youth
218165501,21816550,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20221221.0,20230104,20230104,EXP,,CA-AUROBINDO-AUR-APL-2022-057335,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Possible association between diabetic ketoacidosis and use of a sodium-gCMAJ.. 2021;193:1746-49",17.0,YR,,M,Y,,,20230104,,HP,CA,CA,2023,Q1,Youth
218171911,21817191,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D211433F,,21017.0,,,Injection,,2023,Q1,Injection site pain,,2023,Q1,1,I,20220901.0,20221228.0,20230104,20230104,PER,,US-ELI_LILLY_AND_COMPANY-US202212014758,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230104,,CN,US,US,2023,Q1,Adult
218171911,21817191,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D211433F,,21017.0,,,Injection,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,20220901.0,20221228.0,20230104,20230104,PER,,US-ELI_LILLY_AND_COMPANY-US202212014758,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230104,,CN,US,US,2023,Q1,Adult
218212991,21821299,13,C,INSULINE LISPRO,,1,Unknown,"8 international unit, 3 Times a Day",,,U,,,,,8.0,IU,,TID,2023,Q1,Hyperkalaemia,,2023,Q1,1,I,20220922.0,20221222.0,20230105,20230105,EXP,,FR-AUROBINDO-AUR-APL-2022-056735,AUROBINDO,,72.0,YR,,M,Y,95.0,KG,20230105,,CN,FR,FR,2023,Q1,Elderly
218232212,21823221,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Steroid therapy,,2023,Q1,2,F,,20230204.0,20230105,20230207,EXP,,US-GILEAD-2022-0605859,GILEAD,,30.0,YR,A,F,Y,,,20230207,,CN,US,US,2023,Q1,Young Adult
218232212,21823221,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Respiratory syncytial virus infection,,2023,Q1,2,F,,20230204.0,20230105,20230207,EXP,,US-GILEAD-2022-0605859,GILEAD,,30.0,YR,A,F,Y,,,20230207,,CN,US,US,2023,Q1,Young Adult
218232212,21823221,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Inhalation therapy,,2023,Q1,2,F,,20230204.0,20230105,20230207,EXP,,US-GILEAD-2022-0605859,GILEAD,,30.0,YR,A,F,Y,,,20230207,,CN,US,US,2023,Q1,Young Adult
218232212,21823221,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Hospitalisation,,2023,Q1,2,F,,20230204.0,20230105,20230207,EXP,,US-GILEAD-2022-0605859,GILEAD,,30.0,YR,A,F,Y,,,20230207,,CN,US,US,2023,Q1,Young Adult
218232212,21823221,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Asthma,,2023,Q1,2,F,,20230204.0,20230105,20230207,EXP,,US-GILEAD-2022-0605859,GILEAD,,30.0,YR,A,F,Y,,,20230207,,CN,US,US,2023,Q1,Young Adult
218232212,21823221,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2023,Q1,2,F,,20230204.0,20230105,20230207,EXP,,US-GILEAD-2022-0605859,GILEAD,,30.0,YR,A,F,Y,,,20230207,,CN,US,US,2023,Q1,Young Adult
218232212,21823221,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Product dose omission issue,,2023,Q1,2,F,,20230204.0,20230105,20230207,EXP,,US-GILEAD-2022-0605859,GILEAD,,30.0,YR,A,F,Y,,,20230207,,CN,US,US,2023,Q1,Young Adult
218232212,21823221,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Impaired quality of life,,2023,Q1,2,F,,20230204.0,20230105,20230207,EXP,,US-GILEAD-2022-0605859,GILEAD,,30.0,YR,A,F,Y,,,20230207,,CN,US,US,2023,Q1,Young Adult
218233532,21823353,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Off label use,,2023,Q1,2,F,20220224.0,20230306.0,20230105,20230313,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230313,,HP,US,US,2023,Q1,Adult
218233532,21823353,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pain,,2023,Q1,2,F,20220224.0,20230306.0,20230105,20230313,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230313,,HP,US,US,2023,Q1,Adult
218233532,21823353,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,2,F,20220224.0,20230306.0,20230105,20230313,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230313,,HP,US,US,2023,Q1,Adult
218233532,21823353,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Fungal infection,,2023,Q1,2,F,20220224.0,20230306.0,20230105,20230313,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230313,,HP,US,US,2023,Q1,Adult
218233532,21823353,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Product availability issue,,2023,Q1,2,F,20220224.0,20230306.0,20230105,20230313,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230313,,HP,US,US,2023,Q1,Adult
218233532,21823353,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Adverse event,,2023,Q1,2,F,20220224.0,20230306.0,20230105,20230313,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230313,,HP,US,US,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Swelling face,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Feeling abnormal,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Lip swelling,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Anxiety,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Tearfulness,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Erythema,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Angioedema,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218254661,21825466,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Respiratory rate increased,,2023,Q1,1,I,20221231.0,,20230105,20230105,DIR,643562,,FDA-CTU,,50.0,YR,,F,N,,,20230105,N,PH,US,,2023,Q1,Adult
218284541,21828454,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q1,Device expulsion,,2023,Q1,1,I,20220915.0,20220916.0,20230106,20230106,PER,,"US-COOPERSURGICAL, INC.-US-2022CPS003274",COOPERSURGICAL,,30.0,YR,,F,Y,67.574,KG,20230106,,HP,US,US,2023,Q1,Young Adult
218284541,21828454,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q1,Procedural pain,,2023,Q1,1,I,20220915.0,20220916.0,20230106,20230106,PER,,"US-COOPERSURGICAL, INC.-US-2022CPS003274",COOPERSURGICAL,,30.0,YR,,F,Y,67.574,KG,20230106,,HP,US,US,2023,Q1,Young Adult
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Chills,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Tachycardia,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Thirst,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Feeling abnormal,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Influenza,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pyrexia,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pain,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218302931,21830293,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,1,I,20221130.0,20221223.0,20230106,20230106,EXP,,US-AstraZeneca-2023A003392,ASTRAZENECA,,70.0,YR,,M,Y,,,20230106,,HP,US,,2023,Q1,Elderly
218319821,21831982,20,C,INSULINE LISPRO,,1,,,,,,,UNKNOWN,,,8.0,IU,,,2023,Q1,Hyperkalaemia,,2023,Q1,1,I,20220922.0,20221229.0,20230106,20230106,EXP,FR-AFSSAPS-ST20222481,FR-TEVA-2023-FR-2842936,TEVA,,72.0,YR,E,M,Y,95.0,KG,20230106,,CN,FR,FR,2023,Q1,Elderly
218336932,21833693,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2023,Q1,Respiratory symptom,,2023,Q1,2,F,,20230204.0,20230107,20230210,PER,,US-SA-2023SA005634,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20230210,,MD,US,US,2023,Q1,Young Adult
218336932,21833693,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2023,Q1,Respiratory syncytial virus infection,,2023,Q1,2,F,,20230204.0,20230107,20230210,PER,,US-SA-2023SA005634,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20230210,,MD,US,US,2023,Q1,Young Adult
218336932,21833693,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2023,Q1,Hospitalisation,,2023,Q1,2,F,,20230204.0,20230107,20230210,PER,,US-SA-2023SA005634,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20230210,,MD,US,US,2023,Q1,Young Adult
218358341,21835834,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 iU, QD",,,Y,,,,209196.0,22.0,IU,Solution for injection,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20221223.0,20230105.0,20230109,20230109,EXP,IT-MINISAL02-902899,IT-SA-2023SA005706,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20230109,,MD,IT,IT,2023,Q1,Elderly
218401411,21840141,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230101.0,20230110,20230110,EXP,,CA-TEVA-2023-CA-2843458,TEVA,,64.0,YR,A,M,Y,,,20230110,,HP,CA,CA,2023,Q1,Adult
218401411,21840141,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Extradural abscess,,2023,Q1,1,I,,20230101.0,20230110,20230110,EXP,,CA-TEVA-2023-CA-2843458,TEVA,,64.0,YR,A,M,Y,,,20230110,,HP,CA,CA,2023,Q1,Adult
218401411,21840141,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Post streptococcal glomerulonephritis,,2023,Q1,1,I,,20230101.0,20230110,20230110,EXP,,CA-TEVA-2023-CA-2843458,TEVA,,64.0,YR,A,M,Y,,,20230110,,HP,CA,CA,2023,Q1,Adult
218419134,21841913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,2f418a; 2f459a ; 2f466a,,209196.0,,,Solution for injection,,2023,Q1,No adverse event,,2023,Q1,4,F,,20230125.0,20230110,20230210,EXP,,IT-SA-2023SA006331,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20230210,,CN,IT,IT,2023,Q1,Elderly
218454091,21845409,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20221227.0,20230111,20230111,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-372785,RANBAXY,"Dargel S, Schleussner E, Kloos C, Groten T, Weschenfelder F. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy Childbirth. 2021;21(1):552",23.0,YR,,F,Y,,,20230111,,HP,DE,DE,2023,Q1,Youth
218454091,21845409,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Exposure during pregnancy,,2023,Q1,1,I,,20221227.0,20230111,20230111,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-372785,RANBAXY,"Dargel S, Schleussner E, Kloos C, Groten T, Weschenfelder F. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy Childbirth. 2021;21(1):552",23.0,YR,,F,Y,,,20230111,,HP,DE,DE,2023,Q1,Youth
218454091,21845409,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Foetal death,,2023,Q1,1,I,,20221227.0,20230111,20230111,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-372785,RANBAXY,"Dargel S, Schleussner E, Kloos C, Groten T, Weschenfelder F. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy Childbirth. 2021;21(1):552",23.0,YR,,F,Y,,,20230111,,HP,DE,DE,2023,Q1,Youth
218464603,21846460,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Transient ischaemic attack,,2023,Q1,3,F,20211120.0,20230117.0,20230111,20230119,EXP,,US-ROCHE-2963996,ROCHE,,63.0,YR,,M,Y,88.3,KG,20230119,,MD,US,,2023,Q1,Adult
218477193,21847719,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Anaemia,,2023,Q1,3,F,20221110.0,20230111.0,20230111,20230118,PER,,PL-Eisai Medical Research-EC-2022-128637,EISAI,,75.0,YR,E,F,Y,89.0,KG,20230118,,MD,PL,,2023,Q1,Elderly
218495091,21849509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (as needed)",,,U,,D484039C,,,,,Injection,,2023,Q1,Constipation,,2023,Q1,1,I,20221212.0,20221221.0,20230111,20230111,PER,,US-ELI_LILLY_AND_COMPANY-US202212012361,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230111,,CN,US,US,2023,Q1,Elderly
218495091,21849509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (as needed)",,,U,,D484039C,,,,,Injection,,2023,Q1,Dyspepsia,,2023,Q1,1,I,20221212.0,20221221.0,20230111,20230111,PER,,US-ELI_LILLY_AND_COMPANY-US202212012361,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230111,,CN,US,US,2023,Q1,Elderly
218495091,21849509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (as needed)",,,U,,D484039C,,,,,Injection,,2023,Q1,Nausea,,2023,Q1,1,I,20221212.0,20221221.0,20230111,20230111,PER,,US-ELI_LILLY_AND_COMPANY-US202212012361,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230111,,CN,US,US,2023,Q1,Elderly
218495091,21849509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (as needed)",,,U,,D484039C,,,,,Injection,,2023,Q1,Product dose omission issue,,2023,Q1,1,I,20221212.0,20221221.0,20230111,20230111,PER,,US-ELI_LILLY_AND_COMPANY-US202212012361,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230111,,CN,US,US,2023,Q1,Elderly
218495091,21849509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (as needed)",,,U,,D484039C,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20221212.0,20221221.0,20230111,20230111,PER,,US-ELI_LILLY_AND_COMPANY-US202212012361,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230111,,CN,US,US,2023,Q1,Elderly
218495091,21849509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (as needed)",,,U,,D484039C,,,,,Injection,,2023,Q1,Increased appetite,,2023,Q1,1,I,20221212.0,20221221.0,20230111,20230111,PER,,US-ELI_LILLY_AND_COMPANY-US202212012361,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230111,,CN,US,US,2023,Q1,Elderly
218495091,21849509,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (as needed)",,,U,,D484039C,,,,,Injection,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20221212.0,20221221.0,20230111,20230111,PER,,US-ELI_LILLY_AND_COMPANY-US202212012361,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20230111,,CN,US,US,2023,Q1,Elderly
218517131,21851713,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q1,Staphylococcal infection,,2023,Q1,1,I,20221003.0,20230109.0,20230112,20230112,EXP,,US-SA-2023SA009107,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218517131,21851713,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q1,Back disorder,,2023,Q1,1,I,20221003.0,20230109.0,20230112,20230112,EXP,,US-SA-2023SA009107,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218517131,21851713,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q1,Renal impairment,,2023,Q1,1,I,20221003.0,20230109.0,20230112,20230112,EXP,,US-SA-2023SA009107,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218517131,21851713,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q1,Muscle tightness,,2023,Q1,1,I,20221003.0,20230109.0,20230112,20230112,EXP,,US-SA-2023SA009107,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218534801,21853480,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, Q12H",,,D,,,,,,,,Q12H,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,1,I,,20230109.0,20230112,20230112,PER,,US-SA-2023SA010070,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230112,,CN,US,US,2023,Q1,Elderly
218581731,21858173,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2023,Q1,Cytomegalovirus infection,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,US-AUROBINDO-AUR-APL-2023-001359,AUROBINDO,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant. 2022",12.0,YR,,F,Y,,,20230113,,HP,US,US,2023,Q1,Child
218581731,21858173,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2023,Q1,Urinary tract infection,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,US-AUROBINDO-AUR-APL-2023-001359,AUROBINDO,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant. 2022",12.0,YR,,F,Y,,,20230113,,HP,US,US,2023,Q1,Child
218581731,21858173,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2023,Q1,BK virus infection,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,US-AUROBINDO-AUR-APL-2023-001359,AUROBINDO,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant. 2022",12.0,YR,,F,Y,,,20230113,,HP,US,US,2023,Q1,Child
218581731,21858173,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2023,Q1,Upper respiratory tract infection,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,US-AUROBINDO-AUR-APL-2023-001359,AUROBINDO,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatr-Transplant. 2022",12.0,YR,,F,Y,,,20230113,,HP,US,US,2023,Q1,Child
218581872,21858187,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(U-100) 100 unit/mL subcutaneous pen?with meals,,,,,,,,10.0,IU,,TID,2023,Q1,Flushing,,2023,Q1,2,F,20230301.0,20230317.0,20230113,20230329,PER,,US-Vifor (International) Inc.-VIT-2023-00078,VIFOR,,60.0,YR,,M,Y,104.5,KG,20230329,,HP,US,US,2023,Q1,Adult
218581872,21858187,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(U-100) 100 unit/mL subcutaneous pen?with meals,,,,,,,,10.0,IU,,TID,2023,Q1,Drug hypersensitivity,,2023,Q1,2,F,20230301.0,20230317.0,20230113,20230329,PER,,US-Vifor (International) Inc.-VIT-2023-00078,VIFOR,,60.0,YR,,M,Y,104.5,KG,20230329,,HP,US,US,2023,Q1,Adult
218581872,21858187,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(U-100) 100 unit/mL subcutaneous pen?with meals,,,,,,,,10.0,IU,,TID,2023,Q1,Hyperhidrosis,,2023,Q1,2,F,20230301.0,20230317.0,20230113,20230329,PER,,US-Vifor (International) Inc.-VIT-2023-00078,VIFOR,,60.0,YR,,M,Y,104.5,KG,20230329,,HP,US,US,2023,Q1,Adult
218595941,21859594,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1.2 u, other",,,Y,,,,20563.0,1.2,IU,,,2023,Q1,Anti-insulin antibody increased,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202301001543AA,ELI LILLY AND CO,"Obata Y, et al..Exogenous insulin antibody syndrome in a patient with diabetes secondary to total pancreatectomy.Diabetology International 2022;:.DOI:10.1007/s13340-022-00611-z",74.0,YR,,M,Y,34.4,KG,20230113,,MD,JP,JP,2023,Q1,Elderly
218595941,21859594,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1.2 u, other",,,Y,,,,20563.0,1.2,IU,,,2023,Q1,Hypoglycaemic coma,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202301001543AA,ELI LILLY AND CO,"Obata Y, et al..Exogenous insulin antibody syndrome in a patient with diabetes secondary to total pancreatectomy.Diabetology International 2022;:.DOI:10.1007/s13340-022-00611-z",74.0,YR,,M,Y,34.4,KG,20230113,,MD,JP,JP,2023,Q1,Elderly
218595941,21859594,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1.2 u, other",,,Y,,,,20563.0,1.2,IU,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202301001543AA,ELI LILLY AND CO,"Obata Y, et al..Exogenous insulin antibody syndrome in a patient with diabetes secondary to total pancreatectomy.Diabetology International 2022;:.DOI:10.1007/s13340-022-00611-z",74.0,YR,,M,Y,34.4,KG,20230113,,MD,JP,JP,2023,Q1,Elderly
218595941,21859594,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1.5-3.0unit/day(bolus), 1.575unit/day(basal)",,,Y,,,,20563.0,,,,,2023,Q1,Anti-insulin antibody increased,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202301001543AA,ELI LILLY AND CO,"Obata Y, et al..Exogenous insulin antibody syndrome in a patient with diabetes secondary to total pancreatectomy.Diabetology International 2022;:.DOI:10.1007/s13340-022-00611-z",74.0,YR,,M,Y,34.4,KG,20230113,,MD,JP,JP,2023,Q1,Elderly
218595941,21859594,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1.5-3.0unit/day(bolus), 1.575unit/day(basal)",,,Y,,,,20563.0,,,,,2023,Q1,Hypoglycaemic coma,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202301001543AA,ELI LILLY AND CO,"Obata Y, et al..Exogenous insulin antibody syndrome in a patient with diabetes secondary to total pancreatectomy.Diabetology International 2022;:.DOI:10.1007/s13340-022-00611-z",74.0,YR,,M,Y,34.4,KG,20230113,,MD,JP,JP,2023,Q1,Elderly
218595941,21859594,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1.5-3.0unit/day(bolus), 1.575unit/day(basal)",,,Y,,,,20563.0,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230102.0,20230113,20230113,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202301001543AA,ELI LILLY AND CO,"Obata Y, et al..Exogenous insulin antibody syndrome in a patient with diabetes secondary to total pancreatectomy.Diabetology International 2022;:.DOI:10.1007/s13340-022-00611-z",74.0,YR,,M,Y,34.4,KG,20230113,,MD,JP,JP,2023,Q1,Elderly
218701901,21870190,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Klebsiella bacteraemia,,2023,Q1,1,I,20200207.0,20230112.0,20230117,20230117,EXP,,US-ABBVIE-4272437,ABBVIE,,62.0,YR,,M,Y,,,20230117,,CN,US,US,2023,Q1,Adult
218701901,21870190,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Urethral stent removal,,2023,Q1,1,I,20200207.0,20230112.0,20230117,20230117,EXP,,US-ABBVIE-4272437,ABBVIE,,62.0,YR,,M,Y,,,20230117,,CN,US,US,2023,Q1,Adult
218701901,21870190,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Device related infection,,2023,Q1,1,I,20200207.0,20230112.0,20230117,20230117,EXP,,US-ABBVIE-4272437,ABBVIE,,62.0,YR,,M,Y,,,20230117,,CN,US,US,2023,Q1,Adult
218702501,21870250,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Soft tissue infection,,2023,Q1,1,I,20191011.0,20230112.0,20230117,20230117,EXP,,US-ABBVIE-4272450,ABBVIE,,59.0,YR,,M,Y,112.94,KG,20230117,,CN,US,US,2023,Q1,Adult
218702501,21870250,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Rash erythematous,,2023,Q1,1,I,20191011.0,20230112.0,20230117,20230117,EXP,,US-ABBVIE-4272450,ABBVIE,,59.0,YR,,M,Y,112.94,KG,20230117,,CN,US,US,2023,Q1,Adult
218754991,21875499,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Renal impairment,,2023,Q1,1,I,20221003.0,20230104.0,20230118,20230118,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-372835,RANBAXY,,67.0,YR,,M,Y,,,20230118,,CN,US,US,2023,Q1,Elderly
218754991,21875499,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Muscle tightness,,2023,Q1,1,I,20221003.0,20230104.0,20230118,20230118,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-372835,RANBAXY,,67.0,YR,,M,Y,,,20230118,,CN,US,US,2023,Q1,Elderly
218754991,21875499,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Staphylococcal infection,,2023,Q1,1,I,20221003.0,20230104.0,20230118,20230118,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-372835,RANBAXY,,67.0,YR,,M,Y,,,20230118,,CN,US,US,2023,Q1,Elderly
218754991,21875499,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Back disorder,,2023,Q1,1,I,20221003.0,20230104.0,20230118,20230118,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-372835,RANBAXY,,67.0,YR,,M,Y,,,20230118,,CN,US,US,2023,Q1,Elderly
218803331,21880333,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Disease progression,,2023,Q1,1,I,,,20230117,20230117,DIR,FDA-CDER-CTU-2023-4513,,FDA-CTU,,46.0,YR,,F,N,75.75,KG,20230117,N,MD,US,,2023,Q1,Adult
218803331,21880333,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Malignant neoplasm progression,,2023,Q1,1,I,,,20230117,20230117,DIR,FDA-CDER-CTU-2023-4513,,FDA-CTU,,46.0,YR,,F,N,75.75,KG,20230117,N,MD,US,,2023,Q1,Adult
218808043,21880804,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Cytokine release syndrome,,2023,Q1,3,F,20221221.0,20230202.0,20230118,20230203,PER,,US-GILEAD-2023-0613095,GILEAD,,63.0,YR,A,M,Y,88.1,KG,20230203,,HP,US,US,2023,Q1,Adult
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Wound closure,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Neutropenia,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Decreased appetite,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Oedema,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Central venous catheterisation,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Abdominal pain lower,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pleuritic pain,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Norovirus test positive,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810331,21881033,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Wound infection staphylococcal,,2023,Q1,1,I,20190414.0,20230109.0,20230118,20230118,EXP,,US-ABBVIE-4274024,ABBVIE,,69.0,YR,,M,Y,75.0,KG,20230118,,CN,US,US,2023,Q1,Elderly
218810441,21881044,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Trifascicular block,,2023,Q1,1,I,20190808.0,20230113.0,20230118,20230118,EXP,,US-ABBVIE-4274084,ABBVIE,,71.0,YR,,M,Y,,,20230118,,CN,US,US,2023,Q1,Elderly
218810441,21881044,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Arrhythmia,,2023,Q1,1,I,20190808.0,20230113.0,20230118,20230118,EXP,,US-ABBVIE-4274084,ABBVIE,,71.0,YR,,M,Y,,,20230118,,CN,US,US,2023,Q1,Elderly
218810441,21881044,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20190808.0,20230113.0,20230118,20230118,EXP,,US-ABBVIE-4274084,ABBVIE,,71.0,YR,,M,Y,,,20230118,,CN,US,US,2023,Q1,Elderly
218810441,21881044,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Surgery,,2023,Q1,1,I,20190808.0,20230113.0,20230118,20230118,EXP,,US-ABBVIE-4274084,ABBVIE,,71.0,YR,,M,Y,,,20230118,,CN,US,US,2023,Q1,Elderly
218817021,21881702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 iU, 0-0-0-9, solution for injection/infusion",,,U,,,,209196.0,300.0,IU,Solution for injection,,2023,Q1,Malaise,,2023,Q1,1,I,,20230113.0,20230119,20230119,EXP,,DE-SA-2023SA016206,SANOFI AVENTIS,,86.0,YR,E,F,Y,64.0,KG,20230119,,PH,DE,DE,2023,Q1,Elderly
218817021,21881702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 iU, 0-0-0-9, solution for injection/infusion",,,U,,,,209196.0,300.0,IU,Solution for injection,,2023,Q1,Pruritus,,2023,Q1,1,I,,20230113.0,20230119,20230119,EXP,,DE-SA-2023SA016206,SANOFI AVENTIS,,86.0,YR,E,F,Y,64.0,KG,20230119,,PH,DE,DE,2023,Q1,Elderly
218817021,21881702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 iU, 0-0-0-9, solution for injection/infusion",,,U,,,,209196.0,300.0,IU,Solution for injection,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,,20230113.0,20230119,20230119,EXP,,DE-SA-2023SA016206,SANOFI AVENTIS,,86.0,YR,E,F,Y,64.0,KG,20230119,,PH,DE,DE,2023,Q1,Elderly
218817021,21881702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 iU, 0-0-0-9, solution for injection/infusion",,,U,,,,209196.0,300.0,IU,Solution for injection,,2023,Q1,Musculoskeletal pain,,2023,Q1,1,I,,20230113.0,20230119,20230119,EXP,,DE-SA-2023SA016206,SANOFI AVENTIS,,86.0,YR,E,F,Y,64.0,KG,20230119,,PH,DE,DE,2023,Q1,Elderly
218817021,21881702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 iU, 0-0-0-9, solution for injection/infusion",,,U,,,,209196.0,300.0,IU,Solution for injection,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230113.0,20230119,20230119,EXP,,DE-SA-2023SA016206,SANOFI AVENTIS,,86.0,YR,E,F,Y,64.0,KG,20230119,,PH,DE,DE,2023,Q1,Elderly
218817021,21881702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 iU, 0-0-0-9, solution for injection/infusion",,,U,,,,209196.0,300.0,IU,Solution for injection,,2023,Q1,Confusional state,,2023,Q1,1,I,,20230113.0,20230119,20230119,EXP,,DE-SA-2023SA016206,SANOFI AVENTIS,,86.0,YR,E,F,Y,64.0,KG,20230119,,PH,DE,DE,2023,Q1,Elderly
218817021,21881702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 iU, 0-0-0-9, solution for injection/infusion",,,U,,,,209196.0,300.0,IU,Solution for injection,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230113.0,20230119,20230119,EXP,,DE-SA-2023SA016206,SANOFI AVENTIS,,86.0,YR,E,F,Y,64.0,KG,20230119,,PH,DE,DE,2023,Q1,Elderly
218817021,21881702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 iU, 0-0-0-9, solution for injection/infusion",,,U,,,,209196.0,300.0,IU,Solution for injection,,2023,Q1,Rash,,2023,Q1,1,I,,20230113.0,20230119,20230119,EXP,,DE-SA-2023SA016206,SANOFI AVENTIS,,86.0,YR,E,F,Y,64.0,KG,20230119,,PH,DE,DE,2023,Q1,Elderly
218875571,21887557,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2023,Q1,Pruritus,,2023,Q1,1,I,,20230110.0,20230120,20230120,EXP,DE-BFARM-21006007,DE-NOVOPROD-1011106,NOVO NORDISK,,86.0,YR,,F,Y,64.0,KG,20230120,,PH,DE,DE,2023,Q1,Elderly
218875571,21887557,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2023,Q1,Confusional state,,2023,Q1,1,I,,20230110.0,20230120,20230120,EXP,DE-BFARM-21006007,DE-NOVOPROD-1011106,NOVO NORDISK,,86.0,YR,,F,Y,64.0,KG,20230120,,PH,DE,DE,2023,Q1,Elderly
218875571,21887557,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2023,Q1,Musculoskeletal pain,,2023,Q1,1,I,,20230110.0,20230120,20230120,EXP,DE-BFARM-21006007,DE-NOVOPROD-1011106,NOVO NORDISK,,86.0,YR,,F,Y,64.0,KG,20230120,,PH,DE,DE,2023,Q1,Elderly
218875571,21887557,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,,20230110.0,20230120,20230120,EXP,DE-BFARM-21006007,DE-NOVOPROD-1011106,NOVO NORDISK,,86.0,YR,,F,Y,64.0,KG,20230120,,PH,DE,DE,2023,Q1,Elderly
218875571,21887557,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230110.0,20230120,20230120,EXP,DE-BFARM-21006007,DE-NOVOPROD-1011106,NOVO NORDISK,,86.0,YR,,F,Y,64.0,KG,20230120,,PH,DE,DE,2023,Q1,Elderly
218875571,21887557,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2023,Q1,Malaise,,2023,Q1,1,I,,20230110.0,20230120,20230120,EXP,DE-BFARM-21006007,DE-NOVOPROD-1011106,NOVO NORDISK,,86.0,YR,,F,Y,64.0,KG,20230120,,PH,DE,DE,2023,Q1,Elderly
218875571,21887557,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2023,Q1,Rash,,2023,Q1,1,I,,20230110.0,20230120,20230120,EXP,DE-BFARM-21006007,DE-NOVOPROD-1011106,NOVO NORDISK,,86.0,YR,,F,Y,64.0,KG,20230120,,PH,DE,DE,2023,Q1,Elderly
218875571,21887557,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,,,,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230110.0,20230120,20230120,EXP,DE-BFARM-21006007,DE-NOVOPROD-1011106,NOVO NORDISK,,86.0,YR,,F,Y,64.0,KG,20230120,,PH,DE,DE,2023,Q1,Elderly
218888531,21888853,8,C,INSULIN LISPRO BS,,2,Unknown,UNK,,,,,UNKNOWN,,,,,Injection,,2023,Q1,Rectal ulcer haemorrhage,,2023,Q1,1,I,20220818.0,20230117.0,20230120,20230120,EXP,,JP-ROCHE-3267654,ROCHE,,74.0,YR,,F,Y,37.9,KG,20230120,,PH,JP,JP,2023,Q1,Elderly
218888531,21888853,8,C,INSULIN LISPRO BS,,2,Unknown,UNK,,,,,UNKNOWN,,,,,Injection,,2023,Q1,Decreased appetite,,2023,Q1,1,I,20220818.0,20230117.0,20230120,20230120,EXP,,JP-ROCHE-3267654,ROCHE,,74.0,YR,,F,Y,37.9,KG,20230120,,PH,JP,JP,2023,Q1,Elderly
218947511,21894751,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q1,Completed suicide,,2023,Q1,1,I,20210101.0,20230109.0,20230122,20230122,EXP,,US-APOTEX-2023AP001764,APOTEX,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643",61.0,YR,,F,Y,,,20230122,,MD,US,US,2023,Q1,Adult
218960021,21896002,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2023,Q1,Completed suicide,,2023,Q1,1,I,20210101.0,20230109.0,20230123,20230123,EXP,,US-APOTEX-2023AP002024,APOTEX,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643",29.0,YR,,F,Y,,,20230123,,MD,US,US,2023,Q1,Young Adult
218960021,21896002,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,UNK,,,D,,,,,,,,,2023,Q1,Completed suicide,,2023,Q1,1,I,20210101.0,20230109.0,20230123,20230123,EXP,,US-APOTEX-2023AP002024,APOTEX,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60:12:1381-1643",29.0,YR,,F,Y,,,20230123,,MD,US,US,2023,Q1,Young Adult
218976761,21897676,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,Solution for injection,,2023,Q1,Product administration error,,2023,Q1,1,I,,20230116.0,20230123,20230123,PER,,US-SA-2023SA018557,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20230123,,CN,US,US,2023,Q1,Elderly
218982311,21898231,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 u, each morning",,,U,,,,,42.0,IU,,QD,2023,Q1,Albumin urine present,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 u, each morning",,,U,,,,,42.0,IU,,QD,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 u, each morning",,,U,,,,,42.0,IU,,QD,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 u, each morning",,,U,,,,,42.0,IU,,QD,2023,Q1,Gamma-glutamyltransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 u, each morning",,,U,,,,,42.0,IU,,QD,2023,Q1,Aspartate aminotransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 u, each morning",,,U,,,,,42.0,IU,,QD,2023,Q1,Alanine aminotransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 u, daily (night)",,,U,,,,,38.0,IU,,QD,2023,Q1,Albumin urine present,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 u, daily (night)",,,U,,,,,38.0,IU,,QD,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 u, daily (night)",,,U,,,,,38.0,IU,,QD,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 u, daily (night)",,,U,,,,,38.0,IU,,QD,2023,Q1,Gamma-glutamyltransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 u, daily (night)",,,U,,,,,38.0,IU,,QD,2023,Q1,Aspartate aminotransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982311,21898231,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 u, daily (night)",,,U,,,,,38.0,IU,,QD,2023,Q1,Alanine aminotransferase increased,,2023,Q1,1,I,20220101.0,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004262,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218982391,21898239,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2023,Q1,Pruritus,,2023,Q1,1,I,,20230110.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301003549,ELI LILLY AND CO,,86.0,YR,,F,Y,64.0,KG,20230123,,CN,DE,DE,2023,Q1,Elderly
218982391,21898239,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2023,Q1,Rash,,2023,Q1,1,I,,20230110.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301003549,ELI LILLY AND CO,,86.0,YR,,F,Y,64.0,KG,20230123,,CN,DE,DE,2023,Q1,Elderly
218982391,21898239,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2023,Q1,Musculoskeletal pain,,2023,Q1,1,I,,20230110.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301003549,ELI LILLY AND CO,,86.0,YR,,F,Y,64.0,KG,20230123,,CN,DE,DE,2023,Q1,Elderly
218982391,21898239,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230110.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301003549,ELI LILLY AND CO,,86.0,YR,,F,Y,64.0,KG,20230123,,CN,DE,DE,2023,Q1,Elderly
218982391,21898239,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,,20230110.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301003549,ELI LILLY AND CO,,86.0,YR,,F,Y,64.0,KG,20230123,,CN,DE,DE,2023,Q1,Elderly
218982391,21898239,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2023,Q1,Malaise,,2023,Q1,1,I,,20230110.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301003549,ELI LILLY AND CO,,86.0,YR,,F,Y,64.0,KG,20230123,,CN,DE,DE,2023,Q1,Elderly
218982391,21898239,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2023,Q1,Hypertension,,2023,Q1,1,I,,20230110.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301003549,ELI LILLY AND CO,,86.0,YR,,F,Y,64.0,KG,20230123,,CN,DE,DE,2023,Q1,Elderly
218982391,21898239,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2023,Q1,Confusional state,,2023,Q1,1,I,,20230110.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301003549,ELI LILLY AND CO,,86.0,YR,,F,Y,64.0,KG,20230123,,CN,DE,DE,2023,Q1,Elderly
218988431,21898843,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5+16+16IU/day,,,,,,,,,,,,2023,Q1,Hyperhidrosis,,2023,Q1,1,I,20220526.0,20230118.0,20230123,20230123,EXP,IT-MINISAL02-901434,IT-MYLANLABS-2023M1006455,MYLAN,,71.0,YR,,F,Y,,,20230123,,MD,IT,IT,2023,Q1,Elderly
218988431,21898843,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5+16+16IU/day,,,,,,,,,,,,2023,Q1,Presyncope,,2023,Q1,1,I,20220526.0,20230118.0,20230123,20230123,EXP,IT-MINISAL02-901434,IT-MYLANLABS-2023M1006455,MYLAN,,71.0,YR,,F,Y,,,20230123,,MD,IT,IT,2023,Q1,Elderly
218988431,21898843,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5+16+16IU/day,,,,,,,,,,,,2023,Q1,Bradycardia,,2023,Q1,1,I,20220526.0,20230118.0,20230123,20230123,EXP,IT-MINISAL02-901434,IT-MYLANLABS-2023M1006455,MYLAN,,71.0,YR,,F,Y,,,20230123,,MD,IT,IT,2023,Q1,Elderly
218992471,21899247,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 international unit, bid",,,U,,,,20563.0,60.0,IU,,BID,2023,Q1,Diabetic retinopathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 international unit, bid",,,U,,,,20563.0,60.0,IU,,BID,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 international unit, bid",,,U,,,,20563.0,60.0,IU,,BID,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 international unit, bid",,,U,,,,20563.0,60.0,IU,,BID,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 international unit, bid",,,U,,,,20563.0,60.0,IU,,BID,2023,Q1,Macroangiopathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 international unit, bid",,,U,,,,20563.0,60.0,IU,,BID,2023,Q1,Diabetic neuropathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 international unit, bid",,,U,,,,20563.0,60.0,IU,,BID,2023,Q1,Fatigue,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 international unit, each evening",,,U,,,,20563.0,20.0,IU,,QD,2023,Q1,Diabetic retinopathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 international unit, each evening",,,U,,,,20563.0,20.0,IU,,QD,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 international unit, each evening",,,U,,,,20563.0,20.0,IU,,QD,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 international unit, each evening",,,U,,,,20563.0,20.0,IU,,QD,2023,Q1,Diabetes mellitus,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 international unit, each evening",,,U,,,,20563.0,20.0,IU,,QD,2023,Q1,Macroangiopathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 international unit, each evening",,,U,,,,20563.0,20.0,IU,,QD,2023,Q1,Diabetic neuropathy,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
218992471,21899247,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 international unit, each evening",,,U,,,,20563.0,20.0,IU,,QD,2023,Q1,Fatigue,,2023,Q1,1,I,,20230111.0,20230123,20230123,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202301004164,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230123,,CN,DE,DE,2023,Q1,Adult
219015111,21901511,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,Insulin lispro Mix 75/25 pen,,,,,,,,,,Unknown,,2023,Q1,Death,,2023,Q1,1,I,20230116.0,20230116.0,20230123,20230123,EXP,,US-BIOGEN-2023BI01182975,BIOGEN,,35.0,YR,,F,Y,,,20230123,,PH,US,US,2023,Q1,Adult
219042973,21904297,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Product use issue,,2023,Q1,3,F,,20230327.0,20230124,20230329,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-213814",BOEHRINGER INGELHEIM,,69.0,YR,E,M,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
219050311,21905031,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 to 10 iU, every 6 hrs",,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230121.0,20230124,20230124,EXP,,US-PFIZER INC-PV202300013687,PFIZER,"Spiegel, D.. A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine. Journal of Clinical Psychopharmacology. 2023;43 (1):67-69",56.0,YR,,F,Y,,,20230124,,MD,US,US,2023,Q1,Adult
219050311,21905031,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 to 10 iU, every 6 hrs",,,,,,,,,,,,2023,Q1,Hypoventilation,,2023,Q1,1,I,,20230121.0,20230124,20230124,EXP,,US-PFIZER INC-PV202300013687,PFIZER,"Spiegel, D.. A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine. Journal of Clinical Psychopharmacology. 2023;43 (1):67-69",56.0,YR,,F,Y,,,20230124,,MD,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Hepatic encephalopathy,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Product use issue,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Sepsis,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Chills,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Arthralgia,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Fall,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Hepatocellular carcinoma,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Disease progression,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Pyrexia,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Pain in extremity,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Tachycardia,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219057751,21905775,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 units, before meal",,,,,,,,,,,Q8H,2023,Q1,Inability to afford medication,,2023,Q1,1,I,20200101.0,20230117.0,20230124,20230124,EXP,,US-BAUSCH-BL-2020-021104,BAUSCH AND LOMB,,58.0,YR,,M,Y,59.091,KG,20230124,,CN,US,US,2023,Q1,Adult
219066221,21906622,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q1,Cardiac valve disease,,2023,Q1,1,I,20230101.0,20230118.0,20230125,20230125,PER,,US-ELI_LILLY_AND_COMPANY-US202301008660,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230125,,CN,US,US,2023,Q1,Elderly
219144801,21914480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,Y,,ASKU,,20563.0,,,Injection,,2023,Q1,Drug hypersensitivity,,2023,Q1,1,I,20210701.0,20230118.0,20230126,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202301010225,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230126,,CN,US,US,2023,Q1,Elderly
219144801,21914480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,Y,,ASKU,,20563.0,,,Injection,,2023,Q1,Diarrhoea,,2023,Q1,1,I,20210701.0,20230118.0,20230126,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202301010225,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230126,,CN,US,US,2023,Q1,Elderly
219144801,21914480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,Y,,ASKU,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20210701.0,20230118.0,20230126,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202301010225,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230126,,CN,US,US,2023,Q1,Elderly
219144801,21914480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,Y,,ASKU,,20563.0,,,Injection,,2023,Q1,Nausea,,2023,Q1,1,I,20210701.0,20230118.0,20230126,20230126,PER,,US-ELI_LILLY_AND_COMPANY-US202301010225,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230126,,CN,US,US,2023,Q1,Elderly
219150951,21915095,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, as needed",,,,,,,,,,Injection,,2023,Q1,Paraesthesia,,2023,Q1,1,I,20190118.0,20220110.0,20230126,20230126,PER,,"US-CATALYST PHARMACEUTICALS, INC-2022CAT00013",CATALYST PHARMA,,49.0,YR,,F,Y,72.575,KG,20230126,,CN,US,US,2023,Q1,Adult
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea exertional,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Sinusitis,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Alopecia,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Mucosal inflammation,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Anaemia,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219168481,21916848,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Thrombocytopenia,,2023,Q1,1,I,,20230113.0,20230126,20230126,EXP,,GB-B.Braun Medical Inc.-2137091,B BRAUN,,77.0,YR,,F,Y,,,20230126,,,GB,GB,2023,Q1,Elderly
219186811,21918681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Completed suicide,,2023,Q1,1,I,,20230117.0,20230127,20230127,EXP,,US-GLENMARK PHARMACEUTICALS-2023GMK078069,GLENMARK,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Pham Nathaniel PT, Bronstein AC, Weber JA.. 2021 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 39th Annual Report.. Clinical Toxicology.. 2022;60 (12):1381-1643",61.0,YR,,F,Y,,,20230127,,MD,US,US,2023,Q1,Adult
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea exertional,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Sinusitis,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Mucosal inflammation,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Thrombocytopenia,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Anaemia,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219203401,21920340,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Alopecia,,2023,Q1,1,I,,20230113.0,20230127,20230127,EXP,,GB-B.Braun Medical Inc.-2137187,B BRAUN,,77.0,YR,,F,Y,,,20230127,,,GB,GB,2023,Q1,Elderly
219237681,21923768,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (25/75 + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Headache,,2023,Q1,1,I,,20230120.0,20230130,20230130,EXP,,PT-EMD Serono-E2B_90090520,EMD SERONO INC,,54.0,YR,A,F,Y,,,20230130,,PH,PT,,2023,Q1,Adult
219237681,21923768,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (25/75 + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Ischaemic stroke,,2023,Q1,1,I,,20230120.0,20230130,20230130,EXP,,PT-EMD Serono-E2B_90090520,EMD SERONO INC,,54.0,YR,A,F,Y,,,20230130,,PH,PT,,2023,Q1,Adult
219237681,21923768,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (25/75 + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Chest pain,,2023,Q1,1,I,,20230120.0,20230130,20230130,EXP,,PT-EMD Serono-E2B_90090520,EMD SERONO INC,,54.0,YR,A,F,Y,,,20230130,,PH,PT,,2023,Q1,Adult
219240511,21924051,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,12 units with every meal,,,,,,,,,,,,2023,Q1,Product use in unapproved indication,,2023,Q1,1,I,,20211217.0,20230130,20230130,PER,,US-UCBSA-2021060668,UCB,"Degener T, Quon S, Holtom P, Hsieh E. From prostate to the pons: The first reported case of multi-organ septic emboli and brain empyema from an untreated prostate abscess. Clinical Case Reports. 2021;1-6",47.0,YR,,M,Y,,,20230130,,MD,US,US,2023,Q1,Adult
219240511,21924051,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,12 units with every meal,,,,,,,,,,,,2023,Q1,Seizure,,2023,Q1,1,I,,20211217.0,20230130,20230130,PER,,US-UCBSA-2021060668,UCB,"Degener T, Quon S, Holtom P, Hsieh E. From prostate to the pons: The first reported case of multi-organ septic emboli and brain empyema from an untreated prostate abscess. Clinical Case Reports. 2021;1-6",47.0,YR,,M,Y,,,20230130,,MD,US,US,2023,Q1,Adult
219286892,21928689,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (0/50 IU 60IU in the morning and 64 IU in the evening),,,U,,,,,,,,,2023,Q1,Neuralgia,,2023,Q1,2,F,,20230216.0,20230130,20230225,EXP,,RO-AUROBINDO-AUR-APL-2023-003752,AUROBINDO,"M?d?lina-Ionela Bozac, Dr. Radu Revnic. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. The Romanian Journal of Family Medicine. 2022;5 (4):33-37",68.0,YR,,,Y,,,20230225,,MD,RO,RO,2023,Q1,Elderly
219286892,21928689,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (0/50 IU 60IU in the morning and 64 IU in the evening),,,U,,,,,,,,,2023,Q1,Varicella zoster virus infection,,2023,Q1,2,F,,20230216.0,20230130,20230225,EXP,,RO-AUROBINDO-AUR-APL-2023-003752,AUROBINDO,"M?d?lina-Ionela Bozac, Dr. Radu Revnic. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. The Romanian Journal of Family Medicine. 2022;5 (4):33-37",68.0,YR,,,Y,,,20230225,,MD,RO,RO,2023,Q1,Elderly
219286892,21928689,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (0/50 IU 60IU in the morning and 64 IU in the evening),,,U,,,,,,,,,2023,Q1,Rash,,2023,Q1,2,F,,20230216.0,20230130,20230225,EXP,,RO-AUROBINDO-AUR-APL-2023-003752,AUROBINDO,"M?d?lina-Ionela Bozac, Dr. Radu Revnic. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. The Romanian Journal of Family Medicine. 2022;5 (4):33-37",68.0,YR,,,Y,,,20230225,,MD,RO,RO,2023,Q1,Elderly
219286892,21928689,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (0/50 IU 60IU in the morning and 64 IU in the evening),,,U,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,2,F,,20230216.0,20230130,20230225,EXP,,RO-AUROBINDO-AUR-APL-2023-003752,AUROBINDO,"M?d?lina-Ionela Bozac, Dr. Radu Revnic. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. The Romanian Journal of Family Medicine. 2022;5 (4):33-37",68.0,YR,,,Y,,,20230225,,MD,RO,RO,2023,Q1,Elderly
219286892,21928689,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (0/50 IU 60IU in the morning and 64 IU in the evening),,,U,,,,,,,,,2023,Q1,Pain,,2023,Q1,2,F,,20230216.0,20230130,20230225,EXP,,RO-AUROBINDO-AUR-APL-2023-003752,AUROBINDO,"M?d?lina-Ionela Bozac, Dr. Radu Revnic. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. The Romanian Journal of Family Medicine. 2022;5 (4):33-37",68.0,YR,,,Y,,,20230225,,MD,RO,RO,2023,Q1,Elderly
219293731,21929373,2,SS,INSULIN LISPRO-AABC,INSULIN LISPRO-AABC,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2023,Q1,Injection site pain,,2023,Q1,1,I,20221001.0,20230118.0,20230131,20230131,PER,,US-ELI_LILLY_AND_COMPANY-US202301008848,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20230131,,CN,US,US,2023,Q1,Adult
219293731,21929373,2,SS,INSULIN LISPRO-AABC,INSULIN LISPRO-AABC,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2023,Q1,Therapeutic response delayed,,2023,Q1,1,I,20221001.0,20230118.0,20230131,20230131,PER,,US-ELI_LILLY_AND_COMPANY-US202301008848,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20230131,,CN,US,US,2023,Q1,Adult
219293731,21929373,2,SS,INSULIN LISPRO-AABC,INSULIN LISPRO-AABC,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2023,Q1,Blood glucose fluctuation,,2023,Q1,1,I,20221001.0,20230118.0,20230131,20230131,PER,,US-ELI_LILLY_AND_COMPANY-US202301008848,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20230131,,CN,US,US,2023,Q1,Adult
219293731,21929373,2,SS,INSULIN LISPRO-AABC,INSULIN LISPRO-AABC,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,20221001.0,20230118.0,20230131,20230131,PER,,US-ELI_LILLY_AND_COMPANY-US202301008848,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20230131,,CN,US,US,2023,Q1,Adult
219321601,21932160,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 iU, Q8H",,,D,,,,209196.0,13.0,IU,Solution for injection,Q8H,2023,Q1,Sudden death,,2023,Q1,1,I,20221230.0,20230127.0,20230131,20230131,EXP,IT-MINISAL02-905963,IT-SA-2023SA033906,SANOFI AVENTIS,,53.0,YR,A,M,Y,62.0,KG,20230131,,MD,IT,IT,2023,Q1,Adult
219341901,21934190,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"8.5 u, unknown",,,,,D479811M,,20563.0,8.5,IU,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20230118.0,20230119.0,20230201,20230201,PER,,US-ELI_LILLY_AND_COMPANY-US202301008939,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20230201,,CN,US,US,2023,Q1,Elderly
219341901,21934190,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"8.5 u, unknown",,,,,D479811M,,20563.0,8.5,IU,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230118.0,20230119.0,20230201,20230201,PER,,US-ELI_LILLY_AND_COMPANY-US202301008939,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20230201,,CN,US,US,2023,Q1,Elderly
219347861,21934786,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK Unknown, Unknown",,,D,,,,,,,,,2023,Q1,Completed suicide,,2023,Q1,1,I,20210101.0,20230118.0,20230201,20230201,EXP,,US-ENDO PHARMACEUTICALS INC-2023-000388,ENDO,,29.0,YR,,F,Y,,,20230201,,HP,US,US,2023,Q1,Young Adult
219347901,21934790,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Hypothyroidism,,2023,Q1,1,I,20221121.0,20230125.0,20230201,20230201,EXP,,CH-EXELIXIS-CABO-23060115,EXELIXIS,,81.0,YR,,M,Y,,,20230201,,PH,CH,CH,2023,Q1,Elderly
219347901,21934790,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Gastroenteritis,,2023,Q1,1,I,20221121.0,20230125.0,20230201,20230201,EXP,,CH-EXELIXIS-CABO-23060115,EXELIXIS,,81.0,YR,,M,Y,,,20230201,,PH,CH,CH,2023,Q1,Elderly
219361571,21936157,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, tid",510.0,IU,Y,,,,20563.0,10.0,IU,,TID,2023,Q1,Hypoglycaemic coma,,2023,Q1,1,I,20221231.0,20230119.0,20230201,20230201,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202301008297,ELI LILLY AND CO,,84.0,YR,,M,Y,69.0,KG,20230201,,CN,CN,CN,2023,Q1,Elderly
219386281,21938628,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pancreatitis,,2023,Q1,1,I,20220122.0,20220221.0,20230201,20230201,PER,,US-EXELIXIS-CABO-22049347,EXELIXIS,,64.0,YR,,M,Y,99.773,KG,20230201,,CN,US,US,2023,Q1,Adult
219478871,21947887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,209196.0,,,,,2023,Q1,Umbilical cord abnormality,,2023,Q1,1,I,,20230201.0,20230203,20230203,EXP,,CA-SA-2023SA038189,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20230203,,CN,CA,CA,2023,Q1,Adult
219478871,21947887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,209196.0,,,,,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,1,I,,20230201.0,20230203,20230203,EXP,,CA-SA-2023SA038189,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20230203,,CN,CA,CA,2023,Q1,Adult
219478871,21947887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,209196.0,,,,,2023,Q1,Amniotic fluid volume decreased,,2023,Q1,1,I,,20230201.0,20230203,20230203,EXP,,CA-SA-2023SA038189,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20230203,,CN,CA,CA,2023,Q1,Adult
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Drug hypersensitivity,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Angioedema,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,COVID-19,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Nausea,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Rash,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Autonomic nervous system imbalance,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Wrong technique in device usage process,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Insulin resistance,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Malaise,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Addison's disease,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Post-acute COVID-19 syndrome,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Pallor,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Wrong product administered,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Mast cell activation syndrome,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Illness,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219498591,21949859,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,,,2023,Q1,Autoimmune disorder,,2023,Q1,1,I,20050101.0,20230131.0,20230203,20230203,EXP,,GB-SA-2022SA238475,SANOFI AVENTIS,,23.0,YR,A,F,Y,,,20230203,,MD,GB,GB,2023,Q1,Youth
219504491,21950449,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,unknown,,,,,,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230123.0,20230203,20230203,EXP,,DE-NOVOPROD-1018017,NOVO NORDISK,Susanne Dargel et al.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy and Childbirth. 2021;21:1 to 5,23.0,YR,,F,Y,,,20230203,,HP,DE,DE,2023,Q1,Youth
219504491,21950449,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,unknown,,,,,,,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,1,I,,20230123.0,20230203,20230203,EXP,,DE-NOVOPROD-1018017,NOVO NORDISK,Susanne Dargel et al.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy and Childbirth. 2021;21:1 to 5,23.0,YR,,F,Y,,,20230203,,HP,DE,DE,2023,Q1,Youth
219504491,21950449,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,unknown,,,,,,,2023,Q1,Premature delivery,,2023,Q1,1,I,,20230123.0,20230203,20230203,EXP,,DE-NOVOPROD-1018017,NOVO NORDISK,Susanne Dargel et al.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy and Childbirth. 2021;21:1 to 5,23.0,YR,,F,Y,,,20230203,,HP,DE,DE,2023,Q1,Youth
219504521,21950452,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK (insulin-to-carb ratio of 1:1),,,,,Unknown,,,,,,,2023,Q1,Hiatus hernia,,2023,Q1,1,I,,20230123.0,20230203,20230203,EXP,,DE-NOVOPROD-1018007,NOVO NORDISK,Susanne Dargel et al.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy and Childbirth. 2021;21:1 to 5,23.0,YR,,F,Y,,,20230203,,HP,DE,DE,2023,Q1,Youth
219504521,21950452,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK (insulin-to-carb ratio of 1:1),,,,,Unknown,,,,,,,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,1,I,,20230123.0,20230203,20230203,EXP,,DE-NOVOPROD-1018007,NOVO NORDISK,Susanne Dargel et al.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy and Childbirth. 2021;21:1 to 5,23.0,YR,,F,Y,,,20230203,,HP,DE,DE,2023,Q1,Youth
219504521,21950452,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK (insulin-to-carb ratio of 1:1),,,,,Unknown,,,,,,,2023,Q1,Stillbirth,,2023,Q1,1,I,,20230123.0,20230203,20230203,EXP,,DE-NOVOPROD-1018007,NOVO NORDISK,Susanne Dargel et al.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy and Childbirth. 2021;21:1 to 5,23.0,YR,,F,Y,,,20230203,,HP,DE,DE,2023,Q1,Youth
219504521,21950452,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK (insulin-to-carb ratio of 1:1),,,,,Unknown,,,,,,,2023,Q1,Euglycaemic diabetic ketoacidosis,,2023,Q1,1,I,,20230123.0,20230203,20230203,EXP,,DE-NOVOPROD-1018007,NOVO NORDISK,Susanne Dargel et al.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy and Childbirth. 2021;21:1 to 5,23.0,YR,,F,Y,,,20230203,,HP,DE,DE,2023,Q1,Youth
219547831,21954783,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,250-300 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,250-300 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,250-300 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,150 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,150 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,150 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,440 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,440 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,440 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,30 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,30 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,30 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,13 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,13 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,13 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,29-32 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,29-32 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219547831,21954783,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,29-32 units/day,,,,,,,,,,Solution for injection,,2023,Q1,Insulin autoimmune syndrome,,2023,Q1,1,I,,20230130.0,20230205,20230205,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,"Iida T, Imai H, Sugisawa C, Nagasaka S, Yonemura H, Nishiwaki H, et al.. Case Report A patient with type 1 diabetes mellitus who developed exogenous insulin antibody syndrome ameliorated by immunosuppressive treatment for concomitant systemic lupus erythematosus: A case report.. The Showa University Journal of Medical Sciences. 2022;34:225-232",40.0,YR,A,M,Y,,,20230206,,MD,JP,JP,2023,Q1,Adult
219549061,21954906,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12 IU (4 UI AL MATTINO8 UI A PRANZO E CENA),,,U,,,,,12.0,IU,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220508.0,20230130.0,20230206,20230206,EXP,IT-MINISAL02-888981,NVSC2022IT234355,NOVARTIS,,81.0,YR,,F,Y,,,20230206,,MD,IT,IT,2023,Q1,Elderly
219559481,21955948,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Surgery,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,GR-EMD Serono-9381632,EMD SERONO INC,,68.0,YR,E,M,Y,96.0,KG,20230206,,HP,GR,,2023,Q1,Elderly
219559481,21955948,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Coronary angioplasty,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,GR-EMD Serono-9381632,EMD SERONO INC,,68.0,YR,E,M,Y,96.0,KG,20230206,,HP,GR,,2023,Q1,Elderly
219559481,21955948,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,GR-EMD Serono-9381632,EMD SERONO INC,,68.0,YR,E,M,Y,96.0,KG,20230206,,HP,GR,,2023,Q1,Elderly
219559481,21955948,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Extra dose administered,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,GR-EMD Serono-9381632,EMD SERONO INC,,68.0,YR,E,M,Y,96.0,KG,20230206,,HP,GR,,2023,Q1,Elderly
219559481,21955948,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,GR-EMD Serono-9381632,EMD SERONO INC,,68.0,YR,E,M,Y,96.0,KG,20230206,,HP,GR,,2023,Q1,Elderly
219559481,21955948,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,GR-EMD Serono-9381632,EMD SERONO INC,,68.0,YR,E,M,Y,96.0,KG,20230206,,HP,GR,,2023,Q1,Elderly
219559481,21955948,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Myocardial infarction,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,GR-EMD Serono-9381632,EMD SERONO INC,,68.0,YR,E,M,Y,96.0,KG,20230206,,HP,GR,,2023,Q1,Elderly
219579431,21957943,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ml, by regimen",,,,,,,,,,,,2023,Q1,Polydipsia,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,DE-MYLANLABS-2023M1011542,MYLAN,,81.0,YR,,M,Y,,,20230206,,MD,DE,DE,2023,Q1,Elderly
219579431,21957943,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ml, by regimen",,,,,,,,,,,,2023,Q1,Polyuria,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,DE-MYLANLABS-2023M1011542,MYLAN,,81.0,YR,,M,Y,,,20230206,,MD,DE,DE,2023,Q1,Elderly
219579431,21957943,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ml, by regimen",,,,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,DE-MYLANLABS-2023M1011542,MYLAN,,81.0,YR,,M,Y,,,20230206,,MD,DE,DE,2023,Q1,Elderly
219579431,21957943,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25|75 E/ml, by regimen",,,,,,,,,,,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230131.0,20230206,20230206,EXP,,DE-MYLANLABS-2023M1011542,MYLAN,,81.0,YR,,M,Y,,,20230206,,MD,DE,DE,2023,Q1,Elderly
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Multi-organ disorder,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Eye haemorrhage,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Abdominal pain upper,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Pulmonary oedema,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Thyroid disorder,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Myalgia,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Weight decreased,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Headache,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Malnutrition,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Chest pain,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Pericardial effusion,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Diarrhoea,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Cardiac failure congestive,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Neuropathy peripheral,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219594832,21959483,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Arthritis,,2023,Q1,2,F,,20230220.0,20230206,20230224,EXP,,CA-SA-2023SA038052,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230224,,CN,CA,CA,2023,Q1,Adult
219626621,21962662,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Wrong technique in product usage process,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Hypoacusis,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Wrong technique in product usage process,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Hypoacusis,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Wrong technique in product usage process,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q1,Hypoacusis,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D523163D,,20563.0,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D523163D,,20563.0,,,Injection,,2023,Q1,Wrong technique in product usage process,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D523163D,,20563.0,,,Injection,,2023,Q1,Hypoacusis,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D514820C,,20563.0,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D514820C,,20563.0,,,Injection,,2023,Q1,Wrong technique in product usage process,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D514820C,,20563.0,,,Injection,,2023,Q1,Hypoacusis,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D498916H,,20563.0,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D498916H,,20563.0,,,Injection,,2023,Q1,Wrong technique in product usage process,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219626621,21962662,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D498916H,,20563.0,,,Injection,,2023,Q1,Hypoacusis,,2023,Q1,1,I,20210101.0,20230126.0,20230207,20230207,EXP,,US-ELI_LILLY_AND_COMPANY-US202301013069,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230207,,CN,US,US,2023,Q1,Adult
219627111,21962711,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, 19-17-25-0, prefilled sy",,,U,U,,,,300.0,IU,Injection,,2023,Q1,Abdominal pain upper,,2023,Q1,1,I,20210111.0,20230201.0,20230207,20230207,EXP,,DE-MYLANLABS-2023M1012611,MYLAN,,73.0,YR,,M,Y,74.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
219627111,21962711,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, 19-17-25-0, prefilled sy",,,U,U,,,,300.0,IU,Injection,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,20210111.0,20230201.0,20230207,20230207,EXP,,DE-MYLANLABS-2023M1012611,MYLAN,,73.0,YR,,M,Y,74.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
219627111,21962711,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, 19-17-25-0, prefilled sy",,,U,U,,,,300.0,IU,Injection,,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,1,I,20210111.0,20230201.0,20230207,20230207,EXP,,DE-MYLANLABS-2023M1012611,MYLAN,,73.0,YR,,M,Y,74.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
219627111,21962711,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, 19-17-25-0, prefilled sy",,,U,U,,,,300.0,IU,Injection,,2023,Q1,Lack of application site rotation,,2023,Q1,1,I,20210111.0,20230201.0,20230207,20230207,EXP,,DE-MYLANLABS-2023M1012611,MYLAN,,73.0,YR,,M,Y,74.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
219627111,21962711,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, 19-17-25-0, prefilled sy",,,U,U,,,,300.0,IU,Injection,,2023,Q1,Fatigue,,2023,Q1,1,I,20210111.0,20230201.0,20230207,20230207,EXP,,DE-MYLANLABS-2023M1012611,MYLAN,,73.0,YR,,M,Y,74.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
219627111,21962711,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, 19-17-25-0, prefilled sy",,,U,U,,,,300.0,IU,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20210111.0,20230201.0,20230207,20230207,EXP,,DE-MYLANLABS-2023M1012611,MYLAN,,73.0,YR,,M,Y,74.0,KG,20230207,,PH,DE,DE,2023,Q1,Elderly
219630961,21963096,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",160870.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Thermal burn,,2023,Q1,1,I,20210824.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006129,AEGERION,,57.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630961,21963096,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",160870.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20210824.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006129,AEGERION,,57.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630961,21963096,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",160870.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Thermal burn,,2023,Q1,1,I,20210824.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006129,AEGERION,,57.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630961,21963096,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",160870.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20210824.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006129,AEGERION,,57.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630961,21963096,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 IU international unit(s), bid",160870.0,IU,,,,,,,,,BID,2023,Q1,Thermal burn,,2023,Q1,1,I,20210824.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006129,AEGERION,,57.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630961,21963096,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 IU international unit(s), bid",160870.0,IU,,,,,,,,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20210824.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006129,AEGERION,,57.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Cellulitis,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Cellulitis,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Cellulitis,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Cellulitis,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q1,Cellulitis,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q1,Cellulitis,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,Cellulitis,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,Cellulitis,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219630981,21963098,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,Off label use,,2023,Q1,1,I,20220719.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006128,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631031,21963103,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",194190.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Thermal burn,,2023,Q1,1,I,20220308.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006126,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631031,21963103,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",194190.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220308.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006126,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631031,21963103,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",194190.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Thermal burn,,2023,Q1,1,I,20220308.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006126,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631031,21963103,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",194190.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220308.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006126,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631031,21963103,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",194190.0,IU,,,,,,65.0,IU,,BID,2023,Q1,Thermal burn,,2023,Q1,1,I,20220308.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006126,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631031,21963103,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",194190.0,IU,,,,,,65.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220308.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006126,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631031,21963103,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,Thermal burn,,2023,Q1,1,I,20220308.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006126,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631031,21963103,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,Off label use,,2023,Q1,1,I,20220308.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006126,AEGERION,,58.0,YR,,M,Y,,,20230207,,MD,US,US,2023,Q1,Adult
219631251,21963125,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",,,,,,,,80.0,IU,Solution for injection,BID,2023,Q1,Off label use,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",,,,,,,,80.0,IU,Solution for injection,BID,2023,Q1,Anosmia,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",,,,,,,,80.0,IU,Solution for injection,BID,2023,Q1,Ageusia,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",,,,,,,,80.0,IU,Solution for injection,BID,2023,Q1,COVID-19,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",,,,,,,,85.0,IU,Solution for injection,BID,2023,Q1,Off label use,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",,,,,,,,85.0,IU,Solution for injection,BID,2023,Q1,Anosmia,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",,,,,,,,85.0,IU,Solution for injection,BID,2023,Q1,Ageusia,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",,,,,,,,85.0,IU,Solution for injection,BID,2023,Q1,COVID-19,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,Off label use,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,Anosmia,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,Ageusia,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219631251,21963125,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU international unit(s), tid with meals",,,,,,,,12.0,IU,,TID,2023,Q1,COVID-19,,2023,Q1,1,I,20211009.0,20221104.0,20230207,20230207,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005841,AEGERION,,57.0,YR,,M,Y,84.807,KG,20230207,,CN,US,US,2023,Q1,Adult
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Oropharyngeal pain,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Discomfort,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Diaphragmatic disorder,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Hypoxia,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Oedema peripheral,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Obstructive airways disorder,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Chest discomfort,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Cough,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Asthma,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Dyspnoea,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Full blood count abnormal,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Weight increased,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Left ventricular hypertrophy,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Wheezing,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Pyrexia,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219639402,21963940,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,BID,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,2,F,,20230130.0,20230207,20230209,EXP,,NVSC2023CA020953,NOVARTIS,,83.0,YR,,M,Y,100.0,KG,20230209,,HP,CA,CA,2023,Q1,Elderly
219642492,21964249,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,2,F,,20230220.0,20230207,20230223,EXP,,NVSC2023RO026265,NOVARTIS,"Bozac M, Revnic R. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. THE ROMANIAN JOURNAL OF FAMILY MEDICINE. 2022;5(4):33-7",68.0,YR,,,Y,,,20230223,,HP,RO,RO,2023,Q1,Elderly
219642492,21964249,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Varicella zoster virus infection,,2023,Q1,2,F,,20230220.0,20230207,20230223,EXP,,NVSC2023RO026265,NOVARTIS,"Bozac M, Revnic R. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. THE ROMANIAN JOURNAL OF FAMILY MEDICINE. 2022;5(4):33-7",68.0,YR,,,Y,,,20230223,,HP,RO,RO,2023,Q1,Elderly
219642492,21964249,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Pain,,2023,Q1,2,F,,20230220.0,20230207,20230223,EXP,,NVSC2023RO026265,NOVARTIS,"Bozac M, Revnic R. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. THE ROMANIAN JOURNAL OF FAMILY MEDICINE. 2022;5(4):33-7",68.0,YR,,,Y,,,20230223,,HP,RO,RO,2023,Q1,Elderly
219642492,21964249,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Neuralgia,,2023,Q1,2,F,,20230220.0,20230207,20230223,EXP,,NVSC2023RO026265,NOVARTIS,"Bozac M, Revnic R. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. THE ROMANIAN JOURNAL OF FAMILY MEDICINE. 2022;5(4):33-7",68.0,YR,,,Y,,,20230223,,HP,RO,RO,2023,Q1,Elderly
219642492,21964249,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Rash,,2023,Q1,2,F,,20230220.0,20230207,20230223,EXP,,NVSC2023RO026265,NOVARTIS,"Bozac M, Revnic R. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient. THE ROMANIAN JOURNAL OF FAMILY MEDICINE. 2022;5(4):33-7",68.0,YR,,,Y,,,20230223,,HP,RO,RO,2023,Q1,Elderly
219648172,21964817,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Acute myocardial infarction,,2023,Q1,2,F,20230202.0,20230212.0,20230207,20230214,EXP,,CN-GILEAD-2023-0615648,GILEAD,,67.0,YR,E,M,Y,72.0,KG,20230214,,MD,CN,CN,2023,Q1,Elderly
219648172,21964817,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Cardiogenic shock,,2023,Q1,2,F,20230202.0,20230212.0,20230207,20230214,EXP,,CN-GILEAD-2023-0615648,GILEAD,,67.0,YR,E,M,Y,72.0,KG,20230214,,MD,CN,CN,2023,Q1,Elderly
219659251,21965925,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 iU,,,Y,,,,209196.0,8.0,IU,,,2023,Q1,Urticaria,,2023,Q1,1,I,20230113.0,20230201.0,20230208,20230208,EXP,SE-MPA-2023-000606,SE-SA-2023SA041906,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20230208,,HP,SE,SE,2023,Q1,Adult
219669231,21966923,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,UNK,,,,,,,2023,Q1,Suspected suicide,,2023,Q1,1,I,,20230130.0,20230208,20230208,EXP,,US-NOVAST LABORATORIES INC.-2023NOV000203,NOVAST,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2021 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60(12):1381-1643",29.0,YR,,F,Y,,,20230208,,MD,US,US,2023,Q1,Young Adult
219679431,21967943,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Iridocyclitis,,2023,Q1,1,I,20220624.0,20221104.0,20230208,20230208,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006127,AEGERION,,58.0,YR,,M,Y,,,20230208,,MD,US,US,2023,Q1,Adult
219679431,21967943,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220624.0,20221104.0,20230208,20230208,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006127,AEGERION,,58.0,YR,,M,Y,,,20230208,,MD,US,US,2023,Q1,Adult
219679431,21967943,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Iridocyclitis,,2023,Q1,1,I,20220624.0,20221104.0,20230208,20230208,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006127,AEGERION,,58.0,YR,,M,Y,,,20230208,,MD,US,US,2023,Q1,Adult
219679431,21967943,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220624.0,20221104.0,20230208,20230208,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006127,AEGERION,,58.0,YR,,M,Y,,,20230208,,MD,US,US,2023,Q1,Adult
219679431,21967943,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q1,Iridocyclitis,,2023,Q1,1,I,20220624.0,20221104.0,20230208,20230208,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006127,AEGERION,,58.0,YR,,M,Y,,,20230208,,MD,US,US,2023,Q1,Adult
219679431,21967943,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q1,Off label use,,2023,Q1,1,I,20220624.0,20221104.0,20230208,20230208,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR006127,AEGERION,,58.0,YR,,M,Y,,,20230208,,MD,US,US,2023,Q1,Adult
219739971,21973997,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20230127.0,20230202.0,20230209,20230209,PER,,US-SA-2023SA045089,SANOFI AVENTIS,,53.0,YR,A,F,Y,69.8,KG,20230209,,MD,US,US,2023,Q1,Adult
219739971,21973997,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Pain,,2023,Q1,1,I,20230127.0,20230202.0,20230209,20230209,PER,,US-SA-2023SA045089,SANOFI AVENTIS,,53.0,YR,A,F,Y,69.8,KG,20230209,,MD,US,US,2023,Q1,Adult
219739971,21973997,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Generalised oedema,,2023,Q1,1,I,20230127.0,20230202.0,20230209,20230209,PER,,US-SA-2023SA045089,SANOFI AVENTIS,,53.0,YR,A,F,Y,69.8,KG,20230209,,MD,US,US,2023,Q1,Adult
219739971,21973997,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Feeling abnormal,,2023,Q1,1,I,20230127.0,20230202.0,20230209,20230209,PER,,US-SA-2023SA045089,SANOFI AVENTIS,,53.0,YR,A,F,Y,69.8,KG,20230209,,MD,US,US,2023,Q1,Adult
219739971,21973997,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Limb discomfort,,2023,Q1,1,I,20230127.0,20230202.0,20230209,20230209,PER,,US-SA-2023SA045089,SANOFI AVENTIS,,53.0,YR,A,F,Y,69.8,KG,20230209,,MD,US,US,2023,Q1,Adult
219739971,21973997,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Myalgia,,2023,Q1,1,I,20230127.0,20230202.0,20230209,20230209,PER,,US-SA-2023SA045089,SANOFI AVENTIS,,53.0,YR,A,F,Y,69.8,KG,20230209,,MD,US,US,2023,Q1,Adult
219739971,21973997,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,20230127.0,20230202.0,20230209,20230209,PER,,US-SA-2023SA045089,SANOFI AVENTIS,,53.0,YR,A,F,Y,69.8,KG,20230209,,MD,US,US,2023,Q1,Adult
219762851,21976285,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,UNK,,,,,,,2023,Q1,Suspected suicide,,2023,Q1,1,I,,20230130.0,20230210,20230210,EXP,,US-NOVAST LABORATORIES INC.-2023NOV000125,NOVAST,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al. 2021 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 39th Annual Report. Clinical Toxicology. 2022;60(12):1381-1643",61.0,YR,,F,Y,,,20230210,,MD,US,US,2023,Q1,Adult
219792361,21979236,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Post streptococcal glomerulonephritis,,2023,Q1,1,I,,20230208.0,20230210,20230210,EXP,,NVSC2023CA030259,NOVARTIS,,64.0,YR,,M,Y,,,20230210,,HP,CA,CA,2023,Q1,Adult
219792361,21979236,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Extradural abscess,,2023,Q1,1,I,,20230208.0,20230210,20230210,EXP,,NVSC2023CA030259,NOVARTIS,,64.0,YR,,M,Y,,,20230210,,HP,CA,CA,2023,Q1,Adult
219792361,21979236,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,1,I,,20230208.0,20230210,20230210,EXP,,NVSC2023CA030259,NOVARTIS,,64.0,YR,,M,Y,,,20230210,,HP,CA,CA,2023,Q1,Adult
219794452,21979445,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Pain,,2023,Q1,2,F,,20230207.0,20230210,20230216,EXP,,RO-AstraZeneca-2023A028799,ASTRAZENECA,"M Bozac, Radu R. Neuralgia from varicella-zoster virus infection key aspect in the. The Romanian Journal of Family Medicine. 2022;5(4):33-37.",68.0,YR,,,Y,,,20230216,,MD,RO,,2023,Q1,Elderly
219794452,21979445,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Rash,,2023,Q1,2,F,,20230207.0,20230210,20230216,EXP,,RO-AstraZeneca-2023A028799,ASTRAZENECA,"M Bozac, Radu R. Neuralgia from varicella-zoster virus infection key aspect in the. The Romanian Journal of Family Medicine. 2022;5(4):33-37.",68.0,YR,,,Y,,,20230216,,MD,RO,,2023,Q1,Elderly
219794452,21979445,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Neuralgia,,2023,Q1,2,F,,20230207.0,20230210,20230216,EXP,,RO-AstraZeneca-2023A028799,ASTRAZENECA,"M Bozac, Radu R. Neuralgia from varicella-zoster virus infection key aspect in the. The Romanian Journal of Family Medicine. 2022;5(4):33-37.",68.0,YR,,,Y,,,20230216,,MD,RO,,2023,Q1,Elderly
219794452,21979445,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,2,F,,20230207.0,20230210,20230216,EXP,,RO-AstraZeneca-2023A028799,ASTRAZENECA,"M Bozac, Radu R. Neuralgia from varicella-zoster virus infection key aspect in the. The Romanian Journal of Family Medicine. 2022;5(4):33-37.",68.0,YR,,,Y,,,20230216,,MD,RO,,2023,Q1,Elderly
219794452,21979445,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,,,,,,,,,2023,Q1,Varicella zoster virus infection,,2023,Q1,2,F,,20230207.0,20230210,20230216,EXP,,RO-AstraZeneca-2023A028799,ASTRAZENECA,"M Bozac, Radu R. Neuralgia from varicella-zoster virus infection key aspect in the. The Romanian Journal of Family Medicine. 2022;5(4):33-37.",68.0,YR,,,Y,,,20230216,,MD,RO,,2023,Q1,Elderly
219800121,21980012,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2023,Q1,Completed suicide,,2023,Q1,1,I,,20230202.0,20230210,20230210,EXP,,US-BAUSCH-BL-2023-002141,BAUSCH AND LOMB,"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, Weber J. 2021 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023 JAN 05;60 (12):1381-1643. doi:10.1080/15563650.2022.2132768",61.0,YR,,F,Y,,,20230210,,MD,US,US,2023,Q1,Adult
219808851,21980885,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,1,I,,20230123.0,20230211,20230211,EXP,,DE-TEVA-2023-DE-2851822,TEVA,,23.0,YR,A,F,Y,,,20230210,,HP,DE,DE,2023,Q1,Youth
219808851,21980885,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2023,Q1,Stillbirth,,2023,Q1,1,I,,20230123.0,20230211,20230211,EXP,,DE-TEVA-2023-DE-2851822,TEVA,,23.0,YR,A,F,Y,,,20230210,,HP,DE,DE,2023,Q1,Youth
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Chest discomfort,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Oropharyngeal pain,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Cough,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Asthma,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Oedema peripheral,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Pyrexia,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Hypoxia,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Discomfort,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Diaphragmatic disorder,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Weight increased,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Left ventricular hypertrophy,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Wheezing,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219840301,21984030,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,UNKNOWN,,,,,,QD,2023,Q1,Obstructive airways disorder,,2023,Q1,1,I,,20230130.0,20230213,20230213,EXP,,CA-ROCHE-3281601,ROCHE,,83.0,YR,,M,Y,100.0,KG,20230213,,HP,CA,CA,2023,Q1,Elderly
219846811,21984681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Blindness,,2023,Q1,1,I,20230130.0,20230131.0,20230213,20230213,EXP,,US-ELI_LILLY_AND_COMPANY-US202302000196,ELI LILLY AND CO,,27.0,YR,,M,Y,,,20230213,,CN,US,US,2023,Q1,Young Adult
219875633,21987563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,11  IU,,,,,,,,,,,,2023,Q1,Cytopenia,,2023,Q1,3,F,20230206.0,20230224.0,20230214,20230305,EXP,,DE-JNJFOC-20230214408,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,76.0,KG,20230305,,MD,DE,DE,2023,Q1,Elderly
219875633,21987563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,11  IU,,,,,,,,,,,,2023,Q1,Sinus tachycardia,,2023,Q1,3,F,20230206.0,20230224.0,20230214,20230305,EXP,,DE-JNJFOC-20230214408,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,76.0,KG,20230305,,MD,DE,DE,2023,Q1,Elderly
219875633,21987563,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,11  IU,,,,,,,,,,,,2023,Q1,Deep vein thrombosis,,2023,Q1,3,F,20230206.0,20230224.0,20230214,20230305,EXP,,DE-JNJFOC-20230214408,JOHNSON AND JOHNSON,,76.0,YR,E,M,Y,76.0,KG,20230305,,MD,DE,DE,2023,Q1,Elderly
219878381,21987838,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 iU, QD",,,,,,,,1.0,IU,,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220711.0,20230209.0,20230214,20230214,EXP,IT-MINISAL02-908381,IT-SA-2023SA048992,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20230214,,PH,IT,IT,2023,Q1,Elderly
219878381,21987838,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 iU, QD",,,,,,,,1.0,IU,,QD,2023,Q1,Seizure,,2023,Q1,1,I,20220711.0,20230209.0,20230214,20230214,EXP,IT-MINISAL02-908381,IT-SA-2023SA048992,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20230214,,PH,IT,IT,2023,Q1,Elderly
219920871,21992087,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Unknown,,2023,Q1,Death,,2023,Q1,1,I,20230101.0,20230213.0,20230214,20230214,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-022069,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,,,20230215,,CN,US,US,2023,Q1,Elderly
219930341,21993034,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, Once a Day,Dosaggio: 1Unita di misura: UNITA INTERNAZIONALI, IN MILIONI Freque",,,,,,,,1.0,IU,,QD,2023,Q1,Seizure,,2023,Q1,1,I,20220711.0,20230206.0,20230215,20230215,EXP,,IT-AUROBINDO-AUR-APL-2023-006364,AUROBINDO,,75.0,YR,,M,Y,,,20230215,,PH,IT,IT,2023,Q1,Elderly
219930341,21993034,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, Once a Day,Dosaggio: 1Unita di misura: UNITA INTERNAZIONALI, IN MILIONI Freque",,,,,,,,1.0,IU,,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220711.0,20230206.0,20230215,20230215,EXP,,IT-AUROBINDO-AUR-APL-2023-006364,AUROBINDO,,75.0,YR,,M,Y,,,20230215,,PH,IT,IT,2023,Q1,Elderly
219931231,21993123,10,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, Once a Day (12-12-12)",,,U,,,,,,,,QD,2023,Q1,Confusional state,,2023,Q1,1,I,20230113.0,20230207.0,20230215,20230215,EXP,,FR-AUROBINDO-AUR-APL-2023-006328,AUROBINDO,,79.0,YR,,F,Y,96.0,KG,20230215,,PH,FR,FR,2023,Q1,Elderly
219931231,21993123,10,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, Once a Day (12-12-12)",,,U,,,,,,,,QD,2023,Q1,Abnormal behaviour,,2023,Q1,1,I,20230113.0,20230207.0,20230215,20230215,EXP,,FR-AUROBINDO-AUR-APL-2023-006328,AUROBINDO,,79.0,YR,,F,Y,96.0,KG,20230215,,PH,FR,FR,2023,Q1,Elderly
219931231,21993123,10,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, Once a Day (12-12-12)",,,U,,,,,,,,QD,2023,Q1,Condition aggravated,,2023,Q1,1,I,20230113.0,20230207.0,20230215,20230215,EXP,,FR-AUROBINDO-AUR-APL-2023-006328,AUROBINDO,,79.0,YR,,F,Y,96.0,KG,20230215,,PH,FR,FR,2023,Q1,Elderly
219945591,21994559,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, QD",,,,,,,,1.0,IU,,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220711.0,20230208.0,20230215,20230215,EXP,IT-MINISAL02-908381,NVSC2023IT029825,NOVARTIS,,75.0,YR,,M,Y,,,20230215,,PH,IT,IT,2023,Q1,Elderly
219945591,21994559,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, QD",,,,,,,,1.0,IU,,QD,2023,Q1,Seizure,,2023,Q1,1,I,20220711.0,20230208.0,20230215,20230215,EXP,IT-MINISAL02-908381,NVSC2023IT029825,NOVARTIS,,75.0,YR,,M,Y,,,20230215,,PH,IT,IT,2023,Q1,Elderly
219956642,21995664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,U,,,,,,,Solution for injection,Q6H,2023,Q1,Blood glucose decreased,,2023,Q1,2,F,,20230210.0,20230215,20230221,PER,,US-SA-2023SA051377,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20230221,,CN,US,US,2023,Q1,Elderly
219956642,21995664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,U,,,,,,,Solution for injection,Q6H,2023,Q1,Intentional product misuse,,2023,Q1,2,F,,20230210.0,20230215,20230221,PER,,US-SA-2023SA051377,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20230221,,CN,US,US,2023,Q1,Elderly
219975642,21997564,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2023,Q1,Erysipelas,,2023,Q1,2,F,20220520.0,20230314.0,20230216,20230321,EXP,,FI-JNJFOC-20230229306,JOHNSON AND JOHNSON,,60.0,YR,,F,Y,,,20230321,,MD,FI,FI,2023,Q1,Adult
219984611,21998461,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Clostridium test positive,,2023,Q1,1,I,,20230206.0,20230216,20230216,EXP,,CA-TEVA-2023-CA-2855180,TEVA,,75.0,YR,E,F,Y,84.0,KG,20230216,,PH,CA,CA,2023,Q1,Elderly
219996162,21999616,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Incorrect dose administered,,2023,Q1,2,F,20230206.0,20230207.0,20230216,20230220,EXP,,US-ELI_LILLY_AND_COMPANY-US202302004256,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230220,,CN,US,US,2023,Q1,Adult
219996162,21999616,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Off label use,,2023,Q1,2,F,20230206.0,20230207.0,20230216,20230220,EXP,,US-ELI_LILLY_AND_COMPANY-US202302004256,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230220,,CN,US,US,2023,Q1,Adult
219996162,21999616,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Loss of consciousness,,2023,Q1,2,F,20230206.0,20230207.0,20230216,20230220,EXP,,US-ELI_LILLY_AND_COMPANY-US202302004256,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230220,,CN,US,US,2023,Q1,Adult
219996162,21999616,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Blood glucose fluctuation,,2023,Q1,2,F,20230206.0,20230207.0,20230216,20230220,EXP,,US-ELI_LILLY_AND_COMPANY-US202302004256,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230220,,CN,US,US,2023,Q1,Adult
219996162,21999616,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Retinopathy,,2023,Q1,2,F,20230206.0,20230207.0,20230216,20230220,EXP,,US-ELI_LILLY_AND_COMPANY-US202302004256,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230220,,CN,US,US,2023,Q1,Adult
219996162,21999616,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Blood glucose decreased,,2023,Q1,2,F,20230206.0,20230207.0,20230216,20230220,EXP,,US-ELI_LILLY_AND_COMPANY-US202302004256,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230220,,CN,US,US,2023,Q1,Adult
219998851,21999885,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,D,,,,20563.0,,,,,2023,Q1,Myocardial infarction,,2023,Q1,1,I,,20230210.0,20230216,20230216,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202302005346,ELI LILLY AND CO,,68.0,YR,,M,Y,96.0,KG,20230216,,CN,GR,GR,2023,Q1,Elderly
219998851,21999885,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,D,,,,20563.0,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230210.0,20230216,20230216,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202302005346,ELI LILLY AND CO,,68.0,YR,,M,Y,96.0,KG,20230216,,CN,GR,GR,2023,Q1,Elderly
219998851,21999885,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,D,,,,20563.0,,,,,2023,Q1,Surgery,,2023,Q1,1,I,,20230210.0,20230216,20230216,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202302005346,ELI LILLY AND CO,,68.0,YR,,M,Y,96.0,KG,20230216,,CN,GR,GR,2023,Q1,Elderly
219998851,21999885,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,D,,,,20563.0,,,,,2023,Q1,Coronary angioplasty,,2023,Q1,1,I,,20230210.0,20230216,20230216,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202302005346,ELI LILLY AND CO,,68.0,YR,,M,Y,96.0,KG,20230216,,CN,GR,GR,2023,Q1,Elderly
219998851,21999885,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,D,,,,20563.0,,,,,2023,Q1,Extra dose administered,,2023,Q1,1,I,,20230210.0,20230216,20230216,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202302005346,ELI LILLY AND CO,,68.0,YR,,M,Y,96.0,KG,20230216,,CN,GR,GR,2023,Q1,Elderly
219998851,21999885,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,D,,,,20563.0,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230210.0,20230216,20230216,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202302005346,ELI LILLY AND CO,,68.0,YR,,M,Y,96.0,KG,20230216,,CN,GR,GR,2023,Q1,Elderly
220002471,22000247,14,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, QD (12-12-12)",,,U,,,,,,,,QD,2023,Q1,Abnormal behaviour,,2023,Q1,1,I,20230113.0,20230209.0,20230216,20230216,EXP,FR-AFSSAPS-LY2023000200,NVSC2023FR030770,NOVARTIS,,79.0,YR,,F,Y,96.0,KG,20230216,,PH,FR,FR,2023,Q1,Elderly
220002471,22000247,14,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, QD (12-12-12)",,,U,,,,,,,,QD,2023,Q1,Confusional state,,2023,Q1,1,I,20230113.0,20230209.0,20230216,20230216,EXP,FR-AFSSAPS-LY2023000200,NVSC2023FR030770,NOVARTIS,,79.0,YR,,F,Y,96.0,KG,20230216,,PH,FR,FR,2023,Q1,Elderly
220002471,22000247,14,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, QD (12-12-12)",,,U,,,,,,,,QD,2023,Q1,Condition aggravated,,2023,Q1,1,I,20230113.0,20230209.0,20230216,20230216,EXP,FR-AFSSAPS-LY2023000200,NVSC2023FR030770,NOVARTIS,,79.0,YR,,F,Y,96.0,KG,20230216,,PH,FR,FR,2023,Q1,Elderly
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Joint swelling,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Blood pressure decreased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Influenza,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Spinal pain,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Chest pain,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Breast pain,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Oedema peripheral,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Glomerular filtration rate decreased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Blood creatine increased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Swelling,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Malaise,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220041441,22004144,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,20220101.0,20230207.0,20230217,20230217,EXP,,US-Accord-300446,ACCORD,,52.0,YR,A,F,Y,91.63,KG,20230217,,MD,US,US,2023,Q1,Adult
220046271,22004627,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,Injection,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230209.0,20230217,20230217,EXP,,DE-AUROBINDO-AUR-APL-2023-004193,AUROBINDO,"Dargel S, Schleussner E, Kloos C, Groten T, Weschenfelder F.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient.. BMC-PregnancyChildbirth. 2021;21(1):552",23.0,YR,,F,Y,,,20230217,,HP,DE,DE,2023,Q1,Youth
220046271,22004627,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,Injection,,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,1,I,,20230209.0,20230217,20230217,EXP,,DE-AUROBINDO-AUR-APL-2023-004193,AUROBINDO,"Dargel S, Schleussner E, Kloos C, Groten T, Weschenfelder F.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient.. BMC-PregnancyChildbirth. 2021;21(1):552",23.0,YR,,F,Y,,,20230217,,HP,DE,DE,2023,Q1,Youth
220046271,22004627,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,D,,,,,,,Injection,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230209.0,20230217,20230217,EXP,,DE-AUROBINDO-AUR-APL-2023-004193,AUROBINDO,"Dargel S, Schleussner E, Kloos C, Groten T, Weschenfelder F.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient.. BMC-PregnancyChildbirth. 2021;21(1):552",23.0,YR,,F,Y,,,20230217,,HP,DE,DE,2023,Q1,Youth
220061902,22006190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,2,F,,20230216.0,20230217,20230223,EXP,,DE-PFIZER INC-202300070802,PFIZER,"Dargel, S.. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC Pregnancy and Childbirth. 2021;V21:P552",23.0,YR,,F,Y,,,20230223,,HP,DE,DE,2023,Q1,Youth
220084941,22008494,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,UNKNOWN,,20563.0,,,Injection,,2023,Q1,Gait inability,,2023,Q1,1,I,20230207.0,20230207.0,20230219,20230219,PER,,US-ELI_LILLY_AND_COMPANY-US202302005847,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20230219,,CN,US,US,2023,Q1,Elderly
220084941,22008494,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q1,Gait inability,,2023,Q1,1,I,20230207.0,20230207.0,20230219,20230219,PER,,US-ELI_LILLY_AND_COMPANY-US202302005847,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20230219,,CN,US,US,2023,Q1,Elderly
220093181,22009318,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D456541A,,,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20210206.0,20230209.0,20230220,20230220,PER,,US-ELI_LILLY_AND_COMPANY-US202302005501,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20230220,,CN,US,US,2023,Q1,Adult
220093181,22009318,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20210206.0,20230209.0,20230220,20230220,PER,,US-ELI_LILLY_AND_COMPANY-US202302005501,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20230220,,CN,US,US,2023,Q1,Adult
220119521,22011952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Clostridium test positive,,2023,Q1,1,I,,20230213.0,20230220,20230220,EXP,,NVSC2023CA033367,NOVARTIS,,82.0,YR,,F,Y,70.0,KG,20230220,,PH,CA,CA,2023,Q1,Elderly
220129742,22012974,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25 mg,,,,,,,,25.0,MG,,,2023,Q1,Death,,2023,Q1,2,F,20220524.0,20230228.0,20230220,20230302,EXP,,NVSC2022PT303471,NOVARTIS,,82.0,YR,,F,Y,,,20230302,,CN,PT,PT,2023,Q1,Elderly
220132461,22013246,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50IU 60IU in morning and 64IU in evening,,,U,U,,,,,,,,2023,Q1,Pain,,2023,Q1,1,I,,20230213.0,20230220,20230220,EXP,,RO-MYLANLABS-2023M1016817,MYLAN,"M?d?lina-Ionela Bozac, Dr. Radu Revnic.. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient.. The Romanian Journal of Family Medicine. 2022;5(4):33-37",68.0,YR,,,Y,,,20230220,,MD,RO,RO,2023,Q1,Elderly
220132461,22013246,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50IU 60IU in morning and 64IU in evening,,,U,U,,,,,,,,2023,Q1,Varicella zoster virus infection,,2023,Q1,1,I,,20230213.0,20230220,20230220,EXP,,RO-MYLANLABS-2023M1016817,MYLAN,"M?d?lina-Ionela Bozac, Dr. Radu Revnic.. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient.. The Romanian Journal of Family Medicine. 2022;5(4):33-37",68.0,YR,,,Y,,,20230220,,MD,RO,RO,2023,Q1,Elderly
220132461,22013246,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50IU 60IU in morning and 64IU in evening,,,U,U,,,,,,,,2023,Q1,Neuralgia,,2023,Q1,1,I,,20230213.0,20230220,20230220,EXP,,RO-MYLANLABS-2023M1016817,MYLAN,"M?d?lina-Ionela Bozac, Dr. Radu Revnic.. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient.. The Romanian Journal of Family Medicine. 2022;5(4):33-37",68.0,YR,,,Y,,,20230220,,MD,RO,RO,2023,Q1,Elderly
220132461,22013246,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50IU 60IU in morning and 64IU in evening,,,U,U,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230213.0,20230220,20230220,EXP,,RO-MYLANLABS-2023M1016817,MYLAN,"M?d?lina-Ionela Bozac, Dr. Radu Revnic.. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient.. The Romanian Journal of Family Medicine. 2022;5(4):33-37",68.0,YR,,,Y,,,20230220,,MD,RO,RO,2023,Q1,Elderly
220132461,22013246,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50IU 60IU in morning and 64IU in evening,,,U,U,,,,,,,,2023,Q1,Rash,,2023,Q1,1,I,,20230213.0,20230220,20230220,EXP,,RO-MYLANLABS-2023M1016817,MYLAN,"M?d?lina-Ionela Bozac, Dr. Radu Revnic.. Neuralgia from varicella-zoster virus infection key aspect in the oncology patient.. The Romanian Journal of Family Medicine. 2022;5(4):33-37",68.0,YR,,,Y,,,20230220,,MD,RO,RO,2023,Q1,Elderly
220189921,22018992,14,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, Daily, 12-12-12",,,U,,,,,,,,,2023,Q1,Confusional state,,2023,Q1,1,I,20230113.0,20230208.0,20230222,20230222,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-379846,RANBAXY,,79.0,YR,,F,Y,96.0,KG,20230222,,PH,FR,FR,2023,Q1,Elderly
220189921,22018992,14,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, Daily, 12-12-12",,,U,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,20230113.0,20230208.0,20230222,20230222,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-379846,RANBAXY,,79.0,YR,,F,Y,96.0,KG,20230222,,PH,FR,FR,2023,Q1,Elderly
220189921,22018992,14,C,INSULINE LISPRO,,1,Subcutaneous,"36 dosage form, Daily, 12-12-12",,,U,,,,,,,,,2023,Q1,Abnormal behaviour,,2023,Q1,1,I,20230113.0,20230208.0,20230222,20230222,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-379846,RANBAXY,,79.0,YR,,F,Y,96.0,KG,20230222,,PH,FR,FR,2023,Q1,Elderly
220190441,22019044,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, IN MILLIONS, Daily",,,,,,,,1.0,IU,,,2023,Q1,Seizure,,2023,Q1,1,I,20220711.0,20230208.0,20230222,20230222,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-379220,RANBAXY,,75.0,YR,,M,Y,,,20230222,,PH,IT,IT,2023,Q1,Elderly
220190441,22019044,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, IN MILLIONS, Daily",,,,,,,,1.0,IU,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220711.0,20230208.0,20230222,20230222,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-379220,RANBAXY,,75.0,YR,,M,Y,,,20230222,,PH,IT,IT,2023,Q1,Elderly
220195991,22019599,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,70/30 25 units bid,,,U,,,,,,,,,2023,Q1,Cranial nerve paralysis,,2023,Q1,1,I,,20230208.0,20230222,20230222,EXP,,PR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-380008,RANBAXY,"Puig JH, Llorens Bonilla A, Reimon LA, Negron A, Colon J. Diabetes does it again: case of anisolated cranial nerve palsy caused by hyperglycemia. Am J Med Sci. 2023;365 (Suppl. 1):S69-S70",62.0,YR,,F,Y,,,20230222,,HP,PR,PR,2023,Q1,Adult
220195991,22019599,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,70/30 25 units bid,,,U,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230208.0,20230222,20230222,EXP,,PR-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-380008,RANBAXY,"Puig JH, Llorens Bonilla A, Reimon LA, Negron A, Colon J. Diabetes does it again: case of anisolated cranial nerve palsy caused by hyperglycemia. Am J Med Sci. 2023;365 (Suppl. 1):S69-S70",62.0,YR,,F,Y,,,20230222,,HP,PR,PR,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Oedema peripheral,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Influenza,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Joint swelling,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Spinal pain,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Hypotension,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Swelling,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Glomerular filtration rate decreased,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Blood creatine increased,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Chest pain,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Breast pain,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220204741,22020474,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Malaise,,2023,Q1,1,I,20221201.0,20230210.0,20230222,20230222,EXP,,US-BAYER-2023A017736,BAYER,,52.0,YR,A,F,Y,91.6,KG,20230222,,MD,US,US,2023,Q1,Adult
220215501,22021550,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,1,I,20230130.0,20230214.0,20230222,20230222,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230222,,MD,US,US,2023,Q1,Adult
220215501,22021550,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q1,Off label use,,2023,Q1,1,I,20230130.0,20230214.0,20230222,20230222,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230222,,MD,US,US,2023,Q1,Adult
220215501,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q1,Maternal exposure during pregnancy,,2023,Q1,1,I,20230130.0,20230214.0,20230222,20230222,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230222,,MD,US,US,2023,Q1,Adult
220215501,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q1,Off label use,,2023,Q1,1,I,20230130.0,20230214.0,20230222,20230222,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230222,,MD,US,US,2023,Q1,Adult
220222461,22022246,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,,,,Injection,,2023,Q1,Cerebrovascular accident,,2023,Q1,1,I,20170101.0,20230210.0,20230222,20230222,EXP,,US-ELI_LILLY_AND_COMPANY-US202302006688,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230222,,CN,US,US,2023,Q1,Adult
220222461,22022246,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,,,,Injection,,2023,Q1,Hypertension,,2023,Q1,1,I,20170101.0,20230210.0,20230222,20230222,EXP,,US-ELI_LILLY_AND_COMPANY-US202302006688,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230222,,CN,US,US,2023,Q1,Adult
220222461,22022246,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20170101.0,20230210.0,20230222,20230222,EXP,,US-ELI_LILLY_AND_COMPANY-US202302006688,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230222,,CN,US,US,2023,Q1,Adult
220222461,22022246,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,,,,Injection,,2023,Q1,Heart rate irregular,,2023,Q1,1,I,20170101.0,20230210.0,20230222,20230222,EXP,,US-ELI_LILLY_AND_COMPANY-US202302006688,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230222,,CN,US,US,2023,Q1,Adult
220222461,22022246,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,,,,Injection,,2023,Q1,Accidental underdose,,2023,Q1,1,I,20170101.0,20230210.0,20230222,20230222,EXP,,US-ELI_LILLY_AND_COMPANY-US202302006688,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230222,,CN,US,US,2023,Q1,Adult
220222461,22022246,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,,,,Injection,,2023,Q1,Renal disorder,,2023,Q1,1,I,20170101.0,20230210.0,20230222,20230222,EXP,,US-ELI_LILLY_AND_COMPANY-US202302006688,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230222,,CN,US,US,2023,Q1,Adult
220222461,22022246,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,,,,Injection,,2023,Q1,Incorrect product administration duration,,2023,Q1,1,I,20170101.0,20230210.0,20230222,20230222,EXP,,US-ELI_LILLY_AND_COMPANY-US202302006688,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230222,,CN,US,US,2023,Q1,Adult
220223171,22022317,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, qd (Dosage: 1 Unit of measurement: IU)",,,,,,,,1.0,IU,Injection,QD,2023,Q1,Seizure,,2023,Q1,1,I,20220711.0,20230216.0,20230222,20230222,EXP,IT-MINISAL02-908381,IT-MYLANLABS-2023M1018537,MYLAN,,75.0,YR,,M,Y,,,20230222,,PH,IT,IT,2023,Q1,Elderly
220223171,22022317,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, qd (Dosage: 1 Unit of measurement: IU)",,,,,,,,1.0,IU,Injection,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220711.0,20230216.0,20230222,20230222,EXP,IT-MINISAL02-908381,IT-MYLANLABS-2023M1018537,MYLAN,,75.0,YR,,M,Y,,,20230222,,PH,IT,IT,2023,Q1,Elderly
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Injection site extravasation,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Joint swelling,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Herpes zoster,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Swollen joint count,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Peripheral sensorimotor neuropathy,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Increased appetite,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Generalised oedema,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Urticaria,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Abscess,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Heart rate increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Asthenia,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Nasopharyngitis,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Gamma-glutamyltransferase increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Micturition disorder,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Musculoskeletal disorder,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Myopathy,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Fibrosis,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Abdominal pain,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Vomiting,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Hypotension,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Depression,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Abdominal pain upper,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Tooth disorder,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Therapeutic response decreased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Blood bilirubin increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Myelopathy,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Pneumonia,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Fatigue,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Rheumatoid arthritis,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Endometrial disorder,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Septic shock,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Neuropathy peripheral,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Arthropathy,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Diverticulitis,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Peritonitis,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Ascites,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Pseudomonal bacteraemia,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Influenza,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Congestive hepatopathy,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Blood potassium decreased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Infusion related reaction,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Peripheral swelling,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Malaise,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Gastrointestinal disorder,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Malaise,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Synovitis,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Blood pressure systolic increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Infusion related reaction,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Arthralgia,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Cough,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Enterococcus test positive,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Adrenal insufficiency,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Bone erosion,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Nerve compression,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Blood alkaline phosphatase increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Joint effusion,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Blood pressure diastolic abnormal,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Osteoarthritis,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Hypersensitivity,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Gait disturbance,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Pancytopenia,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Alanine aminotransferase increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Pain,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Intensive care unit acquired weakness,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Neutropenia,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Weight increased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Infusion related reaction,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Body temperature decreased,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Pain in extremity,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Intervertebral disc protrusion,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Pyrexia,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220251451,22025145,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, QD",,,U,,,,,,,,QD,2023,Q1,Nausea,,2023,Q1,1,I,,20230215.0,20230223,20230223,EXP,,NVSC2022CA283563,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20230223,,HP,CA,CA,2023,Q1,Adult
220289651,22028965,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Dosage: 1 Unit of measurement: INTERNATIONAL UNITS, IN MILLIONS Frequency of administration: DAILY ,",,,,,UNKNOWN,,,1.0,IU,,,2023,Q1,Seizure,,2023,Q1,1,I,20220711.0,20230215.0,20230223,20230223,EXP,IT-MINISAL02-908381,IT-TEVA-2023-IT-2858150,TEVA,,75.0,YR,E,M,Y,,,20230223,,PH,IT,IT,2023,Q1,Elderly
220289651,22028965,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Dosage: 1 Unit of measurement: INTERNATIONAL UNITS, IN MILLIONS Frequency of administration: DAILY ,",,,,,UNKNOWN,,,1.0,IU,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220711.0,20230215.0,20230223,20230223,EXP,IT-MINISAL02-908381,IT-TEVA-2023-IT-2858150,TEVA,,75.0,YR,E,M,Y,,,20230223,,PH,IT,IT,2023,Q1,Elderly
220291071,22029107,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"36 Dosage forms Daily; 12-12-12, Unit dose: 36 DF , frequency time : 1 day",,,,,"UNKNOWN,Unknown",,,,,,,2023,Q1,Abnormal behaviour,,2023,Q1,1,I,20230113.0,20230215.0,20230223,20230223,EXP,FR-AFSSAPS-LY2023000200,FR-TEVA-2023-FR-2858054,TEVA,,79.0,YR,E,F,Y,96.0,KG,20230223,,PH,FR,FR,2023,Q1,Elderly
220291071,22029107,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"36 Dosage forms Daily; 12-12-12, Unit dose: 36 DF , frequency time : 1 day",,,,,"UNKNOWN,Unknown",,,,,,,2023,Q1,Confusional state,,2023,Q1,1,I,20230113.0,20230215.0,20230223,20230223,EXP,FR-AFSSAPS-LY2023000200,FR-TEVA-2023-FR-2858054,TEVA,,79.0,YR,E,F,Y,96.0,KG,20230223,,PH,FR,FR,2023,Q1,Elderly
220291071,22029107,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"36 Dosage forms Daily; 12-12-12, Unit dose: 36 DF , frequency time : 1 day",,,,,"UNKNOWN,Unknown",,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,20230113.0,20230215.0,20230223,20230223,EXP,FR-AFSSAPS-LY2023000200,FR-TEVA-2023-FR-2858054,TEVA,,79.0,YR,E,F,Y,96.0,KG,20230223,,PH,FR,FR,2023,Q1,Elderly
220294372,22029437,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Pancreatic cyst,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Vision blurred,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Pancreatic cyst,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Vision blurred,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Pancreatic cyst,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Vision blurred,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Pancreatic cyst,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220294372,22029437,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Vision blurred,,2023,Q1,2,F,20230216.0,20230220.0,20230223,20230302,EXP,,US-ELI_LILLY_AND_COMPANY-US202302007592,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230302,,CN,US,US,2023,Q1,Adult
220303111,22030311,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Myalgia,,2023,Q1,1,I,20220215.0,20220221.0,20230223,20230223,PER,,US-LANTHEUS-LMI-2022-00184,LANTHEUS MEDICAL IMAGING,,63.0,YR,,M,Y,163.0,KG,20230203,,CN,US,US,2023,Q1,Adult
220303111,22030311,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Back pain,,2023,Q1,1,I,20220215.0,20220221.0,20230223,20230223,PER,,US-LANTHEUS-LMI-2022-00184,LANTHEUS MEDICAL IMAGING,,63.0,YR,,M,Y,163.0,KG,20230203,,CN,US,US,2023,Q1,Adult
220303111,22030311,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,1,I,20220215.0,20220221.0,20230223,20230223,PER,,US-LANTHEUS-LMI-2022-00184,LANTHEUS MEDICAL IMAGING,,63.0,YR,,M,Y,163.0,KG,20230203,,CN,US,US,2023,Q1,Adult
220310341,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Anaemia,,2023,Q1,1,I,20220209.0,20230215.0,20230223,20230223,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230223,,MD,US,US,2023,Q1,Adult
220310341,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Gastrointestinal haemorrhage,,2023,Q1,1,I,20220209.0,20230215.0,20230223,20230223,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230223,,MD,US,US,2023,Q1,Adult
220310341,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Sepsis,,2023,Q1,1,I,20220209.0,20230215.0,20230223,20230223,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230223,,MD,US,US,2023,Q1,Adult
220310341,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pneumonia,,2023,Q1,1,I,20220209.0,20230215.0,20230223,20230223,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230223,,MD,US,US,2023,Q1,Adult
220310341,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Septic shock,,2023,Q1,1,I,20220209.0,20230215.0,20230223,20230223,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230223,,MD,US,US,2023,Q1,Adult
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Gastrectomy,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Dizziness,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Cerebral infarction,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Rash,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Foreign body in mouth,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Nausea,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Physical deconditioning,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Gait disturbance,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Dehydration,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Oral pain,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Gastrectomy,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Dizziness,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Cerebral infarction,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Rash,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Foreign body in mouth,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Nausea,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Physical deconditioning,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Gait disturbance,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Dehydration,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220313421,22031342,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 U, TID",,,U,,,,209196.0,,,Solution for injection,Q8H,2023,Q1,Oral pain,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,JP-SAKK-2023SA058061AA,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230224,,CN,JP,JP,2023,Q1,Elderly
220335402,22033540,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q1,Cytokine release syndrome,,2023,Q1,2,F,20230131.0,20230301.0,20230224,20230317,EXP,,US-SA-2023SA046342,SANOFI AVENTIS,,65.0,YR,E,M,Y,90.975,KG,20230314,,MD,US,US,2023,Q1,Elderly
220335402,22033540,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q1,Cytokine release syndrome,,2023,Q1,2,F,20230131.0,20230301.0,20230224,20230317,EXP,,US-SA-2023SA046342,SANOFI AVENTIS,,65.0,YR,E,M,Y,90.975,KG,20230314,,MD,US,US,2023,Q1,Elderly
220335402,22033540,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q1,Cytokine release syndrome,,2023,Q1,2,F,20230131.0,20230301.0,20230224,20230317,EXP,,US-SA-2023SA046342,SANOFI AVENTIS,,65.0,YR,E,M,Y,90.975,KG,20230314,,MD,US,US,2023,Q1,Elderly
220344911,22034491,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Uknown,,,D,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,GR-MYLANLABS-2023M1019195,MYLAN,,68.0,YR,,M,Y,96.0,KG,20230224,,HP,GR,GR,2023,Q1,Elderly
220344911,22034491,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Uknown,,,D,,,,,,,,,2023,Q1,Extra dose administered,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,GR-MYLANLABS-2023M1019195,MYLAN,,68.0,YR,,M,Y,96.0,KG,20230224,,HP,GR,GR,2023,Q1,Elderly
220344911,22034491,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Uknown,,,D,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,GR-MYLANLABS-2023M1019195,MYLAN,,68.0,YR,,M,Y,96.0,KG,20230224,,HP,GR,GR,2023,Q1,Elderly
220344911,22034491,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Uknown,,,D,,,,,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,GR-MYLANLABS-2023M1019195,MYLAN,,68.0,YR,,M,Y,96.0,KG,20230224,,HP,GR,GR,2023,Q1,Elderly
220344911,22034491,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Uknown,,,D,,,,,,,,,2023,Q1,Myocardial infarction,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,GR-MYLANLABS-2023M1019195,MYLAN,,68.0,YR,,M,Y,96.0,KG,20230224,,HP,GR,GR,2023,Q1,Elderly
220344911,22034491,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Uknown,,,D,,,,,,,,,2023,Q1,Surgery,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,GR-MYLANLABS-2023M1019195,MYLAN,,68.0,YR,,M,Y,96.0,KG,20230224,,HP,GR,GR,2023,Q1,Elderly
220344911,22034491,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Uknown,,,D,,,,,,,,,2023,Q1,Coronary angioplasty,,2023,Q1,1,I,,20230220.0,20230224,20230224,EXP,,GR-MYLANLABS-2023M1019195,MYLAN,,68.0,YR,,M,Y,96.0,KG,20230224,,HP,GR,GR,2023,Q1,Elderly
220347263,22034726,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dose=0-4 IU,,,U,,,,,,,,QD,2023,Q1,Febrile neutropenia,,2023,Q1,3,F,20230220.0,20230302.0,20230224,20230309,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-026569,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,47.0,KG,20230309,,MD,US,US,2023,Q1,Adult
220347263,22034726,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dose=0-5 IU,,,U,,,,,,,,,2023,Q1,Febrile neutropenia,,2023,Q1,3,F,20230220.0,20230302.0,20230224,20230309,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-026569,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,47.0,KG,20230309,,MD,US,US,2023,Q1,Adult
220359611,22035961,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 units/ml according to prescription,,,,,Unknown,,,,,,,2023,Q1,Pancreatitis,,2023,Q1,1,I,20221130.0,20230206.0,20230224,20230224,EXP,SE-MPA-2022-022972,SE-NOVOPROD-1022848,NOVO NORDISK,,17.0,YR,,M,Y,93.0,KG,20230215,,MD,SE,SE,2023,Q1,Youth
220359611,22035961,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 units/ml according to prescription,,,,,Unknown,,,,,,,2023,Q1,Thrombosis,,2023,Q1,1,I,20221130.0,20230206.0,20230224,20230224,EXP,SE-MPA-2022-022972,SE-NOVOPROD-1022848,NOVO NORDISK,,17.0,YR,,M,Y,93.0,KG,20230215,,MD,SE,SE,2023,Q1,Youth
220359861,22035986,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,,,,,,,,,,,Unknown,,2023,Q1,Multiple fractures,,2023,Q1,1,I,20230214.0,20230217.0,20230224,20230224,EXP,,US-BIOGEN-2023BI01189080,BIOGEN,,52.0,YR,,M,Y,,,20230224,,CN,US,US,2023,Q1,Adult
220359861,22035986,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,,,,,,,,,,,Unknown,,2023,Q1,Fall,,2023,Q1,1,I,20230214.0,20230217.0,20230224,20230224,EXP,,US-BIOGEN-2023BI01189080,BIOGEN,,52.0,YR,,M,Y,,,20230224,,CN,US,US,2023,Q1,Adult
220388501,22038850,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7 iU,,,U,,,,,7.0,IU,Solution for injection,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220511.0,20230222.0,20230227,20230227,EXP,IT-MINISAL02-909831,IT-SA-2023SA062261,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20230227,,MD,IT,IT,2023,Q1,Elderly
220388501,22038850,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7 iU,,,U,,,,,7.0,IU,Solution for injection,,2023,Q1,Sopor,,2023,Q1,1,I,20220511.0,20230222.0,20230227,20230227,EXP,IT-MINISAL02-909831,IT-SA-2023SA062261,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20230227,,MD,IT,IT,2023,Q1,Elderly
220406282,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,2,F,20230227.0,20230315.0,20230227,20230322,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230322,,HP,US,US,2023,Q1,Elderly
220406282,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q1,Dyspepsia,,2023,Q1,2,F,20230227.0,20230315.0,20230227,20230322,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230322,,HP,US,US,2023,Q1,Elderly
220406282,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,2,F,20230227.0,20230315.0,20230227,20230322,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230322,,HP,US,US,2023,Q1,Elderly
220406282,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q1,Product dose omission issue,,2023,Q1,2,F,20230227.0,20230315.0,20230227,20230322,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230322,,HP,US,US,2023,Q1,Elderly
220406282,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,2,F,20230227.0,20230315.0,20230227,20230322,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230322,,HP,US,US,2023,Q1,Elderly
220407611,22040761,18,C,HUMALOG (Insulin  lispro),,2,,,,,U,,,,,,,Unknown,,2023,Q1,Essential tremor,,2023,Q1,1,I,20210101.0,20230221.0,20230227,20230227,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-026576,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20230227,,CN,US,US,2023,Q1,Elderly
220407611,22040761,18,C,HUMALOG (Insulin  lispro),,2,,,,,U,,,,,,,Unknown,,2023,Q1,Heart rate increased,,2023,Q1,1,I,20210101.0,20230221.0,20230227,20230227,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-026576,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20230227,,CN,US,US,2023,Q1,Elderly
220407611,22040761,18,C,HUMALOG (Insulin  lispro),,2,,,,,U,,,,,,,Unknown,,2023,Q1,Skin cancer,,2023,Q1,1,I,20210101.0,20230221.0,20230227,20230227,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-026576,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20230227,,CN,US,US,2023,Q1,Elderly
220407611,22040761,18,C,HUMALOG (Insulin  lispro),,2,,,,,U,,,,,,,Unknown,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,20210101.0,20230221.0,20230227,20230227,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-026576,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20230227,,CN,US,US,2023,Q1,Elderly
220416921,22041692,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Hypokalaemia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Neutropenia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Leukopenia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Pneumonia pneumococcal,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Hypocalcaemia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Hyponatraemia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: as necessary,,,,,,,,,,,,2023,Q1,Hypokalaemia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: as necessary,,,,,,,,,,,,2023,Q1,Neutropenia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: as necessary,,,,,,,,,,,,2023,Q1,Leukopenia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: as necessary,,,,,,,,,,,,2023,Q1,Pneumonia pneumococcal,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: as necessary,,,,,,,,,,,,2023,Q1,Hypocalcaemia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220416921,22041692,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: as necessary,,,,,,,,,,,,2023,Q1,Hyponatraemia,,2023,Q1,1,I,20200824.0,20230223.0,20230227,20230227,EXP,,DE-ABBVIE-21K-062-4031447-00,ABBVIE,,71.0,YR,,M,Y,75.0,KG,20230227,,MD,DE,DE,2023,Q1,Elderly
220433931,22043393,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(12-8-6),,,U,,,,,26.0,IU,Injection,,2023,Q1,Diabetes mellitus inadequate control,,2023,Q1,1,I,,20230217.0,20230228,20230228,EXP,,JP-EMD Serono-9386452,EMD SERONO INC,,5.0,DEC,A,F,Y,,,20230228,,HP,JP,,2023,Q1,Child
220437801,22043780,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd",,,,,,,,8.0,IU,,QD,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 international unit, qd",,,,,,,,5.0,IU,,QD,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 international unit, qd",,,,,,,,1.0,IU,,QD,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 international unit, qd",,,,,,,,2.0,IU,,QD,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 international unit, qd",,,,,,,,7.0,IU,,QD,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 international unit,,,,,,,,3.0,IU,,,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 international unit,,,,,,,,10.0,IU,,,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,9 international unit,,,,,,,,9.0,IU,,,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 international unit,,,,,,,,4.0,IU,,,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437801,22043780,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 international unit,,,,,,,,6.0,IU,,,2023,Q1,Therapy non-responder,,2023,Q1,1,I,,20230130.0,20230228,20230228,EXP,,CA-MYLANLABS-2023M1021212,MYLAN,,20.0,YR,,F,Y,47.0,KG,20230228,,CN,CA,CA,2023,Q1,Youth
220437991,22043799,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU in the morning, 4 IU at noon and 3 IU in the evening before meals",,,Y,,202109001,,,,,Solution for injection,Q8H,2023,Q1,Starvation,,2023,Q1,1,I,20230219.0,20230222.0,20230228,20230228,EXP,,CN-SA-2023SA064014,SANOFI AVENTIS,,80.0,YR,E,F,Y,52.0,KG,20230228,,HP,CN,CN,2023,Q1,Elderly
220437991,22043799,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU in the morning, 4 IU at noon and 3 IU in the evening before meals",,,Y,,202109001,,,,,Solution for injection,Q8H,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230219.0,20230222.0,20230228,20230228,EXP,,CN-SA-2023SA064014,SANOFI AVENTIS,,80.0,YR,E,F,Y,52.0,KG,20230228,,HP,CN,CN,2023,Q1,Elderly
220437991,22043799,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU in the morning, 4 IU at noon and 3 IU in the evening before meals",,,Y,,202109001,,,,,Solution for injection,Q8H,2023,Q1,Palpitations,,2023,Q1,1,I,20230219.0,20230222.0,20230228,20230228,EXP,,CN-SA-2023SA064014,SANOFI AVENTIS,,80.0,YR,E,F,Y,52.0,KG,20230228,,HP,CN,CN,2023,Q1,Elderly
220437991,22043799,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 iU, TID before meals",,,Y,,,,,3.0,IU,Solution for injection,Q8H,2023,Q1,Starvation,,2023,Q1,1,I,20230219.0,20230222.0,20230228,20230228,EXP,,CN-SA-2023SA064014,SANOFI AVENTIS,,80.0,YR,E,F,Y,52.0,KG,20230228,,HP,CN,CN,2023,Q1,Elderly
220437991,22043799,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 iU, TID before meals",,,Y,,,,,3.0,IU,Solution for injection,Q8H,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230219.0,20230222.0,20230228,20230228,EXP,,CN-SA-2023SA064014,SANOFI AVENTIS,,80.0,YR,E,F,Y,52.0,KG,20230228,,HP,CN,CN,2023,Q1,Elderly
220437991,22043799,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 iU, TID before meals",,,Y,,,,,3.0,IU,Solution for injection,Q8H,2023,Q1,Palpitations,,2023,Q1,1,I,20230219.0,20230222.0,20230228,20230228,EXP,,CN-SA-2023SA064014,SANOFI AVENTIS,,80.0,YR,E,F,Y,52.0,KG,20230228,,HP,CN,CN,2023,Q1,Elderly
220445541,22044554,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Wrong product administered,,2023,Q1,1,I,20230101.0,20230221.0,20230228,20230228,EXP,,US-ELI_LILLY_AND_COMPANY-US202302011078,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230228,,CN,US,US,2023,Q1,Adult
220445541,22044554,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Pancreatitis,,2023,Q1,1,I,20230101.0,20230221.0,20230228,20230228,EXP,,US-ELI_LILLY_AND_COMPANY-US202302011078,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230228,,CN,US,US,2023,Q1,Adult
220445541,22044554,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Drug ineffective,,2023,Q1,1,I,20230101.0,20230221.0,20230228,20230228,EXP,,US-ELI_LILLY_AND_COMPANY-US202302011078,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230228,,CN,US,US,2023,Q1,Adult
220445541,22044554,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Nerve injury,,2023,Q1,1,I,20230101.0,20230221.0,20230228,20230228,EXP,,US-ELI_LILLY_AND_COMPANY-US202302011078,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230228,,CN,US,US,2023,Q1,Adult
220445541,22044554,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Spinal stenosis,,2023,Q1,1,I,20230101.0,20230221.0,20230228,20230228,EXP,,US-ELI_LILLY_AND_COMPANY-US202302011078,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230228,,CN,US,US,2023,Q1,Adult
220445541,22044554,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230101.0,20230221.0,20230228,20230228,EXP,,US-ELI_LILLY_AND_COMPANY-US202302011078,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230228,,CN,US,US,2023,Q1,Adult
220455561,22045556,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 iU, TOTAL",80.0,IU,Y,,,,209196.0,80.0,IU,,,2023,Q1,Hypokalaemia,,2023,Q1,1,I,20220614.0,20230223.0,20230228,20230228,EXP,IT-MINISAL02-910154,IT-SA-2023SA065178,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20230228,,MD,IT,IT,2023,Q1,Elderly
220455561,22045556,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 iU, TOTAL",80.0,IU,Y,,,,209196.0,80.0,IU,,,2023,Q1,Intentional self-injury,,2023,Q1,1,I,20220614.0,20230223.0,20230228,20230228,EXP,IT-MINISAL02-910154,IT-SA-2023SA065178,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20230228,,MD,IT,IT,2023,Q1,Elderly
220455561,22045556,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 iU, TOTAL",80.0,IU,Y,,,,209196.0,80.0,IU,,,2023,Q1,Sopor,,2023,Q1,1,I,20220614.0,20230223.0,20230228,20230228,EXP,IT-MINISAL02-910154,IT-SA-2023SA065178,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20230228,,MD,IT,IT,2023,Q1,Elderly
220455561,22045556,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 iU, TOTAL",80.0,IU,Y,,,,209196.0,80.0,IU,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220614.0,20230223.0,20230228,20230228,EXP,IT-MINISAL02-910154,IT-SA-2023SA065178,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20230228,,MD,IT,IT,2023,Q1,Elderly
220474261,22047426,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Syncope,,2023,Q1,1,I,20230119.0,20230223.0,20230301,20230301,EXP,IT-MINISAL02-910375,IT-SA-2023SA065005,SANOFI AVENTIS,,39.0,YR,A,M,Y,,,20230301,,MD,IT,IT,2023,Q1,Adult
220474261,22047426,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230119.0,20230223.0,20230301,20230301,EXP,IT-MINISAL02-910375,IT-SA-2023SA065005,SANOFI AVENTIS,,39.0,YR,A,M,Y,,,20230301,,MD,IT,IT,2023,Q1,Adult
220501903,22050190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK; 1/2 a unit at meals,,,U,,,,,,,Solution for injection,,2023,Q1,Blood glucose fluctuation,,2023,Q1,3,F,,20230315.0,20230301,20230319,PER,,US-SA-2023SA067062,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20230319,,HP,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Malaise,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Oedema peripheral,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Asthenia,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Dizziness,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Pain in extremity,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Blood creatine increased,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Blood pressure decreased,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Swelling,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Spinal pain,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Arthralgia,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Therapy cessation,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Glomerular filtration rate decreased,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Blood potassium decreased,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Influenza,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Weight increased,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Pain,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Condition aggravated,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Joint swelling,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Chest pain,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220506791,22050679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q1,Breast pain,,2023,Q1,1,I,20221201.0,20230222.0,20230301,20230301,EXP,,US-PFIZER INC-PV202300035635,PFIZER,,52.0,YR,,F,Y,91.6,KG,20230301,,CN,US,US,2023,Q1,Adult
220513863,22051386,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Injection,,2023,Q1,Diabetic foot,,2023,Q1,3,F,20221001.0,20230309.0,20230301,20230313,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-222216",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,60.0,KG,20230313,,MD,JP,JP,2023,Q1,Elderly
220513863,22051386,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Injection,,2023,Q1,Peripheral arterial occlusive disease,,2023,Q1,3,F,20221001.0,20230309.0,20230301,20230313,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-222216",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,60.0,KG,20230313,,MD,JP,JP,2023,Q1,Elderly
220513863,22051386,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Injection,,2023,Q1,Leg amputation,,2023,Q1,3,F,20221001.0,20230309.0,20230301,20230313,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-222216",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,60.0,KG,20230313,,MD,JP,JP,2023,Q1,Elderly
220533001,22053300,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Colitis ulcerative,,2023,Q1,1,I,,20230224.0,20230302,20230302,EXP,,CA-Orion Corporation ORION PHARMA-23_00022370,ORION,,20.0,YR,A,F,Y,,,20230302,,HP,CA,,2023,Q1,Youth
220533001,22053300,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230224.0,20230302,20230302,EXP,,CA-Orion Corporation ORION PHARMA-23_00022370,ORION,,20.0,YR,A,F,Y,,,20230302,,HP,CA,,2023,Q1,Youth
220533001,22053300,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Product dose omission issue,,2023,Q1,1,I,,20230224.0,20230302,20230302,EXP,,CA-Orion Corporation ORION PHARMA-23_00022370,ORION,,20.0,YR,A,F,Y,,,20230302,,HP,CA,,2023,Q1,Youth
220533001,22053300,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,,20230224.0,20230302,20230302,EXP,,CA-Orion Corporation ORION PHARMA-23_00022370,ORION,,20.0,YR,A,F,Y,,,20230302,,HP,CA,,2023,Q1,Youth
220544111,22054411,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,U,,,,209196.0,1.0,IU,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,1,I,20200809.0,20230227.0,20230302,20230302,EXP,FR-EMA-DD-20220830-7180173-082651,FR-SANOFI-AVENTIS R+D-2023SA067613,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20230302,,HP,FR,FR,2023,Q1,Elderly
220544111,22054411,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,U,,,,209196.0,1.0,IU,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,1,I,20200809.0,20230227.0,20230302,20230302,EXP,FR-EMA-DD-20220830-7180173-082651,FR-SANOFI-AVENTIS R+D-2023SA067613,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20230302,,HP,FR,FR,2023,Q1,Elderly
220556981,22055698,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230223.0,20230302,20230302,EXP,,NVSC2023CA044318,NOVARTIS,,17.0,YR,,M,Y,,,20230302,,CN,CA,CA,2023,Q1,Youth
220568781,22056878,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Meningitis aseptic,,2023,Q1,1,I,,20230227.0,20230303,20230303,EXP,,US-STL-000077,Stallion Laboratories,"Vickery SB, Roach JK, Parsons C, Vickery PB. Possible levetiracetam-induced aseptic meningitis versus viral meningitis: Case report and literature review. Nurse Pract. 2022 Jul 1;47(7):32-37.",54.0,YR,A,M,Y,,,20230303,,PH,US,US,2023,Q1,Adult
220603611,22060361,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,,20230223.0,20230303,20230303,EXP,,NVSC2023CA044306,NOVARTIS,,17.0,YR,,M,Y,,,20230303,,HP,CA,CA,2023,Q1,Youth
220624781,22062478,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD",,,Y,,,,209196.0,,,Solution for injection,QD,2023,Q1,Hypokalaemia,,2023,Q1,1,I,20230202.0,20230302.0,20230305,20230305,EXP,ES-AEMPS-1336398,ES-SA-2023SA071285,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20230306,,MD,ES,ES,2023,Q1,Elderly
220624781,22062478,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD",,,Y,,,,209196.0,,,Solution for injection,QD,2023,Q1,Wrong product administered,,2023,Q1,1,I,20230202.0,20230302.0,20230305,20230305,EXP,ES-AEMPS-1336398,ES-SA-2023SA071285,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20230306,,MD,ES,ES,2023,Q1,Elderly
220624781,22062478,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, QD",,,Y,,,,209196.0,,,Solution for injection,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230202.0,20230302.0,20230305,20230305,EXP,ES-AEMPS-1336398,ES-SA-2023SA071285,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20230306,,MD,ES,ES,2023,Q1,Elderly
220627201,22062720,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20230109.0,20230227.0,20230306,20230306,EXP,,NVSC2023DE045247,NOVARTIS,,83.0,YR,,M,Y,70.0,KG,20230306,,MD,DE,DE,2023,Q1,Elderly
220627201,22062720,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q1,Renal impairment,,2023,Q1,1,I,20230109.0,20230227.0,20230306,20230306,EXP,,NVSC2023DE045247,NOVARTIS,,83.0,YR,,M,Y,70.0,KG,20230306,,MD,DE,DE,2023,Q1,Elderly
220635891,22063589,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,20221201.0,20230302.0,20230306,20230306,PER,,US-ELI_LILLY_AND_COMPANY-US202303001930,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20230306,,CN,US,US,2023,Q1,Elderly
220636701,22063670,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q1,Syncope,,2023,Q1,1,I,20230119.0,20230222.0,20230306,20230306,EXP,IT-MINISAL02-910375,IT-NOVOPROD-1030209,NOVO NORDISK,,39.0,YR,,M,Y,,,20230306,,MD,IT,IT,2023,Q1,Adult
220636701,22063670,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230119.0,20230222.0,20230306,20230306,EXP,IT-MINISAL02-910375,IT-NOVOPROD-1030209,NOVO NORDISK,,39.0,YR,,M,Y,,,20230306,,MD,IT,IT,2023,Q1,Adult
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Colorectal adenoma,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Hepatic steatosis,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Large intestine polyp,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Hypervolaemia,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Diverticulum intestinal,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Treatment noncompliance,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Haemorrhoids,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Diastolic dysfunction,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Chronic left ventricular failure,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220666992,22066699,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 unit into skin daily before breakfast, 7 unit Daily before lunch and 7 unit Daily before dinner",,,,,,,,,,Solution for injection,,2023,Q1,Product use issue,,2023,Q1,2,F,20210408.0,20230317.0,20230306,20230323,EXP,,US-BAUSCH-BL-2023-003622,BAUSCH AND LOMB,,91.0,YR,,M,Y,,,20230323,,HP,US,US,2023,Q1,Elderly
220677041,22067704,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2.26 units/kg/day,,,U,,,,,,,Injection,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230227.0,20230307,20230307,EXP,,US-AUROBINDO-AUR-APL-2023-001147,AUROBINDO,"Alkhatib E, Grundman J, Brooks J, Adamusiak A, Janssen E, McNerney K, et al. Insulin hypersensitivity case series in youth with type 1 diabetes.. Pediatr-Diabetes. 2022;23 (Suppl. 31):74-75",14.0,YR,,F,Y,,,20230307,,HP,US,US,2023,Q1,Youth
220680481,22068048,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,20563.0,15.0,IU,Injection,,2023,Q1,Illness,,2023,Q1,1,I,,20230302.0,20230307,20230307,PER,,US-ELI_LILLY_AND_COMPANY-US202303001393,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20230307,,CN,US,US,2023,Q1,Elderly
220680481,22068048,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832C,,20563.0,15.0,IU,Injection,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230302.0,20230307,20230307,PER,,US-ELI_LILLY_AND_COMPANY-US202303001393,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20230307,,CN,US,US,2023,Q1,Elderly
220695471,22069547,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,20230201.0,20230302.0,20230307,20230307,EXP,,US-EXELIXIS-CABO-23061297,EXELIXIS,,38.0,YR,,M,Y,,,20230307,,CN,US,US,2023,Q1,Adult
220695471,22069547,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Platelet count decreased,,2023,Q1,1,I,20230201.0,20230302.0,20230307,20230307,EXP,,US-EXELIXIS-CABO-23061297,EXELIXIS,,38.0,YR,,M,Y,,,20230307,,CN,US,US,2023,Q1,Adult
220695471,22069547,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Muscular weakness,,2023,Q1,1,I,20230201.0,20230302.0,20230307,20230307,EXP,,US-EXELIXIS-CABO-23061297,EXELIXIS,,38.0,YR,,M,Y,,,20230307,,CN,US,US,2023,Q1,Adult
220695471,22069547,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Pain,,2023,Q1,1,I,20230201.0,20230302.0,20230307,20230307,EXP,,US-EXELIXIS-CABO-23061297,EXELIXIS,,38.0,YR,,M,Y,,,20230307,,CN,US,US,2023,Q1,Adult
220716711,22071671,23,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,1,I,,20230222.0,20230307,20230307,EXP,,FR-B.Braun Medical Inc.-2138806,B BRAUN,,74.0,YR,,M,Y,,,20230307,,MD,FR,FR,2023,Q1,Elderly
220731801,22073180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 international unit, tid",,,U,,,,,3.0,IU,,TID,2023,Q1,Fatigue,,2023,Q1,1,I,,20230224.0,20230308,20230308,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202302013843,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230308,,CN,JP,JP,2023,Q1,Elderly
220731801,22073180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 international unit, tid",,,U,,,,,3.0,IU,,TID,2023,Q1,Asthenia,,2023,Q1,1,I,,20230224.0,20230308,20230308,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202302013843,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230308,,CN,JP,JP,2023,Q1,Elderly
220731801,22073180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 international unit, tid",,,U,,,,,3.0,IU,,TID,2023,Q1,Gingival swelling,,2023,Q1,1,I,,20230224.0,20230308,20230308,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202302013843,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230308,,CN,JP,JP,2023,Q1,Elderly
220731801,22073180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 international unit, tid",,,U,,,,,3.0,IU,,TID,2023,Q1,Lacunar infarction,,2023,Q1,1,I,,20230224.0,20230308,20230308,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202302013843,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230308,,CN,JP,JP,2023,Q1,Elderly
220731801,22073180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 international unit, tid",,,U,,,,,3.0,IU,,TID,2023,Q1,Tongue eruption,,2023,Q1,1,I,,20230224.0,20230308,20230308,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202302013843,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230308,,CN,JP,JP,2023,Q1,Elderly
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Full blood count abnormal,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Wheezing,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Therapeutic product effect incomplete,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Gastrooesophageal reflux disease,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Sinusitis,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Obstructive airways disorder,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Throat clearing,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Eczema,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Chronic obstructive pulmonary disease,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Nasal obstruction,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Asthma,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Respiratory tract infection,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Secretion discharge,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Rhinorrhoea,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Sleep disorder,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Dyspnoea exertional,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220759961,22075996,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q1,Nasal congestion,,2023,Q1,1,I,,20230303.0,20230308,20230308,EXP,,CA-SA-2023SA073707,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230309,,HP,CA,CA,2023,Q1,Adult
220760891,22076089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230303.0,20230303.0,20230308,20230308,PER,,US-ELI_LILLY_AND_COMPANY-US202303003080,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20230308,,CN,US,US,2023,Q1,Elderly
220760891,22076089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20230303.0,20230303.0,20230308,20230308,PER,,US-ELI_LILLY_AND_COMPANY-US202303003080,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20230308,,CN,US,US,2023,Q1,Elderly
220760891,22076089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230303.0,20230303.0,20230308,20230308,PER,,US-ELI_LILLY_AND_COMPANY-US202303003080,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20230308,,CN,US,US,2023,Q1,Elderly
220760891,22076089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20230303.0,20230303.0,20230308,20230308,PER,,US-ELI_LILLY_AND_COMPANY-US202303003080,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20230308,,CN,US,US,2023,Q1,Elderly
220760891,22076089,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230303.0,20230303.0,20230308,20230308,PER,,US-ELI_LILLY_AND_COMPANY-US202303003080,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20230308,,CN,US,US,2023,Q1,Elderly
220760891,22076089,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20230303.0,20230303.0,20230308,20230308,PER,,US-ELI_LILLY_AND_COMPANY-US202303003080,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20230308,,CN,US,US,2023,Q1,Elderly
220760891,22076089,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230303.0,20230303.0,20230308,20230308,PER,,US-ELI_LILLY_AND_COMPANY-US202303003080,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20230308,,CN,US,US,2023,Q1,Elderly
220760891,22076089,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20230303.0,20230303.0,20230308,20230308,PER,,US-ELI_LILLY_AND_COMPANY-US202303003080,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20230308,,CN,US,US,2023,Q1,Elderly
220765481,22076548,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Respiratory distress,,2023,Q1,1,I,20160309.0,20230304.0,20230309,20230309,EXP,,US-TAKEDA-US201603950,TAKEDA,,42.0,YR,,M,Y,,,20230309,,MD,US,US,2023,Q1,Adult
220765481,22076548,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20160309.0,20230304.0,20230309,20230309,EXP,,US-TAKEDA-US201603950,TAKEDA,,42.0,YR,,M,Y,,,20230309,,MD,US,US,2023,Q1,Adult
220765481,22076548,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Upper respiratory tract infection,,2023,Q1,1,I,20160309.0,20230304.0,20230309,20230309,EXP,,US-TAKEDA-US201603950,TAKEDA,,42.0,YR,,M,Y,,,20230309,,MD,US,US,2023,Q1,Adult
220765481,22076548,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Respiratory distress,,2023,Q1,1,I,20160309.0,20230304.0,20230309,20230309,EXP,,US-TAKEDA-US201603950,TAKEDA,,42.0,YR,,M,Y,,,20230309,,MD,US,US,2023,Q1,Adult
220765481,22076548,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20160309.0,20230304.0,20230309,20230309,EXP,,US-TAKEDA-US201603950,TAKEDA,,42.0,YR,,M,Y,,,20230309,,MD,US,US,2023,Q1,Adult
220765481,22076548,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Upper respiratory tract infection,,2023,Q1,1,I,20160309.0,20230304.0,20230309,20230309,EXP,,US-TAKEDA-US201603950,TAKEDA,,42.0,YR,,M,Y,,,20230309,,MD,US,US,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Multi-organ disorder,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Thyroid disorder,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Abdominal pain upper,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Pericardial effusion,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Weight decreased,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Arthritis,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Eye haemorrhage,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Chest pain,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Myalgia,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Neuropathy peripheral,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Cardiac failure congestive,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Headache,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Pulmonary oedema,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220770201,22077020,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Malnutrition,,2023,Q1,1,I,,20230303.0,20230309,20230309,EXP,,CA-SA-2023SA073935,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230309,,CN,CA,CA,2023,Q1,Adult
220795281,22079528,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Constipation,,2023,Q1,1,I,20230201.0,20230302.0,20230309,20230309,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-034009,BRISTOL MYERS SQUIBB,,38.0,YR,A,M,Y,,,20230309,,CN,US,US,2023,Q1,Adult
220795281,22079528,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Pain,,2023,Q1,1,I,20230201.0,20230302.0,20230309,20230309,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-034009,BRISTOL MYERS SQUIBB,,38.0,YR,A,M,Y,,,20230309,,CN,US,US,2023,Q1,Adult
220795281,22079528,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Platelet count decreased,,2023,Q1,1,I,20230201.0,20230302.0,20230309,20230309,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-034009,BRISTOL MYERS SQUIBB,,38.0,YR,A,M,Y,,,20230309,,CN,US,US,2023,Q1,Adult
220795281,22079528,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Muscular weakness,,2023,Q1,1,I,20230201.0,20230302.0,20230309,20230309,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-034009,BRISTOL MYERS SQUIBB,,38.0,YR,A,M,Y,,,20230309,,CN,US,US,2023,Q1,Adult
220834801,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230217.0,20230217.0,20230310,20230310,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220834801,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Malaise,,2023,Q1,1,I,20230217.0,20230217.0,20230310,20230310,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220834801,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Abdominal pain upper,,2023,Q1,1,I,20230217.0,20230217.0,20230310,20230310,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220834801,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Influenza like illness,,2023,Q1,1,I,20230217.0,20230217.0,20230310,20230310,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220834801,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Nasopharyngitis,,2023,Q1,1,I,20230217.0,20230217.0,20230310,20230310,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220834801,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q1,Headache,,2023,Q1,1,I,20230217.0,20230217.0,20230310,20230310,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"44 u, prn",,,Y,,,,,44.0,IU,Injection,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"44 u, prn",,,Y,,,,,44.0,IU,Injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"44 u, prn",,,Y,,,,,44.0,IU,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"44 u, prn",,,Y,,,,,44.0,IU,Injection,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"44 u, prn",,,Y,,,,,44.0,IU,Injection,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"44 u, prn",,,Y,,,,,44.0,IU,Injection,,2023,Q1,Inflammatory pain,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"44 u, prn",,,Y,,,,,44.0,IU,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, prn",,,Y,,,,,22.0,IU,Injection,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, prn",,,Y,,,,,22.0,IU,Injection,,2023,Q1,Insulin resistance,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, prn",,,Y,,,,,22.0,IU,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, prn",,,Y,,,,,22.0,IU,Injection,,2023,Q1,COVID-19,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, prn",,,Y,,,,,22.0,IU,Injection,,2023,Q1,Weight increased,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, prn",,,Y,,,,,22.0,IU,Injection,,2023,Q1,Inflammatory pain,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220849241,22084924,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, prn",,,Y,,,,,22.0,IU,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,,20230227.0,20230310,20230310,EXP,,US-ELI_LILLY_AND_COMPANY-US202303004732,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230310,,CN,US,US,2023,Q1,Adult
220852341,22085234,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Malignant neoplasm progression,,2023,Q1,1,I,20221113.0,20230309.0,20230310,20230310,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-035319,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,,,20230310,,HP,US,US,2023,Q1,Elderly
220852341,22085234,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q1,Feeding disorder,,2023,Q1,1,I,20221113.0,20230309.0,20230310,20230310,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-035319,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,,,20230310,,HP,US,US,2023,Q1,Elderly
220889791,22088979,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Renal impairment,,2023,Q1,1,I,20230109.0,20230306.0,20230313,20230313,EXP,,DE-MYLANLABS-2023M1024483,MYLAN,,83.0,YR,,M,Y,70.0,KG,20230313,,MD,DE,DE,2023,Q1,Elderly
220889791,22088979,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q1,Fatigue,,2023,Q1,1,I,20230109.0,20230306.0,20230313,20230313,EXP,,DE-MYLANLABS-2023M1024483,MYLAN,,83.0,YR,,M,Y,70.0,KG,20230313,,MD,DE,DE,2023,Q1,Elderly
220904221,22090422,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Hepatic enzyme increased,,2023,Q1,1,I,,20230308.0,20230313,20230313,EXP,,IL-009507513-2303ISR003518,MERCK,,47.0,YR,,M,Y,,,20230313,,HP,IL,IL,2023,Q1,Adult
220904221,22090422,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Blood bilirubin increased,,2023,Q1,1,I,,20230308.0,20230313,20230313,EXP,,IL-009507513-2303ISR003518,MERCK,,47.0,YR,,M,Y,,,20230313,,HP,IL,IL,2023,Q1,Adult
220904221,22090422,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Autoimmune hepatitis,,2023,Q1,1,I,,20230308.0,20230313,20230313,EXP,,IL-009507513-2303ISR003518,MERCK,,47.0,YR,,M,Y,,,20230313,,HP,IL,IL,2023,Q1,Adult
220922931,22092293,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 international unit,,,,,,,,18.0,IU,,,2023,Q1,Overflow diarrhoea,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220922931,22092293,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 international unit,,,,,,,,18.0,IU,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220922931,22092293,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 international unit,,,,,,,,18.0,IU,,,2023,Q1,Off label use,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220922931,22092293,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 international unit,,,,,,,,15.0,IU,,,2023,Q1,Overflow diarrhoea,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220922931,22092293,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 international unit,,,,,,,,15.0,IU,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220922931,22092293,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 international unit,,,,,,,,15.0,IU,,,2023,Q1,Off label use,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220922931,22092293,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 international unit,,,,,,,,20.0,IU,,,2023,Q1,Overflow diarrhoea,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220922931,22092293,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 international unit,,,,,,,,20.0,IU,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220922931,22092293,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 international unit,,,,,,,,20.0,IU,,,2023,Q1,Off label use,,2023,Q1,1,I,20230129.0,20230308.0,20230314,20230314,PER,IT-MINISAL02-912625,IT-AMGEN-ITASP2023041697,AMGEN,,65.0,YR,E,M,Y,70.0,KG,20230314,,MD,IT,IT,2023,Q1,Elderly
220929581,22092958,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,,,,,,2023,Q1,Dehydration,,2023,Q1,1,I,20230206.0,20230314.0,20230314,20230314,EXP,DE-AMK-264251,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224739",BOEHRINGER INGELHEIM,,75.0,YR,E,M,Y,,,20230314,,PH,DE,DE,2023,Q1,Elderly
220929581,22092958,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,,,,,,2023,Q1,Acidosis,,2023,Q1,1,I,20230206.0,20230314.0,20230314,20230314,EXP,DE-AMK-264251,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224739",BOEHRINGER INGELHEIM,,75.0,YR,E,M,Y,,,20230314,,PH,DE,DE,2023,Q1,Elderly
220929581,22092958,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230206.0,20230314.0,20230314,20230314,EXP,DE-AMK-264251,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224739",BOEHRINGER INGELHEIM,,75.0,YR,E,M,Y,,,20230314,,PH,DE,DE,2023,Q1,Elderly
220929581,22092958,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20230206.0,20230314.0,20230314,20230314,EXP,DE-AMK-264251,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224739",BOEHRINGER INGELHEIM,,75.0,YR,E,M,Y,,,20230314,,PH,DE,DE,2023,Q1,Elderly
220929581,22092958,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,20230206.0,20230314.0,20230314,20230314,EXP,DE-AMK-264251,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-224739",BOEHRINGER INGELHEIM,,75.0,YR,E,M,Y,,,20230314,,PH,DE,DE,2023,Q1,Elderly
220949441,22094944,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D088599D,,,,,Injection,,2023,Q1,Varicose vein,,2023,Q1,1,I,20220101.0,20230302.0,20230314,20230314,PER,,US-ELI_LILLY_AND_COMPANY-US202303001909,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230313,,CN,US,US,2023,Q1,Elderly
220949441,22094944,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D088599D,,,,,Injection,,2023,Q1,Wrong patient received product,,2023,Q1,1,I,20220101.0,20230302.0,20230314,20230314,PER,,US-ELI_LILLY_AND_COMPANY-US202303001909,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230313,,CN,US,US,2023,Q1,Elderly
220949441,22094944,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D088599D,,,,,Injection,,2023,Q1,Arthropod bite,,2023,Q1,1,I,20220101.0,20230302.0,20230314,20230314,PER,,US-ELI_LILLY_AND_COMPANY-US202303001909,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230313,,CN,US,US,2023,Q1,Elderly
220949441,22094944,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q1,Varicose vein,,2023,Q1,1,I,20220101.0,20230302.0,20230314,20230314,PER,,US-ELI_LILLY_AND_COMPANY-US202303001909,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230313,,CN,US,US,2023,Q1,Elderly
220949441,22094944,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q1,Wrong patient received product,,2023,Q1,1,I,20220101.0,20230302.0,20230314,20230314,PER,,US-ELI_LILLY_AND_COMPANY-US202303001909,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230313,,CN,US,US,2023,Q1,Elderly
220949441,22094944,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q1,Arthropod bite,,2023,Q1,1,I,20220101.0,20230302.0,20230314,20230314,PER,,US-ELI_LILLY_AND_COMPANY-US202303001909,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230313,,CN,US,US,2023,Q1,Elderly
220950191,22095019,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,QD,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,1,I,20230309.0,20230309.0,20230314,20230314,PER,,US-ELI_LILLY_AND_COMPANY-US202303006141,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20230313,,CN,US,US,2023,Q1,Adult
220950191,22095019,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,QD,2023,Q1,Overdose,,2023,Q1,1,I,20230309.0,20230309.0,20230314,20230314,PER,,US-ELI_LILLY_AND_COMPANY-US202303006141,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20230313,,CN,US,US,2023,Q1,Adult
220993821,22099382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, every 4 carbs he eats",,,U,,D539191E,,,1.0,IU,Injection,,2023,Q1,Diabetic ketoacidosis,,2023,Q1,1,I,20220901.0,20230303.0,20230315,20230315,EXP,,US-ELI_LILLY_AND_COMPANY-US202303003205,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230315,,CN,US,US,2023,Q1,Adult
220993821,22099382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, every 4 carbs he eats",,,U,,D539191E,,,1.0,IU,Injection,,2023,Q1,Gastrointestinal motility disorder,,2023,Q1,1,I,20220901.0,20230303.0,20230315,20230315,EXP,,US-ELI_LILLY_AND_COMPANY-US202303003205,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230315,,CN,US,US,2023,Q1,Adult
220993821,22099382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, every 4 carbs he eats",,,U,,D539191E,,,1.0,IU,Injection,,2023,Q1,Blood glucose abnormal,,2023,Q1,1,I,20220901.0,20230303.0,20230315,20230315,EXP,,US-ELI_LILLY_AND_COMPANY-US202303003205,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20230315,,CN,US,US,2023,Q1,Adult
221010291,22101029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,(Carbohydrate counting with correction scale up to 10 additional units),,,U,U,,,,,,,,2023,Q1,Prophylaxis against transplant rejection,,2023,Q1,1,I,,20230306.0,20230316,20230316,EXP,,"US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00162",VELOXIS PHARMACEUTICALS,,60.0,YR,,M,Y,68.7,KG,20230316,,PH,US,US,2023,Q1,Adult
221010291,22101029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,(Carbohydrate counting with correction scale up to 10 additional units),,,U,U,,,,,,,,2023,Q1,Cardiac failure,,2023,Q1,1,I,,20230306.0,20230316,20230316,EXP,,"US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00162",VELOXIS PHARMACEUTICALS,,60.0,YR,,M,Y,68.7,KG,20230316,,PH,US,US,2023,Q1,Adult
221010291,22101029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,(Carbohydrate counting with correction scale up to 10 additional units),,,U,U,,,,,,,,2023,Q1,Immunosuppressant drug level decreased,,2023,Q1,1,I,,20230306.0,20230316,20230316,EXP,,"US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00162",VELOXIS PHARMACEUTICALS,,60.0,YR,,M,Y,68.7,KG,20230316,,PH,US,US,2023,Q1,Adult
221010291,22101029,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,(Carbohydrate counting with correction scale up to 10 additional units),,,U,U,,,,,,,,2023,Q1,Acute myocardial infarction,,2023,Q1,1,I,,20230306.0,20230316,20230316,EXP,,"US-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00162",VELOXIS PHARMACEUTICALS,,60.0,YR,,M,Y,68.7,KG,20230316,,PH,US,US,2023,Q1,Adult
221028823,22102882,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Infection,,2023,Q1,3,F,20230308.0,20230320.0,20230316,20230322,EXP,,TR-JNJFOC-20230323567,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,97.0,KG,20230322,,MD,TR,TR,2023,Q1,Elderly
221028823,22102882,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q1,Acute kidney injury,,2023,Q1,3,F,20230308.0,20230320.0,20230316,20230322,EXP,,TR-JNJFOC-20230323567,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,97.0,KG,20230322,,MD,TR,TR,2023,Q1,Elderly
221065451,22106545,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, QD (10 IU breakfast 16 IU lunch 14 IU dinner)",720.0,IU,Y,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,20230126.0,20230308.0,20230317,20230317,EXP,IT-MINISAL02-912207,IT-SA-2023SA077886,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20230313,,HP,IT,IT,2023,Q1,Elderly
221065451,22106545,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, QD (10 IU breakfast 16 IU lunch 14 IU dinner)",720.0,IU,Y,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Dyspnoea,,2023,Q1,1,I,20230126.0,20230308.0,20230317,20230317,EXP,IT-MINISAL02-912207,IT-SA-2023SA077886,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20230313,,HP,IT,IT,2023,Q1,Elderly
221065451,22106545,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, QD (10 IU breakfast 16 IU lunch 14 IU dinner)",720.0,IU,Y,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Therapy non-responder,,2023,Q1,1,I,20230126.0,20230308.0,20230317,20230317,EXP,IT-MINISAL02-912207,IT-SA-2023SA077886,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20230313,,HP,IT,IT,2023,Q1,Elderly
221065451,22106545,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, QD (10 IU breakfast 16 IU lunch 14 IU dinner)",720.0,IU,Y,,,,,40.0,IU,Solution for injection,QD,2023,Q1,Metabolic acidosis,,2023,Q1,1,I,20230126.0,20230308.0,20230317,20230317,EXP,IT-MINISAL02-912207,IT-SA-2023SA077886,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20230313,,HP,IT,IT,2023,Q1,Elderly
221074681,22107468,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q1,Cardiac disorder,,2023,Q1,1,I,20210101.0,20230310.0,20230317,20230317,EXP,,US-SA-2023SA081956,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230317,,CN,US,US,2023,Q1,Adult
221074681,22107468,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q1,Abdominal discomfort,,2023,Q1,1,I,20210101.0,20230310.0,20230317,20230317,EXP,,US-SA-2023SA081956,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230317,,CN,US,US,2023,Q1,Adult
221074681,22107468,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q1,COVID-19,,2023,Q1,1,I,20210101.0,20230310.0,20230317,20230317,EXP,,US-SA-2023SA081956,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230317,,CN,US,US,2023,Q1,Adult
221074681,22107468,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q1,Immune system disorder,,2023,Q1,1,I,20210101.0,20230310.0,20230317,20230317,EXP,,US-SA-2023SA081956,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230317,,CN,US,US,2023,Q1,Adult
221074681,22107468,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q1,Dyspnoea,,2023,Q1,1,I,20210101.0,20230310.0,20230317,20230317,EXP,,US-SA-2023SA081956,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230317,,CN,US,US,2023,Q1,Adult
221074681,22107468,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q1,Steroid dependence,,2023,Q1,1,I,20210101.0,20230310.0,20230317,20230317,EXP,,US-SA-2023SA081956,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230317,,CN,US,US,2023,Q1,Adult
221074681,22107468,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q1,Pancreatitis,,2023,Q1,1,I,20210101.0,20230310.0,20230317,20230317,EXP,,US-SA-2023SA081956,SANOFI AVENTIS,,45.0,YR,A,F,Y,,,20230317,,CN,US,US,2023,Q1,Adult
221074731,22107473,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Pneumonia,,2023,Q1,1,I,20220718.0,20230306.0,20230317,20230317,EXP,,JP-SA-2022SA432161,SANOFI AVENTIS,,47.0,YR,A,M,Y,,,20230317,,MD,JP,JP,2023,Q1,Adult
221074731,22107473,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Glaucoma,,2023,Q1,1,I,20220718.0,20230306.0,20230317,20230317,EXP,,JP-SA-2022SA432161,SANOFI AVENTIS,,47.0,YR,A,M,Y,,,20230317,,MD,JP,JP,2023,Q1,Adult
221074731,22107473,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q1,Cataract,,2023,Q1,1,I,20220718.0,20230306.0,20230317,20230317,EXP,,JP-SA-2022SA432161,SANOFI AVENTIS,,47.0,YR,A,M,Y,,,20230317,,MD,JP,JP,2023,Q1,Adult
221074861,22107486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BU factor: 0.5-0.5-0.5,,,,,,,,,,,,2023,Q1,Gastroenteritis,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BU factor: 0.5-0.5-0.5,,,,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BU factor: 0.5-0.5-0.5,,,,,,,,,,,,2023,Q1,Circulatory collapse,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,prandial: BU factor:1.75-1.75-1.75,,,,,,,,,,,,2023,Q1,Gastroenteritis,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,prandial: BU factor:1.75-1.75-1.75,,,,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,prandial: BU factor:1.75-1.75-1.75,,,,,,,,,,,,2023,Q1,Circulatory collapse,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"bread unit factor 1.2-0.5-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,,,,,,,,2023,Q1,Gastroenteritis,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"bread unit factor 1.2-0.5-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"bread unit factor 1.2-0.5-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,,,,,,,,2023,Q1,Circulatory collapse,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"prandial: bread unit factor 1.0-1.0-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,,,,,,,,2023,Q1,Gastroenteritis,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"prandial: bread unit factor 1.0-1.0-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,,,,,,,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221074861,22107486,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"prandial: bread unit factor 1.0-1.0-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,,,,,,,,2023,Q1,Circulatory collapse,,2023,Q1,1,I,20140101.0,20230306.0,20230317,20230317,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230317,,MD,DE,DE,2023,Q1,Young Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Injection site atrophy,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Hyperhidrosis,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Diabetic ketosis,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Injection site urticaria,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Hyperglycaemia,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Palpitations,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Injection site pruritus,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221081811,22108181,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, Insulin lispro pumping",,,Y,,,,209196.0,,,Solution for injection,,2023,Q1,Hypersensitivity,,2023,Q1,1,I,20170101.0,20230308.0,20230317,20230317,EXP,,CN-SA-2023SA079547,SANOFI AVENTIS,"Li X, Ping F, Li M. A case report of continuous subcutaneous dilution insulin infusion to improve hypersensitivity caused by exogenous insulin. Chin J Diabetes Mellitus.. 2020;12(8):641-4",52.0,YR,A,F,Y,,,20230317,,HP,CN,CN,2023,Q1,Adult
221084441,22108444,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,9.1,MG,,,,,,,,,QD,2023,Q1,Febrile neutropenia,,2023,Q1,1,I,20230220.0,20230221.0,20230317,20230317,PER,,US-ABBVIE-4319371,ABBVIE,,62.0,YR,,F,Y,,,20230317,,MD,US,US,2023,Q1,Adult
221084441,22108444,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: 0.33333333 days,9.1,MG,,,,,,,,,,2023,Q1,Febrile neutropenia,,2023,Q1,1,I,20230220.0,20230221.0,20230317,20230317,PER,,US-ABBVIE-4319371,ABBVIE,,62.0,YR,,F,Y,,,20230317,,MD,US,US,2023,Q1,Adult
221093092,22109309,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,209196.0,,,,Q8H,2023,Q1,Illness,,2023,Q1,2,F,20230313.0,20230326.0,20230317,20230331,PER,,US-SA-2023SA084099,SANOFI AVENTIS,,82.0,YR,E,F,Y,,,20230331,,CN,US,US,2023,Q1,Elderly
221093092,22109309,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,209196.0,,,,Q8H,2023,Q1,Blood glucose increased,,2023,Q1,2,F,20230313.0,20230326.0,20230317,20230331,PER,,US-SA-2023SA084099,SANOFI AVENTIS,,82.0,YR,E,F,Y,,,20230331,,CN,US,US,2023,Q1,Elderly
221103201,22110320,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5-8 units,,,,,,,,,,Injection,,2023,Q1,Rhinovirus infection,,2023,Q1,1,I,20230216.0,20230314.0,20230317,20230317,EXP,,US-JNJFOC-20230234324,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230317,,MD,US,US,2023,Q1,Adult
221103201,22110320,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5-8 units,,,,,,,,,,Injection,,2023,Q1,Enterovirus infection,,2023,Q1,1,I,20230216.0,20230314.0,20230317,20230317,EXP,,US-JNJFOC-20230234324,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230317,,MD,US,US,2023,Q1,Adult
221103201,22110320,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5-8 units,,,,,,,,,,Injection,,2023,Q1,Pyrexia,,2023,Q1,1,I,20230216.0,20230314.0,20230317,20230317,EXP,,US-JNJFOC-20230234324,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230317,,MD,US,US,2023,Q1,Adult
221103201,22110320,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5-8 units,,,,,,,,,,Injection,,2023,Q1,Immune effector cell-associated neurotoxicity syndrome,,2023,Q1,1,I,20230216.0,20230314.0,20230317,20230317,EXP,,US-JNJFOC-20230234324,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230317,,MD,US,US,2023,Q1,Adult
221103201,22110320,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5-8 units,,,,,,,,,,Injection,,2023,Q1,Respiratory failure,,2023,Q1,1,I,20230216.0,20230314.0,20230317,20230317,EXP,,US-JNJFOC-20230234324,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230317,,MD,US,US,2023,Q1,Adult
221103201,22110320,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5-8 units,,,,,,,,,,Injection,,2023,Q1,Pyrexia,,2023,Q1,1,I,20230216.0,20230314.0,20230317,20230317,EXP,,US-JNJFOC-20230234324,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230317,,MD,US,US,2023,Q1,Adult
221103201,22110320,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5-8 units,,,,,,,,,,Injection,,2023,Q1,Pyrexia,,2023,Q1,1,I,20230216.0,20230314.0,20230317,20230317,EXP,,US-JNJFOC-20230234324,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230317,,MD,US,US,2023,Q1,Adult
221103201,22110320,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5-8 units,,,,,,,,,,Injection,,2023,Q1,Cytokine release syndrome,,2023,Q1,1,I,20230216.0,20230314.0,20230317,20230317,EXP,,US-JNJFOC-20230234324,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20230317,,MD,US,US,2023,Q1,Adult
221124121,22112412,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,Solution for injection,,2023,Q1,Inappropriate schedule of product administration,,2023,Q1,1,I,,20230315.0,20230319,20230319,PER,,US-SA-2023SA086388,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20230319,,CN,US,US,2023,Q1,Elderly
221124121,22112412,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,Solution for injection,,2023,Q1,Blood glucose abnormal,,2023,Q1,1,I,,20230315.0,20230319,20230319,PER,,US-SA-2023SA086388,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20230319,,CN,US,US,2023,Q1,Elderly
221124121,22112412,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,209196.0,,,Solution for injection,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230315.0,20230319,20230319,PER,,US-SA-2023SA086388,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20230319,,CN,US,US,2023,Q1,Elderly
221139631,22113963,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk,,,Y,,Unk,,,,,,,2023,Q1,Acidosis,,2023,Q1,1,I,20230206.0,20230313.0,20230320,20230320,EXP,DE-AMK-264251,NVSC2023DE057537,NOVARTIS,,75.0,YR,,M,Y,,,20230320,,PH,DE,DE,2023,Q1,Elderly
221139631,22113963,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk,,,Y,,Unk,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230206.0,20230313.0,20230320,20230320,EXP,DE-AMK-264251,NVSC2023DE057537,NOVARTIS,,75.0,YR,,M,Y,,,20230320,,PH,DE,DE,2023,Q1,Elderly
221139631,22113963,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk,,,Y,,Unk,,,,,,,2023,Q1,Dehydration,,2023,Q1,1,I,20230206.0,20230313.0,20230320,20230320,EXP,DE-AMK-264251,NVSC2023DE057537,NOVARTIS,,75.0,YR,,M,Y,,,20230320,,PH,DE,DE,2023,Q1,Elderly
221139631,22113963,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk,,,Y,,Unk,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20230206.0,20230313.0,20230320,20230320,EXP,DE-AMK-264251,NVSC2023DE057537,NOVARTIS,,75.0,YR,,M,Y,,,20230320,,PH,DE,DE,2023,Q1,Elderly
221139631,22113963,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk,,,Y,,Unk,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,20230206.0,20230313.0,20230320,20230320,EXP,DE-AMK-264251,NVSC2023DE057537,NOVARTIS,,75.0,YR,,M,Y,,,20230320,,PH,DE,DE,2023,Q1,Elderly
221144281,22114428,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,U,,,,,,Infusion,,2023,Q1,Condition aggravated,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,GR-MYLANLABS-2021M1089140,MYLAN,"Xatzipsalti M, Alvertis H, Vazeou A. Laser treatment for lipoatrophy in children with diabetes type 1. Diabet-Int. 2022;13(2):452-455",6.0,YR,,M,Y,23.5,KG,20230320,,HP,GR,GR,2023,Q1,Child
221144281,22114428,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,U,,,,,,Infusion,,2023,Q1,Lipoatrophy,,2023,Q1,1,I,,20230310.0,20230320,20230320,EXP,,GR-MYLANLABS-2021M1089140,MYLAN,"Xatzipsalti M, Alvertis H, Vazeou A. Laser treatment for lipoatrophy in children with diabetes type 1. Diabet-Int. 2022;13(2):452-455",6.0,YR,,M,Y,23.5,KG,20230320,,HP,GR,GR,2023,Q1,Child
221183981,22118398,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D529827H,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230201.0,20230310.0,20230321,20230321,PER,,US-ELI_LILLY_AND_COMPANY-US202303007017,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20230321,,CN,US,US,2023,Q1,Adult
221183981,22118398,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D529827H,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230201.0,20230310.0,20230321,20230321,PER,,US-ELI_LILLY_AND_COMPANY-US202303007017,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20230321,,CN,US,US,2023,Q1,Adult
221183981,22118398,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230201.0,20230310.0,20230321,20230321,PER,,US-ELI_LILLY_AND_COMPANY-US202303007017,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20230321,,CN,US,US,2023,Q1,Adult
221183981,22118398,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230201.0,20230310.0,20230321,20230321,PER,,US-ELI_LILLY_AND_COMPANY-US202303007017,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20230321,,CN,US,US,2023,Q1,Adult
221242291,22124229,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Product dose omission issue,,2023,Q1,1,I,,20230313.0,20230322,20230322,EXP,CA-MHPD-E2B_06023736,CA-Accord-304613,ACCORD,,20.0,YR,A,F,Y,,,20230322,,HP,CA,CA,2023,Q1,Youth
221242291,22124229,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Nausea,,2023,Q1,1,I,,20230313.0,20230322,20230322,EXP,CA-MHPD-E2B_06023736,CA-Accord-304613,ACCORD,,20.0,YR,A,F,Y,,,20230322,,HP,CA,CA,2023,Q1,Youth
221242291,22124229,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Colitis ulcerative,,2023,Q1,1,I,,20230313.0,20230322,20230322,EXP,CA-MHPD-E2B_06023736,CA-Accord-304613,ACCORD,,20.0,YR,A,F,Y,,,20230322,,HP,CA,CA,2023,Q1,Youth
221242291,22124229,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,,20230313.0,20230322,20230322,EXP,CA-MHPD-E2B_06023736,CA-Accord-304613,ACCORD,,20.0,YR,A,F,Y,,,20230322,,HP,CA,CA,2023,Q1,Youth
221278711,22127871,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,Acidosis,,2023,Q1,1,I,20230206.0,20230313.0,20230323,20230323,EXP,,DE-AUROBINDO-AUR-APL-2023-012556,AUROBINDO,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221278711,22127871,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230206.0,20230313.0,20230323,20230323,EXP,,DE-AUROBINDO-AUR-APL-2023-012556,AUROBINDO,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221278711,22127871,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20230206.0,20230313.0,20230323,20230323,EXP,,DE-AUROBINDO-AUR-APL-2023-012556,AUROBINDO,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221278711,22127871,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,Dehydration,,2023,Q1,1,I,20230206.0,20230313.0,20230323,20230323,EXP,,DE-AUROBINDO-AUR-APL-2023-012556,AUROBINDO,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221278711,22127871,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,20230206.0,20230313.0,20230323,20230323,EXP,,DE-AUROBINDO-AUR-APL-2023-012556,AUROBINDO,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221301181,22130118,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 units x 3 times a day,,,U,,,,,4.0,IU,,Q8H,2023,Q1,Eye disorder,,2023,Q1,1,I,,20230321.0,20230323,20230323,PER,,US-SA-2023SA092185,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20230323,,CN,US,US,2023,Q1,Elderly
221301181,22130118,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 units x 3 times a day,,,U,,,,,4.0,IU,,Q8H,2023,Q1,Blood glucose increased,,2023,Q1,1,I,,20230321.0,20230323,20230323,PER,,US-SA-2023SA092185,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20230323,,CN,US,US,2023,Q1,Elderly
221301181,22130118,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 units x 3 times a day,,,U,,,,,4.0,IU,,Q8H,2023,Q1,Wrong technique in product usage process,,2023,Q1,1,I,,20230321.0,20230323,20230323,PER,,US-SA-2023SA092185,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20230323,,CN,US,US,2023,Q1,Elderly
221301181,22130118,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 units x 3 times a day,,,U,,,,,4.0,IU,,Q8H,2023,Q1,Visual impairment,,2023,Q1,1,I,,20230321.0,20230323,20230323,PER,,US-SA-2023SA092185,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20230323,,CN,US,US,2023,Q1,Elderly
221321191,22132119,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,20230206.0,20230317.0,20230323,20230323,EXP,DE-AMK-264251,DE-MYLANLABS-2023M1030002,MYLAN,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221321191,22132119,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20230206.0,20230317.0,20230323,20230323,EXP,DE-AMK-264251,DE-MYLANLABS-2023M1030002,MYLAN,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221321191,22132119,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230206.0,20230317.0,20230323,20230323,EXP,DE-AMK-264251,DE-MYLANLABS-2023M1030002,MYLAN,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221321191,22132119,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,Acidosis,,2023,Q1,1,I,20230206.0,20230317.0,20230323,20230323,EXP,DE-AMK-264251,DE-MYLANLABS-2023M1030002,MYLAN,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221321191,22132119,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q1,Dehydration,,2023,Q1,1,I,20230206.0,20230317.0,20230323,20230323,EXP,DE-AMK-264251,DE-MYLANLABS-2023M1030002,MYLAN,,75.0,YR,,M,Y,,,20230323,,PH,DE,DE,2023,Q1,Elderly
221331951,22133195,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ML VIAL,,,,,,,,,,,,2023,Q1,Pancreas infection,,2023,Q1,1,I,20211115.0,20230320.0,20230324,20230324,EXP,,US-ABBVIE-4335998,ABBVIE,,54.0,YR,,M,Y,,,20230324,,CN,US,US,2023,Q1,Adult
221331951,22133195,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ML VIAL,,,,,,,,,,,,2023,Q1,Skin exfoliation,,2023,Q1,1,I,20211115.0,20230320.0,20230324,20230324,EXP,,US-ABBVIE-4335998,ABBVIE,,54.0,YR,,M,Y,,,20230324,,CN,US,US,2023,Q1,Adult
221331951,22133195,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ML VIAL,,,,,,,,,,,,2023,Q1,Pancreatitis,,2023,Q1,1,I,20211115.0,20230320.0,20230324,20230324,EXP,,US-ABBVIE-4335998,ABBVIE,,54.0,YR,,M,Y,,,20230324,,CN,US,US,2023,Q1,Adult
221402081,22140208,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Presyncope,,2023,Q1,1,I,20220519.0,20230322.0,20230327,20230327,EXP,IT-MINISAL02-914650,IT-SA-2023SA093979,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20230327,,MD,IT,IT,2023,Q1,Elderly
221402081,22140208,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20220519.0,20230322.0,20230327,20230327,EXP,IT-MINISAL02-914650,IT-SA-2023SA093979,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20230327,,MD,IT,IT,2023,Q1,Elderly
221412532,22141253,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,2F8642A,,209196.0,,,Solution for injection,,2023,Q1,Drug hypersensitivity,,2023,Q1,2,F,,20230327.0,20230327,20230330,PER,,US-SA-2023SA095053,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20230330,,HP,US,US,2023,Q1,Elderly
221412532,22141253,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,2F8642A,,209196.0,,,Solution for injection,,2023,Q1,Swelling,,2023,Q1,2,F,,20230327.0,20230327,20230330,PER,,US-SA-2023SA095053,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20230330,,HP,US,US,2023,Q1,Elderly
221414571,22141457,108,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,U,,,,,1.0,IU,Unknown,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,1,I,20200809.0,20230317.0,20230327,20230327,EXP,,FR-Waylis Therapeutics LLC-ATNAHS20210702393,Waylis,,74.0,YR,E,M,Y,,,20230324,,HP,FR,FR,2023,Q1,Elderly
221418361,22141836,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Headache,,2023,Q1,1,I,20221201.0,20230323.0,20230327,20230327,PER,,US-PFIZER INC-202300131094,PFIZER,,59.0,YR,,F,Y,,,20230327,,HP,US,US,2023,Q1,Adult
221418361,22141836,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Drug ineffective,,2023,Q1,1,I,20221201.0,20230323.0,20230327,20230327,PER,,US-PFIZER INC-202300131094,PFIZER,,59.0,YR,,F,Y,,,20230327,,HP,US,US,2023,Q1,Adult
221421071,22142107,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q1,Thrombosis,,2023,Q1,1,I,20230320.0,,20230324,20230324,DIR,FDA-CDER-CTU-2023-22883,,FDA-CTU,,63.0,YR,,F,N,86.45,KG,20230324,N,,US,,2023,Q1,Adult
221442331,22144233,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk,,,U,,,,,,,,,2023,Q1,Ecchymosis,,2023,Q1,1,I,20220929.0,20230320.0,20230328,20230328,EXP,IT-MINISAL02-914397,NVSC2023IT064675,NOVARTIS,,79.0,YR,,M,Y,,,20230328,,PH,IT,IT,2023,Q1,Elderly
221442331,22144233,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unk,,,U,,,,,,,,,2023,Q1,Subdural haematoma,,2023,Q1,1,I,20220929.0,20230320.0,20230328,20230328,EXP,IT-MINISAL02-914397,NVSC2023IT064675,NOVARTIS,,79.0,YR,,M,Y,,,20230328,,PH,IT,IT,2023,Q1,Elderly
221444671,22144467,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Visual impairment,,2023,Q1,1,I,20230321.0,20230306.0,20230328,20230328,PER,,US-ELI_LILLY_AND_COMPANY-US202303012205,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20230328,,CN,US,US,2023,Q1,Elderly
221444671,22144467,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230321.0,20230306.0,20230328,20230328,PER,,US-ELI_LILLY_AND_COMPANY-US202303012205,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20230328,,CN,US,US,2023,Q1,Elderly
221444671,22144467,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q1,Incorrect dose administered,,2023,Q1,1,I,20230321.0,20230306.0,20230328,20230328,PER,,US-ELI_LILLY_AND_COMPANY-US202303012205,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20230328,,CN,US,US,2023,Q1,Elderly
221453761,22145376,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,TID,2023,Q1,Parkinsonism,,2023,Q1,1,I,,20230317.0,20230328,20230328,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230328,,CN,US,US,2023,Q1,Elderly
221453761,22145376,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,TID,2023,Q1,Rehabilitation therapy,,2023,Q1,1,I,,20230317.0,20230328,20230328,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230328,,CN,US,US,2023,Q1,Elderly
221453761,22145376,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,TID,2023,Q1,Coma,,2023,Q1,1,I,,20230317.0,20230328,20230328,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230328,,CN,US,US,2023,Q1,Elderly
221453761,22145376,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,TID,2023,Q1,Diabetic neuropathy,,2023,Q1,1,I,,20230317.0,20230328,20230328,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230328,,CN,US,US,2023,Q1,Elderly
221453761,22145376,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,TID,2023,Q1,Tremor,,2023,Q1,1,I,,20230317.0,20230328,20230328,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230328,,CN,US,US,2023,Q1,Elderly
221453761,22145376,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,TID,2023,Q1,Erythema,,2023,Q1,1,I,,20230317.0,20230328,20230328,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230328,,CN,US,US,2023,Q1,Elderly
221471431,22147143,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q1,Treatment noncompliance,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202303010271,ELI LILLY AND CO,,17.0,YR,,M,Y,,,20230328,,CN,CA,CA,2023,Q1,Youth
221471431,22147143,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q1,Glycosylated haemoglobin increased,,2023,Q1,1,I,,20230320.0,20230328,20230328,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202303010271,ELI LILLY AND CO,,17.0,YR,,M,Y,,,20230328,,CN,CA,CA,2023,Q1,Youth
221485981,22148598,117,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,D,,,,,1.0,IU,,,2023,Q1,Toxic epidermal necrolysis,,2023,Q1,1,I,20220809.0,20230319.0,20230328,20230328,EXP,,FR-BAUSCH-BL-2023-004647,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20230328,,CN,FR,FR,2023,Q1,Elderly
221526561,22152656,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 u, bid (morning and lunch)",,,,,D539191E,,20563.0,18.0,IU,Injection,BID,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 u, bid (morning and lunch)",,,,,D539191E,,20563.0,18.0,IU,Injection,BID,2023,Q1,Lung neoplasm malignant,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 u, bid (morning and lunch)",,,,,D539191E,,20563.0,18.0,IU,Injection,BID,2023,Q1,Injury associated with device,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily (night)",,,,,D539191E,,20563.0,20.0,IU,Injection,QD,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily (night)",,,,,D539191E,,20563.0,20.0,IU,Injection,QD,2023,Q1,Lung neoplasm malignant,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily (night)",,,,,D539191E,,20563.0,20.0,IU,Injection,QD,2023,Q1,Injury associated with device,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 u, bid (morning and lunch)",,,,,D547157C,,20563.0,18.0,IU,Injection,BID,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 u, bid (morning and lunch)",,,,,D547157C,,20563.0,18.0,IU,Injection,BID,2023,Q1,Lung neoplasm malignant,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 u, bid (morning and lunch)",,,,,D547157C,,20563.0,18.0,IU,Injection,BID,2023,Q1,Injury associated with device,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily (night)",,,,,D547157C,,20563.0,20.0,IU,Injection,QD,2023,Q1,Blood glucose increased,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily (night)",,,,,D547157C,,20563.0,20.0,IU,Injection,QD,2023,Q1,Lung neoplasm malignant,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221526561,22152656,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily (night)",,,,,D547157C,,20563.0,20.0,IU,Injection,QD,2023,Q1,Injury associated with device,,2023,Q1,1,I,20230317.0,20230317.0,20230329,20230329,EXP,,US-ELI_LILLY_AND_COMPANY-US202303011061,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20230329,,CN,US,US,2023,Q1,Elderly
221529511,22152951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Infected skin ulcer,,2023,Q1,1,I,20230316.0,20230327.0,20230329,20230329,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-044013,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,92.1,KG,20230329,,PH,US,US,2023,Q1,Elderly
221529511,22152951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Confusional state,,2023,Q1,1,I,20230316.0,20230327.0,20230329,20230329,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-044013,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,92.1,KG,20230329,,PH,US,US,2023,Q1,Elderly
221529511,22152951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Asthenia,,2023,Q1,1,I,20230316.0,20230327.0,20230329,20230329,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-044013,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,92.1,KG,20230329,,PH,US,US,2023,Q1,Elderly
221529511,22152951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Hypercalcaemia,,2023,Q1,1,I,20230316.0,20230327.0,20230329,20230329,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-044013,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,92.1,KG,20230329,,PH,US,US,2023,Q1,Elderly
221530131,22153013,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Blood pressure increased,,2023,Q1,1,I,,20230327.0,20230329,20230329,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-045149,BRISTOL MYERS SQUIBB,,64.0,YR,A,M,Y,,,20230329,,CN,US,US,2023,Q1,Adult
221530131,22153013,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Diarrhoea,,2023,Q1,1,I,,20230327.0,20230329,20230329,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-045149,BRISTOL MYERS SQUIBB,,64.0,YR,A,M,Y,,,20230329,,CN,US,US,2023,Q1,Adult
221530131,22153013,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q1,Taste disorder,,2023,Q1,1,I,,20230327.0,20230329,20230329,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-045149,BRISTOL MYERS SQUIBB,,64.0,YR,A,M,Y,,,20230329,,CN,US,US,2023,Q1,Adult
221539481,22153948,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,as necessary,,,,,,,,,,,,2023,Q1,Renal failure,,2023,Q1,1,I,,20230328.0,20230330,20230330,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-227212",BOEHRINGER INGELHEIM,,86.0,YR,E,F,Y,,,20230330,,MD,IT,IT,2023,Q1,Elderly
221539481,22153948,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,as necessary,,,,,,,,,,,,2023,Q1,Pneumonia,,2023,Q1,1,I,,20230328.0,20230330,20230330,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-227212",BOEHRINGER INGELHEIM,,86.0,YR,E,F,Y,,,20230330,,MD,IT,IT,2023,Q1,Elderly
221539481,22153948,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,as necessary,,,,,,,,,,,,2023,Q1,Cholecystitis acute,,2023,Q1,1,I,,20230328.0,20230330,20230330,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-227212",BOEHRINGER INGELHEIM,,86.0,YR,E,F,Y,,,20230330,,MD,IT,IT,2023,Q1,Elderly
221539481,22153948,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,as necessary,,,,,,,,,,,,2023,Q1,Hepatic failure,,2023,Q1,1,I,,20230328.0,20230330,20230330,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-227212",BOEHRINGER INGELHEIM,,86.0,YR,E,F,Y,,,20230330,,MD,IT,IT,2023,Q1,Elderly
221554401,22155440,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,as necessary,,,,,,,,,,,,2023,Q1,Renal failure,,2023,Q1,1,I,,20230328.0,20230330,20230330,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-227904",BOEHRINGER INGELHEIM,,86.0,YR,E,F,Y,,,20230330,,MD,IT,IT,2023,Q1,Elderly
221554401,22155440,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,as necessary,,,,,,,,,,,,2023,Q1,Hepatic failure,,2023,Q1,1,I,,20230328.0,20230330,20230330,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-227904",BOEHRINGER INGELHEIM,,86.0,YR,E,F,Y,,,20230330,,MD,IT,IT,2023,Q1,Elderly
221580311,22158031,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, daily",336.0,IU,,,D441210,,21017.0,8.0,IU,Injection,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230307.0,20230321.0,20230330,20230330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202303015075,ELI LILLY AND CO,,27.0,YR,,M,Y,68.5,KG,20230330,,CN,CN,CN,2023,Q1,Young Adult
221580311,22158031,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, daily",336.0,IU,,,D441210,,21017.0,8.0,IU,Injection,QD,2023,Q1,Syncope,,2023,Q1,1,I,20230307.0,20230321.0,20230330,20230330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202303015075,ELI LILLY AND CO,,27.0,YR,,M,Y,68.5,KG,20230330,,CN,CN,CN,2023,Q1,Young Adult
221580311,22158031,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, daily",336.0,IU,,,D441210C,,21017.0,8.0,IU,Injection,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230307.0,20230321.0,20230330,20230330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202303015075,ELI LILLY AND CO,,27.0,YR,,M,Y,68.5,KG,20230330,,CN,CN,CN,2023,Q1,Young Adult
221580311,22158031,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, daily",336.0,IU,,,D441210C,,21017.0,8.0,IU,Injection,QD,2023,Q1,Syncope,,2023,Q1,1,I,20230307.0,20230321.0,20230330,20230330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202303015075,ELI LILLY AND CO,,27.0,YR,,M,Y,68.5,KG,20230330,,CN,CN,CN,2023,Q1,Young Adult
221580311,22158031,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily",336.0,IU,,,,,21017.0,10.0,IU,Injection,QD,2023,Q1,Hypoglycaemia,,2023,Q1,1,I,20230307.0,20230321.0,20230330,20230330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202303015075,ELI LILLY AND CO,,27.0,YR,,M,Y,68.5,KG,20230330,,CN,CN,CN,2023,Q1,Young Adult
221580311,22158031,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily",336.0,IU,,,,,21017.0,10.0,IU,Injection,QD,2023,Q1,Syncope,,2023,Q1,1,I,20230307.0,20230321.0,20230330,20230330,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202303015075,ELI LILLY AND CO,,27.0,YR,,M,Y,68.5,KG,20230330,,CN,CN,CN,2023,Q1,Young Adult
221609191,22160919,11,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2023,Q1,Hospitalisation,,2023,Q1,1,I,,,20230330,20230330,DIR,FDA-CDER-CTU-2023-24262,,FDA-CTU,,75.0,YR,,F,N,83.01,KG,20230330,N,,US,,2023,Q1,Elderly
221618911,22161891,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,UNKNOWN,,,,,,,2023,Q1,General physical health deterioration,,2023,Q1,1,I,20230206.0,20230323.0,20230331,20230331,EXP,DE-AMK-264251,DE-TEVA-2023-DE-2871223,TEVA,,75.0,YR,E,M,Y,,,20230331,,PH,DE,DE,2023,Q1,Elderly
221618911,22161891,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,UNKNOWN,,,,,,,2023,Q1,Abdominal pain,,2023,Q1,1,I,20230206.0,20230323.0,20230331,20230331,EXP,DE-AMK-264251,DE-TEVA-2023-DE-2871223,TEVA,,75.0,YR,E,M,Y,,,20230331,,PH,DE,DE,2023,Q1,Elderly
221618911,22161891,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,UNKNOWN,,,,,,,2023,Q1,Dehydration,,2023,Q1,1,I,20230206.0,20230323.0,20230331,20230331,EXP,DE-AMK-264251,DE-TEVA-2023-DE-2871223,TEVA,,75.0,YR,E,M,Y,,,20230331,,PH,DE,DE,2023,Q1,Elderly
221618911,22161891,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,UNKNOWN,,,,,,,2023,Q1,Acidosis,,2023,Q1,1,I,20230206.0,20230323.0,20230331,20230331,EXP,DE-AMK-264251,DE-TEVA-2023-DE-2871223,TEVA,,75.0,YR,E,M,Y,,,20230331,,PH,DE,DE,2023,Q1,Elderly
221618911,22161891,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,UNKNOWN,,,,,,,2023,Q1,Vomiting,,2023,Q1,1,I,20230206.0,20230323.0,20230331,20230331,EXP,DE-AMK-264251,DE-TEVA-2023-DE-2871223,TEVA,,75.0,YR,E,M,Y,,,20230331,,PH,DE,DE,2023,Q1,Elderly
157484643,15748464,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / d), unit dose : 40 IU, frequency time : 1 days",,,U,,UNKNOWN,,,40.0,IU,,,2023,Q2,Chest pain,,2023,Q2,3,F,,20230331.0,20181221,20230410,EXP,,PT-TEVA-2018-PT-989694,TEVA,,54.0,YR,A,F,Y,,,20230410,,PH,PT,PT,2023,Q2,Adult
157484643,15748464,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / d), unit dose : 40 IU, frequency time : 1 days",,,U,,UNKNOWN,,,40.0,IU,,,2023,Q2,Headache,,2023,Q2,3,F,,20230331.0,20181221,20230410,EXP,,PT-TEVA-2018-PT-989694,TEVA,,54.0,YR,A,F,Y,,,20230410,,PH,PT,PT,2023,Q2,Adult
157484643,15748464,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / d), unit dose : 40 IU, frequency time : 1 days",,,U,,UNKNOWN,,,40.0,IU,,,2023,Q2,Ischaemic stroke,,2023,Q2,3,F,,20230331.0,20181221,20230410,EXP,,PT-TEVA-2018-PT-989694,TEVA,,54.0,YR,A,F,Y,,,20230410,,PH,PT,PT,2023,Q2,Adult
160068979,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Renal failure,,2023,Q2,9,F,20060101.0,20230419.0,20190222,20230426,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230426,,LW,US,,2023,Q2,Adult
160068979,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,9,F,20060101.0,20230419.0,20190222,20230426,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230426,,LW,US,,2023,Q2,Adult
160068979,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Nephrogenic anaemia,,2023,Q2,9,F,20060101.0,20230419.0,20190222,20230426,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230426,,LW,US,,2023,Q2,Adult
160068979,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,End stage renal disease,,2023,Q2,9,F,20060101.0,20230419.0,20190222,20230426,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230426,,LW,US,,2023,Q2,Adult
160068979,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Tubulointerstitial nephritis,,2023,Q2,9,F,20060101.0,20230419.0,20190222,20230426,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230426,,LW,US,,2023,Q2,Adult
160068979,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Renal injury,,2023,Q2,9,F,20060101.0,20230419.0,20190222,20230426,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230426,,LW,US,,2023,Q2,Adult
160068979,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Chronic kidney disease,,2023,Q2,9,F,20060101.0,20230419.0,20190222,20230426,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230426,,LW,US,,2023,Q2,Adult
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Nephrogenic anaemia,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,End stage renal disease,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Chronic kidney disease-mineral and bone disorder,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Renal tubular necrosis,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Metabolic acidosis,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Renal failure,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Chronic kidney disease,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
162782133,16278213,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,3,F,20120416.0,20230427.0,20190506,20230501,EXP,,US-AstraZeneca-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20230501,,LW,US,,2023,Q2,Elderly
172939704,17293970,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Drug ineffective,,2023,Q2,4,F,20230101.0,20230421.0,20200121,20230503,PER,,US-SA-2020SA013571,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20230503,,HP,US,US,2023,Q2,Adult
172939704,17293970,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,4,F,20230101.0,20230421.0,20200121,20230503,PER,,US-SA-2020SA013571,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20230503,,HP,US,US,2023,Q2,Adult
172939704,17293970,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Blood glucose decreased,,2023,Q2,4,F,20230101.0,20230421.0,20200121,20230503,PER,,US-SA-2020SA013571,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20230503,,HP,US,US,2023,Q2,Adult
178889799,17888979,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,9,F,20230324.0,20230421.0,20200612,20230430,PER,,US-SA-2020SA147429,SANOFI AVENTIS,,52.0,YR,A,F,Y,65.76,KG,20230501,,HP,US,US,2023,Q2,Adult
178889799,17888979,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Wrong product administered,,2023,Q2,9,F,20230324.0,20230421.0,20200612,20230430,PER,,US-SA-2020SA147429,SANOFI AVENTIS,,52.0,YR,A,F,Y,65.76,KG,20230501,,HP,US,US,2023,Q2,Adult
178889799,17888979,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,9,F,20230324.0,20230421.0,20200612,20230430,PER,,US-SA-2020SA147429,SANOFI AVENTIS,,52.0,YR,A,F,Y,65.76,KG,20230501,,HP,US,US,2023,Q2,Adult
178889799,17888979,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,9,F,20230324.0,20230421.0,20200612,20230430,PER,,US-SA-2020SA147429,SANOFI AVENTIS,,52.0,YR,A,F,Y,65.76,KG,20230501,,HP,US,US,2023,Q2,Adult
178889799,17888979,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Device operational issue,,2023,Q2,9,F,20230324.0,20230421.0,20200612,20230430,PER,,US-SA-2020SA147429,SANOFI AVENTIS,,52.0,YR,A,F,Y,65.76,KG,20230501,,HP,US,US,2023,Q2,Adult
178889799,17888979,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Drug ineffective,,2023,Q2,9,F,20230324.0,20230421.0,20200612,20230430,PER,,US-SA-2020SA147429,SANOFI AVENTIS,,52.0,YR,A,F,Y,65.76,KG,20230501,,HP,US,US,2023,Q2,Adult
178889799,17888979,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Product storage error,,2023,Q2,9,F,20230324.0,20230421.0,20200612,20230430,PER,,US-SA-2020SA147429,SANOFI AVENTIS,,52.0,YR,A,F,Y,65.76,KG,20230501,,HP,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Renal injury,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Multiple fractures,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Asthenia,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Urinary incontinence,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Foot fracture,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Foot fracture,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Emotional distress,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Bone demineralisation,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Osteonecrosis,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Bone density decreased,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Pain,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Anhedonia,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Renal failure,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Anxiety,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Skeletal injury,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Chronic kidney disease,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Bone loss,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Device related infection,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180200364,18020036,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Gait inability,,2023,Q2,4,F,20110101.0,20211207.0,20200714,20230404,EXP,,US-GILEAD-2020-0481902,GILEAD,,49.0,YR,A,F,Y,121.54,KG,20230404,,LW,US,US,2023,Q2,Adult
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Dehydration,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Product name confusion,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Incorrect dose administered,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Bedridden,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Aspartate aminotransferase increased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Urinary incontinence,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Drug clearance decreased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Blood creatinine increased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Immobile,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Contraindicated product administered,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Constipation,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Transaminases increased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Myalgia,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Alanine aminotransferase increased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Oedema peripheral,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Acute kidney injury,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Mobility decreased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Asthenia,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Overdose,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Rhabdomyolysis,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Fatigue,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Blood urea increased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Blood creatine phosphokinase increased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,International normalised ratio increased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Product administration error,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Drug interaction,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Polyuria,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Myoglobin blood increased,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Toxicity to various agents,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180836907,18083690,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, Once a Day",,,U,,,,,42.0,IU,,QD,2023,Q2,Medication error,,2023,Q2,7,F,,20230327.0,20200729,20230410,EXP,,CZ-AUROBINDO-AUR-APL-2020-034147,AUROBINDO,"Martin Vodicka, Ontli^ej Slanar, Michal Pisar, Tomas Salek. n.Rosuvastatin-induced rhabdo:nayolysis due to medication errors (Rhabdonmyolyza po chybnem uzivani rosuvastatinu - kazuistika). Ces. slov. Farm. 2020;69:100-2",74.0,YR,,M,Y,,,20230410,,PH,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Drug interaction,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Acute kidney injury,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Drug clearance decreased,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Constipation,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Contraindicated product administered,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Product name confusion,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Toxicity to various agents,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,International normalised ratio increased,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Rhabdomyolysis,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Product administration error,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Overdose,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
180893493,18089349,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"42 international unit, qd",,,,,,,,42.0,IU,,QD,2023,Q2,Bedridden,,2023,Q2,3,F,,20230331.0,20200730,20230407,EXP,,CZ-LUPIN PHARMACEUTICALS INC.-2020-03807,LUPIN,"Vodicka M, Slanar O, Pisar M, Salek T. Rosuvastatin-induced rhabdomyolysis due to medication errors. Ces. slov. Farm.. 2020;69(2):100-102",74.0,YR,,M,Y,,,20230407,,HP,CZ,CZ,2023,Q2,Elderly
1820299716,18202997,140,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,D,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,16,F,20200809.0,20230605.0,20200827,20230607,EXP,,NVSC2020FR235135,NOVARTIS,,74.0,YR,,M,Y,,,20230607,,MD,FR,FR,2023,Q2,Elderly
1820848934,18208489,116,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,34,F,20200809.0,20230614.0,20200828,20230619,EXP,,FR-BAUSCH-BL-2020-024487,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20230619,,MD,FR,FR,2023,Q2,Elderly
1822548718,18225487,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,U,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,18,F,20200809.0,20230531.0,20200903,20230607,EXP,,FR-AUROBINDO-AUR-APL-2020-045739,AUROBINDO,,74.0,YR,,M,Y,,,20230607,,MD,FR,FR,2023,Q2,Elderly
1822823742,18228237,108,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 iU,,,U,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,42,F,20200809.0,20230605.0,20200903,20230615,EXP,,FR-PFIZER INC-2020340763,PFIZER,,74.0,YR,,M,Y,,,20230615,,MD,FR,FR,2023,Q2,Elderly
1823583925,18235839,74,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,D,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,25,F,20200809.0,20230613.0,20200905,20230622,EXP,,FR-SA-2020SA239827,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20230622,,MD,FR,FR,2023,Q2,Elderly
182556838,18255683,92,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 [iU] (international unit), 1 iu, CO",,,,,,,,,,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,8,F,20200809.0,20230605.0,20200910,20230612,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-BAXTER-2020BAX018061,BAXTER,,74.0,YR,,M,Y,,,20230612,,CN,FR,FR,2023,Q2,Elderly
184082309,18408230,154,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 iu, CO",,,D,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,9,F,20200809.0,20230616.0,20201020,20230620,EXP,,FR-PURDUE-USA-2020-0171568,PURDUE,,74.0,YR,,M,Y,,,20230620,,MD,FR,FR,2023,Q2,Elderly
1848217514,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Arthralgia,,2023,Q2,14,F,20201019.0,20230622.0,20201110,20230626,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Adult
1848217514,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Angina pectoris,,2023,Q2,14,F,20201019.0,20230622.0,20201110,20230626,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Adult
1848217514,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Rash pruritic,,2023,Q2,14,F,20201019.0,20230622.0,20201110,20230626,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Adult
1848217514,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Eczema asteatotic,,2023,Q2,14,F,20201019.0,20230622.0,20201110,20230626,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Adult
1848217514,18482175,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Cataract,,2023,Q2,14,F,20201019.0,20230622.0,20201110,20230626,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20230626,,MD,JP,JP,2023,Q2,Adult
184936635,18493663,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,U,U,,,,200.0,IU,,,2023,Q2,Cystitis,,2023,Q2,5,F,20191201.0,20230606.0,20201111,20230612,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20230612,,MD,CA,CA,2023,Q2,Adult
184936635,18493663,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,U,U,,,,200.0,IU,,,2023,Q2,Diabetes mellitus,,2023,Q2,5,F,20191201.0,20230606.0,20201111,20230612,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20230612,,MD,CA,CA,2023,Q2,Adult
184936635,18493663,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,U,U,,,,200.0,IU,,,2023,Q2,Lung disorder,,2023,Q2,5,F,20191201.0,20230606.0,20201111,20230612,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20230612,,MD,CA,CA,2023,Q2,Adult
184936635,18493663,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,U,U,,,,200.0,IU,,,2023,Q2,Blood cholesterol abnormal,,2023,Q2,5,F,20191201.0,20230606.0,20201111,20230612,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20230612,,MD,CA,CA,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Constipation,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Colitis ulcerative,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Off label use,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Rhinorrhoea,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Pollakiuria,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Abdominal pain,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Asthenia,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,COVID-19,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Fatigue,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Cough,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Diarrhoea,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Dehydration,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Rectal haemorrhage,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Blood glucose increased,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Thirst,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Drug ineffective,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Nasal congestion,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Abdominal pain upper,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Haematochezia,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Rectal tenesmus,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Proctalgia,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Hyperhidrosis,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Diarrhoea haemorrhagic,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Gastrointestinal inflammation,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Weight increased,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Bacterial infection,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Abdominal distension,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,General physical health deterioration,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
1878494514,18784945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2023,Q2,Peripheral coldness,,2023,Q2,14,F,20210220.0,20230530.0,20210125,20230602,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230602,,HP,CO,CO,2023,Q2,Adult
191186299,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Circulatory collapse,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Graft versus host disease,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pancytopenia,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Multiple organ dysfunction syndrome,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Circulatory collapse,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Graft versus host disease,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pancytopenia,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Multiple organ dysfunction syndrome,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Circulatory collapse,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Graft versus host disease,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pancytopenia,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191186299,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Multiple organ dysfunction syndrome,,2023,Q2,9,F,20210313.0,20230330.0,20210410,20230403,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20230403,,MD,US,US,2023,Q2,Elderly
191270152,19127015,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Weight increased,,2023,Q2,2,F,,20230427.0,20210412,20230428,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-034211,BRISTOL MYERS SQUIBB,,69.0,YR,E,F,Y,59.42,KG,20230428,,CN,US,US,2023,Q2,Elderly
191270152,19127015,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Off label use,,2023,Q2,2,F,,20230427.0,20210412,20230428,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-034211,BRISTOL MYERS SQUIBB,,69.0,YR,E,F,Y,59.42,KG,20230428,,CN,US,US,2023,Q2,Elderly
194615615,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Aortic stenosis,,2023,Q2,5,F,20210614.0,20230127.0,20210625,20230630,PER,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230630,,MD,US,US,2023,Q2,Elderly
194615615,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Pruritus,,2023,Q2,5,F,20210614.0,20230127.0,20210625,20230630,PER,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230630,,MD,US,US,2023,Q2,Elderly
194615615,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Anxiety,,2023,Q2,5,F,20210614.0,20230127.0,20210625,20230630,PER,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230630,,MD,US,US,2023,Q2,Elderly
194615615,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Hypoxia,,2023,Q2,5,F,20210614.0,20230127.0,20210625,20230630,PER,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230630,,MD,US,US,2023,Q2,Elderly
194615615,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Seizure,,2023,Q2,5,F,20210614.0,20230127.0,20210625,20230630,PER,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230630,,MD,US,US,2023,Q2,Elderly
194615615,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Nephrolithiasis,,2023,Q2,5,F,20210614.0,20230127.0,20210625,20230630,PER,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230630,,MD,US,US,2023,Q2,Elderly
194615615,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,5,F,20210614.0,20230127.0,20210625,20230630,PER,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230630,,MD,US,US,2023,Q2,Elderly
194615615,19461561,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Escherichia bacteraemia,,2023,Q2,5,F,20210614.0,20230127.0,20210625,20230630,PER,,US-GW PHARMA-202106USGW03047,JAZZ,,67.0,YR,,F,Y,,,20230630,,MD,US,US,2023,Q2,Elderly
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Ligament disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Product use in unapproved indication,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Swelling,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Abscess limb,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Constipation,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Abscess,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Decreased appetite,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Hypoxia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Peripheral swelling,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Shock,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Depression,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Blood glucose increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Blood pressure increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Feeling abnormal,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Blood glucose decreased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Hallucination,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Haemorrhage,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Speech disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Movement disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Memory impairment,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Oropharyngeal discomfort,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Blood glucose increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Asthenia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Fatigue,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Acidosis,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Affective disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Weight fluctuation,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Musculoskeletal pain,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Dry mouth,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Influenza,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Cardiac disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Hunger,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Decreased immune responsiveness,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Ill-defined disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Blood pressure increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Anxiety,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Intentional dose omission,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Psychiatric symptom,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Dyspnoea,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Post procedural haemorrhage,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Abdominal discomfort,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Dysstasia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,"72 U, QD (in the morning)",,,U,,,,,,,,QD,2023,Q2,Cough,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Ligament disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Product use in unapproved indication,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Swelling,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Abscess limb,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Constipation,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Abscess,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Decreased appetite,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Hypoxia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Peripheral swelling,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Shock,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Depression,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Blood glucose increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Blood pressure increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Feeling abnormal,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Blood glucose decreased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Hallucination,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Haemorrhage,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Speech disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Movement disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Memory impairment,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Oropharyngeal discomfort,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Blood glucose increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Asthenia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Fatigue,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Acidosis,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Affective disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Weight fluctuation,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Musculoskeletal pain,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Dry mouth,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Influenza,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Cardiac disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Hunger,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Decreased immune responsiveness,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Ill-defined disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Blood pressure increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Anxiety,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Intentional dose omission,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Psychiatric symptom,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Dyspnoea,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Post procedural haemorrhage,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Abdominal discomfort,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Dysstasia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD, 10 (at the noon)",,,U,,,,,,,,QD,2023,Q2,Cough,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Ligament disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Product use in unapproved indication,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Swelling,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Abscess limb,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Constipation,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Abscess,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Decreased appetite,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Hypoxia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Peripheral swelling,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Shock,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Depression,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Blood glucose increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Blood pressure increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Feeling abnormal,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Blood glucose decreased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Hallucination,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Haemorrhage,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Speech disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Movement disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Memory impairment,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Oropharyngeal discomfort,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Blood glucose increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Asthenia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Fatigue,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Acidosis,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Affective disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Weight fluctuation,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Musculoskeletal pain,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Dry mouth,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Influenza,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Cardiac disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Hunger,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Decreased immune responsiveness,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Ill-defined disorder,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Blood pressure increased,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Anxiety,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Intentional dose omission,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Psychiatric symptom,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Dyspnoea,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Post procedural haemorrhage,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Abdominal discomfort,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Dysstasia,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1949453015,19494530,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 UNK, QD (at night)",,,U,,,,,,,,QD,2023,Q2,Cough,,2023,Q2,15,F,20210517.0,20230427.0,20210705,20230501,EXP,,NVSC2021MX120113,NOVARTIS,,48.0,YR,,M,Y,80.0,KG,20230501,,CN,MX,MX,2023,Q2,Adult
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Viral infection,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Treatment noncompliance,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Menstrual disorder,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Drug ineffective,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Abdominal pain,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Blood bilirubin increased,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,COVID-19,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Hepatic cirrhosis,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Steatohepatitis,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Hyperglycaemia,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Weight decreased,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Jaundice,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Therapy interrupted,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Autoimmune hepatitis,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Influenza,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q2,Laboratory test abnormal,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Viral infection,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Treatment noncompliance,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Menstrual disorder,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Drug ineffective,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Abdominal pain,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Blood bilirubin increased,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,COVID-19,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Hepatic cirrhosis,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Steatohepatitis,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Hyperglycaemia,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Weight decreased,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Jaundice,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Therapy interrupted,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Autoimmune hepatitis,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Influenza,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
1966698217,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q2,Laboratory test abnormal,,2023,Q2,17,F,20201201.0,20230407.0,20210806,20230417,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20230417,,CN,US,US,2023,Q2,Youth
200312534,20031253,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding Scale,,,,,,,,,,,QD,2023,Q2,Streptococcal bacteraemia,,2023,Q2,4,F,20211026.0,20230405.0,20211103,20230412,EXP,,US-ABBVIE-21P-163-4140208-00,ABBVIE,,78.0,YR,,F,Y,,,20230412,,MD,US,US,2023,Q2,Elderly
200490723,20049072,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,,,,,,,,,,2023,Q2,Retinal pigmentation,,2023,Q2,3,F,20191023.0,20230517.0,20211109,20230524,EXP,,US-JNJFOC-20211104505,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230524,,LW,US,US,2023,Q2,Adult
200490723,20049072,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,,,,,,,,,,2023,Q2,Dry age-related macular degeneration,,2023,Q2,3,F,20191023.0,20230517.0,20211109,20230524,EXP,,US-JNJFOC-20211104505,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20230524,,LW,US,US,2023,Q2,Adult
2011662513,20116625,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Atrial fibrillation,,2023,Q2,13,F,20211117.0,20230509.0,20211126,20230511,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230511,,MD,US,,2023,Q2,Elderly
2011662513,20116625,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,,,,,,,,,,2023,Q2,Atrial fibrillation,,2023,Q2,13,F,20211117.0,20230509.0,20211126,20230511,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230511,,MD,US,,2023,Q2,Elderly
2011927713,20119277,103,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Pulmonary embolism,,2023,Q2,13,F,20211118.0,20230510.0,20211126,20230515,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230515,,MD,US,,2023,Q2,Elderly
2011927713,20119277,104,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Pulmonary embolism,,2023,Q2,13,F,20211118.0,20230510.0,20211126,20230515,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230515,,MD,US,,2023,Q2,Elderly
2011927713,20119277,105,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 U,,,,,,,,,,,,2023,Q2,Pulmonary embolism,,2023,Q2,13,F,20211118.0,20230510.0,20211126,20230515,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230515,,MD,US,,2023,Q2,Elderly
2011927713,20119277,106,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,,,,,,,,,,2023,Q2,Pulmonary embolism,,2023,Q2,13,F,20211118.0,20230510.0,20211126,20230515,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230515,,MD,US,,2023,Q2,Elderly
2011927713,20119277,107,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U,,,,,,,,,,,,2023,Q2,Pulmonary embolism,,2023,Q2,13,F,20211118.0,20230510.0,20211126,20230515,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230515,,MD,US,,2023,Q2,Elderly
201564643,20156464,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 dosage form,,,Y,,,,,,,,,2023,Q2,Ovarian cyst,,2023,Q2,3,F,20141111.0,20230613.0,20211207,20230623,EXP,,US-TAKEDA-US-001763,TAKEDA,,55.0,YR,,F,Y,97.959,KG,20230623,,HP,US,US,2023,Q2,Adult
201564643,20156464,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),15 milliliter,,,Y,,,,,15.0,ML,,,2023,Q2,Ovarian cyst,,2023,Q2,3,F,20141111.0,20230613.0,20211207,20230623,EXP,,US-TAKEDA-US-001763,TAKEDA,,55.0,YR,,F,Y,97.959,KG,20230623,,HP,US,US,2023,Q2,Adult
2061608110,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q2,Multiple organ dysfunction syndrome,,2023,Q2,10,F,20220115.0,20230620.0,20220321,20230623,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230623,,PH,JP,JP,2023,Q2,Elderly
2061608110,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q2,Oral candidiasis,,2023,Q2,10,F,20220115.0,20230620.0,20220321,20230623,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230623,,PH,JP,JP,2023,Q2,Elderly
2061608110,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,10,F,20220115.0,20230620.0,20220321,20230623,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230623,,PH,JP,JP,2023,Q2,Elderly
2061608110,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q2,Renal failure,,2023,Q2,10,F,20220115.0,20230620.0,20220321,20230623,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230623,,PH,JP,JP,2023,Q2,Elderly
2061608110,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q2,Rash,,2023,Q2,10,F,20220115.0,20230620.0,20220321,20230623,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230623,,PH,JP,JP,2023,Q2,Elderly
2061608110,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q2,Hyperglycaemia,,2023,Q2,10,F,20220115.0,20230620.0,20220321,20230623,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230623,,PH,JP,JP,2023,Q2,Elderly
2061608110,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q2,Myelosuppression,,2023,Q2,10,F,20220115.0,20230620.0,20220321,20230623,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230623,,PH,JP,JP,2023,Q2,Elderly
206917474,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q2,Adrenocorticotropic hormone deficiency,,2023,Q2,4,F,20211215.0,20230622.0,20220408,20230630,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20230630,,MD,JP,JP,2023,Q2,Adult
206917474,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q2,Hypopituitarism,,2023,Q2,4,F,20211215.0,20230622.0,20220408,20230630,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20230630,,MD,JP,JP,2023,Q2,Adult
206917474,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q2,Hyperkalaemia,,2023,Q2,4,F,20211215.0,20230622.0,20220408,20230630,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20230630,,MD,JP,JP,2023,Q2,Adult
206917474,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q2,Dehydration,,2023,Q2,4,F,20211215.0,20230622.0,20220408,20230630,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20230630,,MD,JP,JP,2023,Q2,Adult
206917474,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q2,Pneumonia cryptococcal,,2023,Q2,4,F,20211215.0,20230622.0,20220408,20230630,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20230630,,MD,JP,JP,2023,Q2,Adult
206917474,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q2,Adrenal insufficiency,,2023,Q2,4,F,20211215.0,20230622.0,20220408,20230630,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20230630,,MD,JP,JP,2023,Q2,Adult
206917474,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q2,Secondary adrenocortical insufficiency,,2023,Q2,4,F,20211215.0,20230622.0,20220408,20230630,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20230630,,MD,JP,JP,2023,Q2,Adult
207285765,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2023,Q2,Hypomagnesaemia,,2023,Q2,5,F,20220211.0,20230420.0,20220420,20230424,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20230424,,HP,US,US,2023,Q2,Elderly
207285765,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2023,Q2,Hypocalcaemia,,2023,Q2,5,F,20220211.0,20230420.0,20220420,20230424,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20230424,,HP,US,US,2023,Q2,Elderly
207285765,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2023,Q2,Thrombocytopenia,,2023,Q2,5,F,20220211.0,20230420.0,20220420,20230424,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20230424,,HP,US,US,2023,Q2,Elderly
207285765,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2023,Q2,Anaemia,,2023,Q2,5,F,20220211.0,20230420.0,20220420,20230424,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20230424,,HP,US,US,2023,Q2,Elderly
2073129113,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q2,Pleural effusion,,2023,Q2,13,F,20220211.0,20230420.0,20220420,20230501,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230501,,HP,US,US,2023,Q2,Elderly
2073129113,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q2,Hypoxia,,2023,Q2,13,F,20220211.0,20230420.0,20220420,20230501,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230501,,HP,US,US,2023,Q2,Elderly
2073129113,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q2,Sepsis,,2023,Q2,13,F,20220211.0,20230420.0,20220420,20230501,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230501,,HP,US,US,2023,Q2,Elderly
2073129113,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q2,Tachycardia,,2023,Q2,13,F,20220211.0,20230420.0,20220420,20230501,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230501,,HP,US,US,2023,Q2,Elderly
2073129113,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q2,Alkalosis,,2023,Q2,13,F,20220211.0,20230420.0,20220420,20230501,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230501,,HP,US,US,2023,Q2,Elderly
2073129113,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2023,Q2,Hypertransaminasaemia,,2023,Q2,13,F,20220211.0,20230420.0,20220420,20230501,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20230501,,HP,US,US,2023,Q2,Elderly
2114551118,21145511,51,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2023,Q2,Hyperglycaemia,,2023,Q2,18,F,20211201.0,20230620.0,20220729,20230622,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20230622,,MD,CA,,2023,Q2,Adult
2114551118,21145511,51,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2023,Q2,Diabetic ketoacidosis,,2023,Q2,18,F,20211201.0,20230620.0,20220729,20230622,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20230622,,MD,CA,,2023,Q2,Adult
2114551118,21145511,51,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2023,Q2,Hyperthyroidism,,2023,Q2,18,F,20211201.0,20230620.0,20220729,20230622,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20230622,,MD,CA,,2023,Q2,Adult
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Palmar-plantar erythrodysaesthesia syndrome,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Decreased appetite,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Nausea,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Dysphonia,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Haematuria,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Stomatitis,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hypothyroidism,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
2116548110,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Bladder tamponade,,2023,Q2,10,F,20220101.0,20230620.0,20220803,20230626,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20230626,,MD,JP,JP,2023,Q2,Elderly
211673806,21167380,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose and frequency unknown,,,,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,6,F,20220601.0,20230428.0,20220803,20230504,PER,,JP-Eisai Medical Research-EC-2022-119234,EISAI,,70.0,YR,E,M,Y,,,20230504,,MD,JP,JP,2023,Q2,Elderly
212079264,21207926,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Product use issue,,2023,Q2,4,F,20221128.0,20230414.0,20220812,20230424,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230424,,HP,US,US,2023,Q2,Adult
212079264,21207926,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Drug resistance,,2023,Q2,4,F,20221128.0,20230414.0,20220812,20230424,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230424,,HP,US,US,2023,Q2,Adult
212079264,21207926,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Respiratory syncytial virus infection,,2023,Q2,4,F,20221128.0,20230414.0,20220812,20230424,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230424,,HP,US,US,2023,Q2,Adult
212079264,21207926,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q2,Cytomegalovirus chorioretinitis,,2023,Q2,4,F,20221128.0,20230414.0,20220812,20230424,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230424,,HP,US,US,2023,Q2,Adult
212079264,21207926,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,,TID,2023,Q2,Product use issue,,2023,Q2,4,F,20221128.0,20230414.0,20220812,20230424,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230424,,HP,US,US,2023,Q2,Adult
212079264,21207926,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,,TID,2023,Q2,Drug resistance,,2023,Q2,4,F,20221128.0,20230414.0,20220812,20230424,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230424,,HP,US,US,2023,Q2,Adult
212079264,21207926,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,,TID,2023,Q2,Respiratory syncytial virus infection,,2023,Q2,4,F,20221128.0,20230414.0,20220812,20230424,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230424,,HP,US,US,2023,Q2,Adult
212079264,21207926,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,,TID,2023,Q2,Cytomegalovirus chorioretinitis,,2023,Q2,4,F,20221128.0,20230414.0,20220812,20230424,EXP,,US-TAKEDA-2022TUS054447,TAKEDA,,60.0,YR,,M,Y,115.7,KG,20230424,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Blood potassium decreased,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Waist circumference increased,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Ascites,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Haematemesis,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Pain in extremity,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Foot fracture,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Death,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Infusion related reaction,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Pneumonia,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Platelet count decreased,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Insurance issue,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Sinusitis,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
212303683,21230368,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK; kwikpen,,,U,,,,,,,,,2023,Q2,Respiratory tract infection,,2023,Q2,3,F,20230506.0,20230513.0,20220818,20230516,EXP,,US-PAREXEL-2021-KAM-US003582,TAKEDA,,61.0,YR,,F,Y,110.0,KG,20230516,,HP,US,US,2023,Q2,Adult
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Sepsis,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Ascites,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Abdominal pain upper,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Lethargy,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Liver abscess,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Asthenia,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Thrombosis,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Hypophagia,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Febrile neutropenia,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Bacteraemia,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Death,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Pneumobilia,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Perihepatic abscess,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Early satiety,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Pain,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Biliary obstruction,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Septic shock,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Cholecystitis,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Splenic vein occlusion,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2130887412,21308874,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q2,Decreased appetite,,2023,Q2,12,F,20220820.0,20230602.0,20220908,20230607,EXP,,NVSC2022US201138,NOVARTIS,,69.0,YR,,M,Y,75.1,KG,20230607,,MD,US,US,2023,Q2,Elderly
2134822010,21348220,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Acute respiratory distress syndrome,,2023,Q2,10,F,20220910.0,20230419.0,20220919,20230421,EXP,,NVSC2022US209258,NOVARTIS,,66.0,YR,,F,Y,111.5,KG,20230421,,MD,US,US,2023,Q2,Elderly
2134822010,21348220,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Acute respiratory failure,,2023,Q2,10,F,20220910.0,20230419.0,20220919,20230421,EXP,,NVSC2022US209258,NOVARTIS,,66.0,YR,,F,Y,111.5,KG,20230421,,MD,US,US,2023,Q2,Elderly
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Cardiac failure congestive,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Weight decreased,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Pulmonary oedema,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Abdominal pain upper,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Thyroid disorder,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Headache,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Myalgia,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Arthritis,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Pericardial effusion,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Multi-organ disorder,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Eye haemorrhage,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Chest pain,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Neuropathy peripheral,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Diarrhoea,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
213979554,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q2,Malnutrition,,2023,Q2,4,F,,20230601.0,20220930,20230605,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230605,,CN,CA,CA,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Tenderness,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Hyperglycaemia,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Death,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Cachexia,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Tachycardia,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Anaemia,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Fatigue,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Haematochezia,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Dehydration,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Pain,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Systemic infection,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Nausea,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,General physical health deterioration,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Depressed level of consciousness,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Condition aggravated,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
2140936213,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,,,2023,Q2,Vomiting,,2023,Q2,13,F,20220702.0,20230530.0,20221004,20230601,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20230601,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Depressed level of consciousness,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Tachycardia,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Pain,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Cachexia,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Tenderness,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Anaemia,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Dehydration,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Nausea,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Hyperglycaemia,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,General physical health deterioration,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Haematochezia,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Vomiting,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Fatigue,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Death,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Condition aggravated,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214194313,21419431,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Schema",,,,,,,,1.0,IU,,,2023,Q2,Systemic infection,,2023,Q2,3,F,20210702.0,20230524.0,20221006,20230530,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20230530,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Anaemia,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Haematochezia,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Tachycardia,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Dehydration,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Pain,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Death,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Fatigue,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Depressed level of consciousness,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Cachexia,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,General physical health deterioration,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Condition aggravated,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Vomiting,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Hyperglycaemia,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Systemic infection,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Nausea,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214348917,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2023,Q2,Tenderness,,2023,Q2,7,F,20210702.0,20230512.0,20221010,20230515,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20230515,,PH,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Tenderness,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,General physical health deterioration,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Death,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Systemic infection,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Nausea,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Cachexia,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Depressed level of consciousness,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Haematochezia,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Fatigue,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Condition aggravated,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Tachycardia,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Vomiting,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Pain,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Dehydration,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
214493987,21449398,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2023,Q2,Anaemia,,2023,Q2,7,F,20210702.0,20230516.0,20221013,20230530,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20230530,,CN,DE,DE,2023,Q2,Adult
215069094,21506909,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Cellulitis,,2023,Q2,4,F,20220910.0,20230426.0,20221026,20230502,EXP,,US-ROCHE-3205294,ROCHE,,57.0,YR,,M,Y,,,20230502,,MD,US,,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,General physical health deterioration,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Vomiting,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Tachycardia,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Nausea,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Fatigue,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Cachexia,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Pain,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Systemic infection,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Condition aggravated,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Death,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Haematochezia,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Depressed level of consciousness,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Hyperglycaemia,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Anaemia,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Tenderness,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215556384,21555638,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU, scheme",,,U,,UNKNOWN,,,1.0,IU,,,2023,Q2,Dehydration,,2023,Q2,4,F,20210702.0,20230525.0,20221104,20230602,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20230602,,PH,DE,DE,2023,Q2,Adult
215867413,21586741,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: as needed,,,,,,,,8.0,IU,Unknown,,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: as needed,,,,,,,,8.0,IU,Unknown,,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: as needed,,,,,,,,8.0,IU,Unknown,,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?2 Units,,,,,,,,,,Unknown,,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?2 Units,,,,,,,,,,Unknown,,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?2 Units,,,,,,,,,,Unknown,,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,76,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?3 Units,,,,,,,,,,Unknown,,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,76,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?3 Units,,,,,,,,,,Unknown,,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,76,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?3 Units,,,,,,,,,,Unknown,,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,77,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 Units,,,,,,,,,,Unknown,QD,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,77,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 Units,,,,,,,,,,Unknown,QD,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,77,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 Units,,,,,,,,,,Unknown,QD,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,78,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?6 units,,,,,,,,,,Unknown,,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,78,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?6 units,,,,,,,,,,Unknown,,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,78,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?6 units,,,,,,,,,,Unknown,,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,79,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 Units,,,,,,,,,,Unknown,QD,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,79,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 Units,,,,,,,,,,Unknown,QD,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,79,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 Units,,,,,,,,,,Unknown,QD,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,80,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 Units,,,,,,,,,,Unknown,QD,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,80,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 Units,,,,,,,,,,Unknown,QD,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,80,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 Units,,,,,,,,,,Unknown,QD,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 Units,,,,,,,,,,Unknown,QD,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 Units,,,,,,,,,,Unknown,QD,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 Units,,,,,,,,,,Unknown,QD,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 Units,,,,,,,,,,Unknown,QD,2023,Q2,Peripheral ischaemia,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 Units,,,,,,,,,,Unknown,QD,2023,Q2,Cholecystitis acute,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
215867413,21586741,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 Units,,,,,,,,,,Unknown,QD,2023,Q2,Biliary sepsis,,2023,Q2,3,F,20200603.0,20230426.0,20221113,20230606,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20230606,,MD,US,US,2023,Q2,Adult
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Aortic valve disease,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Stenosis,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Intentional product use issue,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Stent placement,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Cardiac pacemaker removal,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216577485,21657748,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Incorrect product administration duration,,2023,Q2,5,F,20220516.0,20230531.0,20221129,20230606,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,79.0,KG,20230606,,HP,CA,CA,2023,Q2,Elderly
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Tachycardia,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Tenderness,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Depressed level of consciousness,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Cachexia,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Haematochezia,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Pain,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Nausea,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,General physical health deterioration,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Condition aggravated,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Dehydration,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Anaemia,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Death,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Hyperglycaemia,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Systemic infection,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Vomiting,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
216670063,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2023,Q2,Fatigue,,2023,Q2,3,F,20210702.0,20230603.0,20221201,20230608,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20230608,,PH,DE,DE,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Cerebral infarction,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Pneumonia aspiration,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Haemophagocytic lymphohistiocytosis,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Somnolence,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Cytokine release syndrome,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Tachycardia,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217079282,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Sepsis,,2023,Q2,2,F,20221108.0,20230518.0,20221209,20230523,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20230523,,MD,US,US,2023,Q2,Adult
217556283,21755628,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2023,Q2,Sepsis,,2023,Q2,3,F,20221206.0,20230109.0,20221220,20230403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-155145,BRISTOL MYERS SQUIBB,,66.0,YR,E,F,Y,,,20230403,,HP,US,US,2023,Q2,Elderly
217556283,21755628,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2023,Q2,Pneumonia,,2023,Q2,3,F,20221206.0,20230109.0,20221220,20230403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-155145,BRISTOL MYERS SQUIBB,,66.0,YR,E,F,Y,,,20230403,,HP,US,US,2023,Q2,Elderly
217653543,21765354,15,C,Insulin lispro bs,,2,,"UNK UNK, qd(6unit)",,,,,,,,,,Injection,QD,2023,Q2,Femur fracture,,2023,Q2,3,F,20220726.0,20230616.0,20221222,20230626,EXP,,JP-AMGEN-JPNSP2022218133,AMGEN,,77.0,YR,E,M,Y,46.0,KG,20230624,,MD,JP,JP,2023,Q2,Elderly
217653543,21765354,15,C,Insulin lispro bs,,2,,"UNK UNK, qd(6unit)",,,,,,,,,,Injection,QD,2023,Q2,Fall,,2023,Q2,3,F,20220726.0,20230616.0,20221222,20230626,EXP,,JP-AMGEN-JPNSP2022218133,AMGEN,,77.0,YR,E,M,Y,46.0,KG,20230624,,MD,JP,JP,2023,Q2,Elderly
217666233,21766623,138,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 IU (CO),,,U,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,3,F,20200809.0,20230605.0,20221222,20230607,EXP,,NVSC2020FR370649,NOVARTIS,,74.0,YR,,M,Y,,,20230607,,MD,FR,FR,2023,Q2,Elderly
217725453,21772545,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Cardiac failure,,2023,Q2,3,F,,20221216.0,20221223,20230609,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-154889,BRISTOL MYERS SQUIBB,,74.0,YR,E,,Y,,,20230609,,MD,US,US,2023,Q2,Elderly
219154662,21915466,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75 20U 20U / d)",,,U,,,,,40.0,IU,,QD,2023,Q2,Headache,,2023,Q2,2,F,,20230119.0,20230126,20230403,EXP,,PT-AstraZeneca-2023A015142,ASTRAZENECA,,54.0,YR,,F,Y,,,20230403,,MD,PT,,2023,Q2,Adult
219154662,21915466,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75 20U 20U / d)",,,U,,,,,40.0,IU,,QD,2023,Q2,Ischaemic stroke,,2023,Q2,2,F,,20230119.0,20230126,20230403,EXP,,PT-AstraZeneca-2023A015142,ASTRAZENECA,,54.0,YR,,F,Y,,,20230403,,MD,PT,,2023,Q2,Adult
219154662,21915466,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75 20U 20U / d)",,,U,,,,,40.0,IU,,QD,2023,Q2,Chest pain,,2023,Q2,2,F,,20230119.0,20230126,20230403,EXP,,PT-AstraZeneca-2023A015142,ASTRAZENECA,,54.0,YR,,F,Y,,,20230403,,MD,PT,,2023,Q2,Adult
219478872,21947887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,209196.0,,,Solution for injection,,2023,Q2,Umbilical cord abnormality,,2023,Q2,2,F,,20230523.0,20230203,20230529,EXP,,CA-SA-2023SA038189,SANOFI AVENTIS,,40.0,YR,A,,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
219478872,21947887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,209196.0,,,Solution for injection,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,2,F,,20230523.0,20230203,20230529,EXP,,CA-SA-2023SA038189,SANOFI AVENTIS,,40.0,YR,A,,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
219478872,21947887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,209196.0,,,Solution for injection,,2023,Q2,Amniotic fluid volume decreased,,2023,Q2,2,F,,20230523.0,20230203,20230529,EXP,,CA-SA-2023SA038189,SANOFI AVENTIS,,40.0,YR,A,,Y,,,20230529,,CN,CA,CA,2023,Q2,Adult
219547832,21954783,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,250-300 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,250-300 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,250-300 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,150 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,150 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,150 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,440 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,440 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,440 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,30 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,30 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,30 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,13 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,13 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,13 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,29-32 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin resistance,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,29-32 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Insulin autoimmune syndrome,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219547832,21954783,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,29-32 units/day,,,,,,,,,,Solution for injection,,2023,Q2,Therapeutic response decreased,,2023,Q2,2,F,,20230512.0,20230205,20230515,EXP,,JP-SAKK-2023SA033870AA,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20230516,,MD,JP,JP,2023,Q2,Adult
219596724,21959672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5-7  IU, tid (17 IU qd)",1329.0,IU,,,,,,,,,,2023,Q2,Pre-eclampsia,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5-7  IU, tid (17 IU qd)",1329.0,IU,,,,,,,,,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, tid",1329.0,IU,,,,,,5.0,IU,,TID,2023,Q2,Pre-eclampsia,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, tid",1329.0,IU,,,,,,5.0,IU,,TID,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 IU, qd",1329.0,IU,,,,,,38.0,IU,,QD,2023,Q2,Pre-eclampsia,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"38 IU, qd",1329.0,IU,,,,,,38.0,IU,,QD,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 IU, qd",1329.0,IU,,,,,,42.0,IU,,QD,2023,Q2,Pre-eclampsia,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 IU, qd",1329.0,IU,,,,,,42.0,IU,,QD,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 IU, tid",1329.0,IU,,,,,,3.0,IU,,TID,2023,Q2,Pre-eclampsia,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219596724,21959672,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 IU, tid",1329.0,IU,,,,,,3.0,IU,,TID,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,4,F,20211112.0,20230418.0,20230206,20230501,EXP,,US-NOVOPROD-1017185,NOVO NORDISK,,30.0,YR,,F,Y,117.01,KG,20230501,,MD,US,US,2023,Q2,Young Adult
219975643,21997564,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml,,,,,,,,,,Solution for injection in pre-filled pen,,2023,Q2,Erysipelas,,2023,Q2,3,F,20220520.0,20230425.0,20230216,20230502,EXP,,FI-JNJFOC-20230229306,JOHNSON AND JOHNSON,,60.0,YR,,F,Y,,,20230502,,MD,FI,FI,2023,Q2,Adult
220215502,22021550,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q2,Off label use,,2023,Q2,2,F,20230130.0,20230414.0,20230222,20230419,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230419,,MD,US,US,2023,Q2,Adult
220215502,22021550,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,2,F,20230130.0,20230414.0,20230222,20230419,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230419,,MD,US,US,2023,Q2,Adult
220215502,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q2,Off label use,,2023,Q2,2,F,20230130.0,20230414.0,20230222,20230419,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230419,,MD,US,US,2023,Q2,Adult
220215502,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,2,F,20230130.0,20230414.0,20230222,20230419,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230419,,MD,US,US,2023,Q2,Adult
220310342,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Pneumonia,,2023,Q2,2,F,20220209.0,20230522.0,20230223,20230524,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230524,,MD,US,US,2023,Q2,Adult
220310342,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,2,F,20220209.0,20230522.0,20230223,20230524,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230524,,MD,US,US,2023,Q2,Adult
220310342,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Septic shock,,2023,Q2,2,F,20220209.0,20230522.0,20230223,20230524,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230524,,MD,US,US,2023,Q2,Adult
220310342,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Gastrointestinal haemorrhage,,2023,Q2,2,F,20220209.0,20230522.0,20230223,20230524,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230524,,MD,US,US,2023,Q2,Adult
220310342,22031034,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Sepsis,,2023,Q2,2,F,20220209.0,20230522.0,20230223,20230524,EXP,,US-GILEAD-2022-0569611,GILEAD,,64.0,YR,A,M,Y,78.2,KG,20230524,,MD,US,US,2023,Q2,Adult
220406283,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,3,F,20230227.0,20230315.0,20230227,20230420,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230420,,HP,US,US,2023,Q2,Elderly
220406283,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q2,Abdominal pain,,2023,Q2,3,F,20230227.0,20230315.0,20230227,20230420,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230420,,HP,US,US,2023,Q2,Elderly
220406283,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q2,Dyspepsia,,2023,Q2,3,F,20230227.0,20230315.0,20230227,20230420,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230420,,HP,US,US,2023,Q2,Elderly
220406283,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q2,Product dose omission issue,,2023,Q2,3,F,20230227.0,20230315.0,20230227,20230420,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230420,,HP,US,US,2023,Q2,Elderly
220406283,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q2,Gastroenteritis norovirus,,2023,Q2,3,F,20230227.0,20230315.0,20230227,20230420,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230420,,HP,US,US,2023,Q2,Elderly
220406283,22040628,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-5 units,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,3,F,20230227.0,20230315.0,20230227,20230420,EXP,,US-GILEAD-2023-0618091,GILEAD,,69.0,YR,E,F,Y,61.8,KG,20230420,,HP,US,US,2023,Q2,Elderly
220544112,22054411,14,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,U,,,,209196.0,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,2,F,20200809.0,20230605.0,20230302,20230609,EXP,FR-EMA-DD-20220830-7180173-082651,FR-SANOFI-AVENTIS R+D-2023SA067613,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20230609,,HP,FR,FR,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Hot flush,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Balance disorder,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Headache,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Ageusia,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Decreased appetite,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Fall,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Dizziness,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Abdominal discomfort,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220734532,22073453,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25,,,U,,,,,,,,,2023,Q2,Asthenia,,2023,Q2,2,F,,20230403.0,20230308,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-033378,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,67.0,KG,20230405,,CN,US,US,2023,Q2,Elderly
220753996,22075399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Cytokine release syndrome,,2023,Q2,6,F,20230222.0,20230419.0,20230308,20230426,EXP,,US-ROCHE-3294856,ROCHE,,63.0,YR,,M,Y,97.8,KG,20230426,,MD,US,,2023,Q2,Adult
220753996,22075399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Neutropenia,,2023,Q2,6,F,20230222.0,20230419.0,20230308,20230426,EXP,,US-ROCHE-3294856,ROCHE,,63.0,YR,,M,Y,97.8,KG,20230426,,MD,US,,2023,Q2,Adult
220834802,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Influenza like illness,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Malaise,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Abdominal pain upper,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Nasopharyngitis,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Headache,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Influenza like illness,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Malaise,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Abdominal pain upper,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Nasopharyngitis,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Headache,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Influenza like illness,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Malaise,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Abdominal pain upper,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Nasopharyngitis,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Headache,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Influenza like illness,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Malaise,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Abdominal pain upper,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Nasopharyngitis,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220834802,22083480,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,U,,D523163D,,20563.0,,,Injection,,2023,Q2,Headache,,2023,Q2,2,F,20230217.0,20230519.0,20230310,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202302009765,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Adult
220852342,22085234,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q2,Feeding disorder,,2023,Q2,2,F,20221113.0,20230608.0,20230310,20230607,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-035319,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,,,20230608,,HP,US,US,2023,Q2,Elderly
220852342,22085234,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q2,Malignant neoplasm progression,,2023,Q2,2,F,20221113.0,20230608.0,20230310,20230607,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-035319,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,,,20230608,,HP,US,US,2023,Q2,Elderly
220993822,22099382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, every 4 carbs he eats",,,U,,D539191E,,,1.0,IU,Injection,,2023,Q2,Blood glucose abnormal,,2023,Q2,2,F,20220901.0,20230424.0,20230315,20230504,EXP,,US-ELI_LILLY_AND_COMPANY-US202303003205,ELI LILLY AND CO,,39.0,YR,,M,Y,88.435,KG,20230504,,MD,US,US,2023,Q2,Adult
220993822,22099382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, every 4 carbs he eats",,,U,,D539191E,,,1.0,IU,Injection,,2023,Q2,Pancreatitis,,2023,Q2,2,F,20220901.0,20230424.0,20230315,20230504,EXP,,US-ELI_LILLY_AND_COMPANY-US202303003205,ELI LILLY AND CO,,39.0,YR,,M,Y,88.435,KG,20230504,,MD,US,US,2023,Q2,Adult
220993822,22099382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, every 4 carbs he eats",,,U,,D539191E,,,1.0,IU,Injection,,2023,Q2,Diabetic ketoacidosis,,2023,Q2,2,F,20220901.0,20230424.0,20230315,20230504,EXP,,US-ELI_LILLY_AND_COMPANY-US202303003205,ELI LILLY AND CO,,39.0,YR,,M,Y,88.435,KG,20230504,,MD,US,US,2023,Q2,Adult
220993822,22099382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, every 4 carbs he eats",,,U,,D539191E,,,1.0,IU,Injection,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,20220901.0,20230424.0,20230315,20230504,EXP,,US-ELI_LILLY_AND_COMPANY-US202303003205,ELI LILLY AND CO,,39.0,YR,,M,Y,88.435,KG,20230504,,MD,US,US,2023,Q2,Adult
220993822,22099382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, every 4 carbs he eats",,,U,,D539191E,,,1.0,IU,Injection,,2023,Q2,Gastrointestinal motility disorder,,2023,Q2,2,F,20220901.0,20230424.0,20230315,20230504,EXP,,US-ELI_LILLY_AND_COMPANY-US202303003205,ELI LILLY AND CO,,39.0,YR,,M,Y,88.435,KG,20230504,,MD,US,US,2023,Q2,Adult
221074862,22107486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BU factor: 0.5-0.5-0.5,,,,,unk,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BU factor: 0.5-0.5-0.5,,,,,unk,,,,,,,2023,Q2,Gastroenteritis,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,BU factor: 0.5-0.5-0.5,,,,,unk,,,,,,,2023,Q2,Circulatory collapse,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,prandial: BU factor:1.75-1.75-1.75,,,,,unk,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,prandial: BU factor:1.75-1.75-1.75,,,,,unk,,,,,,,2023,Q2,Gastroenteritis,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,prandial: BU factor:1.75-1.75-1.75,,,,,unk,,,,,,,2023,Q2,Circulatory collapse,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"bread unit factor 1.2-0.5-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,unk,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"bread unit factor 1.2-0.5-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,unk,,,,,,,2023,Q2,Gastroenteritis,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"bread unit factor 1.2-0.5-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,unk,,,,,,,2023,Q2,Circulatory collapse,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"prandial: bread unit factor 1.0-1.0-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,KR76K31,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"prandial: bread unit factor 1.0-1.0-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,KR76K31,,,,,,,2023,Q2,Gastroenteritis,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221074862,22107486,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"prandial: bread unit factor 1.0-1.0-0.5, correction with 1 IU/50 mg/dl } blood glucose 200 mg/dl",,,,,KR76K31,,,,,,,2023,Q2,Circulatory collapse,,2023,Q2,2,F,20140101.0,20230428.0,20230317,20230509,EXP,,DE-NOVOPROD-1036016,NOVO NORDISK,,25.0,YR,,M,Y,54.0,KG,20230509,,MD,DE,DE,2023,Q2,Young Adult
221084442,22108444,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Clostridium difficile infection,,2023,Q2,2,F,20230220.0,20230412.0,20230317,20230420,EXP,,US-ABBVIE-4319371,ABBVIE,,62.0,YR,,F,Y,,,20230420,,MD,US,US,2023,Q2,Adult
221084442,22108444,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Time Interval: 0.33333333 days,,,,,,,,,,,,2023,Q2,Clostridium difficile infection,,2023,Q2,2,F,20230220.0,20230412.0,20230317,20230420,EXP,,US-ABBVIE-4319371,ABBVIE,,62.0,YR,,F,Y,,,20230420,,MD,US,US,2023,Q2,Adult
221100773,22110077,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,3,F,,20230404.0,20230317,20230406,PER,,US-SA-2023SA084837,SANOFI AVENTIS,,96.0,YR,E,F,Y,,,20230406,,HP,US,US,2023,Q2,Elderly
221100773,22110077,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Accidental exposure to product,,2023,Q2,3,F,,20230404.0,20230317,20230406,PER,,US-SA-2023SA084837,SANOFI AVENTIS,,96.0,YR,E,F,Y,,,20230406,,HP,US,US,2023,Q2,Elderly
221100773,22110077,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Device leakage,,2023,Q2,3,F,,20230404.0,20230317,20230406,PER,,US-SA-2023SA084837,SANOFI AVENTIS,,96.0,YR,E,F,Y,,,20230406,,HP,US,US,2023,Q2,Elderly
221300863,22130086,84,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,D,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,3,F,20200809.0,20230403.0,20230323,20230407,EXP,,NVSC2023FR064767,NOVARTIS,,74.0,YR,,M,Y,,,20230407,,MD,FR,FR,2023,Q2,Elderly
221331952,22133195,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ML VIAL,,,,,,,,,,,,2023,Q2,Pancreas infection,,2023,Q2,2,F,20211115.0,20230517.0,20230324,20230522,EXP,,US-ABBVIE-4335998,ABBVIE,,54.0,YR,,M,Y,,,20230522,,CN,US,US,2023,Q2,Adult
221331952,22133195,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ML VIAL,,,,,,,,,,,,2023,Q2,Skin exfoliation,,2023,Q2,2,F,20211115.0,20230517.0,20230324,20230522,EXP,,US-ABBVIE-4335998,ABBVIE,,54.0,YR,,M,Y,,,20230522,,CN,US,US,2023,Q2,Adult
221331952,22133195,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ML VIAL,,,,,,,,,,,,2023,Q2,Pancreatitis,,2023,Q2,2,F,20211115.0,20230517.0,20230324,20230522,EXP,,US-ABBVIE-4335998,ABBVIE,,54.0,YR,,M,Y,,,20230522,,CN,US,US,2023,Q2,Adult
221331952,22133195,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ML VIAL,,,,,,,,,,,,2023,Q2,Pancreatitis,,2023,Q2,2,F,20211115.0,20230517.0,20230324,20230522,EXP,,US-ABBVIE-4335998,ABBVIE,,54.0,YR,,M,Y,,,20230522,,CN,US,US,2023,Q2,Adult
221331952,22133195,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ML VIAL,,,,,,,,,,,,2023,Q2,Psoriasis,,2023,Q2,2,F,20211115.0,20230517.0,20230324,20230522,EXP,,US-ABBVIE-4335998,ABBVIE,,54.0,YR,,M,Y,,,20230522,,CN,US,US,2023,Q2,Adult
221418362,22141836,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,2,F,20221201.0,20230605.0,20230327,20230608,PER,,US-PFIZER INC-202300131094,PFIZER,,59.0,YR,,F,Y,102.04,KG,20230608,,HP,US,US,2023,Q2,Adult
221418362,22141836,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Drug ineffective for unapproved indication,,2023,Q2,2,F,20221201.0,20230605.0,20230327,20230608,PER,,US-PFIZER INC-202300131094,PFIZER,,59.0,YR,,F,Y,102.04,KG,20230608,,HP,US,US,2023,Q2,Adult
221418362,22141836,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Headache,,2023,Q2,2,F,20221201.0,20230605.0,20230327,20230608,PER,,US-PFIZER INC-202300131094,PFIZER,,59.0,YR,,F,Y,102.04,KG,20230608,,HP,US,US,2023,Q2,Adult
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Disorientation,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Intervertebral disc displacement,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Exposure to extreme temperature,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Gait disturbance,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Dehydration,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Fall,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Blood glucose abnormal,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Abdominal pain upper,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Fatigue,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Injury associated with device,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Contusion,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Feeling abnormal,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Pain,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221473712,22147371,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D547157C,,,10.0,IU,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230323.0,20230327.0,20230328,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303013997,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221538552,22153855,126,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,D,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,2,F,20200809.0,20230330.0,20230330,20230411,EXP,,FR-AUROBINDO-AUR-APL-2023-013407,AUROBINDO,,74.0,YR,,M,Y,,,20230411,,MD,FR,FR,2023,Q2,Elderly
221553752,22155375,132,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,D,,,,,1.0,IU,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,2,F,20200809.0,20230402.0,20230330,20230405,EXP,FR-TAKEDA-2023TUS027407,FR-UCBSA-2023016013,UCB,,74.0,YR,,M,Y,,,20230405,,MD,FR,FR,2023,Q2,Elderly
221569285,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Device issue,,2023,Q2,5,F,20230201.0,20230616.0,20230330,20230619,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,97.0,KG,20230619,,HP,US,US,2023,Q2,Elderly
221569285,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,5,F,20230201.0,20230616.0,20230330,20230619,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,97.0,KG,20230619,,HP,US,US,2023,Q2,Elderly
221569285,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Product dispensing issue,,2023,Q2,5,F,20230201.0,20230616.0,20230330,20230619,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,97.0,KG,20230619,,HP,US,US,2023,Q2,Elderly
221569285,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,5,F,20230201.0,20230616.0,20230330,20230619,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,97.0,KG,20230619,,HP,US,US,2023,Q2,Elderly
221569285,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Product dose omission issue,,2023,Q2,5,F,20230201.0,20230616.0,20230330,20230619,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,97.0,KG,20230619,,HP,US,US,2023,Q2,Elderly
221569285,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,5,F,20230201.0,20230616.0,20230330,20230619,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,97.0,KG,20230619,,HP,US,US,2023,Q2,Elderly
221569285,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Product prescribing issue,,2023,Q2,5,F,20230201.0,20230616.0,20230330,20230619,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,97.0,KG,20230619,,HP,US,US,2023,Q2,Elderly
221596483,22159648,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Visual impairment,,2023,Q2,3,F,,20230404.0,20230331,20230405,PER,,US-SA-2023SA099010,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20230405,,HP,US,US,2023,Q2,Elderly
221596483,22159648,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Blood glucose increased,,2023,Q2,3,F,,20230404.0,20230331,20230405,PER,,US-SA-2023SA099010,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20230405,,HP,US,US,2023,Q2,Elderly
221596483,22159648,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,3,F,,20230404.0,20230331,20230405,PER,,US-SA-2023SA099010,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20230405,,HP,US,US,2023,Q2,Elderly
221643931,22164393,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, each morning",,,U,,D518828A,,20563.0,20.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230327.0,20230327.0,20230403,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303015764,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221643931,22164393,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, daily",,,U,,D518828A,,20563.0,8.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230327.0,20230327.0,20230403,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303015764,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221643931,22164393,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, each evening",,,U,,D518828A,,20563.0,16.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230327.0,20230327.0,20230403,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303015764,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221669301,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230101.0,20230328.0,20230403,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221669301,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q2,Stress,,2023,Q2,1,I,20230101.0,20230328.0,20230403,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221669301,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q2,Visual impairment,,2023,Q2,1,I,20230101.0,20230328.0,20230403,20230403,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221681661,22168166,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D261904A,,20563.0,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230316.0,20230327.0,20230403,20230403,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015550,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221681661,22168166,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D261904A,,20563.0,,,Injection,,2023,Q2,Myocardial infarction,,2023,Q2,1,I,20230316.0,20230327.0,20230403,20230403,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015550,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221681661,22168166,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D261904A,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230316.0,20230327.0,20230403,20230403,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015550,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230403,,CN,US,US,2023,Q2,Elderly
221741941,22174194,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Neuropathy peripheral,,2023,Q2,1,I,20230307.0,20230330.0,20230405,20230405,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-047042,BRISTOL MYERS SQUIBB,,70.0,YR,E,F,Y,,,20230405,,CN,US,US,2023,Q2,Elderly
221759271,22175927,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230403.0,20230403.0,20230405,20230405,PER,,US-ELI_LILLY_AND_COMPANY-US202304001973,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20230405,,CN,US,US,2023,Q2,Elderly
221759271,22175927,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230403.0,20230403.0,20230405,20230405,PER,,US-ELI_LILLY_AND_COMPANY-US202304001973,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20230405,,CN,US,US,2023,Q2,Elderly
221759271,22175927,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230403.0,20230403.0,20230405,20230405,PER,,US-ELI_LILLY_AND_COMPANY-US202304001973,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20230405,,CN,US,US,2023,Q2,Elderly
221759271,22175927,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230403.0,20230403.0,20230405,20230405,PER,,US-ELI_LILLY_AND_COMPANY-US202304001973,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20230405,,CN,US,US,2023,Q2,Elderly
221759271,22175927,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D518828A,,20563.0,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230403.0,20230403.0,20230405,20230405,PER,,US-ELI_LILLY_AND_COMPANY-US202304001973,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20230405,,CN,US,US,2023,Q2,Elderly
221759271,22175927,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D518828A,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230403.0,20230403.0,20230405,20230405,PER,,US-ELI_LILLY_AND_COMPANY-US202304001973,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20230405,,CN,US,US,2023,Q2,Elderly
221759622,22175962,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,2,F,20220101.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077609,NOVARTIS,,77.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221759622,22175962,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Cystitis,,2023,Q2,2,F,20220101.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077609,NOVARTIS,,77.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221759622,22175962,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Amnesia,,2023,Q2,2,F,20220101.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077609,NOVARTIS,,77.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221759622,22175962,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Blood pressure decreased,,2023,Q2,2,F,20220101.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077609,NOVARTIS,,77.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221769712,22176971,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,,QD,2023,Q2,Amnesia,,2023,Q2,2,F,20210501.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077143,NOVARTIS,,75.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221769712,22176971,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,,QD,2023,Q2,Wrong technique in product usage process,,2023,Q2,2,F,20210501.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077143,NOVARTIS,,75.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221769712,22176971,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,,QD,2023,Q2,Cerebrovascular accident,,2023,Q2,2,F,20210501.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077143,NOVARTIS,,75.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221769712,22176971,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,,QD,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,2,F,20210501.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077143,NOVARTIS,,75.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221769712,22176971,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,,QD,2023,Q2,Cystitis,,2023,Q2,2,F,20210501.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077143,NOVARTIS,,75.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221769712,22176971,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 IU, QD",,,,,,,,4.0,IU,,QD,2023,Q2,Hypotension,,2023,Q2,2,F,20210501.0,20230411.0,20230405,20230417,EXP,,NVSC2023MX077143,NOVARTIS,,75.0,YR,,F,Y,47.0,KG,20230417,,CN,MX,MX,2023,Q2,Elderly
221812521,22181252,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Mental impairment,,2023,Q2,1,I,20210601.0,20230329.0,20230406,20230406,EXP,,AU-VERTEX PHARMACEUTICALS-2022-016457,VERTEX,,45.0,YR,,M,Y,,,20230406,,MD,AU,AU,2023,Q2,Adult
221812521,22181252,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Depressed mood,,2023,Q2,1,I,20210601.0,20230329.0,20230406,20230406,EXP,,AU-VERTEX PHARMACEUTICALS-2022-016457,VERTEX,,45.0,YR,,M,Y,,,20230406,,MD,AU,AU,2023,Q2,Adult
221812521,22181252,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Overdose,,2023,Q2,1,I,20210601.0,20230329.0,20230406,20230406,EXP,,AU-VERTEX PHARMACEUTICALS-2022-016457,VERTEX,,45.0,YR,,M,Y,,,20230406,,MD,AU,AU,2023,Q2,Adult
221812521,22181252,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Depression,,2023,Q2,1,I,20210601.0,20230329.0,20230406,20230406,EXP,,AU-VERTEX PHARMACEUTICALS-2022-016457,VERTEX,,45.0,YR,,M,Y,,,20230406,,MD,AU,AU,2023,Q2,Adult
221812521,22181252,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Malnutrition,,2023,Q2,1,I,20210601.0,20230329.0,20230406,20230406,EXP,,AU-VERTEX PHARMACEUTICALS-2022-016457,VERTEX,,45.0,YR,,M,Y,,,20230406,,MD,AU,AU,2023,Q2,Adult
221812521,22181252,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Adjustment disorder,,2023,Q2,1,I,20210601.0,20230329.0,20230406,20230406,EXP,,AU-VERTEX PHARMACEUTICALS-2022-016457,VERTEX,,45.0,YR,,M,Y,,,20230406,,MD,AU,AU,2023,Q2,Adult
221812521,22181252,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Anxiety,,2023,Q2,1,I,20210601.0,20230329.0,20230406,20230406,EXP,,AU-VERTEX PHARMACEUTICALS-2022-016457,VERTEX,,45.0,YR,,M,Y,,,20230406,,MD,AU,AU,2023,Q2,Adult
221812521,22181252,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Suicidal ideation,,2023,Q2,1,I,20210601.0,20230329.0,20230406,20230406,EXP,,AU-VERTEX PHARMACEUTICALS-2022-016457,VERTEX,,45.0,YR,,M,Y,,,20230406,,MD,AU,AU,2023,Q2,Adult
221813801,22181380,10,C,Insulin lispro 32 units TID AC,,2,,,,,,,,,,,,,,2023,Q2,Pulmonary embolism,,2023,Q2,1,I,20230404.0,,20230406,20230406,DIR,655334,,FDA-CTU,,72.0,YR,,F,N,129.0,KG,20230406,N,PH,US,,2023,Q2,Elderly
221813801,22181380,10,C,Insulin lispro 32 units TID AC,,2,,,,,,,,,,,,,,2023,Q2,Deep vein thrombosis,,2023,Q2,1,I,20230404.0,,20230406,20230406,DIR,655334,,FDA-CTU,,72.0,YR,,F,N,129.0,KG,20230406,N,PH,US,,2023,Q2,Elderly
221820742,22182074,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,2,F,20230405.0,20230405.0,20230406,20230412,PER,,US-ELI_LILLY_AND_COMPANY-US202304002564,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230412,,CN,US,US,2023,Q2,Adult
221820742,22182074,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Migraine,,2023,Q2,2,F,20230405.0,20230405.0,20230406,20230412,PER,,US-ELI_LILLY_AND_COMPANY-US202304002564,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230412,,CN,US,US,2023,Q2,Adult
221820742,22182074,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D498888C,,20563.0,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,2,F,20230405.0,20230405.0,20230406,20230412,PER,,US-ELI_LILLY_AND_COMPANY-US202304002564,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230412,,CN,US,US,2023,Q2,Adult
221820742,22182074,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D498888C,,20563.0,,,Injection,,2023,Q2,Migraine,,2023,Q2,2,F,20230405.0,20230405.0,20230406,20230412,PER,,US-ELI_LILLY_AND_COMPANY-US202304002564,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230412,,CN,US,US,2023,Q2,Adult
221825741,22182574,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,20230327.0,20230327.0,20230406,20230406,PER,,US-MYLANLABS-2023M1033478,MYLAN,,77.0,YR,,F,Y,,,20230406,,CN,US,US,2023,Q2,Elderly
221825741,22182574,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,20230327.0,20230327.0,20230406,20230406,PER,,US-MYLANLABS-2023M1033478,MYLAN,,77.0,YR,,F,Y,,,20230406,,CN,US,US,2023,Q2,Elderly
221825741,22182574,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230327.0,20230327.0,20230406,20230406,PER,,US-MYLANLABS-2023M1033478,MYLAN,,77.0,YR,,F,Y,,,20230406,,CN,US,US,2023,Q2,Elderly
221837762,22183776,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose and frequency unknown,,,,,,,,,,,,2023,Q2,Haematuria,,2023,Q2,2,F,20230208.0,20230428.0,20230406,20230504,PER,,JP-Eisai Medical Research-EC-2023-137529,EISAI,,70.0,YR,E,M,Y,,,20230504,,MD,JP,JP,2023,Q2,Elderly
221900302,22190030,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2023,Q2,Visual impairment,,2023,Q2,2,F,20230406.0,20230406.0,20230410,20230411,PER,,US-ELI_LILLY_AND_COMPANY-US202304003861,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Elderly
221900302,22190030,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230406.0,20230406.0,20230410,20230411,PER,,US-ELI_LILLY_AND_COMPANY-US202304003861,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Elderly
221923241,22192324,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,UNK,,,,,,,2023,Q2,Completed suicide,,2023,Q2,1,I,,20230327.0,20230410,20230410,EXP,,US-ALVOGEN-2023090142,ALVOGEN,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R, Brown K, Nathaniel PTP, Bronstein AC, Weber JA. 2021 Annual Report of the National Poison Data System (NPDS) from America?s Poison Centers: 39th Annual Report. Clinical Toxicology. 2023-Jan-05;60 (12):1381-1643. doi: https://doi.org/10.1080/15563650.2022.2132768",61.0,YR,,F,Y,,,20230410,,MD,US,US,2023,Q2,Adult
221964451,22196445,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q2,Weight increased,,2023,Q2,1,I,20210701.0,20230403.0,20230411,20230411,EXP,,SE-SA-2023SA108890,SANOFI AVENTIS,,49.0,YR,A,F,Y,,,20230411,,CN,SE,SE,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Cataract,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Immunodeficiency,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Cholelithiasis,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Burns third degree,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose abnormal,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Impaired healing,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Wound secretion,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Cataract,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Immunodeficiency,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Cholelithiasis,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Burns third degree,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose abnormal,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Impaired healing,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Wound secretion,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980891,22198089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D584742A,,20563.0,,,Solution for injection,,2023,Q2,Rhinorrhoea,,2023,Q2,1,I,20150401.0,20230330.0,20230411,20230411,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016786,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230411,,CN,US,US,2023,Q2,Adult
221980942,22198094,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,D560771E,,,20.0,IU,Injection,QD,2023,Q2,Spinal stenosis,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,D560771E,,,20.0,IU,Injection,QD,2023,Q2,Neck injury,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,D560771E,,,20.0,IU,Injection,QD,2023,Q2,Fall,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,D560771E,,,20.0,IU,Injection,QD,2023,Q2,Spinal cord compression,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,D560771E,,,20.0,IU,Injection,QD,2023,Q2,Spinal stenosis,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,D560771E,,,20.0,IU,Injection,QD,2023,Q2,Neck injury,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,D560771E,,,20.0,IU,Injection,QD,2023,Q2,Fall,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,D560771E,,,20.0,IU,Injection,QD,2023,Q2,Spinal cord compression,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,,,,20.0,IU,Injection,QD,2023,Q2,Spinal stenosis,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,,,,20.0,IU,Injection,QD,2023,Q2,Neck injury,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,,,,20.0,IU,Injection,QD,2023,Q2,Fall,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,,,,20.0,IU,Injection,QD,2023,Q2,Spinal cord compression,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,,,,20.0,IU,Injection,QD,2023,Q2,Spinal stenosis,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,,,,20.0,IU,Injection,QD,2023,Q2,Neck injury,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,,,,20.0,IU,Injection,QD,2023,Q2,Fall,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
221980942,22198094,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, daily",,,U,,,,,20.0,IU,Injection,QD,2023,Q2,Spinal cord compression,,2023,Q2,2,F,20220101.0,20230511.0,20230411,20230519,EXP,,US-ELI_LILLY_AND_COMPANY-US202303016806,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20230519,,MD,US,US,2023,Q2,Adult
222009051,22200905,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,Y,,,,209196.0,,,,QD,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230115.0,20230407.0,20230412,20230412,EXP,IT-MINISAL02-917925,IT-SA-2023SA110994,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20230412,,PH,IT,IT,2023,Q2,Elderly
222009051,22200905,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,Y,,,,209196.0,,,,QD,2023,Q2,Sopor,,2023,Q2,1,I,20230115.0,20230407.0,20230412,20230412,EXP,IT-MINISAL02-917925,IT-SA-2023SA110994,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20230412,,PH,IT,IT,2023,Q2,Elderly
222016032,22201603,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2023,Q2,Illness,,2023,Q2,2,F,20230301.0,20230516.0,20230412,20230531,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-051307,BRISTOL MYERS SQUIBB,,71.0,YR,E,F,Y,,,20230531,,CN,US,US,2023,Q2,Elderly
222066341,22206634,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Fall,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Sternal fracture,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Rotator cuff syndrome,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Rib fracture,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Clavicle fracture,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Fall,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Sternal fracture,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Rotator cuff syndrome,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Rib fracture,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222066341,22206634,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Clavicle fracture,,2023,Q2,1,I,20210311.0,20220401.0,20230413,20230413,EXP,,US-JNJFOC-20220405992,JOHNSON AND JOHNSON,,62.0,YR,A,F,Y,,,20230413,,MD,US,US,2023,Q2,Adult
222105371,22210537,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,,,,Solution for injection,,2023,Q2,Nausea,,2023,Q2,1,I,20230411.0,20230411.0,20230414,20230414,PER,,US-ELI_LILLY_AND_COMPANY-US202304005765,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222105371,22210537,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,,,,Solution for injection,,2023,Q2,Abdominal distension,,2023,Q2,1,I,20230411.0,20230411.0,20230414,20230414,PER,,US-ELI_LILLY_AND_COMPANY-US202304005765,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222105371,22210537,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,,,,Solution for injection,,2023,Q2,Vitreous floaters,,2023,Q2,1,I,20230411.0,20230411.0,20230414,20230414,PER,,US-ELI_LILLY_AND_COMPANY-US202304005765,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222105371,22210537,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230411.0,20230411.0,20230414,20230414,PER,,US-ELI_LILLY_AND_COMPANY-US202304005765,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222108131,22210813,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,18.0,IU,Injection,QD,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230202.0,20230407.0,20230414,20230414,EXP,,IT-EMD Serono-9395376,EMD SERONO INC,,87.0,YR,E,M,Y,,,20230414,,MD,IT,,2023,Q2,Elderly
222120411,22212041,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU (4 iu for breakfast, 6 iu for lunch, 8 iu for dinner)",,,U,,,,,18.0,IU,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230202.0,20230410.0,20230414,20230414,EXP,IT-MINISAL02-918444,NVSC2023IT082401,NOVARTIS,,87.0,YR,,M,Y,,,20230414,,MD,IT,IT,2023,Q2,Elderly
222136051,22213605,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,,,20563.0,5.5,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,,,20563.0,5.5,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,,,20563.0,5.5,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,,,20563.0,5.5,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,,,20563.0,5.5,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,,,20563.0,5.5,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,,,20563.0,6.0,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,,,20563.0,6.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,,,20563.0,6.0,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,,,20563.0,6.0,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,,,20563.0,6.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,,,20563.0,6.0,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,,,20563.0,10.0,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,,,20563.0,10.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,,,20563.0,10.0,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,,,20563.0,10.0,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,,,20563.0,10.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,,,20563.0,10.0,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,D430500U,,20563.0,5.5,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,D430500U,,20563.0,5.5,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,D430500U,,20563.0,5.5,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,D430500U,,20563.0,5.5,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,D430500U,,20563.0,5.5,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"5.5 u, each morning",,,U,,D430500U,,20563.0,5.5,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,9,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,D430500U,,20563.0,6.0,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,9,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,D430500U,,20563.0,6.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,9,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,D430500U,,20563.0,6.0,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,10,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,D430500U,,20563.0,6.0,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,10,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,D430500U,,20563.0,6.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,10,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"6 u, daily (lunch)",,,U,,D430500U,,20563.0,6.0,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,11,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,D430500U,,20563.0,10.0,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,11,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,D430500U,,20563.0,10.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,11,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,D430500U,,20563.0,10.0,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,12,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,D430500U,,20563.0,10.0,IU,Injection,QD,2023,Q2,Injury associated with device,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,12,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,D430500U,,20563.0,10.0,IU,Injection,QD,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222136051,22213605,12,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"10 u, each evening (at night)",,,U,,D430500U,,20563.0,10.0,IU,Injection,QD,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230410.0,20230410.0,20230414,20230414,EXP,,US-ELI_LILLY_AND_COMPANY-US202304005473,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230414,,CN,US,US,2023,Q2,Elderly
222168931,22216893,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Heart rate irregular,,2023,Q2,1,I,20221101.0,20230410.0,20230417,20230417,PER,,US-ELI_LILLY_AND_COMPANY-US202304007001,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20230417,,CN,US,US,2023,Q2,Elderly
222190611,22219061,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2023,Q2,Gallbladder rupture,,2023,Q2,1,I,20221001.0,20230411.0,20230417,20230417,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202304004910,ELI LILLY AND CO,,65.0,YR,,M,Y,104.0,KG,20230417,,MD,DE,DE,2023,Q2,Elderly
222190611,22219061,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2023,Q2,Cholelithiasis,,2023,Q2,1,I,20221001.0,20230411.0,20230417,20230417,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202304004910,ELI LILLY AND CO,,65.0,YR,,M,Y,104.0,KG,20230417,,MD,DE,DE,2023,Q2,Elderly
222190611,22219061,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2023,Q2,Cholecystitis,,2023,Q2,1,I,20221001.0,20230411.0,20230417,20230417,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202304004910,ELI LILLY AND CO,,65.0,YR,,M,Y,104.0,KG,20230417,,MD,DE,DE,2023,Q2,Elderly
222199331,22219933,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D564351E,,20563.0,10.0,IU,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230414.0,20230414.0,20230417,20230417,PER,,US-ELI_LILLY_AND_COMPANY-US202304007782,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230417,,CN,US,US,2023,Q2,Adult
222199331,22219933,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D564351E,,20563.0,10.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,1,I,20230414.0,20230414.0,20230417,20230417,PER,,US-ELI_LILLY_AND_COMPANY-US202304007782,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20230417,,CN,US,US,2023,Q2,Adult
222257791,22225779,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518832D,,,,,Injection,,2023,Q2,Heart rate irregular,,2023,Q2,1,I,20221101.0,20230410.0,20230418,20230418,PER,,US-ELI_LILLY_AND_COMPANY-US202304006330,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20230418,,CN,US,US,2023,Q2,Elderly
222262632,22226263,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,COVID-19,,2023,Q2,2,F,20221125.0,20230601.0,20230419,20230607,EXP,,NVSC2022US276629,NOVARTIS,,56.0,YR,,M,Y,108.0,KG,20230607,,MD,US,US,2023,Q2,Adult
222264211,22226421,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 units/vial, Once a Day",,,U,,,,,,,,QD,2023,Q2,Drug interaction,,2023,Q2,1,I,20230313.0,20230410.0,20230419,20230419,EXP,,IT-AUROBINDO-AUR-APL-2023-030640,AUROBINDO,,73.0,YR,,F,Y,,,20230419,,MD,IT,IT,2023,Q2,Elderly
222264211,22226421,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 units/vial, Once a Day",,,U,,,,,,,,QD,2023,Q2,Gingival bleeding,,2023,Q2,1,I,20230313.0,20230410.0,20230419,20230419,EXP,,IT-AUROBINDO-AUR-APL-2023-030640,AUROBINDO,,73.0,YR,,F,Y,,,20230419,,MD,IT,IT,2023,Q2,Elderly
222264802,22226480,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D564351E,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230416.0,20230417.0,20230419,20230419,PER,,US-ELI_LILLY_AND_COMPANY-US202304008478,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20230419,,PH,US,US,2023,Q2,Adult
222264802,22226480,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230416.0,20230417.0,20230419,20230419,PER,,US-ELI_LILLY_AND_COMPANY-US202304008478,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20230419,,PH,US,US,2023,Q2,Adult
222307491,22230749,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Feeling abnormal,,2023,Q2,1,I,20230413.0,20230418.0,20230420,20230420,PER,,US-ELI_LILLY_AND_COMPANY-US202304008385,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20230420,,CN,US,US,2023,Q2,Adult
222307491,22230749,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230413.0,20230418.0,20230420,20230420,PER,,US-ELI_LILLY_AND_COMPANY-US202304008385,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20230420,,CN,US,US,2023,Q2,Adult
222307491,22230749,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Feeling abnormal,,2023,Q2,1,I,20230413.0,20230418.0,20230420,20230420,PER,,US-ELI_LILLY_AND_COMPANY-US202304008385,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20230420,,CN,US,US,2023,Q2,Adult
222307491,22230749,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230413.0,20230418.0,20230420,20230420,PER,,US-ELI_LILLY_AND_COMPANY-US202304008385,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20230420,,CN,US,US,2023,Q2,Adult
222307491,22230749,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518829A,,20563.0,,,Injection,,2023,Q2,Feeling abnormal,,2023,Q2,1,I,20230413.0,20230418.0,20230420,20230420,PER,,US-ELI_LILLY_AND_COMPANY-US202304008385,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20230420,,CN,US,US,2023,Q2,Adult
222307491,22230749,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518829A,,20563.0,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230413.0,20230418.0,20230420,20230420,PER,,US-ELI_LILLY_AND_COMPANY-US202304008385,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20230420,,CN,US,US,2023,Q2,Adult
222307491,22230749,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518829A,,20563.0,,,Injection,,2023,Q2,Feeling abnormal,,2023,Q2,1,I,20230413.0,20230418.0,20230420,20230420,PER,,US-ELI_LILLY_AND_COMPANY-US202304008385,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20230420,,CN,US,US,2023,Q2,Adult
222307491,22230749,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518829A,,20563.0,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230413.0,20230418.0,20230420,20230420,PER,,US-ELI_LILLY_AND_COMPANY-US202304008385,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20230420,,CN,US,US,2023,Q2,Adult
222315484,22231548,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ML,,,,,,,,,,Solution for injection in pre-filled pen,,2023,Q2,Abdominal pain upper,,2023,Q2,4,F,20230401.0,20230503.0,20230420,20230505,PER,,US-BIOGEN-2022BI01169288,BIOGEN,,58.0,YR,,F,Y,,,20230505,,CN,US,US,2023,Q2,Adult
222315484,22231548,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ML,,,,,,,,,,Solution for injection in pre-filled pen,,2023,Q2,Muscle spasms,,2023,Q2,4,F,20230401.0,20230503.0,20230420,20230505,PER,,US-BIOGEN-2022BI01169288,BIOGEN,,58.0,YR,,F,Y,,,20230505,,CN,US,US,2023,Q2,Adult
222315484,22231548,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ML,,,,,,,,,,Solution for injection in pre-filled pen,,2023,Q2,Back pain,,2023,Q2,4,F,20230401.0,20230503.0,20230420,20230505,PER,,US-BIOGEN-2022BI01169288,BIOGEN,,58.0,YR,,F,Y,,,20230505,,CN,US,US,2023,Q2,Adult
222315484,22231548,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ML,,,,,,,,,,Solution for injection in pre-filled pen,,2023,Q2,Pain in extremity,,2023,Q2,4,F,20230401.0,20230503.0,20230420,20230505,PER,,US-BIOGEN-2022BI01169288,BIOGEN,,58.0,YR,,F,Y,,,20230505,,CN,US,US,2023,Q2,Adult
222315484,22231548,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ML,,,,,,,,,,Solution for injection in pre-filled pen,,2023,Q2,Restless legs syndrome,,2023,Q2,4,F,20230401.0,20230503.0,20230420,20230505,PER,,US-BIOGEN-2022BI01169288,BIOGEN,,58.0,YR,,F,Y,,,20230505,,CN,US,US,2023,Q2,Adult
222315484,22231548,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ML,,,,,,,,,,Solution for injection in pre-filled pen,,2023,Q2,Decreased appetite,,2023,Q2,4,F,20230401.0,20230503.0,20230420,20230505,PER,,US-BIOGEN-2022BI01169288,BIOGEN,,58.0,YR,,F,Y,,,20230505,,CN,US,US,2023,Q2,Adult
222340821,22234082,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,6 units,,,,,,,,,,,TID,2023,Q2,Acute myocardial infarction,,2023,Q2,1,I,,20230411.0,20230420,20230420,EXP,,"US-Allegis Pharmaceuticals, LLC-APL202304-000021",ALLEGIS PHARMACEUTICALS,,54.0,YR,A,M,Y,,,20230420,,MD,US,,2023,Q2,Adult
222340821,22234082,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,6 units,,,,,,,,,,,TID,2023,Q2,Product use in unapproved indication,,2023,Q2,1,I,,20230411.0,20230420,20230420,EXP,,"US-Allegis Pharmaceuticals, LLC-APL202304-000021",ALLEGIS PHARMACEUTICALS,,54.0,YR,A,M,Y,,,20230420,,MD,US,,2023,Q2,Adult
222348401,22234840,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Drug-induced liver injury,,2023,Q2,1,I,20230213.0,20230417.0,20230420,20230420,EXP,CH-SM-2023-11812,CH-PFIZER INC-202300161602,PFIZER,,75.0,YR,,F,Y,,,20230420,,MD,CH,CH,2023,Q2,Elderly
222379711,22237971,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,UNK,,,,,,,2023,Q2,Non-cardiogenic pulmonary oedema,,2023,Q2,1,I,,20230411.0,20230421,20230421,EXP,,US-AVET LIFESCIENCES LTD-2023-AVET-000100,EMCURE,"Schwartz AH, Sieminski S.. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event.. Am J Ophthalmol Case Rep.. 2023;30:101827",59.0,YR,,F,Y,,,20230421,,HP,US,US,2023,Q2,Adult
222384321,22238432,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,,,D520950E,,20563.0,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230420.0,20230420.0,20230421,20230421,PER,,US-ELI_LILLY_AND_COMPANY-US202304010684,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20230421,,CN,US,US,2023,Q2,Elderly
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Liver function test increased,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Product use issue,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Rhabdomyolysis,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Fall,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Blood creatine phosphokinase increased,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Gait inability,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222401121,22240112,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Contraindicated product administered,,2023,Q2,1,I,,20230419.0,20230421,20230421,EXP,,CA-PFIZER INC-202300163548,PFIZER,,61.0,YR,,M,Y,,,20230421,,PH,CA,CA,2023,Q2,Adult
222439031,22243903,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"35 u, each morning",,,,,,,,35.0,IU,Injection,QD,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"35 u, each morning",,,,,,,,35.0,IU,Injection,QD,2023,Q2,Irritability,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"35 u, each morning",,,,,,,,35.0,IU,Injection,QD,2023,Q2,Blood pressure increased,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 u, each evening",,,,,,,,45.0,IU,Injection,QD,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 u, each evening",,,,,,,,45.0,IU,Injection,QD,2023,Q2,Irritability,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 u, each evening",,,,,,,,45.0,IU,Injection,QD,2023,Q2,Blood pressure increased,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"35 u, each morning",,,,,D460025D,,,35.0,IU,Injection,QD,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"35 u, each morning",,,,,D460025D,,,35.0,IU,Injection,QD,2023,Q2,Irritability,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"35 u, each morning",,,,,D460025D,,,35.0,IU,Injection,QD,2023,Q2,Blood pressure increased,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 u, each evening",,,,,D460025D,,,45.0,IU,Injection,QD,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 u, each evening",,,,,D460025D,,,45.0,IU,Injection,QD,2023,Q2,Irritability,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222439031,22243903,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 u, each evening",,,,,D460025D,,,45.0,IU,Injection,QD,2023,Q2,Blood pressure increased,,2023,Q2,1,I,20230416.0,20230420.0,20230424,20230424,PER,,US-ELI_LILLY_AND_COMPANY-US202304010848,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20230424,,CN,US,US,2023,Q2,Elderly
222454961,22245496,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Non-cardiogenic pulmonary oedema,,2023,Q2,1,I,,20230413.0,20230424,20230424,EXP,,US-Indicus Pharma-000943,INDICUS,"Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. Am J Ophthalmol Case Rep. 2023 Mar 15;30:101827.",59.0,YR,A,F,Y,,,20230424,,HP,US,US,2023,Q2,Adult
222454981,22245498,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Non-cardiogenic pulmonary oedema,,2023,Q2,1,I,,20230413.0,20230424,20230424,EXP,,US-Accord-309227,ACCORD,"Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. Am J Ophthalmol Case Rep. 2023 Mar 15;30:101827.",59.0,YR,A,F,Y,,,20230424,,HP,US,US,2023,Q2,Adult
222455001,22245500,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Non-cardiogenic pulmonary oedema,,2023,Q2,1,I,,20230413.0,20230424,20230424,EXP,,US-MankindUS-000061,MANKIND PHARMA,"Schwartz AH, Sieminski S. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event. Am J Ophthalmol Case Rep. 2023 Mar 15;30:101827.",59.0,YR,A,F,Y,,,20230424,,HP,US,US,2023,Q2,Adult
222455011,22245501,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q2,Drug-induced liver injury,,2023,Q2,1,I,20230213.0,20230417.0,20230424,20230424,EXP,CH-SM-2023-11812,NVSC2023CH087526,NOVARTIS,,75.0,YR,,F,Y,,,20230424,,MD,CH,CH,2023,Q2,Elderly
222455571,22245557,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Therapy interrupted,,2023,Q2,1,I,20230414.0,,20230421,20230421,DIR,FDA-CDER-CTU-2023-29929,,FDA-CTU,,69.0,YR,,M,N,183.0,LBS,20230421,N,HP,US,,2023,Q2,Elderly
222455571,22245557,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Localised infection,,2023,Q2,1,I,20230414.0,,20230421,20230421,DIR,FDA-CDER-CTU-2023-29929,,FDA-CTU,,69.0,YR,,M,N,183.0,LBS,20230421,N,HP,US,,2023,Q2,Elderly
222455571,22245557,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Endocrine disorder,,2023,Q2,1,I,20230414.0,,20230421,20230421,DIR,FDA-CDER-CTU-2023-29929,,FDA-CTU,,69.0,YR,,M,N,183.0,LBS,20230421,N,HP,US,,2023,Q2,Elderly
222461761,22246176,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,,,,,,,Solution for injection,,2023,Q2,Sopor,,2023,Q2,1,I,20220414.0,20230420.0,20230424,20230424,EXP,IT-MINISAL02-919938,IT-SA-2023SA126277,SANOFI AVENTIS,,92.0,YR,E,F,Y,,,20230424,,MD,IT,IT,2023,Q2,Elderly
222461761,22246176,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,,,,,,,Solution for injection,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20220414.0,20230420.0,20230424,20230424,EXP,IT-MINISAL02-919938,IT-SA-2023SA126277,SANOFI AVENTIS,,92.0,YR,E,F,Y,,,20230424,,MD,IT,IT,2023,Q2,Elderly
222461761,22246176,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,,,,,,,Solution for injection,,2023,Q2,Loss of consciousness,,2023,Q2,1,I,20220414.0,20230420.0,20230424,20230424,EXP,IT-MINISAL02-919938,IT-SA-2023SA126277,SANOFI AVENTIS,,92.0,YR,E,F,Y,,,20230424,,MD,IT,IT,2023,Q2,Elderly
222478431,22247843,14,C,lispro 50lis50npl,,2,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Clostridium test positive,,2023,Q2,1,I,,20230412.0,20230425,20230425,EXP,,CA-AUROBINDO-AUR-APL-2023-031679,AUROBINDO,,82.0,YR,,F,Y,70.0,KG,20230425,,PH,CA,CA,2023,Q2,Elderly
222511972,22251197,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,15.0,IU,Injection,,2023,Q2,Sinusitis,,2023,Q2,2,F,20230317.0,20230627.0,20230425,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202304008914,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Elderly
222511972,22251197,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,15.0,IU,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,2,F,20230317.0,20230627.0,20230425,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202304008914,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Elderly
222511972,22251197,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,15.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,2,F,20230317.0,20230627.0,20230425,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202304008914,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Elderly
222511972,22251197,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,15.0,IU,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230317.0,20230627.0,20230425,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202304008914,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Elderly
222511972,22251197,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,15.0,IU,Injection,,2023,Q2,Sinusitis,,2023,Q2,2,F,20230317.0,20230627.0,20230425,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202304008914,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Elderly
222511972,22251197,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,15.0,IU,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,2,F,20230317.0,20230627.0,20230425,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202304008914,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Elderly
222511972,22251197,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,15.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,2,F,20230317.0,20230627.0,20230425,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202304008914,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Elderly
222511972,22251197,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,15.0,IU,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,2,F,20230317.0,20230627.0,20230425,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202304008914,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Elderly
222557221,22255722,10,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2023,Q2,Asthma,,2023,Q2,1,I,20230328.0,,20230425,20230425,DIR,FDA-CDER-CTU-2023-30895,,FDA-CTU,,77.0,YR,,M,N,,,20230425,Y,PH,US,,2023,Q2,Elderly
222557221,22255722,10,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2023,Q2,Chronic obstructive pulmonary disease,,2023,Q2,1,I,20230328.0,,20230425,20230425,DIR,FDA-CDER-CTU-2023-30895,,FDA-CTU,,77.0,YR,,M,N,,,20230425,Y,PH,US,,2023,Q2,Elderly
222557221,22255722,10,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2023,Q2,Cardiac failure congestive,,2023,Q2,1,I,20230328.0,,20230425,20230425,DIR,FDA-CDER-CTU-2023-30895,,FDA-CTU,,77.0,YR,,M,N,,,20230425,Y,PH,US,,2023,Q2,Elderly
222562781,22256278,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,Solution for injection,,2023,Q2,Loss of consciousness,,2023,Q2,1,I,20220414.0,20230417.0,20230426,20230426,EXP,IT-MINISAL02-919938,IT-ELI_LILLY_AND_COMPANY-IT202304007816,ELI LILLY AND CO,,92.0,YR,,F,Y,,,20230426,,CN,IT,IT,2023,Q2,Elderly
222562781,22256278,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,Solution for injection,,2023,Q2,Sopor,,2023,Q2,1,I,20220414.0,20230417.0,20230426,20230426,EXP,IT-MINISAL02-919938,IT-ELI_LILLY_AND_COMPANY-IT202304007816,ELI LILLY AND CO,,92.0,YR,,F,Y,,,20230426,,CN,IT,IT,2023,Q2,Elderly
222562781,22256278,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,Solution for injection,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20220414.0,20230417.0,20230426,20230426,EXP,IT-MINISAL02-919938,IT-ELI_LILLY_AND_COMPANY-IT202304007816,ELI LILLY AND CO,,92.0,YR,,F,Y,,,20230426,,CN,IT,IT,2023,Q2,Elderly
222564282,22256428,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"38 international unit, qd (14-12-12 units)",,,U,,,,,38.0,IU,Injection,QD,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,,20230602.0,20230426,20230607,EXP,,CZ-MYLANLABS-2023M1042581,MYLAN,Smahelova A.. When and why IDeglira and IDegAsp or insulin therapy and cognitive disorders. Acta Medicinae. 2023;13(2-3):82-84,76.0,YR,,M,Y,,,20230607,,MD,CZ,CZ,2023,Q2,Elderly
222564282,22256428,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"38 international unit, qd (14-12-12 units)",,,U,,,,,38.0,IU,Injection,QD,2023,Q2,Product dose omission issue,,2023,Q2,2,F,,20230602.0,20230426,20230607,EXP,,CZ-MYLANLABS-2023M1042581,MYLAN,Smahelova A.. When and why IDeglira and IDegAsp or insulin therapy and cognitive disorders. Acta Medicinae. 2023;13(2-3):82-84,76.0,YR,,M,Y,,,20230607,,MD,CZ,CZ,2023,Q2,Elderly
222564282,22256428,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"38 international unit, qd (14-12-12 units)",,,U,,,,,38.0,IU,Injection,QD,2023,Q2,Intentional product misuse,,2023,Q2,2,F,,20230602.0,20230426,20230607,EXP,,CZ-MYLANLABS-2023M1042581,MYLAN,Smahelova A.. When and why IDeglira and IDegAsp or insulin therapy and cognitive disorders. Acta Medicinae. 2023;13(2-3):82-84,76.0,YR,,M,Y,,,20230607,,MD,CZ,CZ,2023,Q2,Elderly
222564282,22256428,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"38 international unit, qd (14-12-12 units)",,,U,,,,,38.0,IU,Injection,QD,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230602.0,20230426,20230607,EXP,,CZ-MYLANLABS-2023M1042581,MYLAN,Smahelova A.. When and why IDeglira and IDegAsp or insulin therapy and cognitive disorders. Acta Medicinae. 2023;13(2-3):82-84,76.0,YR,,M,Y,,,20230607,,MD,CZ,CZ,2023,Q2,Elderly
222564282,22256428,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, short-term prandial bolus insulin lispro 14",,,U,,,,,,,Injection,,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,,20230602.0,20230426,20230607,EXP,,CZ-MYLANLABS-2023M1042581,MYLAN,Smahelova A.. When and why IDeglira and IDegAsp or insulin therapy and cognitive disorders. Acta Medicinae. 2023;13(2-3):82-84,76.0,YR,,M,Y,,,20230607,,MD,CZ,CZ,2023,Q2,Elderly
222564282,22256428,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, short-term prandial bolus insulin lispro 14",,,U,,,,,,,Injection,,2023,Q2,Product dose omission issue,,2023,Q2,2,F,,20230602.0,20230426,20230607,EXP,,CZ-MYLANLABS-2023M1042581,MYLAN,Smahelova A.. When and why IDeglira and IDegAsp or insulin therapy and cognitive disorders. Acta Medicinae. 2023;13(2-3):82-84,76.0,YR,,M,Y,,,20230607,,MD,CZ,CZ,2023,Q2,Elderly
222564282,22256428,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, short-term prandial bolus insulin lispro 14",,,U,,,,,,,Injection,,2023,Q2,Intentional product misuse,,2023,Q2,2,F,,20230602.0,20230426,20230607,EXP,,CZ-MYLANLABS-2023M1042581,MYLAN,Smahelova A.. When and why IDeglira and IDegAsp or insulin therapy and cognitive disorders. Acta Medicinae. 2023;13(2-3):82-84,76.0,YR,,M,Y,,,20230607,,MD,CZ,CZ,2023,Q2,Elderly
222564282,22256428,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, short-term prandial bolus insulin lispro 14",,,U,,,,,,,Injection,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,,20230602.0,20230426,20230607,EXP,,CZ-MYLANLABS-2023M1042581,MYLAN,Smahelova A.. When and why IDeglira and IDegAsp or insulin therapy and cognitive disorders. Acta Medicinae. 2023;13(2-3):82-84,76.0,YR,,M,Y,,,20230607,,MD,CZ,CZ,2023,Q2,Elderly
222579341,22257934,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,UNK,,,,,,,2023,Q2,Non-cardiogenic pulmonary oedema,,2023,Q2,1,I,,20230414.0,20230427,20230427,EXP,,US-NOVAST LABORATORIES INC.-2023NOV000240,NOVAST,"Schwartz AH, Sieminski S.. Acetazolamide induced noncardiogenic pulmonary edema, an underreported serious adverse event.. Am J Ophthalmol Case Rep. 2023;30",59.0,YR,,F,Y,,,20230426,,HP,US,US,2023,Q2,Adult
222583261,22258326,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,N,,D518828A,,20563.0,,,Injection,,2023,Q2,Pain in extremity,,2023,Q2,1,I,20230311.0,20230426.0,20230427,20230427,PER,,US-ELI_LILLY_AND_COMPANY-US202304013993,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20230427,,CN,US,US,2023,Q2,Adult
222583261,22258326,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,N,,D518828A,,20563.0,,,Injection,,2023,Q2,Sleep disorder due to a general medical condition,,2023,Q2,1,I,20230311.0,20230426.0,20230427,20230427,PER,,US-ELI_LILLY_AND_COMPANY-US202304013993,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20230427,,CN,US,US,2023,Q2,Adult
222649801,22264980,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 unit, qd",,,,,,,,,,,QD,2023,Q2,Incorrect dosage administered,,2023,Q2,1,I,20220623.0,20230321.0,20230428,20230428,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200492,MYOVANT SCIENCES,,62.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Adult
222649801,22264980,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 unit, qd",,,,,,,,,,,QD,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20220623.0,20230321.0,20230428,20230428,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200492,MYOVANT SCIENCES,,62.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Adult
222649801,22264980,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 unit, qd",,,,,,,,,,,QD,2023,Q2,Cerebrovascular accident,,2023,Q2,1,I,20220623.0,20230321.0,20230428,20230428,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200492,MYOVANT SCIENCES,,62.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Adult
222649801,22264980,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 unit, qd",,,,,,,,,,,QD,2023,Q2,Therapy interrupted,,2023,Q2,1,I,20220623.0,20230321.0,20230428,20230428,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0200492,MYOVANT SCIENCES,,62.0,YR,,M,Y,,,20230428,,CN,US,US,2023,Q2,Adult
222659491,22265949,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"4 iu for breakfast, 6 iu for lunch, 8 iu for dinner",,,U,,UNKNOWN,,,18.0,IU,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230202.0,20230418.0,20230428,20230428,EXP,IT-MINISAL02-918444,IT-TEVA-2023-IT-2879784,TEVA,,87.0,YR,E,M,Y,,,20230428,,MD,IT,IT,2023,Q2,Elderly
222671401,22267140,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,20230415.0,,20230428,20230428,DIR,658101,,FDA-CTU,,71.0,YR,,F,N,120.0,KG,20230428,Y,CN,US,,2023,Q2,Elderly
222671401,22267140,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Underdose,,2023,Q2,1,I,20230415.0,,20230428,20230428,DIR,658101,,FDA-CTU,,71.0,YR,,F,N,120.0,KG,20230428,Y,CN,US,,2023,Q2,Elderly
222673051,22267305,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Nausea,,2023,Q2,1,I,,20230421.0,20230428,20230428,EXP,,CA-TEVA-2023-CA-2880983,TEVA,,20.0,YR,A,F,Y,,,20230428,,HP,CA,CA,2023,Q2,Youth
222673051,22267305,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Colitis ulcerative,,2023,Q2,1,I,,20230421.0,20230428,20230428,EXP,,CA-TEVA-2023-CA-2880983,TEVA,,20.0,YR,A,F,Y,,,20230428,,HP,CA,CA,2023,Q2,Youth
222673051,22267305,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230421.0,20230428,20230428,EXP,,CA-TEVA-2023-CA-2880983,TEVA,,20.0,YR,A,F,Y,,,20230428,,HP,CA,CA,2023,Q2,Youth
222673051,22267305,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,,20230421.0,20230428,20230428,EXP,,CA-TEVA-2023-CA-2880983,TEVA,,20.0,YR,A,F,Y,,,20230428,,HP,CA,CA,2023,Q2,Youth
222711462,22271146,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, tid (8-8-8 U)",,,Y,U,,,,8.0,IU,,TID,2023,Q2,No adverse event,,2023,Q2,2,F,,20230501.0,20230501,20230510,EXP,,CZ-MYLANLABS-2023M1044321,MYLAN,Maule P. Xultophy - multiple effectiveness in one daily dose. CASE REPORTS IN DIABETOLOGY. 2023;21(1):18-21,71.0,YR,,M,Y,98.0,KG,20230510,,MD,CZ,CZ,2023,Q2,Elderly
222711462,22271146,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2023,Q2,No adverse event,,2023,Q2,2,F,,20230501.0,20230501,20230510,EXP,,CZ-MYLANLABS-2023M1044321,MYLAN,Maule P. Xultophy - multiple effectiveness in one daily dose. CASE REPORTS IN DIABETOLOGY. 2023;21(1):18-21,71.0,YR,,M,Y,98.0,KG,20230510,,MD,CZ,CZ,2023,Q2,Elderly
222732001,22273200,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,4U for lunch,,,,,,,,,,,,2023,Q2,Gingival bleeding,,2023,Q2,1,I,20230313.0,20230420.0,20230502,20230502,EXP,IT-MINISAL02-918992,IT-TEVA-2023-IT-2880914,TEVA,,73.0,YR,E,F,Y,,,20230428,,MD,IT,IT,2023,Q2,Elderly
222732001,22273200,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,4U for lunch,,,,,,,,,,,,2023,Q2,Drug interaction,,2023,Q2,1,I,20230313.0,20230420.0,20230502,20230502,EXP,IT-MINISAL02-918992,IT-TEVA-2023-IT-2880914,TEVA,,73.0,YR,E,F,Y,,,20230428,,MD,IT,IT,2023,Q2,Elderly
222735401,22273540,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Clostridium test positive,,2023,Q2,1,I,,20230419.0,20230502,20230502,EXP,,CA-AUROBINDO-AUR-APL-2023-032913,AUROBINDO,,67.0,YR,,M,Y,138.0,KG,20230502,,PH,CA,CA,2023,Q2,Elderly
222738101,22273810,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Insomnia,,2023,Q2,1,I,20230330.0,20230425.0,20230502,20230502,PER,,US-PFIZER INC-202300170315,PFIZER,,58.0,YR,,F,Y,,,20230502,,HP,US,US,2023,Q2,Adult
222738101,22273810,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,20230330.0,20230425.0,20230502,20230502,PER,,US-PFIZER INC-202300170315,PFIZER,,58.0,YR,,F,Y,,,20230502,,HP,US,US,2023,Q2,Adult
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Pharyngeal paraesthesia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Off label use,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Nausea,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Oropharyngeal pain,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Throat tightness,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Throat irritation,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Paraesthesia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Haemorrhoids,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Tonsillitis,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Myalgia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Headache,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Pharyngeal paraesthesia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Off label use,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Nausea,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Oropharyngeal pain,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Throat tightness,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Throat irritation,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Paraesthesia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Haemorrhoids,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Tonsillitis,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Myalgia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Headache,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Pharyngeal paraesthesia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Off label use,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Nausea,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Oropharyngeal pain,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Throat tightness,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Throat irritation,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Paraesthesia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Haemorrhoids,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Tonsillitis,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Myalgia,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222777211,22277721,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Headache,,2023,Q2,1,I,,20230426.0,20230503,20230503,EXP,,CA-JNJFOC-20230465148,JOHNSON AND JOHNSON,,20.0,YR,A,F,Y,70.0,KG,20230503,,HP,CA,CA,2023,Q2,Youth
222778731,22277873,3,C,INSULINE LISPRO,,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Cerebellar syndrome,,2023,Q2,1,I,20230210.0,20230420.0,20230503,20230503,EXP,,FR-AUROBINDO-AUR-APL-2023-033517,AUROBINDO,,54.0,YR,,F,Y,75.0,KG,20230503,,PH,FR,FR,2023,Q2,Adult
222807101,22280710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, bid",144.0,IU,Y,,D482382,,21017.0,18.0,IU,,BID,2023,Q2,Dyspnoea,,2023,Q2,1,I,20230422.0,20230425.0,20230503,20230503,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202304014358,ELI LILLY AND CO,,68.0,YR,,F,Y,51.0,KG,20230503,,CN,CN,CN,2023,Q2,Elderly
222807101,22280710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, bid",144.0,IU,Y,,D482382,,21017.0,18.0,IU,,BID,2023,Q2,Palpitations,,2023,Q2,1,I,20230422.0,20230425.0,20230503,20230503,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202304014358,ELI LILLY AND CO,,68.0,YR,,F,Y,51.0,KG,20230503,,CN,CN,CN,2023,Q2,Elderly
222807101,22280710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, bid",144.0,IU,Y,,D482382,,21017.0,18.0,IU,,BID,2023,Q2,Rash,,2023,Q2,1,I,20230422.0,20230425.0,20230503,20230503,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202304014358,ELI LILLY AND CO,,68.0,YR,,F,Y,51.0,KG,20230503,,CN,CN,CN,2023,Q2,Elderly
222807101,22280710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, bid",144.0,IU,Y,,D482382,,21017.0,18.0,IU,,BID,2023,Q2,Injection site rash,,2023,Q2,1,I,20230422.0,20230425.0,20230503,20230503,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202304014358,ELI LILLY AND CO,,68.0,YR,,F,Y,51.0,KG,20230503,,CN,CN,CN,2023,Q2,Elderly
222807101,22280710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, bid",144.0,IU,Y,,D482382,,21017.0,18.0,IU,,BID,2023,Q2,Pruritus,,2023,Q2,1,I,20230422.0,20230425.0,20230503,20230503,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202304014358,ELI LILLY AND CO,,68.0,YR,,F,Y,51.0,KG,20230503,,CN,CN,CN,2023,Q2,Elderly
222833601,22283360,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Clostridium difficile infection,,2023,Q2,1,I,,20230420.0,20230504,20230504,EXP,,CA-AUROBINDO-AUR-APL-2023-033821,AUROBINDO,,74.0,YR,,F,Y,,,20230504,,HP,CA,CA,2023,Q2,Elderly
222837311,22283731,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,Frequency text: Not provided,,,U,,,,,,,,,2023,Q2,Abdominal pain,,2023,Q2,1,I,,20230501.0,20230504,20230504,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203393,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20230504,,MD,CA,CA,2023,Q2,Elderly
222837311,22283731,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,Frequency text: Not provided,,,U,,,,,,,,,2023,Q2,Small intestinal obstruction,,2023,Q2,1,I,,20230501.0,20230504,20230504,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203393,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20230504,,MD,CA,CA,2023,Q2,Elderly
222837311,22283731,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,Frequency text: Not provided,,,U,,,,,,,,,2023,Q2,Urinary tract obstruction,,2023,Q2,1,I,,20230501.0,20230504,20230504,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203393,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20230504,,MD,CA,CA,2023,Q2,Elderly
222837311,22283731,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,Frequency text: Not provided,,,U,,,,,,,,,2023,Q2,Dehydration,,2023,Q2,1,I,,20230501.0,20230504,20230504,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203393,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20230504,,MD,CA,CA,2023,Q2,Elderly
222837311,22283731,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,Frequency text: Not provided,,,U,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230501.0,20230504,20230504,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210203393,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20230504,,MD,CA,CA,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Enterobacter pneumonia,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Candida pneumonia,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Pyrexia,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Lung disorder,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Klebsiella infection,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Dyspnoea,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Pneumonia klebsiella,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Pulmonary toxicity,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Respiratory failure,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 SC according to KC,,,D,,,,,,,Unknown,Q12H,2023,Q2,Drug interaction,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Enterobacter pneumonia,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Candida pneumonia,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Pyrexia,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Lung disorder,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Klebsiella infection,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Dyspnoea,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Pneumonia klebsiella,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Pulmonary toxicity,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Respiratory failure,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222858692,22285869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,D,,,,,,,Unknown,,2023,Q2,Drug interaction,,2023,Q2,2,F,20210101.0,20230509.0,20230504,20230510,EXP,,CZ-JNJFOC-20230506751,JOHNSON AND JOHNSON,"Tisancinova J, Tisancinova J, Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone.",67.0,YR,E,M,Y,98.0,KG,20230511,,HP,CZ,CZ,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Helicobacter gastritis,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Abdominal pain,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Chest pain,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,N-terminal prohormone brain natriuretic peptide increased,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Gastrointestinal bacterial overgrowth,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Hypoaesthesia,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Pyelonephritis,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Nausea,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Impaired gastric emptying,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Gastroenteritis,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Hypotension,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Vomiting,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Headache,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Troponin increased,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222883693,22288369,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID (10sq tid before meals (unspecified-current)",,,,,,,,,,,TID,2023,Q2,Diarrhoea,,2023,Q2,3,F,20221026.0,20230526.0,20230505,20230605,EXP,,NVSC2023US100698,NOVARTIS,,67.0,YR,,F,Y,59.55,KG,20230602,,HP,US,US,2023,Q2,Elderly
222889531,22288953,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Cardiac failure congestive,,2023,Q2,1,I,20230301.0,20230425.0,20230505,20230505,EXP,,US-BAYER-2023A058838,BAYER,,77.0,YR,E,M,Y,,,20230505,,PH,US,US,2023,Q2,Elderly
222889531,22288953,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Asthma,,2023,Q2,1,I,20230301.0,20230425.0,20230505,20230505,EXP,,US-BAYER-2023A058838,BAYER,,77.0,YR,E,M,Y,,,20230505,,PH,US,US,2023,Q2,Elderly
222889531,22288953,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Asthma-chronic obstructive pulmonary disease overlap syndrome,,2023,Q2,1,I,20230301.0,20230425.0,20230505,20230505,EXP,,US-BAYER-2023A058838,BAYER,,77.0,YR,E,M,Y,,,20230505,,PH,US,US,2023,Q2,Elderly
222893391,22289339,84,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 iu, QID",,,,,,,,15.0,IU,,QID,2023,Q2,Gastrointestinal haemorrhage,,2023,Q2,1,I,20230116.0,20230123.0,20230505,20230505,EXP,,US-BAYER-2023A062792,BAYER,,63.0,YR,A,M,Y,106.59,KG,20230505,,MD,US,US,2023,Q2,Adult
222893391,22289339,84,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 iu, QID",,,,,,,,15.0,IU,,QID,2023,Q2,Colitis ischaemic,,2023,Q2,1,I,20230116.0,20230123.0,20230505,20230505,EXP,,US-BAYER-2023A062792,BAYER,,63.0,YR,A,M,Y,106.59,KG,20230505,,MD,US,US,2023,Q2,Adult
222901211,22290121,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,22 international unit,,,U,U,,,,22.0,IU,,,2023,Q2,Drug ineffective,,2023,Q2,1,I,,20230425.0,20230505,20230505,EXP,,CZ-MYLANLABS-2023M1045707,MYLAN,Pavlikova B. A three-day fasting test as an aid for deciding on treatment de-escalation in long-term diabetics. CASE REPORTS IN DIABETOLOGY. 2023;21(1):27-29,75.0,YR,,F,Y,,,20230505,,MD,CZ,CZ,2023,Q2,Elderly
222917981,22291798,84,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 iu, QID",,,,,,,,15.0,IU,,,2023,Q2,Colitis ischaemic,,2023,Q2,1,I,20230116.0,20230123.0,20230507,20230507,EXP,,US-JNJFOC-20230514512,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,106.59,KG,20230508,,MD,US,US,2023,Q2,Adult
222917981,22291798,84,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 iu, QID",,,,,,,,15.0,IU,,,2023,Q2,Gastrointestinal haemorrhage,,2023,Q2,1,I,20230116.0,20230123.0,20230507,20230507,EXP,,US-JNJFOC-20230514512,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,106.59,KG,20230508,,MD,US,US,2023,Q2,Adult
222930921,22293092,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,22 units approx,,,U,,,,,,,,,2023,Q2,Therapeutic product effect incomplete,,2023,Q2,1,I,,20230425.0,20230508,20230508,EXP,,CZ-AUROBINDO-AUR-APL-2023-034510,AUROBINDO,Pavlikova B. A three-day fasting test as an aid for deciding on treatment de-escalation in long-term diabetics. CASE REPORTS IN DIABETOLOGY. 2023;21(1):27-29,75.0,YR,,F,Y,,,20230508,,HP,CZ,CZ,2023,Q2,Elderly
222937181,22293718,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 dosage form (8 units before meals ),,,U,U,,,,,,Injection,,2023,Q2,Angioedema,,2023,Q2,1,I,,20230427.0,20230508,20230508,EXP,,US-MYLANLABS-2021M1074291,MYLAN,"Perman B, Narechania S, Malesker M. RECURRENT ANGIOEDEMA FOLLOWING ANGIOTENSIN CONVERTING ENZYME INHIBITOR DISCONTINUATION. Chest 2021;160 (Suppl.)(4):A691.",86.0,YR,,M,Y,,,20230508,,MD,US,US,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Pneumonia klebsiella,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Enterobacter pneumonia,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Candida pneumonia,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Klebsiella infection,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Lung disorder,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Drug interaction,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Pyrexia,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Dyspnoea,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Pulmonary toxicity,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(30-28-0),,,,,,,,,,Injection,BID,2023,Q2,Respiratory failure,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Pneumonia klebsiella,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Enterobacter pneumonia,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Candida pneumonia,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Klebsiella infection,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Lung disorder,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Drug interaction,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Pyrexia,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Dyspnoea,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Pulmonary toxicity,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222947782,22294778,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 SC according to KC,,,,,,,,,,Injection,,2023,Q2,Respiratory failure,,2023,Q2,2,F,20210101.0,20230510.0,20230508,20230515,EXP,,CZ-MYLANLABS-2023M1047662,MYLAN,Tisancinova J. Pulmonary toxicity of amiodarone and dronedarone. UNKNOWN. unk;unk:unk,67.0,YR,,M,Y,98.0,KG,20230515,,HP,CZ,CZ,2023,Q2,Elderly
222951992,22295199,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2023,Q2,Encephalopathy,,2023,Q2,2,F,20230324.0,20230505.0,20230508,20230510,EXP,,US-ROCHE-3342001,ROCHE,,85.0,YR,,F,Y,113.4,KG,20230510,,MD,US,,2023,Q2,Elderly
222977281,22297728,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS (8 units before meals),,,,,,,,,,,,2023,Q2,Angioedema,,2023,Q2,1,I,,20230427.0,20230509,20230509,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP006590,STRIDES,"Perman B, Narechania S, Malesker M.. Recurrent Angioedema Following Angiotensin Converting Enzyme Inhibitor Discontinuation.. Chest. 2021;160(4):A691.",86.0,YR,,M,Y,,,20230509,,MD,US,US,2023,Q2,Elderly
223022541,22302254,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, daily",,,U,,,,20563.0,,,Injection,QD,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230101.0,20230505.0,20230510,20230510,PER,,US-ELI_LILLY_AND_COMPANY-US202305004303,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20230510,,CN,US,US,2023,Q2,Adult
223022541,22302254,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, daily",,,U,,,,20563.0,,,Injection,QD,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230101.0,20230505.0,20230510,20230510,PER,,US-ELI_LILLY_AND_COMPANY-US202305004303,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20230510,,CN,US,US,2023,Q2,Adult
223022541,22302254,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, daily",,,U,,,,20563.0,,,Injection,QD,2023,Q2,Disturbance in attention,,2023,Q2,1,I,20230101.0,20230505.0,20230510,20230510,PER,,US-ELI_LILLY_AND_COMPANY-US202305004303,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20230510,,CN,US,US,2023,Q2,Adult
223032172,22303217,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,,,UNKNOWN,,,,,Unknown,,2023,Q2,Hyperglycaemia,,2023,Q2,2,F,20230407.0,20230525.0,20230510,20230609,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-23-01357,HIKMA,,18.0,YR,,M,Y,120.4,KG,20230609,,HP,US,US,2023,Q2,Youth
223036091,22303609,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Hospice care,,2023,Q2,1,I,,,20230509,20230509,DIR,FDA-CDER-CTU-2023-34602,,FDA-CTU,,78.0,YR,,M,N,80.74,KG,20230509,N,HP,US,,2023,Q2,Elderly
223036951,22303695,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,UNKNOWN,,,,,,,2023,Q2,Angioedema,,2023,Q2,1,I,,20230427.0,20230510,20230510,EXP,,US-drreddys-LIT/USA/23/0164658,DR REDDYS,"Perman B, Narechania S, Malesker M. Geriatric Pharmacotherapy Case Series: Recurrent Angioedema Following Discontinuation of ACE Inhibitor Therapy. Sr Care Pharm. 2023;38(1):16-20. doi:10.4140/TCP.n.2023.16",86.0,YR,E,M,Y,,,20230510,,HP,US,US,2023,Q2,Elderly
223068821,22306882,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Unknown,,2023,Q2,Death,,2023,Q2,1,I,20230508.0,20230509.0,20230511,20230511,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-066567,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,,,20230511,,HP,US,US,2023,Q2,Elderly
223122941,22312294,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,1,I,,20230509.0,20230512,20230512,EXP,,NVSC2023US106151,NOVARTIS,"Shahid D, Patruno M, Manessis A. Case Study: A Challenging Case of Management of Preexisting Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. ENDOCRINE PRACTICE. 2023;29:S23-S24",33.0,YR,,F,Y,,,20230512,,HP,US,US,2023,Q2,Young Adult
223122941,22312294,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Premature delivery,,2023,Q2,1,I,,20230509.0,20230512,20230512,EXP,,NVSC2023US106151,NOVARTIS,"Shahid D, Patruno M, Manessis A. Case Study: A Challenging Case of Management of Preexisting Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. ENDOCRINE PRACTICE. 2023;29:S23-S24",33.0,YR,,F,Y,,,20230512,,HP,US,US,2023,Q2,Young Adult
223122941,22312294,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Pre-eclampsia,,2023,Q2,1,I,,20230509.0,20230512,20230512,EXP,,NVSC2023US106151,NOVARTIS,"Shahid D, Patruno M, Manessis A. Case Study: A Challenging Case of Management of Preexisting Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. ENDOCRINE PRACTICE. 2023;29:S23-S24",33.0,YR,,F,Y,,,20230512,,HP,US,US,2023,Q2,Young Adult
223122941,22312294,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Maternal exposure before pregnancy,,2023,Q2,1,I,,20230509.0,20230512,20230512,EXP,,NVSC2023US106151,NOVARTIS,"Shahid D, Patruno M, Manessis A. Case Study: A Challenging Case of Management of Preexisting Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies. ENDOCRINE PRACTICE. 2023;29:S23-S24",33.0,YR,,F,Y,,,20230512,,HP,US,US,2023,Q2,Young Adult
223128921,22312892,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Rash macular,,2023,Q2,1,I,20230508.0,20230509.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305006137,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223128921,22312892,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Pruritus,,2023,Q2,1,I,20230508.0,20230509.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305006137,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Tooth fracture,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Weight decreased,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Toothache,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Tooth fracture,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Weight decreased,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Toothache,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,D518829A,,20563.0,120.0,IU,Injection,QD,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Tooth fracture,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Weight decreased,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Toothache,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Tooth fracture,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Weight decreased,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Toothache,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223150651,22315065,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"120 u, daily",,,,,,,20563.0,120.0,IU,Injection,QD,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230508.0,20230512,20230512,PER,,US-ELI_LILLY_AND_COMPANY-US202305004607,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20230512,,CN,US,US,2023,Q2,Adult
223152602,22315260,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 dosage form,,,,,,,,,,,,2023,Q2,Angioedema,,2023,Q2,2,F,,20230522.0,20230512,20230529,EXP,,US-TAKEDA-2021TUS063345,TAKEDA,"Perman B, Narechania S. Geriatric pharmacotherapy case series: recurrent angioedema following discontinuation of ace inhibitor therapy. THE SENIOR CARE PHARMACIST. 2023;38(1):16-20",86.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Elderly
223152602,22315260,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 dosage form,,,,,,,,,,,,2023,Q2,Off label use,,2023,Q2,2,F,,20230522.0,20230512,20230529,EXP,,US-TAKEDA-2021TUS063345,TAKEDA,"Perman B, Narechania S. Geriatric pharmacotherapy case series: recurrent angioedema following discontinuation of ace inhibitor therapy. THE SENIOR CARE PHARMACIST. 2023;38(1):16-20",86.0,YR,,M,Y,,,20230529,,MD,US,US,2023,Q2,Elderly
223153061,22315306,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223153061,22315306,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Pulmonary hypertension,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223153061,22315306,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,General physical condition abnormal,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223153061,22315306,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223153061,22315306,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q2,Tachyarrhythmia,,2023,Q2,1,I,20230414.0,20230504.0,20230512,20230512,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202305002683,ELI LILLY AND CO,,70.0,YR,,F,Y,122.0,KG,20230512,,CN,DE,DE,2023,Q2,Elderly
223182921,22318292,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q2,Blood glucose fluctuation,,2023,Q2,1,I,20220901.0,20230512.0,20230515,20230515,PER,,US-ELI_LILLY_AND_COMPANY-US202305007854,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20230515,,CN,US,US,2023,Q2,Adult
223182921,22318292,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q2,Drug ineffective,,2023,Q2,1,I,20220901.0,20230512.0,20230515,20230515,PER,,US-ELI_LILLY_AND_COMPANY-US202305007854,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20230515,,CN,US,US,2023,Q2,Adult
223182921,22318292,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q2,Weight increased,,2023,Q2,1,I,20220901.0,20230512.0,20230515,20230515,PER,,US-ELI_LILLY_AND_COMPANY-US202305007854,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20230515,,CN,US,US,2023,Q2,Adult
223182921,22318292,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q2,Glycosylated haemoglobin increased,,2023,Q2,1,I,20220901.0,20230512.0,20230515,20230515,PER,,US-ELI_LILLY_AND_COMPANY-US202305007854,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20230515,,CN,US,US,2023,Q2,Adult
223187673,22318767,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Asthenia,,2023,Q2,3,F,20230413.0,20230515.0,20230515,20230519,EXP,,CA-SA-2023SA147688,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Adult
223187673,22318767,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Post procedural complication,,2023,Q2,3,F,20230413.0,20230515.0,20230515,20230519,EXP,,CA-SA-2023SA147688,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Adult
223187673,22318767,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Diverticular perforation,,2023,Q2,3,F,20230413.0,20230515.0,20230515,20230519,EXP,,CA-SA-2023SA147688,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Adult
223187673,22318767,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Abdominal pain,,2023,Q2,3,F,20230413.0,20230515.0,20230515,20230519,EXP,,CA-SA-2023SA147688,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20230519,,MD,CA,CA,2023,Q2,Adult
223201081,22320108,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Product storage error,,2023,Q2,1,I,20230505.0,20230511.0,20230515,20230515,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305004358,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20230515,,CN,JP,JP,2023,Q2,Elderly
223201081,22320108,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Cerebral infarction,,2023,Q2,1,I,20230505.0,20230511.0,20230515,20230515,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305004358,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20230515,,CN,JP,JP,2023,Q2,Elderly
223210421,22321042,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223210421,22321042,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Pulmonary hypertension,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223210421,22321042,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Tachyarrhythmia,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223210421,22321042,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223210421,22321042,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,General physical condition abnormal,,2023,Q2,1,I,20230414.0,20230509.0,20230515,20230515,EXP,,DE-MYLANLABS-2023M1049674,MYLAN,,7.0,DEC,,F,Y,122.0,KG,20230515,,MD,DE,DE,2023,Q2,Child
223224641,22322464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,0-4 units qHS,,,,,,,,,,,/HR,2023,Q2,Blood phosphorus increased,,2023,Q2,1,I,20230426.0,20230511.0,20230516,20230516,EXP,,US-ABBVIE-4765572,ABBVIE,,66.0,YR,,M,Y,94.9,KG,20230516,,MD,US,US,2023,Q2,Elderly
223224641,22322464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,0-4 units qHS,,,,,,,,,,,/HR,2023,Q2,Blood uric acid increased,,2023,Q2,1,I,20230426.0,20230511.0,20230516,20230516,EXP,,US-ABBVIE-4765572,ABBVIE,,66.0,YR,,M,Y,94.9,KG,20230516,,MD,US,US,2023,Q2,Elderly
223224641,22322464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,0-4 units qHS,,,,,,,,,,,/HR,2023,Q2,Blood lactate dehydrogenase increased,,2023,Q2,1,I,20230426.0,20230511.0,20230516,20230516,EXP,,US-ABBVIE-4765572,ABBVIE,,66.0,YR,,M,Y,94.9,KG,20230516,,MD,US,US,2023,Q2,Elderly
223224641,22322464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,0-4 units qHS,,,,,,,,,,,/HR,2023,Q2,Blood creatinine increased,,2023,Q2,1,I,20230426.0,20230511.0,20230516,20230516,EXP,,US-ABBVIE-4765572,ABBVIE,,66.0,YR,,M,Y,94.9,KG,20230516,,MD,US,US,2023,Q2,Elderly
223224641,22322464,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Time Interval: 0.33333333 days: 0-5 units before meals,,,,,,,,,,,,2023,Q2,Blood phosphorus increased,,2023,Q2,1,I,20230426.0,20230511.0,20230516,20230516,EXP,,US-ABBVIE-4765572,ABBVIE,,66.0,YR,,M,Y,94.9,KG,20230516,,MD,US,US,2023,Q2,Elderly
223224641,22322464,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Time Interval: 0.33333333 days: 0-5 units before meals,,,,,,,,,,,,2023,Q2,Blood uric acid increased,,2023,Q2,1,I,20230426.0,20230511.0,20230516,20230516,EXP,,US-ABBVIE-4765572,ABBVIE,,66.0,YR,,M,Y,94.9,KG,20230516,,MD,US,US,2023,Q2,Elderly
223224641,22322464,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Time Interval: 0.33333333 days: 0-5 units before meals,,,,,,,,,,,,2023,Q2,Blood lactate dehydrogenase increased,,2023,Q2,1,I,20230426.0,20230511.0,20230516,20230516,EXP,,US-ABBVIE-4765572,ABBVIE,,66.0,YR,,M,Y,94.9,KG,20230516,,MD,US,US,2023,Q2,Elderly
223224641,22322464,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Time Interval: 0.33333333 days: 0-5 units before meals,,,,,,,,,,,,2023,Q2,Blood creatinine increased,,2023,Q2,1,I,20230426.0,20230511.0,20230516,20230516,EXP,,US-ABBVIE-4765572,ABBVIE,,66.0,YR,,M,Y,94.9,KG,20230516,,MD,US,US,2023,Q2,Elderly
223230711,22323071,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Application site pain,,2023,Q2,1,I,20230426.0,,20230512,20230512,DIR,659967,,FDA-CTU,,60.0,YR,,M,N,126.0,KG,20230512,N,CN,US,,2023,Q2,Adult
223230711,22323071,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Application site pain,,2023,Q2,1,I,20230426.0,,20230512,20230512,DIR,659967,,FDA-CTU,,60.0,YR,,M,N,126.0,KG,20230512,N,CN,US,,2023,Q2,Adult
223230711,22323071,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Recalled product administered,,2023,Q2,1,I,20230426.0,,20230512,20230512,DIR,659967,,FDA-CTU,,60.0,YR,,M,N,126.0,KG,20230512,N,CN,US,,2023,Q2,Adult
223230711,22323071,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Application site erythema,,2023,Q2,1,I,20230426.0,,20230512,20230512,DIR,659967,,FDA-CTU,,60.0,YR,,M,N,126.0,KG,20230512,N,CN,US,,2023,Q2,Adult
223237861,22323786,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Inadequate analgesia,,2023,Q2,1,I,20230414.0,,20230512,20230512,DIR,660043,,FDA-CTU,,76.0,YR,,F,N,103.5,KG,20230512,N,CN,US,,2023,Q2,Elderly
223237861,22323786,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Emotional distress,,2023,Q2,1,I,20230414.0,,20230512,20230512,DIR,660043,,FDA-CTU,,76.0,YR,,F,N,103.5,KG,20230512,N,CN,US,,2023,Q2,Elderly
223237861,22323786,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230414.0,,20230512,20230512,DIR,660043,,FDA-CTU,,76.0,YR,,F,N,103.5,KG,20230512,N,CN,US,,2023,Q2,Elderly
223237861,22323786,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Product dispensing error,,2023,Q2,1,I,20230414.0,,20230512,20230512,DIR,660043,,FDA-CTU,,76.0,YR,,F,N,103.5,KG,20230512,N,CN,US,,2023,Q2,Elderly
223237861,22323786,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Malaise,,2023,Q2,1,I,20230414.0,,20230512,20230512,DIR,660043,,FDA-CTU,,76.0,YR,,F,N,103.5,KG,20230512,N,CN,US,,2023,Q2,Elderly
223238922,22323892,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Interstitial lung disease,,2023,Q2,2,F,20230327.0,20230623.0,20230516,20230630,EXP,,IT-AstraZeneca-2023A106129,ASTRAZENECA,,77.0,YR,,F,Y,72.0,KG,20230630,,MD,IT,,2023,Q2,Elderly
223306651,22330665,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Pulmonary hypertension,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223306651,22330665,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Tachyarrhythmia,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223306651,22330665,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,General physical condition abnormal,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223306651,22330665,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Anaemia,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223306651,22330665,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q2,Renal impairment,,2023,Q2,1,I,20230414.0,20230504.0,20230517,20230517,EXP,,DE-AUROBINDO-AUR-APL-2023-035769,AUROBINDO,,7.0,DEC,,F,Y,122.0,KG,20230517,,MD,DE,DE,2023,Q2,Child
223321291,22332129,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Renal transplant,,2023,Q2,1,I,20230503.0,,20230516,20230516,DIR,660366,,FDA-CTU,,20.0,YR,,F,N,,,20230516,N,PH,US,,2023,Q2,Youth
223321291,22332129,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Renal failure,,2023,Q2,1,I,20230503.0,,20230516,20230516,DIR,660366,,FDA-CTU,,20.0,YR,,F,N,,,20230516,N,PH,US,,2023,Q2,Youth
223321291,22332129,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Heart transplant,,2023,Q2,1,I,20230503.0,,20230516,20230516,DIR,660366,,FDA-CTU,,20.0,YR,,F,N,,,20230516,N,PH,US,,2023,Q2,Youth
223334301,22333430,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, 1X",,,D,,,,,,,Solution for injection,1X,2023,Q2,Visual impairment,,2023,Q2,1,I,20230101.0,20230515.0,20230517,20230517,PER,,US-SA-2023SA151347,SANOFI AVENTIS,,64.0,YR,E,F,Y,,,20230517,,CN,US,US,2023,Q2,Adult
223334301,22333430,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, 1X",,,D,,,,,,,Solution for injection,1X,2023,Q2,Wrong product administered,,2023,Q2,1,I,20230101.0,20230515.0,20230517,20230517,PER,,US-SA-2023SA151347,SANOFI AVENTIS,,64.0,YR,E,F,Y,,,20230517,,CN,US,US,2023,Q2,Adult
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Syncope,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Fall,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Pain in extremity,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Pulmonary arterial hypertension,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Pericardial effusion,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Scratch,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Dysphagia,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Subarachnoid haemorrhage,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Gastrointestinal haemorrhage,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Haemoglobin decreased,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Disease progression,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Troponin T,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Pleural effusion,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Blood pressure increased,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Tachycardia,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Headache,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Rib fracture,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Arthritis,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223336421,22333642,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q2,Brain natriuretic peptide abnormal,,2023,Q2,1,I,20181209.0,20230510.0,20230517,20230517,EXP,,SE-JNJFOC-A-CH2018-183636,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,80.0,KG,20230517,,MD,SE,SE,2023,Q2,Elderly
223403611,22340361,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),As necessary,,,Y,,,,,15.0,ML,,,2023,Q2,Sepsis,,2023,Q2,1,I,20170509.0,20230512.0,20230518,20230518,EXP,,US-TAKEDA-US-002469,TAKEDA,,58.0,YR,,F,Y,98.0,KG,20230518,,HP,US,US,2023,Q2,Adult
223411921,22341192,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484039C,,,,,Injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484039C,,,,,Injection,,2023,Q2,Product storage error,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484039C,,,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484039C,,,,,Injection,,2023,Q2,Cough,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484039C,,,,,Injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484039C,,,,,Injection,,2023,Q2,Product storage error,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484039C,,,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484039C,,,,,Injection,,2023,Q2,Cough,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,,,,Injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,,,,Injection,,2023,Q2,Product storage error,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,,,,Injection,,2023,Q2,Cough,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,,,,Injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,,,,Injection,,2023,Q2,Product storage error,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,,,,Injection,,2023,Q2,Cough,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Product storage error,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Cough,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Product storage error,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Cough,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Seasonal allergy,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Product storage error,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223411921,22341192,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q2,Cough,,2023,Q2,1,I,20230401.0,20230516.0,20230518,20230518,PER,,US-ELI_LILLY_AND_COMPANY-US202305009600,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230518,,CN,US,US,2023,Q2,Elderly
223412381,22341238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,1,I,,20230507.0,20230518,20230518,EXP,,US-ELI_LILLY_AND_COMPANY-US202305008329,ELI LILLY AND CO,"Daiena Shahid, Maria Patruno, Anastasios Manessis..Abstract #1407760: Case Study: A Challenging Case of Management of Pre-existing Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies..Endocrine Practice Conference 2023;29(5Supplement):(ppS23-S24).DOI:https://doi.org/10.1016/j.eprac.2023.03.056",33.0,YR,,F,Y,,,20230518,,HP,US,US,2023,Q2,Young Adult
223412381,22341238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,1,I,,20230507.0,20230518,20230518,EXP,,US-ELI_LILLY_AND_COMPANY-US202305008329,ELI LILLY AND CO,"Daiena Shahid, Maria Patruno, Anastasios Manessis..Abstract #1407760: Case Study: A Challenging Case of Management of Pre-existing Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies..Endocrine Practice Conference 2023;29(5Supplement):(ppS23-S24).DOI:https://doi.org/10.1016/j.eprac.2023.03.056",33.0,YR,,F,Y,,,20230518,,HP,US,US,2023,Q2,Young Adult
223412381,22341238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2023,Q2,Pre-eclampsia,,2023,Q2,1,I,,20230507.0,20230518,20230518,EXP,,US-ELI_LILLY_AND_COMPANY-US202305008329,ELI LILLY AND CO,"Daiena Shahid, Maria Patruno, Anastasios Manessis..Abstract #1407760: Case Study: A Challenging Case of Management of Pre-existing Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies..Endocrine Practice Conference 2023;29(5Supplement):(ppS23-S24).DOI:https://doi.org/10.1016/j.eprac.2023.03.056",33.0,YR,,F,Y,,,20230518,,HP,US,US,2023,Q2,Young Adult
223412381,22341238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2023,Q2,Drug hypersensitivity,,2023,Q2,1,I,,20230507.0,20230518,20230518,EXP,,US-ELI_LILLY_AND_COMPANY-US202305008329,ELI LILLY AND CO,"Daiena Shahid, Maria Patruno, Anastasios Manessis..Abstract #1407760: Case Study: A Challenging Case of Management of Pre-existing Type 2 Diabetes Mellitus During Pregnancy in a Patient with Multiple Insulin Allergies..Endocrine Practice Conference 2023;29(5Supplement):(ppS23-S24).DOI:https://doi.org/10.1016/j.eprac.2023.03.056",33.0,YR,,F,Y,,,20230518,,HP,US,US,2023,Q2,Young Adult
223426921,22342692,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, tid",,,,,D518832D,,,,,Injection,TID,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230517.0,20230518.0,20230519,20230519,PER,,US-ELI_LILLY_AND_COMPANY-US202305011119,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20230519,,CN,US,US,2023,Q2,Elderly
223426921,22342692,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, tid",,,,,,,,,,Injection,TID,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230517.0,20230518.0,20230519,20230519,PER,,US-ELI_LILLY_AND_COMPANY-US202305011119,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20230519,,CN,US,US,2023,Q2,Elderly
223435691,22343569,3,C,INSULIN 75/25 LISPRO PEN,,2,,,,,U,,,,,,,,,2023,Q2,Swelling,,2023,Q2,1,I,,20230508.0,20230519,20230519,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-065940,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,80.6,KG,20230519,,PH,US,US,2023,Q2,Adult
223436174,22343617,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Sepsis,,2023,Q2,4,F,20230417.0,20230529.0,20230519,20230531,EXP,,CN-ROCHE-3334770,ROCHE,,59.0,YR,,M,Y,81.0,KG,20230531,,MD,CN,,2023,Q2,Adult
223436174,22343617,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Fungal infection,,2023,Q2,4,F,20230417.0,20230529.0,20230519,20230531,EXP,,CN-ROCHE-3334770,ROCHE,,59.0,YR,,M,Y,81.0,KG,20230531,,MD,CN,,2023,Q2,Adult
223436174,22343617,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,COVID-19 pneumonia,,2023,Q2,4,F,20230417.0,20230529.0,20230519,20230531,EXP,,CN-ROCHE-3334770,ROCHE,,59.0,YR,,M,Y,81.0,KG,20230531,,MD,CN,,2023,Q2,Adult
223436174,22343617,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q2,Platelet count decreased,,2023,Q2,4,F,20230417.0,20230529.0,20230519,20230531,EXP,,CN-ROCHE-3334770,ROCHE,,59.0,YR,,M,Y,81.0,KG,20230531,,MD,CN,,2023,Q2,Adult
223502261,22350226,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230401.0,20230519.0,20230522,20230522,PER,,US-ELI_LILLY_AND_COMPANY-US202305012406,ELI LILLY AND CO,,55.0,YR,,,Y,,,20230522,,CN,US,US,2023,Q2,Adult
223502261,22350226,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Irritability,,2023,Q2,1,I,20230401.0,20230519.0,20230522,20230522,PER,,US-ELI_LILLY_AND_COMPANY-US202305012406,ELI LILLY AND CO,,55.0,YR,,,Y,,,20230522,,CN,US,US,2023,Q2,Adult
223502261,22350226,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2023,Q2,Visual impairment,,2023,Q2,1,I,20230401.0,20230519.0,20230522,20230522,PER,,US-ELI_LILLY_AND_COMPANY-US202305012406,ELI LILLY AND CO,,55.0,YR,,,Y,,,20230522,,CN,US,US,2023,Q2,Adult
223502261,22350226,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594620C,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230401.0,20230519.0,20230522,20230522,PER,,US-ELI_LILLY_AND_COMPANY-US202305012406,ELI LILLY AND CO,,55.0,YR,,,Y,,,20230522,,CN,US,US,2023,Q2,Adult
223502261,22350226,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594620C,,20563.0,,,Solution for injection,,2023,Q2,Irritability,,2023,Q2,1,I,20230401.0,20230519.0,20230522,20230522,PER,,US-ELI_LILLY_AND_COMPANY-US202305012406,ELI LILLY AND CO,,55.0,YR,,,Y,,,20230522,,CN,US,US,2023,Q2,Adult
223502261,22350226,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594620C,,20563.0,,,Solution for injection,,2023,Q2,Visual impairment,,2023,Q2,1,I,20230401.0,20230519.0,20230522,20230522,PER,,US-ELI_LILLY_AND_COMPANY-US202305012406,ELI LILLY AND CO,,55.0,YR,,,Y,,,20230522,,CN,US,US,2023,Q2,Adult
223510311,22351031,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Fatigue,,2023,Q2,1,I,,,20230520,20230520,DIR,FDA-CDER-CTU-2023-37932,,FDA-CTU,,62.0,YR,,M,N,88.45,KG,20230520,N,,US,,2023,Q2,Adult
223510311,22351031,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,,20230520,20230520,DIR,FDA-CDER-CTU-2023-37932,,FDA-CTU,,62.0,YR,,M,N,88.45,KG,20230520,N,,US,,2023,Q2,Adult
223538381,22353838,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,U,,D584203D,,21017.0,20.0,IU,Injection,QD,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230520.0,20230522.0,20230523,20230523,PER,,US-ELI_LILLY_AND_COMPANY-US202305013063,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20230523,,CN,US,US,2023,Q2,Adult
223545141,22354514,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Blindness unilateral,,2023,Q2,1,I,20230416.0,,20230522,20230522,DIR,661023,,FDA-CTU,,57.0,YR,,F,N,,,20230522,,CN,US,,2023,Q2,Adult
223545141,22354514,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Cerebrovascular accident,,2023,Q2,1,I,20230416.0,,20230522,20230522,DIR,661023,,FDA-CTU,,57.0,YR,,F,N,,,20230522,,CN,US,,2023,Q2,Adult
223577932,22357793,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,2,F,20230501.0,20230522.0,20230524,20230528,PER,,US-AMGEN-USASP2023088529,AMGEN,,66.0,YR,E,F,Y,,,20230528,,HP,US,US,2023,Q2,Elderly
223577932,22357793,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Nausea,,2023,Q2,2,F,20230501.0,20230522.0,20230524,20230528,PER,,US-AMGEN-USASP2023088529,AMGEN,,66.0,YR,E,F,Y,,,20230528,,HP,US,US,2023,Q2,Elderly
223577932,22357793,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Abdominal discomfort,,2023,Q2,2,F,20230501.0,20230522.0,20230524,20230528,PER,,US-AMGEN-USASP2023088529,AMGEN,,66.0,YR,E,F,Y,,,20230528,,HP,US,US,2023,Q2,Elderly
223671912,22367191,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Live birth,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223671912,22367191,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Urticaria,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223671912,22367191,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Drug hypersensitivity,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223671912,22367191,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Dyspnoea,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223671912,22367191,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,2,F,,20230601.0,20230525,20230604,EXP,,US-TEVA-2023-US-2889315,TEVA,,33.0,YR,A,F,Y,,,20230604,,HP,US,US,2023,Q2,Young Adult
223705831,22370583,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230524.0,20230526,20230526,PER,,US-SA-2023SA161486,SANOFI AVENTIS,,50.0,YR,A,M,Y,,,20230526,,CN,US,US,2023,Q2,Adult
223710742,22371074,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Upper respiratory tract infection,,2023,Q2,2,F,20220801.0,20230601.0,20230526,20230607,EXP,,US-UCBSA-2023025830,UCB,,58.0,YR,,F,Y,126.98,KG,20230607,,HP,US,US,2023,Q2,Adult
223710742,22371074,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Ear infection,,2023,Q2,2,F,20220801.0,20230601.0,20230526,20230607,EXP,,US-UCBSA-2023025830,UCB,,58.0,YR,,F,Y,126.98,KG,20230607,,HP,US,US,2023,Q2,Adult
223710742,22371074,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Rheumatoid arthritis,,2023,Q2,2,F,20220801.0,20230601.0,20230526,20230607,EXP,,US-UCBSA-2023025830,UCB,,58.0,YR,,F,Y,126.98,KG,20230607,,HP,US,US,2023,Q2,Adult
223710742,22371074,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Neuropathy peripheral,,2023,Q2,2,F,20220801.0,20230601.0,20230526,20230607,EXP,,US-UCBSA-2023025830,UCB,,58.0,YR,,F,Y,126.98,KG,20230607,,HP,US,US,2023,Q2,Adult
223710742,22371074,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,COVID-19,,2023,Q2,2,F,20220801.0,20230601.0,20230526,20230607,EXP,,US-UCBSA-2023025830,UCB,,58.0,YR,,F,Y,126.98,KG,20230607,,HP,US,US,2023,Q2,Adult
223710742,22371074,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Urinary tract infection,,2023,Q2,2,F,20220801.0,20230601.0,20230526,20230607,EXP,,US-UCBSA-2023025830,UCB,,58.0,YR,,F,Y,126.98,KG,20230607,,HP,US,US,2023,Q2,Adult
223710742,22371074,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q2,Drug ineffective,,2023,Q2,2,F,20220801.0,20230601.0,20230526,20230607,EXP,,US-UCBSA-2023025830,UCB,,58.0,YR,,F,Y,126.98,KG,20230607,,HP,US,US,2023,Q2,Adult
223728421,22372842,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Malignant melanoma,,2023,Q2,1,I,20210330.0,20230516.0,20230526,20230526,EXP,,IT-TAKEDA-2023TUS051696,TAKEDA,,74.0,YR,,F,Y,,,20230526,,MD,IT,IT,2023,Q2,Elderly
223771291,22377129,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Off label use,,2023,Q2,1,I,,20230523.0,20230529,20230529,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-073926,BRISTOL MYERS SQUIBB,,50.0,YR,A,F,Y,,,20230529,,MD,US,US,2023,Q2,Adult
223792521,22379252,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML KWIKPEN 3 ML,,,U,,,,,,,,,2023,Q2,Cytopenia,,2023,Q2,1,I,20230501.0,20230524.0,20230529,20230529,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-073686,BRISTOL MYERS SQUIBB,,71.0,YR,E,F,Y,92.53,KG,20230529,,PH,US,US,2023,Q2,Elderly
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Hepatomegaly,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Abdominal discomfort,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Cold sweat,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Fatigue,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Decreased appetite,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Diabetic hepatopathy,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Pain,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Somnolence,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Palpitations,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Intentional overdose,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2023,Q2,Tachycardia,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Hepatomegaly,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Abdominal discomfort,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Cold sweat,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Fatigue,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Decreased appetite,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Diabetic hepatopathy,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Abdominal pain upper,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Pain,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Somnolence,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Palpitations,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Intentional overdose,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223802721,22380272,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,21000 U,,,U,,,,,,,Solution for injection,,2023,Q2,Tachycardia,,2023,Q2,1,I,,20230522.0,20230529,20230529,EXP,,JP-SA-2023SA157871,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20230529,,MD,JP,JP,2023,Q2,Young Adult
223818961,22381896,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 dosage form, Once a Day,4 U/die.",,,U,,,,,,,,QD,2023,Q2,Diarrhoea,,2023,Q2,1,I,20230101.0,20230520.0,20230530,20230530,EXP,,IT-AUROBINDO-AUR-APL-2023-038578,AUROBINDO,,54.0,YR,,M,Y,67.0,KG,20230530,,PH,IT,IT,2023,Q2,Adult
223818961,22381896,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 dosage form, Once a Day,4 U/die.",,,U,,,,,,,,QD,2023,Q2,Asthenia,,2023,Q2,1,I,20230101.0,20230520.0,20230530,20230530,EXP,,IT-AUROBINDO-AUR-APL-2023-038578,AUROBINDO,,54.0,YR,,M,Y,67.0,KG,20230530,,PH,IT,IT,2023,Q2,Adult
223818961,22381896,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 dosage form, Once a Day,4 U/die.",,,U,,,,,,,,QD,2023,Q2,Transaminases increased,,2023,Q2,1,I,20230101.0,20230520.0,20230530,20230530,EXP,,IT-AUROBINDO-AUR-APL-2023-038578,AUROBINDO,,54.0,YR,,M,Y,67.0,KG,20230530,,PH,IT,IT,2023,Q2,Adult
223818961,22381896,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 dosage form, Once a Day,4 U/die.",,,U,,,,,,,,QD,2023,Q2,Mucosal inflammation,,2023,Q2,1,I,20230101.0,20230520.0,20230530,20230530,EXP,,IT-AUROBINDO-AUR-APL-2023-038578,AUROBINDO,,54.0,YR,,M,Y,67.0,KG,20230530,,PH,IT,IT,2023,Q2,Adult
223818961,22381896,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 dosage form, Once a Day,4 U/die.",,,U,,,,,,,,QD,2023,Q2,Neurotoxicity,,2023,Q2,1,I,20230101.0,20230520.0,20230530,20230530,EXP,,IT-AUROBINDO-AUR-APL-2023-038578,AUROBINDO,,54.0,YR,,M,Y,67.0,KG,20230530,,PH,IT,IT,2023,Q2,Adult
223828271,22382827,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Facial bones fracture,,2023,Q2,1,I,20230511.0,20230522.0,20230530,20230530,EXP,,US-MYLANLABS-2023M1055121,MYLAN,,44.0,YR,,M,Y,54.88,KG,20230530,,MD,US,US,2023,Q2,Adult
223828271,22382827,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230511.0,20230522.0,20230530,20230530,EXP,,US-MYLANLABS-2023M1055121,MYLAN,,44.0,YR,,M,Y,54.88,KG,20230530,,MD,US,US,2023,Q2,Adult
223828271,22382827,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hospitalisation,,2023,Q2,1,I,20230511.0,20230522.0,20230530,20230530,EXP,,US-MYLANLABS-2023M1055121,MYLAN,,44.0,YR,,M,Y,54.88,KG,20230530,,MD,US,US,2023,Q2,Adult
223828271,22382827,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hallucination,,2023,Q2,1,I,20230511.0,20230522.0,20230530,20230530,EXP,,US-MYLANLABS-2023M1055121,MYLAN,,44.0,YR,,M,Y,54.88,KG,20230530,,MD,US,US,2023,Q2,Adult
223829061,22382906,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Vomiting,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,CA-JNJFOC-20230566632,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,81.0,KG,20230530,,HP,CA,CA,2023,Q2,Elderly
223829061,22382906,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,CA-JNJFOC-20230566632,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,81.0,KG,20230530,,HP,CA,CA,2023,Q2,Elderly
223829061,22382906,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Condition aggravated,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,CA-JNJFOC-20230566632,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,81.0,KG,20230530,,HP,CA,CA,2023,Q2,Elderly
223829061,22382906,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Nausea,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,CA-JNJFOC-20230566632,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,81.0,KG,20230530,,HP,CA,CA,2023,Q2,Elderly
223829061,22382906,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q2,Arthralgia,,2023,Q2,1,I,,20230524.0,20230530,20230530,EXP,,CA-JNJFOC-20230566632,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,81.0,KG,20230530,,HP,CA,CA,2023,Q2,Elderly
223841951,22384195,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,,,,,,8.0,IU,,TID,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,1,I,,20230518.0,20230530,20230530,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305012648,ELI LILLY AND CO,Kawahara J..Acute-onset type 1 diabetes mellitus during insulin therapy for type 2 diabetes mellitus.Japanese Journal of Hospital General Medicine 2022;18(5):364-369.,35.0,YR,,F,Y,,,20230530,,MD,JP,JP,2023,Q2,Adult
223841951,22384195,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,,,,,,8.0,IU,,TID,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,,20230518.0,20230530,20230530,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305012648,ELI LILLY AND CO,Kawahara J..Acute-onset type 1 diabetes mellitus during insulin therapy for type 2 diabetes mellitus.Japanese Journal of Hospital General Medicine 2022;18(5):364-369.,35.0,YR,,F,Y,,,20230530,,MD,JP,JP,2023,Q2,Adult
223841951,22384195,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,,,,,,8.0,IU,,TID,2023,Q2,Type 1 diabetes mellitus,,2023,Q2,1,I,,20230518.0,20230530,20230530,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305012648,ELI LILLY AND CO,Kawahara J..Acute-onset type 1 diabetes mellitus during insulin therapy for type 2 diabetes mellitus.Japanese Journal of Hospital General Medicine 2022;18(5):364-369.,35.0,YR,,F,Y,,,20230530,,MD,JP,JP,2023,Q2,Adult
223841951,22384195,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 international unit, tid",,,,,,,,10.0,IU,,TID,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,1,I,,20230518.0,20230530,20230530,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305012648,ELI LILLY AND CO,Kawahara J..Acute-onset type 1 diabetes mellitus during insulin therapy for type 2 diabetes mellitus.Japanese Journal of Hospital General Medicine 2022;18(5):364-369.,35.0,YR,,F,Y,,,20230530,,MD,JP,JP,2023,Q2,Adult
223841951,22384195,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 international unit, tid",,,,,,,,10.0,IU,,TID,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,,20230518.0,20230530,20230530,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305012648,ELI LILLY AND CO,Kawahara J..Acute-onset type 1 diabetes mellitus during insulin therapy for type 2 diabetes mellitus.Japanese Journal of Hospital General Medicine 2022;18(5):364-369.,35.0,YR,,F,Y,,,20230530,,MD,JP,JP,2023,Q2,Adult
223841951,22384195,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 international unit, tid",,,,,,,,10.0,IU,,TID,2023,Q2,Type 1 diabetes mellitus,,2023,Q2,1,I,,20230518.0,20230530,20230530,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305012648,ELI LILLY AND CO,Kawahara J..Acute-onset type 1 diabetes mellitus during insulin therapy for type 2 diabetes mellitus.Japanese Journal of Hospital General Medicine 2022;18(5):364-369.,35.0,YR,,F,Y,,,20230530,,MD,JP,JP,2023,Q2,Adult
223861632,22386163,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, tid (8-8-8 U)",,,Y,,,,,24.0,IU,,QD,2023,Q2,Lipids increased,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, tid (8-8-8 U)",,,Y,,,,,24.0,IU,,QD,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, tid (8-8-8 U)",,,Y,,,,,24.0,IU,,QD,2023,Q2,Diabetes mellitus,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, tid (8-8-8 U)",,,Y,,,,,24.0,IU,,QD,2023,Q2,Hypertension,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, tid (8-8-8 U)",,,Y,,,,,24.0,IU,,QD,2023,Q2,Weight increased,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q2,Lipids increased,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q2,Diabetes mellitus,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q2,Hypertension,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223861632,22386163,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2023,Q2,Weight increased,,2023,Q2,2,F,20161001.0,20230601.0,20230530,20230605,EXP,,CZ-BAUSCH-BL-2023-007905,BAUSCH AND LOMB,Maule P. Xultophy-mnohocetna efektivita v jedne denni davce. Kazuistiky V Diabetologii. 2023 JAN;21(1):18-21.,71.0,YR,,M,Y,98.0,KG,20230605,,MD,CZ,CZ,2023,Q2,Elderly
223864271,22386427,16,C,Insulin lispro bs,,2,Oral,,,,,,,,,,,Injection,,2023,Q2,Off label use,,2023,Q2,1,I,20230206.0,20230517.0,20230531,20230531,EXP,,JP-AMGEN-JPNSP2023090505,AMGEN,,82.0,YR,E,M,Y,76.0,KG,20230530,,PH,JP,JP,2023,Q2,Elderly
223864271,22386427,16,C,Insulin lispro bs,,2,Oral,,,,,,,,,,,Injection,,2023,Q2,Drug-induced liver injury,,2023,Q2,1,I,20230206.0,20230517.0,20230531,20230531,EXP,,JP-AMGEN-JPNSP2023090505,AMGEN,,82.0,YR,E,M,Y,76.0,KG,20230530,,PH,JP,JP,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Essential hypertension,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Cataract nuclear,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Thrombocytopenia,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Immune thrombocytopenia,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Hyperlipidaemia,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Cataract diabetic,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Deafness neurosensory,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Splenomegaly,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223906851,22390685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Insulin-requiring type 2 diabetes mellitus,,2023,Q2,1,I,20131114.0,20230524.0,20230531,20230531,EXP,,US-ABBVIE-5185553,ABBVIE,,68.0,YR,,M,Y,,,20230531,,MD,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Neutrophil count decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Pyrexia,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Aspartate aminotransferase increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood urea increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Carbon dioxide decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Cytokine release syndrome,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood lactate dehydrogenase decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Prothrombin time shortened,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood uric acid decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood sodium decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood chloride decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Infection,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Haematocrit decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Red blood cell count decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood fibrinogen increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,C-reactive protein increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Lymphocyte count decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Basophil count increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Monocyte count increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood bilirubin decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood alkaline phosphatase increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood potassium increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood calcium decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Eosinophil count increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Neutrophil count increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Interleukin level increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Lymphocyte count increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Fibrin D dimer increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Blood fibrinogen decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Mean platelet volume decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Alanine aminotransferase increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Haemoglobin decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,White blood cell count decreased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223910793,22391079,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (TIDAC+HS),,,U,,,,,,,Injection,,2023,Q2,Band neutrophil percentage increased,,2023,Q2,3,F,20230306.0,20230622.0,20230601,20230629,PER,,NVSC2023US122124,NOVARTIS,,76.0,YR,,F,Y,64.0,KG,20230629,,HP,US,US,2023,Q2,Elderly
223912851,22391285,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Swelling face,,2023,Q2,1,I,20230401.0,20230526.0,20230601,20230601,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-075042,BRISTOL MYERS SQUIBB,,59.0,YR,A,F,Y,87.5,KG,20230601,,CN,US,US,2023,Q2,Adult
223912851,22391285,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Pneumonia,,2023,Q2,1,I,20230401.0,20230526.0,20230601,20230601,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-075042,BRISTOL MYERS SQUIBB,,59.0,YR,A,F,Y,87.5,KG,20230601,,CN,US,US,2023,Q2,Adult
223915501,22391550,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Adverse event,,2023,Q2,1,I,,20230525.0,20230601,20230601,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-077066,BRISTOL MYERS SQUIBB,,64.0,YR,A,M,Y,,,20230601,,CN,US,US,2023,Q2,Adult
223921863,22392186,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Device issue,,2023,Q2,3,F,,20230615.0,20230601,20230626,30DAY,,US-PFIZER INC-202300203511,PFIZER,,14.0,YR,,M,Y,56.69,KG,20230626,,CN,US,US,2023,Q2,Youth
223921863,22392186,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Device delivery system issue,,2023,Q2,3,F,,20230615.0,20230601,20230626,30DAY,,US-PFIZER INC-202300203511,PFIZER,,14.0,YR,,M,Y,56.69,KG,20230626,,CN,US,US,2023,Q2,Youth
223921863,22392186,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q2,Device leakage,,2023,Q2,3,F,,20230615.0,20230601,20230626,30DAY,,US-PFIZER INC-202300203511,PFIZER,,14.0,YR,,M,Y,56.69,KG,20230626,,CN,US,US,2023,Q2,Youth
223989281,22398928,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,20563.0,,,,,2023,Q2,Enterocutaneous fistula,,2023,Q2,1,I,,20230523.0,20230602,20230602,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305015390,ELI LILLY AND CO,"Togashi H,et al..A case of insulin antibody-positive type 2 diabetes mellitus in which dulaglutide was effective against blood sugar fluctuations.Diabetes 2023;66(S):S261.",93.0,YR,,F,Y,,,20230602,,MD,JP,JP,2023,Q2,Elderly
223989281,22398928,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,20563.0,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,1,I,,20230523.0,20230602,20230602,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305015390,ELI LILLY AND CO,"Togashi H,et al..A case of insulin antibody-positive type 2 diabetes mellitus in which dulaglutide was effective against blood sugar fluctuations.Diabetes 2023;66(S):S261.",93.0,YR,,F,Y,,,20230602,,MD,JP,JP,2023,Q2,Elderly
223989281,22398928,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,20563.0,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20230523.0,20230602,20230602,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305015390,ELI LILLY AND CO,"Togashi H,et al..A case of insulin antibody-positive type 2 diabetes mellitus in which dulaglutide was effective against blood sugar fluctuations.Diabetes 2023;66(S):S261.",93.0,YR,,F,Y,,,20230602,,MD,JP,JP,2023,Q2,Elderly
223989281,22398928,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,20563.0,,,,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,,20230523.0,20230602,20230602,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202305015390,ELI LILLY AND CO,"Togashi H,et al..A case of insulin antibody-positive type 2 diabetes mellitus in which dulaglutide was effective against blood sugar fluctuations.Diabetes 2023;66(S):S261.",93.0,YR,,F,Y,,,20230602,,MD,JP,JP,2023,Q2,Elderly
223991821,22399182,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"50 international unit, daily",,,Y,,202112016,,20563.0,50.0,IU,,QD,2023,Q2,Seizure,,2023,Q2,1,I,20230516.0,20230524.0,20230602,20230602,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202305014940,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230602,,CN,CN,CN,2023,Q2,Elderly
223991821,22399182,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2023,Q2,Seizure,,2023,Q2,1,I,20230516.0,20230524.0,20230602,20230602,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202305014940,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20230602,,CN,CN,CN,2023,Q2,Elderly
223996351,22399635,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,,QD,2023,Q2,Vomiting,,2023,Q2,1,I,20230413.0,20230523.0,20230602,20230602,EXP,IT-MINISAL02-926070,IT-ELI_LILLY_AND_COMPANY-IT202305013344,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230602,,CN,IT,IT,2023,Q2,Elderly
223996351,22399635,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,,QD,2023,Q2,Asthenia,,2023,Q2,1,I,20230413.0,20230523.0,20230602,20230602,EXP,IT-MINISAL02-926070,IT-ELI_LILLY_AND_COMPANY-IT202305013344,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230602,,CN,IT,IT,2023,Q2,Elderly
223996351,22399635,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,,QD,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230413.0,20230523.0,20230602,20230602,EXP,IT-MINISAL02-926070,IT-ELI_LILLY_AND_COMPANY-IT202305013344,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230602,,CN,IT,IT,2023,Q2,Elderly
225205481,22520548,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",528.0,IU,Y,,,,20563.0,16.0,IU,Solution for injection,TID,2023,Q2,Hypoglycaemic coma,,2023,Q2,1,I,20230511.0,20230526.0,20230605,20230605,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202305016829,ELI LILLY AND CO,,79.0,YR,,F,Y,55.0,KG,20230605,,CN,CN,CN,2023,Q2,Elderly
225225022,22522502,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units in the morning, 4 units in the afternoon, 6 units in the evening, and 0 units before going t",,,U,,,,,,,,,2023,Q2,Blood pressure decreased,,2023,Q2,2,F,,20230619.0,20230605,20230623,EXP,,NVSJ2023JP008750,NOVARTIS,,52.0,YR,,M,Y,52.0,KG,20230622,,MD,JP,JP,2023,Q2,Adult
225230831,22523083,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,unk,,,U,,,,,,,Solution for injection,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230428.0,20230601.0,20230606,20230606,EXP,IT-MINISAL02-927049,IT-SA-2023SA171051,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20230606,,MD,IT,IT,2023,Q2,Elderly
225230831,22523083,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,unk,,,U,,,,,,,Solution for injection,,2023,Q2,Syncope,,2023,Q2,1,I,20230428.0,20230601.0,20230606,20230606,EXP,IT-MINISAL02-927049,IT-SA-2023SA171051,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20230606,,MD,IT,IT,2023,Q2,Elderly
225256131,22525613,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Serum ferritin increased,,2023,Q2,1,I,20230201.0,,20230605,20230605,DIR,662429,,FDA-CTU,,70.0,YR,,M,N,109.8,KG,20230605,Y,,US,,2023,Q2,Elderly
225256131,22525613,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Immune effector cell-associated neurotoxicity syndrome,,2023,Q2,1,I,20230201.0,,20230605,20230605,DIR,662429,,FDA-CTU,,70.0,YR,,M,N,109.8,KG,20230605,Y,,US,,2023,Q2,Elderly
225256131,22525613,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Atrial fibrillation,,2023,Q2,1,I,20230201.0,,20230605,20230605,DIR,662429,,FDA-CTU,,70.0,YR,,M,N,109.8,KG,20230605,Y,,US,,2023,Q2,Elderly
225256131,22525613,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Cytokine release syndrome,,2023,Q2,1,I,20230201.0,,20230605,20230605,DIR,662429,,FDA-CTU,,70.0,YR,,M,N,109.8,KG,20230605,Y,,US,,2023,Q2,Elderly
225358601,22535860,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNKNOWN,,,,,Unknown,,2023,Q2,Diarrhoea,,2023,Q2,1,I,20230101.0,20230526.0,20230608,20230608,EXP,IT-MINISAL02-925662,IT-Hikma Pharmaceuticals USA Inc.-IT-H14001-23-62384,HIKMA,,54.0,YR,,M,Y,67.0,KG,20230608,,PH,IT,IT,2023,Q2,Adult
225358601,22535860,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNKNOWN,,,,,Unknown,,2023,Q2,Asthenia,,2023,Q2,1,I,20230101.0,20230526.0,20230608,20230608,EXP,IT-MINISAL02-925662,IT-Hikma Pharmaceuticals USA Inc.-IT-H14001-23-62384,HIKMA,,54.0,YR,,M,Y,67.0,KG,20230608,,PH,IT,IT,2023,Q2,Adult
225358601,22535860,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNKNOWN,,,,,Unknown,,2023,Q2,Neurotoxicity,,2023,Q2,1,I,20230101.0,20230526.0,20230608,20230608,EXP,IT-MINISAL02-925662,IT-Hikma Pharmaceuticals USA Inc.-IT-H14001-23-62384,HIKMA,,54.0,YR,,M,Y,67.0,KG,20230608,,PH,IT,IT,2023,Q2,Adult
225358601,22535860,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNKNOWN,,,,,Unknown,,2023,Q2,Mucosal inflammation,,2023,Q2,1,I,20230101.0,20230526.0,20230608,20230608,EXP,IT-MINISAL02-925662,IT-Hikma Pharmaceuticals USA Inc.-IT-H14001-23-62384,HIKMA,,54.0,YR,,M,Y,67.0,KG,20230608,,PH,IT,IT,2023,Q2,Adult
225358601,22535860,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNKNOWN,,,,,Unknown,,2023,Q2,Transaminases increased,,2023,Q2,1,I,20230101.0,20230526.0,20230608,20230608,EXP,IT-MINISAL02-925662,IT-Hikma Pharmaceuticals USA Inc.-IT-H14001-23-62384,HIKMA,,54.0,YR,,M,Y,67.0,KG,20230608,,PH,IT,IT,2023,Q2,Adult
225363351,22536335,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q2,Nervousness,,2023,Q2,1,I,20230606.0,20230607.0,20230608,20230608,PER,,US-ELI_LILLY_AND_COMPANY-US202306004855,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20230608,,CN,US,US,2023,Q2,Adult
225387691,22538769,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 Dosage forms Daily; 4 units/day,,,,,UNKNOWN,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,20230101.0,20230531.0,20230609,20230609,EXP,IT-MINISAL02-925662,IT-TEVA-2023-IT-2894782,TEVA,,54.0,YR,A,M,Y,67.0,KG,20230609,,PH,IT,IT,2023,Q2,Adult
225387691,22538769,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 Dosage forms Daily; 4 units/day,,,,,UNKNOWN,,,,,,,2023,Q2,Asthenia,,2023,Q2,1,I,20230101.0,20230531.0,20230609,20230609,EXP,IT-MINISAL02-925662,IT-TEVA-2023-IT-2894782,TEVA,,54.0,YR,A,M,Y,67.0,KG,20230609,,PH,IT,IT,2023,Q2,Adult
225387691,22538769,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 Dosage forms Daily; 4 units/day,,,,,UNKNOWN,,,,,,,2023,Q2,Neurotoxicity,,2023,Q2,1,I,20230101.0,20230531.0,20230609,20230609,EXP,IT-MINISAL02-925662,IT-TEVA-2023-IT-2894782,TEVA,,54.0,YR,A,M,Y,67.0,KG,20230609,,PH,IT,IT,2023,Q2,Adult
225387691,22538769,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 Dosage forms Daily; 4 units/day,,,,,UNKNOWN,,,,,,,2023,Q2,Transaminases increased,,2023,Q2,1,I,20230101.0,20230531.0,20230609,20230609,EXP,IT-MINISAL02-925662,IT-TEVA-2023-IT-2894782,TEVA,,54.0,YR,A,M,Y,67.0,KG,20230609,,PH,IT,IT,2023,Q2,Adult
225387691,22538769,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 Dosage forms Daily; 4 units/day,,,,,UNKNOWN,,,,,,,2023,Q2,Mucosal inflammation,,2023,Q2,1,I,20230101.0,20230531.0,20230609,20230609,EXP,IT-MINISAL02-925662,IT-TEVA-2023-IT-2894782,TEVA,,54.0,YR,A,M,Y,67.0,KG,20230609,,PH,IT,IT,2023,Q2,Adult
225407531,22540753,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (6 units before lunch and dinner),,,,,,,,,,,,2023,Q2,Preterm premature rupture of membranes,,2023,Q2,1,I,,20230525.0,20230609,20230609,EXP,,HK-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393321,RANBAXY,"Yau TTL, Yu SCY, Cheng J Y-K, Kwok JSS, Ma RCW. GCK-MODY in pregnancy: A pregnant woman with diabetes and a small-for-gestational-age fetus. Clin Case Rep. 2022;10:e06629",42.0,YR,,F,Y,,,20230609,,HP,HK,HK,2023,Q2,Adult
225407531,22540753,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (6 units before lunch and dinner),,,,,,,,,,,,2023,Q2,Premature delivery,,2023,Q2,1,I,,20230525.0,20230609,20230609,EXP,,HK-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393321,RANBAXY,"Yau TTL, Yu SCY, Cheng J Y-K, Kwok JSS, Ma RCW. GCK-MODY in pregnancy: A pregnant woman with diabetes and a small-for-gestational-age fetus. Clin Case Rep. 2022;10:e06629",42.0,YR,,F,Y,,,20230609,,HP,HK,HK,2023,Q2,Adult
225407531,22540753,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (6 units before lunch and dinner),,,,,,,,,,,,2023,Q2,Exposure during pregnancy,,2023,Q2,1,I,,20230525.0,20230609,20230609,EXP,,HK-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-393321,RANBAXY,"Yau TTL, Yu SCY, Cheng J Y-K, Kwok JSS, Ma RCW. GCK-MODY in pregnancy: A pregnant woman with diabetes and a small-for-gestational-age fetus. Clin Case Rep. 2022;10:e06629",42.0,YR,,F,Y,,,20230609,,HP,HK,HK,2023,Q2,Adult
225416401,22541640,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Death,,2023,Q2,1,I,20230510.0,,20230608,20230608,DIR,FDA-CDER-CTU-2023-42385,,FDA-CTU,,79.0,YR,,F,N,,,20230605,N,,US,,2023,Q2,Elderly
225862631,22586263,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,1,I,,20230607.0,20230611,20230611,PER,,US-SA-2023SA175415,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20230611,,CN,US,US,2023,Q2,Elderly
225929951,22592995,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 units with meals,,,Y,,,,,,,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 units with meals,,,Y,,,,,,,,,2023,Q2,Overdose,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 units with meals,,,Y,,,,,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 units with meals,,,Y,,,,,,,,,2023,Q2,Toxicity to various agents,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 units with meals,,,Y,,,,,,,,,2023,Q2,Hallucination,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2023,Q2,Drug interaction,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2023,Q2,Overdose,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2023,Q2,Toxicity to various agents,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225929951,22592995,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2023,Q2,Hallucination,,2023,Q2,1,I,,20190905.0,20230613,20230613,EXP,,CA-TEVA-2023-CA-2897174,TEVA,"Gunaratne K, Austin E, Wu PE. Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. BMC-Res-Notes 2018;11(1):331.",56.0,YR,A,M,Y,,,20230613,,HP,CA,CA,2023,Q2,Adult
225939001,22593900,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Atrial fibrillation,,2023,Q2,1,I,20230201.0,20230605.0,20230613,20230613,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-079587,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,110.68,KG,20230612,,HP,US,US,2023,Q2,Elderly
225939001,22593900,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Cytokine release syndrome,,2023,Q2,1,I,20230201.0,20230605.0,20230613,20230613,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-079587,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,110.68,KG,20230612,,HP,US,US,2023,Q2,Elderly
225939001,22593900,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Immune effector cell-associated neurotoxicity syndrome,,2023,Q2,1,I,20230201.0,20230605.0,20230613,20230613,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-079587,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,110.68,KG,20230612,,HP,US,US,2023,Q2,Elderly
225967681,22596768,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Toxic epidermal necrolysis,,2023,Q2,1,I,,20230531.0,20230613,20230613,EXP,,FR-B.Braun Medical Inc.-2142665,B BRAUN,,74.0,YR,,M,Y,,,20230613,,MD,FR,FR,2023,Q2,Elderly
225994431,22599443,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Acute respiratory failure,,2023,Q2,1,I,,20230609.0,20230614,20230614,EXP,,CA-AstraZeneca-2023A134920,ASTRAZENECA,,59.0,YR,,F,Y,,,20230614,,MD,CA,,2023,Q2,Adult
225994431,22599443,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Pneumonitis,,2023,Q2,1,I,,20230609.0,20230614,20230614,EXP,,CA-AstraZeneca-2023A134920,ASTRAZENECA,,59.0,YR,,F,Y,,,20230614,,MD,CA,,2023,Q2,Adult
225998251,22599825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,1,I,,20230609.0,20230614,20230614,EXP,,RO-MYLANLABS-2023M1061630,MYLAN,"Condrea A, Grama A, Grama O.. Respiratory tract infections ? Always a trigger for developing DKA in children with type 1 diabetes?. Ro J Pediatr. 2023;72(1):21-3",5.0,YR,,M,Y,,,20230614,,MD,RO,RO,2023,Q2,Child
226051971,22605197,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10U-8U-12U,,,Y,,,,20563.0,,,,TID,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20230606.0,20230615,20230615,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306005375,ELI LILLY AND CO,"Kanako Kadowaki, et al..A case of pancreatic diabetes which blood glucose control improved by changing administration timing of long-acting insulin analog.The 128th annual meeting of Chugoku branch Japanese Society of Internal Medicine 2023;:.",68.0,YR,,M,Y,53.4,KG,20230615,,MD,JP,JP,2023,Q2,Elderly
226051971,22605197,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10U-8U-12U,,,Y,,,,20563.0,,,,TID,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,,20230606.0,20230615,20230615,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306005375,ELI LILLY AND CO,"Kanako Kadowaki, et al..A case of pancreatic diabetes which blood glucose control improved by changing administration timing of long-acting insulin analog.The 128th annual meeting of Chugoku branch Japanese Society of Internal Medicine 2023;:.",68.0,YR,,M,Y,53.4,KG,20230615,,MD,JP,JP,2023,Q2,Elderly
226051971,22605197,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10U-8U-12U,,,Y,,,,20563.0,,,,TID,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230606.0,20230615,20230615,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306005375,ELI LILLY AND CO,"Kanako Kadowaki, et al..A case of pancreatic diabetes which blood glucose control improved by changing administration timing of long-acting insulin analog.The 128th annual meeting of Chugoku branch Japanese Society of Internal Medicine 2023;:.",68.0,YR,,M,Y,53.4,KG,20230615,,MD,JP,JP,2023,Q2,Elderly
226051971,22605197,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,14U-6U-3U,,,Y,,,,20563.0,,,,TID,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20230606.0,20230615,20230615,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306005375,ELI LILLY AND CO,"Kanako Kadowaki, et al..A case of pancreatic diabetes which blood glucose control improved by changing administration timing of long-acting insulin analog.The 128th annual meeting of Chugoku branch Japanese Society of Internal Medicine 2023;:.",68.0,YR,,M,Y,53.4,KG,20230615,,MD,JP,JP,2023,Q2,Elderly
226051971,22605197,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,14U-6U-3U,,,Y,,,,20563.0,,,,TID,2023,Q2,Blood glucose decreased,,2023,Q2,1,I,,20230606.0,20230615,20230615,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306005375,ELI LILLY AND CO,"Kanako Kadowaki, et al..A case of pancreatic diabetes which blood glucose control improved by changing administration timing of long-acting insulin analog.The 128th annual meeting of Chugoku branch Japanese Society of Internal Medicine 2023;:.",68.0,YR,,M,Y,53.4,KG,20230615,,MD,JP,JP,2023,Q2,Elderly
226051971,22605197,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,14U-6U-3U,,,Y,,,,20563.0,,,,TID,2023,Q2,Hyperglycaemia,,2023,Q2,1,I,,20230606.0,20230615,20230615,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306005375,ELI LILLY AND CO,"Kanako Kadowaki, et al..A case of pancreatic diabetes which blood glucose control improved by changing administration timing of long-acting insulin analog.The 128th annual meeting of Chugoku branch Japanese Society of Internal Medicine 2023;:.",68.0,YR,,M,Y,53.4,KG,20230615,,MD,JP,JP,2023,Q2,Elderly
226076731,22607673,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"per sliding scale 4 times a day, unknown",,,,,,,20563.0,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230613.0,20230614.0,20230616,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202306009406,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Elderly
226076731,22607673,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"per sliding scale 4 times a day, unknown",,,,,D578902A,,20563.0,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230613.0,20230614.0,20230616,20230616,PER,,US-ELI_LILLY_AND_COMPANY-US202306009406,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230616,,CN,US,US,2023,Q2,Elderly
226148151,22614815,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D546652A,,20563.0,,,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230612.0,20230616.0,20230619,20230619,PER,,US-ELI_LILLY_AND_COMPANY-US202306011169,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20230619,,CN,US,US,2023,Q2,Elderly
226196641,22619664,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q2,Blood glucose abnormal,,2023,Q2,1,I,,20230616.0,20230620,20230620,PER,,US-SA-2023SA187317,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20230620,,CN,US,US,2023,Q2,Adult
226206781,22620678,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D513617A,,20563.0,,,Solution for injection,,2023,Q2,Drug ineffective,,2023,Q2,1,I,20230614.0,20230619.0,20230620,20230620,PER,,US-ELI_LILLY_AND_COMPANY-US202306012156,ELI LILLY AND CO,,67.0,YR,,,Y,,,20230620,,CN,US,US,2023,Q2,Elderly
226206781,22620678,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D513617A,,20563.0,,,Solution for injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20230614.0,20230619.0,20230620,20230620,PER,,US-ELI_LILLY_AND_COMPANY-US202306012156,ELI LILLY AND CO,,67.0,YR,,,Y,,,20230620,,CN,US,US,2023,Q2,Elderly
226206781,22620678,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D513617A,,20563.0,,,Solution for injection,,2023,Q2,Hypoacusis,,2023,Q2,1,I,20230614.0,20230619.0,20230620,20230620,PER,,US-ELI_LILLY_AND_COMPANY-US202306012156,ELI LILLY AND CO,,67.0,YR,,,Y,,,20230620,,CN,US,US,2023,Q2,Elderly
226275061,22627506,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2023,Q2,Vision blurred,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2023,Q2,Vision blurred,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D549451A,,20563.0,10.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D549451A,,20563.0,10.0,IU,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D549451A,,20563.0,10.0,IU,Injection,,2023,Q2,Vision blurred,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D549451A,,20563.0,10.0,IU,Injection,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D549451A,,20563.0,10.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D549451A,,20563.0,10.0,IU,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D549451A,,20563.0,10.0,IU,Injection,,2023,Q2,Vision blurred,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226275061,22627506,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D549451A,,20563.0,10.0,IU,Injection,,2023,Q2,Diabetes mellitus inadequate control,,2023,Q2,1,I,20230501.0,20230619.0,20230622,20230622,PER,,US-ELI_LILLY_AND_COMPANY-US202306013635,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20230622,,CN,US,US,2023,Q2,Elderly
226312561,22631256,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Dyspepsia,,2023,Q2,1,I,20230525.0,20230530.0,20230623,20230623,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002101,ACADIA PHARMACEUTICALS,,67.0,YR,,F,Y,,,20230623,,CN,US,US,2023,Q2,Elderly
226312561,22631256,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Product dose omission issue,,2023,Q2,1,I,20230525.0,20230530.0,20230623,20230623,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002101,ACADIA PHARMACEUTICALS,,67.0,YR,,F,Y,,,20230623,,CN,US,US,2023,Q2,Elderly
226312561,22631256,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Headache,,2023,Q2,1,I,20230525.0,20230530.0,20230623,20230623,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2023-PIM-002101,ACADIA PHARMACEUTICALS,,67.0,YR,,F,Y,,,20230623,,CN,US,US,2023,Q2,Elderly
226334311,22633431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, dosage form: not specified, reported as LISPRO 50LIS50NPL",,,,,,,,,,,,2023,Q2,Gait inability,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,CA-ORGANON-O2306CAN002043,ORGANON,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226334311,22633431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, dosage form: not specified, reported as LISPRO 50LIS50NPL",,,,,,,,,,,,2023,Q2,Liver function test increased,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,CA-ORGANON-O2306CAN002043,ORGANON,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226334311,22633431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, dosage form: not specified, reported as LISPRO 50LIS50NPL",,,,,,,,,,,,2023,Q2,Rhabdomyolysis,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,CA-ORGANON-O2306CAN002043,ORGANON,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226334311,22633431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, dosage form: not specified, reported as LISPRO 50LIS50NPL",,,,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,CA-ORGANON-O2306CAN002043,ORGANON,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226334311,22633431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, dosage form: not specified, reported as LISPRO 50LIS50NPL",,,,,,,,,,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,CA-ORGANON-O2306CAN002043,ORGANON,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226334311,22633431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, dosage form: not specified, reported as LISPRO 50LIS50NPL",,,,,,,,,,,,2023,Q2,Blood creatine phosphokinase increased,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,CA-ORGANON-O2306CAN002043,ORGANON,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226334311,22633431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, dosage form: not specified, reported as LISPRO 50LIS50NPL",,,,,,,,,,,,2023,Q2,Fall,,2023,Q2,1,I,,20230615.0,20230623,20230623,EXP,,CA-ORGANON-O2306CAN002043,ORGANON,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226344651,22634465,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Drug interaction,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,CA-AUROBINDO-AUR-APL-2023-042659,AUROBINDO,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226344651,22634465,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Liver function test increased,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,CA-AUROBINDO-AUR-APL-2023-042659,AUROBINDO,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226344651,22634465,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Rhabdomyolysis,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,CA-AUROBINDO-AUR-APL-2023-042659,AUROBINDO,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226344651,22634465,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Gait inability,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,CA-AUROBINDO-AUR-APL-2023-042659,AUROBINDO,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226344651,22634465,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Fall,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,CA-AUROBINDO-AUR-APL-2023-042659,AUROBINDO,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226344651,22634465,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Acute kidney injury,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,CA-AUROBINDO-AUR-APL-2023-042659,AUROBINDO,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226344651,22634465,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q2,Blood creatine phosphokinase increased,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,CA-AUROBINDO-AUR-APL-2023-042659,AUROBINDO,,61.0,YR,,M,Y,,,20230623,,PH,CA,CA,2023,Q2,Adult
226355131,22635513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Headache,,2023,Q2,1,I,,20230619.0,20230623,20230623,EXP,,CA-JNJFOC-20230652477,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,105.0,KG,20230623,,HP,CA,CA,2023,Q2,Young Adult
226355131,22635513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Maternal exposure during pregnancy,,2023,Q2,1,I,,20230619.0,20230623,20230623,EXP,,CA-JNJFOC-20230652477,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,105.0,KG,20230623,,HP,CA,CA,2023,Q2,Young Adult
226355131,22635513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Retained placenta or membranes,,2023,Q2,1,I,,20230619.0,20230623,20230623,EXP,,CA-JNJFOC-20230652477,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,105.0,KG,20230623,,HP,CA,CA,2023,Q2,Young Adult
226355131,22635513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Weight decreased,,2023,Q2,1,I,,20230619.0,20230623,20230623,EXP,,CA-JNJFOC-20230652477,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,105.0,KG,20230623,,HP,CA,CA,2023,Q2,Young Adult
226355131,22635513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Sepsis,,2023,Q2,1,I,,20230619.0,20230623,20230623,EXP,,CA-JNJFOC-20230652477,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,105.0,KG,20230623,,HP,CA,CA,2023,Q2,Young Adult
226355131,22635513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Chills,,2023,Q2,1,I,,20230619.0,20230623,20230623,EXP,,CA-JNJFOC-20230652477,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,105.0,KG,20230623,,HP,CA,CA,2023,Q2,Young Adult
226355131,22635513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Pyrexia,,2023,Q2,1,I,,20230619.0,20230623,20230623,EXP,,CA-JNJFOC-20230652477,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,105.0,KG,20230623,,HP,CA,CA,2023,Q2,Young Adult
226355131,22635513,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q2,Urinary tract infection,,2023,Q2,1,I,,20230619.0,20230623,20230623,EXP,,CA-JNJFOC-20230652477,JOHNSON AND JOHNSON,,30.0,YR,A,F,Y,105.0,KG,20230623,,HP,CA,CA,2023,Q2,Young Adult
226355421,22635542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100u / mL SQ QD per sliding scale,,,D,,,,,,,,,2023,Q2,Product use issue,,2023,Q2,1,I,20230529.0,20230530.0,20230623,20230623,PER,,"US-RIGEL PHARMACEUTICALS, INC.-2023OLU000029",RIGEL PHARMACEUTICALS,,63.0,YR,,M,Y,83.9,KG,20230623,,CN,US,US,2023,Q2,Adult
226355421,22635542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100u / mL SQ QD per sliding scale,,,D,,,,,,,,,2023,Q2,Vomiting,,2023,Q2,1,I,20230529.0,20230530.0,20230623,20230623,PER,,"US-RIGEL PHARMACEUTICALS, INC.-2023OLU000029",RIGEL PHARMACEUTICALS,,63.0,YR,,M,Y,83.9,KG,20230623,,CN,US,US,2023,Q2,Adult
226355421,22635542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100u / mL SQ QD per sliding scale,,,D,,,,,,,,,2023,Q2,Haemoptysis,,2023,Q2,1,I,20230529.0,20230530.0,20230623,20230623,PER,,"US-RIGEL PHARMACEUTICALS, INC.-2023OLU000029",RIGEL PHARMACEUTICALS,,63.0,YR,,M,Y,83.9,KG,20230623,,CN,US,US,2023,Q2,Adult
226355421,22635542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100u / mL SQ QD per sliding scale,,,D,,,,,,,,,2023,Q2,Nausea,,2023,Q2,1,I,20230529.0,20230530.0,20230623,20230623,PER,,"US-RIGEL PHARMACEUTICALS, INC.-2023OLU000029",RIGEL PHARMACEUTICALS,,63.0,YR,,M,Y,83.9,KG,20230623,,CN,US,US,2023,Q2,Adult
226363251,22636325,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,US-ELI_LILLY_AND_COMPANY-US202306007918,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230623,,CN,US,US,2023,Q2,Adult
226363251,22636325,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Diabetic ketoacidosis,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,US-ELI_LILLY_AND_COMPANY-US202306007918,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230623,,CN,US,US,2023,Q2,Adult
226363251,22636325,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q2,Loss of therapeutic response,,2023,Q2,1,I,,20230612.0,20230623,20230623,EXP,,US-ELI_LILLY_AND_COMPANY-US202306007918,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230623,,CN,US,US,2023,Q2,Adult
226388962,22638896,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, prn, sliding scale based on blood sugar",,,U,,,,,24.0,IU,Injection,,2023,Q2,Blood glucose decreased,,2023,Q2,2,F,20230603.0,20230613.0,20230626,20230628,PER,,US-ELI_LILLY_AND_COMPANY-US202306011536,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226388962,22638896,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, prn, sliding scale based on blood sugar",,,U,,,,,24.0,IU,Injection,,2023,Q2,Visual impairment,,2023,Q2,2,F,20230603.0,20230613.0,20230626,20230628,PER,,US-ELI_LILLY_AND_COMPANY-US202306011536,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226388962,22638896,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, prn, sliding scale based on blood sugar",,,U,,,,,24.0,IU,Injection,,2023,Q2,Incorrect dose administered,,2023,Q2,2,F,20230603.0,20230613.0,20230626,20230628,PER,,US-ELI_LILLY_AND_COMPANY-US202306011536,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226388962,22638896,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, prn, sliding scale based on blood sugar",,,U,,,,,24.0,IU,Injection,,2023,Q2,Flatulence,,2023,Q2,2,F,20230603.0,20230613.0,20230626,20230628,PER,,US-ELI_LILLY_AND_COMPANY-US202306011536,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226388962,22638896,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, prn, sliding scale based on blood sugar",,,U,,,,,24.0,IU,Injection,,2023,Q2,Gastrooesophageal reflux disease,,2023,Q2,2,F,20230603.0,20230613.0,20230626,20230628,PER,,US-ELI_LILLY_AND_COMPANY-US202306011536,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226402011,22640201,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, tid",,,U,,,,20563.0,10.0,IU,Injection,TID,2023,Q2,Underdose,,2023,Q2,1,I,20230621.0,20230621.0,20230626,20230626,PER,,US-ELI_LILLY_AND_COMPANY-US202306014362,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230624,,CN,US,US,2023,Q2,Adult
226402011,22640201,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, tid",,,U,,,,20563.0,10.0,IU,Injection,TID,2023,Q2,Underdose,,2023,Q2,1,I,20230621.0,20230621.0,20230626,20230626,PER,,US-ELI_LILLY_AND_COMPANY-US202306014362,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230624,,CN,US,US,2023,Q2,Adult
226402011,22640201,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, tid",,,U,,D580163D,,20563.0,10.0,IU,Injection,TID,2023,Q2,Underdose,,2023,Q2,1,I,20230621.0,20230621.0,20230626,20230626,PER,,US-ELI_LILLY_AND_COMPANY-US202306014362,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230624,,CN,US,US,2023,Q2,Adult
226402011,22640201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, tid",,,U,,D580163D,,20563.0,10.0,IU,Injection,TID,2023,Q2,Underdose,,2023,Q2,1,I,20230621.0,20230621.0,20230626,20230626,PER,,US-ELI_LILLY_AND_COMPANY-US202306014362,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20230624,,CN,US,US,2023,Q2,Adult
226416441,22641644,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO WHOLE SYRINGES,,,U,,,,20563.0,,,,,2023,Q2,Sopor,,2023,Q2,1,I,20230226.0,20230615.0,20230626,20230626,EXP,IT-MINISAL02-930370,IT-ELI_LILLY_AND_COMPANY-IT202306009385,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230626,,CN,IT,IT,2023,Q2,Adult
226416441,22641644,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TWO WHOLE SYRINGES,,,U,,,,20563.0,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230226.0,20230615.0,20230626,20230626,EXP,IT-MINISAL02-930370,IT-ELI_LILLY_AND_COMPANY-IT202306009385,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20230626,,CN,IT,IT,2023,Q2,Adult
226422941,22642294,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,,20230621.0,20230626,20230626,EXP,GB-MHRA-MIDB-ea7bd518-9042-41f7-b157-903da0166491,GB-ELI_LILLY_AND_COMPANY-GB202306014150,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20230626,,CN,GB,GB,2023,Q2,Elderly
226422941,22642294,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,,,2023,Q2,Fall,,2023,Q2,1,I,,20230621.0,20230626,20230626,EXP,GB-MHRA-MIDB-ea7bd518-9042-41f7-b157-903da0166491,GB-ELI_LILLY_AND_COMPANY-GB202306014150,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20230626,,CN,GB,GB,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Tracheostomy,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Akinesia,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Pneumonia,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Skin abrasion,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Pneumonia aspiration,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Enteral nutrition,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Inappropriate schedule of product administration,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Tachypnoea,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Speech disorder,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Pneumonia aspiration,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Type 2 diabetes mellitus,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226435482,22643548,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25 IU,,,,,,,,,,,,2023,Q2,Secretion discharge,,2023,Q2,2,F,20211101.0,20230623.0,20230627,20230628,EXP,,DE-ABBVIE-4722215,ABBVIE,,77.0,YR,,M,Y,,,20230628,,CN,DE,DE,2023,Q2,Elderly
226491161,22649116,10,C,INSULINE LISPRO,,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230619.0,20230628,20230628,EXP,,FR-STRIDES ARCOLAB LIMITED-2023SP010277,STRIDES,"Guion-Firmin J, Tessier S, Lepelley M, Faillie JL, Montastruc JL.. Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan: A pharmacovigilance study.. Fundam-Clin-Pharmacol. 2022;36(2):378-389.",62.0,YR,,M,Y,,,20230628,,HP,FR,FR,2023,Q2,Adult
226491161,22649116,10,C,INSULINE LISPRO,,1,Unknown,UNK,,,,,,,,,,,,2023,Q2,Hypovolaemic shock,,2023,Q2,1,I,,20230619.0,20230628,20230628,EXP,,FR-STRIDES ARCOLAB LIMITED-2023SP010277,STRIDES,"Guion-Firmin J, Tessier S, Lepelley M, Faillie JL, Montastruc JL.. Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan: A pharmacovigilance study.. Fundam-Clin-Pharmacol. 2022;36(2):378-389.",62.0,YR,,M,Y,,,20230628,,HP,FR,FR,2023,Q2,Adult
226508441,22650844,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q2,Tremor,,2023,Q2,1,I,,20230615.0,20230628,20230628,EXP,,CH-TEVA-2023-CH-2901625,TEVA,,72.0,YR,E,M,Y,,,20230628,,HP,CH,CH,2023,Q2,Elderly
226508711,22650871,11,C,INSULINE LISPRO,,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Hypovolaemic shock,,2023,Q2,1,I,,20230619.0,20230628,20230628,EXP,,FR-MYLANLABS-2023M1067260,MYLAN,"Guion-Firmin J, Tessier S, Lepelley M, Faillie JL, Montastruc JL. Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan: A pharmacovigilance study. Fundam-Clin-Pharmacol 2022;36(2):378-389.",62.0,YR,,M,Y,,,20230628,,HP,FR,FR,2023,Q2,Adult
226508711,22650871,11,C,INSULINE LISPRO,,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,,20230619.0,20230628,20230628,EXP,,FR-MYLANLABS-2023M1067260,MYLAN,"Guion-Firmin J, Tessier S, Lepelley M, Faillie JL, Montastruc JL. Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan: A pharmacovigilance study. Fundam-Clin-Pharmacol 2022;36(2):378-389.",62.0,YR,,M,Y,,,20230628,,HP,FR,FR,2023,Q2,Adult
226521471,22652147,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, prn (with sliding scale)",,,U,,,,,8.0,IU,Injection,,2023,Q2,COVID-19,,2023,Q2,1,I,20220101.0,20230616.0,20230628,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202306012304,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226521471,22652147,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, prn (with sliding scale)",,,U,,,,,8.0,IU,Injection,,2023,Q2,Myocarditis,,2023,Q2,1,I,20220101.0,20230616.0,20230628,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202306012304,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226521471,22652147,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, prn (with sliding scale)",,,U,,,,,8.0,IU,Injection,,2023,Q2,Pneumonia viral,,2023,Q2,1,I,20220101.0,20230616.0,20230628,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202306012304,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226521471,22652147,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, prn (with sliding scale)",,,U,,,,,8.0,IU,Injection,,2023,Q2,Pericarditis,,2023,Q2,1,I,20220101.0,20230616.0,20230628,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202306012304,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226521471,22652147,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, prn (with sliding scale)",,,U,,,,,8.0,IU,Injection,,2023,Q2,Pneumonia bacterial,,2023,Q2,1,I,20220101.0,20230616.0,20230628,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202306012304,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226521471,22652147,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, prn (with sliding scale)",,,U,,,,,8.0,IU,Injection,,2023,Q2,Blood glucose increased,,2023,Q2,1,I,20220101.0,20230616.0,20230628,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202306012304,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226521471,22652147,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, prn (with sliding scale)",,,U,,,,,8.0,IU,Injection,,2023,Q2,Cardiac failure,,2023,Q2,1,I,20220101.0,20230616.0,20230628,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202306012304,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226521471,22652147,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, prn (with sliding scale)",,,U,,,,,8.0,IU,Injection,,2023,Q2,Weight increased,,2023,Q2,1,I,20220101.0,20230616.0,20230628,20230628,EXP,,US-ELI_LILLY_AND_COMPANY-US202306012304,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20230628,,CN,US,US,2023,Q2,Adult
226543391,22654339,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 units before breakfast, 4 units before lunch, 4 units before dinner",,,Y,,,,,,,Injection,,2023,Q2,Pruritus,,2023,Q2,1,I,20230614.0,20230621.0,20230629,20230629,EXP,,CN-AstraZeneca-2023A147207,ASTRAZENECA,,44.0,YR,,M,Y,79.0,KG,20230629,,MD,CN,,2023,Q2,Adult
226543391,22654339,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 units before breakfast, 4 units before lunch, 4 units before dinner",,,Y,,,,,,,Injection,,2023,Q2,Rash,,2023,Q2,1,I,20230614.0,20230621.0,20230629,20230629,EXP,,CN-AstraZeneca-2023A147207,ASTRAZENECA,,44.0,YR,,M,Y,79.0,KG,20230629,,MD,CN,,2023,Q2,Adult
226543391,22654339,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 units before breakfast, 4 units before lunch, 4 units before dinner",,,Y,,,,,,,Injection,,2023,Q2,Drug hypersensitivity,,2023,Q2,1,I,20230614.0,20230621.0,20230629,20230629,EXP,,CN-AstraZeneca-2023A147207,ASTRAZENECA,,44.0,YR,,M,Y,79.0,KG,20230629,,MD,CN,,2023,Q2,Adult
226599441,22659944,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,4 U/die.,,,,,,,,,,,,2023,Q2,Asthenia,,2023,Q2,1,I,20230101.0,20230617.0,20230630,20230630,EXP,IT-MINISAL02-925662,IT-Accord-363370,ACCORD,,54.0,YR,A,M,Y,67.0,KG,20230630,,PH,IT,IT,2023,Q2,Adult
226599441,22659944,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,4 U/die.,,,,,,,,,,,,2023,Q2,Transaminases increased,,2023,Q2,1,I,20230101.0,20230617.0,20230630,20230630,EXP,IT-MINISAL02-925662,IT-Accord-363370,ACCORD,,54.0,YR,A,M,Y,67.0,KG,20230630,,PH,IT,IT,2023,Q2,Adult
226599441,22659944,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,4 U/die.,,,,,,,,,,,,2023,Q2,Neurotoxicity,,2023,Q2,1,I,20230101.0,20230617.0,20230630,20230630,EXP,IT-MINISAL02-925662,IT-Accord-363370,ACCORD,,54.0,YR,A,M,Y,67.0,KG,20230630,,PH,IT,IT,2023,Q2,Adult
226599441,22659944,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,4 U/die.,,,,,,,,,,,,2023,Q2,Mucosal inflammation,,2023,Q2,1,I,20230101.0,20230617.0,20230630,20230630,EXP,IT-MINISAL02-925662,IT-Accord-363370,ACCORD,,54.0,YR,A,M,Y,67.0,KG,20230630,,PH,IT,IT,2023,Q2,Adult
226599441,22659944,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,4 U/die.,,,,,,,,,,,,2023,Q2,Diarrhoea,,2023,Q2,1,I,20230101.0,20230617.0,20230630,20230630,EXP,IT-MINISAL02-925662,IT-Accord-363370,ACCORD,,54.0,YR,A,M,Y,67.0,KG,20230630,,PH,IT,IT,2023,Q2,Adult
226601451,22660145,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2023,Q2,Hospitalisation,,2023,Q2,1,I,,20230627.0,20230630,20230630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-091562,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,80.0,KG,20230630,,PH,US,US,2023,Q2,Elderly
226609011,22660901,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 international unit, 4 iu for breakfast, 6 iu for lunch, 8 iu for dinner",,,U,,,,,18.0,IU,,,2023,Q2,Hypoglycaemia,,2023,Q2,1,I,20230202.0,20230616.0,20230630,20230630,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396373,RANBAXY,,87.0,YR,,M,Y,,,20230630,,MD,IT,IT,2023,Q2,Elderly
146954172,14695417,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Pseudohyponatraemia,,2023,Q3,2,F,,20230720.0,20180329,20230730,EXP,,US-TEVA-2018-US-874811,TEVA,,69.0,YR,E,M,Y,,,20230730,,HP,US,US,2023,Q3,Elderly
146954172,14695417,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Vanishing bile duct syndrome,,2023,Q3,2,F,,20230720.0,20180329,20230730,EXP,,US-TEVA-2018-US-874811,TEVA,,69.0,YR,E,M,Y,,,20230730,,HP,US,US,2023,Q3,Elderly
146954172,14695417,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Drug-induced liver injury,,2023,Q3,2,F,,20230720.0,20180329,20230730,EXP,,US-TEVA-2018-US-874811,TEVA,,69.0,YR,E,M,Y,,,20230730,,HP,US,US,2023,Q3,Elderly
155975992,15597599,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 units before breakfast, 8 units before lunch, and 11 units before dinner",,,U,,,,,,,,,2023,Q3,Small fibre neuropathy,,2023,Q3,2,F,,20230720.0,20181108,20230730,EXP,,US-TEVA-2018-US-972703,TEVA,,20.0,YR,A,M,Y,51.8,KG,20230730,,MD,US,US,2023,Q3,Youth
1600689710,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,End stage renal disease,,2023,Q3,10,F,20060101.0,20230717.0,20190222,20230725,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230725,,LW,US,,2023,Q3,Adult
1600689710,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Chronic kidney disease,,2023,Q3,10,F,20060101.0,20230717.0,20190222,20230725,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230725,,LW,US,,2023,Q3,Adult
1600689710,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Tubulointerstitial nephritis,,2023,Q3,10,F,20060101.0,20230717.0,20190222,20230725,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230725,,LW,US,,2023,Q3,Adult
1600689710,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Renal failure,,2023,Q3,10,F,20060101.0,20230717.0,20190222,20230725,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230725,,LW,US,,2023,Q3,Adult
1600689710,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Renal injury,,2023,Q3,10,F,20060101.0,20230717.0,20190222,20230725,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230725,,LW,US,,2023,Q3,Adult
1600689710,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Nephrogenic anaemia,,2023,Q3,10,F,20060101.0,20230717.0,20190222,20230725,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230725,,LW,US,,2023,Q3,Adult
1600689710,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Huntington's disease,,2023,Q3,10,F,20060101.0,20230717.0,20190222,20230725,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230725,,LW,US,,2023,Q3,Adult
1600689710,16006897,38,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,10,F,20060101.0,20230717.0,20190222,20230725,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20230725,,LW,US,,2023,Q3,Adult
164824882,16482488,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 unit injection thrice daily,,,U,,,,,,,,TID,2023,Q3,Central nervous system lymphoma,,2023,Q3,2,F,,20230721.0,20190627,20230731,EXP,,US-TEVA-2019-US-1067948,TEVA,,61.0,YR,A,F,Y,,,20230801,,HP,US,US,2023,Q3,Adult
164824882,16482488,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 unit injection thrice daily,,,U,,,,,,,,TID,2023,Q3,Post transplant lymphoproliferative disorder,,2023,Q3,2,F,,20230721.0,20190627,20230731,EXP,,US-TEVA-2019-US-1067948,TEVA,,61.0,YR,A,F,Y,,,20230801,,HP,US,US,2023,Q3,Adult
169652233,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Head injury,,2023,Q3,3,F,20190722.0,20230721.0,20191028,20230726,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20230726,,MD,FR,FR,2023,Q3,Elderly
169652233,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Hypotension,,2023,Q3,3,F,20190722.0,20230721.0,20191028,20230726,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20230726,,MD,FR,FR,2023,Q3,Elderly
169652233,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Cerebral haemorrhage,,2023,Q3,3,F,20190722.0,20230721.0,20191028,20230726,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20230726,,MD,FR,FR,2023,Q3,Elderly
169652233,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Intraventricular haemorrhage,,2023,Q3,3,F,20190722.0,20230721.0,20191028,20230726,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20230726,,MD,FR,FR,2023,Q3,Elderly
169652233,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Malaise,,2023,Q3,3,F,20190722.0,20230721.0,20191028,20230726,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20230726,,MD,FR,FR,2023,Q3,Elderly
169652233,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Coma,,2023,Q3,3,F,20190722.0,20230721.0,20191028,20230726,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20230726,,MD,FR,FR,2023,Q3,Elderly
169652233,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Subarachnoid haemorrhage,,2023,Q3,3,F,20190722.0,20230721.0,20191028,20230726,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20230726,,MD,FR,FR,2023,Q3,Elderly
172939705,17293970,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,5,F,20230101.0,20230907.0,20200121,20230913,PER,,US-SA-2020SA013571,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20230913,,HP,US,US,2023,Q3,Adult
172939705,17293970,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Blood glucose decreased,,2023,Q3,5,F,20230101.0,20230907.0,20200121,20230913,PER,,US-SA-2020SA013571,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20230913,,HP,US,US,2023,Q3,Adult
172939705,17293970,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Drug ineffective,,2023,Q3,5,F,20230101.0,20230907.0,20200121,20230913,PER,,US-SA-2020SA013571,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20230913,,HP,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Hypovolaemia,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Death,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Small intestinal obstruction,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Lactic acidosis,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Septic shock,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Cardio-respiratory arrest,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Acute kidney injury,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Emphysematous pyelonephritis,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Leukocytosis,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Thrombocytopenia,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Portal venous gas,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Brain injury,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Glycosuria,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
176206002,17620600,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,30.0,IU,,Q8H,2023,Q3,Colitis ischaemic,,2023,Q3,2,F,,20230713.0,20200403,20230717,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-NB-017586",BOEHRINGER INGELHEIM,"Echeverria P, Rynerson Z, Saa J. Emphysematous kidney and pyelonephritis in a diabetic woman managed with empagliflozin. Critical Care Medicine. 2020;48(1):",60.0,YR,A,F,Y,,,20230717,,MD,US,US,2023,Q3,Adult
1820593326,18205933,84,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 international unit, unknown",,,U,,,,,1.0,IU,,,2023,Q3,Toxic epidermal necrolysis,,2023,Q3,26,F,20200809.0,20230804.0,20200827,20230809,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008010103,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230809,,CN,FR,FR,2023,Q3,Elderly
1820848935,18208489,116,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,,,,,1.0,IU,,,2023,Q3,Toxic epidermal necrolysis,,2023,Q3,35,F,20200809.0,20230811.0,20200828,20230817,EXP,,FR-BAUSCH-BL-2020-024487,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20230818,,MD,FR,FR,2023,Q3,Elderly
182416598,18241659,41,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,D,,,,,1.0,IU,,,2023,Q3,Toxic epidermal necrolysis,,2023,Q3,8,F,20200809.0,20230626.0,20200908,20230709,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-Accord-199762,ACCORD,,75.0,YR,E,M,Y,,,20230708,,MD,FR,FR,2023,Q3,Elderly
182556839,18255683,105,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 [iU] (international unit), 1 iu, CO",,,U,,,,,,,,,2023,Q3,Toxic epidermal necrolysis,,2023,Q3,9,F,20200809.0,20230807.0,20200910,20230814,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-BAXTER-2020BAX018061,BAXTER,,74.0,YR,,M,Y,,,20230814,,CN,FR,FR,2023,Q3,Elderly
1840823010,18408230,158,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 iu, CO",,,D,,,,,1.0,IU,,,2023,Q3,Toxic epidermal necrolysis,,2023,Q3,10,F,20200809.0,20230811.0,20201020,20230814,EXP,,FR-PURDUE-USA-2020-0171568,PURDUE,,74.0,YR,,M,Y,,,20230814,,MD,FR,FR,2023,Q3,Elderly
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Thirst,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Gastrointestinal inflammation,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Fatigue,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Diarrhoea haemorrhagic,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Dehydration,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Pollakiuria,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,COVID-19,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Malaise,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Abdominal pain,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Constipation,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Weight increased,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Blood glucose increased,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Asthenia,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Peripheral coldness,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Cough,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Rectal haemorrhage,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Abdominal distension,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Haematochezia,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Colitis ulcerative,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Diarrhoea,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Rectal tenesmus,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Hyperhidrosis,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Nasal congestion,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,General physical health deterioration,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Drug ineffective,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Bacterial infection,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Rhinorrhoea,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Proctalgia,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Off label use,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
1878494515,18784945,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, qd",,,,,,,,,,,QD,2023,Q3,Abdominal pain upper,,2023,Q3,15,F,20210220.0,20230726.0,20210125,20230729,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20230729,,CN,CO,CO,2023,Q3,Adult
2011662515,20116625,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Atrial fibrillation,,2023,Q3,15,F,20211117.0,20230807.0,20211126,20230811,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230811,,MD,US,,2023,Q3,Elderly
2011662515,20116625,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,,,,,,,,,,2023,Q3,Atrial fibrillation,,2023,Q3,15,F,20211117.0,20230807.0,20211126,20230811,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230811,,MD,US,,2023,Q3,Elderly
2011662515,20116625,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U,,,,,,,,,,,,2023,Q3,Atrial fibrillation,,2023,Q3,15,F,20211117.0,20230807.0,20211126,20230811,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230811,,MD,US,,2023,Q3,Elderly
2011927715,20119277,104,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Pulmonary embolism,,2023,Q3,15,F,20211118.0,20230802.0,20211126,20230807,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230807,,MD,US,,2023,Q3,Elderly
2011927715,20119277,105,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Pulmonary embolism,,2023,Q3,15,F,20211118.0,20230802.0,20211126,20230807,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230807,,MD,US,,2023,Q3,Elderly
2011927715,20119277,106,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 U,,,,,,,,,,,,2023,Q3,Pulmonary embolism,,2023,Q3,15,F,20211118.0,20230802.0,20211126,20230807,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230807,,MD,US,,2023,Q3,Elderly
2011927715,20119277,107,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,,,,,,,,,,2023,Q3,Pulmonary embolism,,2023,Q3,15,F,20211118.0,20230802.0,20211126,20230807,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230807,,MD,US,,2023,Q3,Elderly
2011927715,20119277,108,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U,,,,,,,,,,,,2023,Q3,Pulmonary embolism,,2023,Q3,15,F,20211118.0,20230802.0,20211126,20230807,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20230807,,MD,US,,2023,Q3,Elderly
2061608113,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q3,Myelosuppression,,2023,Q3,13,F,20220115.0,20230919.0,20220321,20230921,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230921,,PH,JP,JP,2023,Q3,Elderly
2061608113,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q3,Toxic epidermal necrolysis,,2023,Q3,13,F,20220115.0,20230919.0,20220321,20230921,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230921,,PH,JP,JP,2023,Q3,Elderly
2061608113,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q3,Renal failure,,2023,Q3,13,F,20220115.0,20230919.0,20220321,20230921,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230921,,PH,JP,JP,2023,Q3,Elderly
2061608113,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q3,Multiple organ dysfunction syndrome,,2023,Q3,13,F,20220115.0,20230919.0,20220321,20230921,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230921,,PH,JP,JP,2023,Q3,Elderly
2061608113,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q3,Hyperglycaemia,,2023,Q3,13,F,20220115.0,20230919.0,20220321,20230921,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230921,,PH,JP,JP,2023,Q3,Elderly
2061608113,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q3,Rash,,2023,Q3,13,F,20220115.0,20230919.0,20220321,20230921,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230921,,PH,JP,JP,2023,Q3,Elderly
2061608113,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q3,Oral candidiasis,,2023,Q3,13,F,20220115.0,20230919.0,20220321,20230921,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20230921,,PH,JP,JP,2023,Q3,Elderly
210361703,21036170,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g carbohydrates with meals and snacks,,,U,,,,,,,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,3,F,,20230802.0,20220701,20230803,EXP,,CA-BAUSCH-BL-2022-016780,BAUSCH AND LOMB,"Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of a sodium-glucose co-transporter 2 inhibitor in a 17-year-old man with type 2 diabetes. CMAJ. 2021 SEP 07;193:E1746-49. doi:10.1503/cmaj.202627-f",17.0,YR,,M,Y,,,20230803,,MD,CA,CA,2023,Q3,Youth
210361703,21036170,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g carbohydrates with meals and snacks,,,U,,,,,,,,,2023,Q3,Treatment noncompliance,,2023,Q3,3,F,,20230802.0,20220701,20230803,EXP,,CA-BAUSCH-BL-2022-016780,BAUSCH AND LOMB,"Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of a sodium-glucose co-transporter 2 inhibitor in a 17-year-old man with type 2 diabetes. CMAJ. 2021 SEP 07;193:E1746-49. doi:10.1503/cmaj.202627-f",17.0,YR,,M,Y,,,20230803,,MD,CA,CA,2023,Q3,Youth
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Weight decreased,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Multi-organ disorder,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Myalgia,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Chest pain,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Thyroid disorder,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Neuropathy peripheral,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Eye haemorrhage,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Arthritis,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Pulmonary oedema,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Cardiac failure congestive,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Pericardial effusion,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Abdominal pain upper,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Diarrhoea,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Malnutrition,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214058054,21405805,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Headache,,2023,Q3,4,F,,20230720.0,20221004,20230725,EXP,,CA-SA-2022SA401433,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230725,,CN,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Abdominal pain upper,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Eye haemorrhage,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Diarrhoea,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Headache,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Myalgia,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Cardiac failure congestive,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Weight decreased,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Malnutrition,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Pericardial effusion,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Arthritis,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Thyroid disorder,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Chest pain,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Multi-organ disorder,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Neuropathy peripheral,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214168693,21416869,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Pulmonary oedema,,2023,Q3,3,F,,20230704.0,20221006,20230710,EXP,,CA-SA-2022SA401856,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230710,,HP,CA,CA,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Hyperglycaemia,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Systemic infection,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Dehydration,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Tenderness,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Death,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Haematochezia,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,General physical health deterioration,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Vomiting,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Anaemia,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Depressed level of consciousness,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Pain,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Cachexia,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Nausea,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Fatigue,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Tachycardia,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
214437006,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2023,Q3,Condition aggravated,,2023,Q3,6,F,20210207.0,20221117.0,20221012,20230804,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20230804,,PH,DE,DE,2023,Q3,Adult
215597403,21559740,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
215597403,21559740,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Diabetic ketoacidosis,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
215597403,21559740,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q3,Treatment noncompliance,,2023,Q3,3,F,,20230719.0,20221107,20230725,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20230725,,HP,CA,CA,2023,Q3,Youth
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Condition aggravated,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Death,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Dehydration,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Cachexia,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Tenderness,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,General physical health deterioration,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Pain,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Systemic infection,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Haematochezia,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Anaemia,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Hyperglycaemia,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Tachycardia,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Fatigue,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Vomiting,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Depressed level of consciousness,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216245055,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2023,Q3,Nausea,,2023,Q3,5,F,,20230831.0,20221121,20230912,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20230912,,PH,DE,DE,2023,Q3,Adult
216356086,21635608,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, qid",,,,,,,,,,,QID,2023,Q3,Acute kidney injury,,2023,Q3,6,F,20221115.0,20230821.0,20221123,20230827,EXP,,US-SEATTLE GENETICS-2022SGN10891,SEATTLE GENETICS,,74.0,YR,,M,Y,93.424,KG,20230827,,MD,US,US,2023,Q3,Elderly
217556284,21755628,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2023,Q3,Sepsis,,2023,Q3,4,F,20221206.0,20230109.0,20221220,20230730,5DAY,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-155145,BRISTOL MYERS SQUIBB,,66.0,YR,E,F,Y,,,20230730,,HP,US,US,2023,Q3,Elderly
217556284,21755628,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2023,Q3,Pneumonia,,2023,Q3,4,F,20221206.0,20230109.0,20221220,20230730,5DAY,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-155145,BRISTOL MYERS SQUIBB,,66.0,YR,E,F,Y,,,20230730,,HP,US,US,2023,Q3,Elderly
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Viral pharyngitis,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Product distribution issue,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Abdominal pain upper,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Headache,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Product use issue,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Fungal infection,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Pain,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Pancreatitis,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Product availability issue,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
218233537,21823353,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Insurance issue,,2023,Q3,7,F,20220224.0,20230925.0,20230105,20230927,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,93.87,KG,20230927,,CN,US,US,2023,Q3,Adult
220215506,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q3,Iron deficiency anaemia,,2023,Q3,6,F,20230101.0,20230901.0,20230222,20230912,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230912,,MD,US,US,2023,Q3,Adult
220215506,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q3,Maternal exposure during pregnancy,,2023,Q3,6,F,20230101.0,20230901.0,20230222,20230912,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230912,,MD,US,US,2023,Q3,Adult
220215506,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q3,Off label use,,2023,Q3,6,F,20230101.0,20230901.0,20230222,20230912,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230912,,MD,US,US,2023,Q3,Adult
220215506,22021550,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q3,Iron deficiency anaemia,,2023,Q3,6,F,20230101.0,20230901.0,20230222,20230912,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230912,,MD,US,US,2023,Q3,Adult
220215506,22021550,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q3,Maternal exposure during pregnancy,,2023,Q3,6,F,20230101.0,20230901.0,20230222,20230912,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230912,,MD,US,US,2023,Q3,Adult
220215506,22021550,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q3,Off label use,,2023,Q3,6,F,20230101.0,20230901.0,20230222,20230912,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20230912,,MD,US,US,2023,Q3,Adult
220433932,22043393,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(12-8-6),,,U,,Unknown,,,26.0,IU,Injection,,2023,Q3,Diabetes mellitus inadequate control,,2023,Q3,2,F,,20230731.0,20230228,20230808,EXP,,JP-EMD Serono-9386452,EMD SERONO INC,,5.0,DEC,A,F,Y,,,20230808,,HP,JP,JP,2023,Q3,Child
220544113,22054411,17,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,U,,,,209196.0,1.0,IU,,,2023,Q3,Toxic epidermal necrolysis,,2023,Q3,3,F,20200809.0,20230809.0,20230302,20230811,EXP,FR-EMA-DD-20220830-7180173-082651,FR-SANOFI-AVENTIS R+D-2023SA067613,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20230811,,MD,FR,FR,2023,Q3,Elderly
220627202,22062720,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,2,F,20230109.0,20230908.0,20230306,20230912,EXP,,NVSC2023DE045247,NOVARTIS,,83.0,YR,,M,Y,70.0,KG,20230912,,MD,DE,DE,2023,Q3,Elderly
220627202,22062720,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Neutropenia,,2023,Q3,2,F,20230109.0,20230908.0,20230306,20230912,EXP,,NVSC2023DE045247,NOVARTIS,,83.0,YR,,M,Y,70.0,KG,20230912,,MD,DE,DE,2023,Q3,Elderly
220627202,22062720,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Renal impairment,,2023,Q3,2,F,20230109.0,20230908.0,20230306,20230912,EXP,,NVSC2023DE045247,NOVARTIS,,83.0,YR,,M,Y,70.0,KG,20230912,,MD,DE,DE,2023,Q3,Elderly
221028824,22102882,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Renal impairment,,2023,Q3,4,F,20230308.0,20230907.0,20230316,20230911,EXP,,TR-JNJFOC-20230323567,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,97.0,KG,20230911,,MD,TR,TR,2023,Q3,Elderly
221028824,22102882,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Pyrexia,,2023,Q3,4,F,20230308.0,20230907.0,20230316,20230911,EXP,,TR-JNJFOC-20230323567,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,97.0,KG,20230911,,MD,TR,TR,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Kidney infection,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Rash,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Weight decreased,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Blood potassium increased,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Dizziness,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Anaphylactic reaction,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Erythema,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Vomiting,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Rehabilitation therapy,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Seizure,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Blood disorder,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Diabetic neuropathy,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Anaphylactic shock,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Urticaria,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Parkinsonism,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Diabetic ketoacidosis,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Tremor,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Coma,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Kidney infection,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Rash,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Weight decreased,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Blood potassium increased,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Dizziness,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Anaphylactic reaction,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Erythema,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Vomiting,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Rehabilitation therapy,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Seizure,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Blood disorder,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Diabetic neuropathy,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Anaphylactic shock,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Urticaria,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Parkinsonism,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Diabetic ketoacidosis,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Tremor,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221453763,22145376,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q3,Coma,,2023,Q3,3,F,,20230919.0,20230328,20230929,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20230929,,CN,US,US,2023,Q3,Elderly
221530132,22153013,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Taste disorder,,2023,Q3,2,F,,20230706.0,20230329,20230706,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-045149,BRISTOL MYERS SQUIBB,,64.0,YR,A,M,Y,,,20230706,,CN,US,US,2023,Q3,Adult
221530132,22153013,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,2,F,,20230706.0,20230329,20230706,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-045149,BRISTOL MYERS SQUIBB,,64.0,YR,A,M,Y,,,20230706,,CN,US,US,2023,Q3,Adult
221530132,22153013,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Blood pressure increased,,2023,Q3,2,F,,20230706.0,20230329,20230706,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-045149,BRISTOL MYERS SQUIBB,,64.0,YR,A,M,Y,,,20230706,,CN,US,US,2023,Q3,Adult
221669302,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Ear congestion,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Visual impairment,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Asthenia,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Stress,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Ear congestion,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Visual impairment,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Asthenia,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q3,Stress,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Ear congestion,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Visual impairment,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Asthenia,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Stress,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Ear congestion,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Visual impairment,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Asthenia,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Stress,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Ear congestion,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Visual impairment,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Asthenia,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Stress,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Ear congestion,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Visual impairment,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Asthenia,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
221669302,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q3,Stress,,2023,Q3,2,F,20230101.0,20230828.0,20230403,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Visual impairment,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Feeling hot,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Tinnitus,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Hyperhidrosis,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Peripheral coldness,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Depression,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Migraine,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222206762,22220676,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units AC,,,N,,Unknown,,,,,,,2023,Q3,Vision blurred,,2023,Q3,2,F,20230305.0,20230706.0,20230417,20230717,EXP,,US-NOVOPROD-1046362,NOVO NORDISK,,60.0,YR,,F,Y,,,20230717,,CN,US,US,2023,Q3,Adult
222594542,22259454,16,C,LISPRO 50LIS50NPL,,2,,,,,,,Unknown,,,,,Not specified,,2023,Q3,Dyspnoea,,2023,Q3,2,F,,20230717.0,20230427,20230725,EXP,,CA-FreseniusKabi-FK202305299,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
222594542,22259454,16,C,LISPRO 50LIS50NPL,,2,,,,,,,Unknown,,,,,Not specified,,2023,Q3,Lethargy,,2023,Q3,2,F,,20230717.0,20230427,20230725,EXP,,CA-FreseniusKabi-FK202305299,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
222594542,22259454,16,C,LISPRO 50LIS50NPL,,2,,,,,,,Unknown,,,,,Not specified,,2023,Q3,Depressed level of consciousness,,2023,Q3,2,F,,20230717.0,20230427,20230725,EXP,,CA-FreseniusKabi-FK202305299,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
222594542,22259454,16,C,LISPRO 50LIS50NPL,,2,,,,,,,Unknown,,,,,Not specified,,2023,Q3,Withdrawal of life support,,2023,Q3,2,F,,20230717.0,20230427,20230725,EXP,,CA-FreseniusKabi-FK202305299,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
222594542,22259454,16,C,LISPRO 50LIS50NPL,,2,,,,,,,Unknown,,,,,Not specified,,2023,Q3,Clostridium test positive,,2023,Q3,2,F,,20230717.0,20230427,20230725,EXP,,CA-FreseniusKabi-FK202305299,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
222594542,22259454,16,C,LISPRO 50LIS50NPL,,2,,,,,,,Unknown,,,,,Not specified,,2023,Q3,Palliative care,,2023,Q3,2,F,,20230717.0,20230427,20230725,EXP,,CA-FreseniusKabi-FK202305299,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
222594542,22259454,16,C,LISPRO 50LIS50NPL,,2,,,,,,,Unknown,,,,,Not specified,,2023,Q3,Unresponsive to stimuli,,2023,Q3,2,F,,20230717.0,20230427,20230725,EXP,,CA-FreseniusKabi-FK202305299,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
222595422,22259542,12,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,NOT SPECIFIED,,2023,Q3,Oxygen consumption increased,,2023,Q3,2,F,,20230814.0,20230427,20230818,EXP,,CA-FreseniusKabi-FK202305297,FRESENIUS KABI,,73.0,YR,E,M,Y,67.0,KG,20230818,,PH,CA,CA,2023,Q3,Elderly
222595422,22259542,12,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,NOT SPECIFIED,,2023,Q3,Clostridium test positive,,2023,Q3,2,F,,20230814.0,20230427,20230818,EXP,,CA-FreseniusKabi-FK202305297,FRESENIUS KABI,,73.0,YR,E,M,Y,67.0,KG,20230818,,PH,CA,CA,2023,Q3,Elderly
222595422,22259542,12,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,NOT SPECIFIED,,2023,Q3,Pneumonia aspiration,,2023,Q3,2,F,,20230814.0,20230427,20230818,EXP,,CA-FreseniusKabi-FK202305297,FRESENIUS KABI,,73.0,YR,E,M,Y,67.0,KG,20230818,,PH,CA,CA,2023,Q3,Elderly
222665773,22266577,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Hyperglycaemia,,2023,Q3,3,F,20230407.0,20230627.0,20230428,20230703,EXP,,US-PFIZER INC-PV202300076424,PFIZER,,18.0,YR,,M,Y,120.4,KG,20230703,,HP,US,US,2023,Q3,Youth
223556963,22355696,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Cutaneous amyloidosis,,2023,Q3,3,F,,20230823.0,20230523,20230829,EXP,FR-SA-2023SA139491,FR-MYLANLABS-2023M1052743,MYLAN,"Dubernet A, Toulmonde M, Colombat M, Hartog C, Riviere E.. Insulin amyloidosis: A case report. Frontiers in Medicine. 2023;10:1-5",55.0,YR,,M,Y,,,20230829,,HP,FR,FR,2023,Q3,Adult
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Blood glucose fluctuation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Drug ineffective,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site pruritus,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Diplopia,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Blood pressure increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site inflammation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site infection,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Urticaria,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site erythema,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Drug hypersensitivity,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site mass,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Dermal cyst,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Blood glucose fluctuation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Drug ineffective,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site pruritus,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Diplopia,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Blood pressure increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site inflammation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site infection,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Urticaria,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site erythema,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Drug hypersensitivity,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Injection site mass,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Dermal cyst,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Blood glucose fluctuation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Drug ineffective,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site pruritus,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Diplopia,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Blood pressure increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site inflammation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site infection,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Urticaria,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site erythema,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Drug hypersensitivity,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site mass,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Dermal cyst,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Blood glucose fluctuation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Drug ineffective,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site pruritus,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Diplopia,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Blood pressure increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site inflammation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site infection,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Urticaria,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site erythema,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Drug hypersensitivity,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Injection site mass,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Dermal cyst,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Blood glucose fluctuation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Drug ineffective,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Injection site pruritus,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Diplopia,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Blood pressure increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Injection site inflammation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Injection site infection,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Injection site pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Urticaria,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Injection site erythema,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Drug hypersensitivity,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Injection site mass,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,ASKU,,,,,Solution for injection,,2023,Q3,Dermal cyst,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Blood glucose fluctuation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Drug ineffective,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Injection site pruritus,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Diplopia,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Blood pressure increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Injection site inflammation,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Injection site infection,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Injection site pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Urticaria,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Injection site erythema,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Pain,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Drug hypersensitivity,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Injection site mass,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
223575274,22357527,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D549451A,,,,,Injection,,2023,Q3,Dermal cyst,,2023,Q3,4,F,,20230718.0,20230524,20230724,PER,,US-ELI_LILLY_AND_COMPANY-US202211002088,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
2239218610,22392186,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Device delivery system issue,,2023,Q3,10,F,,20230804.0,20230601,20230821,30DAY,,US-PFIZER INC-202300203511,PFIZER,,14.0,YR,,M,Y,56.69,KG,20230821,,CN,US,US,2023,Q3,Youth
2239218610,22392186,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Device issue,,2023,Q3,10,F,,20230804.0,20230601,20230821,30DAY,,US-PFIZER INC-202300203511,PFIZER,,14.0,YR,,M,Y,56.69,KG,20230821,,CN,US,US,2023,Q3,Youth
2239218610,22392186,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Device leakage,,2023,Q3,10,F,,20230804.0,20230601,20230821,30DAY,,US-PFIZER INC-202300203511,PFIZER,,14.0,YR,,M,Y,56.69,KG,20230821,,CN,US,US,2023,Q3,Youth
223995593,22399559,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Monoplegia,,2023,Q3,3,F,20230526.0,20230914.0,20230602,20230925,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
223995593,22399559,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Spinal fracture,,2023,Q3,3,F,20230526.0,20230914.0,20230602,20230925,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
223995593,22399559,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Therapy interrupted,,2023,Q3,3,F,20230526.0,20230914.0,20230602,20230925,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
223995593,22399559,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Fall,,2023,Q3,3,F,20230526.0,20230914.0,20230602,20230925,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
225191972,22519197,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Pulmonary embolism,,2023,Q3,2,F,,20230714.0,20230605,20230717,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-078095,BRISTOL MYERS SQUIBB,,74.0,YR,E,F,Y,140.16,KG,20230717,,HP,US,US,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood glucose increased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood calcium decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Platelet distribution width decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood pressure systolic increased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Ammonia increased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Haemolysis,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood creatine phosphokinase decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood bilirubin unconjugated increased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Prothrombin level decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,13,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Heart rate decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood glucose increased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood calcium decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Platelet distribution width decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood pressure systolic increased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Ammonia increased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Haemolysis,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood creatine phosphokinase decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Blood bilirubin unconjugated increased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Prothrombin level decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225412203,22541220,14,C,INSULIN LISPRO BS,,2,,1 DF,,,,,,,,,,,,2023,Q3,Heart rate decreased,,2023,Q3,3,F,20230520.0,20230705.0,20230609,20230710,EXP,,JP-PFIZER INC-PV202300100120,PFIZER,,76.0,YR,,M,Y,55.5,KG,20230710,,PH,JP,JP,2023,Q3,Elderly
225946192,22594619,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Death,,2023,Q3,2,F,20230625.0,20230629.0,20230613,20230705,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0600194,MYOVANT SCIENCES,,78.0,YR,,M,Y,,,20230705,,CN,US,US,2023,Q3,Elderly
225946192,22594619,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Mechanical ventilation,,2023,Q3,2,F,20230625.0,20230629.0,20230613,20230705,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0600194,MYOVANT SCIENCES,,78.0,YR,,M,Y,,,20230705,,CN,US,US,2023,Q3,Elderly
226015122,22601512,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,0000,,,,,,,,,,,,2023,Q3,Road traffic accident,,2023,Q3,2,F,20230609.0,20230710.0,20230614,20230712,EXP,,US-JAZZ PHARMACEUTICALS-2023-US-012665,JAZZ,,32.0,YR,,F,Y,,,20230712,,CN,US,US,2023,Q3,Young Adult
226064018,22606401,89,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,QID,2023,Q3,Constipation,,2023,Q3,8,F,20230406.0,20230821.0,20230615,20230829,EXP,,US-BAYER-2023A051125,BAYER,,64.0,YR,A,M,Y,106.59,KG,20230829,,MD,US,US,2023,Q3,Adult
226064018,22606401,89,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,QID,2023,Q3,Sepsis,,2023,Q3,8,F,20230406.0,20230821.0,20230615,20230829,EXP,,US-BAYER-2023A051125,BAYER,,64.0,YR,A,M,Y,106.59,KG,20230829,,MD,US,US,2023,Q3,Adult
226064018,22606401,89,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,QID,2023,Q3,Hypotension,,2023,Q3,8,F,20230406.0,20230821.0,20230615,20230829,EXP,,US-BAYER-2023A051125,BAYER,,64.0,YR,A,M,Y,106.59,KG,20230829,,MD,US,US,2023,Q3,Adult
226064018,22606401,89,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,QID,2023,Q3,Gastrointestinal haemorrhage,,2023,Q3,8,F,20230406.0,20230821.0,20230615,20230829,EXP,,US-BAYER-2023A051125,BAYER,,64.0,YR,A,M,Y,106.59,KG,20230829,,MD,US,US,2023,Q3,Adult
226064018,22606401,89,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,QID,2023,Q3,Anaemia,,2023,Q3,8,F,20230406.0,20230821.0,20230615,20230829,EXP,,US-BAYER-2023A051125,BAYER,,64.0,YR,A,M,Y,106.59,KG,20230829,,MD,US,US,2023,Q3,Adult
226219883,22621988,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"26 international unit, prn",,,U,,1645281,,20563.0,26.0,IU,Solution for injection,,2023,Q3,Arthralgia,,2023,Q3,3,F,20230606.0,20230623.0,20230620,20230705,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202306006754,ELI LILLY AND CO,,23.0,YR,,F,Y,92.4,KG,20230705,,MD,PL,PL,2023,Q3,Youth
226295204,22629520,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,15 u,,,,,,,,15.0,IU,,,2023,Q3,Metastases to lymph nodes,,2023,Q3,4,F,20230501.0,20230803.0,20230622,20230815,EXP,,US-ELI_LILLY_AND_COMPANY-US202306010989,ELI LILLY AND CO,,44.0,YR,,M,Y,102.0,KG,20230815,,CN,US,US,2023,Q3,Adult
226295204,22629520,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,15 u,,,,,,,,15.0,IU,,,2023,Q3,Medullary thyroid cancer,,2023,Q3,4,F,20230501.0,20230803.0,20230622,20230815,EXP,,US-ELI_LILLY_AND_COMPANY-US202306010989,ELI LILLY AND CO,,44.0,YR,,M,Y,102.0,KG,20230815,,CN,US,US,2023,Q3,Adult
226329522,22632952,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dosage: 24-16-22 units,,,Y,,,,209196.0,,,Solution for injection,,2023,Q3,Alanine aminotransferase increased,,2023,Q3,2,F,20230126.0,20230628.0,20230623,20230707,EXP,,PL-SA-2023SA190880,SANOFI AVENTIS,,31.0,YR,A,M,Y,86.0,KG,20230707,,HP,PL,PL,2023,Q3,Young Adult
226329522,22632952,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dosage: 24-16-22 units,,,Y,,,,209196.0,,,Solution for injection,,2023,Q3,Aspartate aminotransferase increased,,2023,Q3,2,F,20230126.0,20230628.0,20230623,20230707,EXP,,PL-SA-2023SA190880,SANOFI AVENTIS,,31.0,YR,A,M,Y,86.0,KG,20230707,,HP,PL,PL,2023,Q3,Young Adult
226417034,22641703,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-5 U Every evening,,,,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,4,F,20230608.0,20230714.0,20230626,20230719,EXP,,US-ABBVIE-5298625,ABBVIE,,69.0,YR,,M,Y,59.874,KG,20230719,,MD,US,US,2023,Q3,Elderly
226508442,22650844,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Tremor,,2023,Q3,2,F,,20230802.0,20230628,20230811,EXP,,CH-TEVA-2023-CH-2901625,TEVA,,72.0,YR,E,M,Y,,,20230811,,HP,CH,CH,2023,Q3,Elderly
226516982,22651698,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2023,Q3,Hypomagnesaemia,,2023,Q3,2,F,,20230622.0,20230628,20230705,EXP,,CH-MYLANLABS-2023M1067130,MYLAN,"Dr. med. (RS) Lazic M, Dr. med. Dr. sc. nat. Henzi A, PD Dr. med. Brack T. Tremor in the polymedicated patient. Schweizerische Arztezeitung+Swiss Medical Forum. 2023;1-5",72.0,YR,,M,Y,,,20230705,,MD,CH,CH,2023,Q3,Elderly
226563053,22656305,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 Units SQ 3x daily with meals,,,Y,,,,,,,,,2023,Q3,Cytokine release syndrome,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 Units SQ 3x daily with meals,,,Y,,,,,,,,,2023,Q3,Immune effector cell-associated neurotoxicity syndrome,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 Units SQ 3x daily with meals,,,Y,,,,,,,,,2023,Q3,Haemophagocytic lymphohistiocytosis,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 Units SQ 3x daily with meals,,,Y,,,,,,,,,2023,Q3,Candida infection,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 Units SQ 3x daily with meals,,,Y,,,,,,,,,2023,Q3,Shock,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 Units SQ 3x daily with meals,,,Y,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Insulin lispro 0-8 Units SQ bedtime,,,Y,,,,,,,,,2023,Q3,Cytokine release syndrome,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Insulin lispro 0-8 Units SQ bedtime,,,Y,,,,,,,,,2023,Q3,Immune effector cell-associated neurotoxicity syndrome,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Insulin lispro 0-8 Units SQ bedtime,,,Y,,,,,,,,,2023,Q3,Haemophagocytic lymphohistiocytosis,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Insulin lispro 0-8 Units SQ bedtime,,,Y,,,,,,,,,2023,Q3,Candida infection,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Insulin lispro 0-8 Units SQ bedtime,,,Y,,,,,,,,,2023,Q3,Shock,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226563053,22656305,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Insulin lispro 0-8 Units SQ bedtime,,,Y,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,3,F,20230612.0,20230905.0,20230629,20230919,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-090983,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20230919,,HP,US,US,2023,Q3,Elderly
226609182,22660918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24-16-22 units, unknown",,,Y,,,,20563.0,,,,,2023,Q3,Aspartate aminotransferase increased,,2023,Q3,2,F,20230126.0,20230710.0,20230630,20230718,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202306016085,ELI LILLY AND CO,,31.0,YR,,M,Y,86.0,KG,20230718,,CN,PL,PL,2023,Q3,Young Adult
226609182,22660918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24-16-22 units, unknown",,,Y,,,,20563.0,,,,,2023,Q3,Alanine aminotransferase increased,,2023,Q3,2,F,20230126.0,20230710.0,20230630,20230718,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202306016085,ELI LILLY AND CO,,31.0,YR,,M,Y,86.0,KG,20230718,,CN,PL,PL,2023,Q3,Young Adult
226627854,22662785,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 international unit, prn",,,U,,135519,,20563.0,16.0,IU,,,2023,Q3,Chronic granulomatous disease,,2023,Q3,4,F,20230508.0,20230828.0,20230702,20230904,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202306014502,ELI LILLY AND CO,,31.0,YR,,M,Y,83.7,KG,20230904,,MD,PL,PL,2023,Q3,Young Adult
226627854,22662785,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 international unit, prn",,,U,,135519,,20563.0,16.0,IU,,,2023,Q3,Meniscus injury,,2023,Q3,4,F,20230508.0,20230828.0,20230702,20230904,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202306014502,ELI LILLY AND CO,,31.0,YR,,M,Y,83.7,KG,20230904,,MD,PL,PL,2023,Q3,Young Adult
226659231,22665923,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230601.0,20230627.0,20230703,20230703,PER,,US-ELI_LILLY_AND_COMPANY-US202306017863,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20230703,,CN,US,US,2023,Q3,Adult
226674421,22667442,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Hospitalisation,,2023,Q3,1,I,,20230627.0,20230704,20230704,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-091403,BRISTOL MYERS SQUIBB,,76.0,YR,E,F,Y,,,20230704,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Abdominal discomfort,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Sleep disorder,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Restlessness,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Abdominal distension,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Hyperglycaemia,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Pain,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Feeling abnormal,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Fatigue,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Product use in unapproved indication,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226692022,22669202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,2F8747A,,209196.0,,,Solution for injection,,2023,Q3,Poor quality sleep,,2023,Q3,2,F,,20230711.0,20230704,20230717,PER,,US-SA-2023SA202751,SANOFI AVENTIS,,68.0,YR,E,F,Y,102.0,KG,20230717,,CN,US,US,2023,Q3,Elderly
226729951,22672995,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Dyspnoea exertional,,2023,Q3,1,I,,20230629.0,20230705,20230705,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-093872,BRISTOL MYERS SQUIBB,,73.0,YR,E,F,Y,92.99,KG,20230705,,MD,US,US,2023,Q3,Elderly
226751481,22675148,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,,,2023,Q3,Diabetes mellitus inadequate control,,2023,Q3,1,I,,20230622.0,20230706,20230706,EXP,,JP-NOVOPROD-795026,NOVO NORDISK,K. Yoshimura et al.. A case of pregnancy with diabetes needed high dose of insulin for glycaemic control during perinatal period. Program and abstracts of the 57th Kinki Regional Meeting of The Japan Diabetes S,25.0,YR,,F,Y,92.9,KG,20230706,,MD,JP,JP,2023,Q3,Young Adult
226751481,22675148,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,,,2023,Q3,Obstructed labour,,2023,Q3,1,I,,20230622.0,20230706,20230706,EXP,,JP-NOVOPROD-795026,NOVO NORDISK,K. Yoshimura et al.. A case of pregnancy with diabetes needed high dose of insulin for glycaemic control during perinatal period. Program and abstracts of the 57th Kinki Regional Meeting of The Japan Diabetes S,25.0,YR,,F,Y,92.9,KG,20230706,,MD,JP,JP,2023,Q3,Young Adult
226751481,22675148,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,,,2023,Q3,Diabetes mellitus inadequate control,,2023,Q3,1,I,,20230622.0,20230706,20230706,EXP,,JP-NOVOPROD-795026,NOVO NORDISK,K. Yoshimura et al.. A case of pregnancy with diabetes needed high dose of insulin for glycaemic control during perinatal period. Program and abstracts of the 57th Kinki Regional Meeting of The Japan Diabetes S,25.0,YR,,F,Y,92.9,KG,20230706,,MD,JP,JP,2023,Q3,Young Adult
226751481,22675148,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,,20230622.0,20230706,20230706,EXP,,JP-NOVOPROD-795026,NOVO NORDISK,K. Yoshimura et al.. A case of pregnancy with diabetes needed high dose of insulin for glycaemic control during perinatal period. Program and abstracts of the 57th Kinki Regional Meeting of The Japan Diabetes S,25.0,YR,,F,Y,92.9,KG,20230706,,MD,JP,JP,2023,Q3,Young Adult
226751481,22675148,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,,,2023,Q3,Maternal exposure during pregnancy,,2023,Q3,1,I,,20230622.0,20230706,20230706,EXP,,JP-NOVOPROD-795026,NOVO NORDISK,K. Yoshimura et al.. A case of pregnancy with diabetes needed high dose of insulin for glycaemic control during perinatal period. Program and abstracts of the 57th Kinki Regional Meeting of The Japan Diabetes S,25.0,YR,,F,Y,92.9,KG,20230706,,MD,JP,JP,2023,Q3,Young Adult
226751481,22675148,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,,,2023,Q3,Blood pressure increased,,2023,Q3,1,I,,20230622.0,20230706,20230706,EXP,,JP-NOVOPROD-795026,NOVO NORDISK,K. Yoshimura et al.. A case of pregnancy with diabetes needed high dose of insulin for glycaemic control during perinatal period. Program and abstracts of the 57th Kinki Regional Meeting of The Japan Diabetes S,25.0,YR,,F,Y,92.9,KG,20230706,,MD,JP,JP,2023,Q3,Young Adult
226754621,22675462,9,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,General physical health deterioration,,2023,Q3,1,I,,20230629.0,20230706,20230706,EXP,,CA-AstraZeneca-2023A153466,ASTRAZENECA,,67.0,YR,,F,Y,102.0,KG,20230706,,MD,CA,,2023,Q3,Elderly
226754621,22675462,9,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Anion gap increased,,2023,Q3,1,I,,20230629.0,20230706,20230706,EXP,,CA-AstraZeneca-2023A153466,ASTRAZENECA,,67.0,YR,,F,Y,102.0,KG,20230706,,MD,CA,,2023,Q3,Elderly
226754621,22675462,9,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,,20230629.0,20230706,20230706,EXP,,CA-AstraZeneca-2023A153466,ASTRAZENECA,,67.0,YR,,F,Y,102.0,KG,20230706,,MD,CA,,2023,Q3,Elderly
226754621,22675462,9,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Decreased appetite,,2023,Q3,1,I,,20230629.0,20230706,20230706,EXP,,CA-AstraZeneca-2023A153466,ASTRAZENECA,,67.0,YR,,F,Y,102.0,KG,20230706,,MD,CA,,2023,Q3,Elderly
226754621,22675462,9,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,,20230629.0,20230706,20230706,EXP,,CA-AstraZeneca-2023A153466,ASTRAZENECA,,67.0,YR,,F,Y,102.0,KG,20230706,,MD,CA,,2023,Q3,Elderly
226754621,22675462,9,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,,20230629.0,20230706,20230706,EXP,,CA-AstraZeneca-2023A153466,ASTRAZENECA,,67.0,YR,,F,Y,102.0,KG,20230706,,MD,CA,,2023,Q3,Elderly
226754621,22675462,9,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,,20230629.0,20230706,20230706,EXP,,CA-AstraZeneca-2023A153466,ASTRAZENECA,,67.0,YR,,F,Y,102.0,KG,20230706,,MD,CA,,2023,Q3,Elderly
226769361,22676936,10,C,INSULINE LISPRO,,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypovolaemic shock,,2023,Q3,1,I,,20230626.0,20230706,20230706,EXP,,FR-TEVA-2023-FR-2903069,TEVA,,62.0,YR,A,M,Y,,,20230706,,HP,FR,FR,2023,Q3,Adult
226769361,22676936,10,C,INSULINE LISPRO,,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diarrhoea,Diarrhoea,2023,Q3,1,I,,20230626.0,20230706,20230706,EXP,,FR-TEVA-2023-FR-2903069,TEVA,,62.0,YR,A,M,Y,,,20230706,,HP,FR,FR,2023,Q3,Adult
226781556,22678155,90,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,,2023,Q3,Hypotension,,2023,Q3,6,F,20230406.0,20230821.0,20230706,20230830,EXP,,US-JNJFOC-20230708631,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,106.59,KG,20230830,,MD,US,US,2023,Q3,Adult
226781556,22678155,90,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,,2023,Q3,Sepsis,,2023,Q3,6,F,20230406.0,20230821.0,20230706,20230830,EXP,,US-JNJFOC-20230708631,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,106.59,KG,20230830,,MD,US,US,2023,Q3,Adult
226781556,22678155,90,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,,2023,Q3,Anaemia,,2023,Q3,6,F,20230406.0,20230821.0,20230706,20230830,EXP,,US-JNJFOC-20230708631,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,106.59,KG,20230830,,MD,US,US,2023,Q3,Adult
226781556,22678155,90,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,,2023,Q3,Gastrointestinal haemorrhage,,2023,Q3,6,F,20230406.0,20230821.0,20230706,20230830,EXP,,US-JNJFOC-20230708631,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,106.59,KG,20230830,,MD,US,US,2023,Q3,Adult
226781556,22678155,90,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.75 iu, QID",,,,,,,,3.75,IU,,,2023,Q3,Constipation,,2023,Q3,6,F,20230406.0,20230821.0,20230706,20230830,EXP,,US-JNJFOC-20230708631,JOHNSON AND JOHNSON,,64.0,YR,A,M,Y,106.59,KG,20230830,,MD,US,US,2023,Q3,Adult
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Dyslipidaemia,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Amenorrhoea,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Hypoaesthesia,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Abdominal distension,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Muscle spasms,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Intentional product misuse,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Ketoacidosis,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Increased appetite,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Blood glucose fluctuation,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Diabetes mellitus inadequate control,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Diabetic nephropathy,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Hypoglycaemia,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Transaminases increased,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Menstrual disorder,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Insulin resistance,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Developmental delay,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Loss of consciousness,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Suicide attempt,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Mauriac syndrome,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Microalbuminuria,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Injection site atrophy,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226794792,22679479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Hepatomegaly,,2023,Q3,2,F,,20230705.0,20230707,20230711,EXP,,RU-SA-2023SA205188,SANOFI AVENTIS,,14.0,YR,T,F,Y,,,20230711,,HP,RU,RU,2023,Q3,Youth
226797451,22679745,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D518829A,,20563.0,10.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230705.0,20230706.0,20230707,20230707,PER,,US-ELI_LILLY_AND_COMPANY-US202307003927,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20230707,,CN,US,US,2023,Q3,Elderly
226797451,22679745,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D518829A,,20563.0,10.0,IU,Injection,,2023,Q3,Product dose omission issue,,2023,Q3,1,I,20230705.0,20230706.0,20230707,20230707,PER,,US-ELI_LILLY_AND_COMPANY-US202307003927,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20230707,,CN,US,US,2023,Q3,Elderly
226878171,22687817,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, bid (each morning and evening)",,,,,,,,22.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, bid (each morning and evening)",,,,,D420813A,,,24.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, bid (each morning and evening)",,,,,D420813A,,,24.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, bid (each morning and evening)",,,,,D420813A,,,24.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, bid (each morning and evening)",,,,,D420813A,,,24.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, bid (each morning and evening)",,,,,D420813A,,,24.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, bid (each morning and evening)",,,,,D420813A,,,24.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, bid (each morning and evening)",,,,,D420813A,,,24.0,IU,Injection,BID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, bid (each morning and evening)",,,,,D420813A,,,24.0,IU,Injection,BID,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, other, 18-20 units per meal",,,,,D549451A,,,18.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, other, 18-20 units per meal",,,,,D549451A,,,18.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, other, 18-20 units per meal",,,,,D549451A,,,18.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, other, 18-20 units per meal",,,,,D549451A,,,18.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, other, 18-20 units per meal",,,,,D549451A,,,18.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, other, 18-20 units per meal",,,,,D549451A,,,18.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, other, 18-20 units per meal",,,,,D549451A,,,18.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, other, 18-20 units per meal",,,,,D549451A,,,18.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, other",,,,,D549451A,,,60.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, other",,,,,D549451A,,,60.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, other",,,,,D549451A,,,60.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, other",,,,,D549451A,,,60.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, other",,,,,D549451A,,,60.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, other",,,,,D549451A,,,60.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, other",,,,,D549451A,,,60.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226878171,22687817,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, other",,,,,D549451A,,,60.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20220518.0,20230630.0,20230710,20230710,PER,,US-ELI_LILLY_AND_COMPANY-US202206000935,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20230710,,CN,US,US,2023,Q3,Elderly
226895231,22689523,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,15 mL,,,,,3F509A,,,15.0,ML,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20210101.0,20230706.0,20230711,20230711,EXP,,IT-SA-2023SA192489,SANOFI AVENTIS,,72.0,YR,E,M,Y,47.0,KG,20230711,,CN,IT,IT,2023,Q3,Elderly
226895231,22689523,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,15 mL,,,,,3F509A,,,15.0,ML,Solution for injection,,2023,Q3,Gastric disorder,,2023,Q3,1,I,20210101.0,20230706.0,20230711,20230711,EXP,,IT-SA-2023SA192489,SANOFI AVENTIS,,72.0,YR,E,M,Y,47.0,KG,20230711,,CN,IT,IT,2023,Q3,Elderly
226895231,22689523,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,15 mL,,,,,3F509A,,,15.0,ML,Solution for injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20210101.0,20230706.0,20230711,20230711,EXP,,IT-SA-2023SA192489,SANOFI AVENTIS,,72.0,YR,E,M,Y,47.0,KG,20230711,,CN,IT,IT,2023,Q3,Elderly
226895231,22689523,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,15 mL,,,,,3F509A,,,15.0,ML,Solution for injection,,2023,Q3,Gastric cancer,,2023,Q3,1,I,20210101.0,20230706.0,20230711,20230711,EXP,,IT-SA-2023SA192489,SANOFI AVENTIS,,72.0,YR,E,M,Y,47.0,KG,20230711,,CN,IT,IT,2023,Q3,Elderly
226895231,22689523,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,15 mL,,,,,3F509A,,,15.0,ML,Solution for injection,,2023,Q3,Feeding disorder,,2023,Q3,1,I,20210101.0,20230706.0,20230711,20230711,EXP,,IT-SA-2023SA192489,SANOFI AVENTIS,,72.0,YR,E,M,Y,47.0,KG,20230711,,CN,IT,IT,2023,Q3,Elderly
226895231,22689523,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,15 mL,,,,,3F509A,,,15.0,ML,Solution for injection,,2023,Q3,Pancreatic carcinoma,,2023,Q3,1,I,20210101.0,20230706.0,20230711,20230711,EXP,,IT-SA-2023SA192489,SANOFI AVENTIS,,72.0,YR,E,M,Y,47.0,KG,20230711,,CN,IT,IT,2023,Q3,Elderly
226895231,22689523,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,15 mL,,,,,3F509A,,,15.0,ML,Solution for injection,,2023,Q3,Hepatic cancer,,2023,Q3,1,I,20210101.0,20230706.0,20230711,20230711,EXP,,IT-SA-2023SA192489,SANOFI AVENTIS,,72.0,YR,E,M,Y,47.0,KG,20230711,,CN,IT,IT,2023,Q3,Elderly
226895661,22689566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, tid",120.0,IU,U,,202109009,,,8.0,IU,,TID,2023,Q3,Palpitations,,2023,Q3,1,I,20230222.0,20230630.0,20230711,20230711,EXP,CN-NMPA-5101821043965202300224,CN-NOVOPROD-1086765,NOVO NORDISK,,52.0,YR,,M,Y,65.0,KG,20230711,,HP,CN,CN,2023,Q3,Adult
226895661,22689566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, tid",120.0,IU,U,,202109009,,,8.0,IU,,TID,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,20230222.0,20230630.0,20230711,20230711,EXP,CN-NMPA-5101821043965202300224,CN-NOVOPROD-1086765,NOVO NORDISK,,52.0,YR,,M,Y,65.0,KG,20230711,,HP,CN,CN,2023,Q3,Adult
226895661,22689566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, tid",120.0,IU,U,,202109009,,,8.0,IU,,TID,2023,Q3,Hyperhidrosis,,2023,Q3,1,I,20230222.0,20230630.0,20230711,20230711,EXP,CN-NMPA-5101821043965202300224,CN-NOVOPROD-1086765,NOVO NORDISK,,52.0,YR,,M,Y,65.0,KG,20230711,,HP,CN,CN,2023,Q3,Adult
226915571,22691557,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101G,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226915571,22691557,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101G,,20563.0,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226915571,22691557,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101G,,20563.0,,,Injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226915571,22691557,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101G,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226915571,22691557,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101G,,20563.0,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226915571,22691557,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101G,,20563.0,,,Injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226915571,22691557,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226915571,22691557,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226915571,22691557,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230709.0,20230710.0,20230711,20230711,PER,,US-ELI_LILLY_AND_COMPANY-US202307005596,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230711,,CN,US,US,2023,Q3,Elderly
226917243,22691724,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,Unknown,Q6H,2023,Q3,Sepsis,,2023,Q3,3,F,20230608.0,20230810.0,20230711,20230825,PER,,US-JNJFOC-20230707535,JOHNSON AND JOHNSON,,54.0,YR,A,F,Y,57.9,KG,20230825,,HP,US,US,2023,Q3,Adult
226917243,22691724,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,Unknown,Q6H,2023,Q3,Pneumonia aspiration,,2023,Q3,3,F,20230608.0,20230810.0,20230711,20230825,PER,,US-JNJFOC-20230707535,JOHNSON AND JOHNSON,,54.0,YR,A,F,Y,57.9,KG,20230825,,HP,US,US,2023,Q3,Adult
226917243,22691724,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,Unknown,Q6H,2023,Q3,Cytokine release syndrome,,2023,Q3,3,F,20230608.0,20230810.0,20230711,20230825,PER,,US-JNJFOC-20230707535,JOHNSON AND JOHNSON,,54.0,YR,A,F,Y,57.9,KG,20230825,,HP,US,US,2023,Q3,Adult
226917243,22691724,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,Unknown,Q6H,2023,Q3,Atrial fibrillation,,2023,Q3,3,F,20230608.0,20230810.0,20230711,20230825,PER,,US-JNJFOC-20230707535,JOHNSON AND JOHNSON,,54.0,YR,A,F,Y,57.9,KG,20230825,,HP,US,US,2023,Q3,Adult
226917243,22691724,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,Unknown,Q2H,2023,Q3,Sepsis,,2023,Q3,3,F,20230608.0,20230810.0,20230711,20230825,PER,,US-JNJFOC-20230707535,JOHNSON AND JOHNSON,,54.0,YR,A,F,Y,57.9,KG,20230825,,HP,US,US,2023,Q3,Adult
226917243,22691724,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,Unknown,Q2H,2023,Q3,Pneumonia aspiration,,2023,Q3,3,F,20230608.0,20230810.0,20230711,20230825,PER,,US-JNJFOC-20230707535,JOHNSON AND JOHNSON,,54.0,YR,A,F,Y,57.9,KG,20230825,,HP,US,US,2023,Q3,Adult
226917243,22691724,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,Unknown,Q2H,2023,Q3,Cytokine release syndrome,,2023,Q3,3,F,20230608.0,20230810.0,20230711,20230825,PER,,US-JNJFOC-20230707535,JOHNSON AND JOHNSON,,54.0,YR,A,F,Y,57.9,KG,20230825,,HP,US,US,2023,Q3,Adult
226917243,22691724,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,Unknown,Q2H,2023,Q3,Atrial fibrillation,,2023,Q3,3,F,20230608.0,20230810.0,20230711,20230825,PER,,US-JNJFOC-20230707535,JOHNSON AND JOHNSON,,54.0,YR,A,F,Y,57.9,KG,20230825,,HP,US,US,2023,Q3,Adult
226921162,22692116,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 iU, 3x/day",,,,,,,,18.0,IU,,TID,2023,Q3,C-reactive protein increased,,2023,Q3,2,F,20230518.0,20230830.0,20230711,20230830,EXP,,PL-PFIZER INC-PV202300118772,PFIZER,,66.0,YR,,F,Y,114.0,KG,20230830,,MD,PL,PL,2023,Q3,Elderly
226921162,22692116,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 iU, 3x/day",,,,,,,,18.0,IU,,TID,2023,Q3,Chills,,2023,Q3,2,F,20230518.0,20230830.0,20230711,20230830,EXP,,PL-PFIZER INC-PV202300118772,PFIZER,,66.0,YR,,F,Y,114.0,KG,20230830,,MD,PL,PL,2023,Q3,Elderly
226921162,22692116,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 iU, 3x/day",,,,,,,,18.0,IU,,TID,2023,Q3,Asthenia,,2023,Q3,2,F,20230518.0,20230830.0,20230711,20230830,EXP,,PL-PFIZER INC-PV202300118772,PFIZER,,66.0,YR,,F,Y,114.0,KG,20230830,,MD,PL,PL,2023,Q3,Elderly
226921162,22692116,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 iU, 3x/day",,,,,,,,18.0,IU,,TID,2023,Q3,Thrombocytopenia,,2023,Q3,2,F,20230518.0,20230830.0,20230711,20230830,EXP,,PL-PFIZER INC-PV202300118772,PFIZER,,66.0,YR,,F,Y,114.0,KG,20230830,,MD,PL,PL,2023,Q3,Elderly
226966831,22696683,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 unit, TID",,,Y,,202112021,,,,,Injection,TID,2023,Q3,Amaurosis,,2023,Q3,1,I,20230626.0,20230707.0,20230712,20230712,EXP,,NVSC2023CN153880,NOVARTIS,,60.0,YR,,M,Y,58.0,KG,20230712,,HP,CN,CN,2023,Q3,Adult
226966831,22696683,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 unit, TID",,,Y,,202112021,,,,,Injection,TID,2023,Q3,Dizziness,,2023,Q3,1,I,20230626.0,20230707.0,20230712,20230712,EXP,,NVSC2023CN153880,NOVARTIS,,60.0,YR,,M,Y,58.0,KG,20230712,,HP,CN,CN,2023,Q3,Adult
226966831,22696683,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 unit, TID",,,Y,,202112021,,,,,Injection,TID,2023,Q3,Wrong technique in product usage process,,2023,Q3,1,I,20230626.0,20230707.0,20230712,20230712,EXP,,NVSC2023CN153880,NOVARTIS,,60.0,YR,,M,Y,58.0,KG,20230712,,HP,CN,CN,2023,Q3,Adult
226966831,22696683,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 unit, TID",,,Y,,202112021,,,,,Injection,TID,2023,Q3,Prescribed underdose,,2023,Q3,1,I,20230626.0,20230707.0,20230712,20230712,EXP,,NVSC2023CN153880,NOVARTIS,,60.0,YR,,M,Y,58.0,KG,20230712,,HP,CN,CN,2023,Q3,Adult
226966831,22696683,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 unit, TID",,,Y,,202112021,,,,,Injection,TID,2023,Q3,Palpitations,,2023,Q3,1,I,20230626.0,20230707.0,20230712,20230712,EXP,,NVSC2023CN153880,NOVARTIS,,60.0,YR,,M,Y,58.0,KG,20230712,,HP,CN,CN,2023,Q3,Adult
226966831,22696683,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 unit, TID",,,Y,,202112021,,,,,Injection,TID,2023,Q3,Hypotension,,2023,Q3,1,I,20230626.0,20230707.0,20230712,20230712,EXP,,NVSC2023CN153880,NOVARTIS,,60.0,YR,,M,Y,58.0,KG,20230712,,HP,CN,CN,2023,Q3,Adult
226970141,22697014,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Hyperkalaemia,,2023,Q3,1,I,20220809.0,20230627.0,20230712,20230712,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-398534,RANBAXY,,70.0,YR,,M,Y,,,20230712,,MD,IT,IT,2023,Q3,Elderly
227037041,22703704,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNK,,,,,,,2023,Q3,Hypernatraemia,,2023,Q3,1,I,,20230704.0,20230714,20230714,EXP,,US-AVET LIFESCIENCES LTD-2023-AVET-000206,EMCURE,"Desai D, Pati S, Evangelista MCA.. A Case of Hypernatremia With Dementia. Cureus. 2023;15(5):e39603",56.0,YR,,F,Y,,,20230713,,HP,US,US,2023,Q3,Adult
227102271,22710227,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"Dose Description : 5 U, QD (in morning)",,,,,,,,5.0,IU,Unknown,QD,2023,Q3,Agranulocytosis,,2023,Q3,1,I,20220506.0,20230712.0,20230717,20230717,EXP,,DE-CHATTEMPRD-2023SA108365,CHATTEM,,62.0,YR,A,M,Y,,,20230717,,MD,DE,DE,2023,Q3,Adult
227102271,22710227,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"Dose Description : 5 U, QD (in morning)",,,,,,,,5.0,IU,Unknown,QD,2023,Q3,Haemolysis,,2023,Q3,1,I,20220506.0,20230712.0,20230717,20230717,EXP,,DE-CHATTEMPRD-2023SA108365,CHATTEM,,62.0,YR,A,M,Y,,,20230717,,MD,DE,DE,2023,Q3,Adult
227102271,22710227,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"Dose Description : 6 iU, BID",,,,,,,,6.0,IU,Unknown,,2023,Q3,Agranulocytosis,,2023,Q3,1,I,20220506.0,20230712.0,20230717,20230717,EXP,,DE-CHATTEMPRD-2023SA108365,CHATTEM,,62.0,YR,A,M,Y,,,20230717,,MD,DE,DE,2023,Q3,Adult
227102271,22710227,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"Dose Description : 6 iU, BID",,,,,,,,6.0,IU,Unknown,,2023,Q3,Haemolysis,,2023,Q3,1,I,20220506.0,20230712.0,20230717,20230717,EXP,,DE-CHATTEMPRD-2023SA108365,CHATTEM,,62.0,YR,A,M,Y,,,20230717,,MD,DE,DE,2023,Q3,Adult
227107022,22710702,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Injection,,2023,Q3,Pneumonia,,2023,Q3,2,F,20230630.0,20230717.0,20230717,20230724,EXP,,US-Eisai Medical Research-EC-2023-144160,EISAI,,62.0,YR,A,F,Y,105.7,KG,20230724,,MD,US,,2023,Q3,Adult
227107022,22710702,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Injection,,2023,Q3,Clostridium difficile infection,,2023,Q3,2,F,20230630.0,20230717.0,20230717,20230724,EXP,,US-Eisai Medical Research-EC-2023-144160,EISAI,,62.0,YR,A,F,Y,105.7,KG,20230724,,MD,US,,2023,Q3,Adult
227107022,22710702,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Injection,,2023,Q3,Diarrhoea,,2023,Q3,2,F,20230630.0,20230717.0,20230717,20230724,EXP,,US-Eisai Medical Research-EC-2023-144160,EISAI,,62.0,YR,A,F,Y,105.7,KG,20230724,,MD,US,,2023,Q3,Adult
227107022,22710702,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Injection,,2023,Q3,Hypoxia,,2023,Q3,2,F,20230630.0,20230717.0,20230717,20230724,EXP,,US-Eisai Medical Research-EC-2023-144160,EISAI,,62.0,YR,A,F,Y,105.7,KG,20230724,,MD,US,,2023,Q3,Adult
227107022,22710702,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Injection,,2023,Q3,Dehydration,,2023,Q3,2,F,20230630.0,20230717.0,20230717,20230724,EXP,,US-Eisai Medical Research-EC-2023-144160,EISAI,,62.0,YR,A,F,Y,105.7,KG,20230724,,MD,US,,2023,Q3,Adult
227107022,22710702,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Injection,,2023,Q3,Chronic obstructive pulmonary disease,,2023,Q3,2,F,20230630.0,20230717.0,20230717,20230724,EXP,,US-Eisai Medical Research-EC-2023-144160,EISAI,,62.0,YR,A,F,Y,105.7,KG,20230724,,MD,US,,2023,Q3,Adult
227107022,22710702,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Injection,,2023,Q3,Norovirus infection,,2023,Q3,2,F,20230630.0,20230717.0,20230717,20230724,EXP,,US-Eisai Medical Research-EC-2023-144160,EISAI,,62.0,YR,A,F,Y,105.7,KG,20230724,,MD,US,,2023,Q3,Adult
227175881,22717588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Incorrect route of product administration,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Coma,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Palpitations,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Poor quality product administered,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Memory impairment,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Incorrect route of product administration,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Coma,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Palpitations,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Poor quality product administered,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Memory impairment,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Incorrect route of product administration,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Coma,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Palpitations,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Poor quality product administered,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Memory impairment,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Incorrect route of product administration,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Hypoacusis,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Coma,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Palpitations,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Poor quality product administered,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227175881,22717588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q3,Memory impairment,,2023,Q3,1,I,20230316.0,20230710.0,20230718,20230718,EXP,,US-ELI_LILLY_AND_COMPANY-US202307006064,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20230718,,CN,US,US,2023,Q3,Adult
227296563,22729656,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 iU/mL,,,,,,,,200.0,IU,,,2023,Q3,General physical health deterioration,,2023,Q3,3,F,20230130.0,20230721.0,20230720,20230728,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202307010482,ELI LILLY AND CO,,71.0,YR,,F,Y,52.0,KG,20230728,,HP,IT,IT,2023,Q3,Elderly
227296563,22729656,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 iU/mL,,,,,,,,200.0,IU,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,20230130.0,20230721.0,20230720,20230728,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202307010482,ELI LILLY AND CO,,71.0,YR,,F,Y,52.0,KG,20230728,,HP,IT,IT,2023,Q3,Elderly
227296563,22729656,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,iU/mL,,,,,,,,,,,,2023,Q3,General physical health deterioration,,2023,Q3,3,F,20230130.0,20230721.0,20230720,20230728,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202307010482,ELI LILLY AND CO,,71.0,YR,,F,Y,52.0,KG,20230728,,HP,IT,IT,2023,Q3,Elderly
227296563,22729656,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,iU/mL,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,3,F,20230130.0,20230721.0,20230720,20230728,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202307010482,ELI LILLY AND CO,,71.0,YR,,F,Y,52.0,KG,20230728,,HP,IT,IT,2023,Q3,Elderly
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Cardiomyopathy,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Epilepsy,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Cerebrovascular accident,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Arrhythmia,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Dizziness,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Expired product administered,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Loss of consciousness,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227336521,22733652,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2023,Q3,Amphetamines positive,,2023,Q3,1,I,,20230710.0,20230720,20230720,EXP,,US-TEVA-2023-US-2906496,TEVA,,54.0,YR,A,M,Y,,,20230721,,HP,US,US,2023,Q3,Adult
227338991,22733899,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,,20230707.0,20230721,20230721,EXP,,FR-AUROBINDO-AUR-APL-2023-046040,AUROBINDO,"Guion-Firmin Julia, Tessier Samuel,  Lepelley M, Faillie Jean-Luc, Montastruc Jean-Louis.. Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan. Fundam-ClinPharmacol. 2022;36(2):378-389",67.0,YR,,F,Y,,,20230721,,HP,FR,FR,2023,Q3,Elderly
227338991,22733899,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Gastrointestinal disorder,,2023,Q3,1,I,,20230707.0,20230721,20230721,EXP,,FR-AUROBINDO-AUR-APL-2023-046040,AUROBINDO,"Guion-Firmin Julia, Tessier Samuel,  Lepelley M, Faillie Jean-Luc, Montastruc Jean-Louis.. Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan. Fundam-ClinPharmacol. 2022;36(2):378-389",67.0,YR,,F,Y,,,20230721,,HP,FR,FR,2023,Q3,Elderly
227349491,22734949,1,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 to 9 unit per meal,,,,,,,,,,,,2023,Q3,Joint injury,,2023,Q3,1,I,20230306.0,20230706.0,20230721,20230721,EXP,,US-NOVOPROD-1072960,NOVO NORDISK,,65.0,YR,,F,Y,,,20230721,,HP,US,US,2023,Q3,Elderly
227349491,22734949,1,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 to 9 unit per meal,,,,,,,,,,,,2023,Q3,Fall,,2023,Q3,1,I,20230306.0,20230706.0,20230721,20230721,EXP,,US-NOVOPROD-1072960,NOVO NORDISK,,65.0,YR,,F,Y,,,20230721,,HP,US,US,2023,Q3,Elderly
227349491,22734949,1,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 to 9 unit per meal,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230306.0,20230706.0,20230721,20230721,EXP,,US-NOVOPROD-1072960,NOVO NORDISK,,65.0,YR,,F,Y,,,20230721,,HP,US,US,2023,Q3,Elderly
227349651,22734965,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 IU, tid",,,,,202110013,,,2.0,IU,,TID,2023,Q3,Ascites,,2023,Q3,1,I,20230601.0,20230711.0,20230721,20230721,EXP,CN-NMPA-1311021513692202300162,CN-NOVOPROD-1090936,NOVO NORDISK,,7.0,YR,,F,Y,20.0,KG,20230721,,HP,CN,CN,2023,Q3,Child
227349651,22734965,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 IU, tid",,,,,202110013,,,2.0,IU,,TID,2023,Q3,Oedema peripheral,,2023,Q3,1,I,20230601.0,20230711.0,20230721,20230721,EXP,CN-NMPA-1311021513692202300162,CN-NOVOPROD-1090936,NOVO NORDISK,,7.0,YR,,F,Y,20.0,KG,20230721,,HP,CN,CN,2023,Q3,Child
227349651,22734965,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 IU, tid",,,,,202110013,,,2.0,IU,,TID,2023,Q3,Eyelid oedema,,2023,Q3,1,I,20230601.0,20230711.0,20230721,20230721,EXP,CN-NMPA-1311021513692202300162,CN-NOVOPROD-1090936,NOVO NORDISK,,7.0,YR,,F,Y,20.0,KG,20230721,,HP,CN,CN,2023,Q3,Child
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Malnutrition,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Eye haemorrhage,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Headache,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Myalgia,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Diarrhoea,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Cardiac failure congestive,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Pericardial effusion,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Pulmonary oedema,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Thyroid disorder,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Neuropathy peripheral,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Arthritis,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Abdominal pain upper,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Chest pain,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227369961,22736996,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Multi-organ disorder,,2023,Q3,1,I,,20230719.0,20230721,20230721,EXP,,CA-SA-2023SA221144,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230721,,CN,CA,CA,2023,Q3,Adult
227378721,22737872,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-10 Units; four times a day,,,U,,,,,,,Injection,,2023,Q3,Brain oedema,,2023,Q3,1,I,20210314.0,20210315.0,20230721,20230721,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210304462,BRISTOL MYERS SQUIBB,,78.0,YR,E,F,Y,75.2,KG,20230721,,MD,US,US,2023,Q3,Elderly
227378721,22737872,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-10 Units; four times a day,,,U,,,,,,,Injection,,2023,Q3,Immune effector cell-associated neurotoxicity syndrome,,2023,Q3,1,I,20210314.0,20210315.0,20230721,20230721,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210304462,BRISTOL MYERS SQUIBB,,78.0,YR,E,F,Y,75.2,KG,20230721,,MD,US,US,2023,Q3,Elderly
227378721,22737872,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-10 Units; four times a day,,,U,,,,,,,Injection,,2023,Q3,Cytokine release syndrome,,2023,Q3,1,I,20210314.0,20210315.0,20230721,20230721,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210304462,BRISTOL MYERS SQUIBB,,78.0,YR,E,F,Y,75.2,KG,20230721,,MD,US,US,2023,Q3,Elderly
227382442,22738244,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Escherichia sepsis,,2023,Q3,2,F,20230713.0,20230725.0,20230721,20230731,EXP,,US-PFIZER INC-PV202300126137,PFIZER,,60.0,YR,,F,Y,72.109,KG,20230731,,MD,US,US,2023,Q3,Adult
227382442,22738244,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Febrile neutropenia,,2023,Q3,2,F,20230713.0,20230725.0,20230721,20230731,EXP,,US-PFIZER INC-PV202300126137,PFIZER,,60.0,YR,,F,Y,72.109,KG,20230731,,MD,US,US,2023,Q3,Adult
227382442,22738244,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Clostridium difficile colitis,,2023,Q3,2,F,20230713.0,20230725.0,20230721,20230731,EXP,,US-PFIZER INC-PV202300126137,PFIZER,,60.0,YR,,F,Y,72.109,KG,20230731,,MD,US,US,2023,Q3,Adult
227399261,22739926,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Escherichia sepsis,,2023,Q3,1,I,20230713.0,20230719.0,20230723,20230723,EXP,,US-SANDOZ-SDZ2023US004355,SANDOZ,,60.0,YR,,F,Y,72.27,KG,20230723,,MD,US,US,2023,Q3,Adult
227399261,22739926,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Clostridium difficile colitis,,2023,Q3,1,I,20230713.0,20230719.0,20230723,20230723,EXP,,US-SANDOZ-SDZ2023US004355,SANDOZ,,60.0,YR,,F,Y,72.27,KG,20230723,,MD,US,US,2023,Q3,Adult
227399261,22739926,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Febrile neutropenia,,2023,Q3,1,I,20230713.0,20230719.0,20230723,20230723,EXP,,US-SANDOZ-SDZ2023US004355,SANDOZ,,60.0,YR,,F,Y,72.27,KG,20230723,,MD,US,US,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Neuropathy peripheral,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Pericardial effusion,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Chest pain,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Multi-organ disorder,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Headache,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Thyroid disorder,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Myalgia,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Eye haemorrhage,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Arthritis,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Diarrhoea,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Pulmonary oedema,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Malnutrition,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Cardiac failure congestive,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Abdominal pain upper,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227408672,22740867,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2023,Q3,Weight decreased,,2023,Q3,2,F,,20230809.0,20230724,20230814,EXP,,CA-SA-2023SA222302,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20230814,,HP,CA,CA,2023,Q3,Adult
227424081,22742408,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20230101.0,20230719.0,20230724,20230724,PER,,US-SA-2023SA222958,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
227424081,22742408,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Malaise,,2023,Q3,1,I,20230101.0,20230719.0,20230724,20230724,PER,,US-SA-2023SA222958,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
227424081,22742408,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230101.0,20230719.0,20230724,20230724,PER,,US-SA-2023SA222958,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
227424081,22742408,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Headache,,2023,Q3,1,I,20230101.0,20230719.0,20230724,20230724,PER,,US-SA-2023SA222958,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20230724,,CN,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Bronchitis,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Asthenia,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Chronic obstructive pulmonary disease,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Blister,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Depressed mood,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Asthma,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Urinary tract infection,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Cough,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Liver disorder,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Renal disorder,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Sleep apnoea syndrome,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227426582,22742658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q3,Malaise,,2023,Q3,2,F,,20230814.0,20230724,20230824,PER,,US-SA-2023SA220979,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20230824,,MD,US,US,2023,Q3,Elderly
227443201,22744320,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Confusional state,,2023,Q3,1,I,20230714.0,20230717.0,20230724,20230724,EXP,,US-BAYER-2023A103759,BAYER,,41.0,YR,A,F,Y,,,20230724,,CN,US,US,2023,Q3,Adult
227443201,22744320,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Cerebral haemorrhage,,2023,Q3,1,I,20230714.0,20230717.0,20230724,20230724,EXP,,US-BAYER-2023A103759,BAYER,,41.0,YR,A,F,Y,,,20230724,,CN,US,US,2023,Q3,Adult
227443201,22744320,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Hemiparesis,,2023,Q3,1,I,20230714.0,20230717.0,20230724,20230724,EXP,,US-BAYER-2023A103759,BAYER,,41.0,YR,A,F,Y,,,20230724,,CN,US,US,2023,Q3,Adult
227483571,22748357,14,C,LISPRO 50LIS50NPL,,2,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202311070,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227483571,22748357,14,C,LISPRO 50LIS50NPL,,2,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Withdrawal of life support,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202311070,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227483571,22748357,14,C,LISPRO 50LIS50NPL,,2,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Lethargy,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202311070,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227483571,22748357,14,C,LISPRO 50LIS50NPL,,2,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Depressed level of consciousness,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202311070,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227483571,22748357,14,C,LISPRO 50LIS50NPL,,2,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Clostridium test positive,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202311070,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227483571,22748357,14,C,LISPRO 50LIS50NPL,,2,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Palliative care,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202311070,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227483571,22748357,14,C,LISPRO 50LIS50NPL,,2,,NOT SPECIFIED,,,,,,,,,,,,2023,Q3,Unresponsive to stimuli,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202311070,FRESENIUS KABI,,75.0,YR,E,F,Y,84.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227484451,22748445,10,C,LISPRO 50 LIS 50 NPL,,2,,,,,U,,,,,,,NOT SPECIFIED,,2023,Q3,Prothrombin time prolonged,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202310974,FRESENIUS KABI,,87.0,YR,E,F,Y,66.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227484451,22748445,10,C,LISPRO 50 LIS 50 NPL,,2,,,,,U,,,,,,,NOT SPECIFIED,,2023,Q3,Haemoglobin decreased,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202310974,FRESENIUS KABI,,87.0,YR,E,F,Y,66.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227484451,22748445,10,C,LISPRO 50 LIS 50 NPL,,2,,,,,U,,,,,,,NOT SPECIFIED,,2023,Q3,Haematoma,,2023,Q3,1,I,,20230717.0,20230725,20230725,EXP,,CA-FreseniusKabi-FK202310974,FRESENIUS KABI,,87.0,YR,E,F,Y,66.0,KG,20230725,,PH,CA,CA,2023,Q3,Elderly
227502221,22750222,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 iU, QD (20ui in the morning, 30ui at lunch, 30ui in the evening)",,,U,,,,,80.0,IU,Solution for injection,QD,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,20230115.0,20230720.0,20230726,20230726,EXP,IT-MINISAL02-935003,IT-SA-2023SA224271,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20230726,,HP,IT,IT,2023,Q3,Adult
227502221,22750222,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 iU, QD (20ui in the morning, 30ui at lunch, 30ui in the evening)",,,U,,,,,80.0,IU,Solution for injection,QD,2023,Q3,Sopor,,2023,Q3,1,I,20230115.0,20230720.0,20230726,20230726,EXP,IT-MINISAL02-935003,IT-SA-2023SA224271,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20230726,,HP,IT,IT,2023,Q3,Adult
227502701,22750270,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518828A,,20563.0,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230724.0,20230724.0,20230726,20230726,PER,,US-ELI_LILLY_AND_COMPANY-US202307014215,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20230726,,CN,US,US,2023,Q3,Adult
227514901,22751490,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Acidosis,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Diabetic ketoacidosis,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Ketonuria,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Dyslipidaemia,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Acidosis,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Diabetic ketoacidosis,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Ketonuria,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,8 U,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Dyslipidaemia,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,d,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Acidosis,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,d,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Diabetic ketoacidosis,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,d,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Ketonuria,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,d,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227514901,22751490,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,d,,,U,,,,209196.0,,,Solution for injection,QD,2023,Q3,Dyslipidaemia,,2023,Q3,1,I,,20230719.0,20230726,20230726,EXP,,IN-SA-2023SA223555,SANOFI AVENTIS,,7.0,YR,C,F,Y,18.0,KG,20230726,,HP,IN,IN,2023,Q3,Child
227521731,22752173,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q3,Hypersensitivity,,2023,Q3,1,I,20230501.0,20230724.0,20230726,20230726,PER,,US-ELI_LILLY_AND_COMPANY-US202307014577,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20230726,,CN,US,US,2023,Q3,Adult
227521731,22752173,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q3,Pruritus,,2023,Q3,1,I,20230501.0,20230724.0,20230726,20230726,PER,,US-ELI_LILLY_AND_COMPANY-US202307014577,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20230726,,CN,US,US,2023,Q3,Adult
227521731,22752173,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2023,Q3,Skin infection,,2023,Q3,1,I,20230501.0,20230724.0,20230726,20230726,PER,,US-ELI_LILLY_AND_COMPANY-US202307014577,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20230726,,CN,US,US,2023,Q3,Adult
227529591,22752959,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,20220801.0,20220830.0,20230726,20230726,PER,,US-SEBELA IRELAND LIMITED-2022SEB00063,SEBELA,,56.0,YR,,M,Y,78.005,KG,20230726,,CN,US,US,2023,Q3,Adult
227529591,22752959,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Product substitution issue,,2023,Q3,1,I,20220801.0,20220830.0,20230726,20230726,PER,,US-SEBELA IRELAND LIMITED-2022SEB00063,SEBELA,,56.0,YR,,M,Y,78.005,KG,20230726,,CN,US,US,2023,Q3,Adult
227529591,22752959,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,20220801.0,20220830.0,20230726,20230726,PER,,US-SEBELA IRELAND LIMITED-2022SEB00063,SEBELA,,56.0,YR,,M,Y,78.005,KG,20230726,,CN,US,US,2023,Q3,Adult
227529591,22752959,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Therapeutic product effect incomplete,,2023,Q3,1,I,20220801.0,20220830.0,20230726,20230726,PER,,US-SEBELA IRELAND LIMITED-2022SEB00063,SEBELA,,56.0,YR,,M,Y,78.005,KG,20230726,,CN,US,US,2023,Q3,Adult
227529591,22752959,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Anxiety,,2023,Q3,1,I,20220801.0,20220830.0,20230726,20230726,PER,,US-SEBELA IRELAND LIMITED-2022SEB00063,SEBELA,,56.0,YR,,M,Y,78.005,KG,20230726,,CN,US,US,2023,Q3,Adult
227556961,22755696,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"unit, 5-6-6",,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,1,I,20220501.0,20230717.0,20230727,20230727,EXP,,DE-AMGEN-DEUSP2023125089,AMGEN,"Allgaier,R. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose. Drugs in R and D. 2023;23(2):93-98",62.0,YR,A,,Y,,,20230727,,HP,DE,DE,2023,Q3,Adult
227556961,22755696,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"unit, 5-6-6",,,,,,,,,,,,2023,Q3,Haemolysis,,2023,Q3,1,I,20220501.0,20230717.0,20230727,20230727,EXP,,DE-AMGEN-DEUSP2023125089,AMGEN,"Allgaier,R. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose. Drugs in R and D. 2023;23(2):93-98",62.0,YR,A,,Y,,,20230727,,HP,DE,DE,2023,Q3,Adult
227576291,22757629,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, unknown",,,,,D578904A,,20563.0,15.0,IU,Injection,,2023,Q3,Product dose omission issue,,2023,Q3,1,I,20230721.0,20230724.0,20230727,20230727,PER,,US-ELI_LILLY_AND_COMPANY-US202307014352,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20230727,,CN,US,US,2023,Q3,Adult
227576291,22757629,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, unknown",,,,,D578904A,,20563.0,15.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230721.0,20230724.0,20230727,20230727,PER,,US-ELI_LILLY_AND_COMPANY-US202307014352,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20230727,,CN,US,US,2023,Q3,Adult
227615511,22761551,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,according to glucemias,,,U,,,,,,,,,2023,Q3,Rash maculo-papular,,2023,Q3,1,I,20230625.0,20230720.0,20230728,20230728,EXP,ES-AEMPS-1393840,ES-SA-2023SA220597,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20230728,,MD,ES,ES,2023,Q3,Elderly
227628092,22762809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Epistaxis,,2023,Q3,2,F,20230713.0,20230804.0,20230728,20230820,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-105687,BRISTOL MYERS SQUIBB,,75.0,YR,E,M,Y,80.0,KG,20230821,,HP,US,US,2023,Q3,Elderly
227628092,22762809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Thrombocytopenia,,2023,Q3,2,F,20230713.0,20230804.0,20230728,20230820,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-105687,BRISTOL MYERS SQUIBB,,75.0,YR,E,M,Y,80.0,KG,20230821,,HP,US,US,2023,Q3,Elderly
227628092,22762809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Haemoptysis,,2023,Q3,2,F,20230713.0,20230804.0,20230728,20230820,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-105687,BRISTOL MYERS SQUIBB,,75.0,YR,E,M,Y,80.0,KG,20230821,,HP,US,US,2023,Q3,Elderly
227628092,22762809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Deep vein thrombosis,,2023,Q3,2,F,20230713.0,20230804.0,20230728,20230820,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-105687,BRISTOL MYERS SQUIBB,,75.0,YR,E,M,Y,80.0,KG,20230821,,HP,US,US,2023,Q3,Elderly
227638241,22763824,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Dose Description : according to glycemia,,,,U,Asked But Unknown,,,,,Unknown,,2023,Q3,Photosensitivity reaction,,2023,Q3,1,I,20220711.0,20230714.0,20230730,20230730,EXP,,FR-CHATTEMPRD-2022SA330407,CHATTEM,,75.0,YR,E,M,Y,74.0,KG,20230730,,PH,FR,FR,2023,Q3,Elderly
227638421,22763842,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown (sliding scale)",,,U,,D564351E,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230401.0,20230727.0,20230730,20230730,PER,,US-ELI_LILLY_AND_COMPANY-US202307016894,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230730,,CN,US,US,2023,Q3,Adult
227638421,22763842,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown (sliding scale)",,,U,,D564351E,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230401.0,20230727.0,20230730,20230730,PER,,US-ELI_LILLY_AND_COMPANY-US202307016894,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230730,,CN,US,US,2023,Q3,Adult
227638421,22763842,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230401.0,20230727.0,20230730,20230730,PER,,US-ELI_LILLY_AND_COMPANY-US202307016894,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230730,,CN,US,US,2023,Q3,Adult
227638421,22763842,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230401.0,20230727.0,20230730,20230730,PER,,US-ELI_LILLY_AND_COMPANY-US202307016894,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230730,,CN,US,US,2023,Q3,Adult
227638521,22763852,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, tid",,,U,,D578902A,,20563.0,15.0,IU,Injection,TID,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230726.0,20230726.0,20230730,20230730,PER,,US-ELI_LILLY_AND_COMPANY-US202307016357,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230730,,CN,US,US,2023,Q3,Adult
227638521,22763852,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, tid",,,U,,D578902A,,20563.0,15.0,IU,Injection,TID,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230726.0,20230726.0,20230730,20230730,PER,,US-ELI_LILLY_AND_COMPANY-US202307016357,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230730,,CN,US,US,2023,Q3,Adult
227638521,22763852,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230726.0,20230726.0,20230730,20230730,PER,,US-ELI_LILLY_AND_COMPANY-US202307016357,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230730,,CN,US,US,2023,Q3,Adult
227638521,22763852,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230726.0,20230726.0,20230730,20230730,PER,,US-ELI_LILLY_AND_COMPANY-US202307016357,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20230730,,CN,US,US,2023,Q3,Adult
227646061,22764606,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Febrile neutropenia,,2023,Q3,1,I,20230713.0,20230713.0,20230731,20230731,EXP,,US-SANDOZ-SDZ2023US006923,SANDOZ,,60.0,YR,,F,Y,72.109,KG,20230731,,MD,US,US,2023,Q3,Adult
227646061,22764606,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Clostridium difficile colitis,,2023,Q3,1,I,20230713.0,20230713.0,20230731,20230731,EXP,,US-SANDOZ-SDZ2023US006923,SANDOZ,,60.0,YR,,F,Y,72.109,KG,20230731,,MD,US,US,2023,Q3,Adult
227646061,22764606,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q3,Escherichia sepsis,,2023,Q3,1,I,20230713.0,20230713.0,20230731,20230731,EXP,,US-SANDOZ-SDZ2023US006923,SANDOZ,,60.0,YR,,F,Y,72.109,KG,20230731,,MD,US,US,2023,Q3,Adult
227656051,22765605,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Dose Description : 10 iU, QD",,,,,,,,10.0,IU,Unknown,QD,2023,Q3,Pancytopenia,,2023,Q3,1,I,20230517.0,20230717.0,20230731,20230731,EXP,,FR-CHATTEMPRD-2023SA185260,CHATTEM,,53.0,YR,A,M,Y,54.0,KG,20230731,,MD,FR,FR,2023,Q3,Adult
227671971,22767197,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Vomiting,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Headache,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Irritability,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Illness,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Vomiting,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Headache,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Irritability,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101H,,20563.0,,,Injection,,2023,Q3,Illness,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Vomiting,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Headache,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Irritability,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Illness,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Vomiting,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Headache,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Irritability,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227671971,22767197,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Illness,,2023,Q3,1,I,20230727.0,20230728.0,20230731,20230731,PER,,US-ELI_LILLY_AND_COMPANY-US202307018139,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20230731,,HP,US,US,2023,Q3,Child
227739051,22773905,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Hospitalisation,,2023,Q3,1,I,,20230718.0,20230801,20230801,EXP,,"US-Stemline Therapeutics, Inc.-2023ST002001",STEMLINE THERAPEUTICS,,75.0,YR,E,F,Y,,,20230728,,HP,US,US,2023,Q3,Elderly
227760181,22776018,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230731.0,20230801.0,20230802,20230802,PER,,US-ELI_LILLY_AND_COMPANY-US202308001153,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20230802,,CN,US,US,2023,Q3,Elderly
227760181,22776018,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230731.0,20230801.0,20230802,20230802,PER,,US-ELI_LILLY_AND_COMPANY-US202308001153,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20230802,,CN,US,US,2023,Q3,Elderly
227760181,22776018,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D498888C,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230731.0,20230801.0,20230802,20230802,PER,,US-ELI_LILLY_AND_COMPANY-US202308001153,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20230802,,CN,US,US,2023,Q3,Elderly
227760181,22776018,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D498888C,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230731.0,20230801.0,20230802,20230802,PER,,US-ELI_LILLY_AND_COMPANY-US202308001153,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20230802,,CN,US,US,2023,Q3,Elderly
227763661,22776366,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 u, daily",,,U,,,,,15.0,IU,Injection,QD,2023,Q3,Dizziness,,2023,Q3,1,I,20230701.0,20230728.0,20230802,20230802,PER,,US-ELI_LILLY_AND_COMPANY-US202308000516,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20230802,,CN,US,US,2023,Q3,Adult
227763661,22776366,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 u, daily",,,U,,,,,15.0,IU,Injection,QD,2023,Q3,Nausea,,2023,Q3,1,I,20230701.0,20230728.0,20230802,20230802,PER,,US-ELI_LILLY_AND_COMPANY-US202308000516,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20230802,,CN,US,US,2023,Q3,Adult
227763661,22776366,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 u, daily",,,U,,,,,15.0,IU,Injection,QD,2023,Q3,Vomiting,,2023,Q3,1,I,20230701.0,20230728.0,20230802,20230802,PER,,US-ELI_LILLY_AND_COMPANY-US202308000516,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20230802,,CN,US,US,2023,Q3,Adult
227763661,22776366,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 u, daily",,,U,,,,,15.0,IU,Injection,QD,2023,Q3,Head discomfort,,2023,Q3,1,I,20230701.0,20230728.0,20230802,20230802,PER,,US-ELI_LILLY_AND_COMPANY-US202308000516,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20230802,,CN,US,US,2023,Q3,Adult
227782662,22778266,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Off label use,,2023,Q3,2,F,20230801.0,20230915.0,20230802,20230918,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-108159,BRISTOL MYERS SQUIBB,,77.0,YR,E,F,Y,,,20230918,,PH,US,US,2023,Q3,Elderly
227803891,22780389,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,U,Asked But Unknown,,,,,Solution for injection,,2023,Q3,Intraventricular haemorrhage,,2023,Q3,1,I,20190722.0,20230721.0,20230803,20230803,EXP,,FR-CHATTEMPRD-2019SA295981,CHATTEM,,81.0,YR,E,M,Y,93.0,KG,20230803,,MD,FR,FR,2023,Q3,Elderly
227803891,22780389,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,U,Asked But Unknown,,,,,Solution for injection,,2023,Q3,Cerebral haemorrhage,,2023,Q3,1,I,20190722.0,20230721.0,20230803,20230803,EXP,,FR-CHATTEMPRD-2019SA295981,CHATTEM,,81.0,YR,E,M,Y,93.0,KG,20230803,,MD,FR,FR,2023,Q3,Elderly
227803891,22780389,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,U,Asked But Unknown,,,,,Solution for injection,,2023,Q3,Subarachnoid haemorrhage,,2023,Q3,1,I,20190722.0,20230721.0,20230803,20230803,EXP,,FR-CHATTEMPRD-2019SA295981,CHATTEM,,81.0,YR,E,M,Y,93.0,KG,20230803,,MD,FR,FR,2023,Q3,Elderly
227803891,22780389,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,U,Asked But Unknown,,,,,Solution for injection,,2023,Q3,Malaise,,2023,Q3,1,I,20190722.0,20230721.0,20230803,20230803,EXP,,FR-CHATTEMPRD-2019SA295981,CHATTEM,,81.0,YR,E,M,Y,93.0,KG,20230803,,MD,FR,FR,2023,Q3,Elderly
227803891,22780389,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,U,Asked But Unknown,,,,,Solution for injection,,2023,Q3,Coma,,2023,Q3,1,I,20190722.0,20230721.0,20230803,20230803,EXP,,FR-CHATTEMPRD-2019SA295981,CHATTEM,,81.0,YR,E,M,Y,93.0,KG,20230803,,MD,FR,FR,2023,Q3,Elderly
227803891,22780389,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,U,Asked But Unknown,,,,,Solution for injection,,2023,Q3,Head injury,,2023,Q3,1,I,20190722.0,20230721.0,20230803,20230803,EXP,,FR-CHATTEMPRD-2019SA295981,CHATTEM,,81.0,YR,E,M,Y,93.0,KG,20230803,,MD,FR,FR,2023,Q3,Elderly
227803891,22780389,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,U,Asked But Unknown,,,,,Solution for injection,,2023,Q3,Hypotension,,2023,Q3,1,I,20190722.0,20230721.0,20230803,20230803,EXP,,FR-CHATTEMPRD-2019SA295981,CHATTEM,,81.0,YR,E,M,Y,93.0,KG,20230803,,MD,FR,FR,2023,Q3,Elderly
227817241,22781724,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,D539191E,,,,,Injection,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,D539191E,,,,,Injection,,2023,Q3,Dehydration,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,D539191E,,,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,D539191E,,,,,Injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,D539191E,,,,,Injection,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,D539191E,,,,,Injection,,2023,Q3,Dehydration,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,D539191E,,,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,D539191E,,,,,Injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,,,,,,Injection,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,,,,,,Injection,,2023,Q3,Dehydration,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,,,,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,,,,,,Injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,,,,,,Injection,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,,,,,,Injection,,2023,Q3,Dehydration,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,,,,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227817241,22781724,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (On sliding scale)",,,,,,,,,,Injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230725.0,20230725.0,20230803,20230803,EXP,,US-ELI_LILLY_AND_COMPANY-US202307015432,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20230803,,CN,US,US,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Toxicity to various agents,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Hyperthyroidism,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Drug titration,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Pulmonary mass,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Product administration error,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Drug dose titration not performed,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Generalised oedema,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Pulmonary toxicity,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227837421,22783742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230801.0,,20230803,20230803,DIR,669067,,FDA-CTU,,60.0,YR,,M,N,144.3,KG,20230803,N,PH,US,,2023,Q3,Adult
227842616,22784261,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, q6h",,,U,,,,,,,,,2023,Q3,Anaphylactic reaction,,2023,Q3,6,F,20230722.0,20230908.0,20230803,20230913,PER,,"US-REGENERON PHARMACEUTICALS, INC.-2023-095404",REGENERON,,64.0,YR,,M,Y,,,20230913,,MD,US,US,2023,Q3,Adult
227842616,22784261,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, q6h",,,U,,,,,,,,,2023,Q3,Blood creatine phosphokinase increased,,2023,Q3,6,F,20230722.0,20230908.0,20230803,20230913,PER,,"US-REGENERON PHARMACEUTICALS, INC.-2023-095404",REGENERON,,64.0,YR,,M,Y,,,20230913,,MD,US,US,2023,Q3,Adult
227842616,22784261,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, q6h",,,U,,,,,,,,,2023,Q3,Myasthenia gravis,,2023,Q3,6,F,20230722.0,20230908.0,20230803,20230913,PER,,"US-REGENERON PHARMACEUTICALS, INC.-2023-095404",REGENERON,,64.0,YR,,M,Y,,,20230913,,MD,US,US,2023,Q3,Adult
227842616,22784261,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, q6h",,,U,,,,,,,,,2023,Q3,Rhabdomyolysis,,2023,Q3,6,F,20230722.0,20230908.0,20230803,20230913,PER,,"US-REGENERON PHARMACEUTICALS, INC.-2023-095404",REGENERON,,64.0,YR,,M,Y,,,20230913,,MD,US,US,2023,Q3,Adult
227842616,22784261,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, q6h",,,U,,,,,,,,,2023,Q3,Myositis,,2023,Q3,6,F,20230722.0,20230908.0,20230803,20230913,PER,,"US-REGENERON PHARMACEUTICALS, INC.-2023-095404",REGENERON,,64.0,YR,,M,Y,,,20230913,,MD,US,US,2023,Q3,Adult
227842616,22784261,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, q6h",,,U,,,,,,,,,2023,Q3,Myasthenia gravis,,2023,Q3,6,F,20230722.0,20230908.0,20230803,20230913,PER,,"US-REGENERON PHARMACEUTICALS, INC.-2023-095404",REGENERON,,64.0,YR,,M,Y,,,20230913,,MD,US,US,2023,Q3,Adult
227861141,22786114,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"4 iU, QD",728.0,IU,U,,,,209196.0,4.0,IU,Solution for injection,QD,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,20230702.0,20230803.0,20230804,20230804,EXP,IT-MINISAL02-937958,IT-SA-2023SA237194,SANOFI AVENTIS,,87.0,YR,E,M,Y,,,20230804,,MD,IT,IT,2023,Q3,Elderly
227894342,22789434,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, single",,,,,,,,8.0,IU,,,2023,Q3,COVID-19 pneumonia,,2023,Q3,2,F,20230429.0,20230901.0,20230804,20230905,EXP,,KR-GENMAB-2023-00774,GENMAB,,49.0,YR,,M,Y,83.3,KG,20230905,,MD,KR,KR,2023,Q3,Adult
227912901,22791290,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, unknown",,,Y,,D578902A,,,60.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230724.0,20230727.0,20230807,20230807,PER,,US-ELI_LILLY_AND_COMPANY-US202307018163,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230807,,CN,US,US,2023,Q3,Adult
227912901,22791290,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, unknown",,,Y,,D578902A,,,60.0,IU,Injection,,2023,Q3,Drug ineffective,,2023,Q3,1,I,20230724.0,20230727.0,20230807,20230807,PER,,US-ELI_LILLY_AND_COMPANY-US202307018163,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230807,,CN,US,US,2023,Q3,Adult
227968961,22796896,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, unknown",,,,,D564351E,,20563.0,15.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230804.0,20230804.0,20230808,20230808,PER,,US-ELI_LILLY_AND_COMPANY-US202308004015,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20230808,,CN,US,US,2023,Q3,Elderly
227968961,22796896,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, unknown",,,,,D564351E,,20563.0,15.0,IU,Injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230804.0,20230804.0,20230808,20230808,PER,,US-ELI_LILLY_AND_COMPANY-US202308004015,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20230808,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Respiratory failure,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Limb mass,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Fatigue,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Peripheral swelling,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Fracture pain,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Stomatitis,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Asthenia,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Upper limb fracture,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Dizziness,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Ageusia,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
227971792,22797179,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,Not available,,,,,,,2023,Q3,Pneumonia,,2023,Q3,2,F,20230628.0,20230918.0,20230808,20230925,EXP,,US-ABBVIE-5351718,ABBVIE,,68.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
228006561,22800656,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"30 iU, QD",,,U,,,,,30.0,IU,Solution for injection,QD,2023,Q3,Medullary thyroid cancer,,2023,Q3,1,I,,20230802.0,20230808,20230808,EXP,IT-ELI_LILLY_AND_COMPANY-IT202302014267,IT-SA-2023SA238849,SANOFI AVENTIS,,68.0,YR,E,,Y,,,20230808,,MD,IT,IT,2023,Q3,Elderly
228006561,22800656,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"8 international unit, each morning",,,U,,,,,8.0,IU,Solution for injection,QD,2023,Q3,Medullary thyroid cancer,,2023,Q3,1,I,,20230802.0,20230808,20230808,EXP,IT-ELI_LILLY_AND_COMPANY-IT202302014267,IT-SA-2023SA238849,SANOFI AVENTIS,,68.0,YR,E,,Y,,,20230808,,MD,IT,IT,2023,Q3,Elderly
228006561,22800656,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"15 international unit, at lunch",,,U,,,,,15.0,IU,Solution for injection,QD,2023,Q3,Medullary thyroid cancer,,2023,Q3,1,I,,20230802.0,20230808,20230808,EXP,IT-ELI_LILLY_AND_COMPANY-IT202302014267,IT-SA-2023SA238849,SANOFI AVENTIS,,68.0,YR,E,,Y,,,20230808,,MD,IT,IT,2023,Q3,Elderly
228070371,22807037,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, unknown",,,,,D546652A,,20563.0,6.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230809.0,20230809.0,20230810,20230810,PER,,US-ELI_LILLY_AND_COMPANY-US202308006143,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20230810,,CN,US,US,2023,Q3,Elderly
228070371,22807037,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, unknown",,,,,D546652A,,20563.0,6.0,IU,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230809.0,20230809.0,20230810,20230810,PER,,US-ELI_LILLY_AND_COMPANY-US202308006143,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20230810,,CN,US,US,2023,Q3,Elderly
228092301,22809230,1,C,INSULIN LISPRO,INSULIN LISPRO,1,,20 IU ? 15IU ? 20 IU preprandial,,,,,Unknown,,,55.0,IU,,QD,2023,Q3,Eructation,,2023,Q3,1,I,20230201.0,20230724.0,20230810,20230810,EXP,DE-BFARM-23005634,DE-NOVOPROD-1095722,NOVO NORDISK,,61.0,YR,,M,Y,102.0,KG,20230810,,MD,DE,DE,2023,Q3,Adult
228092301,22809230,1,C,INSULIN LISPRO,INSULIN LISPRO,1,,20 IU ? 15IU ? 20 IU preprandial,,,,,Unknown,,,55.0,IU,,QD,2023,Q3,Abdominal pain upper,,2023,Q3,1,I,20230201.0,20230724.0,20230810,20230810,EXP,DE-BFARM-23005634,DE-NOVOPROD-1095722,NOVO NORDISK,,61.0,YR,,M,Y,102.0,KG,20230810,,MD,DE,DE,2023,Q3,Adult
228092301,22809230,1,C,INSULIN LISPRO,INSULIN LISPRO,1,,20 IU ? 15IU ? 20 IU preprandial,,,,,Unknown,,,55.0,IU,,QD,2023,Q3,Pancreatitis acute,,2023,Q3,1,I,20230201.0,20230724.0,20230810,20230810,EXP,DE-BFARM-23005634,DE-NOVOPROD-1095722,NOVO NORDISK,,61.0,YR,,M,Y,102.0,KG,20230810,,MD,DE,DE,2023,Q3,Adult
228092301,22809230,1,C,INSULIN LISPRO,INSULIN LISPRO,1,,20 IU ? 15IU ? 20 IU preprandial,,,,,Unknown,,,55.0,IU,,QD,2023,Q3,Nausea,,2023,Q3,1,I,20230201.0,20230724.0,20230810,20230810,EXP,DE-BFARM-23005634,DE-NOVOPROD-1095722,NOVO NORDISK,,61.0,YR,,M,Y,102.0,KG,20230810,,MD,DE,DE,2023,Q3,Adult
228133182,22813318,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q3,Off label use,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q3,Intraductal papillary-mucinous carcinoma of pancreas,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q3,Weight decreased,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 international unit, bid",204220.0,IU,,,,,,80.0,IU,,BID,2023,Q3,Pulmonary mass,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q3,Off label use,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q3,Intraductal papillary-mucinous carcinoma of pancreas,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q3,Weight decreased,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"85 international unit, bid",204220.0,IU,,,,,,85.0,IU,,BID,2023,Q3,Pulmonary mass,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q3,Off label use,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q3,Intraductal papillary-mucinous carcinoma of pancreas,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q3,Weight decreased,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 international unit, bid",204220.0,IU,,,,,,65.0,IU,,BID,2023,Q3,Pulmonary mass,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 international unit, tid",,,,,,,,30.0,IU,,TID,2023,Q3,Off label use,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 international unit, tid",,,,,,,,30.0,IU,,TID,2023,Q3,Intraductal papillary-mucinous carcinoma of pancreas,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 international unit, tid",,,,,,,,30.0,IU,,TID,2023,Q3,Weight decreased,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 international unit, tid",,,,,,,,30.0,IU,,TID,2023,Q3,Pulmonary mass,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, tid",,,,,,,,12.0,IU,,TID,2023,Q3,Off label use,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, tid",,,,,,,,12.0,IU,,TID,2023,Q3,Intraductal papillary-mucinous carcinoma of pancreas,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, tid",,,,,,,,12.0,IU,,TID,2023,Q3,Weight decreased,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228133182,22813318,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, tid",,,,,,,,12.0,IU,,TID,2023,Q3,Pulmonary mass,,2023,Q3,2,F,20220901.0,20230822.0,20230811,20230830,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006625,AEGERION,,58.0,YR,,M,Y,76.2,KG,20230830,,MD,US,US,2023,Q3,Adult
228149501,22814950,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,,,20230810,20230810,DIR,670040,,FDA-CTU,,74.0,YR,,F,N,59.2,KG,20230810,N,CN,US,,2023,Q3,Elderly
228165001,22816500,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,D584203D,,21017.0,50.0,IU,Injection,QD,2023,Q3,Rectal haemorrhage,,2023,Q3,1,I,20230802.0,20230804.0,20230811,20230811,EXP,,US-ELI_LILLY_AND_COMPANY-US202308003939,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230811,,CN,US,US,2023,Q3,Elderly
228165001,22816500,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,D584203D,,21017.0,50.0,IU,Injection,QD,2023,Q3,Arthritis bacterial,,2023,Q3,1,I,20230802.0,20230804.0,20230811,20230811,EXP,,US-ELI_LILLY_AND_COMPANY-US202308003939,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230811,,CN,US,US,2023,Q3,Elderly
228165001,22816500,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,D584203D,,21017.0,50.0,IU,Injection,QD,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230802.0,20230804.0,20230811,20230811,EXP,,US-ELI_LILLY_AND_COMPANY-US202308003939,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230811,,CN,US,US,2023,Q3,Elderly
228165001,22816500,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,D584203D,,21017.0,50.0,IU,Injection,QD,2023,Q3,Drug ineffective,,2023,Q3,1,I,20230802.0,20230804.0,20230811,20230811,EXP,,US-ELI_LILLY_AND_COMPANY-US202308003939,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230811,,CN,US,US,2023,Q3,Elderly
228165001,22816500,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, each evening",,,U,,D584203D,,21017.0,24.0,IU,Injection,QD,2023,Q3,Rectal haemorrhage,,2023,Q3,1,I,20230802.0,20230804.0,20230811,20230811,EXP,,US-ELI_LILLY_AND_COMPANY-US202308003939,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230811,,CN,US,US,2023,Q3,Elderly
228165001,22816500,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, each evening",,,U,,D584203D,,21017.0,24.0,IU,Injection,QD,2023,Q3,Arthritis bacterial,,2023,Q3,1,I,20230802.0,20230804.0,20230811,20230811,EXP,,US-ELI_LILLY_AND_COMPANY-US202308003939,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230811,,CN,US,US,2023,Q3,Elderly
228165001,22816500,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, each evening",,,U,,D584203D,,21017.0,24.0,IU,Injection,QD,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230802.0,20230804.0,20230811,20230811,EXP,,US-ELI_LILLY_AND_COMPANY-US202308003939,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230811,,CN,US,US,2023,Q3,Elderly
228165001,22816500,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, each evening",,,U,,D584203D,,21017.0,24.0,IU,Injection,QD,2023,Q3,Drug ineffective,,2023,Q3,1,I,20230802.0,20230804.0,20230811,20230811,EXP,,US-ELI_LILLY_AND_COMPANY-US202308003939,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20230811,,CN,US,US,2023,Q3,Elderly
228203341,22820334,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011783,APOTEX,,17.0,YR,,M,Y,,,20230814,,CN,CA,CA,2023,Q3,Youth
228203341,22820334,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Treatment noncompliance,,2023,Q3,1,I,,20230803.0,20230814,20230814,EXP,,CA-APOTEX-2023AP011783,APOTEX,,17.0,YR,,M,Y,,,20230814,,CN,CA,CA,2023,Q3,Youth
228220591,22822059,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6 units every 4 hours as needed,,,,,,,,,,Injection,Q4H,2023,Q3,Off label use,,2023,Q3,1,I,20230728.0,20230808.0,20230814,20230814,EXP,,US-ROCHE-3402157,ROCHE,,62.0,YR,,F,Y,103.0,KG,20230814,,MD,US,,2023,Q3,Adult
228220591,22822059,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6 units every 4 hours as needed,,,,,,,,,,Injection,Q4H,2023,Q3,Incorrect product administration duration,,2023,Q3,1,I,20230728.0,20230808.0,20230814,20230814,EXP,,US-ROCHE-3402157,ROCHE,,62.0,YR,,F,Y,103.0,KG,20230814,,MD,US,,2023,Q3,Adult
228220591,22822059,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6 units every 4 hours as needed,,,,,,,,,,Injection,Q4H,2023,Q3,Acute hepatic failure,,2023,Q3,1,I,20230728.0,20230808.0,20230814,20230814,EXP,,US-ROCHE-3402157,ROCHE,,62.0,YR,,F,Y,103.0,KG,20230814,,MD,US,,2023,Q3,Adult
228220591,22822059,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6 units every 4 hours as needed,,,,,,,,,,Injection,Q4H,2023,Q3,Liver function test increased,,2023,Q3,1,I,20230728.0,20230808.0,20230814,20230814,EXP,,US-ROCHE-3402157,ROCHE,,62.0,YR,,F,Y,103.0,KG,20230814,,MD,US,,2023,Q3,Adult
228220591,22822059,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6 units every 4 hours as needed,,,,,,,,,,Injection,Q4H,2023,Q3,Asthenia,,2023,Q3,1,I,20230728.0,20230808.0,20230814,20230814,EXP,,US-ROCHE-3402157,ROCHE,,62.0,YR,,F,Y,103.0,KG,20230814,,MD,US,,2023,Q3,Adult
228220591,22822059,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6 units every 4 hours as needed,,,,,,,,,,Injection,Q4H,2023,Q3,Blood creatine phosphokinase increased,,2023,Q3,1,I,20230728.0,20230808.0,20230814,20230814,EXP,,US-ROCHE-3402157,ROCHE,,62.0,YR,,F,Y,103.0,KG,20230814,,MD,US,,2023,Q3,Adult
228220591,22822059,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6 units every 4 hours as needed,,,,,,,,,,Injection,Q4H,2023,Q3,Rhabdomyolysis,,2023,Q3,1,I,20230728.0,20230808.0,20230814,20230814,EXP,,US-ROCHE-3402157,ROCHE,,62.0,YR,,F,Y,103.0,KG,20230814,,MD,US,,2023,Q3,Adult
228223522,22822352,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU, tid",,,,,,,,6.0,IU,,Q8H,2023,Q3,Renal impairment,,2023,Q3,2,F,20210312.0,20230913.0,20230815,20230921,EXP,,DE-ESPERIONTHERAPEUTICS-2023DEU00881,ESPERION THERAPEUTICS,,49.0,YR,,M,Y,115.0,KG,20230921,,MD,DE,DE,2023,Q3,Adult
228270641,22827064,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230621.0,20230814.0,20230816,20230816,PER,,US-ELI_LILLY_AND_COMPANY-US202306015166,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20230816,,CN,US,US,2023,Q3,Adult
228270641,22827064,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230621.0,20230814.0,20230816,20230816,PER,,US-ELI_LILLY_AND_COMPANY-US202306015166,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20230816,,CN,US,US,2023,Q3,Adult
228282783,22828278,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 u,,,,,,,,16.0,IU,Injection,,2023,Q3,Blood triglycerides increased,,2023,Q3,3,F,20230729.0,20230915.0,20230816,20230923,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202308007685,ELI LILLY AND CO,,34.0,YR,,F,Y,71.3,KG,20230923,,CN,JP,JP,2023,Q3,Young Adult
228284871,22828487,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D549451A,,20563.0,,,Injection,,2023,Q3,Product dose omission issue,,2023,Q3,1,I,20230814.0,20230814.0,20230816,20230816,PER,,US-ELI_LILLY_AND_COMPANY-US202308008891,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20230816,,CN,US,US,2023,Q3,Elderly
228284871,22828487,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D549451A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230814.0,20230814.0,20230816,20230816,PER,,US-ELI_LILLY_AND_COMPANY-US202308008891,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20230816,,CN,US,US,2023,Q3,Elderly
228287371,22828737,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Atrial fibrillation,,2023,Q3,1,I,,20230814.0,20230816,20230816,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114780,BRISTOL MYERS SQUIBB,,85.0,YR,E,F,Y,,,20230816,,HP,US,US,2023,Q3,Elderly
228317271,22831727,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown",,,U,,D455780C,,20563.0,14.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230815.0,20230816.0,20230817,20230817,PER,,US-ELI_LILLY_AND_COMPANY-US202308010144,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20230817,,CN,US,US,2023,Q3,Elderly
228335012,22833501,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 international unit, bid",,,Y,,D564484AA,,21018.0,28.0,IU,,BID,2023,Q3,Fatigue,,2023,Q3,2,F,20230727.0,20230805.0,20230817,20230818,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202308006531,ELI LILLY AND CO,,56.0,YR,,F,Y,80.0,KG,20230818,,CN,CN,CN,2023,Q3,Adult
228335012,22833501,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 international unit, bid",,,Y,,D564484AA,,21018.0,28.0,IU,,BID,2023,Q3,Hypoglycaemia,,2023,Q3,2,F,20230727.0,20230805.0,20230817,20230818,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202308006531,ELI LILLY AND CO,,56.0,YR,,F,Y,80.0,KG,20230818,,CN,CN,CN,2023,Q3,Adult
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Tonsillitis,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Throat irritation,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Paraesthesia,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Haemorrhoids,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Throat tightness,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Myalgia,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Drug specific antibody present,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Therapeutic product effect incomplete,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Pharyngeal paraesthesia,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Headache,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Off label use,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Abdominal pain upper,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228355851,22835585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Oropharyngeal pain,,2023,Q3,1,I,,20230808.0,20230818,20230818,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-21359,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,70.0,KG,20230815,,HP,CA,CA,2023,Q3,Youth
228366171,22836617,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(dosage text: according to blood glucose),,,,,,,,,,,,2023,Q3,Drug reaction with eosinophilia and systemic symptoms,,2023,Q3,1,I,20230719.0,20230811.0,20230818,20230818,EXP,FR-AFSSAPS-CN2023000708,FR-BAXTER-2023BAX028395,BAXTER,,61.0,YR,,M,Y,97.1,KG,20230818,,MD,FR,FR,2023,Q3,Adult
228491931,22849193,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Brain neoplasm malignant,,2023,Q3,1,I,20230801.0,,20230821,20230821,DIR,FDA-CDER-CTU-2023-60851,,FDA-CTU,,76.0,YR,,M,N,81.65,KG,20230818,N,HP,US,,2023,Q3,Elderly
228491931,22849193,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Malignant neoplasm progression,,2023,Q3,1,I,20230801.0,,20230821,20230821,DIR,FDA-CDER-CTU-2023-60851,,FDA-CTU,,76.0,YR,,M,N,81.65,KG,20230818,N,HP,US,,2023,Q3,Elderly
228491971,22849197,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Hospitalisation,,2023,Q3,1,I,,,20230821,20230821,DIR,FDA-CDER-CTU-2023-61047,,FDA-CTU,,57.0,YR,,M,N,,,20230821,N,PH,US,,2023,Q3,Adult
228510151,22851015,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 iU, TID",,,Y,,D276024,,209196.0,8.0,IU,Solution for injection,Q8H,2023,Q3,Hypokalaemia,,2023,Q3,1,I,20210611.0,20230815.0,20230822,20230822,EXP,,CN-SA-2023SA252497,SANOFI AVENTIS,,70.0,YR,E,F,Y,40.0,KG,20230822,,HP,CN,CN,2023,Q3,Elderly
228510151,22851015,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 iU, TID",,,Y,,D276024,,209196.0,8.0,IU,Solution for injection,Q8H,2023,Q3,Hypoglycaemic coma,,2023,Q3,1,I,20210611.0,20230815.0,20230822,20230822,EXP,,CN-SA-2023SA252497,SANOFI AVENTIS,,70.0,YR,E,F,Y,40.0,KG,20230822,,HP,CN,CN,2023,Q3,Elderly
228510151,22851015,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 iU, TID",,,Y,,D276024,,209196.0,8.0,IU,Solution for injection,Q8H,2023,Q3,Depressed level of consciousness,,2023,Q3,1,I,20210611.0,20230815.0,20230822,20230822,EXP,,CN-SA-2023SA252497,SANOFI AVENTIS,,70.0,YR,E,F,Y,40.0,KG,20230822,,HP,CN,CN,2023,Q3,Elderly
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Intensive care unit acquired weakness,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthenia,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Abdominal pain,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Joint effusion,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Ascites,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Generalised oedema,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Blood pressure diastolic abnormal,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Micturition disorder,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Joint swelling,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Alanine aminotransferase increased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Heart rate increased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Adrenal insufficiency,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Peripheral sensorimotor neuropathy,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Nasopharyngitis,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Rheumatoid arthritis,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypotension,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Neuropathy peripheral,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Depression,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Weight increased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Increased appetite,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Therapeutic response decreased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Blood alkaline phosphatase increased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Nerve compression,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Herpes zoster,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Pancytopenia,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Blood potassium decreased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Fibrosis,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Infusion related reaction,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Gastrointestinal disorder,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Endometrial disorder,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Myelopathy,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Gamma-glutamyltransferase increased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Pain,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Neutropenia,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Synovitis,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Peritonitis,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Osteoarthritis,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Peripheral swelling,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypersensitivity,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Injection site extravasation,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Influenza,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diverticulitis,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Congestive hepatopathy,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Blood pressure increased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Bone erosion,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Pseudomonal bacteraemia,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Gait disturbance,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Tooth disorder,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Abscess,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Septic shock,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Myopathy,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Blood bilirubin increased,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Intervertebral disc protrusion,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228557951,22855795,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Enterococcus test positive,,2023,Q3,1,I,,20230814.0,20230823,20230823,EXP,,CA-FreseniusKabi-FK202312646,FRESENIUS KABI,,62.0,YR,A,F,Y,67.0,KG,20230823,,HP,CA,CA,2023,Q3,Adult
228563671,22856367,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, once daily",,,U,,,,,,,Injection,,2023,Q3,Euglycaemic diabetic ketoacidosis,,2023,Q3,1,I,,20230815.0,20230823,20230823,EXP,,CN-AstraZeneca-2023A190147,ASTRAZENECA,"Yongfang S., Fanghua Z., et al.. Three Cases of Euglycemic Diabetic Ketoacidosis Induced by Dapagliflozin and Literature Review. JOURNAL OF QINGDAO UNIVERSITY (MEDICAL SCIENCES) 2023;59:1-3.",38.0,YR,,F,Y,69.0,KG,20230823,,MD,CN,,2023,Q3,Adult
228563671,22856367,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, once daily",,,U,,,,,,,Injection,,2023,Q3,Exposure during pregnancy,,2023,Q3,1,I,,20230815.0,20230823,20230823,EXP,,CN-AstraZeneca-2023A190147,ASTRAZENECA,"Yongfang S., Fanghua Z., et al.. Three Cases of Euglycemic Diabetic Ketoacidosis Induced by Dapagliflozin and Literature Review. JOURNAL OF QINGDAO UNIVERSITY (MEDICAL SCIENCES) 2023;59:1-3.",38.0,YR,,F,Y,69.0,KG,20230823,,MD,CN,,2023,Q3,Adult
228568391,22856839,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,,20230620.0,20230823,20230823,PER,,"US-Stemline Therapeutics, Inc.-2023ST001568",STEMLINE THERAPEUTICS,,45.0,YR,A,F,Y,,,20230822,,CN,US,US,2023,Q3,Adult
228568391,22856839,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Arthralgia,,2023,Q3,1,I,,20230620.0,20230823,20230823,PER,,"US-Stemline Therapeutics, Inc.-2023ST001568",STEMLINE THERAPEUTICS,,45.0,YR,A,F,Y,,,20230822,,CN,US,US,2023,Q3,Adult
228581921,22858192,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Chronic kidney disease,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Limb injury,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Chronic kidney disease,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Limb injury,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Chronic kidney disease,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Limb injury,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Chronic kidney disease,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Limb injury,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Glycosylated haemoglobin increased,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228581921,22858192,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230817.0,20230817.0,20230824,20230824,EXP,,US-ELI_LILLY_AND_COMPANY-US202308012561,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20230824,,CN,US,US,2023,Q3,Elderly
228607473,22860747,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, every 8 hours",,,,,,,,10.0,IU,,Q8H,2023,Q3,Respiratory tract infection,,2023,Q3,3,F,20230808.0,20230829.0,20230824,20230907,EXP,,GR-GENMAB-2023-01530,GENMAB,,45.0,YR,,F,Y,,,20230907,,MD,GR,GR,2023,Q3,Adult
228608581,22860858,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556732,,20563.0,,,,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,,20230818.0,20230824,20230824,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202308012121,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230824,,PH,FI,FI,2023,Q3,Adult
228608581,22860858,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556732,,20563.0,,,,,2023,Q3,Ketoacidosis,,2023,Q3,1,I,,20230818.0,20230824,20230824,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202308012121,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230824,,PH,FI,FI,2023,Q3,Adult
228608581,22860858,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556732,,20563.0,,,,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230818.0,20230824,20230824,EXP,,FI-ELI_LILLY_AND_COMPANY-FI202308012121,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20230824,,PH,FI,FI,2023,Q3,Adult
228615051,22861505,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100u / mL SQ QD per sliding scale,,,D,,,,,,,,,2023,Q3,Death,,2023,Q3,1,I,20230815.0,20230816.0,20230824,20230824,EXP,,"US-RIGEL PHARMACEUTICALS, INC.-2023OLU000041",RIGEL PHARMACEUTICALS,,63.0,YR,,M,Y,83.9,KG,20230824,,CN,US,US,2023,Q3,Adult
228617431,22861743,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Colitis ulcerative,,2023,Q3,1,I,,20230816.0,20230824,20230824,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-22127,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Youth
228617431,22861743,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230816.0,20230824,20230824,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-22127,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Youth
228617431,22861743,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230816.0,20230824,20230824,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-22127,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Youth
228617431,22861743,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,,,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230816.0,20230824,20230824,EXP,,CA-SAMSUNG BIOEPIS-SB-2023-22127,SAMSUNG BIOEPIS,,20.0,YR,A,F,Y,,,20230824,,HP,CA,CA,2023,Q3,Youth
228745201,22874520,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Neoplasm malignant,,2023,Q3,1,I,20220401.0,20230824.0,20230828,20230828,EXP,,US-ELI_LILLY_AND_COMPANY-US202308015728,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230828,,CN,US,US,2023,Q3,Elderly
228745201,22874520,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q3,Neoplasm malignant,,2023,Q3,1,I,20220401.0,20230824.0,20230828,20230828,EXP,,US-ELI_LILLY_AND_COMPANY-US202308015728,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230828,,CN,US,US,2023,Q3,Elderly
228745201,22874520,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D578904A,,20563.0,,,Injection,,2023,Q3,Neoplasm malignant,,2023,Q3,1,I,20220401.0,20230824.0,20230828,20230828,EXP,,US-ELI_LILLY_AND_COMPANY-US202308015728,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230828,,CN,US,US,2023,Q3,Elderly
228745201,22874520,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D578904A,,20563.0,,,Injection,,2023,Q3,Neoplasm malignant,,2023,Q3,1,I,20220401.0,20230824.0,20230828,20230828,EXP,,US-ELI_LILLY_AND_COMPANY-US202308015728,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230828,,CN,US,US,2023,Q3,Elderly
228760091,22876009,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Maternal exposure during pregnancy,,2023,Q3,1,I,20230811.0,20230822.0,20230829,20230829,EXP,,US-GILEAD-2023-0627787,GILEAD,,20.0,YR,A,F,Y,,,20230829,,CN,US,US,2023,Q3,Youth
228760091,22876009,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,1,I,20230811.0,20230822.0,20230829,20230829,EXP,,US-GILEAD-2023-0627787,GILEAD,,20.0,YR,A,F,Y,,,20230829,,CN,US,US,2023,Q3,Youth
228767021,22876702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",7710.0,IU,Y,,202112016,,,10.0,IU,Solution for injection,Q8H,2023,Q3,Blood glucose fluctuation,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",7710.0,IU,Y,,202112016,,,10.0,IU,Solution for injection,Q8H,2023,Q3,Hypoglycaemic coma,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",7710.0,IU,Y,,202112016,,,10.0,IU,Solution for injection,Q8H,2023,Q3,Unresponsive to stimuli,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",7710.0,IU,Y,,202112016,,,10.0,IU,Solution for injection,Q8H,2023,Q3,Loss of consciousness,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",7710.0,IU,Y,,202112016,,,10.0,IU,Solution for injection,Q8H,2023,Q3,Blood pressure systolic increased,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",7710.0,IU,Y,,202112016,,,10.0,IU,Solution for injection,Q8H,2023,Q3,Hyperhidrosis,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",7710.0,IU,Y,,202112016,,,10.0,IU,Solution for injection,Q8H,2023,Q3,Breath sounds abnormal,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU, TID",7710.0,IU,Y,,202112016,,,5.0,IU,Solution for injection,Q8H,2023,Q3,Blood glucose fluctuation,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU, TID",7710.0,IU,Y,,202112016,,,5.0,IU,Solution for injection,Q8H,2023,Q3,Hypoglycaemic coma,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU, TID",7710.0,IU,Y,,202112016,,,5.0,IU,Solution for injection,Q8H,2023,Q3,Unresponsive to stimuli,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU, TID",7710.0,IU,Y,,202112016,,,5.0,IU,Solution for injection,Q8H,2023,Q3,Loss of consciousness,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU, TID",7710.0,IU,Y,,202112016,,,5.0,IU,Solution for injection,Q8H,2023,Q3,Blood pressure systolic increased,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU, TID",7710.0,IU,Y,,202112016,,,5.0,IU,Solution for injection,Q8H,2023,Q3,Hyperhidrosis,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228767021,22876702,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU, TID",7710.0,IU,Y,,202112016,,,5.0,IU,Solution for injection,Q8H,2023,Q3,Breath sounds abnormal,,2023,Q3,1,I,20230815.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259571,SANOFI AVENTIS,,61.0,YR,A,M,Y,65.0,KG,20230829,,HP,CN,CN,2023,Q3,Adult
228776711,22877671,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK iU/mL,,,,,,,,,,,,2023,Q3,General physical health deterioration,,2023,Q3,1,I,20230130.0,20230818.0,20230829,20230829,EXP,IT-EMA-2023720-AUTODUP-1689888174736,IT-Accord-375484,ACCORD,,71.0,YR,E,F,Y,52.0,KG,20230829,,MD,IT,IT,2023,Q3,Elderly
228776711,22877671,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK iU/mL,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230130.0,20230818.0,20230829,20230829,EXP,IT-EMA-2023720-AUTODUP-1689888174736,IT-Accord-375484,ACCORD,,71.0,YR,E,F,Y,52.0,KG,20230829,,MD,IT,IT,2023,Q3,Elderly
228776711,22877671,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,200 iU/mL,,,,,,,,,,,,2023,Q3,General physical health deterioration,,2023,Q3,1,I,20230130.0,20230818.0,20230829,20230829,EXP,IT-EMA-2023720-AUTODUP-1689888174736,IT-Accord-375484,ACCORD,,71.0,YR,E,F,Y,52.0,KG,20230829,,MD,IT,IT,2023,Q3,Elderly
228776711,22877671,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,200 iU/mL,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,1,I,20230130.0,20230818.0,20230829,20230829,EXP,IT-EMA-2023720-AUTODUP-1689888174736,IT-Accord-375484,ACCORD,,71.0,YR,E,F,Y,52.0,KG,20230829,,MD,IT,IT,2023,Q3,Elderly
228792281,22879228,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, TID",,,Y,,202112016,,,6.0,IU,Solution for injection,Q8H,2023,Q3,Condition aggravated,,2023,Q3,1,I,20230813.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259586,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20230829,,HP,CN,CN,2023,Q3,Elderly
228792281,22879228,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, TID",,,Y,,202112016,,,6.0,IU,Solution for injection,Q8H,2023,Q3,Confusional state,,2023,Q3,1,I,20230813.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259586,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20230829,,HP,CN,CN,2023,Q3,Elderly
228792281,22879228,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, TID",,,Y,,202112016,,,6.0,IU,Solution for injection,Q8H,2023,Q3,Hypoglycaemic unconsciousness,,2023,Q3,1,I,20230813.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259586,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20230829,,HP,CN,CN,2023,Q3,Elderly
228792281,22879228,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, TID",,,Y,,202112016,,,6.0,IU,Solution for injection,Q8H,2023,Q3,Unresponsive to stimuli,,2023,Q3,1,I,20230813.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259586,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20230829,,HP,CN,CN,2023,Q3,Elderly
228792281,22879228,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, TID",,,Y,,202112016,,,6.0,IU,Solution for injection,Q8H,2023,Q3,Peripheral swelling,,2023,Q3,1,I,20230813.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259586,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20230829,,HP,CN,CN,2023,Q3,Elderly
228792281,22879228,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, TID",,,Y,,202112016,,,6.0,IU,Solution for injection,Q8H,2023,Q3,Generalised oedema,,2023,Q3,1,I,20230813.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259586,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20230829,,HP,CN,CN,2023,Q3,Elderly
228792281,22879228,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, TID",,,Y,,202112016,,,6.0,IU,Solution for injection,Q8H,2023,Q3,Hypoglycaemic coma,,2023,Q3,1,I,20230813.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259586,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20230829,,HP,CN,CN,2023,Q3,Elderly
228792281,22879228,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, TID",,,Y,,202112016,,,6.0,IU,Solution for injection,Q8H,2023,Q3,Hypotension,,2023,Q3,1,I,20230813.0,20230822.0,20230829,20230829,EXP,,CN-SA-2023SA259586,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20230829,,HP,CN,CN,2023,Q3,Elderly
228805541,22880554,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, daily",,,,,D578904A,,20563.0,12.0,IU,Injection,QD,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230801.0,20230828.0,20230829,20230829,PER,,US-ELI_LILLY_AND_COMPANY-US202308017716,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20230829,,CN,US,US,2023,Q3,Elderly
228810801,22881080,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q3,Death,,2023,Q3,1,I,,20230829.0,20230830,20230830,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-122043,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,,,20230830,,HP,US,US,2023,Q3,Adult
228827021,22882702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, tid",,,Y,,202112016,,20563.0,10.0,IU,,TID,2023,Q3,Hypoglycaemic coma,,2023,Q3,1,I,20230815.0,20230822.0,20230830,20230830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202308014822,ELI LILLY AND CO,,60.0,YR,,M,Y,65.0,KG,20230830,,CN,CN,CN,2023,Q3,Adult
228827021,22882702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, tid",,,Y,,202112016,,20563.0,10.0,IU,,TID,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,20230815.0,20230822.0,20230830,20230830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202308014822,ELI LILLY AND CO,,60.0,YR,,M,Y,65.0,KG,20230830,,CN,CN,CN,2023,Q3,Adult
228827021,22882702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, tid",,,Y,,202112016,,20563.0,10.0,IU,,TID,2023,Q3,Coronary artery disease,,2023,Q3,1,I,20230815.0,20230822.0,20230830,20230830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202308014822,ELI LILLY AND CO,,60.0,YR,,M,Y,65.0,KG,20230830,,CN,CN,CN,2023,Q3,Adult
228827021,22882702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, tid",,,Y,,202112016,,20563.0,5.0,IU,,TID,2023,Q3,Hypoglycaemic coma,,2023,Q3,1,I,20230815.0,20230822.0,20230830,20230830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202308014822,ELI LILLY AND CO,,60.0,YR,,M,Y,65.0,KG,20230830,,CN,CN,CN,2023,Q3,Adult
228827021,22882702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, tid",,,Y,,202112016,,20563.0,5.0,IU,,TID,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,20230815.0,20230822.0,20230830,20230830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202308014822,ELI LILLY AND CO,,60.0,YR,,M,Y,65.0,KG,20230830,,CN,CN,CN,2023,Q3,Adult
228827021,22882702,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, tid",,,Y,,202112016,,20563.0,5.0,IU,,TID,2023,Q3,Coronary artery disease,,2023,Q3,1,I,20230815.0,20230822.0,20230830,20230830,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202308014822,ELI LILLY AND CO,,60.0,YR,,M,Y,65.0,KG,20230830,,CN,CN,CN,2023,Q3,Adult
228867451,22886745,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,Y,,D395986A,,20563.0,10.0,IU,Injection,,2023,Q3,Weight increased,,2023,Q3,1,I,20230717.0,20230824.0,20230831,20230831,PER,,US-ELI_LILLY_AND_COMPANY-US202308015726,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20230831,,CN,US,US,2023,Q3,Elderly
228867451,22886745,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,Y,,D395986A,,20563.0,10.0,IU,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230717.0,20230824.0,20230831,20230831,PER,,US-ELI_LILLY_AND_COMPANY-US202308015726,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20230831,,CN,US,US,2023,Q3,Elderly
228867451,22886745,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,Y,,D395986A,,20563.0,10.0,IU,Injection,,2023,Q3,Product storage error,,2023,Q3,1,I,20230717.0,20230824.0,20230831,20230831,PER,,US-ELI_LILLY_AND_COMPANY-US202308015726,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20230831,,CN,US,US,2023,Q3,Elderly
228879941,22887994,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Blood glucose decreased,,2023,Q3,1,I,20230829.0,20230829.0,20230831,20230831,PER,,US-SA-2023SA265274,SANOFI AVENTIS,,42.0,YR,A,F,Y,,,20230831,,CN,US,US,2023,Q3,Adult
228879941,22887994,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Fatigue,,2023,Q3,1,I,20230829.0,20230829.0,20230831,20230831,PER,,US-SA-2023SA265274,SANOFI AVENTIS,,42.0,YR,A,F,Y,,,20230831,,CN,US,US,2023,Q3,Adult
228939572,22893957,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Anxiety,,2023,Q3,2,F,20230815.0,20230901.0,20230901,20230906,EXP,,US-UNITED THERAPEUTICS-UNT-2023-022459,UNITED THERAPEUTICS,,76.0,YR,,F,Y,82.54,KG,20230906,,CN,US,US,2023,Q3,Elderly
228939572,22893957,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Dyspnoea,,2023,Q3,2,F,20230815.0,20230901.0,20230901,20230906,EXP,,US-UNITED THERAPEUTICS-UNT-2023-022459,UNITED THERAPEUTICS,,76.0,YR,,F,Y,82.54,KG,20230906,,CN,US,US,2023,Q3,Elderly
228939572,22893957,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Stress,,2023,Q3,2,F,20230815.0,20230901.0,20230901,20230906,EXP,,US-UNITED THERAPEUTICS-UNT-2023-022459,UNITED THERAPEUTICS,,76.0,YR,,F,Y,82.54,KG,20230906,,CN,US,US,2023,Q3,Elderly
228939572,22893957,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Pulmonary hypertension,,2023,Q3,2,F,20230815.0,20230901.0,20230901,20230906,EXP,,US-UNITED THERAPEUTICS-UNT-2023-022459,UNITED THERAPEUTICS,,76.0,YR,,F,Y,82.54,KG,20230906,,CN,US,US,2023,Q3,Elderly
228939572,22893957,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Pulmonary oedema,,2023,Q3,2,F,20230815.0,20230901.0,20230901,20230906,EXP,,US-UNITED THERAPEUTICS-UNT-2023-022459,UNITED THERAPEUTICS,,76.0,YR,,F,Y,82.54,KG,20230906,,CN,US,US,2023,Q3,Elderly
228939572,22893957,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Heart rate increased,,2023,Q3,2,F,20230815.0,20230901.0,20230901,20230906,EXP,,US-UNITED THERAPEUTICS-UNT-2023-022459,UNITED THERAPEUTICS,,76.0,YR,,F,Y,82.54,KG,20230906,,CN,US,US,2023,Q3,Elderly
228939572,22893957,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Acidosis,,2023,Q3,2,F,20230815.0,20230901.0,20230901,20230906,EXP,,US-UNITED THERAPEUTICS-UNT-2023-022459,UNITED THERAPEUTICS,,76.0,YR,,F,Y,82.54,KG,20230906,,CN,US,US,2023,Q3,Elderly
228939572,22893957,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q3,Atrial fibrillation,,2023,Q3,2,F,20230815.0,20230901.0,20230901,20230906,EXP,,US-UNITED THERAPEUTICS-UNT-2023-022459,UNITED THERAPEUTICS,,76.0,YR,,F,Y,82.54,KG,20230906,,CN,US,US,2023,Q3,Elderly
228954641,22895464,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25 KWP,,,,,,,,,,Injection,,2023,Q3,Constipation,,2023,Q3,1,I,,20230822.0,20230901,20230901,PER,,US-Vifor (International) Inc.-VIT-2023-06371,VIFOR,,86.0,YR,,M,Y,,,20230901,,CN,US,US,2023,Q3,Elderly
228955253,22895525,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5,,,D,,,,,,,Injection,,2023,Q3,Cytokine release syndrome,,2023,Q3,3,F,20230629.0,20230912.0,20230901,20230918,EXP,,US-JNJFOC-20230736446,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,91.5,KG,20230918,,MD,US,US,2023,Q3,Adult
228955253,22895525,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-12,,,D,,,,,,,Injection,,2023,Q3,Cytokine release syndrome,,2023,Q3,3,F,20230629.0,20230912.0,20230901,20230918,EXP,,US-JNJFOC-20230736446,JOHNSON AND JOHNSON,,51.0,YR,A,M,Y,91.5,KG,20230918,,MD,US,US,2023,Q3,Adult
228956171,22895617,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, tid (injected three times a day every time she eats)",,,,,,,,,,Unknown,TID,2023,Q3,Device mechanical issue,,2023,Q3,1,I,20230815.0,20230815.0,20230901,20230901,PER,,US-MYLANLABS-2023M1086907,MYLAN,,58.0,YR,,F,Y,80.74,KG,20230901,,CN,US,US,2023,Q3,Adult
228956171,22895617,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, tid (injected three times a day every time she eats)",,,,,,,,,,Unknown,TID,2023,Q3,Wrong technique in product usage process,,2023,Q3,1,I,20230815.0,20230815.0,20230901,20230901,PER,,US-MYLANLABS-2023M1086907,MYLAN,,58.0,YR,,F,Y,80.74,KG,20230901,,CN,US,US,2023,Q3,Adult
228956171,22895617,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, tid (injected three times a day every time she eats)",,,,,,,,,,Unknown,TID,2023,Q3,Weight increased,,2023,Q3,1,I,20230815.0,20230815.0,20230901,20230901,PER,,US-MYLANLABS-2023M1086907,MYLAN,,58.0,YR,,F,Y,80.74,KG,20230901,,CN,US,US,2023,Q3,Adult
228977171,22897717,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Wrong product administered,,2023,Q3,1,I,20230829.0,20230830.0,20230902,20230902,PER,,US-ELI_LILLY_AND_COMPANY-US202309000164,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230902,,CN,US,US,2023,Q3,Elderly
228977171,22897717,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230829.0,20230830.0,20230902,20230902,PER,,US-ELI_LILLY_AND_COMPANY-US202309000164,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20230902,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Paraesthesia oral,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Cardiac failure,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Skin burning sensation,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Product prescribing issue,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Asthenia,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Dysphonia,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Rash erythematous,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Tooth disorder,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Weight decreased,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Hypothyroidism,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Cataract,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Dehydration,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Hypertension,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Inappropriate schedule of product administration,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Decreased appetite,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229074752,22907475,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Oedema peripheral,,2023,Q3,2,F,20230710.0,20230920.0,20230905,20230926,EXP,,US-EXELIXIS-CABO-23065106,EXELIXIS,,68.0,YR,,M,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229089091,22908909,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,DURATION OF THERAPY ASSIGNED BY OFFICE,,,U,,,,,,,Solution for injection,,2023,Q3,Metabolic acidosis,,2023,Q3,1,I,20230803.0,20230831.0,20230905,20230905,EXP,IT-MINISAL02-941707,IT-SA-2023SA267937,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20230906,,MD,IT,IT,2023,Q3,Elderly
229092362,22909236,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (supplemental scale),,,U,,,,,,,Injection,,2023,Q3,Pneumonia,,2023,Q3,2,F,20230814.0,20230920.0,20230906,20230928,PER,,NVSC2023US190527,NOVARTIS,,69.0,YR,,F,Y,58.0,KG,20230928,,HP,US,US,2023,Q3,Elderly
229092362,22909236,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (supplemental scale),,,U,,,,,,,Injection,,2023,Q3,Hypoxia,,2023,Q3,2,F,20230814.0,20230920.0,20230906,20230928,PER,,NVSC2023US190527,NOVARTIS,,69.0,YR,,F,Y,58.0,KG,20230928,,HP,US,US,2023,Q3,Elderly
229092362,22909236,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (supplemental scale),,,U,,,,,,,Injection,,2023,Q3,Cytokine release syndrome,,2023,Q3,2,F,20230814.0,20230920.0,20230906,20230928,PER,,NVSC2023US190527,NOVARTIS,,69.0,YR,,F,Y,58.0,KG,20230928,,HP,US,US,2023,Q3,Elderly
229092362,22909236,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (supplemental scale),,,U,,,,,,,Injection,,2023,Q3,Blood pressure systolic increased,,2023,Q3,2,F,20230814.0,20230920.0,20230906,20230928,PER,,NVSC2023US190527,NOVARTIS,,69.0,YR,,F,Y,58.0,KG,20230928,,HP,US,US,2023,Q3,Elderly
229092362,22909236,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (supplemental scale),,,U,,,,,,,Injection,,2023,Q3,Blood pressure diastolic increased,,2023,Q3,2,F,20230814.0,20230920.0,20230906,20230928,PER,,NVSC2023US190527,NOVARTIS,,69.0,YR,,F,Y,58.0,KG,20230928,,HP,US,US,2023,Q3,Elderly
229092362,22909236,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (supplemental scale),,,U,,,,,,,Injection,,2023,Q3,Pyrexia,,2023,Q3,2,F,20230814.0,20230920.0,20230906,20230928,PER,,NVSC2023US190527,NOVARTIS,,69.0,YR,,F,Y,58.0,KG,20230928,,HP,US,US,2023,Q3,Elderly
229104752,22910475,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Acute myocardial infarction,,2023,Q3,2,F,20230411.0,20230905.0,20230906,20230907,EXP,,US-ROCHE-3353984,ROCHE,,77.0,YR,,M,Y,,,20230907,,MD,US,,2023,Q3,Elderly
229104752,22910475,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Thrombocytopenia,,2023,Q3,2,F,20230411.0,20230905.0,20230906,20230907,EXP,,US-ROCHE-3353984,ROCHE,,77.0,YR,,M,Y,,,20230907,,MD,US,,2023,Q3,Elderly
229104752,22910475,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Pneumonia,,2023,Q3,2,F,20230411.0,20230905.0,20230906,20230907,EXP,,US-ROCHE-3353984,ROCHE,,77.0,YR,,M,Y,,,20230907,,MD,US,,2023,Q3,Elderly
229104752,22910475,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,2,F,20230411.0,20230905.0,20230906,20230907,EXP,,US-ROCHE-3353984,ROCHE,,77.0,YR,,M,Y,,,20230907,,MD,US,,2023,Q3,Elderly
229104752,22910475,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Acute respiratory failure,,2023,Q3,2,F,20230411.0,20230905.0,20230906,20230907,EXP,,US-ROCHE-3353984,ROCHE,,77.0,YR,,M,Y,,,20230907,,MD,US,,2023,Q3,Elderly
229104752,22910475,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Hypoxia,,2023,Q3,2,F,20230411.0,20230905.0,20230906,20230907,EXP,,US-ROCHE-3353984,ROCHE,,77.0,YR,,M,Y,,,20230907,,MD,US,,2023,Q3,Elderly
229104752,22910475,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Septic shock,,2023,Q3,2,F,20230411.0,20230905.0,20230906,20230907,EXP,,US-ROCHE-3353984,ROCHE,,77.0,YR,,M,Y,,,20230907,,MD,US,,2023,Q3,Elderly
229118321,22911832,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,Solution for injection,,2023,Q3,Tremor,,2023,Q3,1,I,,20230831.0,20230906,20230906,PER,,US-SA-2023SA269610,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20230906,,MD,US,US,2023,Q3,Elderly
229141131,22914113,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10.000000 IU, three times every one day",,,U,,202112016,,,,,Injection,,2023,Q3,Hypoglycaemic coma,,2023,Q3,1,I,20230826.0,20230901.0,20230906,20230906,EXP,,CN-AstraZeneca-2023A203075,ASTRAZENECA,,24332.0,DY,,M,Y,,,20230906,,MD,CN,,2023,Q3,Elderly
229181521,22918152,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Hepatic cancer stage IV,,2023,Q3,1,I,20220901.0,20230901.0,20230907,20230907,EXP,,US-ELI_LILLY_AND_COMPANY-US202309001206,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20230907,,CN,US,US,2023,Q3,Elderly
229181521,22918152,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q3,Hepatic cancer stage IV,,2023,Q3,1,I,20220901.0,20230901.0,20230907,20230907,EXP,,US-ELI_LILLY_AND_COMPANY-US202309001206,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20230907,,CN,US,US,2023,Q3,Elderly
229181521,22918152,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, unknown",,,U,,D549451A,,20563.0,4.0,IU,Injection,,2023,Q3,Hepatic cancer stage IV,,2023,Q3,1,I,20220901.0,20230901.0,20230907,20230907,EXP,,US-ELI_LILLY_AND_COMPANY-US202309001206,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20230907,,CN,US,US,2023,Q3,Elderly
229181521,22918152,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, unknown",,,U,,D549451A,,20563.0,4.0,IU,Injection,,2023,Q3,Hepatic cancer stage IV,,2023,Q3,1,I,20220901.0,20230901.0,20230907,20230907,EXP,,US-ELI_LILLY_AND_COMPANY-US202309001206,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20230907,,CN,US,US,2023,Q3,Elderly
229234791,22923479,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Oedema peripheral,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923832,TEVA,,13.0,YR,T,F,Y,75.0,KG,20230908,,HP,CA,CA,2023,Q3,Child
229234791,22923479,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Somnolence,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923832,TEVA,,13.0,YR,T,F,Y,75.0,KG,20230908,,HP,CA,CA,2023,Q3,Child
229234791,22923479,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Cyanosis,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923832,TEVA,,13.0,YR,T,F,Y,75.0,KG,20230908,,HP,CA,CA,2023,Q3,Child
229234791,22923479,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Pulmonary embolism,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923832,TEVA,,13.0,YR,T,F,Y,75.0,KG,20230908,,HP,CA,CA,2023,Q3,Child
229234791,22923479,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Venous thrombosis,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923832,TEVA,,13.0,YR,T,F,Y,75.0,KG,20230908,,HP,CA,CA,2023,Q3,Child
229234791,22923479,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Deep vein thrombosis,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923832,TEVA,,13.0,YR,T,F,Y,75.0,KG,20230908,,HP,CA,CA,2023,Q3,Child
229234791,22923479,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Pain in extremity,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923832,TEVA,,13.0,YR,T,F,Y,75.0,KG,20230908,,HP,CA,CA,2023,Q3,Child
229234791,22923479,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923832,TEVA,,13.0,YR,T,F,Y,75.0,KG,20230908,,HP,CA,CA,2023,Q3,Child
229243141,22924314,14,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Rhabdomyolysis,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923916,TEVA,,61.0,YR,A,M,Y,,,20230908,,PH,CA,CA,2023,Q3,Adult
229243141,22924314,14,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Blood creatine phosphokinase increased,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923916,TEVA,,61.0,YR,A,M,Y,,,20230908,,PH,CA,CA,2023,Q3,Adult
229243141,22924314,14,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Fall,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923916,TEVA,,61.0,YR,A,M,Y,,,20230908,,PH,CA,CA,2023,Q3,Adult
229243141,22924314,14,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Drug interaction,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923916,TEVA,,61.0,YR,A,M,Y,,,20230908,,PH,CA,CA,2023,Q3,Adult
229243141,22924314,14,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Gait inability,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923916,TEVA,,61.0,YR,A,M,Y,,,20230908,,PH,CA,CA,2023,Q3,Adult
229243141,22924314,14,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923916,TEVA,,61.0,YR,A,M,Y,,,20230908,,PH,CA,CA,2023,Q3,Adult
229243141,22924314,14,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2023,Q3,Liver function test increased,,2023,Q3,1,I,,20230831.0,20230908,20230908,EXP,,CA-TEVA-2023-CA-2923916,TEVA,,61.0,YR,A,M,Y,,,20230908,,PH,CA,CA,2023,Q3,Adult
229250701,22925070,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q3,Febrile neutropenia,,2023,Q3,1,I,20230829.0,20230831.0,20230908,20230908,EXP,,JP-JNJFOC-20230906819,JOHNSON AND JOHNSON,,77.0,YR,E,F,Y,43.6,KG,20230908,,MD,JP,JP,2023,Q3,Elderly
229269891,22926989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2023,Q3,Neutropenia,,2023,Q3,1,I,,20221223.0,20230911,20230911,PER,US-MLMSERVICE-20221220-3992553-1,US-STRIDES ARCOLAB LIMITED-2022SP017467,STRIDES,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatric Transplantation.. 2022",13.0,YR,,F,Y,,,20230911,,MD,US,US,2023,Q3,Child
229269891,22926989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2023,Q3,Transplant rejection,,2023,Q3,1,I,,20221223.0,20230911,20230911,PER,US-MLMSERVICE-20221220-3992553-1,US-STRIDES ARCOLAB LIMITED-2022SP017467,STRIDES,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatric Transplantation.. 2022",13.0,YR,,F,Y,,,20230911,,MD,US,US,2023,Q3,Child
229269891,22926989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2023,Q3,Adverse drug reaction,,2023,Q3,1,I,,20221223.0,20230911,20230911,PER,US-MLMSERVICE-20221220-3992553-1,US-STRIDES ARCOLAB LIMITED-2022SP017467,STRIDES,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatric Transplantation.. 2022",13.0,YR,,F,Y,,,20230911,,MD,US,US,2023,Q3,Child
229269891,22926989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2023,Q3,Urinary tract infection,,2023,Q3,1,I,,20221223.0,20230911,20230911,PER,US-MLMSERVICE-20221220-3992553-1,US-STRIDES ARCOLAB LIMITED-2022SP017467,STRIDES,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatric Transplantation.. 2022",13.0,YR,,F,Y,,,20230911,,MD,US,US,2023,Q3,Child
229269891,22926989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2023,Q3,Off label use,,2023,Q3,1,I,,20221223.0,20230911,20230911,PER,US-MLMSERVICE-20221220-3992553-1,US-STRIDES ARCOLAB LIMITED-2022SP017467,STRIDES,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatric Transplantation.. 2022",13.0,YR,,F,Y,,,20230911,,MD,US,US,2023,Q3,Child
229269891,22926989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2023,Q3,Cytomegalovirus infection,,2023,Q3,1,I,,20221223.0,20230911,20230911,PER,US-MLMSERVICE-20221220-3992553-1,US-STRIDES ARCOLAB LIMITED-2022SP017467,STRIDES,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatric Transplantation.. 2022",13.0,YR,,F,Y,,,20230911,,MD,US,US,2023,Q3,Child
229269891,22926989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2023,Q3,BK virus infection,,2023,Q3,1,I,,20221223.0,20230911,20230911,PER,US-MLMSERVICE-20221220-3992553-1,US-STRIDES ARCOLAB LIMITED-2022SP017467,STRIDES,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatric Transplantation.. 2022",13.0,YR,,F,Y,,,20230911,,MD,US,US,2023,Q3,Child
229269891,22926989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2023,Q3,Upper respiratory tract infection,,2023,Q3,1,I,,20221223.0,20230911,20230911,PER,US-MLMSERVICE-20221220-3992553-1,US-STRIDES ARCOLAB LIMITED-2022SP017467,STRIDES,"Adamusiak AM, Ramanathan K, Moe T, Bellin MD, Kandaswamy R.. Effective treatment of diabetes, improved quality of life and accelerated cognitive development after pancreas transplantation in a child with type 1 diabetes and allergy to manufactured insulin preparations. Pediatric Transplantation.. 2022",13.0,YR,,F,Y,,,20230911,,MD,US,US,2023,Q3,Child
229274462,22927446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D604077A,,,,,Injection,,2023,Q3,Arthralgia,,2023,Q3,2,F,20230801.0,20230908.0,20230911,20230911,PER,,US-ELI_LILLY_AND_COMPANY-US202309004989,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20230911,,CN,US,US,2023,Q3,Adult
229282761,22928276,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (Other/unspecified),,,U,U,Unknown,,,,,,,2023,Q3,Renal impairment,,2023,Q3,1,I,,20220914.0,20230911,20230911,EXP,DE-ADRED-07767-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10120,ALKEM,,48.0,YR,,M,Y,72.0,KG,20230911,,PH,DE,DE,2023,Q3,Adult
229296291,22929629,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Colitis ulcerative,,2023,Q3,1,I,,20230904.0,20230911,20230911,EXP,,CA-FreseniusKabi-FK202313894,FRESENIUS KABI,,20.0,YR,A,F,Y,,,20230911,,HP,CA,CA,2023,Q3,Youth
229296291,22929629,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Product dose omission issue,,2023,Q3,1,I,,20230904.0,20230911,20230911,EXP,,CA-FreseniusKabi-FK202313894,FRESENIUS KABI,,20.0,YR,A,F,Y,,,20230911,,HP,CA,CA,2023,Q3,Youth
229296291,22929629,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,,20230904.0,20230911,20230911,EXP,,CA-FreseniusKabi-FK202313894,FRESENIUS KABI,,20.0,YR,A,F,Y,,,20230911,,HP,CA,CA,2023,Q3,Youth
229296291,22929629,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Drug ineffective,,2023,Q3,1,I,,20230904.0,20230911,20230911,EXP,,CA-FreseniusKabi-FK202313894,FRESENIUS KABI,,20.0,YR,A,F,Y,,,20230911,,HP,CA,CA,2023,Q3,Youth
229301231,22930123,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,U,,,,,,,,2023,Q3,Pain,,2023,Q3,1,I,,20230220.0,20230911,20230911,EXP,,RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384228,RANBAXY,,68.0,YR,,,Y,,,20230911,,MD,RO,RO,2023,Q3,Elderly
229301231,22930123,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,U,,,,,,,,2023,Q3,Neuralgia,,2023,Q3,1,I,,20230220.0,20230911,20230911,EXP,,RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384228,RANBAXY,,68.0,YR,,,Y,,,20230911,,MD,RO,RO,2023,Q3,Elderly
229301231,22930123,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,U,,,,,,,,2023,Q3,Rash,,2023,Q3,1,I,,20230220.0,20230911,20230911,EXP,,RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384228,RANBAXY,,68.0,YR,,,Y,,,20230911,,MD,RO,RO,2023,Q3,Elderly
229301231,22930123,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,U,,,,,,,,2023,Q3,Condition aggravated,,2023,Q3,1,I,,20230220.0,20230911,20230911,EXP,,RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384228,RANBAXY,,68.0,YR,,,Y,,,20230911,,MD,RO,RO,2023,Q3,Elderly
229301231,22930123,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0/50 IU 60IU in the morning and 64 IU in the evening,,,U,U,,,,,,,,2023,Q3,Varicella zoster virus infection,,2023,Q3,1,I,,20230220.0,20230911,20230911,EXP,,RO-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-384228,RANBAXY,,68.0,YR,,,Y,,,20230911,,MD,RO,RO,2023,Q3,Elderly
229311211,22931121,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D564351E,,,,,Injection,,2023,Q3,Dizziness,,2023,Q3,1,I,20230905.0,20230905.0,20230911,20230911,EXP,,US-ELI_LILLY_AND_COMPANY-US202309002823,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20230911,,CN,US,US,2023,Q3,Elderly
229311211,22931121,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D564351E,,,,,Injection,,2023,Q3,Vomiting,,2023,Q3,1,I,20230905.0,20230905.0,20230911,20230911,EXP,,US-ELI_LILLY_AND_COMPANY-US202309002823,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20230911,,CN,US,US,2023,Q3,Elderly
229311211,22931121,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D564351E,,,,,Injection,,2023,Q3,Headache,,2023,Q3,1,I,20230905.0,20230905.0,20230911,20230911,EXP,,US-ELI_LILLY_AND_COMPANY-US202309002823,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20230911,,CN,US,US,2023,Q3,Elderly
229311211,22931121,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D564351E,,,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230905.0,20230905.0,20230911,20230911,EXP,,US-ELI_LILLY_AND_COMPANY-US202309002823,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20230911,,CN,US,US,2023,Q3,Elderly
229311211,22931121,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q3,Dizziness,,2023,Q3,1,I,20230905.0,20230905.0,20230911,20230911,EXP,,US-ELI_LILLY_AND_COMPANY-US202309002823,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20230911,,CN,US,US,2023,Q3,Elderly
229311211,22931121,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q3,Vomiting,,2023,Q3,1,I,20230905.0,20230905.0,20230911,20230911,EXP,,US-ELI_LILLY_AND_COMPANY-US202309002823,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20230911,,CN,US,US,2023,Q3,Elderly
229311211,22931121,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q3,Headache,,2023,Q3,1,I,20230905.0,20230905.0,20230911,20230911,EXP,,US-ELI_LILLY_AND_COMPANY-US202309002823,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20230911,,CN,US,US,2023,Q3,Elderly
229311211,22931121,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230905.0,20230905.0,20230911,20230911,EXP,,US-ELI_LILLY_AND_COMPANY-US202309002823,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20230911,,CN,US,US,2023,Q3,Elderly
229345281,22934528,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Septic shock,,2023,Q3,1,I,,20210311.0,20230912,20230912,EXP,,US-Marksans Pharma Limited-2145856,MARKSANS,"Umeda T, Minami T, Bartolomei K, Summerhill E. Metformin-Associated Lactic Acidosis: A Case Report. Drug Saf Case Rep. 2018 Feb 9;5(1):8. doi: 10.1007/s40800-018-0076-1. PMID: 29427160; PMCID: PMC5807253.",54.0,YR,,F,Y,,,20230912,,HP,US,US,2023,Q3,Adult
229345281,22934528,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Cardiogenic shock,,2023,Q3,1,I,,20210311.0,20230912,20230912,EXP,,US-Marksans Pharma Limited-2145856,MARKSANS,"Umeda T, Minami T, Bartolomei K, Summerhill E. Metformin-Associated Lactic Acidosis: A Case Report. Drug Saf Case Rep. 2018 Feb 9;5(1):8. doi: 10.1007/s40800-018-0076-1. PMID: 29427160; PMCID: PMC5807253.",54.0,YR,,F,Y,,,20230912,,HP,US,US,2023,Q3,Adult
229345281,22934528,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Lactic acidosis,,2023,Q3,1,I,,20210311.0,20230912,20230912,EXP,,US-Marksans Pharma Limited-2145856,MARKSANS,"Umeda T, Minami T, Bartolomei K, Summerhill E. Metformin-Associated Lactic Acidosis: A Case Report. Drug Saf Case Rep. 2018 Feb 9;5(1):8. doi: 10.1007/s40800-018-0076-1. PMID: 29427160; PMCID: PMC5807253.",54.0,YR,,F,Y,,,20230912,,HP,US,US,2023,Q3,Adult
229345281,22934528,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Renal impairment,,2023,Q3,1,I,,20210311.0,20230912,20230912,EXP,,US-Marksans Pharma Limited-2145856,MARKSANS,"Umeda T, Minami T, Bartolomei K, Summerhill E. Metformin-Associated Lactic Acidosis: A Case Report. Drug Saf Case Rep. 2018 Feb 9;5(1):8. doi: 10.1007/s40800-018-0076-1. PMID: 29427160; PMCID: PMC5807253.",54.0,YR,,F,Y,,,20230912,,HP,US,US,2023,Q3,Adult
229345281,22934528,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Cardio-respiratory arrest,,2023,Q3,1,I,,20210311.0,20230912,20230912,EXP,,US-Marksans Pharma Limited-2145856,MARKSANS,"Umeda T, Minami T, Bartolomei K, Summerhill E. Metformin-Associated Lactic Acidosis: A Case Report. Drug Saf Case Rep. 2018 Feb 9;5(1):8. doi: 10.1007/s40800-018-0076-1. PMID: 29427160; PMCID: PMC5807253.",54.0,YR,,F,Y,,,20230912,,HP,US,US,2023,Q3,Adult
229345281,22934528,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q3,Hypoglycaemia,,2023,Q3,1,I,,20210311.0,20230912,20230912,EXP,,US-Marksans Pharma Limited-2145856,MARKSANS,"Umeda T, Minami T, Bartolomei K, Summerhill E. Metformin-Associated Lactic Acidosis: A Case Report. Drug Saf Case Rep. 2018 Feb 9;5(1):8. doi: 10.1007/s40800-018-0076-1. PMID: 29427160; PMCID: PMC5807253.",54.0,YR,,F,Y,,,20230912,,HP,US,US,2023,Q3,Adult
229360071,22936007,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,Injection,,2023,Q3,Loss of consciousness,,2023,Q3,1,I,20230401.0,20230906.0,20230912,20230912,EXP,,US-ELI_LILLY_AND_COMPANY-US202309003475,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20230912,,CN,US,US,2023,Q3,Adult
229360071,22936007,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,Injection,,2023,Q3,Blood pressure decreased,,2023,Q3,1,I,20230401.0,20230906.0,20230912,20230912,EXP,,US-ELI_LILLY_AND_COMPANY-US202309003475,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20230912,,CN,US,US,2023,Q3,Adult
229360071,22936007,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,Injection,,2023,Q3,Transient ischaemic attack,,2023,Q3,1,I,20230401.0,20230906.0,20230912,20230912,EXP,,US-ELI_LILLY_AND_COMPANY-US202309003475,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20230912,,CN,US,US,2023,Q3,Adult
229360071,22936007,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,20563.0,,,Injection,,2023,Q3,Cerebrovascular accident,,2023,Q3,1,I,20230401.0,20230906.0,20230912,20230912,EXP,,US-ELI_LILLY_AND_COMPANY-US202309003475,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20230912,,CN,US,US,2023,Q3,Adult
229360071,22936007,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,Injection,,2023,Q3,Loss of consciousness,,2023,Q3,1,I,20230401.0,20230906.0,20230912,20230912,EXP,,US-ELI_LILLY_AND_COMPANY-US202309003475,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20230912,,CN,US,US,2023,Q3,Adult
229360071,22936007,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,Injection,,2023,Q3,Blood pressure decreased,,2023,Q3,1,I,20230401.0,20230906.0,20230912,20230912,EXP,,US-ELI_LILLY_AND_COMPANY-US202309003475,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20230912,,CN,US,US,2023,Q3,Adult
229360071,22936007,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,Injection,,2023,Q3,Transient ischaemic attack,,2023,Q3,1,I,20230401.0,20230906.0,20230912,20230912,EXP,,US-ELI_LILLY_AND_COMPANY-US202309003475,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20230912,,CN,US,US,2023,Q3,Adult
229360071,22936007,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,Injection,,2023,Q3,Cerebrovascular accident,,2023,Q3,1,I,20230401.0,20230906.0,20230912,20230912,EXP,,US-ELI_LILLY_AND_COMPANY-US202309003475,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20230912,,CN,US,US,2023,Q3,Adult
229370613,22937061,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Gait inability,,2023,Q3,3,F,20200109.0,20230922.0,20230912,20230924,EXP,,US-ABBVIE-5403320,ABBVIE,,76.0,YR,,F,Y,56.0,KG,20230924,,CN,US,US,2023,Q3,Elderly
229370613,22937061,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,General physical health deterioration,,2023,Q3,3,F,20200109.0,20230922.0,20230912,20230924,EXP,,US-ABBVIE-5403320,ABBVIE,,76.0,YR,,F,Y,56.0,KG,20230924,,CN,US,US,2023,Q3,Elderly
229370613,22937061,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Joint stiffness,,2023,Q3,3,F,20200109.0,20230922.0,20230912,20230924,EXP,,US-ABBVIE-5403320,ABBVIE,,76.0,YR,,F,Y,56.0,KG,20230924,,CN,US,US,2023,Q3,Elderly
229370613,22937061,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Loss of personal independence in daily activities,,2023,Q3,3,F,20200109.0,20230922.0,20230912,20230924,EXP,,US-ABBVIE-5403320,ABBVIE,,76.0,YR,,F,Y,56.0,KG,20230924,,CN,US,US,2023,Q3,Elderly
229370613,22937061,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Therapeutic product effect incomplete,,2023,Q3,3,F,20200109.0,20230922.0,20230912,20230924,EXP,,US-ABBVIE-5403320,ABBVIE,,76.0,YR,,F,Y,56.0,KG,20230924,,CN,US,US,2023,Q3,Elderly
229391981,22939198,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D578904A,,20563.0,,,Injection,,2023,Q3,Memory impairment,,2023,Q3,1,I,20230606.0,20230911.0,20230913,20230913,PER,,US-ELI_LILLY_AND_COMPANY-US202309006870,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20230913,,CN,US,US,2023,Q3,Adult
229391981,22939198,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D578904A,,20563.0,,,Injection,,2023,Q3,Stress,,2023,Q3,1,I,20230606.0,20230911.0,20230913,20230913,PER,,US-ELI_LILLY_AND_COMPANY-US202309006870,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20230913,,CN,US,US,2023,Q3,Adult
229391981,22939198,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D578904A,,20563.0,,,Injection,,2023,Q3,Tibia fracture,,2023,Q3,1,I,20230606.0,20230911.0,20230913,20230913,PER,,US-ELI_LILLY_AND_COMPANY-US202309006870,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20230913,,CN,US,US,2023,Q3,Adult
229391981,22939198,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D578904A,,20563.0,,,Injection,,2023,Q3,Fall,,2023,Q3,1,I,20230606.0,20230911.0,20230913,20230913,PER,,US-ELI_LILLY_AND_COMPANY-US202309006870,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20230913,,CN,US,US,2023,Q3,Adult
229422191,22942219,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Neutropenia,,2023,Q3,1,I,20230109.0,20230908.0,20230914,20230914,EXP,,DE-SANDOZ INC.-NVSC2023DE045247,SANDOZ,,83.0,YR,,M,Y,70.0,KG,20230914,,MD,DE,DE,2023,Q3,Elderly
229422191,22942219,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,20230109.0,20230908.0,20230914,20230914,EXP,,DE-SANDOZ INC.-NVSC2023DE045247,SANDOZ,,83.0,YR,,M,Y,70.0,KG,20230914,,MD,DE,DE,2023,Q3,Elderly
229422191,22942219,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q3,Renal impairment,,2023,Q3,1,I,20230109.0,20230908.0,20230914,20230914,EXP,,DE-SANDOZ INC.-NVSC2023DE045247,SANDOZ,,83.0,YR,,M,Y,70.0,KG,20230914,,MD,DE,DE,2023,Q3,Elderly
229448752,22944875,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-3-3 units,,,U,,,,,,,,,2023,Q3,Insulin C-peptide increased,,2023,Q3,2,F,,20230913.0,20230914,20230920,EXP,,NVSC2023JP198818,NOVARTIS,"Tanji Y, Sawada S, Numahata T, Watanabe T, Munakata Y, A. Marked increase in urinary C-peptide levels after treatment with sacubitril/valsartan in patients with type 2 diabetes mellitus and hypertension. INTERNAL MEDICINE. 2023;1-6",48.0,YR,,M,Y,,,20230920,,HP,JP,JP,2023,Q3,Adult
229448762,22944876,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (daily dose: 10-3-4 units),,,U,,,,,,,,,2023,Q3,Insulin C-peptide increased,,2023,Q3,2,F,,20230913.0,20230914,20230920,EXP,,NVSC2023JP198819,NOVARTIS,"Tanji Y, Sawada S, Numahata T, Watanabe T, Munakata Y, Akai H. Marked Increase in Urinary C-peptide Levels after Treatment with Sacubitril/Valsartan in Patients with Type 2 Diabetes Mellitus and Hypertension. INTERNAL MEDICINE. 2023;1-6",59.0,YR,,M,Y,,,20230920,,HP,JP,JP,2023,Q3,Adult
229456241,22945624,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Pruritus,,2023,Q3,1,I,,20230908.0,20230914,20230914,EXP,,CA-009507513-2309CAN003820,MERCK,,37.0,YR,,F,Y,104.0,KG,20230914,,PH,CA,CA,2023,Q3,Adult
229456241,22945624,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Urticaria,,2023,Q3,1,I,,20230908.0,20230914,20230914,EXP,,CA-009507513-2309CAN003820,MERCK,,37.0,YR,,F,Y,104.0,KG,20230914,,PH,CA,CA,2023,Q3,Adult
229456241,22945624,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Acute generalised exanthematous pustulosis,,2023,Q3,1,I,,20230908.0,20230914,20230914,EXP,,CA-009507513-2309CAN003820,MERCK,,37.0,YR,,F,Y,104.0,KG,20230914,,PH,CA,CA,2023,Q3,Adult
229456241,22945624,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Skin burning sensation,,2023,Q3,1,I,,20230908.0,20230914,20230914,EXP,,CA-009507513-2309CAN003820,MERCK,,37.0,YR,,F,Y,104.0,KG,20230914,,PH,CA,CA,2023,Q3,Adult
229478391,22947839,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D578904A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230914.0,20230914.0,20230915,20230915,PER,,US-ELI_LILLY_AND_COMPANY-US202309008562,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20230915,,CN,US,US,2023,Q3,Elderly
229497451,22949745,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,25,,,U,,,,,,,,,2023,Q3,Wound complication,,2023,Q3,1,I,20230627.0,20230912.0,20230915,20230915,EXP,,"LK-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-261166",BOEHRINGER INGELHEIM,,56.0,YR,A,M,Y,70.0,KG,20230915,,CN,LK,LK,2023,Q3,Adult
229497451,22949745,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,25,,,U,,,,,,,,,2023,Q3,Skin wound,,2023,Q3,1,I,20230627.0,20230912.0,20230915,20230915,EXP,,"LK-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-261166",BOEHRINGER INGELHEIM,,56.0,YR,A,M,Y,70.0,KG,20230915,,CN,LK,LK,2023,Q3,Adult
229516431,22951643,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2023,Q3,Off label use,,2023,Q3,1,I,20230901.0,20230913.0,20230918,20230918,PER,,US-Blueprint Medicines Corporation-SP-US-2023-001407,BLUEPRINT MEDICINES,,34.0,YR,A,F,Y,,,20230918,,HP,US,US,2023,Q3,Young Adult
229518091,22951809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthenia,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Decreased appetite,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypertension,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Rash erythematous,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypothyroidism,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Fatigue,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Asthenia,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Decreased appetite,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypertension,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Rash erythematous,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229518091,22951809,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q3,Hypothyroidism,,2023,Q3,1,I,20230710.0,20230905.0,20230918,20230918,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (Sliding scale)",,,,,D518829A,,,,,Injection,,2023,Q3,Product dispensing error,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (Sliding scale)",,,,,D518829A,,,,,Injection,,2023,Q3,Fall,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (Sliding scale)",,,,,D518829A,,,,,Injection,,2023,Q3,Infection,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (Sliding scale)",,,,,D518829A,,,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (Sliding scale)",,,,,D518829A,,,,,Injection,,2023,Q3,Product dispensing error,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (Sliding scale)",,,,,D518829A,,,,,Injection,,2023,Q3,Fall,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (Sliding scale)",,,,,D518829A,,,,,Injection,,2023,Q3,Infection,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (Sliding scale)",,,,,D518829A,,,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,4,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,,"UNK UNK, prn (Sliding scale)",,,U,,,,20563.0,,,Injection,,2023,Q3,Product dispensing error,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,4,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,,"UNK UNK, prn (Sliding scale)",,,U,,,,20563.0,,,Injection,,2023,Q3,Fall,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,4,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,,"UNK UNK, prn (Sliding scale)",,,U,,,,20563.0,,,Injection,,2023,Q3,Infection,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229553631,22955363,4,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,,"UNK UNK, prn (Sliding scale)",,,U,,,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230101.0,20230912.0,20230918,20230918,EXP,,US-ELI_LILLY_AND_COMPANY-US202309006988,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229556551,22955655,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, tid",,,U,,D580163D,,20563.0,,,Injection,TID,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230701.0,20230915.0,20230918,20230918,PER,,US-ELI_LILLY_AND_COMPANY-US202309009800,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229556551,22955655,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, tid",,,U,,D580163D,,20563.0,,,Injection,TID,2023,Q3,Vision blurred,,2023,Q3,1,I,20230701.0,20230915.0,20230918,20230918,PER,,US-ELI_LILLY_AND_COMPANY-US202309009800,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229556551,22955655,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, tid",,,U,,D580163D,,20563.0,,,Injection,TID,2023,Q3,Injection site bruising,,2023,Q3,1,I,20230701.0,20230915.0,20230918,20230918,PER,,US-ELI_LILLY_AND_COMPANY-US202309009800,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20230918,,CN,US,US,2023,Q3,Elderly
229587821,22958782,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Electrocardiogram QT prolonged,,2023,Q3,1,I,,20230918.0,20230919,20230919,EXP,,CA-GILEAD-2023-0644365,GILEAD,,72.0,YR,E,M,Y,73.0,KG,20230919,,HP,CA,CA,2023,Q3,Elderly
229587821,22958782,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Liver function test abnormal,,2023,Q3,1,I,,20230918.0,20230919,20230919,EXP,,CA-GILEAD-2023-0644365,GILEAD,,72.0,YR,E,M,Y,73.0,KG,20230919,,HP,CA,CA,2023,Q3,Elderly
229587821,22958782,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Atrioventricular block,,2023,Q3,1,I,,20230918.0,20230919,20230919,EXP,,CA-GILEAD-2023-0644365,GILEAD,,72.0,YR,E,M,Y,73.0,KG,20230919,,HP,CA,CA,2023,Q3,Elderly
229587821,22958782,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Bradycardia,,2023,Q3,1,I,,20230918.0,20230919,20230919,EXP,,CA-GILEAD-2023-0644365,GILEAD,,72.0,YR,E,M,Y,73.0,KG,20230919,,HP,CA,CA,2023,Q3,Elderly
229589771,22958977,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 international unit, daily",,,U,,D562692H,,20563.0,2.0,IU,,QD,2023,Q3,Administration site reaction,,2023,Q3,1,I,20230901.0,20230913.0,20230919,20230919,EXP,PT-INFARMED-F202309-118,PT-ELI_LILLY_AND_COMPANY-PT202309007376,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20230919,,CN,PT,PT,2023,Q3,Elderly
229589771,22958977,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 international unit, daily",,,U,,D562692H,,20563.0,2.0,IU,,QD,2023,Q3,Injection site vesicles,,2023,Q3,1,I,20230901.0,20230913.0,20230919,20230919,EXP,PT-INFARMED-F202309-118,PT-ELI_LILLY_AND_COMPANY-PT202309007376,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20230919,,CN,PT,PT,2023,Q3,Elderly
229656291,22965629,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D604077A,,20563.0,,,Injection,,2023,Q3,Blood glucose increased,,2023,Q3,1,I,20230916.0,20230920.0,20230921,20230921,PER,,US-ELI_LILLY_AND_COMPANY-US202309011699,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20230921,,CN,US,US,2023,Q3,Elderly
229745031,22974503,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Pain in extremity,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Peripheral artery occlusion,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Palliative care,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Thromboembolectomy,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Clostridium test positive,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Pain in extremity,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Peripheral artery occlusion,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Palliative care,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Thromboembolectomy,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229745031,22974503,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q3,Clostridium test positive,,2023,Q3,1,I,,20230920.0,20230923,20230923,EXP,,CA-SANDOZ INC.-SDZ2023CA032762,SANDOZ,,80.0,YR,,F,Y,80.0,KG,20230923,,PH,CA,CA,2023,Q3,Elderly
229753941,22975394,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q3,Malaise,,2023,Q3,1,I,,20230915.0,20230924,20230924,EXP,,JP-SAKK-2023SA150621AA,SANOFI AVENTIS,"Yamawaki T, Hamada N, Cho J, Mori Y.. A Case of Hyponatremia During Insulin Therapy.. Journal of the Japan Diabetes Society.. 2023;66:581",69.0,YR,E,M,Y,,,20230925,,MD,JP,JP,2023,Q3,Elderly
229753941,22975394,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q3,Dehydration,,2023,Q3,1,I,,20230915.0,20230924,20230924,EXP,,JP-SAKK-2023SA150621AA,SANOFI AVENTIS,"Yamawaki T, Hamada N, Cho J, Mori Y.. A Case of Hyponatremia During Insulin Therapy.. Journal of the Japan Diabetes Society.. 2023;66:581",69.0,YR,E,M,Y,,,20230925,,MD,JP,JP,2023,Q3,Elderly
229753941,22975394,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q3,Hyponatraemia,,2023,Q3,1,I,,20230915.0,20230924,20230924,EXP,,JP-SAKK-2023SA150621AA,SANOFI AVENTIS,"Yamawaki T, Hamada N, Cho J, Mori Y.. A Case of Hyponatremia During Insulin Therapy.. Journal of the Japan Diabetes Society.. 2023;66:581",69.0,YR,E,M,Y,,,20230925,,MD,JP,JP,2023,Q3,Elderly
229765741,22976574,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578904A,,20563.0,,,Injection,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230921.0,20230921.0,20230925,20230925,PER,,US-ELI_LILLY_AND_COMPANY-US202309013164,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20230925,,CN,US,US,2023,Q3,Elderly
229804881,22980488,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Streptococcal bacteraemia,,2023,Q3,1,I,,20230920.0,20230925,20230925,EXP,,US-PFIZER INC-PV202300159581,PFIZER,,66.0,YR,,F,Y,75.193,KG,20230925,,MD,US,US,2023,Q3,Elderly
229804881,22980488,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Enterococcal sepsis,,2023,Q3,1,I,,20230920.0,20230925,20230925,EXP,,US-PFIZER INC-PV202300159581,PFIZER,,66.0,YR,,F,Y,75.193,KG,20230925,,MD,US,US,2023,Q3,Elderly
229804881,22980488,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Cellulitis,,2023,Q3,1,I,,20230920.0,20230925,20230925,EXP,,US-PFIZER INC-PV202300159581,PFIZER,,66.0,YR,,F,Y,75.193,KG,20230925,,MD,US,US,2023,Q3,Elderly
229804881,22980488,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Sepsis,,2023,Q3,1,I,,20230920.0,20230925,20230925,EXP,,US-PFIZER INC-PV202300159581,PFIZER,,66.0,YR,,F,Y,75.193,KG,20230925,,MD,US,US,2023,Q3,Elderly
229804881,22980488,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Schizophrenia,,2023,Q3,1,I,,20230920.0,20230925,20230925,EXP,,US-PFIZER INC-PV202300159581,PFIZER,,66.0,YR,,F,Y,75.193,KG,20230925,,MD,US,US,2023,Q3,Elderly
229851651,22985165,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578902A,,20563.0,,,Injection,,2023,Q3,Influenza,,2023,Q3,1,I,20230901.0,20230925.0,20230926,20230926,PER,,US-ELI_LILLY_AND_COMPANY-US202309014366,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229851651,22985165,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578902A,,20563.0,,,Injection,,2023,Q3,Decreased appetite,,2023,Q3,1,I,20230901.0,20230925.0,20230926,20230926,PER,,US-ELI_LILLY_AND_COMPANY-US202309014366,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229851651,22985165,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578902A,,20563.0,,,Injection,,2023,Q3,Injury associated with device,,2023,Q3,1,I,20230901.0,20230925.0,20230926,20230926,PER,,US-ELI_LILLY_AND_COMPANY-US202309014366,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20230926,,CN,US,US,2023,Q3,Elderly
229879441,22987944,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,14 units with every meal,,,,,,,,,,,,2023,Q3,Acute myeloid leukaemia,,2023,Q3,1,I,20171110.0,20230518.0,20230926,20230926,PER,,US-PROGENICS PHARMACEUTICALS/LANTHEUS HOLDINGS-LMI-2023-00290,PROGENICS PHARMACEUTICALS,,70.0,YR,,M,Y,103.0,KG,20230925,,MD,US,US,2023,Q3,Elderly
229932311,22993231,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Urticaria,,2023,Q3,1,I,,20230925.0,20230927,20230927,PER,,US-PFIZER INC-PV202300161129,PFIZER,,47.0,YR,,F,Y,,,20230927,,HP,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Diarrhoea,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Gastrointestinal haemorrhage,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Acute respiratory failure,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Encephalopathy,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Skin laceration,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Fall,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Acute kidney injury,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Asthenia,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Cardiac arrest,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Hypertension,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Type 2 diabetes mellitus,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229987301,22998730,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Q bedtime, correction dose",,,,,,,,,,,,2023,Q3,Cardiac failure chronic,,2023,Q3,1,I,20230903.0,20230914.0,20230928,20230928,EXP,,US-TG THERAPEUTICS INC.-TGT002972,TG THERAPEUTICS,,61.0,YR,,M,Y,99.1,KG,20230928,,MD,US,US,2023,Q3,Adult
229998271,22999827,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Diabetes mellitus,,2023,Q3,1,I,20230927.0,,20230927,20230927,DIR,FDA-CDER-CTU-2023-71418,,FDA-CTU,,82.0,YR,,M,N,,,20230927,N,HP,US,,2023,Q3,Elderly
229998271,22999827,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Skin disorder,,2023,Q3,1,I,20230927.0,,20230927,20230927,DIR,FDA-CDER-CTU-2023-71418,,FDA-CTU,,82.0,YR,,M,N,,,20230927,N,HP,US,,2023,Q3,Elderly
229998271,22999827,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Nausea,,2023,Q3,1,I,20230927.0,,20230927,20230927,DIR,FDA-CDER-CTU-2023-71418,,FDA-CTU,,82.0,YR,,M,N,,,20230927,N,HP,US,,2023,Q3,Elderly
229998271,22999827,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Vomiting,,2023,Q3,1,I,20230927.0,,20230927,20230927,DIR,FDA-CDER-CTU-2023-71418,,FDA-CTU,,82.0,YR,,M,N,,,20230927,N,HP,US,,2023,Q3,Elderly
229998271,22999827,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Hypertension,,2023,Q3,1,I,20230927.0,,20230927,20230927,DIR,FDA-CDER-CTU-2023-71418,,FDA-CTU,,82.0,YR,,M,N,,,20230927,N,HP,US,,2023,Q3,Elderly
229998271,22999827,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Gastrooesophageal reflux disease,,2023,Q3,1,I,20230927.0,,20230927,20230927,DIR,FDA-CDER-CTU-2023-71418,,FDA-CTU,,82.0,YR,,M,N,,,20230927,N,HP,US,,2023,Q3,Elderly
230020561,23002056,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Solution for injection,,2023,Q3,Cellulitis,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-SA-2023SA290099,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,F,Y,,,20230928,,HP,CA,CA,2023,Q3,Youth
230020561,23002056,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Solution for injection,,2023,Q3,Type III immune complex mediated reaction,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-SA-2023SA290099,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,F,Y,,,20230928,,HP,CA,CA,2023,Q3,Youth
230020561,23002056,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Solution for injection,,2023,Q3,Abscess,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-SA-2023SA290099,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,F,Y,,,20230928,,HP,CA,CA,2023,Q3,Youth
230020561,23002056,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Solution for injection,,2023,Q3,Diabetic ketoacidosis,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-SA-2023SA290099,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,F,Y,,,20230928,,HP,CA,CA,2023,Q3,Youth
230020561,23002056,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Solution for injection,,2023,Q3,Adhesion,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-SA-2023SA290099,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,F,Y,,,20230928,,HP,CA,CA,2023,Q3,Youth
230020561,23002056,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Solution for injection,,2023,Q3,Diabetes mellitus inadequate control,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-SA-2023SA290099,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,F,Y,,,20230928,,HP,CA,CA,2023,Q3,Youth
230020561,23002056,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Solution for injection,,2023,Q3,Medical device site infection,,2023,Q3,1,I,,20230922.0,20230928,20230928,EXP,,CA-SA-2023SA290099,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,F,Y,,,20230928,,HP,CA,CA,2023,Q3,Youth
230059051,23005905,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2023,Q3,Type III immune complex mediated reaction,,2023,Q3,1,I,,20230922.0,20230929,20230929,EXP,,CA-SA-2023SA290098,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unkn;Unknown:Unknown,17.0,YR,T,F,Y,,,20230929,,HP,CA,CA,2023,Q3,Youth
230074421,23007442,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q3,Incorrect dose administered,,2023,Q3,1,I,20230801.0,20230927.0,20230929,20230929,PER,,US-ELI_LILLY_AND_COMPANY-US202309016317,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20230929,,CN,US,US,2023,Q3,Adult
230200141,23020014,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Death,,2023,Q3,1,I,20230101.0,,20230929,20230929,DIR,FDA-CDER-CTU-2023-72429,,FDA-CTU,,69.0,YR,,F,N,,,20230929,N,HP,US,,2023,Q3,Elderly
230203811,23020381,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q3,Death,,2023,Q3,1,I,20230101.0,,20230929,20230929,DIR,FDA-CDER-CTU-2023-72601,,FDA-CTU,,69.0,YR,,F,N,,,20230929,N,HP,US,,2023,Q3,Elderly
1489664944,14896649,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, daily (21 ug/m2, QD)",,,D,,,,,21.0,UG/M**2,,,2023,Q4,Premature baby,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, daily (21 ug/m2, QD)",,,D,,,,,21.0,UG/M**2,,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, daily (21 ug/m2, QD)",,,D,,,,,21.0,UG/M**2,,,2023,Q4,Low birth weight baby,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, daily (21 ug/m2, QD)",,,D,,,,,21.0,UG/M**2,,,2023,Q4,Foetal disorder,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, daily (21 ug/m2, QD)",,,D,,,,,21.0,UG/M**2,,,2023,Q4,Neutropenia neonatal,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, daily (7 ug/m2, QD)",,,D,,,,,7.0,UG/M**2,,,2023,Q4,Premature baby,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, daily (7 ug/m2, QD)",,,D,,,,,7.0,UG/M**2,,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, daily (7 ug/m2, QD)",,,D,,,,,7.0,UG/M**2,,,2023,Q4,Low birth weight baby,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, daily (7 ug/m2, QD)",,,D,,,,,7.0,UG/M**2,,,2023,Q4,Foetal disorder,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
1489664944,14896649,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, daily (7 ug/m2, QD)",,,D,,,,,7.0,UG/M**2,,,2023,Q4,Neutropenia neonatal,,2023,Q4,44,F,20170804.0,20231025.0,20180515,20231025,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20231025,,PH,FR,FR,2023,Q4,Child
149319782,14931978,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,100unit/ml,,,,,,,,,,Injection,,2023,Q4,Death,,2023,Q4,2,F,20231030.0,20231213.0,20180524,20231226,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2018-007690,ACADIA PHARMACEUTICALS,,74.0,YR,,M,Y,,,20231226,,CN,US,US,2023,Q4,Elderly
149319782,14931978,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,100unit/ml,,,,,,,,,,Injection,,2023,Q4,Prescribed underdose,,2023,Q4,2,F,20231030.0,20231213.0,20180524,20231226,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2018-007690,ACADIA PHARMACEUTICALS,,74.0,YR,,M,Y,,,20231226,,CN,US,US,2023,Q4,Elderly
1520081613,15200816,30,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q4,Premature baby,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,30,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q4,Low birth weight baby,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,30,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q4,Foetal exposure during pregnancy,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,30,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q4,Neutropenia neonatal,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,30,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2023,Q4,Foetal disorder,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, QD",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q4,Premature baby,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, QD",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q4,Low birth weight baby,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, QD",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q4,Foetal exposure during pregnancy,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, QD",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q4,Neutropenia neonatal,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
1520081613,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ug/m2, QD",21.0,UG/M**2,D,,,,,7.0,UG/M**2,,QD,2023,Q4,Foetal disorder,,2023,Q4,13,F,20170914.0,20231012.0,20180726,20231016,EXP,,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20231016,,PH,FR,FR,2023,Q4,Child
155318694,15531869,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Drug abuse,,2023,Q4,4,F,20180927.0,20231117.0,20181019,20231127,EXP,,IT-AUROBINDO-AUR-APL-2018-050851,AUROBINDO,,82.0,YR,,F,Y,,,20231127,,PH,IT,IT,2023,Q4,Elderly
155318694,15531869,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,4,F,20180927.0,20231117.0,20181019,20231127,EXP,,IT-AUROBINDO-AUR-APL-2018-050851,AUROBINDO,,82.0,YR,,F,Y,,,20231127,,PH,IT,IT,2023,Q4,Elderly
155318694,15531869,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,4,F,20180927.0,20231117.0,20181019,20231127,EXP,,IT-AUROBINDO-AUR-APL-2018-050851,AUROBINDO,,82.0,YR,,F,Y,,,20231127,,PH,IT,IT,2023,Q4,Elderly
155318694,15531869,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2023,Q4,Overdose,,2023,Q4,4,F,20180927.0,20231117.0,20181019,20231127,EXP,,IT-AUROBINDO-AUR-APL-2018-050851,AUROBINDO,,82.0,YR,,F,Y,,,20231127,,PH,IT,IT,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Rash,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Fungal infection,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Visual impairment,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Neuropathy peripheral,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Bladder cancer,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Self esteem decreased,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Urinary tract infection,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Pain,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Feeling jittery,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Infection,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Feeling abnormal,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Pain in extremity,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Nervousness,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1577022126,15770221,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Product dispensing error,,2023,Q4,26,F,,20231204.0,20181228,20231214,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20231214,,MD,US,US,2023,Q4,Elderly
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Dyspepsia,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Nasopharyngitis,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Bronchitis,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Chest discomfort,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Respiratory disorder,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Pyrexia,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Diabetes mellitus,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Constipation,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Infusion site pruritus,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Groin abscess,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Upper respiratory tract infection,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Infusion site rash,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Cough,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
1750785610,17507856,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Thyroid disorder,,2023,Q4,10,F,20220101.0,20231107.0,20200306,20231115,EXP,,US-SHIRE-US202008578,TAKEDA,,22.0,YR,,M,Y,118.0,KG,20231115,,CN,US,US,2023,Q4,Youth
181067802,18106780,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 international unit,,,,,,,,8.0,IU,,,2023,Q4,Diabetes mellitus,,2023,Q4,2,F,20190912.0,20231122.0,20200803,20231128,EXP,,JP-ABBVIE-20P-087-3508737-00,ABBVIE,,75.0,YR,,M,Y,70.8,KG,20231128,,MD,JP,JP,2023,Q4,Elderly
1822548721,18225487,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,U,,,,,1.0,IU,,,2023,Q4,Toxic epidermal necrolysis,,2023,Q4,21,F,20200809.0,20231013.0,20200903,20231021,EXP,,FR-AUROBINDO-AUR-APL-2020-045739,AUROBINDO,,74.0,YR,,M,Y,,,20231021,,MD,FR,FR,2023,Q4,Elderly
1822823744,18228237,112,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 iU,,,U,,,,,1.0,IU,,,2023,Q4,Toxic epidermal necrolysis,,2023,Q4,44,F,20200809.0,20231011.0,20200903,20231019,EXP,,FR-PFIZER INC-2020340763,PFIZER,,74.0,YR,,M,Y,,,20231019,,MD,FR,FR,2023,Q4,Elderly
1823583928,18235839,81,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,D,,,,,1.0,IU,,,2023,Q4,Toxic epidermal necrolysis,,2023,Q4,28,F,20200809.0,20230809.0,20200905,20231026,EXP,,FR-SA-2020SA239827,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20231026,,HP,FR,FR,2023,Q4,Elderly
184936637,18493663,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,,,,,,200.0,IU,,,2023,Q4,Cystitis,,2023,Q4,7,F,20191201.0,20231226.0,20201111,20231229,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20231229,,MD,CA,CA,2023,Q4,Adult
184936637,18493663,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,,,,,,200.0,IU,,,2023,Q4,Diabetes mellitus,,2023,Q4,7,F,20191201.0,20231226.0,20201111,20231229,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20231229,,MD,CA,CA,2023,Q4,Adult
184936637,18493663,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,,,,,,200.0,IU,,,2023,Q4,Full blood count abnormal,,2023,Q4,7,F,20191201.0,20231226.0,20201111,20231229,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20231229,,MD,CA,CA,2023,Q4,Adult
184936637,18493663,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,,,,,,200.0,IU,,,2023,Q4,Lung disorder,,2023,Q4,7,F,20191201.0,20231226.0,20201111,20231229,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20231229,,MD,CA,CA,2023,Q4,Adult
184936637,18493663,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,,,,,,200.0,IU,,,2023,Q4,Blood cholesterol abnormal,,2023,Q4,7,F,20191201.0,20231226.0,20201111,20231229,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,54.0,YR,,M,Y,,,20231229,,MD,CA,CA,2023,Q4,Adult
186639098,18663909,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Parasitic gastroenteritis,,2023,Q4,8,F,20200504.0,20231014.0,20201225,20231026,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20231026,,MD,IT,,2023,Q4,Adult
186639098,18663909,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Cytomegalovirus enteritis,,2023,Q4,8,F,20200504.0,20231014.0,20201225,20231026,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20231026,,MD,IT,,2023,Q4,Adult
187177203,18717720,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Therapeutic response shortened,,2023,Q4,3,F,20210105.0,20231206.0,20210108,20231214,PER,,US-SA-2021SA004265,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20231214,,HP,US,US,2023,Q4,Elderly
187177203,18717720,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Off label use,,2023,Q4,3,F,20210105.0,20231206.0,20210108,20231214,PER,,US-SA-2021SA004265,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20231214,,HP,US,US,2023,Q4,Elderly
187177203,18717720,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Glycosylated haemoglobin abnormal,,2023,Q4,3,F,20210105.0,20231206.0,20210108,20231214,PER,,US-SA-2021SA004265,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20231214,,HP,US,US,2023,Q4,Elderly
187177203,18717720,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20210105.0,20231206.0,20210108,20231214,PER,,US-SA-2021SA004265,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20231214,,HP,US,US,2023,Q4,Elderly
187177203,18717720,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,3,F,20210105.0,20231206.0,20210108,20231214,PER,,US-SA-2021SA004265,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20231214,,HP,US,US,2023,Q4,Elderly
194888242,19488824,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,for every 50 mg/dL glucose above 200 mg/dl on the first and second day following chemotherapy,,,U,,,,,3.0,IU,,,2023,Q4,Hyperglycaemia,,2023,Q4,2,F,,20231122.0,20210702,20231128,EXP,,US-BAUSCH-BL-2021-021917,BAUSCH AND LOMB,"Zhang F, Karam J. Glycemic profile of intravenous dexamethasone-induced hyperglycemia using continuous glucose monitoring. American Journal of Case Reports. 2021 APR 28;22(1):E930733-1-E930733-7. doi:10.12659/AJCR.930733",70.0,YR,,F,Y,,,20231128,,MD,US,US,2023,Q4,Elderly
194888242,19488824,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,5.0,IU,,,2023,Q4,Hyperglycaemia,,2023,Q4,2,F,,20231122.0,20210702,20231128,EXP,,US-BAUSCH-BL-2021-021917,BAUSCH AND LOMB,"Zhang F, Karam J. Glycemic profile of intravenous dexamethasone-induced hyperglycemia using continuous glucose monitoring. American Journal of Case Reports. 2021 APR 28;22(1):E930733-1-E930733-7. doi:10.12659/AJCR.930733",70.0,YR,,F,Y,,,20231128,,MD,US,US,2023,Q4,Elderly
194888242,19488824,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,increased to 15 units with an additional 2 units for every 50 mg/dL glucose,,,U,,,,,15.0,IU,,,2023,Q4,Hyperglycaemia,,2023,Q4,2,F,,20231122.0,20210702,20231128,EXP,,US-BAUSCH-BL-2021-021917,BAUSCH AND LOMB,"Zhang F, Karam J. Glycemic profile of intravenous dexamethasone-induced hyperglycemia using continuous glucose monitoring. American Journal of Case Reports. 2021 APR 28;22(1):E930733-1-E930733-7. doi:10.12659/AJCR.930733",70.0,YR,,F,Y,,,20231128,,MD,US,US,2023,Q4,Elderly
194888242,19488824,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,increased to 15 units with an additional 2 units for every 50 mg/dL glucose,,,U,,,,,2.0,IU,,,2023,Q4,Hyperglycaemia,,2023,Q4,2,F,,20231122.0,20210702,20231128,EXP,,US-BAUSCH-BL-2021-021917,BAUSCH AND LOMB,"Zhang F, Karam J. Glycemic profile of intravenous dexamethasone-induced hyperglycemia using continuous glucose monitoring. American Journal of Case Reports. 2021 APR 28;22(1):E930733-1-E930733-7. doi:10.12659/AJCR.930733",70.0,YR,,F,Y,,,20231128,,MD,US,US,2023,Q4,Elderly
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Abdominal pain,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Autoimmune hepatitis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Influenza,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Therapy interrupted,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Jaundice,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,COVID-19,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Viral infection,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Hyperglycaemia,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Laboratory test abnormal,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Weight decreased,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Hepatic cirrhosis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Treatment noncompliance,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Arthralgia,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Blood bilirubin increased,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Drug ineffective,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Steatohepatitis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2023,Q4,Menstrual disorder,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Abdominal pain,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Autoimmune hepatitis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Influenza,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Therapy interrupted,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Jaundice,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,COVID-19,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Viral infection,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Hyperglycaemia,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Laboratory test abnormal,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Weight decreased,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Hepatic cirrhosis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Treatment noncompliance,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Arthralgia,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Blood bilirubin increased,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Drug ineffective,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Steatohepatitis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2023,Q4,Menstrual disorder,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Abdominal pain,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Autoimmune hepatitis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Influenza,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Therapy interrupted,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Jaundice,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,COVID-19,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Viral infection,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Hyperglycaemia,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Laboratory test abnormal,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Weight decreased,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Hepatic cirrhosis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Treatment noncompliance,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Arthralgia,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Blood bilirubin increased,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Drug ineffective,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Steatohepatitis,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
1966698219,19666982,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 international unit, bid",,,,,,,,14.0,IU,,BID,2023,Q4,Menstrual disorder,,2023,Q4,19,F,20201201.0,20231006.0,20210806,20231017,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20231017,,CN,US,US,2023,Q4,Youth
2061608114,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q4,Multiple organ dysfunction syndrome,,2023,Q4,14,F,20220115.0,20231027.0,20220321,20231102,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20231102,,PH,JP,JP,2023,Q4,Elderly
2061608114,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q4,Rash,,2023,Q4,14,F,20220115.0,20231027.0,20220321,20231102,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20231102,,PH,JP,JP,2023,Q4,Elderly
2061608114,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q4,Myelosuppression,,2023,Q4,14,F,20220115.0,20231027.0,20220321,20231102,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20231102,,PH,JP,JP,2023,Q4,Elderly
2061608114,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q4,Toxic epidermal necrolysis,,2023,Q4,14,F,20220115.0,20231027.0,20220321,20231102,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20231102,,PH,JP,JP,2023,Q4,Elderly
2061608114,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q4,Hyperglycaemia,,2023,Q4,14,F,20220115.0,20231027.0,20220321,20231102,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20231102,,PH,JP,JP,2023,Q4,Elderly
2061608114,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q4,Renal failure,,2023,Q4,14,F,20220115.0,20231027.0,20220321,20231102,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20231102,,PH,JP,JP,2023,Q4,Elderly
2061608114,20616081,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,,,,,,,,Injection,,2023,Q4,Oral candidiasis,,2023,Q4,14,F,20220115.0,20231027.0,20220321,20231102,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,"Suzuki S, Hasegawa A, Tomii K, Tsutsui Y, Murata M, Kobayashi A, et al.. Histopathological study on drug eruption due to enfortumab vedotin. The Japanese Journal of Dermatology (The 122nd Annual Meeting of the Japanese De. 2023;133(5):1351",71.0,YR,,M,Y,,,20231102,,PH,JP,JP,2023,Q4,Elderly
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Urticaria,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Complication associated with device,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Pneumonia,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Seizure,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Drug hypersensitivity,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Headache,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Blood sodium decreased,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Infusion related reaction,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
207106417,20710641,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,7,F,20231219.0,20231220.0,20220414,20231228,EXP,,US-TAKEDA-2022TUS024431,TAKEDA,,41.0,YR,,M,Y,102.0,KG,20231228,,CN,US,US,2023,Q4,Adult
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Immune-mediated hypothyroidism,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Dysphonia,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Decreased appetite,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Haematuria,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Bladder tamponade,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Palmar-plantar erythrodysaesthesia syndrome,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2116548111,21165481,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Stomatitis,,2023,Q4,11,F,20220101.0,20231122.0,20220803,20231127,EXP,,JP-009507513-2207JPN001031J,MERCK,,71.0,YR,,M,Y,,,20231127,,MD,JP,JP,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Pneumobilia,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Death,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Decreased appetite,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Asthenia,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Liver abscess,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Pain,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Septic shock,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Biliary obstruction,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Splenic vein occlusion,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Ascites,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Product use in unapproved indication,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Bacteraemia,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Thrombosis,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Hypophagia,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Sepsis,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Cholecystitis,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Lethargy,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Early satiety,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Perihepatic abscess,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
2130887420,21308874,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 Unit, ONCE/SINGLE",,,D,,,,,,,,,2023,Q4,Pancreatic failure,,2023,Q4,20,F,20220820.0,20231215.0,20220908,20231227,EXP,,NVSC2022US201138,NOVARTIS,,68.0,YR,,M,Y,75.3,KG,20231227,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Hip fracture,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Skin haemorrhage,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Skin swelling,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Fall,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Fall,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Therapeutic product effect incomplete,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Head injury,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
214462423,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Middle insomnia,,2023,Q4,3,F,20220801.0,20231114.0,20221012,20231118,EXP,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20231118,,MD,US,US,2023,Q4,Elderly
215069095,21506909,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q4,Cellulitis,,2023,Q4,5,F,20220910.0,20231030.0,20221026,20231104,EXP,,US-ROCHE-3205294,ROCHE,,57.0,YR,,M,Y,,,20231104,,MD,US,,2023,Q4,Adult
217653544,21765354,13,C,Insulin lispro bs,,2,,"UNK UNK, qd(6unit)",,,,,,,,,,Injection,QD,2023,Q4,Femur fracture,,2023,Q4,4,F,20220726.0,20230927.0,20221222,20231004,EXP,,JP-AMGEN-JPNSP2022218133,AMGEN,,77.0,YR,E,M,Y,46.0,KG,20231003,,MD,JP,JP,2023,Q4,Elderly
217653544,21765354,13,C,Insulin lispro bs,,2,,"UNK UNK, qd(6unit)",,,,,,,,,,Injection,QD,2023,Q4,Fall,,2023,Q4,4,F,20220726.0,20230927.0,20221222,20231004,EXP,,JP-AMGEN-JPNSP2022218133,AMGEN,,77.0,YR,E,M,Y,46.0,KG,20231003,,MD,JP,JP,2023,Q4,Elderly
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Pancreatitis,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Malaise,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Headache,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Migraine,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Pain,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Viral pharyngitis,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Product availability issue,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Product distribution issue,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Product use issue,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Fungal infection,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218233539,21823353,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Insurance issue,,2023,Q4,9,F,20220224.0,20231122.0,20230105,20231129,EXP,,US-TAKEDA-2022TUS014101,TAKEDA,,43.0,YR,,F,Y,94.0,KG,20231129,,CN,US,US,2023,Q4,Adult
218336044,21833604,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Back pain,,2023,Q4,4,F,20220813.0,20231122.0,20230107,20231204,EXP,,US-Accord-294379,ACCORD,,66.0,YR,E,M,Y,84.8,KG,20231204,,HP,US,US,2023,Q4,Elderly
218336044,21833604,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,4,F,20220813.0,20231122.0,20230107,20231204,EXP,,US-Accord-294379,ACCORD,,66.0,YR,E,M,Y,84.8,KG,20231204,,HP,US,US,2023,Q4,Elderly
218336044,21833604,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,4,F,20220813.0,20231122.0,20230107,20231204,EXP,,US-Accord-294379,ACCORD,,66.0,YR,E,M,Y,84.8,KG,20231204,,HP,US,US,2023,Q4,Elderly
218336044,21833604,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Abdominal pain,,2023,Q4,4,F,20220813.0,20231122.0,20230107,20231204,EXP,,US-Accord-294379,ACCORD,,66.0,YR,E,M,Y,84.8,KG,20231204,,HP,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Vomiting,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Flushing,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Pain in extremity,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Nausea,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Asthenia,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Peripheral swelling,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Dyspnoea exertional,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Memory impairment,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Fall,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Muscular weakness,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Contusion,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Pruritus,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Diabetic neuropathy,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219304098,21930409,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,100 unit/ml solution as directed injection,,,,,,,,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,8,F,20231101.0,20231201.0,20230131,20231208,EXP,,US-BIOGEN-2023BI01184547,BIOGEN,,65.0,YR,,F,Y,,,20231208,,CN,US,US,2023,Q4,Elderly
219659252,21965925,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,8 iU,,,Y,,2F463A,,209196.0,8.0,IU,,,2023,Q4,Urticaria,,2023,Q4,2,F,20230113.0,20231025.0,20230208,20231031,EXP,SE-MPA-2023-000606,SE-SA-2023SA041906,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20231031,,HP,SE,SE,2023,Q4,Adult
220215507,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q4,Premature delivery,,2023,Q4,7,F,20230101.0,20231027.0,20230222,20231101,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20231101,,MD,US,US,2023,Q4,Adult
220215507,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q4,Iron deficiency anaemia,,2023,Q4,7,F,20230101.0,20231027.0,20230222,20231101,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20231101,,MD,US,US,2023,Q4,Adult
220215507,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,7,F,20230101.0,20231027.0,20230222,20231101,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20231101,,MD,US,US,2023,Q4,Adult
220215507,22021550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,20.0,IU,Solution for injection/infusion,,2023,Q4,Off label use,,2023,Q4,7,F,20230101.0,20231027.0,20230222,20231101,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20231101,,MD,US,US,2023,Q4,Adult
220215507,22021550,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q4,Premature delivery,,2023,Q4,7,F,20230101.0,20231027.0,20230222,20231101,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20231101,,MD,US,US,2023,Q4,Adult
220215507,22021550,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q4,Iron deficiency anaemia,,2023,Q4,7,F,20230101.0,20231027.0,20230222,20231101,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20231101,,MD,US,US,2023,Q4,Adult
220215507,22021550,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,7,F,20230101.0,20231027.0,20230222,20231101,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20231101,,MD,US,US,2023,Q4,Adult
220215507,22021550,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,0.9,IU,Solution for injection/infusion,,2023,Q4,Off label use,,2023,Q4,7,F,20230101.0,20231027.0,20230222,20231101,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006281,AEGERION,,40.0,YR,,F,Y,61.678,KG,20231101,,MD,US,US,2023,Q4,Adult
220406315,22040631,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 units in the morning, 7 units in the afternoon, and 11 units in the evening",,,,,,,,,,,TID,2023,Q4,Dehydration,,2023,Q4,5,F,20220916.0,20231116.0,20230227,20231128,EXP,,JP-PFIZER INC-PV202300022437,PFIZER,,56.0,YR,,M,Y,76.2,KG,20231127,,PH,JP,JP,2023,Q4,Adult
220406315,22040631,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 units in the morning, 7 units in the afternoon, and 11 units in the evening",,,,,,,,,,,TID,2023,Q4,Labelled drug-drug interaction medication error,,2023,Q4,5,F,20220916.0,20231116.0,20230227,20231128,EXP,,JP-PFIZER INC-PV202300022437,PFIZER,,56.0,YR,,M,Y,76.2,KG,20231127,,PH,JP,JP,2023,Q4,Adult
220406315,22040631,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 units in the morning, 7 units in the afternoon, and 11 units in the evening",,,,,,,,,,,TID,2023,Q4,Renal impairment,,2023,Q4,5,F,20220916.0,20231116.0,20230227,20231128,EXP,,JP-PFIZER INC-PV202300022437,PFIZER,,56.0,YR,,M,Y,76.2,KG,20231127,,PH,JP,JP,2023,Q4,Adult
220406315,22040631,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 units in the morning, 7 units in the afternoon, and 11 units in the evening",,,,,,,,,,,TID,2023,Q4,Immunosuppressant drug level increased,,2023,Q4,5,F,20220916.0,20231116.0,20230227,20231128,EXP,,JP-PFIZER INC-PV202300022437,PFIZER,,56.0,YR,,M,Y,76.2,KG,20231127,,PH,JP,JP,2023,Q4,Adult
220406315,22040631,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 units in the morning, 7 units in the afternoon, and 11 units in the evening",,,,,,,,,,,TID,2023,Q4,Off label use,,2023,Q4,5,F,20220916.0,20231116.0,20230227,20231128,EXP,,JP-PFIZER INC-PV202300022437,PFIZER,,56.0,YR,,M,Y,76.2,KG,20231127,,PH,JP,JP,2023,Q4,Adult
220406315,22040631,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 units in the morning, 7 units in the afternoon, and 11 units in the evening",,,,,,,,,,,TID,2023,Q4,Drug interaction,,2023,Q4,5,F,20220916.0,20231116.0,20230227,20231128,EXP,,JP-PFIZER INC-PV202300022437,PFIZER,,56.0,YR,,M,Y,76.2,KG,20231127,,PH,JP,JP,2023,Q4,Adult
220406315,22040631,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 units in the morning, 7 units in the afternoon, and 11 units in the evening",,,,,,,,,,,TID,2023,Q4,Ileus paralytic,,2023,Q4,5,F,20220916.0,20231116.0,20230227,20231128,EXP,,JP-PFIZER INC-PV202300022437,PFIZER,,56.0,YR,,M,Y,76.2,KG,20231127,,PH,JP,JP,2023,Q4,Adult
220406315,22040631,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 units in the morning, 7 units in the afternoon, and 11 units in the evening",,,,,,,,,,,TID,2023,Q4,Acute kidney injury,,2023,Q4,5,F,20220916.0,20231116.0,20230227,20231128,EXP,,JP-PFIZER INC-PV202300022437,PFIZER,,56.0,YR,,M,Y,76.2,KG,20231127,,PH,JP,JP,2023,Q4,Adult
220798995,22079899,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 units/3 mL (4 in the morning, 2 in the evening)",,,U,,,,,,,Injection,,2023,Q4,Immune-mediated cholangitis,,2023,Q4,5,F,20230124.0,20231003.0,20230309,20231003,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-034193,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,54.9,KG,20231003,,MD,JP,JP,2023,Q4,Elderly
220889793,22088979,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Neutropenia,,2023,Q4,3,F,20230109.0,20231003.0,20230313,20231009,EXP,,DE-MYLANLABS-2023M1024483,MYLAN,,83.0,YR,,M,Y,70.0,KG,20231009,,MD,DE,DE,2023,Q4,Elderly
220889793,22088979,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Fatigue,,2023,Q4,3,F,20230109.0,20231003.0,20230313,20231009,EXP,,DE-MYLANLABS-2023M1024483,MYLAN,,83.0,YR,,M,Y,70.0,KG,20231009,,MD,DE,DE,2023,Q4,Elderly
220889793,22088979,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Renal impairment,,2023,Q4,3,F,20230109.0,20231003.0,20230313,20231009,EXP,,DE-MYLANLABS-2023M1024483,MYLAN,,83.0,YR,,M,Y,70.0,KG,20231009,,MD,DE,DE,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Dizziness,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Tremor,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Urticaria,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Erythema,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Parkinsonism,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Diabetic ketoacidosis,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Anaphylactic shock,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Kidney infection,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Anaphylactic reaction,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Rehabilitation therapy,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Rash,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Diabetic neuropathy,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Coma,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Seizure,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Blood potassium increased,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Vomiting,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Blood disorder,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 12 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Dizziness,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Tremor,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Urticaria,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Weight decreased,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Erythema,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Parkinsonism,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Diabetic ketoacidosis,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Anaphylactic shock,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Kidney infection,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Anaphylactic reaction,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Rehabilitation therapy,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Rash,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Diabetic neuropathy,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Coma,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Seizure,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Blood potassium increased,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Vomiting,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Blood disorder,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221453764,22145376,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/ml ?Inject 9 units, 10 units and 12 units before meals",,,,,,,,,,,TID,2023,Q4,Loss of personal independence in daily activities,,2023,Q4,4,F,,20231023.0,20230328,20231102,EXP,,US-TEVA-2023-US-2869412,TEVA,,71.0,YR,E,F,Y,72.12,KG,20231102,,CN,US,US,2023,Q4,Elderly
221569286,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Device issue,,2023,Q4,6,F,20220501.0,20231006.0,20230330,20231016,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,107.0,KG,20231016,,HP,US,US,2023,Q4,Elderly
221569286,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,6,F,20220501.0,20231006.0,20230330,20231016,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,107.0,KG,20231016,,HP,US,US,2023,Q4,Elderly
221569286,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Product prescribing issue,,2023,Q4,6,F,20220501.0,20231006.0,20230330,20231016,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,107.0,KG,20231016,,HP,US,US,2023,Q4,Elderly
221569286,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Product dose omission issue,,2023,Q4,6,F,20220501.0,20231006.0,20230330,20231016,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,107.0,KG,20231016,,HP,US,US,2023,Q4,Elderly
221569286,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Product dispensing issue,,2023,Q4,6,F,20220501.0,20231006.0,20230330,20231016,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,107.0,KG,20231016,,HP,US,US,2023,Q4,Elderly
221569286,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,6,F,20220501.0,20231006.0,20230330,20231016,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,107.0,KG,20231016,,HP,US,US,2023,Q4,Elderly
221569286,22156928,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,6,F,20220501.0,20231006.0,20230330,20231016,PER,,US-SA-2023SA098953,SANOFI AVENTIS,,66.0,YR,E,F,Y,107.0,KG,20231016,,HP,US,US,2023,Q4,Elderly
221669303,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D578904A,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Brain injury,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Stress,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Ear congestion,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Asthenia,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
221669303,22166930,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,3,F,20230101.0,20231117.0,20230403,20231129,EXP,,US-ELI_LILLY_AND_COMPANY-US202303015437,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231129,,CN,US,US,2023,Q4,Elderly
223436178,22343617,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q4,COVID-19 pneumonia,,2023,Q4,8,F,20230417.0,20231121.0,20230519,20231123,EXP,,CN-ROCHE-3334770,ROCHE,,59.0,YR,,M,Y,81.0,KG,20231123,,MD,CN,,2023,Q4,Adult
223436178,22343617,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q4,Sepsis,,2023,Q4,8,F,20230417.0,20231121.0,20230519,20231123,EXP,,CN-ROCHE-3334770,ROCHE,,59.0,YR,,M,Y,81.0,KG,20231123,,MD,CN,,2023,Q4,Adult
223436178,22343617,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q4,Platelet count decreased,,2023,Q4,8,F,20230417.0,20231121.0,20230519,20231123,EXP,,CN-ROCHE-3334770,ROCHE,,59.0,YR,,M,Y,81.0,KG,20231123,,MD,CN,,2023,Q4,Adult
223436178,22343617,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q4,Fungal infection,,2023,Q4,8,F,20230417.0,20231121.0,20230519,20231123,EXP,,CN-ROCHE-3334770,ROCHE,,59.0,YR,,M,Y,81.0,KG,20231123,,MD,CN,,2023,Q4,Adult
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Abdominal pain,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Jaundice,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Abdominal pain upper,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Sepsis,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Death,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Back pain,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Pancreatitis,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Spinal pain,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Pancreatitis acute,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Renal failure,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223927528,22392752,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 [iU], tid",,,,,,,,16.0,IU,,TID,2023,Q4,Nausea,,2023,Q4,8,F,20230523.0,20230927.0,20230601,20231002,EXP,,CO-EXELIXIS-CABO-23064242,EXELIXIS,,21.0,YR,,M,Y,70.0,KG,20231002,,CN,CO,CO,2023,Q4,Youth
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Impaired healing,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Spinal fracture,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Asthenia,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Monoplegia,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Bradyphrenia,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Hot flush,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Therapy interrupted,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Amnesia,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
223995594,22399559,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,4,F,20230526.0,20231102.0,20230602,20231109,EXP,,US-MYOVANT SCIENCES GMBH-2023MYSCI0500810,MYOVANT SCIENCES,,69.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Vomiting,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Immune thrombocytopenia,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Biliary dilatation,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Splenomegaly,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Bronchitis,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Myelosuppression,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Venoocclusive liver disease,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Malignant neoplasm progression,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Rheumatoid arthritis,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Platelet count decreased,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Blood bilirubin increased,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226025014,22602501,12,C,INSULIN LISPRO BIOSIMILAR 1,,2,Subcutaneous,"4 units, q8h",,,U,,,,,,,Injection,,2023,Q4,Pneumonia,,2023,Q4,4,F,20220920.0,20231128.0,20230614,20231205,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2023-082544,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,64.5,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
226170562,22617056,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Pancreatic neoplasm,,2023,Q4,2,F,20230109.0,20231012.0,20230620,20231019,EXP,,DE-ROCHE-3368326,ROCHE,,55.0,YR,,F,Y,,,20231019,,MD,DE,,2023,Q4,Adult
226295416,22629541,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q4,Asphyxia,,2023,Q4,6,F,20230616.0,20231205.0,20230622,20231211,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306011217,ELI LILLY AND CO,,87.0,YR,,M,Y,56.0,KG,20231211,,PH,JP,JP,2023,Q4,Elderly
226295416,22629541,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2023,Q4,Vomiting,,2023,Q4,6,F,20230616.0,20231205.0,20230622,20231211,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202306011217,ELI LILLY AND CO,,87.0,YR,,M,Y,56.0,KG,20231211,,PH,JP,JP,2023,Q4,Elderly
226609012,22660901,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 international unit, 4 iu for breakfast, 6 iu for lunch, 8 iu for dinner",,,U,,,,,18.0,IU,,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,20230202.0,20231023.0,20230630,20231026,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-396373,RANBAXY,,87.0,YR,,M,Y,,,20231026,,MD,IT,IT,2023,Q4,Elderly
227782663,22778266,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Off label use,,2023,Q4,3,F,,20231025.0,20230802,20231107,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-108159,BRISTOL MYERS SQUIBB,,77.0,YR,E,F,Y,,,20231107,,PH,US,US,2023,Q4,Elderly
227782663,22778266,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,3,F,,20231025.0,20230802,20231107,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-108159,BRISTOL MYERS SQUIBB,,77.0,YR,E,F,Y,,,20231107,,PH,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Hot flush,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Intentional dose omission,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Illness,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Constipation,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Feeling abnormal,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Blood pressure fluctuation,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Headache,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228003774,22800377,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,4,F,20230601.0,20231010.0,20230808,20231014,PER,,US-UNITED THERAPEUTICS-UNT-2023-020512,UNITED THERAPEUTICS,,77.0,YR,,F,Y,65.76,KG,20231014,,CN,US,US,2023,Q4,Elderly
228054883,22805488,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Hypovolaemic shock,,2023,Q4,3,F,20230707.0,20231128.0,20230809,20231208,PER,,US-JAZZ PHARMACEUTICALS-2023-US-016933,JAZZ,,74.0,YR,,M,Y,81.0,KG,20231208,,MD,US,US,2023,Q4,Elderly
228207414,22820741,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2,OTHER,FOUR TIMES DAILY",,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,4,F,20230803.0,20231018.0,20230814,20231020,EXP,,US-GILEAD-2023-0639288,GILEAD,,76.0,YR,E,M,Y,93.0,KG,20231020,,MD,US,US,2023,Q4,Elderly
228207414,22820741,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2,OTHER,FOUR TIMES DAILY",,,,,,,,,,,,2023,Q4,Pyrexia,,2023,Q4,4,F,20230803.0,20231018.0,20230814,20231020,EXP,,US-GILEAD-2023-0639288,GILEAD,,76.0,YR,E,M,Y,93.0,KG,20231020,,MD,US,US,2023,Q4,Elderly
228207414,22820741,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2,OTHER,FOUR TIMES DAILY",,,,,,,,,,,,2023,Q4,Ecthyma,,2023,Q4,4,F,20230803.0,20231018.0,20230814,20231020,EXP,,US-GILEAD-2023-0639288,GILEAD,,76.0,YR,E,M,Y,93.0,KG,20231020,,MD,US,US,2023,Q4,Elderly
228252243,22825224,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,(with meals),,,U,,,,,,,,,2023,Q4,Product storage error,,2023,Q4,3,F,20230101.0,20230927.0,20230816,20231001,EXP,,US-SA-2023SA247099,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20231001,,HP,US,US,2023,Q4,Adult
228252243,22825224,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,(with meals),,,U,,,,,,,,,2023,Q4,Abdominal discomfort,,2023,Q4,3,F,20230101.0,20230927.0,20230816,20231001,EXP,,US-SA-2023SA247099,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20231001,,HP,US,US,2023,Q4,Adult
228252243,22825224,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,(with meals),,,U,,,,,,,,,2023,Q4,Pancreatitis,,2023,Q4,3,F,20230101.0,20230927.0,20230816,20231001,EXP,,US-SA-2023SA247099,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20231001,,HP,US,US,2023,Q4,Adult
228252243,22825224,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,(with meals),,,U,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20230101.0,20230927.0,20230816,20231001,EXP,,US-SA-2023SA247099,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20231001,,HP,US,US,2023,Q4,Adult
228264078,22826407,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q4,Hepatorenal syndrome,,2023,Q4,8,F,20230810.0,20231115.0,20230816,20231120,EXP,,DE-ROCHE-3405124,ROCHE,,74.0,YR,,M,Y,89.0,KG,20231120,,MD,DE,,2023,Q4,Elderly
228264078,22826407,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2023,Q4,Drug-induced liver injury,,2023,Q4,8,F,20230810.0,20231115.0,20230816,20231120,EXP,,DE-ROCHE-3405124,ROCHE,,74.0,YR,,M,Y,89.0,KG,20231120,,MD,DE,,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Fall,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Gastroenteritis,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Psoas abscess,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Ulna fracture,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Subdural haematoma,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Myocardial infarction,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Arthralgia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Seroma,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Localised infection,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Hypothyroidism,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Femoral neck fracture,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Haematoma,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Dental caries,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Atelectasis,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Hypertension,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Myositis,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Epistaxis,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Aortic aneurysm,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Trigeminal neuralgia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Diarrhoea,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Pleural effusion,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Insomnia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Pseudomonal bacteraemia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Pancytopenia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Alpha haemolytic streptococcal infection,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Periodontal disease,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Hypokalaemia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Aspergillus test positive,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Confusional state,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Aphasia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Implant site extravasation,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Pulmonary hypertension,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Micrococcus infection,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Febrile neutropenia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, Nightly",,,U,,,,,,,,QD,2023,Q4,Differentiation syndrome,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Fall,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Gastroenteritis,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Psoas abscess,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Ulna fracture,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Subdural haematoma,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Myocardial infarction,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Seroma,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Localised infection,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Hypothyroidism,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Femoral neck fracture,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Haematoma,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Dental caries,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Atelectasis,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Myositis,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Epistaxis,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Aortic aneurysm,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Trigeminal neuralgia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Pleural effusion,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Insomnia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Pseudomonal bacteraemia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Pancytopenia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Alpha haemolytic streptococcal infection,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Periodontal disease,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Hypokalaemia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Aspergillus test positive,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Confusional state,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Aphasia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Implant site extravasation,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Pulmonary hypertension,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Micrococcus infection,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
228318753,22831875,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-5 units, 3x daily with meals",,,U,,,,,,,,,2023,Q4,Differentiation syndrome,,2023,Q4,3,F,20230509.0,20231108.0,20230817,20231123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-114601,BRISTOL MYERS SQUIBB,,67.0,YR,E,F,Y,,,20231123,,HP,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Xeroderma,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Upper respiratory tract infection,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Decreased appetite,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Nausea,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Dyspnoea exertional,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Lung opacity,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Ichthyosis,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Electrocardiogram QT prolonged,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Candida infection,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Soft tissue infection,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Insomnia,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
2283388411,22833884,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit per mL,,,U,,,,,,,,,2023,Q4,Hepatic enzyme increased,,2023,Q4,11,F,20230401.0,20231214.0,20230817,20231221,EXP,,NVSC2023US179507,NOVARTIS,,71.0,YR,,M,Y,58.5,KG,20231221,,MD,US,US,2023,Q4,Elderly
228488042,22848804,11,C,INSULIN LISPRO BS,,2,,,,,U,,,,,,,Injection,,2023,Q4,Pemphigoid,,2023,Q4,2,F,20210601.0,20230925.0,20230822,20231004,EXP,,JP-SA-2023SA254147,SANOFI AVENTIS,,66.0,YR,E,F,Y,49.0,KG,20231004,,PH,JP,JP,2023,Q4,Elderly
228553675,22855367,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 Unknown,,,,,,,,,,,,2023,Q4,Herpes zoster,,2023,Q4,5,F,20230718.0,20231012.0,20230823,20231016,EXP,,JP-ABBVIE-5356150,ABBVIE,,80.0,YR,,M,Y,,,20231016,,MD,JP,JP,2023,Q4,Elderly
228553675,22855367,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 Unknown,,,,,,,,,,,,2023,Q4,Vesicoureteric reflux,,2023,Q4,5,F,20230718.0,20231012.0,20230823,20231016,EXP,,JP-ABBVIE-5356150,ABBVIE,,80.0,YR,,M,Y,,,20231016,,MD,JP,JP,2023,Q4,Elderly
228553675,22855367,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 Unknown,,,,,,,,,,,,2023,Q4,Renal impairment,,2023,Q4,5,F,20230718.0,20231012.0,20230823,20231016,EXP,,JP-ABBVIE-5356150,ABBVIE,,80.0,YR,,M,Y,,,20231016,,MD,JP,JP,2023,Q4,Elderly
228553675,22855367,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 Unknown,,,,,,,,,,,,2023,Q4,Blood creatinine increased,,2023,Q4,5,F,20230718.0,20231012.0,20230823,20231016,EXP,,JP-ABBVIE-5356150,ABBVIE,,80.0,YR,,M,Y,,,20231016,,MD,JP,JP,2023,Q4,Elderly
228553675,22855367,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 Unknown,,,,,,,,,,,,2023,Q4,Gastrointestinal disorder,,2023,Q4,5,F,20230718.0,20231012.0,20230823,20231016,EXP,,JP-ABBVIE-5356150,ABBVIE,,80.0,YR,,M,Y,,,20231016,,MD,JP,JP,2023,Q4,Elderly
228553675,22855367,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 Unknown,,,,,,,,,,,,2023,Q4,Meningitis,,2023,Q4,5,F,20230718.0,20231012.0,20230823,20231016,EXP,,JP-ABBVIE-5356150,ABBVIE,,80.0,YR,,M,Y,,,20231016,,MD,JP,JP,2023,Q4,Elderly
228568392,22856839,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Breast pain,,2023,Q4,2,F,20230725.0,20230727.0,20230823,20231117,PER,,"US-Stemline Therapeutics, Inc.-2023ST001568",STEMLINE THERAPEUTICS,,45.0,YR,A,F,Y,,,20231116,,CN,US,US,2023,Q4,Adult
228568392,22856839,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,2,F,20230725.0,20230727.0,20230823,20231117,PER,,"US-Stemline Therapeutics, Inc.-2023ST001568",STEMLINE THERAPEUTICS,,45.0,YR,A,F,Y,,,20231116,,CN,US,US,2023,Q4,Adult
228568392,22856839,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,2,F,20230725.0,20230727.0,20230823,20231117,PER,,"US-Stemline Therapeutics, Inc.-2023ST001568",STEMLINE THERAPEUTICS,,45.0,YR,A,F,Y,,,20231116,,CN,US,US,2023,Q4,Adult
228568392,22856839,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,2,F,20230725.0,20230727.0,20230823,20231117,PER,,"US-Stemline Therapeutics, Inc.-2023ST001568",STEMLINE THERAPEUTICS,,45.0,YR,A,F,Y,,,20231116,,CN,US,US,2023,Q4,Adult
228685935,22868593,5,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,1,,,,,,,,,,,,Injection,,2023,Q4,Bradycardia,,2023,Q4,5,F,20230815.0,20230928.0,20230825,20231004,EXP,,CN-Eisai Medical Research-EC-2023-147217,EISAI,,39.0,YR,A,M,Y,60.0,KG,20231004,,MD,CN,,2023,Q4,Adult
228810802,22881080,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Death,,2023,Q4,2,F,,20231129.0,20230830,20231129,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-122043,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,,,20231129,,HP,US,US,2023,Q4,Adult
229250702,22925070,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,2,F,20230829.0,20231122.0,20230908,20231126,EXP,,JP-JNJFOC-20230906819,JOHNSON AND JOHNSON,,77.0,YR,E,F,Y,43.6,KG,20231127,,MD,JP,JP,2023,Q4,Elderly
229334772,22933477,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D580163D,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D580163D,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D580163D,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D580163D,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549273C,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549273C,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D578902A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D578902A,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D578902A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D578902A,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549452A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549452A,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D518831A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229334772,22933477,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D518831A,,20563.0,,,Injection,,2023,Q4,Accidental underdose,,2023,Q4,2,F,20230911.0,20231003.0,20230912,20231006,PER,,US-ELI_LILLY_AND_COMPANY-US202309006032,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231006,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Oedema peripheral,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Cardiac failure,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Rash erythematous,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Asthenia,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Inappropriate schedule of product administration,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Dysphonia,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Tooth disorder,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Hypothyroidism,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Cataract,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Paraesthesia oral,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Dehydration,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Decreased appetite,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Nausea,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Product prescribing issue,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Skin burning sensation,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229518092,22951809,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,2,F,20230710.0,20231122.0,20230918,20231128,EXP,,US-SANDOZ INC.-SDZ2023US029049,SANDOZ,,68.0,YR,,M,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
229535012,22953501,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 kit,,,,,,,,,,Injection,,2023,Q4,Pneumonia,,2023,Q4,2,F,20230727.0,20231012.0,20230918,20231017,EXP,,JP-009507513-2309JPN005471,MERCK,,76.0,YR,,F,Y,,,20231017,,PH,JP,JP,2023,Q4,Elderly
229535012,22953501,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 kit,,,,,,,,,,Injection,,2023,Q4,Urinary tract infection,,2023,Q4,2,F,20230727.0,20231012.0,20230918,20231017,EXP,,JP-009507513-2309JPN005471,MERCK,,76.0,YR,,F,Y,,,20231017,,PH,JP,JP,2023,Q4,Elderly
229535012,22953501,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 kit,,,,,,,,,,Injection,,2023,Q4,Cardiac failure chronic,,2023,Q4,2,F,20230727.0,20231012.0,20230918,20231017,EXP,,JP-009507513-2309JPN005471,MERCK,,76.0,YR,,F,Y,,,20231017,,PH,JP,JP,2023,Q4,Elderly
229605503,22960550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Respiratory tract infection,,2023,Q4,3,F,20230601.0,20230927.0,20230920,20231003,EXP,,GR-MYLANLABS-2023M1098643,MYLAN,,45.0,YR,,F,Y,,,20231003,,MD,GR,GR,2023,Q4,Adult
229605503,22960550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Pyrexia,,2023,Q4,3,F,20230601.0,20230927.0,20230920,20231003,EXP,,GR-MYLANLABS-2023M1098643,MYLAN,,45.0,YR,,F,Y,,,20231003,,MD,GR,GR,2023,Q4,Adult
229605503,22960550,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,COVID-19,,2023,Q4,3,F,20230601.0,20230927.0,20230920,20231003,EXP,,GR-MYLANLABS-2023M1098643,MYLAN,,45.0,YR,,F,Y,,,20231003,,MD,GR,GR,2023,Q4,Adult
229613872,22961387,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Pneumocystis jirovecii pneumonia,,2023,Q4,2,F,20230502.0,20230928.0,20230920,20231003,EXP,,ES-SA-2023SA138208,SANOFI AVENTIS,,61.0,YR,A,F,Y,71.3,KG,20231003,,MD,ES,ES,2023,Q4,Adult
229636583,22963658,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 international unit, tid",52.0,IU,,,,,,3.0,IU,,TID,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, tid",52.0,IU,,,,,,4.0,IU,,TID,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"7 international unit, daily",52.0,IU,,,,,,7.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"5 international unit, daily",52.0,IU,,,,,,5.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"6 international unit, daily",52.0,IU,,,,,,6.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 international unit, daily",52.0,IU,,,,,,10.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"11 international unit, daily",52.0,IU,,,,,,11.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"6 international unit, daily",52.0,IU,,,,,,6.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 international unit, daily",52.0,IU,,,,,,2.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, daily",52.0,IU,,,,,,4.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 international unit, daily",52.0,IU,,,,,,2.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, daily",52.0,IU,,,,,,4.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 international unit, daily",52.0,IU,,,,,,3.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, daily",52.0,IU,,,,,,4.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 international unit, daily",52.0,IU,,,,,,8.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 international unit, tid",52.0,IU,,,,,,2.0,IU,,TID,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 international unit, daily",52.0,IU,,,,,,2.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 international unit, daily",52.0,IU,,,,,,2.0,IU,,QD,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229636583,22963658,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 international unit, tid",52.0,IU,,,,,,2.0,IU,,TID,2023,Q4,Ketoacidosis,,2023,Q4,3,F,20230715.0,20231011.0,20230921,20231017,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202309006756,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231017,,CN,JP,JP,2023,Q4,Elderly
229774624,22977462,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Rash pruritic,,2023,Q4,4,F,20230822.0,20231031.0,20230925,20231115,PER,,US-PFIZER INC-202300296713,PFIZER,,64.0,YR,,M,Y,74.4,KG,20231115,,MD,US,US,2023,Q4,Adult
229774624,22977462,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Rash maculo-papular,,2023,Q4,4,F,20230822.0,20231031.0,20230925,20231115,PER,,US-PFIZER INC-202300296713,PFIZER,,64.0,YR,,M,Y,74.4,KG,20231115,,MD,US,US,2023,Q4,Adult
230059052,23005905,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Type III immune complex mediated reaction,,2023,Q4,2,F,,20231025.0,20230929,20231031,EXP,,CA-SA-2023SA290098,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unkn;Unknown:Unknown,17.0,YR,T,F,Y,64.0,KG,20231031,,HP,CA,CA,2023,Q4,Youth
230059052,23005905,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Cellulitis,,2023,Q4,2,F,,20231025.0,20230929,20231031,EXP,,CA-SA-2023SA290098,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unkn;Unknown:Unknown,17.0,YR,T,F,Y,64.0,KG,20231031,,HP,CA,CA,2023,Q4,Youth
230059052,23005905,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Abscess,,2023,Q4,2,F,,20231025.0,20230929,20231031,EXP,,CA-SA-2023SA290098,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unkn;Unknown:Unknown,17.0,YR,T,F,Y,64.0,KG,20231031,,HP,CA,CA,2023,Q4,Youth
230059052,23005905,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,2,F,,20231025.0,20230929,20231031,EXP,,CA-SA-2023SA290098,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unkn;Unknown:Unknown,17.0,YR,T,F,Y,64.0,KG,20231031,,HP,CA,CA,2023,Q4,Youth
230059052,23005905,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Medical device site infection,,2023,Q4,2,F,,20231025.0,20230929,20231031,EXP,,CA-SA-2023SA290098,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unkn;Unknown:Unknown,17.0,YR,T,F,Y,64.0,KG,20231031,,HP,CA,CA,2023,Q4,Youth
230059052,23005905,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,2,F,,20231025.0,20230929,20231031,EXP,,CA-SA-2023SA290098,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unkn;Unknown:Unknown,17.0,YR,T,F,Y,64.0,KG,20231031,,HP,CA,CA,2023,Q4,Youth
230059052,23005905,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2023,Q4,Adhesion,,2023,Q4,2,F,,20231025.0,20230929,20231031,EXP,,CA-SA-2023SA290098,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unkn;Unknown:Unknown,17.0,YR,T,F,Y,64.0,KG,20231031,,HP,CA,CA,2023,Q4,Youth
230074422,23007442,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Extra dose administered,,2023,Q4,2,F,20230801.0,20231107.0,20230929,20231109,PER,,US-ELI_LILLY_AND_COMPANY-US202309016317,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Adult
230074422,23007442,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20230801.0,20231107.0,20230929,20231109,PER,,US-ELI_LILLY_AND_COMPANY-US202309016317,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20231109,,CN,US,US,2023,Q4,Adult
230137701,23013770,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dose- 20.0 IU (International Unit) Frequency- 3 every 1 Days,,,U,,,,209196.0,20.0,IU,Solution for injection,Q8H,2023,Q4,Oedema peripheral,,2023,Q4,1,I,,20230922.0,20231001,20231001,EXP,,CA-SA-2023SA291130,SANOFI AVENTIS,,77.0,YR,E,M,Y,107.0,KG,20231001,,HP,CA,CA,2023,Q4,Elderly
230137701,23013770,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dose- 20.0 IU (International Unit) Frequency- 3 every 1 Days,,,U,,,,209196.0,20.0,IU,Solution for injection,Q8H,2023,Q4,Poor peripheral circulation,,2023,Q4,1,I,,20230922.0,20231001,20231001,EXP,,CA-SA-2023SA291130,SANOFI AVENTIS,,77.0,YR,E,M,Y,107.0,KG,20231001,,HP,CA,CA,2023,Q4,Elderly
230137701,23013770,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dose- 20.0 IU (International Unit) Frequency- 3 every 1 Days,,,U,,,,209196.0,20.0,IU,Solution for injection,Q8H,2023,Q4,Blister,,2023,Q4,1,I,,20230922.0,20231001,20231001,EXP,,CA-SA-2023SA291130,SANOFI AVENTIS,,77.0,YR,E,M,Y,107.0,KG,20231001,,HP,CA,CA,2023,Q4,Elderly
230291431,23029143,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,1,I,,20230926.0,20231004,20231004,EXP,,CA-SANDOZ INC.-SDZ2023CA035814,SANDOZ,,20.0,YR,,F,Y,,,20231004,,HP,CA,CA,2023,Q4,Youth
230291431,23029143,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Colitis ulcerative,,2023,Q4,1,I,,20230926.0,20231004,20231004,EXP,,CA-SANDOZ INC.-SDZ2023CA035814,SANDOZ,,20.0,YR,,F,Y,,,20231004,,HP,CA,CA,2023,Q4,Youth
230291431,23029143,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20230926.0,20231004,20231004,EXP,,CA-SANDOZ INC.-SDZ2023CA035814,SANDOZ,,20.0,YR,,F,Y,,,20231004,,HP,CA,CA,2023,Q4,Youth
230291431,23029143,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,,20230926.0,20231004,20231004,EXP,,CA-SANDOZ INC.-SDZ2023CA035814,SANDOZ,,20.0,YR,,F,Y,,,20231004,,HP,CA,CA,2023,Q4,Youth
230301861,23030186,13,C,INSULIN LISPRO BS,,2,,,,,,,,,,,,Injection,,2023,Q4,Pemphigoid,,2023,Q4,1,I,20210601.0,20230925.0,20231005,20231005,EXP,,JP-EMD Serono-2023478365,EMD SERONO INC,,66.0,YR,E,F,Y,49.0,KG,20231005,,PH,JP,JP,2023,Q4,Elderly
230320302,23032030,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,unk,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,2,F,20230924.0,20231102.0,20231005,20231110,PER,,US-SA-2023SA299672,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20231110,,HP,US,US,2023,Q4,Elderly
230320302,23032030,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,unk,,,U,,,,,,,,,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,2,F,20230924.0,20231102.0,20231005,20231110,PER,,US-SA-2023SA299672,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20231110,,HP,US,US,2023,Q4,Elderly
230341461,23034146,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Death,,2023,Q4,1,I,20230125.0,20231003.0,20231005,20231005,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-141500,BRISTOL MYERS SQUIBB,,89.0,YR,E,F,Y,,,20231005,,CN,US,US,2023,Q4,Elderly
230351391,23035139,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Colitis ulcerative,,2023,Q4,1,I,,20230925.0,20231005,20231005,EXP,,CA-TEVA-2023-CA-2930880,TEVA,,20.0,YR,A,F,Y,,,20231005,,HP,CA,CA,2023,Q4,Youth
230351391,23035139,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20230925.0,20231005,20231005,EXP,,CA-TEVA-2023-CA-2930880,TEVA,,20.0,YR,A,F,Y,,,20231005,,HP,CA,CA,2023,Q4,Youth
230351391,23035139,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,1,I,,20230925.0,20231005,20231005,EXP,,CA-TEVA-2023-CA-2930880,TEVA,,20.0,YR,A,F,Y,,,20231005,,HP,CA,CA,2023,Q4,Youth
230351391,23035139,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,,20230925.0,20231005,20231005,EXP,,CA-TEVA-2023-CA-2930880,TEVA,,20.0,YR,A,F,Y,,,20231005,,HP,CA,CA,2023,Q4,Youth
230357421,23035742,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,25 IU/day,,,Y,,,,,25.0,IU,,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20230924.0,20231006,20231006,EXP,,"CN-Saptalis Pharmaceuticals,LLC-000388",SAPTALIS PHARMACEUTICALS,"CN-Saptalis Pharmaceuticals,LLC-000388-01_Initial Source Document",49.0,YR,A,F,Y,,,20231006,,HP,CN,,2023,Q4,Adult
230357421,23035742,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,25 IU/day,,,Y,,,,,25.0,IU,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20230924.0,20231006,20231006,EXP,,"CN-Saptalis Pharmaceuticals,LLC-000388",SAPTALIS PHARMACEUTICALS,"CN-Saptalis Pharmaceuticals,LLC-000388-01_Initial Source Document",49.0,YR,A,F,Y,,,20231006,,HP,CN,,2023,Q4,Adult
230357421,23035742,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,56 IU/day,,,Y,,,,,56.0,IU,,QD,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20230924.0,20231006,20231006,EXP,,"CN-Saptalis Pharmaceuticals,LLC-000388",SAPTALIS PHARMACEUTICALS,"CN-Saptalis Pharmaceuticals,LLC-000388-01_Initial Source Document",49.0,YR,A,F,Y,,,20231006,,HP,CN,,2023,Q4,Adult
230357421,23035742,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,56 IU/day,,,Y,,,,,56.0,IU,,QD,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20230924.0,20231006,20231006,EXP,,"CN-Saptalis Pharmaceuticals,LLC-000388",SAPTALIS PHARMACEUTICALS,"CN-Saptalis Pharmaceuticals,LLC-000388-01_Initial Source Document",49.0,YR,A,F,Y,,,20231006,,HP,CN,,2023,Q4,Adult
230396551,23039655,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.5 international unit, daily",1.0,IU,,,202202008,,20563.0,0.5,IU,,QD,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,1,I,20230917.0,20230927.0,20231006,20231006,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202309016882,ELI LILLY AND CO,,66.0,YR,,F,Y,70.0,KG,20231006,,CN,CN,CN,2023,Q4,Elderly
230396551,23039655,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.5 international unit, daily",1.0,IU,,,202202008,,20563.0,0.5,IU,,QD,2023,Q4,Anaphylactic reaction,,2023,Q4,1,I,20230917.0,20230927.0,20231006,20231006,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202309016882,ELI LILLY AND CO,,66.0,YR,,F,Y,70.0,KG,20231006,,CN,CN,CN,2023,Q4,Elderly
230396551,23039655,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.5 international unit, daily",1.0,IU,,,202202008,,20563.0,0.5,IU,,QD,2023,Q4,Septic shock,,2023,Q4,1,I,20230917.0,20230927.0,20231006,20231006,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202309016882,ELI LILLY AND CO,,66.0,YR,,F,Y,70.0,KG,20231006,,CN,CN,CN,2023,Q4,Elderly
230396551,23039655,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.5 international unit, daily",1.0,IU,,,202202008,,20563.0,0.5,IU,,QD,2023,Q4,Abscess limb,,2023,Q4,1,I,20230917.0,20230927.0,20231006,20231006,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202309016882,ELI LILLY AND CO,,66.0,YR,,F,Y,70.0,KG,20231006,,CN,CN,CN,2023,Q4,Elderly
230398132,23039813,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D564351E,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231004.0,20231006.0,20231006,20231012,EXP,,US-ELI_LILLY_AND_COMPANY-US202310003583,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231012,,CN,US,US,2023,Q4,Elderly
230398132,23039813,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D564351E,,20563.0,,,Injection,,2023,Q4,Metastatic neoplasm,,2023,Q4,2,F,20231004.0,20231006.0,20231006,20231012,EXP,,US-ELI_LILLY_AND_COMPANY-US202310003583,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231012,,CN,US,US,2023,Q4,Elderly
230398132,23039813,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D564351E,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231004.0,20231006.0,20231006,20231012,EXP,,US-ELI_LILLY_AND_COMPANY-US202310003583,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20231012,,CN,US,US,2023,Q4,Elderly
230436164,23043616,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,10.0,IU,,Q8H,2023,Q4,Pyrexia,,2023,Q4,4,F,20230808.0,20231025.0,20231009,20231031,EXP,,GR-ROCHE-3411153,ROCHE,,45.0,YR,,F,Y,78.0,KG,20231031,,MD,GR,,2023,Q4,Adult
230436164,23043616,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,10.0,IU,,Q8H,2023,Q4,COVID-19,,2023,Q4,4,F,20230808.0,20231025.0,20231009,20231031,EXP,,GR-ROCHE-3411153,ROCHE,,45.0,YR,,F,Y,78.0,KG,20231031,,MD,GR,,2023,Q4,Adult
230436164,23043616,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,10.0,IU,,Q8H,2023,Q4,Pneumonia,,2023,Q4,4,F,20230808.0,20231025.0,20231009,20231031,EXP,,GR-ROCHE-3411153,ROCHE,,45.0,YR,,F,Y,78.0,KG,20231031,,MD,GR,,2023,Q4,Adult
230436164,23043616,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,10.0,IU,,Q8H,2023,Q4,COVID-19 pneumonia,,2023,Q4,4,F,20230808.0,20231025.0,20231009,20231031,EXP,,GR-ROCHE-3411153,ROCHE,,45.0,YR,,F,Y,78.0,KG,20231031,,MD,GR,,2023,Q4,Adult
230436164,23043616,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,10.0,IU,,Q8H,2023,Q4,Respiratory tract infection,,2023,Q4,4,F,20230808.0,20231025.0,20231009,20231031,EXP,,GR-ROCHE-3411153,ROCHE,,45.0,YR,,F,Y,78.0,KG,20231031,,MD,GR,,2023,Q4,Adult
230460422,23046042,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,junior kwikpen,,,,,,,,,,,,2023,Q4,Ocular hyperaemia,,2023,Q4,2,F,20230901.0,20231009.0,20231009,20231023,PER,,US-FARMAPROD-202309-2900,DOMPE FARMACEUTICI,,28.0,YR,A,M,Y,,,20231020,,MD,US,,2023,Q4,Young Adult
230460422,23046042,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,junior kwikpen,,,,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20230901.0,20231009.0,20231009,20231023,PER,,US-FARMAPROD-202309-2900,DOMPE FARMACEUTICI,,28.0,YR,A,M,Y,,,20231020,,MD,US,,2023,Q4,Young Adult
230460422,23046042,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,junior kwikpen,,,,,,,,,,,,2023,Q4,Pneumonia,,2023,Q4,2,F,20230901.0,20231009.0,20231009,20231023,PER,,US-FARMAPROD-202309-2900,DOMPE FARMACEUTICI,,28.0,YR,A,M,Y,,,20231020,,MD,US,,2023,Q4,Young Adult
230460422,23046042,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,junior kwikpen,,,,,,,,,,,,2023,Q4,Carbon monoxide poisoning,Carbon monoxide poisoning,2023,Q4,2,F,20230901.0,20231009.0,20231009,20231023,PER,,US-FARMAPROD-202309-2900,DOMPE FARMACEUTICI,,28.0,YR,A,M,Y,,,20231020,,MD,US,,2023,Q4,Young Adult
230479251,23047925,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Bacterial infection,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Stenosis,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Urinary tract infection,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Anal abscess,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Immune system disorder,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Bacterial infection,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Stenosis,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Urinary tract infection,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Anal abscess,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230479251,23047925,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Immune system disorder,,2023,Q4,1,I,20220401.0,20230928.0,20231010,20231010,PER,,US-ELI_LILLY_AND_COMPANY-US202310000591,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20231010,,CN,US,US,2023,Q4,Elderly
230498562,23049856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Headache,,2023,Q4,2,F,20230901.0,20231005.0,20231010,20231012,EXP,,US-UNITED THERAPEUTICS-UNT-2023-027358,UNITED THERAPEUTICS,,54.0,YR,,F,Y,75.283,KG,20231012,,CN,US,US,2023,Q4,Adult
230498562,23049856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Fall,,2023,Q4,2,F,20230901.0,20231005.0,20231010,20231012,EXP,,US-UNITED THERAPEUTICS-UNT-2023-027358,UNITED THERAPEUTICS,,54.0,YR,,F,Y,75.283,KG,20231012,,CN,US,US,2023,Q4,Adult
230498562,23049856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Coccydynia,,2023,Q4,2,F,20230901.0,20231005.0,20231010,20231012,EXP,,US-UNITED THERAPEUTICS-UNT-2023-027358,UNITED THERAPEUTICS,,54.0,YR,,F,Y,75.283,KG,20231012,,CN,US,US,2023,Q4,Adult
230498562,23049856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,2,F,20230901.0,20231005.0,20231010,20231012,EXP,,US-UNITED THERAPEUTICS-UNT-2023-027358,UNITED THERAPEUTICS,,54.0,YR,,F,Y,75.283,KG,20231012,,CN,US,US,2023,Q4,Adult
230498562,23049856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,2,F,20230901.0,20231005.0,20231010,20231012,EXP,,US-UNITED THERAPEUTICS-UNT-2023-027358,UNITED THERAPEUTICS,,54.0,YR,,F,Y,75.283,KG,20231012,,CN,US,US,2023,Q4,Adult
230498562,23049856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Balance disorder,,2023,Q4,2,F,20230901.0,20231005.0,20231010,20231012,EXP,,US-UNITED THERAPEUTICS-UNT-2023-027358,UNITED THERAPEUTICS,,54.0,YR,,F,Y,75.283,KG,20231012,,CN,US,US,2023,Q4,Adult
230537591,23053759,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D609625D,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,1,I,20230501.0,20231010.0,20231011,20231011,PER,,US-ELI_LILLY_AND_COMPANY-US202310005936,ELI LILLY AND CO,,46.0,YR,,,Y,,,20231011,,CN,US,US,2023,Q4,Adult
230537591,23053759,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D549451A,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,1,I,20230501.0,20231010.0,20231011,20231011,PER,,US-ELI_LILLY_AND_COMPANY-US202310005936,ELI LILLY AND CO,,46.0,YR,,,Y,,,20231011,,CN,US,US,2023,Q4,Adult
230543911,23054391,10,C,Lispro (Insulin),,2,,,,,,,,,,,,,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,20230929.0,20231006.0,20231011,20231011,EXP,,US-Fresenius Medical Care Renal Therapies Group-FMC-2310-001097,FRESENIUS MEDICAL CARE,,40.0,YR,A,M,Y,70.9,KG,20231011,,HP,US,US,2023,Q4,Adult
230543911,23054391,10,C,Lispro (Insulin),,2,,,,,,,,,,,,,,2023,Q4,Azotaemia,,2023,Q4,1,I,20230929.0,20231006.0,20231011,20231011,EXP,,US-Fresenius Medical Care Renal Therapies Group-FMC-2310-001097,FRESENIUS MEDICAL CARE,,40.0,YR,A,M,Y,70.9,KG,20231011,,HP,US,US,2023,Q4,Adult
230543911,23054391,10,C,Lispro (Insulin),,2,,,,,,,,,,,,,,2023,Q4,Cellulitis,,2023,Q4,1,I,20230929.0,20231006.0,20231011,20231011,EXP,,US-Fresenius Medical Care Renal Therapies Group-FMC-2310-001097,FRESENIUS MEDICAL CARE,,40.0,YR,A,M,Y,70.9,KG,20231011,,HP,US,US,2023,Q4,Adult
230556221,23055622,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other (sliding scale)",,,,,D591481C,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231009.0,20231010.0,20231011,20231011,PER,,US-ELI_LILLY_AND_COMPANY-US202310005960,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20231011,,CN,US,US,2023,Q4,Elderly
230556221,23055622,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other (sliding scale)",,,,,D591481C,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231009.0,20231010.0,20231011,20231011,PER,,US-ELI_LILLY_AND_COMPANY-US202310005960,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20231011,,CN,US,US,2023,Q4,Elderly
230556221,23055622,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231009.0,20231010.0,20231011,20231011,PER,,US-ELI_LILLY_AND_COMPANY-US202310005960,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20231011,,CN,US,US,2023,Q4,Elderly
230556221,23055622,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231009.0,20231010.0,20231011,20231011,PER,,US-ELI_LILLY_AND_COMPANY-US202310005960,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20231011,,CN,US,US,2023,Q4,Elderly
230569401,23056940,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20230930.0,20231005.0,20231012,20231012,EXP,,US-ELI_LILLY_AND_COMPANY-US202310003329,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20231012,,CN,US,US,2023,Q4,Elderly
230569401,23056940,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20230930.0,20231005.0,20231012,20231012,EXP,,US-ELI_LILLY_AND_COMPANY-US202310003329,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20231012,,CN,US,US,2023,Q4,Elderly
230569401,23056940,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20230930.0,20231005.0,20231012,20231012,EXP,,US-ELI_LILLY_AND_COMPANY-US202310003329,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20231012,,CN,US,US,2023,Q4,Elderly
230569401,23056940,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539191E,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20230930.0,20231005.0,20231012,20231012,EXP,,US-ELI_LILLY_AND_COMPANY-US202310003329,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20231012,,CN,US,US,2023,Q4,Elderly
230576261,23057626,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Dose Description : 9 iU;3/days,,,,,,,,9.0,IU,Unknown,,2023,Q4,Fatigue,,2023,Q4,1,I,20221101.0,20231002.0,20231012,20231012,EXP,,US-CHATTEMPRD-2023SA126568,CHATTEM,,61.0,YR,A,F,Y,113.3,KG,20231012,,HP,US,US,2023,Q4,Adult
230576261,23057626,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Dose Description : 9 iU;3/days,,,,,,,,9.0,IU,Unknown,,2023,Q4,Oedema peripheral,,2023,Q4,1,I,20221101.0,20231002.0,20231012,20231012,EXP,,US-CHATTEMPRD-2023SA126568,CHATTEM,,61.0,YR,A,F,Y,113.3,KG,20231012,,HP,US,US,2023,Q4,Adult
230576261,23057626,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Dose Description : 9 iU;3/days,,,,,,,,9.0,IU,Unknown,,2023,Q4,Back pain,,2023,Q4,1,I,20221101.0,20231002.0,20231012,20231012,EXP,,US-CHATTEMPRD-2023SA126568,CHATTEM,,61.0,YR,A,F,Y,113.3,KG,20231012,,HP,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Drug ineffective,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Renal disorder,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Renal pain,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Musculoskeletal discomfort,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Wrong technique in product usage process,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Drug ineffective,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Feeding disorder,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Drug ineffective,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Renal disorder,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Renal pain,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Musculoskeletal discomfort,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Blood glucose increased,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Wrong technique in product usage process,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Drug ineffective,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230586813,23058681,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D609625D,,20563.0,35.0,IU,Injection,TID,2023,Q4,Feeding disorder,,2023,Q4,3,F,20231009.0,20231016.0,20231012,20231018,PER,,US-ELI_LILLY_AND_COMPANY-US202310006845,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20231018,,CN,US,US,2023,Q4,Adult
230618181,23061818,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 milligram, Once a Day",,,U,,,,,24.0,MG,,QD,2023,Q4,Dyspnoea,,2023,Q4,1,I,20230417.0,20231005.0,20231013,20231013,EXP,,IT-AUROBINDO-AUR-APL-2023-062877,AUROBINDO,,88.0,YR,,M,Y,,,20231013,,HP,IT,IT,2023,Q4,Elderly
230618181,23061818,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 milligram, Once a Day",,,U,,,,,24.0,MG,,QD,2023,Q4,Drug ineffective,,2023,Q4,1,I,20230417.0,20231005.0,20231013,20231013,EXP,,IT-AUROBINDO-AUR-APL-2023-062877,AUROBINDO,,88.0,YR,,M,Y,,,20231013,,HP,IT,IT,2023,Q4,Elderly
230618181,23061818,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 milligram, Once a Day",,,U,,,,,24.0,MG,,QD,2023,Q4,Hypertensive crisis,,2023,Q4,1,I,20230417.0,20231005.0,20231013,20231013,EXP,,IT-AUROBINDO-AUR-APL-2023-062877,AUROBINDO,,88.0,YR,,M,Y,,,20231013,,HP,IT,IT,2023,Q4,Elderly
230618181,23061818,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 milligram, Once a Day",,,U,,,,,24.0,MG,,QD,2023,Q4,Chest pain,,2023,Q4,1,I,20230417.0,20231005.0,20231013,20231013,EXP,,IT-AUROBINDO-AUR-APL-2023-062877,AUROBINDO,,88.0,YR,,M,Y,,,20231013,,HP,IT,IT,2023,Q4,Elderly
230637911,23063791,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,1,I,20230601.0,20230922.0,20231013,20231013,PER,,US-ELI_LILLY_AND_COMPANY-US202309013979,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20231013,,CN,US,US,2023,Q4,Adult
230637911,23063791,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20230601.0,20230922.0,20231013,20231013,PER,,US-ELI_LILLY_AND_COMPANY-US202309013979,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20231013,,CN,US,US,2023,Q4,Adult
230637911,23063791,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Diabetic eye disease,,2023,Q4,1,I,20230601.0,20230922.0,20231013,20231013,PER,,US-ELI_LILLY_AND_COMPANY-US202309013979,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20231013,,CN,US,US,2023,Q4,Adult
230644411,23064441,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1-21 Units UNK, q6h",,,,,,,,,,,QID,2023,Q4,Colitis ischaemic,,2023,Q4,1,I,20200922.0,20231009.0,20231013,20231013,EXP,,US-AMGEN-USACT2020170073,AMGEN,,61.0,YR,A,M,Y,100.0,KG,20231013,,MD,US,US,2023,Q4,Adult
230702074,23070207,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,under the skin/ before meals?InPen,,,,,,,,10.0,IU,,Q8H,2023,Q4,Ascites,,2023,Q4,4,F,20230101.0,20231109.0,20231016,20231113,EXP,,US-BAUSCH-BL-2023-011239,BAUSCH AND LOMB,,69.0,YR,,M,Y,61.2,KG,20231113,,MD,US,US,2023,Q4,Elderly
230702074,23070207,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,under the skin/ before meals?InPen,,,,,,,,10.0,IU,,Q8H,2023,Q4,Condition aggravated,,2023,Q4,4,F,20230101.0,20231109.0,20231016,20231113,EXP,,US-BAUSCH-BL-2023-011239,BAUSCH AND LOMB,,69.0,YR,,M,Y,61.2,KG,20231113,,MD,US,US,2023,Q4,Elderly
230702074,23070207,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,under the skin/ before meals?InPen,,,,,,,,10.0,IU,,Q8H,2023,Q4,Hepatic cirrhosis,,2023,Q4,4,F,20230101.0,20231109.0,20231016,20231113,EXP,,US-BAUSCH-BL-2023-011239,BAUSCH AND LOMB,,69.0,YR,,M,Y,61.2,KG,20231113,,MD,US,US,2023,Q4,Elderly
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Abdominal discomfort,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Headache,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Epistaxis,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Presyncope,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Dizziness,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Blood pressure decreased,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230727901,23072790,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,,20231011.0,20231017,20231017,PER,,US-GILEAD-2023-0647245,GILEAD,,57.0,YR,A,F,Y,89.8,KG,20231017,,CN,US,US,2023,Q4,Adult
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Ocular icterus,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Paracoccidioides infection,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Hepatic encephalopathy,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Muscle atrophy,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Back pain,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Product use issue,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Insurance issue,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-12 units TID AC,,,,,,,,,,,,2023,Q4,Condition aggravated,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Ocular icterus,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Paracoccidioides infection,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Hepatic encephalopathy,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Muscle atrophy,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Back pain,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Product use issue,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Insurance issue,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230758781,23075878,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8  units TID AC,,,,,,,,,,,,2023,Q4,Condition aggravated,,2023,Q4,1,I,,20231012.0,20231017,20231017,EXP,,US-BAUSCH-BL-2023-015310,BAUSCH AND LOMB,,65.0,YR,,F,Y,94.6,KG,20231017,,MD,US,US,2023,Q4,Elderly
230825991,23082599,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units, qd (at each meal)",,,D,,Unknown,,,,,,QD,2023,Q4,Exposure during pregnancy,,2023,Q4,1,I,,20230926.0,20231019,20231019,EXP,,IT-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-11143,ALKEM,"Burlina S, Dalfra MG, Caprino R, Lapolla A.. A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. Acta Diabetologica. 2023;60:137-38",38.0,YR,,F,Y,,,20231019,,HP,IT,IT,2023,Q4,Adult
230825991,23082599,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 units, bid (at breakfast and lunch)",,,D,,Unknown,,,,,,Q12H,2023,Q4,Exposure during pregnancy,,2023,Q4,1,I,,20230926.0,20231019,20231019,EXP,,IT-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-11143,ALKEM,"Burlina S, Dalfra MG, Caprino R, Lapolla A.. A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. Acta Diabetologica. 2023;60:137-38",38.0,YR,,F,Y,,,20231019,,HP,IT,IT,2023,Q4,Adult
230825991,23082599,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 units, hs (at dinner)",,,D,,Unknown,,,,,,,2023,Q4,Exposure during pregnancy,,2023,Q4,1,I,,20230926.0,20231019,20231019,EXP,,IT-ALKEM LABORATORIES LIMITED-US-ALKEM-2023-11143,ALKEM,"Burlina S, Dalfra MG, Caprino R, Lapolla A.. A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. Acta Diabetologica. 2023;60:137-38",38.0,YR,,F,Y,,,20231019,,HP,IT,IT,2023,Q4,Adult
230863621,23086362,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Clostridium difficile colitis,,2023,Q4,1,I,20230713.0,20230719.0,20231019,20231019,EXP,,US-SANDOZ INC.-SDZ2023US006923,SANDOZ,,60.0,YR,,F,Y,72.109,KG,20231019,,MD,US,US,2023,Q4,Adult
230863621,23086362,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Escherichia sepsis,,2023,Q4,1,I,20230713.0,20230719.0,20231019,20231019,EXP,,US-SANDOZ INC.-SDZ2023US006923,SANDOZ,,60.0,YR,,F,Y,72.109,KG,20231019,,MD,US,US,2023,Q4,Adult
230863621,23086362,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,1,I,20230713.0,20230719.0,20231019,20231019,EXP,,US-SANDOZ INC.-SDZ2023US006923,SANDOZ,,60.0,YR,,F,Y,72.109,KG,20231019,,MD,US,US,2023,Q4,Adult
230875521,23087552,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Renal failure,,2023,Q4,1,I,20230701.0,20231018.0,20231020,20231020,EXP,,"MX-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-267972",BOEHRINGER INGELHEIM,,45.0,YR,A,F,Y,,,20231020,,MD,MX,MX,2023,Q4,Adult
230875521,23087552,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Ketoacidosis,,2023,Q4,1,I,20230701.0,20231018.0,20231020,20231020,EXP,,"MX-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-267972",BOEHRINGER INGELHEIM,,45.0,YR,A,F,Y,,,20231020,,MD,MX,MX,2023,Q4,Adult
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,Off label use,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,Haematological infection,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,Localised infection,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,Off label use,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,Seizure,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,Pneumonia,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,COVID-19,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,Blood pressure increased,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963633,23096363,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, 3x/day 6 units TID",,,,,,,,,,,TID,2023,Q4,Renal failure,,2023,Q4,3,F,20230101.0,20231215.0,20231023,20231227,EXP,,CA-PFIZER INC-202300173686,PFIZER,,70.0,YR,,F,Y,58.0,KG,20231227,,HP,CA,CA,2023,Q4,Elderly
230963991,23096399,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q4,Injury associated with device,,2023,Q4,1,I,20231020.0,20231020.0,20231023,20231023,PER,,US-ELI_LILLY_AND_COMPANY-US202310012866,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20231023,,CN,US,US,2023,Q4,Elderly
230963991,23096399,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D591481C,,20563.0,,,Injection,,2023,Q4,Pain,,2023,Q4,1,I,20231020.0,20231020.0,20231023,20231023,PER,,US-ELI_LILLY_AND_COMPANY-US202310012866,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20231023,,CN,US,US,2023,Q4,Elderly
230976101,23097610,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,21.0,UG/M**2,,QD,2023,Q4,Premature baby,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,21.0,UG/M**2,,QD,2023,Q4,Neutropenia neonatal,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,21.0,UG/M**2,,QD,2023,Q4,Foetal exposure during pregnancy,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,21.0,UG/M**2,,QD,2023,Q4,Low birth weight baby,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,21.0,UG/M**2,,QD,2023,Q4,Foetal disorder,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"7 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,7.0,UG/M**2,,QD,2023,Q4,Premature baby,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"7 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,7.0,UG/M**2,,QD,2023,Q4,Neutropenia neonatal,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"7 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,7.0,UG/M**2,,QD,2023,Q4,Foetal exposure during pregnancy,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"7 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,7.0,UG/M**2,,QD,2023,Q4,Low birth weight baby,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230976101,23097610,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"7 ug/m2, QD",21.0,UG/M**2,D,U,Asked But Unknown,,,7.0,UG/M**2,,QD,2023,Q4,Foetal disorder,,2023,Q4,1,I,20170914.0,20210407.0,20231023,20231023,EXP,,FR-CHATTEMPRD-2018SA153712,CHATTEM,,1.0,DY,N,M,Y,1.89,KG,20231023,,PH,FR,FR,2023,Q4,Child
230983802,23098380,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D604077A,,20563.0,,,Injection,,2023,Q4,Skin laceration,,2023,Q4,2,F,20230901.0,20231017.0,20231023,20231026,EXP,,US-ELI_LILLY_AND_COMPANY-US202310009285,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20231026,,CN,US,US,2023,Q4,Adult
230983802,23098380,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D604077A,,20563.0,,,Injection,,2023,Q4,Limb injury,,2023,Q4,2,F,20230901.0,20231017.0,20231023,20231026,EXP,,US-ELI_LILLY_AND_COMPANY-US202310009285,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20231026,,CN,US,US,2023,Q4,Adult
230983971,23098397,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, tid",1620.0,IU,Y,Y,,,20563.0,10.0,IU,,TID,2023,Q4,Drug eruption,Drug eruption,2023,Q4,1,I,20230802.0,20231011.0,20231023,20231023,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202310006804,ELI LILLY AND CO,,60.0,YR,,M,Y,64.2,KG,20231023,,CN,CN,CN,2023,Q4,Adult
230983971,23098397,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, tid",1620.0,IU,Y,Y,D575382E,,20563.0,10.0,IU,,TID,2023,Q4,Drug eruption,Drug eruption,2023,Q4,1,I,20230802.0,20231011.0,20231023,20231023,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202310006804,ELI LILLY AND CO,,60.0,YR,,M,Y,64.2,KG,20231023,,CN,CN,CN,2023,Q4,Adult
230985451,23098545,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,24.0,MG,,,2023,Q4,Chest pain,,2023,Q4,1,I,20230417.0,20231013.0,20231023,20231023,EXP,IT-MINISAL02-947392,IT-TEVA-2023-IT-2937621,TEVA,,88.0,YR,E,M,Y,,,20231023,,HP,IT,IT,2023,Q4,Elderly
230985451,23098545,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,24.0,MG,,,2023,Q4,Hypertensive crisis,,2023,Q4,1,I,20230417.0,20231013.0,20231023,20231023,EXP,IT-MINISAL02-947392,IT-TEVA-2023-IT-2937621,TEVA,,88.0,YR,E,M,Y,,,20231023,,HP,IT,IT,2023,Q4,Elderly
230985451,23098545,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,24.0,MG,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20230417.0,20231013.0,20231023,20231023,EXP,IT-MINISAL02-947392,IT-TEVA-2023-IT-2937621,TEVA,,88.0,YR,E,M,Y,,,20231023,,HP,IT,IT,2023,Q4,Elderly
230985451,23098545,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,24.0,MG,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20230417.0,20231013.0,20231023,20231023,EXP,IT-MINISAL02-947392,IT-TEVA-2023-IT-2937621,TEVA,,88.0,YR,E,M,Y,,,20231023,,HP,IT,IT,2023,Q4,Elderly
230986441,23098644,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518829A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231019.0,20231023.0,20231023,20231023,PER,,US-ELI_LILLY_AND_COMPANY-US202310013076,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20231023,,CN,US,US,2023,Q4,Adult
230986441,23098644,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D518829A,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231019.0,20231023.0,20231023,20231023,PER,,US-ELI_LILLY_AND_COMPANY-US202310013076,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20231023,,CN,US,US,2023,Q4,Adult
231038251,23103825,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Fungal pharyngitis,,2023,Q4,1,I,20231016.0,,20231024,20231024,DIR,678576,,FDA-CTU,,58.0,YR,,UNK,N,,,20231024,N,MD,US,,2023,Q4,Adult
231038251,23103825,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Candida infection,,2023,Q4,1,I,20231016.0,,20231024,20231024,DIR,678576,,FDA-CTU,,58.0,YR,,UNK,N,,,20231024,N,MD,US,,2023,Q4,Adult
231038251,23103825,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Laryngitis fungal,,2023,Q4,1,I,20231016.0,,20231024,20231024,DIR,678576,,FDA-CTU,,58.0,YR,,UNK,N,,,20231024,N,MD,US,,2023,Q4,Adult
231065041,23106504,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,Unknown,,,100.0,IU,,,2023,Q4,Neck injury,,2023,Q4,1,I,20230916.0,20231018.0,20231025,20231025,EXP,,ZA-AstraZeneca-2023A237459,ASTRAZENECA,,64.0,YR,,M,Y,,,20231026,,CN,ZA,,2023,Q4,Adult
231114471,23111447,5,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,1,,,,,,,,,,,,Injection,,2023,Q4,Bradycardia,,2023,Q4,1,I,20230815.0,20231017.0,20231026,20231026,EXP,,CN-Eisai-EC-2023-147217,EISAI,,39.0,YR,A,M,Y,60.0,KG,20231026,,MD,CN,CN,2023,Q4,Adult
231139551,23113955,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,24.0,MG,,,2023,Q4,Hypertensive crisis,,2023,Q4,1,I,20230417.0,20231017.0,20231027,20231027,EXP,IT-MINISAL02-947392,IT-Accord-386399,ACCORD,,88.0,YR,E,M,Y,,,20231027,,HP,IT,IT,2023,Q4,Elderly
231139551,23113955,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,24.0,MG,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20230417.0,20231017.0,20231027,20231027,EXP,IT-MINISAL02-947392,IT-Accord-386399,ACCORD,,88.0,YR,E,M,Y,,,20231027,,HP,IT,IT,2023,Q4,Elderly
231139551,23113955,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,24.0,MG,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20230417.0,20231017.0,20231027,20231027,EXP,IT-MINISAL02-947392,IT-Accord-386399,ACCORD,,88.0,YR,E,M,Y,,,20231027,,HP,IT,IT,2023,Q4,Elderly
231139551,23113955,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,24.0,MG,,,2023,Q4,Chest pain,,2023,Q4,1,I,20230417.0,20231017.0,20231027,20231027,EXP,IT-MINISAL02-947392,IT-Accord-386399,ACCORD,,88.0,YR,E,M,Y,,,20231027,,HP,IT,IT,2023,Q4,Elderly
231154431,23115443,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,unk,,,U,,,,,,,,,2023,Q4,Dysphoria,,2023,Q4,1,I,20230503.0,20231020.0,20231027,20231027,EXP,,CN-SA-2023SA328734,SANOFI AVENTIS,,7.0,YR,C,F,Y,26.0,KG,20231027,,HP,CN,CN,2023,Q4,Child
231154431,23115443,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,unk,,,U,,,,,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,20230503.0,20231020.0,20231027,20231027,EXP,,CN-SA-2023SA328734,SANOFI AVENTIS,,7.0,YR,C,F,Y,26.0,KG,20231027,,HP,CN,CN,2023,Q4,Child
231158241,23115824,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Unknown,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231023.0,20231027,20231027,EXP,,CA-MYLANLABS-2023M1112652,MYLAN,,17.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Youth
231158241,23115824,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Unknown,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,1,I,,20231023.0,20231027,20231027,EXP,,CA-MYLANLABS-2023M1112652,MYLAN,,17.0,YR,,M,Y,,,20231027,,CN,CA,CA,2023,Q4,Youth
231170131,23117013,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D598643A,,20563.0,,,Solution for injection,,2023,Q4,Product storage error,,2023,Q4,1,I,20231020.0,20231026.0,20231027,20231027,PER,,US-ELI_LILLY_AND_COMPANY-US202310016331,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20231027,,CN,US,US,2023,Q4,Adult
231170131,23117013,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D598643A,,20563.0,,,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231020.0,20231026.0,20231027,20231027,PER,,US-ELI_LILLY_AND_COMPANY-US202310016331,ELI LILLY AND CO,,43.0,YR,,M,Y,,,20231027,,CN,US,US,2023,Q4,Adult
231216742,23121674,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q4,Altered state of consciousness,,2023,Q4,2,F,,20231109.0,20231029,20231115,EXP,,JP-SAKK-2023SA325639AA,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20231116,,MD,JP,JP,2023,Q4,Adult
231216742,23121674,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q4,Renal impairment,,2023,Q4,2,F,,20231109.0,20231029,20231115,EXP,,JP-SAKK-2023SA325639AA,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20231116,,MD,JP,JP,2023,Q4,Adult
231216742,23121674,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q4,Intentional overdose,,2023,Q4,2,F,,20231109.0,20231029,20231115,EXP,,JP-SAKK-2023SA325639AA,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20231116,,MD,JP,JP,2023,Q4,Adult
231216742,23121674,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231109.0,20231029,20231115,EXP,,JP-SAKK-2023SA325639AA,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20231116,,MD,JP,JP,2023,Q4,Adult
231237651,23123765,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Urinary tract infection,,2023,Q4,1,I,20210101.0,20231030.0,20231030,20231030,EXP,SE-SEMPA-2023-015019,"SE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-269772",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,87.0,KG,20231030,,MD,SE,SE,2023,Q4,Elderly
231237651,23123765,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Balanoposthitis,,2023,Q4,1,I,20210101.0,20231030.0,20231030,20231030,EXP,SE-SEMPA-2023-015019,"SE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-269772",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,87.0,KG,20231030,,MD,SE,SE,2023,Q4,Elderly
231237651,23123765,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Fungal infection,,2023,Q4,1,I,20210101.0,20231030.0,20231030,20231030,EXP,SE-SEMPA-2023-015019,"SE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-269772",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,87.0,KG,20231030,,MD,SE,SE,2023,Q4,Elderly
231245151,23124515,6,C,lispro ,,2,,,,,,,,,,,,,,2023,Q4,Muscle necrosis,,2023,Q4,1,I,20230114.0,,20231029,20231029,DIR,679114,,FDA-CTU,,40.0,YR,,F,N,93.6,KG,20231029,N,CN,US,,2023,Q4,Adult
231245151,23124515,6,C,lispro ,,2,,,,,,,,,,,,,,2023,Q4,Myopathy,,2023,Q4,1,I,20230114.0,,20231029,20231029,DIR,679114,,FDA-CTU,,40.0,YR,,F,N,93.6,KG,20231029,N,CN,US,,2023,Q4,Adult
231269301,23126930,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20230901.0,20231023.0,20231030,20231030,EXP,,US-ELI_LILLY_AND_COMPANY-US202310014704,ELI LILLY AND CO,,48.0,YR,,F,Y,,,20231030,,CN,US,US,2023,Q4,Adult
231281042,23128104,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 iU, BID",,,U,,,,,22.0,IU,,Q12H,2023,Q4,Ocular hyperaemia,,2023,Q4,2,F,,20231124.0,20231031,20231204,EXP,,CA-SA-2023SA330575,SANOFI AVENTIS,,75.0,YR,E,F,Y,92.0,KG,20231204,,CN,CA,CA,2023,Q4,Elderly
231281042,23128104,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2023,Q4,Ocular hyperaemia,,2023,Q4,2,F,,20231124.0,20231031,20231204,EXP,,CA-SA-2023SA330575,SANOFI AVENTIS,,75.0,YR,E,F,Y,92.0,KG,20231204,,CN,CA,CA,2023,Q4,Elderly
231291841,23129184,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,,,,,20563.0,40.0,IU,Solution for injection,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20231029.0,20231030.0,20231031,20231031,PER,,US-ELI_LILLY_AND_COMPANY-US202310017464,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20231031,,CN,US,US,2023,Q4,Youth
231291841,23129184,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,,,,,20563.0,40.0,IU,Solution for injection,,2023,Q4,Poor quality sleep,,2023,Q4,1,I,20231029.0,20231030.0,20231031,20231031,PER,,US-ELI_LILLY_AND_COMPANY-US202310017464,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20231031,,CN,US,US,2023,Q4,Youth
231291841,23129184,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,,,,,20563.0,40.0,IU,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231029.0,20231030.0,20231031,20231031,PER,,US-ELI_LILLY_AND_COMPANY-US202310017464,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20231031,,CN,US,US,2023,Q4,Youth
231291841,23129184,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,,,D554744A,,20563.0,40.0,IU,Solution for injection,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20231029.0,20231030.0,20231031,20231031,PER,,US-ELI_LILLY_AND_COMPANY-US202310017464,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20231031,,CN,US,US,2023,Q4,Youth
231291841,23129184,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,,,D554744A,,20563.0,40.0,IU,Solution for injection,,2023,Q4,Poor quality sleep,,2023,Q4,1,I,20231029.0,20231030.0,20231031,20231031,PER,,US-ELI_LILLY_AND_COMPANY-US202310017464,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20231031,,CN,US,US,2023,Q4,Youth
231291841,23129184,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,,,D554744A,,20563.0,40.0,IU,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231029.0,20231030.0,20231031,20231031,PER,,US-ELI_LILLY_AND_COMPANY-US202310017464,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20231031,,CN,US,US,2023,Q4,Youth
231306751,23130675,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, TID",,,U,,,,,10.0,IU,,Q8H,2023,Q4,Headache,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, TID",,,U,,,,,10.0,IU,,Q8H,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, TID",,,U,,,,,10.0,IU,,Q8H,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, TID",,,U,,,,,10.0,IU,,Q8H,2023,Q4,Loss of consciousness,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, TID",,,U,,,,,10.0,IU,,Q8H,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 iU, TID",,,U,,,,,20.0,IU,,Q8H,2023,Q4,Headache,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 iU, TID",,,U,,,,,20.0,IU,,Q8H,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 iU, TID",,,U,,,,,20.0,IU,,Q8H,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 iU, TID",,,U,,,,,20.0,IU,,Q8H,2023,Q4,Loss of consciousness,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 iU, TID",,,U,,,,,20.0,IU,,Q8H,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 iU, TID",,,U,,,,,4.0,IU,,Q8H,2023,Q4,Headache,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 iU, TID",,,U,,,,,4.0,IU,,Q8H,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 iU, TID",,,U,,,,,4.0,IU,,Q8H,2023,Q4,Gastrointestinal disorder,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 iU, TID",,,U,,,,,4.0,IU,,Q8H,2023,Q4,Loss of consciousness,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231306751,23130675,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 iU, TID",,,U,,,,,4.0,IU,,Q8H,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231024.0,20231024.0,20231031,20231031,EXP,,US-SA-2023SA331315,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20231031,,CN,US,US,2023,Q4,Elderly
231311071,23131107,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 U, bid",,,,,,,,,,,BID,2023,Q4,B-lymphocyte count increased,,2023,Q4,1,I,,20231027.0,20231031,20231031,EXP,,IT-SANDOZ INC.-SDZ2023IT047924,SANDOZ,"Claudio Candia, Francesco Coppa, Lucia Abagnale, Francesco Perna, Antonio Molino. Mepolizumab treatment in a patient with previous livertransplantation: One year follow-up. Respiratory Medicine Case Report. 2023;46",68.0,YR,,F,Y,,,20231031,,HP,IT,IT,2023,Q4,Elderly
231316331,23131633,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,,,2023,Q4,Pulmonary embolism,,2023,Q4,1,I,,20231019.0,20231031,20231031,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202310012122,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231031,,CN,DE,DE,2023,Q4,Elderly
231316331,23131633,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231019.0,20231031,20231031,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202310012122,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231031,,CN,DE,DE,2023,Q4,Elderly
231316391,23131639,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, tid",,,U,,,,20563.0,15.0,IU,Injection,TID,2023,Q4,Localised infection,,2023,Q4,1,I,20230201.0,20231030.0,20231031,20231031,EXP,,US-ELI_LILLY_AND_COMPANY-US202310017663,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20231031,,CN,US,US,2023,Q4,Adult
231316391,23131639,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"42 u, daily",,,U,,,,20563.0,42.0,IU,Injection,QD,2023,Q4,Localised infection,,2023,Q4,1,I,20230201.0,20231030.0,20231031,20231031,EXP,,US-ELI_LILLY_AND_COMPANY-US202310017663,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20231031,,CN,US,US,2023,Q4,Adult
231322771,23132277,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q4,Hyperglycaemia,,2023,Q4,1,I,20230126.0,20231030.0,20231101,20231101,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-2023-014479,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,96.0,KG,20231101,,HP,BR,BR,2023,Q4,Elderly
231322771,23132277,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2023,Q4,Hyperglycaemia,,2023,Q4,1,I,20230126.0,20231030.0,20231101,20231101,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-2023-014479,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,96.0,KG,20231101,,HP,BR,BR,2023,Q4,Elderly
231356302,23135630,4,C,INSULIN LISPRO BS,,2,Subcutaneous,UNK,,,,,Unknown,,,,,,,2023,Q4,Blood creatine phosphokinase increased,,2023,Q4,2,F,20230914.0,20231127.0,20231101,20231207,EXP,JP-MHLW-i2310004492,JP-NOVOPROD-1132322,NOVO NORDISK,,81.0,YR,,M,Y,74.1,KG,20231207,,PH,JP,JP,2023,Q4,Elderly
231356302,23135630,4,C,INSULIN LISPRO BS,,2,Subcutaneous,UNK,,,,,Unknown,,,,,,,2023,Q4,Myoglobin blood increased,,2023,Q4,2,F,20230914.0,20231127.0,20231101,20231207,EXP,JP-MHLW-i2310004492,JP-NOVOPROD-1132322,NOVO NORDISK,,81.0,YR,,M,Y,74.1,KG,20231207,,PH,JP,JP,2023,Q4,Elderly
231359892,23135989,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50% insulin lispro + 50% intermediate-acting insulin lispro at 18 units daily,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Altered state of consciousness,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50% insulin lispro + 50% intermediate-acting insulin lispro at 18 units daily,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Intentional overdose,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50% insulin lispro + 50% intermediate-acting insulin lispro at 18 units daily,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Condition aggravated,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50% insulin lispro + 50% intermediate-acting insulin lispro at 18 units daily,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Hypoglycaemic encephalopathy,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50% insulin lispro + 50% intermediate-acting insulin lispro at 18 units daily,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Hypoglycaemic coma,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50% insulin lispro + 50% intermediate-acting insulin lispro at 18 units daily,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50% insulin lispro + 50% intermediate-acting insulin lispro at 18 units daily,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Aspiration,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Altered state of consciousness,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Intentional overdose,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Condition aggravated,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Hypoglycaemic encephalopathy,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Hypoglycaemic coma,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Hypoglycaemia,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231359892,23135989,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,Y,,,209196.0,,,Solution for injection,,2023,Q4,Aspiration,,2023,Q4,2,F,,20231030.0,20231102,20231102,EXP,,JP-SA-2023SA333591,SANOFI AVENTIS,"Iio T, Tsutsumi T, Koma J, Kadono M, Nakano K, Fukui M.. A case of a patient with type 2 diabetes mellitus complicated by depression who died of overdose of insulin in a suicide attempt.. The 60th Kinki Regional Meeting of the Japan Diabetes Society (14-Oct-2023).. UNK;UNK:113",71.0,YR,E,M,Y,,,20231102,,MD,JP,JP,2023,Q4,Elderly
231365211,23136521,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101J,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231031.0,20231101.0,20231102,20231102,PER,,US-ELI_LILLY_AND_COMPANY-US202311000946,ELI LILLY AND CO,,10.0,YR,,M,Y,,,20231102,,CN,US,US,2023,Q4,Child
231365211,23136521,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D556101J,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231031.0,20231101.0,20231102,20231102,PER,,US-ELI_LILLY_AND_COMPANY-US202311000946,ELI LILLY AND CO,,10.0,YR,,M,Y,,,20231102,,CN,US,US,2023,Q4,Child
231367521,23136752,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D598642D,,20563.0,,,Solution for injection,,2023,Q4,Wrist fracture,,2023,Q4,1,I,20221001.0,20231101.0,20231102,20231102,PER,,US-ELI_LILLY_AND_COMPANY-US202311000931,ELI LILLY AND CO,,63.0,YR,,,Y,,,20231102,,CN,US,US,2023,Q4,Adult
231367521,23136752,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D598642D,,20563.0,,,Solution for injection,,2023,Q4,Osteoporosis,,2023,Q4,1,I,20221001.0,20231101.0,20231102,20231102,PER,,US-ELI_LILLY_AND_COMPANY-US202311000931,ELI LILLY AND CO,,63.0,YR,,,Y,,,20231102,,CN,US,US,2023,Q4,Adult
231367521,23136752,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D598642D,,20563.0,,,Solution for injection,,2023,Q4,Ankle fracture,,2023,Q4,1,I,20221001.0,20231101.0,20231102,20231102,PER,,US-ELI_LILLY_AND_COMPANY-US202311000931,ELI LILLY AND CO,,63.0,YR,,,Y,,,20231102,,CN,US,US,2023,Q4,Adult
231379312,23137931,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,Dose unknown,,,,,,,,,,Injection,,2023,Q4,Hepatic rupture,,2023,Q4,2,F,20231024.0,20231109.0,20231102,20231113,EXP,,JP-AstraZeneca-2023A248157,ASTRAZENECA,,73.0,YR,,M,Y,,,20231113,,MD,JP,,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Dry skin,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Glomerular filtration rate abnormal,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Hiatus hernia,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Cardiomegaly,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Small intestinal obstruction,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Abscess,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Balance disorder,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Hypertension,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Diverticular perforation,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Leukocytosis,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Oedema,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Diverticulitis,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Red cell distribution width increased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Spinal pain,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Atrial fibrillation,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,White blood cell count increased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Mean cell haemoglobin concentration decreased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Pneumoperitoneum,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Type 2 diabetes mellitus,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Cholelithiasis,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Chronic obstructive pulmonary disease,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Skin warm,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Syncope,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Lymphocyte count decreased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Prothrombin time prolonged,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Colectomy,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Asthma,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Intestinal resection,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Red blood cell count increased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Swelling,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Colostomy,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Pelvic abscess,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Intestinal perforation,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Arrhythmia,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Night sweats,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Cardiac failure chronic,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Arthralgia,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Blood sodium decreased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Neutrophil count increased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Blood chloride decreased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,SARS-CoV-2 test positive,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,International normalised ratio increased,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Obstructive sleep apnoea syndrome,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231402471,23140247,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,Q4H,2023,Q4,Fatigue,,2023,Q4,1,I,20230522.0,20231026.0,20231102,20231102,EXP,,US-ABBVIE-5475172,ABBVIE,,69.0,YR,,F,Y,,,20231102,,CN,US,US,2023,Q4,Elderly
231435221,23143522,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"20 UNK, qid",,,,,,,,,,,QID,2023,Q4,Premature baby,,2023,Q4,1,I,20230907.0,20231027.0,20231103,20231103,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006736,AEGERION,,0.0,YR,,M,Y,3.175,KG,20231103,,MD,US,US,2023,Q4,Child
231435221,23143522,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"20 UNK, qid",,,,,,,,,,,QID,2023,Q4,Foetal exposure during pregnancy,,2023,Q4,1,I,20230907.0,20231027.0,20231103,20231103,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006736,AEGERION,,0.0,YR,,M,Y,3.175,KG,20231103,,MD,US,US,2023,Q4,Child
231435221,23143522,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"0.9 IU/hr, continous via pump",,,,,,,,,,,,2023,Q4,Premature baby,,2023,Q4,1,I,20230907.0,20231027.0,20231103,20231103,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006736,AEGERION,,0.0,YR,,M,Y,3.175,KG,20231103,,MD,US,US,2023,Q4,Child
231435221,23143522,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"0.9 IU/hr, continous via pump",,,,,,,,,,,,2023,Q4,Foetal exposure during pregnancy,,2023,Q4,1,I,20230907.0,20231027.0,20231103,20231103,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR006736,AEGERION,,0.0,YR,,M,Y,3.175,KG,20231103,,MD,US,US,2023,Q4,Child
231450831,23145083,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 units three times a day,,,,,,,,,,,,2023,Q4,Arrhythmia,,2023,Q4,1,I,,20231025.0,20231103,20231103,EXP,,US-Fresenius Medical Care Renal Therapies Group-FMC-2311-001199,FRESENIUS MEDICAL CARE,,66.0,YR,E,M,Y,,,20231103,,HP,US,US,2023,Q4,Elderly
231480591,23148059,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,unknown,,,,,,,2023,Q4,Malaise,,2023,Q4,1,I,,20231031.0,20231106,20231106,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2023-14571",IPSEN,,44.0,YR,A,M,Y,81.64,KG,20231106,,CN,US,US,2023,Q4,Adult
231480591,23148059,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,unknown,,,,,,,2023,Q4,Neoplasm,,2023,Q4,1,I,,20231031.0,20231106,20231106,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2023-14571",IPSEN,,44.0,YR,A,M,Y,81.64,KG,20231106,,CN,US,US,2023,Q4,Adult
231480591,23148059,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,unknown,,,,,,,2023,Q4,Cancer surgery,,2023,Q4,1,I,,20231031.0,20231106,20231106,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2023-14571",IPSEN,,44.0,YR,A,M,Y,81.64,KG,20231106,,CN,US,US,2023,Q4,Adult
231496341,23149634,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 international unit, daily",,,U,,,,,18.0,IU,,QD,2023,Q4,Suicide attempt,,2023,Q4,1,I,,20231031.0,20231106,20231106,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202311001110,ELI LILLY AND CO,"Iio T, et al..A case of a type 2 diabetic patient with depression who died after taking an insulin overdose for a suicide attempt.The 60th Japan Diabetes Society Kinki Regional Meeting 2023;:113.",71.0,YR,,M,Y,,,20231106,,MD,JP,JP,2023,Q4,Elderly
231496341,23149634,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 international unit, daily",,,U,,,,,18.0,IU,,QD,2023,Q4,Hypoglycaemic encephalopathy,,2023,Q4,1,I,,20231031.0,20231106,20231106,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202311001110,ELI LILLY AND CO,"Iio T, et al..A case of a type 2 diabetic patient with depression who died after taking an insulin overdose for a suicide attempt.The 60th Japan Diabetes Society Kinki Regional Meeting 2023;:113.",71.0,YR,,M,Y,,,20231106,,MD,JP,JP,2023,Q4,Elderly
231496341,23149634,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 international unit, daily",,,U,,,,,18.0,IU,,QD,2023,Q4,Extra dose administered,,2023,Q4,1,I,,20231031.0,20231106,20231106,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202311001110,ELI LILLY AND CO,"Iio T, et al..A case of a type 2 diabetic patient with depression who died after taking an insulin overdose for a suicide attempt.The 60th Japan Diabetes Society Kinki Regional Meeting 2023;:113.",71.0,YR,,M,Y,,,20231106,,MD,JP,JP,2023,Q4,Elderly
231496341,23149634,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 international unit, daily",,,U,,,,,18.0,IU,,QD,2023,Q4,Aspiration,,2023,Q4,1,I,,20231031.0,20231106,20231106,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202311001110,ELI LILLY AND CO,"Iio T, et al..A case of a type 2 diabetic patient with depression who died after taking an insulin overdose for a suicide attempt.The 60th Japan Diabetes Society Kinki Regional Meeting 2023;:113.",71.0,YR,,M,Y,,,20231106,,MD,JP,JP,2023,Q4,Elderly
231509651,23150965,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231106.0,20231106.0,20231106,20231106,PER,,US-ELI_LILLY_AND_COMPANY-US202311003145,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20231106,,CN,US,US,2023,Q4,Adult
231509651,23150965,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231106.0,20231106.0,20231106,20231106,PER,,US-ELI_LILLY_AND_COMPANY-US202311003145,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20231106,,CN,US,US,2023,Q4,Adult
231509651,23150965,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D604077A,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231106.0,20231106.0,20231106,20231106,PER,,US-ELI_LILLY_AND_COMPANY-US202311003145,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20231106,,CN,US,US,2023,Q4,Adult
231509651,23150965,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D604077A,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231106.0,20231106.0,20231106,20231106,PER,,US-ELI_LILLY_AND_COMPANY-US202311003145,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20231106,,CN,US,US,2023,Q4,Adult
231516901,23151690,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578904A,,,,,Injection,,2023,Q4,Incorrect product administration duration,,2023,Q4,1,I,20221201.0,20231106.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311003276,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20231107,,CN,US,US,2023,Q4,Adult
231516901,23151690,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578904A,,,,,Injection,,2023,Q4,Hypoacusis,,2023,Q4,1,I,20221201.0,20231106.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311003276,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20231107,,CN,US,US,2023,Q4,Adult
231560301,23156030,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Arthritis,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Confusional state,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Arthritis,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Confusional state,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Arthritis,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Confusional state,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Arthritis,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Confusional state,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Arthritis,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Confusional state,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163D,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Arthritis,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Confusional state,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Arthritis,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Confusional state,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231560301,23156030,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D609625D,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231101.0,20231101.0,20231107,20231107,PER,,US-ELI_LILLY_AND_COMPANY-US202311002388,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231107,,CN,US,US,2023,Q4,Elderly
231669111,23166911,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK iU/mL,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20230130.0,20231025.0,20231109,20231109,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-417383,RANBAXY,,71.0,YR,,F,Y,52.0,KG,20231109,,MD,IT,IT,2023,Q4,Elderly
231669111,23166911,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK iU/mL,,,U,,,,,,,,,2023,Q4,General physical health deterioration,,2023,Q4,1,I,20230130.0,20231025.0,20231109,20231109,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-417383,RANBAXY,,71.0,YR,,F,Y,52.0,KG,20231109,,MD,IT,IT,2023,Q4,Elderly
231669111,23166911,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 iU/mL,,,U,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20230130.0,20231025.0,20231109,20231109,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-417383,RANBAXY,,71.0,YR,,F,Y,52.0,KG,20231109,,MD,IT,IT,2023,Q4,Elderly
231669111,23166911,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 iU/mL,,,U,,,,,,,,,2023,Q4,General physical health deterioration,,2023,Q4,1,I,20230130.0,20231025.0,20231109,20231109,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2023RR-417383,RANBAXY,,71.0,YR,,F,Y,52.0,KG,20231109,,MD,IT,IT,2023,Q4,Elderly
231673201,23167320,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,U,,UNKNOWN,,20563.0,,,Solution for injection,,2023,Q4,Hypoglycaemic unconsciousness,,2023,Q4,1,I,20230506.0,20231106.0,20231109,20231109,PER,,US-ELI_LILLY_AND_COMPANY-US202311005743,ELI LILLY AND CO,,53.0,YR,,M,Y,82.2,KG,20231109,,MD,US,US,2023,Q4,Adult
231673201,23167320,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,U,,UNKNOWN,,20563.0,,,Solution for injection,,2023,Q4,Hypoglycaemic unconsciousness,,2023,Q4,1,I,20230506.0,20231106.0,20231109,20231109,PER,,US-ELI_LILLY_AND_COMPANY-US202311005743,ELI LILLY AND CO,,53.0,YR,,M,Y,82.2,KG,20231109,,MD,US,US,2023,Q4,Adult
231694361,23169436,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,8.0,IU,,BID,2023,Q4,Asthma,,2023,Q4,1,I,,20231030.0,20231110,20231110,EXP,,IT-PBT-008579,PANACEA BIOTEC,"Candia C, Coppa F, Abagnale L, Perna F, Molino A. Mepolizumab treatment in a patient with previous liver transplantation: One year follow-up. Respir Med Case Rep. 2023 Oct 16;46:101933. doi: 10.1016/j.rmcr.2023.101933.",68.0,YR,E,F,Y,,,20231110,,HP,IT,IT,2023,Q4,Elderly
231696611,23169661,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU,before three meal",,,Y,,202207009,,209196.0,5.0,IU,Solution for injection,,2023,Q4,Product use in unapproved indication,,2023,Q4,1,I,20231020.0,20231102.0,20231110,20231110,EXP,,CN-SA-2023SA345584,SANOFI AVENTIS,,57.0,YR,A,F,Y,55.2,KG,20231110,,HP,CN,CN,2023,Q4,Adult
231696611,23169661,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 iU,before three meal",,,Y,,202207009,,209196.0,5.0,IU,Solution for injection,,2023,Q4,Oedema,,2023,Q4,1,I,20231020.0,20231102.0,20231110,20231110,EXP,,CN-SA-2023SA345584,SANOFI AVENTIS,,57.0,YR,A,F,Y,55.2,KG,20231110,,HP,CN,CN,2023,Q4,Adult
231696611,23169661,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,Solution for injection,,2023,Q4,Product use in unapproved indication,,2023,Q4,1,I,20231020.0,20231102.0,20231110,20231110,EXP,,CN-SA-2023SA345584,SANOFI AVENTIS,,57.0,YR,A,F,Y,55.2,KG,20231110,,HP,CN,CN,2023,Q4,Adult
231696611,23169661,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,Solution for injection,,2023,Q4,Oedema,,2023,Q4,1,I,20231020.0,20231102.0,20231110,20231110,EXP,,CN-SA-2023SA345584,SANOFI AVENTIS,,57.0,YR,A,F,Y,55.2,KG,20231110,,HP,CN,CN,2023,Q4,Adult
231696611,23169661,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,Solution for injection,,2023,Q4,Product use in unapproved indication,,2023,Q4,1,I,20231020.0,20231102.0,20231110,20231110,EXP,,CN-SA-2023SA345584,SANOFI AVENTIS,,57.0,YR,A,F,Y,55.2,KG,20231110,,HP,CN,CN,2023,Q4,Adult
231696611,23169661,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,Solution for injection,,2023,Q4,Oedema,,2023,Q4,1,I,20231020.0,20231102.0,20231110,20231110,EXP,,CN-SA-2023SA345584,SANOFI AVENTIS,,57.0,YR,A,F,Y,55.2,KG,20231110,,HP,CN,CN,2023,Q4,Adult
231704531,23170453,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q4,Injection site erythema,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q4,Angioedema,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q4,Urticaria,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q4,Condition aggravated,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,,,2023,Q4,Anaphylactic reaction,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,,,2023,Q4,Injection site erythema,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,,,2023,Q4,Angioedema,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,,,2023,Q4,Urticaria,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,,,2023,Q4,Condition aggravated,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231704531,23170453,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,,,2023,Q4,Anaphylactic reaction,,2023,Q4,1,I,,20231101.0,20231110,20231110,EXP,,US-SA-2023SA340369,SANOFI AVENTIS,"Weber J, Kobernick A, Smego A, Raman V, Meder M, Workman J, Finch A, Banwell E. Possible Insulin Allergy Presenting with Anaphylaxis. Hormone Research in Paediatrics. 2023;96:84-5",22.0,MON,I,M,Y,,,20231110,,HP,US,US,2023,Q4,Youth
231725371,23172537,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231001.0,20231102.0,20231110,20231110,EXP,,US-ELI_LILLY_AND_COMPANY-US202311004216,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20231110,,CN,US,US,2023,Q4,Adult
231761982,23176198,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,2,F,,20231220.0,20231113,20231222,EXP,,US-ALXN-202310GLO000415US,ALEXION PHARMACEUTICALS,,37.0,YR,,F,Y,66.0,KG,20231222,,MD,US,US,2023,Q4,Adult
231761982,23176198,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Diabetic coma,,2023,Q4,2,F,,20231220.0,20231113,20231222,EXP,,US-ALXN-202310GLO000415US,ALEXION PHARMACEUTICALS,,37.0,YR,,F,Y,66.0,KG,20231222,,MD,US,US,2023,Q4,Adult
231774102,23177410,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, bid",,,U,U,,,,,,,,2023,Q4,B-lymphocyte count increased,,2023,Q4,2,F,,20231130.0,20231113,20231207,EXP,,"IT-VELOXIS PHARMACEUTICALS, INC.-2023-VEL-00696",VELOXIS PHARMACEUTICALS,"Candia C, Coppa F, Abagnale L, Perna F, Molino A... Mepolizumab treatment in a patient with previous livertransplantation: One year follow-up.. Respiratory Medicine Case Report.. 2023;46:1-4",68.0,YR,,F,Y,,,20231207,,HP,IT,IT,2023,Q4,Elderly
231787721,23178772,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,20.0,IU,U,,,,,,,,,2023,Q4,Dermatitis exfoliative generalised,,2023,Q4,1,I,20230901.0,20231110.0,20231113,20231113,EXP,IT-MINISAL02-953874,IT-BRISTOL-MYERS SQUIBB COMPANY-2023-162076,BRISTOL MYERS SQUIBB,,83.0,YR,E,M,Y,90.0,KG,20231113,,MD,IT,IT,2023,Q4,Elderly
231878461,23187846,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,1,I,20221018.0,20221101.0,20231115,20231115,PER,,US-NOVOPROD-977646,NOVO NORDISK,,76.0,YR,,F,Y,,,20231115,,CN,US,US,2023,Q4,Elderly
231878461,23187846,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2023,Q4,Hypersensitivity,,2023,Q4,1,I,20221018.0,20221101.0,20231115,20231115,PER,,US-NOVOPROD-977646,NOVO NORDISK,,76.0,YR,,F,Y,,,20231115,,CN,US,US,2023,Q4,Elderly
231889692,23188969,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"60 u, daily",,,U,,,,20563.0,60.0,IU,Injection,QD,2023,Q4,Pulmonary mass,,2023,Q4,2,F,20231102.0,20231117.0,20231115,20231128,EXP,,US-ELI_LILLY_AND_COMPANY-US202311002808,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
231889692,23188969,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"60 u, daily",,,U,,,,20563.0,60.0,IU,Injection,QD,2023,Q4,Breast cancer recurrent,,2023,Q4,2,F,20231102.0,20231117.0,20231115,20231128,EXP,,US-ELI_LILLY_AND_COMPANY-US202311002808,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20231128,,CN,US,US,2023,Q4,Elderly
231906501,23190650,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,8.0,IU,,,2023,Q4,Liver injury,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,BE-Accord-389798,ACCORD,"Thijs S, Balti E, Degraeve C, Coremans P. Isomorphic (Koebner) Phenomenon Induced by Insulin Analogue Injections in Psoriasis. JCEM Case Rep. 2022 Nov 30;1(1):luac016.",56.0,YR,A,F,Y,,,20231116,,HP,BE,BE,2023,Q4,Adult
231924551,23192455,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Myasthenia gravis,,2023,Q4,1,I,20231009.0,20231102.0,20231116,20231116,EXP,,US-ALXN-202311GLO000034US,ALEXION PHARMACEUTICALS,,36.0,YR,,F,Y,,,20231116,,MD,US,US,2023,Q4,Adult
231937151,23193715,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Death,,2023,Q4,1,I,20231113.0,20231114.0,20231116,20231116,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-165361,BRISTOL MYERS SQUIBB,,92.0,YR,E,F,Y,,,20231117,,CN,US,US,2023,Q4,Elderly
231938381,23193838,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q4,Injection site erythema,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q4,Hypersensitivity,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q4,Anaphylactic reaction,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,20563.0,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,20563.0,,,,,2023,Q4,Injection site erythema,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,20563.0,,,,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,20563.0,,,,,2023,Q4,Hypersensitivity,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231938381,23193838,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,20563.0,,,,,2023,Q4,Anaphylactic reaction,,2023,Q4,1,I,,20231105.0,20231116,20231116,EXP,,US-ELI_LILLY_AND_COMPANY-US202311006788,ELI LILLY AND CO,"Weber J.,Kobernick A.,Smego A.,Raman V.,Meder M.,Workman J., et. al..Possible Insulin Allergy Presenting with Anaphylaxis..Hormone Research in Paediatrics. Conf Pediatric Endocrine Society Annual Meeting 2023;96(3):84-85.DOI:10.1159/000531602",22.0,MON,,M,Y,,,20231116,,MD,US,US,2023,Q4,Youth
231974141,23197414,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2023,Q4,Off label use,,2023,Q4,1,I,20230314.0,20231106.0,20231117,20231117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-159035,BRISTOL MYERS SQUIBB,,81.0,YR,E,M,Y,,,20231117,,HP,US,US,2023,Q4,Elderly
231974141,23197414,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2023,Q4,Death,,2023,Q4,1,I,20230314.0,20231106.0,20231117,20231117,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-159035,BRISTOL MYERS SQUIBB,,81.0,YR,E,M,Y,,,20231117,,HP,US,US,2023,Q4,Elderly
231982221,23198222,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231116.0,20231117,20231117,EXP,,CA-SANDOZ INC.-SDZ2023CA055163,SANDOZ,,17.0,YR,,M,Y,,,20231117,,CN,CA,CA,2023,Q4,Youth
231982221,23198222,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Glycosylated haemoglobin increased,,2023,Q4,1,I,,20231116.0,20231117,20231117,EXP,,CA-SANDOZ INC.-SDZ2023CA055163,SANDOZ,,17.0,YR,,M,Y,,,20231117,,CN,CA,CA,2023,Q4,Youth
231991121,23199112,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,1,I,,20230921.0,20231117,20231117,PER,,"US-Stemline Therapeutics, Inc.-2023ST003398",STEMLINE THERAPEUTICS,,76.0,YR,E,F,Y,,,20231117,,CN,US,US,2023,Q4,Elderly
231993961,23199396,6,C,Insulin Lispro Injection,,2,,,,,,,,,,,,Injection,,2023,Q4,Disease progression,,2023,Q4,1,I,,20231018.0,20231117,20231117,PER,,"US-Stemline Therapeutics, Inc.-2023ST003926",STEMLINE THERAPEUTICS,,45.0,YR,A,F,Y,,,20231116,,CN,US,US,2023,Q4,Adult
232011271,23201127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,INSULINA LISPRO,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20231001.0,20231109.0,20231118,20231118,EXP,IT-MINISAL02-951492,IT-TEVA-2023-IT-2946050,TEVA,,59.0,YR,A,F,Y,,,20231118,,HP,IT,IT,2023,Q4,Adult
232011271,23201127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,INSULINA LISPRO,,,,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,20231001.0,20231109.0,20231118,20231118,EXP,IT-MINISAL02-951492,IT-TEVA-2023-IT-2946050,TEVA,,59.0,YR,A,F,Y,,,20231118,,HP,IT,IT,2023,Q4,Adult
232011271,23201127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,INSULINA LISPRO,,,,,,,,,,,,2023,Q4,Depressed level of consciousness,,2023,Q4,1,I,20231001.0,20231109.0,20231118,20231118,EXP,IT-MINISAL02-951492,IT-TEVA-2023-IT-2946050,TEVA,,59.0,YR,A,F,Y,,,20231118,,HP,IT,IT,2023,Q4,Adult
232011271,23201127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,INSULINA LISPRO,,,,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,1,I,20231001.0,20231109.0,20231118,20231118,EXP,IT-MINISAL02-951492,IT-TEVA-2023-IT-2946050,TEVA,,59.0,YR,A,F,Y,,,20231118,,HP,IT,IT,2023,Q4,Adult
232029351,23202935,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Nausea,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-MYLANLABS-2023M1123358,MYLAN,,20.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Youth
232029351,23202935,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-MYLANLABS-2023M1123358,MYLAN,,20.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Youth
232029351,23202935,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-MYLANLABS-2023M1123358,MYLAN,,20.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Youth
232029351,23202935,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Unknown,,2023,Q4,Colitis ulcerative,,2023,Q4,1,I,,20231116.0,20231120,20231120,EXP,,CA-MYLANLABS-2023M1123358,MYLAN,,20.0,YR,,F,Y,,,20231120,,HP,CA,CA,2023,Q4,Youth
232058262,23205826,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25 Kwik pen,,,,,,,,,,,,2023,Q4,Anaemia,,2023,Q4,2,F,,20231211.0,20231120,20231222,PER,,US-Taiho Oncology Inc-2023-009320,TAIHO ONCOLOGY INC,,78.0,YR,E,M,Y,76.2,KG,20231222,,CN,US,US,2023,Q4,Elderly
232058262,23205826,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,75/25 Kwik pen,,,,,,,,,,,,2023,Q4,Product dose omission in error,,2023,Q4,2,F,,20231211.0,20231120,20231222,PER,,US-Taiho Oncology Inc-2023-009320,TAIHO ONCOLOGY INC,,78.0,YR,E,M,Y,76.2,KG,20231222,,CN,US,US,2023,Q4,Elderly
232110952,23211095,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Peripheral swelling,,2023,Q4,2,F,20230901.0,20231115.0,20231121,20231128,PER,,US-SA-2023SA308227,SANOFI AVENTIS,,59.0,YR,A,M,Y,101.6,KG,20231128,,CN,US,US,2023,Q4,Adult
232110952,23211095,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Injection site erythema,,2023,Q4,2,F,20230901.0,20231115.0,20231121,20231128,PER,,US-SA-2023SA308227,SANOFI AVENTIS,,59.0,YR,A,M,Y,101.6,KG,20231128,,CN,US,US,2023,Q4,Adult
232110952,23211095,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Injection site pruritus,,2023,Q4,2,F,20230901.0,20231115.0,20231121,20231128,PER,,US-SA-2023SA308227,SANOFI AVENTIS,,59.0,YR,A,M,Y,101.6,KG,20231128,,CN,US,US,2023,Q4,Adult
232110952,23211095,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Injection site swelling,,2023,Q4,2,F,20230901.0,20231115.0,20231121,20231128,PER,,US-SA-2023SA308227,SANOFI AVENTIS,,59.0,YR,A,M,Y,101.6,KG,20231128,,CN,US,US,2023,Q4,Adult
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Tenderness,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Intestinal malrotation,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Localised oedema,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Tachycardia,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Abdominal pain,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Cardiac disorder,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Periorbital oedema,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Oedema peripheral,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Tachypnoea,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Abdominal distension,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Chest pain,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Pericardial effusion,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Pulmonary congestion,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Orthopnoea,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Face oedema,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Hypervolaemia,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Pleural effusion,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232114081,23211408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD (multiple)",,,U,,,,209196.0,,,Solution for injection,QD,2023,Q4,Hypertension,,2023,Q4,1,I,,20231113.0,20231121,20231121,EXP,,US-SA-2023SA356260,SANOFI AVENTIS,"Pauley ME, Tan S, Sikand G, Cobry EC.. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes.. Clinical Diabetes.. 2022;40(2):253-6.",14.0,YR,T,F,Y,,,20231121,,HP,US,US,2023,Q4,Youth
232184161,23218416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Respiratory failure,,2023,Q4,1,I,,20231120.0,20231122,20231122,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273690",BOEHRINGER INGELHEIM,"Penna LE, Rivera MO, Burgos AR, Martin LM, Nieves YR, Cordero NH. SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges. Journal of Endocrine Society. 2022;doi:10.1210/jendso/bvac150.692.",61.0,YR,A,M,Y,,,20231122,,MD,US,US,2023,Q4,Adult
232184161,23218416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,General physical health deterioration,,2023,Q4,1,I,,20231120.0,20231122,20231122,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273690",BOEHRINGER INGELHEIM,"Penna LE, Rivera MO, Burgos AR, Martin LM, Nieves YR, Cordero NH. SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges. Journal of Endocrine Society. 2022;doi:10.1210/jendso/bvac150.692.",61.0,YR,A,M,Y,,,20231122,,MD,US,US,2023,Q4,Adult
232184161,23218416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Sepsis,,2023,Q4,1,I,,20231120.0,20231122,20231122,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273690",BOEHRINGER INGELHEIM,"Penna LE, Rivera MO, Burgos AR, Martin LM, Nieves YR, Cordero NH. SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges. Journal of Endocrine Society. 2022;doi:10.1210/jendso/bvac150.692.",61.0,YR,A,M,Y,,,20231122,,MD,US,US,2023,Q4,Adult
232184161,23218416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Candida infection,,2023,Q4,1,I,,20231120.0,20231122,20231122,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273690",BOEHRINGER INGELHEIM,"Penna LE, Rivera MO, Burgos AR, Martin LM, Nieves YR, Cordero NH. SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges. Journal of Endocrine Society. 2022;doi:10.1210/jendso/bvac150.692.",61.0,YR,A,M,Y,,,20231122,,MD,US,US,2023,Q4,Adult
232184161,23218416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Penile abscess,,2023,Q4,1,I,,20231120.0,20231122,20231122,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273690",BOEHRINGER INGELHEIM,"Penna LE, Rivera MO, Burgos AR, Martin LM, Nieves YR, Cordero NH. SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges. Journal of Endocrine Society. 2022;doi:10.1210/jendso/bvac150.692.",61.0,YR,A,M,Y,,,20231122,,MD,US,US,2023,Q4,Adult
232184161,23218416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231120.0,20231122,20231122,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273690",BOEHRINGER INGELHEIM,"Penna LE, Rivera MO, Burgos AR, Martin LM, Nieves YR, Cordero NH. SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges. Journal of Endocrine Society. 2022;doi:10.1210/jendso/bvac150.692.",61.0,YR,A,M,Y,,,20231122,,MD,US,US,2023,Q4,Adult
232190261,23219026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,for three years,,,,,UNK,,,,,,,2023,Q4,Liver function test abnormal,,2023,Q4,1,I,,20231114.0,20231122,20231122,EXP,,BE-ALVOGEN-2023092591,ALVOGEN,"Thijs S, Balti E, Degraeve C, Coremans P. lsomorphic (Koebner) Phenomenon Induced by Insulin Analogue Injections in Psoriasis. JCEM Case Reports. 2023;1 (1):1-3. doi:https://d0i.org/10.1210/jcemcr/luac0l6",56.0,YR,,F,Y,,,20231122,,HP,BE,BE,2023,Q4,Adult
232190261,23219026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,for three years,,,,,UNK,,,,,,,2023,Q4,Liver injury,,2023,Q4,1,I,,20231114.0,20231122,20231122,EXP,,BE-ALVOGEN-2023092591,ALVOGEN,"Thijs S, Balti E, Degraeve C, Coremans P. lsomorphic (Koebner) Phenomenon Induced by Insulin Analogue Injections in Psoriasis. JCEM Case Reports. 2023;1 (1):1-3. doi:https://d0i.org/10.1210/jcemcr/luac0l6",56.0,YR,,F,Y,,,20231122,,HP,BE,BE,2023,Q4,Adult
232195981,23219598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,,20231110.0,20231122,20231122,EXP,,US-ELI_LILLY_AND_COMPANY-US202311007330,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20231122,,CN,US,US,2023,Q4,Elderly
232195981,23219598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231110.0,20231122,20231122,EXP,,US-ELI_LILLY_AND_COMPANY-US202311007330,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20231122,,CN,US,US,2023,Q4,Elderly
232216971,23221697,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,,,,67.2,IU,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232216971,23221697,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,,,,67.2,IU,Solution for injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232216971,23221697,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,,,,67.2,IU,Solution for injection,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232216971,23221697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,D655857C,,,67.2,IU,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232216971,23221697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,D655857C,,,67.2,IU,Solution for injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232216971,23221697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,D655857C,,,67.2,IU,Solution for injection,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232216971,23221697,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,D648424C,,,67.2,IU,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232216971,23221697,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,D648424C,,,67.2,IU,Solution for injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232216971,23221697,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"67.2 u, unknown",,,,,D648424C,,,67.2,IU,Solution for injection,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20231030.0,20231120.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311012865,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232219722,23221972,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown",,,U,,D546652A,,20563.0,10.0,IU,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown",,,U,,D546652A,,20563.0,10.0,IU,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown",,,U,,D546652A,,20563.0,10.0,IU,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown",,,U,,D546652A,,20563.0,10.0,IU,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown",,,U,,D546652A,,20563.0,10.0,IU,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown",,,U,,D546652A,,20563.0,10.0,IU,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232219722,23221972,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231121.0,20231127.0,20231123,20231129,PER,,US-ELI_LILLY_AND_COMPANY-US202311013636,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20231129,,CN,US,US,2023,Q4,Adult
232224971,23222497,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding Scale,,,,,D609625D,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231101.0,20231122.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311013667,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232224971,23222497,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding Scale,,,,,D609625D,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231101.0,20231122.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311013667,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232224971,23222497,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231101.0,20231122.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311013667,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232224971,23222497,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231101.0,20231122.0,20231123,20231123,PER,,US-ELI_LILLY_AND_COMPANY-US202311013667,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20231123,,CN,US,US,2023,Q4,Elderly
232225091,23222509,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 UNITS, (before meals)",,,,,,,,,,Unknown,,2023,Q4,Off label use,,2023,Q4,1,I,,20231114.0,20231123,20231123,EXP,,US-ENDO PHARMACEUTICALS INC-2023-005821,ENDO,"Mishriky BM, Cummings DM, Powell JR. Amantadine induced Severe Hypoglycemia in a patient with Type 1 Diabetes and Multiple Sclerosis. Journal of the Endocrine Society. 2020;4:A101",34.0,YR,,M,Y,88.0,KG,20231123,,MD,US,US,2023,Q4,Young Adult
232225091,23222509,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 UNITS, (before meals)",,,,,,,,,,Unknown,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231114.0,20231123,20231123,EXP,,US-ENDO PHARMACEUTICALS INC-2023-005821,ENDO,"Mishriky BM, Cummings DM, Powell JR. Amantadine induced Severe Hypoglycemia in a patient with Type 1 Diabetes and Multiple Sclerosis. Journal of the Endocrine Society. 2020;4:A101",34.0,YR,,M,Y,88.0,KG,20231123,,MD,US,US,2023,Q4,Young Adult
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Oedema,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Pulmonary oedema,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Abdominal pain,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Oedema peripheral,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Non-cardiac chest pain,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Face oedema,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Abdominal distension,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Localised oedema,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Periorbital oedema,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232228211,23222821,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Multiple daily injection regimen,,,,,,,,,,,,2023,Q4,Orthopnoea,,2023,Q4,1,I,,20231113.0,20231123,20231123,EXP,,US-BAXTER-2023BAX035968,BAXTER,,14.0,YR,,F,Y,56.7,KG,20231123,,HP,US,US,2023,Q4,Youth
232231151,23223115,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Post procedural complication,,2023,Q4,1,I,,20231117.0,20231123,20231123,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273440",BOEHRINGER INGELHEIM,"Vaghasia N, Bononi P, Custodio P. Diabetes and Glucose Metabolism ODP195 Euglycemic diabetic ketoacidosis after bariatric surgery in association with use of SGLT2i.. Journal of the Endocrine Society. 2022;6 (1): 312. doi:10.1210/jendso/bvac150.647.",43.0,YR,A,M,Y,,,20231123,,MD,US,US,2023,Q4,Adult
232231151,23223115,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Euglycaemic diabetic ketoacidosis,,2023,Q4,1,I,,20231117.0,20231123,20231123,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-273440",BOEHRINGER INGELHEIM,"Vaghasia N, Bononi P, Custodio P. Diabetes and Glucose Metabolism ODP195 Euglycemic diabetic ketoacidosis after bariatric surgery in association with use of SGLT2i.. Journal of the Endocrine Society. 2022;6 (1): 312. doi:10.1210/jendso/bvac150.647.",43.0,YR,A,M,Y,,,20231123,,MD,US,US,2023,Q4,Adult
232232661,23223266,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 international unit,,,U,,202207011,,,6.0,IU,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,20231111.0,20231113.0,20231123,20231123,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202311013241,ELI LILLY AND CO,,75.0,YR,,M,Y,60.0,KG,20231123,,CN,CN,CN,2023,Q4,Elderly
232232661,23223266,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 international unit,,,U,,202207011,,,6.0,IU,,,2023,Q4,Blood glucose abnormal,,2023,Q4,1,I,20231111.0,20231113.0,20231123,20231123,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202311013241,ELI LILLY AND CO,,75.0,YR,,M,Y,60.0,KG,20231123,,CN,CN,CN,2023,Q4,Elderly
232239631,23223963,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"110 U, TID",,,U,,,,,,,Solution for injection,Q8H,2023,Q4,Disability,,2023,Q4,1,I,,20231115.0,20231124,20231124,EXP,,US-SA-2023SA359404,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20231124,,MD,US,US,2023,Q4,Adult
232255971,23225597,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Pneumonia haemophilus,,2023,Q4,1,I,,20231115.0,20231124,20231124,EXP,,CA-ROCHE-3458863,ROCHE,,73.0,YR,,F,Y,192.0,KG,20231124,,HP,CA,,2023,Q4,Elderly
232255971,23225597,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Erosive oesophagitis,,2023,Q4,1,I,,20231115.0,20231124,20231124,EXP,,CA-ROCHE-3458863,ROCHE,,73.0,YR,,F,Y,192.0,KG,20231124,,HP,CA,,2023,Q4,Elderly
232255971,23225597,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Reactive gastropathy,,2023,Q4,1,I,,20231115.0,20231124,20231124,EXP,,CA-ROCHE-3458863,ROCHE,,73.0,YR,,F,Y,192.0,KG,20231124,,HP,CA,,2023,Q4,Elderly
232255971,23225597,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,1,I,,20231115.0,20231124,20231124,EXP,,CA-ROCHE-3458863,ROCHE,,73.0,YR,,F,Y,192.0,KG,20231124,,HP,CA,,2023,Q4,Elderly
232255971,23225597,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Transfusion,,2023,Q4,1,I,,20231115.0,20231124,20231124,EXP,,CA-ROCHE-3458863,ROCHE,,73.0,YR,,F,Y,192.0,KG,20231124,,HP,CA,,2023,Q4,Elderly
232255971,23225597,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Pneumonia,,2023,Q4,1,I,,20231115.0,20231124,20231124,EXP,,CA-ROCHE-3458863,ROCHE,,73.0,YR,,F,Y,192.0,KG,20231124,,HP,CA,,2023,Q4,Elderly
232255971,23225597,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Duodenal ulcer,,2023,Q4,1,I,,20231115.0,20231124,20231124,EXP,,CA-ROCHE-3458863,ROCHE,,73.0,YR,,F,Y,192.0,KG,20231124,,HP,CA,,2023,Q4,Elderly
232260572,23226057,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q4,Dizziness,,2023,Q4,2,F,20230519.0,20231212.0,20231124,20231226,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67171,HIKMA,,67.0,YR,,F,Y,122.4,KG,20231226,,HP,US,US,2023,Q4,Elderly
232260572,23226057,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q4,Vertigo positional,,2023,Q4,2,F,20230519.0,20231212.0,20231124,20231226,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67171,HIKMA,,67.0,YR,,F,Y,122.4,KG,20231226,,HP,US,US,2023,Q4,Elderly
232260572,23226057,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q4,Peripheral swelling,,2023,Q4,2,F,20230519.0,20231212.0,20231124,20231226,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67171,HIKMA,,67.0,YR,,F,Y,122.4,KG,20231226,,HP,US,US,2023,Q4,Elderly
232260572,23226057,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q4,Pain in extremity,,2023,Q4,2,F,20230519.0,20231212.0,20231124,20231226,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67171,HIKMA,,67.0,YR,,F,Y,122.4,KG,20231226,,HP,US,US,2023,Q4,Elderly
232260572,23226057,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2023,Q4,Muscular weakness,,2023,Q4,2,F,20230519.0,20231212.0,20231124,20231226,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-23-67171,HIKMA,,67.0,YR,,F,Y,122.4,KG,20231226,,HP,US,US,2023,Q4,Elderly
232285721,23228572,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 IU international unit(s) (before meals ),,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231115.0,20231125,20231125,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017506,STRIDES,"Mishriky BM, Cummings DM, Powell JR.. Amantadine Induced Severe Hypoglycemia in a Patient With Type 1 Diabetes and Multiple Sclerosis. J-Endocr-Soc. 2020;4 (Suppl. 1):A101 abstr. SAT-689.",34.0,YR,,M,Y,,,20231125,,MD,US,US,2023,Q4,Young Adult
232285721,23228572,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 IU international unit(s) (before meals ),,,,,,,,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231115.0,20231125,20231125,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017506,STRIDES,"Mishriky BM, Cummings DM, Powell JR.. Amantadine Induced Severe Hypoglycemia in a Patient With Type 1 Diabetes and Multiple Sclerosis. J-Endocr-Soc. 2020;4 (Suppl. 1):A101 abstr. SAT-689.",34.0,YR,,M,Y,,,20231125,,MD,US,US,2023,Q4,Young Adult
232285721,23228572,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 IU international unit(s),,,,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231115.0,20231125,20231125,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017506,STRIDES,"Mishriky BM, Cummings DM, Powell JR.. Amantadine Induced Severe Hypoglycemia in a Patient With Type 1 Diabetes and Multiple Sclerosis. J-Endocr-Soc. 2020;4 (Suppl. 1):A101 abstr. SAT-689.",34.0,YR,,M,Y,,,20231125,,MD,US,US,2023,Q4,Young Adult
232285721,23228572,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 IU international unit(s),,,,,,,,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231115.0,20231125,20231125,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017506,STRIDES,"Mishriky BM, Cummings DM, Powell JR.. Amantadine Induced Severe Hypoglycemia in a Patient With Type 1 Diabetes and Multiple Sclerosis. J-Endocr-Soc. 2020;4 (Suppl. 1):A101 abstr. SAT-689.",34.0,YR,,M,Y,,,20231125,,MD,US,US,2023,Q4,Young Adult
232309961,23230996,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231115.0,20231127,20231127,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420395,RANBAXY,"Panjawatanan P, Jha S, Hughes J, Riesenfeld E. A Case of Concomitant COVID-19 Infection- Induced Acute Respiratory Distress Syndrome and Diabetic Ketoacidosis: Another Challenge in Fluid Management. J Endocrine Soc. 2021;5(Suppl.):A357-A358",59.0,YR,,M,Y,,,20231127,,MD,US,US,2023,Q4,Adult
232309961,23230996,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231115.0,20231127,20231127,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-420395,RANBAXY,"Panjawatanan P, Jha S, Hughes J, Riesenfeld E. A Case of Concomitant COVID-19 Infection- Induced Acute Respiratory Distress Syndrome and Diabetic Ketoacidosis: Another Challenge in Fluid Management. J Endocrine Soc. 2021;5(Suppl.):A357-A358",59.0,YR,,M,Y,,,20231127,,MD,US,US,2023,Q4,Adult
232329831,23232983,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231115.0,20231128,20231128,EXP,,US-drreddys-LIT/USA/23/0187152,DR REDDYS,"Panjawatanan P, Jha S, Hughes J, Riesenfeld E. A Case of Concomitant COVID-19 Infection- Induced Acute Respiratory Distress Syndrome and Diabetic Ketoacidosis: Another Challenge in Fluid Management. Journal of the Endocrine Society. 2021;5:. doi:/10.1210/jendso/bvab048.727",59.0,YR,A,M,Y,,,20231128,,HP,US,US,2023,Q4,Adult
232329831,23232983,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2023,Q4,Acute respiratory distress syndrome,,2023,Q4,1,I,,20231115.0,20231128,20231128,EXP,,US-drreddys-LIT/USA/23/0187152,DR REDDYS,"Panjawatanan P, Jha S, Hughes J, Riesenfeld E. A Case of Concomitant COVID-19 Infection- Induced Acute Respiratory Distress Syndrome and Diabetic Ketoacidosis: Another Challenge in Fluid Management. Journal of the Endocrine Society. 2021;5:. doi:/10.1210/jendso/bvab048.727",59.0,YR,A,M,Y,,,20231128,,HP,US,US,2023,Q4,Adult
232336491,23233649,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units,,,,,,,,,,Not provided,QD,2023,Q4,Product use in unapproved indication,,2023,Q4,1,I,,20231114.0,20231128,20231128,EXP,,US-ADAMAS Pharma-ADM202311-004546,ADAMAS PHARMA,,34.0,YR,,M,Y,88.0,KG,20231128,,HP,US,,2023,Q4,Young Adult
232336491,23233649,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units,,,,,,,,,,Not provided,QD,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231114.0,20231128,20231128,EXP,,US-ADAMAS Pharma-ADM202311-004546,ADAMAS PHARMA,,34.0,YR,,M,Y,88.0,KG,20231128,,HP,US,,2023,Q4,Young Adult
232336491,23233649,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units,,,,,,,,,,Not provided,QD,2023,Q4,Product use in unapproved indication,,2023,Q4,1,I,,20231114.0,20231128,20231128,EXP,,US-ADAMAS Pharma-ADM202311-004546,ADAMAS PHARMA,,34.0,YR,,M,Y,88.0,KG,20231128,,HP,US,,2023,Q4,Young Adult
232336491,23233649,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units,,,,,,,,,,Not provided,QD,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231114.0,20231128,20231128,EXP,,US-ADAMAS Pharma-ADM202311-004546,ADAMAS PHARMA,,34.0,YR,,M,Y,88.0,KG,20231128,,HP,US,,2023,Q4,Young Adult
232354021,23235402,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD; 8-9 IU x 3/DAY",,,U,,,,,,,,QD,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,20231008.0,20231120.0,20231128,20231128,EXP,IT-MINISAL02-954572,IT-SA-2023SA363384,SANOFI AVENTIS,,19.0,YR,A,M,Y,,,20231128,,MD,IT,IT,2023,Q4,Youth
232372441,23237244,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 iU, daily",,,,,Unknown,,,8.0,IU,,,2023,Q4,Liver injury,,2023,Q4,1,I,,20231120.0,20231128,20231128,EXP,,BE-PFIZER INC-202300385669,PFIZER,"Thijs, S.. Isomorphic (Koebner) Phenomenon Induced by Insulin Analogue Injections in Psoriasis.. JCEM Case Reports. 2023;1:1-3",56.0,YR,,F,Y,,,20231128,,HP,BE,BE,2023,Q4,Adult
232401951,23240195,12,C,Insulin lispro 100 u/ml,,2,,,,,,,,,,,,,,2023,Q4,Malaise,,2023,Q4,1,I,20231126.0,,20231128,20231128,DIR,682631,,FDA-CTU,,79.0,YR,,F,N,,,20231128,N,PH,US,,2023,Q4,Elderly
232410431,23241043,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, qd, Received multiple daily injection regimen",,,U,U,,,,,,Injection,QD,2023,Q4,Oedema,,2023,Q4,1,I,,20231115.0,20231129,20231129,EXP,,US-MYLANLABS-2023M1124153,MYLAN,"Pauley ME, Tan S, Sikand G, Cobry EC. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes. Clin-Diabet 2022; 40 (2): 253-256.",14.0,YR,,F,Y,,,20231127,,HP,US,US,2023,Q4,Youth
232410431,23241043,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, qd, Received multiple daily injection regimen",,,U,U,,,,,,Injection,QD,2023,Q4,Off label use,,2023,Q4,1,I,,20231115.0,20231129,20231129,EXP,,US-MYLANLABS-2023M1124153,MYLAN,"Pauley ME, Tan S, Sikand G, Cobry EC. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes. Clin-Diabet 2022; 40 (2): 253-256.",14.0,YR,,F,Y,,,20231127,,HP,US,US,2023,Q4,Youth
232410431,23241043,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, qd, Received multiple daily injection regimen",,,U,U,,,,,,Injection,QD,2023,Q4,Pericardial effusion,,2023,Q4,1,I,,20231115.0,20231129,20231129,EXP,,US-MYLANLABS-2023M1124153,MYLAN,"Pauley ME, Tan S, Sikand G, Cobry EC. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes. Clin-Diabet 2022; 40 (2): 253-256.",14.0,YR,,F,Y,,,20231127,,HP,US,US,2023,Q4,Youth
232410431,23241043,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, qd, Received multiple daily injection regimen",,,U,U,,,,,,Injection,QD,2023,Q4,Pleural effusion,,2023,Q4,1,I,,20231115.0,20231129,20231129,EXP,,US-MYLANLABS-2023M1124153,MYLAN,"Pauley ME, Tan S, Sikand G, Cobry EC. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes. Clin-Diabet 2022; 40 (2): 253-256.",14.0,YR,,F,Y,,,20231127,,HP,US,US,2023,Q4,Youth
232410431,23241043,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, qd, Received multiple daily injection regimen",,,U,U,,,,,,Injection,QD,2023,Q4,Hypokalaemia,,2023,Q4,1,I,,20231115.0,20231129,20231129,EXP,,US-MYLANLABS-2023M1124153,MYLAN,"Pauley ME, Tan S, Sikand G, Cobry EC. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes. Clin-Diabet 2022; 40 (2): 253-256.",14.0,YR,,F,Y,,,20231127,,HP,US,US,2023,Q4,Youth
232410431,23241043,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, qd, Received multiple daily injection regimen",,,U,U,,,,,,Injection,QD,2023,Q4,Weight increased,,2023,Q4,1,I,,20231115.0,20231129,20231129,EXP,,US-MYLANLABS-2023M1124153,MYLAN,"Pauley ME, Tan S, Sikand G, Cobry EC. Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes. Clin-Diabet 2022; 40 (2): 253-256.",14.0,YR,,F,Y,,,20231127,,HP,US,US,2023,Q4,Youth
232420541,23242054,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 iU, TID",,,N,,Unknown,,209196.0,24.0,IU,Solution for injection,Q8H,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231121.0,20231129,20231129,EXP,,GB-SA-2023SA364941,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20231129,,HP,GB,GB,2023,Q4,Young Adult
232420541,23242054,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 iU, TID",,,N,,Unknown,,209196.0,24.0,IU,Solution for injection,Q8H,2023,Q4,Blood insulin increased,,2023,Q4,1,I,,20231121.0,20231129,20231129,EXP,,GB-SA-2023SA364941,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20231129,,HP,GB,GB,2023,Q4,Young Adult
232420541,23242054,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 iU, TID",,,N,,Unknown,,209196.0,24.0,IU,Solution for injection,Q8H,2023,Q4,Insulin C-peptide decreased,,2023,Q4,1,I,,20231121.0,20231129,20231129,EXP,,GB-SA-2023SA364941,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20231129,,HP,GB,GB,2023,Q4,Young Adult
232420541,23242054,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 iU, TID",,,N,,Unknown,,209196.0,24.0,IU,Solution for injection,Q8H,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,1,I,,20231121.0,20231129,20231129,EXP,,GB-SA-2023SA364941,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20231129,,HP,GB,GB,2023,Q4,Young Adult
232420541,23242054,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"24 iU, TID",,,N,,Unknown,,209196.0,24.0,IU,Solution for injection,Q8H,2023,Q4,Insulinoma,,2023,Q4,1,I,,20231121.0,20231129,20231129,EXP,,GB-SA-2023SA364941,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20231129,,HP,GB,GB,2023,Q4,Young Adult
232424152,23242415,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Chills,,2023,Q4,2,F,20231031.0,20231129.0,20231129,20231205,EXP,,JP-PFIZER INC-PV202300184862,PFIZER,,76.0,YR,,M,Y,56.0,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
232424152,23242415,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Melaena,,2023,Q4,2,F,20231031.0,20231129.0,20231129,20231205,EXP,,JP-PFIZER INC-PV202300184862,PFIZER,,76.0,YR,,M,Y,56.0,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
232424152,23242415,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Pyrexia,,2023,Q4,2,F,20231031.0,20231129.0,20231129,20231205,EXP,,JP-PFIZER INC-PV202300184862,PFIZER,,76.0,YR,,M,Y,56.0,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
232424152,23242415,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Loss of consciousness,,2023,Q4,2,F,20231031.0,20231129.0,20231129,20231205,EXP,,JP-PFIZER INC-PV202300184862,PFIZER,,76.0,YR,,M,Y,56.0,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
232424152,23242415,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Gastrointestinal haemorrhage,,2023,Q4,2,F,20231031.0,20231129.0,20231129,20231205,EXP,,JP-PFIZER INC-PV202300184862,PFIZER,,76.0,YR,,M,Y,56.0,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
232424152,23242415,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Cardiac failure congestive,,2023,Q4,2,F,20231031.0,20231129.0,20231129,20231205,EXP,,JP-PFIZER INC-PV202300184862,PFIZER,,76.0,YR,,M,Y,56.0,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
232424152,23242415,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2023,Q4,Haemorrhoids,,2023,Q4,2,F,20231031.0,20231129.0,20231129,20231205,EXP,,JP-PFIZER INC-PV202300184862,PFIZER,,76.0,YR,,M,Y,56.0,KG,20231205,,MD,JP,JP,2023,Q4,Elderly
232457331,23245733,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Liver function test increased,,2023,Q4,1,I,20231127.0,,20231129,20231129,DIR,682793,,FDA-CTU,,91.0,YR,,M,N,82.9,KG,20231129,N,PH,US,,2023,Q4,Elderly
232469171,23246917,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Unknown,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231122.0,20231130,20231130,EXP,,US-MYLANLABS-2023M1126832,MYLAN,"El Musa Penna L, Rivera MO, Burgos AR, Marin LM, Nieves YR, Cordero NH, et al. SGLT2 Inhibitor-Induced Euglycemic DKA and its Challenges. J-Endocr-Soc 2022; 6 (Suppl. 1) A333-A334 abstr. ODP244.",61.0,YR,,M,Y,,,20231130,,MD,US,US,2023,Q4,Adult
232480221,23248022,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose and frequency unknown,,,,,,,,,,,,2023,Q4,Hypertension,,2023,Q4,1,I,20220601.0,20231122.0,20231130,20231130,PER,,JP-Eisai-EC-2022-119234,EISAI,,70.0,YR,E,M,Y,,,20231130,,MD,JP,JP,2023,Q4,Elderly
232480501,23248050,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, unknown",,,U,,D455780C,,20563.0,5.0,IU,Injection,,2023,Q4,Pneumonia,,2023,Q4,1,I,20230801.0,20231121.0,20231130,20231130,EXP,,US-ELI_LILLY_AND_COMPANY-US202311013342,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20231130,,CN,US,US,2023,Q4,Elderly
232480501,23248050,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, unknown",,,U,,D455780C,,20563.0,5.0,IU,Injection,,2023,Q4,Decreased appetite,,2023,Q4,1,I,20230801.0,20231121.0,20231130,20231130,EXP,,US-ELI_LILLY_AND_COMPANY-US202311013342,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20231130,,CN,US,US,2023,Q4,Elderly
232480501,23248050,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, unknown",,,U,,D455780C,,20563.0,5.0,IU,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20230801.0,20231121.0,20231130,20231130,EXP,,US-ELI_LILLY_AND_COMPANY-US202311013342,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20231130,,CN,US,US,2023,Q4,Elderly
232480501,23248050,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, unknown",,,U,,D455780C,,20563.0,5.0,IU,Injection,,2023,Q4,Colitis,,2023,Q4,1,I,20230801.0,20231121.0,20231130,20231130,EXP,,US-ELI_LILLY_AND_COMPANY-US202311013342,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20231130,,CN,US,US,2023,Q4,Elderly
232480501,23248050,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, unknown",,,U,,D455780C,,20563.0,5.0,IU,Injection,,2023,Q4,Diverticulitis,,2023,Q4,1,I,20230801.0,20231121.0,20231130,20231130,EXP,,US-ELI_LILLY_AND_COMPANY-US202311013342,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20231130,,CN,US,US,2023,Q4,Elderly
232480501,23248050,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, unknown",,,U,,D455780C,,20563.0,5.0,IU,Injection,,2023,Q4,Sepsis,,2023,Q4,1,I,20230801.0,20231121.0,20231130,20231130,EXP,,US-ELI_LILLY_AND_COMPANY-US202311013342,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20231130,,CN,US,US,2023,Q4,Elderly
232480501,23248050,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, unknown",,,U,,D455780C,,20563.0,5.0,IU,Injection,,2023,Q4,Blood pressure increased,,2023,Q4,1,I,20230801.0,20231121.0,20231130,20231130,EXP,,US-ELI_LILLY_AND_COMPANY-US202311013342,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20231130,,CN,US,US,2023,Q4,Elderly
232511181,23251118,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose and frequency unknown,,,,,,,,,,,,2023,Q4,Haematuria,,2023,Q4,1,I,20230208.0,20231122.0,20231201,20231201,PER,,JP-Eisai-EC-2023-137529,EISAI,,70.0,YR,E,M,Y,,,20231201,,MD,JP,JP,2023,Q4,Elderly
232546611,23254661,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Vision blurred,,2023,Q4,1,I,20231127.0,20231130.0,20231203,20231203,PER,,US-ELI_LILLY_AND_COMPANY-US202312000207,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20231203,,CN,US,US,2023,Q4,Elderly
232546611,23254661,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231127.0,20231130.0,20231203,20231203,PER,,US-ELI_LILLY_AND_COMPANY-US202312000207,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20231203,,CN,US,US,2023,Q4,Elderly
232546611,23254661,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231127.0,20231130.0,20231203,20231203,PER,,US-ELI_LILLY_AND_COMPANY-US202312000207,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20231203,,CN,US,US,2023,Q4,Elderly
232546611,23254661,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D546652A,,20563.0,,,Injection,,2023,Q4,Product storage error,,2023,Q4,1,I,20231127.0,20231130.0,20231203,20231203,PER,,US-ELI_LILLY_AND_COMPANY-US202312000207,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20231203,,CN,US,US,2023,Q4,Elderly
232546801,23254680,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2023,Q4,Hyperglycaemia,,2023,Q4,1,I,,20231122.0,20231203,20231203,EXP,,US-AUROBINDO-AUR-APL-2023-074631,AUROBINDO,"Alkhatib EH, Grundman JB, Adamusiak AM, Bellin MD, Brooks JP, Buckley KS, et al.. Case Report: Insulin hypersensitivity in youth with type 1 diabetes.. Frontiers in Endocrinology. 2023;14:1226231",1.0,DEC,,F,Y,,,20231203,,MD,US,US,2023,Q4,Child
232550471,23255047,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(U-100) 100 unit/ml,,,,,,,,,,,,2023,Q4,Lip dry,,2023,Q4,1,I,20230210.0,20230222.0,20231203,20231203,EXP,,US-AMNEAL PHARMACEUTICALS-2023-AMRX-00683,AMNEAL,,15.0,YR,,F,Y,,,20231203,,MD,US,US,2023,Q4,Youth
232550471,23255047,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(U-100) 100 unit/ml,,,,,,,,,,,,2023,Q4,Dry skin,,2023,Q4,1,I,20230210.0,20230222.0,20231203,20231203,EXP,,US-AMNEAL PHARMACEUTICALS-2023-AMRX-00683,AMNEAL,,15.0,YR,,F,Y,,,20231203,,MD,US,US,2023,Q4,Youth
232550471,23255047,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(U-100) 100 unit/ml,,,,,,,,,,,,2023,Q4,Nasal dryness,,2023,Q4,1,I,20230210.0,20230222.0,20231203,20231203,EXP,,US-AMNEAL PHARMACEUTICALS-2023-AMRX-00683,AMNEAL,,15.0,YR,,F,Y,,,20231203,,MD,US,US,2023,Q4,Youth
232550471,23255047,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(U-100) 100 unit/ml,,,,,,,,,,,,2023,Q4,Chapped lips,,2023,Q4,1,I,20230210.0,20230222.0,20231203,20231203,EXP,,US-AMNEAL PHARMACEUTICALS-2023-AMRX-00683,AMNEAL,,15.0,YR,,F,Y,,,20231203,,MD,US,US,2023,Q4,Youth
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Thyroid disorder,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Cardiac failure congestive,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pulmonary oedema,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Malnutrition,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pericardial effusion,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Neuropathy peripheral,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Headache,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Multi-organ disorder,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Arthritis,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Myalgia,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Chest pain,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Eye haemorrhage,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232556681,23255668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,,20231124.0,20231203,20231203,EXP,,CA-SA-2023SA369223,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231204,,CN,CA,CA,2023,Q4,Adult
232559021,23255902,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 UNITS, premeal",,,D,,,,,,,,,2023,Q4,Influenza,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017876,STRIDES,"Iqbal I, Khan MAA, Ahmad M, Mehreen R.. Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab.. J-Endocr-Soc. 2023;7 (Suppl.1):A434-A435abstr.THU374",66.0,YR,,F,Y,,,20231204,,MD,US,US,2023,Q4,Elderly
232559021,23255902,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 UNITS, premeal",,,D,,,,,,,,,2023,Q4,Anxiety,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017876,STRIDES,"Iqbal I, Khan MAA, Ahmad M, Mehreen R.. Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab.. J-Endocr-Soc. 2023;7 (Suppl.1):A434-A435abstr.THU374",66.0,YR,,F,Y,,,20231204,,MD,US,US,2023,Q4,Elderly
232559021,23255902,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 UNITS, premeal",,,D,,,,,,,,,2023,Q4,Restlessness,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017876,STRIDES,"Iqbal I, Khan MAA, Ahmad M, Mehreen R.. Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab.. J-Endocr-Soc. 2023;7 (Suppl.1):A434-A435abstr.THU374",66.0,YR,,F,Y,,,20231204,,MD,US,US,2023,Q4,Elderly
232559021,23255902,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 UNITS, premeal",,,D,,,,,,,,,2023,Q4,Death,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017876,STRIDES,"Iqbal I, Khan MAA, Ahmad M, Mehreen R.. Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab.. J-Endocr-Soc. 2023;7 (Suppl.1):A434-A435abstr.THU374",66.0,YR,,F,Y,,,20231204,,MD,US,US,2023,Q4,Elderly
232559021,23255902,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 UNITS, premeal",,,D,,,,,,,,,2023,Q4,Staphylococcal bacteraemia,,2023,Q4,1,I,,20231122.0,20231204,20231204,EXP,,US-STRIDES ARCOLAB LIMITED-2023SP017876,STRIDES,"Iqbal I, Khan MAA, Ahmad M, Mehreen R.. Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab.. J-Endocr-Soc. 2023;7 (Suppl.1):A434-A435abstr.THU374",66.0,YR,,F,Y,,,20231204,,MD,US,US,2023,Q4,Elderly
232567522,23256752,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163G,,20563.0,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,2,F,20231201.0,20231201.0,20231204,20231220,PER,,US-ELI_LILLY_AND_COMPANY-US202312000760,ELI LILLY AND CO,,91.0,YR,,F,Y,,,20231220,,CN,US,US,2023,Q4,Elderly
232567522,23256752,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D580163G,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231201.0,20231201.0,20231204,20231220,PER,,US-ELI_LILLY_AND_COMPANY-US202312000760,ELI LILLY AND CO,,91.0,YR,,F,Y,,,20231220,,CN,US,US,2023,Q4,Elderly
232578841,23257884,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,,,,U,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,1,I,20201111.0,20231120.0,20231204,20231204,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101214,BRISTOL MYERS SQUIBB,,73.0,YR,E,F,Y,86.0,KG,20231204,,HP,US,US,2023,Q4,Elderly
232578841,23257884,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,,,,U,,,,,,,,,2023,Q4,Colitis,,2023,Q4,1,I,20201111.0,20231120.0,20231204,20231204,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101214,BRISTOL MYERS SQUIBB,,73.0,YR,E,F,Y,86.0,KG,20231204,,HP,US,US,2023,Q4,Elderly
232578841,23257884,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,COVID-19,,2023,Q4,1,I,20201111.0,20231120.0,20231204,20231204,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101214,BRISTOL MYERS SQUIBB,,73.0,YR,E,F,Y,86.0,KG,20231204,,HP,US,US,2023,Q4,Elderly
232578841,23257884,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Colitis,,2023,Q4,1,I,20201111.0,20231120.0,20231204,20231204,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101214,BRISTOL MYERS SQUIBB,,73.0,YR,E,F,Y,86.0,KG,20231204,,HP,US,US,2023,Q4,Elderly
232580791,23258079,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Chronic kidney disease,,2023,Q4,1,I,20221201.0,20231128.0,20231204,20231204,EXP,,US-TAKEDA-2023TUS018262,TAKEDA,,75.0,YR,,M,Y,,,20231204,,HP,US,US,2023,Q4,Elderly
232580791,23258079,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Wrong technique in device usage process,,2023,Q4,1,I,20221201.0,20231128.0,20231204,20231204,EXP,,US-TAKEDA-2023TUS018262,TAKEDA,,75.0,YR,,M,Y,,,20231204,,HP,US,US,2023,Q4,Elderly
232580791,23258079,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20221201.0,20231128.0,20231204,20231204,EXP,,US-TAKEDA-2023TUS018262,TAKEDA,,75.0,YR,,M,Y,,,20231204,,HP,US,US,2023,Q4,Elderly
232580791,23258079,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Syringe issue,,2023,Q4,1,I,20221201.0,20231128.0,20231204,20231204,EXP,,US-TAKEDA-2023TUS018262,TAKEDA,,75.0,YR,,M,Y,,,20231204,,HP,US,US,2023,Q4,Elderly
232584051,23258405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, BID",4536.0,IU,,,,,,12.0,IU,Injection,BID,2023,Q4,Headache,,2023,Q4,1,I,20230808.0,20231128.0,20231204,20231204,EXP,,CN-BAYER-2023A173262,BAYER,,73.0,YR,E,M,Y,65.0,KG,20231204,,HP,CN,CN,2023,Q4,Elderly
232584051,23258405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, BID",4536.0,IU,,,,,,12.0,IU,Injection,BID,2023,Q4,Amaurosis fugax,,2023,Q4,1,I,20230808.0,20231128.0,20231204,20231204,EXP,,CN-BAYER-2023A173262,BAYER,,73.0,YR,E,M,Y,65.0,KG,20231204,,HP,CN,CN,2023,Q4,Elderly
232584051,23258405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, BID",4536.0,IU,,,,,,12.0,IU,Injection,BID,2023,Q4,Dizziness,,2023,Q4,1,I,20230808.0,20231128.0,20231204,20231204,EXP,,CN-BAYER-2023A173262,BAYER,,73.0,YR,E,M,Y,65.0,KG,20231204,,HP,CN,CN,2023,Q4,Elderly
232584051,23258405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, BID",4536.0,IU,,,,,,12.0,IU,Injection,BID,2023,Q4,Cold sweat,,2023,Q4,1,I,20230808.0,20231128.0,20231204,20231204,EXP,,CN-BAYER-2023A173262,BAYER,,73.0,YR,E,M,Y,65.0,KG,20231204,,HP,CN,CN,2023,Q4,Elderly
232584051,23258405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, BID",4536.0,IU,,,,,,12.0,IU,Injection,BID,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,20230808.0,20231128.0,20231204,20231204,EXP,,CN-BAYER-2023A173262,BAYER,,73.0,YR,E,M,Y,65.0,KG,20231204,,HP,CN,CN,2023,Q4,Elderly
232584051,23258405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, BID",4536.0,IU,,,,,,12.0,IU,Injection,BID,2023,Q4,Pallor,,2023,Q4,1,I,20230808.0,20231128.0,20231204,20231204,EXP,,CN-BAYER-2023A173262,BAYER,,73.0,YR,E,M,Y,65.0,KG,20231204,,HP,CN,CN,2023,Q4,Elderly
232587981,23258798,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 iU, TID",,,Y,,202112020,,,16.0,IU,Solution for injection,Q8H,2023,Q4,Cold sweat,,2023,Q4,1,I,20231120.0,20231123.0,20231204,20231204,EXP,,CN-SA-2023SA371553,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20231204,,HP,CN,CN,2023,Q4,Adult
232587981,23258798,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 iU, TID",,,Y,,202112020,,,16.0,IU,Solution for injection,Q8H,2023,Q4,Loss of consciousness,,2023,Q4,1,I,20231120.0,20231123.0,20231204,20231204,EXP,,CN-SA-2023SA371553,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20231204,,HP,CN,CN,2023,Q4,Adult
232587981,23258798,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 iU, TID",,,Y,,202112020,,,16.0,IU,Solution for injection,Q8H,2023,Q4,Hypoglycaemic coma,,2023,Q4,1,I,20231120.0,20231123.0,20231204,20231204,EXP,,CN-SA-2023SA371553,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20231204,,HP,CN,CN,2023,Q4,Adult
232587981,23258798,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 iU, TID",,,Y,,202112020,,,16.0,IU,Solution for injection,Q8H,2023,Q4,Palpitations,,2023,Q4,1,I,20231120.0,20231123.0,20231204,20231204,EXP,,CN-SA-2023SA371553,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20231204,,HP,CN,CN,2023,Q4,Adult
232587981,23258798,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 iU, TID",,,Y,,202112020,,,16.0,IU,Solution for injection,Q8H,2023,Q4,Chest discomfort,,2023,Q4,1,I,20231120.0,20231123.0,20231204,20231204,EXP,,CN-SA-2023SA371553,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20231204,,HP,CN,CN,2023,Q4,Adult
232587981,23258798,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 iU, TID",,,Y,,202112020,,,16.0,IU,Solution for injection,Q8H,2023,Q4,Blood pressure increased,,2023,Q4,1,I,20231120.0,20231123.0,20231204,20231204,EXP,,CN-SA-2023SA371553,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20231204,,HP,CN,CN,2023,Q4,Adult
232614251,23261425,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 u, daily",,,U,,D604077A,,20563.0,22.0,IU,Injection,QD,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231204.0,20231204.0,20231205,20231205,PER,,US-ELI_LILLY_AND_COMPANY-US202312001534,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20231205,,CN,US,US,2023,Q4,Elderly
232614251,23261425,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 u, daily",,,U,,D591481C,,20563.0,22.0,IU,Injection,QD,2023,Q4,Incorrect dose administered,,2023,Q4,1,I,20231204.0,20231204.0,20231205,20231205,PER,,US-ELI_LILLY_AND_COMPANY-US202312001534,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20231205,,CN,US,US,2023,Q4,Elderly
232630591,23263059,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before meals,,,,,,,,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231120.0,20231205,20231205,EXP,,"US-UPSHER-SMITH LABORATORIES, LLC-2023USL00970",UPSHER-SMITH,"Mishriky B, Cummings D, Powell J.. Amantadine Induced Severe Hypoglycemia in a Patient With Type 1 Diabetes and Multiple Sclerosis.. J. Endocr. Soc.. 2020;4:A101",34.0,YR,,M,Y,88.0,KG,20231205,,MD,US,US,2023,Q4,Young Adult
232664421,23266442,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, tid",,,,,Unknown,,,24.0,IU,,,2023,Q4,Insulin C-peptide decreased,,2023,Q4,1,I,,20231123.0,20231206,20231206,EXP,,GB-LAURUS LABS LIMITED-2023LAU000112,LAURUS LABS LIMITED,,33.0,YR,,F,Y,,,20231206,,HP,GB,GB,2023,Q4,Young Adult
232664421,23266442,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, tid",,,,,Unknown,,,24.0,IU,,,2023,Q4,Insulinoma,,2023,Q4,1,I,,20231123.0,20231206,20231206,EXP,,GB-LAURUS LABS LIMITED-2023LAU000112,LAURUS LABS LIMITED,,33.0,YR,,F,Y,,,20231206,,HP,GB,GB,2023,Q4,Young Adult
232664421,23266442,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, tid",,,,,Unknown,,,24.0,IU,,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,1,I,,20231123.0,20231206,20231206,EXP,,GB-LAURUS LABS LIMITED-2023LAU000112,LAURUS LABS LIMITED,,33.0,YR,,F,Y,,,20231206,,HP,GB,GB,2023,Q4,Young Adult
232664421,23266442,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, tid",,,,,Unknown,,,24.0,IU,,,2023,Q4,Blood insulin increased,,2023,Q4,1,I,,20231123.0,20231206,20231206,EXP,,GB-LAURUS LABS LIMITED-2023LAU000112,LAURUS LABS LIMITED,,33.0,YR,,F,Y,,,20231206,,HP,GB,GB,2023,Q4,Young Adult
232664421,23266442,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, tid",,,,,Unknown,,,24.0,IU,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231123.0,20231206,20231206,EXP,,GB-LAURUS LABS LIMITED-2023LAU000112,LAURUS LABS LIMITED,,33.0,YR,,F,Y,,,20231206,,HP,GB,GB,2023,Q4,Young Adult
232672871,23267287,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Wrong patient received product,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Wrong patient received product,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Wrong patient received product,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Maternal exposure during pregnancy,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232672871,23267287,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D594578A,,20563.0,,,Injection,,2023,Q4,Wrong patient received product,,2023,Q4,1,I,20231123.0,20231127.0,20231206,20231206,PER,,US-ELI_LILLY_AND_COMPANY-US202311016080,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20231206,,CN,US,US,2023,Q4,Adult
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Anal ulcer haemorrhage,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Paraesthesia,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Red blood cell sedimentation rate increased,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Erythema,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Joint swelling,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Oedema peripheral,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Reaction to excipient,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Lysozyme increased,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Rheumatoid arthritis,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Pulmonary embolism,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Scab,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Skin exfoliation,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Rheumatoid factor increased,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Hypersensitivity,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Fibrin D dimer increased,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232687681,23268768,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"3-10,IU,",,,U,,,,,,,,,2023,Q4,Organising pneumonia,,2023,Q4,1,I,20230120.0,20231205.0,20231206,20231206,EXP,FI-FIMEA-202301807,FI-SA-2023SA379220,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20231206,,CN,FI,FI,2023,Q4,Elderly
232708651,23270865,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Pneumonia,,2023,Q4,1,I,,20231205.0,20231207,20231207,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-176358,BRISTOL MYERS SQUIBB,,74.0,YR,E,F,Y,,,20231207,,PH,US,US,2023,Q4,Elderly
232708651,23270865,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2023,Q4,Off label use,,2023,Q4,1,I,,20231205.0,20231207,20231207,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2023-176358,BRISTOL MYERS SQUIBB,,74.0,YR,E,F,Y,,,20231207,,PH,US,US,2023,Q4,Elderly
232708771,23270877,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,Unknown,,,50.0,IU,,Q12H,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231206.0,20231207,20231207,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277022",BOEHRINGER INGELHEIM,,72.0,YR,E,F,Y,57.0,KG,20231207,,CN,CA,CA,2023,Q4,Elderly
232708771,23270877,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,Unknown,,,50.0,IU,,Q12H,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231206.0,20231207,20231207,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-277022",BOEHRINGER INGELHEIM,,72.0,YR,E,F,Y,57.0,KG,20231207,,CN,CA,CA,2023,Q4,Elderly
232716931,23271693,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Post procedural complication,,2023,Q4,1,I,20231204.0,20231206.0,20231206,20231206,DIR,FDA-CDER-CTU-2023-89488,,FDA-CTU,,58.0,YR,,F,N,81.8,KG,20231206,N,PH,US,,2023,Q4,Adult
232716931,23271693,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Hysterectomy,,2023,Q4,1,I,20231204.0,20231206.0,20231206,20231206,DIR,FDA-CDER-CTU-2023-89488,,FDA-CTU,,58.0,YR,,F,N,81.8,KG,20231206,N,PH,US,,2023,Q4,Adult
232722011,23272201,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2023,Q4,Eye irritation,,2023,Q4,1,I,,20230929.0,20231207,20231207,PER,,"US-Amphastar Pharmaceuticals, Inc.-2149070",AMPHASTAR,,55.0,YR,,F,Y,,,20231207,,CN,COUNTRY NOT SPECIFIED,US,2023,Q4,Adult
232722011,23272201,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2023,Q4,Dry eye,,2023,Q4,1,I,,20230929.0,20231207,20231207,PER,,"US-Amphastar Pharmaceuticals, Inc.-2149070",AMPHASTAR,,55.0,YR,,F,Y,,,20231207,,CN,COUNTRY NOT SPECIFIED,US,2023,Q4,Adult
232722011,23272201,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2023,Q4,Eye pain,,2023,Q4,1,I,,20230929.0,20231207,20231207,PER,,"US-Amphastar Pharmaceuticals, Inc.-2149070",AMPHASTAR,,55.0,YR,,F,Y,,,20231207,,CN,COUNTRY NOT SPECIFIED,US,2023,Q4,Adult
232722011,23272201,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2023,Q4,Blood glucose decreased,,2023,Q4,1,I,,20230929.0,20231207,20231207,PER,,"US-Amphastar Pharmaceuticals, Inc.-2149070",AMPHASTAR,,55.0,YR,,F,Y,,,20231207,,CN,COUNTRY NOT SPECIFIED,US,2023,Q4,Adult
232722011,23272201,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2023,Q4,Eye haemorrhage,,2023,Q4,1,I,,20230929.0,20231207,20231207,PER,,"US-Amphastar Pharmaceuticals, Inc.-2149070",AMPHASTAR,,55.0,YR,,F,Y,,,20231207,,CN,COUNTRY NOT SPECIFIED,US,2023,Q4,Adult
232722011,23272201,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2023,Q4,Eye pruritus,,2023,Q4,1,I,,20230929.0,20231207,20231207,PER,,"US-Amphastar Pharmaceuticals, Inc.-2149070",AMPHASTAR,,55.0,YR,,F,Y,,,20231207,,CN,COUNTRY NOT SPECIFIED,US,2023,Q4,Adult
232727191,23272719,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 IU,,,,,,,,,,,,2023,Q4,Neoplasm,,2023,Q4,1,I,,20231117.0,20231207,20231207,EXP,,ZA-AstraZeneca-2023A277654,ASTRAZENECA,,54.0,YR,,M,Y,,,20231207,,CN,ZA,,2023,Q4,Adult
232767011,23276701,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Disease complication,,2023,Q4,1,I,20231204.0,20231206.0,20231207,20231207,DIR,FDA-CDER-CTU-2023-89822,,FDA-CTU,,58.0,YR,,F,N,81.8,KG,20231206,N,HP,US,,2023,Q4,Adult
232773781,23277378,7,C,LISPRO 50LIS50NPL,,2,,FORM: NOT SPECIFIED,,,,,,,,,,,,2023,Q4,Clostridium test positive,,2023,Q4,1,I,,20231204.0,20231208,20231208,EXP,,CA-FreseniusKabi-FK202319902,FRESENIUS KABI,,65.0,YR,E,M,Y,110.0,KG,20231208,,PH,CA,CA,2023,Q4,Elderly
232773781,23277378,7,C,LISPRO 50LIS50NPL,,2,,FORM: NOT SPECIFIED,,,,,,,,,,,,2023,Q4,Urosepsis,,2023,Q4,1,I,,20231204.0,20231208,20231208,EXP,,CA-FreseniusKabi-FK202319902,FRESENIUS KABI,,65.0,YR,E,M,Y,110.0,KG,20231208,,PH,CA,CA,2023,Q4,Elderly
232773781,23277378,7,C,LISPRO 50LIS50NPL,,2,,FORM: NOT SPECIFIED,,,,,,,,,,,,2023,Q4,Pyrexia,,2023,Q4,1,I,,20231204.0,20231208,20231208,EXP,,CA-FreseniusKabi-FK202319902,FRESENIUS KABI,,65.0,YR,E,M,Y,110.0,KG,20231208,,PH,CA,CA,2023,Q4,Elderly
232780741,23278074,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578901A,,20563.0,,,Injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231206.0,20231206.0,20231208,20231208,PER,,US-ELI_LILLY_AND_COMPANY-US202312003751,ELI LILLY AND CO,,21.0,YR,,,Y,,,20231208,,CN,US,US,2023,Q4,Youth
232780741,23278074,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578901A,,20563.0,,,Injection,,2023,Q4,Blood ketone body increased,,2023,Q4,1,I,20231206.0,20231206.0,20231208,20231208,PER,,US-ELI_LILLY_AND_COMPANY-US202312003751,ELI LILLY AND CO,,21.0,YR,,,Y,,,20231208,,CN,US,US,2023,Q4,Youth
232780741,23278074,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D578901A,,20563.0,,,Injection,,2023,Q4,Product storage error,,2023,Q4,1,I,20231206.0,20231206.0,20231208,20231208,PER,,US-ELI_LILLY_AND_COMPANY-US202312003751,ELI LILLY AND CO,,21.0,YR,,,Y,,,20231208,,CN,US,US,2023,Q4,Youth
232807251,23280725,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,,,,Injection,,2023,Q4,Visual impairment,,2023,Q4,1,I,20231207.0,20231208.0,20231211,20231211,PER,,US-ELI_LILLY_AND_COMPANY-US202312005086,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20231211,,CN,US,US,2023,Q4,Adult
232807251,23280725,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231207.0,20231208.0,20231211,20231211,PER,,US-ELI_LILLY_AND_COMPANY-US202312005086,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20231211,,CN,US,US,2023,Q4,Adult
232807251,23280725,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D547157C,,,,,Injection,,2023,Q4,Blood glucose abnormal,,2023,Q4,1,I,20231207.0,20231208.0,20231211,20231211,PER,,US-ELI_LILLY_AND_COMPANY-US202312005086,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20231211,,CN,US,US,2023,Q4,Adult
232838871,23283887,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, daily",,,,,,,,,,,QD,2023,Q4,Cutaneous vasculitis,,2023,Q4,1,I,20230530.0,20231129.0,20231211,20231211,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202309001391,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20231211,,CN,DE,DE,2023,Q4,Elderly
232838871,23283887,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, daily",,,,,,,,,,,QD,2023,Q4,Neurodermatitis,,2023,Q4,1,I,20230530.0,20231129.0,20231211,20231211,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202309001391,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20231211,,CN,DE,DE,2023,Q4,Elderly
232871541,23287154,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK u, unknown",,,,,D591481C,,20563.0,,,Injection,,2023,Q4,Blood glucose abnormal,,2023,Q4,1,I,,20231206.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312004640,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Elderly
232871541,23287154,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose abnormal,,2023,Q4,1,I,,20231206.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312004640,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Elderly
232899161,23289916,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Injection site pain,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Injection site pain,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D556101D,,20563.0,,,Injection,,2023,Q4,Injection site pain,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D556101D,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D556101D,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D556101D,,20563.0,,,Injection,,2023,Q4,Injection site pain,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D556101D,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232899161,23289916,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D556101D,,20563.0,,,Injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231114.0,20231212.0,20231212,20231212,PER,,US-ELI_LILLY_AND_COMPANY-US202312006750,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20231212,,CN,US,US,2023,Q4,Adult
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Oedema peripheral,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Arthralgia,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Scab,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Hypersensitivity,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Joint swelling,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Reaction to excipient,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Rheumatoid factor increased,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Lysozyme increased,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Organising pneumonia,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Fibrin D dimer increased,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Pruritus,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Skin exfoliation,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Anal ulcer haemorrhage,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Rheumatoid arthritis,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Paraesthesia,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Erythema,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Pulmonary embolism,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232904211,23290421,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,3-10 IU,,,U,,,,,,,,,2023,Q4,Red blood cell sedimentation rate increased,,2023,Q4,1,I,20230120.0,20231130.0,20231213,20231213,EXP,FI-FIMEA-202301807,FI-NOVOPROD-1146773,NOVO NORDISK,,65.0,YR,,M,Y,,,20231213,,CN,FI,FI,2023,Q4,Elderly
232919211,23291921,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid (7 units three times a day before meals)",,,U,U,,,,,,Injection,TID,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,,20231205.0,20231213,20231213,EXP,,US-MYLANLABS-2023M1131608,MYLAN,"Jain AK, Shah A, Bhat G. Olanzapine-Induced Diabetic Ketoacidosis: A Reversible Etiology Overlooked in Psychiatric Patients. AACE-Clin-Case-Rep 2023;.",73.0,YR,,F,Y,,,20231213,,MD,US,US,2023,Q4,Elderly
232919211,23291921,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid (7 units three times a day before meals)",,,U,U,,,,,,Injection,TID,2023,Q4,Treatment noncompliance,,2023,Q4,1,I,,20231205.0,20231213,20231213,EXP,,US-MYLANLABS-2023M1131608,MYLAN,"Jain AK, Shah A, Bhat G. Olanzapine-Induced Diabetic Ketoacidosis: A Reversible Etiology Overlooked in Psychiatric Patients. AACE-Clin-Case-Rep 2023;.",73.0,YR,,F,Y,,,20231213,,MD,US,US,2023,Q4,Elderly
232919211,23291921,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid (7 units three times a day before meals)",,,U,U,,,,,,Injection,TID,2023,Q4,Off label use,,2023,Q4,1,I,,20231205.0,20231213,20231213,EXP,,US-MYLANLABS-2023M1131608,MYLAN,"Jain AK, Shah A, Bhat G. Olanzapine-Induced Diabetic Ketoacidosis: A Reversible Etiology Overlooked in Psychiatric Patients. AACE-Clin-Case-Rep 2023;.",73.0,YR,,F,Y,,,20231213,,MD,US,US,2023,Q4,Elderly
232945781,23294578,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q4,Discomfort,,2023,Q4,1,I,,20231130.0,20231213,20231213,EXP,,US-ELI_LILLY_AND_COMPANY-US202312003030,ELI LILLY AND CO,"Alkhatib E.H.,Grundman J.B.,Adamusiak A.M.,Bellin M.D.,Brooks J.P.,Buckley K.S.,Janssen E.M.,Kitcharoensakkul M.,McNerney K.P.,Pfeifer T.L.,Polk B.I.,Marks B.E..Case Report: Insulin hypersensitivity in youth with type 1 diabetes..Frontiers in Endocrinology. 2023;14:.DOI:10.3389/fendo.2023.1226231",16.0,YR,,F,Y,,,20231213,,HP,US,US,2023,Q4,Youth
232945781,23294578,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q4,Type III immune complex mediated reaction,,2023,Q4,1,I,,20231130.0,20231213,20231213,EXP,,US-ELI_LILLY_AND_COMPANY-US202312003030,ELI LILLY AND CO,"Alkhatib E.H.,Grundman J.B.,Adamusiak A.M.,Bellin M.D.,Brooks J.P.,Buckley K.S.,Janssen E.M.,Kitcharoensakkul M.,McNerney K.P.,Pfeifer T.L.,Polk B.I.,Marks B.E..Case Report: Insulin hypersensitivity in youth with type 1 diabetes..Frontiers in Endocrinology. 2023;14:.DOI:10.3389/fendo.2023.1226231",16.0,YR,,F,Y,,,20231213,,HP,US,US,2023,Q4,Youth
232945781,23294578,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,,,2023,Q4,Hyperglycaemia,,2023,Q4,1,I,,20231130.0,20231213,20231213,EXP,,US-ELI_LILLY_AND_COMPANY-US202312003030,ELI LILLY AND CO,"Alkhatib E.H.,Grundman J.B.,Adamusiak A.M.,Bellin M.D.,Brooks J.P.,Buckley K.S.,Janssen E.M.,Kitcharoensakkul M.,McNerney K.P.,Pfeifer T.L.,Polk B.I.,Marks B.E..Case Report: Insulin hypersensitivity in youth with type 1 diabetes..Frontiers in Endocrinology. 2023;14:.DOI:10.3389/fendo.2023.1226231",16.0,YR,,F,Y,,,20231213,,HP,US,US,2023,Q4,Youth
232948571,23294857,50,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 IU (CO),,,U,,,,,1.0,IU,,,2023,Q4,Toxic epidermal necrolysis,,2023,Q4,1,I,20200809.0,20231206.0,20231213,20231213,EXP,,FR-SANDOZ INC.-NVSC2020FR370649,SANDOZ,,74.0,YR,,M,Y,,,20231213,,MD,FR,FR,2023,Q4,Elderly
232979391,23297939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,50.0,IU,,Q12H,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018461,BAUSCH AND LOMB,,72.0,YR,,F,Y,57.0,KG,20231214,,CN,CA,CA,2023,Q4,Elderly
232979391,23297939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,50.0,IU,,Q12H,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231213.0,20231214,20231214,EXP,,CA-BAUSCH-BL-2023-018461,BAUSCH AND LOMB,,72.0,YR,,F,Y,57.0,KG,20231214,,CN,CA,CA,2023,Q4,Elderly
232980562,23298056,6,C,Insulin lispro bs,,2,Subcutaneous,"8 IU, once a day",,,,,,,,,,Injection,,2023,Q4,Hepatocellular carcinoma,,2023,Q4,2,F,20231121.0,20231212.0,20231214,20231220,EXP,,JP-BAXTER-2023BAX038208,BAXTER,,52.0,YR,,M,Y,91.6,KG,20231220,,MD,JP,JP,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Malnutrition,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Neuropathy peripheral,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Myalgia,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pericardial effusion,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Thyroid disorder,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Multi-organ disorder,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Chest pain,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Eye haemorrhage,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Cardiac failure congestive,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Diarrhoea,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Pulmonary oedema,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Headache,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233005351,23300535,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Arthritis,,2023,Q4,1,I,,20231209.0,20231215,20231215,EXP,CA-SA-SAC20231211000896,CA-SA-2023SA384165,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20231215,,HP,CA,CA,2023,Q4,Adult
233010012,23301001,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11/7/11 units, 3 times a day",,,,,,,,,,Injection,,2023,Q4,Ileus paralytic,,2023,Q4,2,F,20220101.0,20231220.0,20231215,20231228,EXP,,JP-MYLANLABS-2023M1132051,MYLAN,"Tomida T, Itohara K, Yamamoto K, Kimura T, Fujita K, Uda A, et al. A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19. Drug-Metab-Pharmacokinet 2023; 53.. 2023;53",56.0,YR,,M,Y,84.5,KG,20231228,,HP,JP,JP,2023,Q4,Adult
233010012,23301001,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11/7/11 units, 3 times a day",,,,,,,,,,Injection,,2023,Q4,Acute kidney injury,,2023,Q4,2,F,20220101.0,20231220.0,20231215,20231228,EXP,,JP-MYLANLABS-2023M1132051,MYLAN,"Tomida T, Itohara K, Yamamoto K, Kimura T, Fujita K, Uda A, et al. A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19. Drug-Metab-Pharmacokinet 2023; 53.. 2023;53",56.0,YR,,M,Y,84.5,KG,20231228,,HP,JP,JP,2023,Q4,Adult
233010012,23301001,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11/7/11 units, 3 times a day",,,,,,,,,,Injection,,2023,Q4,Hyperkalaemia,,2023,Q4,2,F,20220101.0,20231220.0,20231215,20231228,EXP,,JP-MYLANLABS-2023M1132051,MYLAN,"Tomida T, Itohara K, Yamamoto K, Kimura T, Fujita K, Uda A, et al. A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19. Drug-Metab-Pharmacokinet 2023; 53.. 2023;53",56.0,YR,,M,Y,84.5,KG,20231228,,HP,JP,JP,2023,Q4,Adult
233010012,23301001,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11/7/11 units, 3 times a day",,,,,,,,,,Injection,,2023,Q4,Drug interaction,,2023,Q4,2,F,20220101.0,20231220.0,20231215,20231228,EXP,,JP-MYLANLABS-2023M1132051,MYLAN,"Tomida T, Itohara K, Yamamoto K, Kimura T, Fujita K, Uda A, et al. A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19. Drug-Metab-Pharmacokinet 2023; 53.. 2023;53",56.0,YR,,M,Y,84.5,KG,20231228,,HP,JP,JP,2023,Q4,Adult
233010012,23301001,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11/7/11 units, 3 times a day",,,,,,,,,,Injection,,2023,Q4,Drug level increased,,2023,Q4,2,F,20220101.0,20231220.0,20231215,20231228,EXP,,JP-MYLANLABS-2023M1132051,MYLAN,"Tomida T, Itohara K, Yamamoto K, Kimura T, Fujita K, Uda A, et al. A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19. Drug-Metab-Pharmacokinet 2023; 53.. 2023;53",56.0,YR,,M,Y,84.5,KG,20231228,,HP,JP,JP,2023,Q4,Adult
233027271,23302727,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,,,,U,,,,,,,,,2023,Q4,Toxicity to various agents,,2023,Q4,1,I,,20231212.0,20231215,20231215,EXP,,US-AstraZeneca-2023A285557,ASTRAZENECA,"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein + Carol DesLauriers. 2022 Annual Report of the National Poison Data System? (NPDS) from America?s Poison Centers?: 40th Annual Report. Clinical Toxicology 2022;61(10):717-939.",23.0,YR,,F,Y,,,20231215,,MD,US,,2023,Q4,Youth
233027271,23302727,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,,,,U,,,,,,,,,2023,Q4,Completed suicide,,2023,Q4,1,I,,20231212.0,20231215,20231215,EXP,,US-AstraZeneca-2023A285557,ASTRAZENECA,"David D. Gummin, James B. Mowry, Michael C. Beuhler, Daniel A. Spyker, Laura J. Rivers, Ryan Feldman, Kaitlyn Brown, Nathaniel P.T. Pham, Alvin C. Bronstein + Carol DesLauriers. 2022 Annual Report of the National Poison Data System? (NPDS) from America?s Poison Centers?: 40th Annual Report. Clinical Toxicology 2022;61(10):717-939.",23.0,YR,,F,Y,,,20231215,,MD,US,,2023,Q4,Youth
233062991,23306299,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Musculoskeletal disorder,,2023,Q4,1,I,20230912.0,20231211.0,20231218,20231218,EXP,,US-ABBVIE-5529161,ABBVIE,,76.0,YR,,M,Y,,,20231218,,CN,US,US,2023,Q4,Elderly
233062991,23306299,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Urinary tract infection,,2023,Q4,1,I,20230912.0,20231211.0,20231218,20231218,EXP,,US-ABBVIE-5529161,ABBVIE,,76.0,YR,,M,Y,,,20231218,,CN,US,US,2023,Q4,Elderly
233066172,23306617,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D594578A,,20563.0,,,Injection,,2023,Q4,Migraine,,2023,Q4,2,F,20231215.0,20231219.0,20231218,20231220,PER,,US-ELI_LILLY_AND_COMPANY-US202312009475,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20231220,,CN,US,US,2023,Q4,Elderly
233066172,23306617,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D594578A,,20563.0,,,Injection,,2023,Q4,Incorrect dose administered,,2023,Q4,2,F,20231215.0,20231219.0,20231218,20231220,PER,,US-ELI_LILLY_AND_COMPANY-US202312009475,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20231220,,CN,US,US,2023,Q4,Elderly
233079171,23307917,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,mix 75-25,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,1,I,20231101.0,20231211.0,20231218,20231218,EXP,,US-PFIZER INC-202300444331,PFIZER,,72.0,YR,,F,Y,,,20231218,,HP,US,US,2023,Q4,Elderly
233079171,23307917,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,mix 75-25,,,,,,,,,,,,2023,Q4,Thrombosis,,2023,Q4,1,I,20231101.0,20231211.0,20231218,20231218,EXP,,US-PFIZER INC-202300444331,PFIZER,,72.0,YR,,F,Y,,,20231218,,HP,US,US,2023,Q4,Elderly
233079171,23307917,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,mix 75-25,,,,,,,,,,,,2023,Q4,Stasis dermatitis,,2023,Q4,1,I,20231101.0,20231211.0,20231218,20231218,EXP,,US-PFIZER INC-202300444331,PFIZER,,72.0,YR,,F,Y,,,20231218,,HP,US,US,2023,Q4,Elderly
233079171,23307917,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,mix 75-25,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,20231101.0,20231211.0,20231218,20231218,EXP,,US-PFIZER INC-202300444331,PFIZER,,72.0,YR,,F,Y,,,20231218,,HP,US,US,2023,Q4,Elderly
233149101,23314910,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,D578902A,,20563.0,,,Injection,,2023,Q4,COVID-19,,2023,Q4,1,I,20231001.0,20231214.0,20231219,20231219,EXP,,US-ELI_LILLY_AND_COMPANY-US202312008349,ELI LILLY AND CO,,96.0,YR,,M,Y,,,20231219,,CN,US,US,2023,Q4,Elderly
233156591,23315659,50,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,D,,,,,1.0,IU,,,2023,Q4,Toxic epidermal necrolysis,,2023,Q4,1,I,20200809.0,20231206.0,20231219,20231219,EXP,,FR-SANDOZ INC.-NVSC2020FR235135,SANDOZ,,74.0,YR,,M,Y,,,20231219,,MD,FR,FR,2023,Q4,Elderly
233199291,23319929,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Asthenia,,2023,Q4,1,I,20231212.0,20231213.0,20231220,20231220,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2023-27759",IPSEN,,70.0,YR,E,F,Y,60.8,KG,20231220,,CN,US,US,2023,Q4,Elderly
233199291,23319929,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,1,I,20231212.0,20231213.0,20231220,20231220,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2023-27759",IPSEN,,70.0,YR,E,F,Y,60.8,KG,20231220,,CN,US,US,2023,Q4,Elderly
233199291,23319929,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Bone pain,,2023,Q4,1,I,20231212.0,20231213.0,20231220,20231220,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2023-27759",IPSEN,,70.0,YR,E,F,Y,60.8,KG,20231220,,CN,US,US,2023,Q4,Elderly
233207191,23320719,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,20563.0,,,,,2023,Q4,Extra dose administered,,2023,Q4,1,I,,20231212.0,20231220,20231220,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202312007975,ELI LILLY AND CO,"Tatsumoto T, et al..A case of type 2 diabetes in which a large amount of GLP-1 receptor agonist and insulin were injected subcutaneously in a suicide attempt.The 61st Kyushu Regional Meeting of the Japan Diabetes Society 2023;:152.",35.0,YR,,M,Y,,,20231220,,MD,JP,JP,2023,Q4,Adult
233207191,23320719,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,20563.0,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231212.0,20231220,20231220,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202312007975,ELI LILLY AND CO,"Tatsumoto T, et al..A case of type 2 diabetes in which a large amount of GLP-1 receptor agonist and insulin were injected subcutaneously in a suicide attempt.The 61st Kyushu Regional Meeting of the Japan Diabetes Society 2023;:152.",35.0,YR,,M,Y,,,20231220,,MD,JP,JP,2023,Q4,Adult
233207191,23320719,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,20563.0,,,,,2023,Q4,Suicide attempt,,2023,Q4,1,I,,20231212.0,20231220,20231220,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202312007975,ELI LILLY AND CO,"Tatsumoto T, et al..A case of type 2 diabetes in which a large amount of GLP-1 receptor agonist and insulin were injected subcutaneously in a suicide attempt.The 61st Kyushu Regional Meeting of the Japan Diabetes Society 2023;:152.",35.0,YR,,M,Y,,,20231220,,MD,JP,JP,2023,Q4,Adult
233224031,23322403,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,Ingestion,,,D,,,,,,,,,2023,Q4,Completed suicide,,2023,Q4,1,I,,20231213.0,20231220,20231220,EXP,,US-BAUSCH-BL-2023-018636,BAUSCH AND LOMB,"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 DEC 12;61(10):717-939. doi:10.1080/15563650.2023.2268981",61.0,YR,,M,Y,,,20231220,,MD,US,US,2023,Q4,Adult
233224031,23322403,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,Parenteral,,,D,,,,,,,,,2023,Q4,Completed suicide,,2023,Q4,1,I,,20231213.0,20231220,20231220,EXP,,US-BAUSCH-BL-2023-018636,BAUSCH AND LOMB,"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 DEC 12;61(10):717-939. doi:10.1080/15563650.2023.2268981",61.0,YR,,M,Y,,,20231220,,MD,US,US,2023,Q4,Adult
233237261,23323726,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,Ingestion,,,D,,,,,,,,,2023,Q4,Completed suicide,,2023,Q4,1,I,,20231213.0,20231220,20231220,EXP,,US-BAUSCH-BL-2023-018527,BAUSCH AND LOMB,"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 DEC 12;61(10):717-939. doi:10.1080/15563650.2023.2268981",23.0,YR,,F,Y,,,20231221,,MD,US,US,2023,Q4,Youth
233237261,23323726,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,,,,D,,,,,,,,,2023,Q4,Completed suicide,,2023,Q4,1,I,,20231213.0,20231220,20231220,EXP,,US-BAUSCH-BL-2023-018527,BAUSCH AND LOMB,"Gummin D, Mowry J, Beuhler M, Spyker D, Rivers L, Feldman R, Brown K, Pham N, Bronstein A, DesLauriers C. 2022 Annual Report of the National Poison Data System (NPDS) from America^s Poison Centers: 40th Annual Report. Clinical Toxicology. 2023 DEC 12;61(10):717-939. doi:10.1080/15563650.2023.2268981",23.0,YR,,F,Y,,,20231221,,MD,US,US,2023,Q4,Youth
233270021,23327002,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D598642A,,20563.0,,,Solution for injection,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231213.0,20231218.0,20231221,20231221,EXP,,US-ELI_LILLY_AND_COMPANY-US202312010496,ELI LILLY AND CO,,17.0,YR,,F,Y,,,20231221,,CN,US,US,2023,Q4,Youth
233270021,23327002,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D598642A,,20563.0,,,Solution for injection,,2023,Q4,Headache,,2023,Q4,1,I,20231213.0,20231218.0,20231221,20231221,EXP,,US-ELI_LILLY_AND_COMPANY-US202312010496,ELI LILLY AND CO,,17.0,YR,,F,Y,,,20231221,,CN,US,US,2023,Q4,Youth
233270021,23327002,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D598642A,,20563.0,,,Solution for injection,,2023,Q4,Weight decreased,,2023,Q4,1,I,20231213.0,20231218.0,20231221,20231221,EXP,,US-ELI_LILLY_AND_COMPANY-US202312010496,ELI LILLY AND CO,,17.0,YR,,F,Y,,,20231221,,CN,US,US,2023,Q4,Youth
233270021,23327002,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D598642A,,20563.0,,,Solution for injection,,2023,Q4,Drug ineffective,,2023,Q4,1,I,20231213.0,20231218.0,20231221,20231221,EXP,,US-ELI_LILLY_AND_COMPANY-US202312010496,ELI LILLY AND CO,,17.0,YR,,F,Y,,,20231221,,CN,US,US,2023,Q4,Youth
233270021,23327002,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D598642A,,20563.0,,,Solution for injection,,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,20231213.0,20231218.0,20231221,20231221,EXP,,US-ELI_LILLY_AND_COMPANY-US202312010496,ELI LILLY AND CO,,17.0,YR,,F,Y,,,20231221,,CN,US,US,2023,Q4,Youth
233270021,23327002,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D598642A,,20563.0,,,Solution for injection,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20231213.0,20231218.0,20231221,20231221,EXP,,US-ELI_LILLY_AND_COMPANY-US202312010496,ELI LILLY AND CO,,17.0,YR,,F,Y,,,20231221,,CN,US,US,2023,Q4,Youth
233279751,23327975,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Hyperphosphataemia,,2023,Q4,1,I,20231027.0,20231206.0,20231221,20231221,EXP,,US-FMCRTG-FMC-2312-001430,FRESENIUS MEDICAL CARE,,77.0,YR,E,M,Y,,,20231221,,HP,US,US,2023,Q4,Elderly
233279751,23327975,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Pleural effusion,,2023,Q4,1,I,20231027.0,20231206.0,20231221,20231221,EXP,,US-FMCRTG-FMC-2312-001430,FRESENIUS MEDICAL CARE,,77.0,YR,E,M,Y,,,20231221,,HP,US,US,2023,Q4,Elderly
233279751,23327975,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Peritonitis bacterial,,2023,Q4,1,I,20231027.0,20231206.0,20231221,20231221,EXP,,US-FMCRTG-FMC-2312-001430,FRESENIUS MEDICAL CARE,,77.0,YR,E,M,Y,,,20231221,,HP,US,US,2023,Q4,Elderly
233279751,23327975,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Catheter site infection,,2023,Q4,1,I,20231027.0,20231206.0,20231221,20231221,EXP,,US-FMCRTG-FMC-2312-001430,FRESENIUS MEDICAL CARE,,77.0,YR,E,M,Y,,,20231221,,HP,US,US,2023,Q4,Elderly
233279751,23327975,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Hyperkalaemia,,2023,Q4,1,I,20231027.0,20231206.0,20231221,20231221,EXP,,US-FMCRTG-FMC-2312-001430,FRESENIUS MEDICAL CARE,,77.0,YR,E,M,Y,,,20231221,,HP,US,US,2023,Q4,Elderly
233322121,23332212,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Emotional distress,,2023,Q4,1,I,,20231207.0,20231222,20231222,PER,,US-NEUROCRINE BIOSCIENCES INC.-2023NBI10846,NEUROCRINE BIOSCIENCES,,63.0,YR,,F,Y,,,20231222,,CN,US,US,2023,Q4,Adult
233322121,23332212,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Tardive dyskinesia,,2023,Q4,1,I,,20231207.0,20231222,20231222,PER,,US-NEUROCRINE BIOSCIENCES INC.-2023NBI10846,NEUROCRINE BIOSCIENCES,,63.0,YR,,F,Y,,,20231222,,CN,US,US,2023,Q4,Adult
233328901,23332890,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 international unit, bid",,,U,,,,,50.0,IU,,BID,2023,Q4,Otitis externa,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018205,APOTEX,,72.0,YR,,F,Y,57.0,KG,20231222,,HP,CA,CA,2023,Q4,Elderly
233328901,23332890,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 international unit, bid",,,U,,,,,50.0,IU,,BID,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231215.0,20231222,20231222,EXP,,CA-APOTEX-2023AP018205,APOTEX,,72.0,YR,,F,Y,57.0,KG,20231222,,HP,CA,CA,2023,Q4,Elderly
233392161,23339216,6,C,ISULIN LISPRO,,2,,,,,,,,,,,,,,2023,Q4,Death,,2023,Q4,1,I,20231201.0,20231221.0,20231226,20231226,EXP,,US-AstraZeneca-2023A291214,ASTRAZENECA,,990.0,MON,,M,Y,70.3,KG,20231226,,CN,US,,2023,Q4,Elderly
233393131,23339313,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 - 8 - 2,,,,,,,,11.0,IU,Injection,TID,2023,Q4,Hydronephrosis,,2023,Q4,1,I,20220225.0,20231221.0,20231226,20231226,EXP,,JP-AstraZeneca-2022A229546,ASTRAZENECA,,81.0,YR,,F,Y,32.0,KG,20231226,,MD,JP,,2023,Q4,Elderly
233393131,23339313,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 - 8 - 2,,,,,,,,11.0,IU,Injection,TID,2023,Q4,Pulmonary congestion,,2023,Q4,1,I,20220225.0,20231221.0,20231226,20231226,EXP,,JP-AstraZeneca-2022A229546,ASTRAZENECA,,81.0,YR,,F,Y,32.0,KG,20231226,,MD,JP,,2023,Q4,Elderly
233393131,23339313,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 - 8 - 2,,,,,,,,11.0,IU,Injection,TID,2023,Q4,Decreased appetite,,2023,Q4,1,I,20220225.0,20231221.0,20231226,20231226,EXP,,JP-AstraZeneca-2022A229546,ASTRAZENECA,,81.0,YR,,F,Y,32.0,KG,20231226,,MD,JP,,2023,Q4,Elderly
233393131,23339313,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 - 8 - 2,,,,,,,,11.0,IU,Injection,TID,2023,Q4,Urinary tract infection,,2023,Q4,1,I,20220225.0,20231221.0,20231226,20231226,EXP,,JP-AstraZeneca-2022A229546,ASTRAZENECA,,81.0,YR,,F,Y,32.0,KG,20231226,,MD,JP,,2023,Q4,Elderly
233393131,23339313,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 - 8 - 2,,,,,,,,11.0,IU,Injection,TID,2023,Q4,Venous thrombosis limb,,2023,Q4,1,I,20220225.0,20231221.0,20231226,20231226,EXP,,JP-AstraZeneca-2022A229546,ASTRAZENECA,,81.0,YR,,F,Y,32.0,KG,20231226,,MD,JP,,2023,Q4,Elderly
233393131,23339313,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 - 8 - 2,,,,,,,,11.0,IU,Injection,TID,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20220225.0,20231221.0,20231226,20231226,EXP,,JP-AstraZeneca-2022A229546,ASTRAZENECA,,81.0,YR,,F,Y,32.0,KG,20231226,,MD,JP,,2023,Q4,Elderly
233393131,23339313,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 - 8 - 2,,,,,,,,11.0,IU,Injection,TID,2023,Q4,Diabetic ketoacidosis,,2023,Q4,1,I,20220225.0,20231221.0,20231226,20231226,EXP,,JP-AstraZeneca-2022A229546,ASTRAZENECA,,81.0,YR,,F,Y,32.0,KG,20231226,,MD,JP,,2023,Q4,Elderly
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Haematuria,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Anaemia,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Sepsis,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Atrial fibrillation,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Tachycardia,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Hyperbilirubinaemia,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Weight decreased,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Toxicity to various agents,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Intracardiac mass,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Vomiting,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Tubulointerstitial nephritis,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Diarrhoea,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Lower gastrointestinal haemorrhage,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Urinary tract infection,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Nasopharyngitis,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Decreased appetite,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Encephalopathy,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Stomatitis,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Urinary retention,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Leukopenia,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Nausea,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Febrile neutropenia,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Vitamin D deficiency,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Acute kidney injury,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Fatigue,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Hypotension,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Abdominal pain upper,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Brain fog,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Gastroenteritis,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233416081,23341608,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Hyponatraemia,,2023,Q4,1,I,20230923.0,20231221.0,20231227,20231227,EXP,,US-GILEAD-2023-0651798,GILEAD,,51.0,YR,A,F,Y,96.0,KG,20231227,,MD,US,US,2023,Q4,Adult
233420552,23342055,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Visual impairment,,2023,Q4,2,F,,20231220.0,20231227,20231229,PER,,US-SA-2023SA396214,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20231229,,HP,US,US,2023,Q4,Elderly
233420552,23342055,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Hypoacusis,,2023,Q4,2,F,,20231220.0,20231227,20231229,PER,,US-SA-2023SA396214,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20231229,,HP,US,US,2023,Q4,Elderly
233420552,23342055,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2023,Q4,Diabetes mellitus inadequate control,,2023,Q4,2,F,,20231220.0,20231227,20231229,PER,,US-SA-2023SA396214,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20231229,,HP,US,US,2023,Q4,Elderly
233421631,23342163,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,209196.0,,,Solution for injection,,2023,Q4,Rash maculo-papular,,2023,Q4,1,I,20231120.0,20231215.0,20231227,20231227,EXP,FR-AFSSAPS-RN2023001314,FR-SA-2023SA396704,SANOFI AVENTIS,,75.0,YR,E,F,Y,65.0,KG,20231227,,MD,FR,FR,2023,Q4,Elderly
233422561,23342256,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,20563.0,,,,,2023,Q4,Suicide attempt,,2023,Q4,1,I,,20231219.0,20231227,20231227,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202312011094,ELI LILLY AND CO,"Hirota Y, et al..A case of liver dysfunction due to long-term administration of high-concentration glucose solution due to insulin preparation overdose.The 51st Annual Meeting of the Japanese Association for Acute Medicine 2023;:579.",68.0,YR,,F,Y,,,20231227,,MD,JP,JP,2023,Q4,Elderly
233422561,23342256,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,20563.0,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231219.0,20231227,20231227,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202312011094,ELI LILLY AND CO,"Hirota Y, et al..A case of liver dysfunction due to long-term administration of high-concentration glucose solution due to insulin preparation overdose.The 51st Annual Meeting of the Japanese Association for Acute Medicine 2023;:579.",68.0,YR,,F,Y,,,20231227,,MD,JP,JP,2023,Q4,Elderly
233422561,23342256,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,20563.0,,,,,2023,Q4,Extra dose administered,,2023,Q4,1,I,,20231219.0,20231227,20231227,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202312011094,ELI LILLY AND CO,"Hirota Y, et al..A case of liver dysfunction due to long-term administration of high-concentration glucose solution due to insulin preparation overdose.The 51st Annual Meeting of the Japanese Association for Acute Medicine 2023;:579.",68.0,YR,,F,Y,,,20231227,,MD,JP,JP,2023,Q4,Elderly
233422561,23342256,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,20563.0,,,,,2023,Q4,Hepatic function abnormal,,2023,Q4,1,I,,20231219.0,20231227,20231227,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202312011094,ELI LILLY AND CO,"Hirota Y, et al..A case of liver dysfunction due to long-term administration of high-concentration glucose solution due to insulin preparation overdose.The 51st Annual Meeting of the Japanese Association for Acute Medicine 2023;:579.",68.0,YR,,F,Y,,,20231227,,MD,JP,JP,2023,Q4,Elderly
233432431,23343243,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, via insulin pump",,,,,,,,,,,,2023,Q4,Product use complaint,,2023,Q4,1,I,20230201.0,20231113.0,20231227,20231227,PER,,"US-UPSHER-SMITH LABORATORIES, LLC-2023USL00944",UPSHER-SMITH,,82.0,YR,,F,Y,72.562,KG,20231227,,CN,US,US,2023,Q4,Elderly
233432431,23343243,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, via insulin pump",,,,,,,,,,,,2023,Q4,Regurgitation,,2023,Q4,1,I,20230201.0,20231113.0,20231227,20231227,PER,,"US-UPSHER-SMITH LABORATORIES, LLC-2023USL00944",UPSHER-SMITH,,82.0,YR,,F,Y,72.562,KG,20231227,,CN,US,US,2023,Q4,Elderly
233432431,23343243,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, via insulin pump",,,,,,,,,,,,2023,Q4,Wrong technique in product usage process,,2023,Q4,1,I,20230201.0,20231113.0,20231227,20231227,PER,,"US-UPSHER-SMITH LABORATORIES, LLC-2023USL00944",UPSHER-SMITH,,82.0,YR,,F,Y,72.562,KG,20231227,,CN,US,US,2023,Q4,Elderly
233447951,23344795,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D655857C,,20563.0,,,Solution for injection,,2023,Q4,Accidental underdose,,2023,Q4,1,I,20231221.0,20231221.0,20231228,20231228,PER,,US-ELI_LILLY_AND_COMPANY-US202312013208,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20231228,,CN,US,US,2023,Q4,Adult
233447951,23344795,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D655857C,,20563.0,,,Solution for injection,,2023,Q4,Cardiac disorder,,2023,Q4,1,I,20231221.0,20231221.0,20231228,20231228,PER,,US-ELI_LILLY_AND_COMPANY-US202312013208,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20231228,,CN,US,US,2023,Q4,Adult
233447951,23344795,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D655857C,,20563.0,,,Solution for injection,,2023,Q4,Off label use,,2023,Q4,1,I,20231221.0,20231221.0,20231228,20231228,PER,,US-ELI_LILLY_AND_COMPANY-US202312013208,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20231228,,CN,US,US,2023,Q4,Adult
233447951,23344795,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D655857C,,20563.0,,,Solution for injection,,2023,Q4,Visual impairment,,2023,Q4,1,I,20231221.0,20231221.0,20231228,20231228,PER,,US-ELI_LILLY_AND_COMPANY-US202312013208,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20231228,,CN,US,US,2023,Q4,Adult
233447961,23344796,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Product dose omission issue,,2023,Q4,1,I,20231226.0,20231227.0,20231228,20231228,PER,,US-ELI_LILLY_AND_COMPANY-US202312014930,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20231228,,CN,US,US,2023,Q4,Adult
233447961,23344796,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2023,Q4,Injection site pain,,2023,Q4,1,I,20231226.0,20231227.0,20231228,20231228,PER,,US-ELI_LILLY_AND_COMPANY-US202312014930,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20231228,,CN,US,US,2023,Q4,Adult
233452961,23345296,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Neutropenia,,2023,Q4,1,I,,20231216.0,20231228,20231228,EXP,,US-AUROBINDO-AUR-APL-2021-002081,AUROBINDO,"Torrico T, Kiai N, Meza C, Salam MT, Abdijadid S.. Suspected Aripiprazole-induced neutropenia in a geriatric patient: a case report. BMC Geriatrics. 2020;20(1):1-5",68.0,YR,,M,Y,,,20231228,,HP,US,US,2023,Q4,Elderly
233452961,23345296,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Drug ineffective,,2023,Q4,1,I,,20231216.0,20231228,20231228,EXP,,US-AUROBINDO-AUR-APL-2021-002081,AUROBINDO,"Torrico T, Kiai N, Meza C, Salam MT, Abdijadid S.. Suspected Aripiprazole-induced neutropenia in a geriatric patient: a case report. BMC Geriatrics. 2020;20(1):1-5",68.0,YR,,M,Y,,,20231228,,HP,US,US,2023,Q4,Elderly
233452961,23345296,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2023,Q4,Hypotension,,2023,Q4,1,I,,20231216.0,20231228,20231228,EXP,,US-AUROBINDO-AUR-APL-2021-002081,AUROBINDO,"Torrico T, Kiai N, Meza C, Salam MT, Abdijadid S.. Suspected Aripiprazole-induced neutropenia in a geriatric patient: a case report. BMC Geriatrics. 2020;20(1):1-5",68.0,YR,,M,Y,,,20231228,,HP,US,US,2023,Q4,Elderly
233458241,23345824,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Dyspnoea,,2023,Q4,1,I,20231201.0,20231215.0,20231228,20231228,EXP,,US-Eisai-EC-2023-155905,EISAI,,69.0,YR,E,F,Y,103.0,KG,20231228,,CN,US,US,2023,Q4,Elderly
233458241,23345824,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Pleural effusion,,2023,Q4,1,I,20231201.0,20231215.0,20231228,20231228,EXP,,US-Eisai-EC-2023-155905,EISAI,,69.0,YR,E,F,Y,103.0,KG,20231228,,CN,US,US,2023,Q4,Elderly
233458241,23345824,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Death,,2023,Q4,1,I,20231201.0,20231215.0,20231228,20231228,EXP,,US-Eisai-EC-2023-155905,EISAI,,69.0,YR,E,F,Y,103.0,KG,20231228,,CN,US,US,2023,Q4,Elderly
233459252,23345925,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D539184H,,21017.0,,,Injection,,2023,Q4,Wrong product administered,,2023,Q4,2,F,20231223.0,20231227.0,20231228,20231229,PER,,US-ELI_LILLY_AND_COMPANY-US202312015020,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20231229,,CN,US,US,2023,Q4,Elderly
233459252,23345925,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D560771E,,,,,Injection,,2023,Q4,Wrong product administered,,2023,Q4,2,F,20231223.0,20231227.0,20231228,20231229,PER,,US-ELI_LILLY_AND_COMPANY-US202312015020,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20231229,,CN,US,US,2023,Q4,Elderly
233471151,23347115,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose and frequency unknown,,,,,,,,,,,,2023,Q4,Death,,2023,Q4,1,I,20211009.0,20231225.0,20231228,20231228,PER,,PL-Eisai-EC-2023-155900,EISAI,,75.0,YR,E,M,Y,66.0,KG,20231228,,MD,PL,PL,2023,Q4,Elderly
233490561,23349056,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,600IU,,,U,,,,,,,,,2023,Q4,Suicide attempt,,2023,Q4,1,I,,20231218.0,20231229,20231229,EXP,,JP-NOVOPROD-1156352,NOVO NORDISK,Hirota Y. A case which required long-term administration of high concentration of glucose solution due to overdose of insulin preparation and presented hepatic function disorder. The 51st Annual Meeting of the Japanese Association for Acute Medicine. 2023;1-233,68.0,YR,,F,Y,,,20231229,,HP,JP,JP,2023,Q4,Elderly
233490561,23349056,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,600IU,,,U,,,,,,,,,2023,Q4,Hypoglycaemia,,2023,Q4,1,I,,20231218.0,20231229,20231229,EXP,,JP-NOVOPROD-1156352,NOVO NORDISK,Hirota Y. A case which required long-term administration of high concentration of glucose solution due to overdose of insulin preparation and presented hepatic function disorder. The 51st Annual Meeting of the Japanese Association for Acute Medicine. 2023;1-233,68.0,YR,,F,Y,,,20231229,,HP,JP,JP,2023,Q4,Elderly
233490561,23349056,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,600IU,,,U,,,,,,,,,2023,Q4,Intentional overdose,,2023,Q4,1,I,,20231218.0,20231229,20231229,EXP,,JP-NOVOPROD-1156352,NOVO NORDISK,Hirota Y. A case which required long-term administration of high concentration of glucose solution due to overdose of insulin preparation and presented hepatic function disorder. The 51st Annual Meeting of the Japanese Association for Acute Medicine. 2023;1-233,68.0,YR,,F,Y,,,20231229,,HP,JP,JP,2023,Q4,Elderly
233490561,23349056,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,600IU,,,U,,,,,,,,,2023,Q4,Transaminases increased,,2023,Q4,1,I,,20231218.0,20231229,20231229,EXP,,JP-NOVOPROD-1156352,NOVO NORDISK,Hirota Y. A case which required long-term administration of high concentration of glucose solution due to overdose of insulin preparation and presented hepatic function disorder. The 51st Annual Meeting of the Japanese Association for Acute Medicine. 2023;1-233,68.0,YR,,F,Y,,,20231229,,HP,JP,JP,2023,Q4,Elderly
233497121,23349712,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,22.0 IU (International Unit);Two times a day,,,U,,,,,,,,,2023,Q4,Ocular hyperaemia,,2023,Q4,1,I,,20231221.0,20231229,20231229,EXP,,CA-AstraZeneca-2023A292688,ASTRAZENECA,,75.0,YR,,F,Y,92.0,KG,20231229,,MD,CA,,2023,Q4,Elderly
233497121,23349712,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,22.0 IU (International Unit);Two times a day,,,U,,,,,,,,,2023,Q4,Ocular hyperaemia,,2023,Q4,1,I,,20231221.0,20231229,20231229,EXP,,CA-AstraZeneca-2023A292688,ASTRAZENECA,,75.0,YR,,F,Y,92.0,KG,20231229,,MD,CA,,2023,Q4,Elderly
233497121,23349712,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2023,Q4,Ocular hyperaemia,,2023,Q4,1,I,,20231221.0,20231229,20231229,EXP,,CA-AstraZeneca-2023A292688,ASTRAZENECA,,75.0,YR,,F,Y,92.0,KG,20231229,,MD,CA,,2023,Q4,Elderly
233497121,23349712,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2023,Q4,Ocular hyperaemia,,2023,Q4,1,I,,20231221.0,20231229,20231229,EXP,,CA-AstraZeneca-2023A292688,ASTRAZENECA,,75.0,YR,,F,Y,92.0,KG,20231229,,MD,CA,,2023,Q4,Elderly
233530881,23353088,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Electrocardiogram QT prolonged,,2023,Q4,1,I,,20231127.0,20231230,20231230,EXP,,CH-TEVA-VS-3135352,TEVA,"Lazic M, Brack T, Henzi A. What is your diagnosis? Tremor in the polimedic patient Internet-Doc 2023;104(24):56-58.",72.0,YR,,,Y,,,20231230,,HP,CH,CH,2023,Q4,Elderly
233530881,23353088,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Calcium deficiency,,2023,Q4,1,I,,20231127.0,20231230,20231230,EXP,,CH-TEVA-VS-3135352,TEVA,"Lazic M, Brack T, Henzi A. What is your diagnosis? Tremor in the polimedic patient Internet-Doc 2023;104(24):56-58.",72.0,YR,,,Y,,,20231230,,HP,CH,CH,2023,Q4,Elderly
233530881,23353088,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Hypokalaemia,,2023,Q4,1,I,,20231127.0,20231230,20231230,EXP,,CH-TEVA-VS-3135352,TEVA,"Lazic M, Brack T, Henzi A. What is your diagnosis? Tremor in the polimedic patient Internet-Doc 2023;104(24):56-58.",72.0,YR,,,Y,,,20231230,,HP,CH,CH,2023,Q4,Elderly
233530881,23353088,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2023,Q4,Hypomagnesaemia,,2023,Q4,1,I,,20231127.0,20231230,20231230,EXP,,CH-TEVA-VS-3135352,TEVA,"Lazic M, Brack T, Henzi A. What is your diagnosis? Tremor in the polimedic patient Internet-Doc 2023;104(24):56-58.",72.0,YR,,,Y,,,20231230,,HP,CH,CH,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Acute kidney injury,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Gait inability,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Pyrexia,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Mental status changes,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Blood glucose increased,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Lethargy,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Influenza,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Hyporesponsive to stimuli,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
233572411,23357241,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2023,Q4,Electrocardiogram QT prolonged,,2023,Q4,1,I,20231225.0,20231230.0,20231230,20231230,DIR,686160,,FDA-CTU,,73.0,YR,,M,N,,,20231230,N,CN,US,,2023,Q4,Elderly
